PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dimitrova, N; Chen, YCM; Spector, DL; de Lange, T				Dimitrova, Nadya; Chen, Yi-Chun M.; Spector, David L.; de Lange, Titia			53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility	NATURE			English	Article							DNA-DAMAGE; PROTEIN 53BP1; MDC1; TRF2; ATM; BINDING; PROTECTION; DYNAMICS; MEDIATOR; LENGTH	Double- strand breaks activate the ataxia telangiectasia mutated ( ATM) kinase, which promotes the accumulation of DNA damage factors in the chromatin surrounding the break. The functional significance of the resulting DNA damage foci is poorly understood. Here we show that 53BP1 ( also known as TRP53BP1), a component of DNA damage foci, changes the dynamic behaviour of chromatin to promote DNA repair. We used conditional deletion of the shelterin component TRF2 ( also known as TERF2) from mouse cells ( TRF2(fl/-)) to deprotect telomeres, which, like doublestrand breaks, activate the ATM kinase, accumulate 53BP1 and are processed by non- homologous end joining (NHEJ)(1,2). Deletion of TRF2 from 53BP1- deficient cells established that NHEJ of dysfunctional telomeres is strongly dependent on the binding of 53BP1 to damaged chromosome ends. To address the mechanism by which 53BP1 promotes NHEJ, we used time- lapse microscopy to measure telomere dynamics before and after their deprotection. Imaging showed that deprotected telomeres are more mobile and sample larger territories within the nucleus. This change in chromatin dynamics was dependent on 53BP1 and ATM but did not require a functional NHEJ pathway. We propose that the binding of 53BP1 near DNA breaks changes the dynamic behaviour of the local chromatin, thereby facilitating NHEJ repair reactions that involve distant sites, including joining of dysfunctional telomeres and AID ( also known as AICDA)- induced breaks in immunoglobulin class- switch recombination.	[Dimitrova, Nadya; de Lange, Titia] Rockefeller Univ, New York, NY 10065 USA; [Chen, Yi-Chun M.; Spector, David L.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Rockefeller University; Cold Spring Harbor Laboratory	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [GM049046]; NIH Director's Pioneer Award [OD000379, EY18244, GM42694]; HHMI pre-doctoral fellowship; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R01GM042694, R37GM049046] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI pre-doctoral fellowship(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to J. Chen for his gift of 53BP1- and MDC1-deficient mice. We thank D. White for expert mouse husbandry. We thank the Bio- Imaging Facilities at Cold Spring Harbor Laboratory and at The Rockefeller University. J. Petrini is thanked for his gift of NBS1 antibody, A. Sfeir for providing the TRF1 antibody and A. Konishi for the BP1- 2 construct. M. Dimitrov is thanked for mathematical advice on data analysis, and S. Jaramillo and Y. Fu for Matlab programming. Members of the de Lange laboratory are thanked for comments on the manuscript. This work was supported by a grant from the NIH (GM049046) and by the NIH Director's Pioneer Award (OD000379) to T. d. L., and grants from the NIH to D. L. S. (EY18244 and GM42694). N. D. was supported by an HHMI pre-doctoral fellowship.	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	31	421	428	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					524	U51		10.1038/nature07433	http://dx.doi.org/10.1038/nature07433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931659	Green Accepted			2022-12-24	WOS:000261170500043
J	Ennis, S; Jomary, C; Mullins, R; Cree, A; Chen, XL; MacLeod, A; Jones, S; Collins, A; Stone, E; Lotery, A				Ennis, Sarah; Jomary, Catherine; Mullins, Robert; Cree, Angela; Chen, Xaoli; MacLeod, Alex; Jones, Stephen; Collins, Andrew; Stone, Edwin; Lotery, Andrew			Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study	LANCET			English	Article							COMPLEMENT FACTOR-H; RANIBIZUMAB; RISK; POLYMORPHISM; METAANALYSIS; BEVACIZUMAB; MECHANISMS; INHIBITOR; COMPONENT; DISEASE	Background Age-related macular degeneration is the most prevalent form of visual impairment and blindness in developed countries. Genetic studies have made advancements in establishing the molecular cause of this disease, identifying mutations in the complement factor H (CFH) gene and a locus on chromosome 10 encompassing the HTRA1/LOC387715/ARMS2 genes. Variants in complement 3 (C3) and an HLA locus containing both factor B and C2 genes have also been implicated. We aimed to identify further genetic risk factors for this disease. Methods We used a case-control study design in a UK sample of patients with age-related macular degeneration (n=479) and controls (n=479) and undertook a low-density screen of 32 genes using 93 single nucleotide polymorphisms (SNPs). Genes were selected as candidates on the basis of potential functional relevance to age-related macular degeneration. Significant initial findings were confirmed by replication in an independent US cohort of 248 unrelated patients with disease and 252 controls, and by high-density genotyping around association signals. Findings The SNP variant rs2511989, located within intron six of the SERPING1 gene, showed highly significant genotypic association with age-related macular degeneration (uncorrected p=4.0x10(-5), corrected p=0.00372). We detected no evidence for association between disease and the other 31 candidate genes. The odds ratio for age-related macular degeneration in rs251.1989 G/A heterozygotes compared with wild type G/G homozygotes was 0 . 63 (95% CI 0 . 47-0 . 84). A similar comparison of the A/A homozygotes with the wild type yielded an odds ratio of 0 . 44 (0.31-0 . 64). We replicated the observed genotypic association in a US cohort (p=0.008). Furthermore, a secondary high-density genotyping study across the SERPING1 gene region identified five additional S N P variants similarly associated with age-related macular degeneration (rs2244169, rs2511990, rs2509897, rs1005510, and rs2511988). Interpretation Genetic variation in SERPING1 significantly alters susceptibility to age-related macular degeneration. SERPING1 encodes the C1 inhibitor, which has a crucial role in inhibition of complement component 1 (C1) and might implicate the classic pathway of complement activation in this disease. Funding Macula Vision Research Foundation, the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, the American Health Assistance Foundation, National institutes of Health, the Howard Hughes Medical Institute.	[Jomary, Catherine; Cree, Angela; Chen, Xaoli; Lotery, Andrew] Southampton Gen Hosp, Clin Neurosci Div, Southampton SO16 6YD, Hants, England; [MacLeod, Alex; Lotery, Andrew] Southampton Gen Hosp, Southampton Eye Unit, Southampton SO16 6YD, Hants, England; [Ennis, Sarah; Collins, Andrew] Southampton Gen Hosp, Div Human Genet, Genet Epidemiol & Bioinformat Grp, Southampton SO16 6YD, Hants, England; [Mullins, Robert; Stone, Edwin] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Jones, Stephen] Kings Coll London, Rayne Inst, St Thomas Hosp, London WC2R 2LS, England; [Stone, Edwin] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Southampton; University of Southampton; University of Southampton; University of Iowa; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Howard Hughes Medical Institute	Lotery, A (corresponding author), Southampton Gen Hosp, Clin Neurosci Div, Mailpoint 806, Southampton SO16 6YD, Hants, England.	a.j.lotery@southampton.ac.uk	Jomary, Catherine/A-2854-2011; Collins, Andrew/A-6595-2010; Collins, Andrew/S-2196-2019; Mullins, Robert F/I-6717-2013	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; Lotery, Andrew/0000-0001-5541-4305; Mullins, Robert/0000-0002-5006-0891; Stone, Edwin M./0000-0003-3343-4414; Cree, Angela/0000-0002-1987-8900	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust; Brian Mercer Trust; American Health Assistance Foundation; N I H [EY-017451, EY-016822]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY017451, R01EY016822] Funding Source: NIH RePORTER	Macula Vision Research Foundation (MVRF); Macular Disease Society; Wellcome Trust(Wellcome TrustEuropean Commission); Brian Mercer Trust; American Health Assistance Foundation; N I H(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	For the UK studies. this research was supported by the Macula Vision Research Foundation (MVRF), the Macular Disease Society, the Wellcome Trust, Brian Mercer Trust, and the American Health Assistance Foundation. Aspects of the US-based study were Funded by the MVRF (RM), N I H grants EY-017451 (RM) and EY-016822 (B). and the Howard Hughes Medical Institute (ES). We thank Helen Griffiths, Elizabeth Faidley. Benjamin Roos, and Jessica Skeie for providing laboratory assistance; The Southampton WTCRF muses for help with sample collection; Lee Murphy and Angie Fawkes at the Edinburgh WTCRF: Jane Collier at KBioscience: and all study participants for agreeing to contribute to this research.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Bonastre J, 2002, Eur J Health Econ, V3, P94, DOI 10.1007/s10198-002-0104-y; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lotery A, 2007, BRIT J OPHTHALMOL, V91, P1303, DOI 10.1136/bjo.2007.116939; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mullins RF, 2006, MOL VIS, V12, P224; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Raftery JP, 2007, BRIT MED J, V334, P381, DOI 10.1136/bmj.39128.708565.3A; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Steemers FJ, 2005, PHARMACOGENOMICS, V6, P777, DOI 10.2217/14622416.6.7.777; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	30	129	132	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1828	1834		10.1016/S0140-6736(08)61348-3	http://dx.doi.org/10.1016/S0140-6736(08)61348-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18842294	Green Accepted			2022-12-24	WOS:000261112000025
J	Athale, CA; Dinarina, A; Mora-Coral, M; Pugieux, C; Nedelec, F; Karsenti, E				Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric			Regulation of Microtubule Dynamics by Reaction Cascades Around Chromosomes	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; MITOTIC-SPINDLE; GRADIENT; EFFICIENT; CHROMATIN; SYSTEMS; GTPASES; CELLS	During spindle assembly, chromosomes generate gradients of microtubule stabilization through a reaction- diffusion process, but how this is achieved is not well understood. We measured the spatial distribution of microtubule aster asymmetry around chromosomes by incubating centrosomes and micropatterned chromatin patches in frog egg extracts. We then screened for microtubule stabilization gradient shapes that would generate such spatial distributions with the use of computer simulations. Only a long- range, sharply decaying microtubule stabilization gradient could generate aster asymmetries fitting the experimental data. We propose a reaction- diffusion model that combines the chromosome generated Ran- guanosine triphosphate- Importin reaction network to a secondary phosphorylation network as a potential mechanism for the generation of such gradients.	[Athale, Chaitanya A.; Dinarina, Ana; Mora-Coral, Maria; Pugieux, Celine; Nedelec, Francois; Karsenti, Eric] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, Heidelberg, Germany.	karsenti@embl.de	Nedelec, Francois J/H-3317-2011; Athale, Chaitanya/G-8883-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Athale, Chaitanya/0000-0002-9506-2153; Nedelec, Francois/0000-0002-8141-5288	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education; European Union Specific Targeted Research Project BioMics; Human Frontier Science Program [RGY85]	Modeling and Simulation the Bioscience (BIOMS); Spanish ministry of education(Spanish Government); European Union Specific Targeted Research Project BioMics(European Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Foethke for inputs about the Cytosim code, M. Caudron and R. Carazo-Salas for sharing data, M. Loose for help in the initial set up of chromatin bead patterns, and the EMBL Advanced Light Microscopy Facility for invaluable help with microscopy. We acknowledge the center for Modeling and Simulation the Bioscience (BIOMS) for funding F.N. and C.A.A., the Spanish ministry of education for funding M.M.-C., European Union Specific Targeted Research Project BioMics for funding A.D., and support from Human Frontier Science Program grant RGY85.	Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Van Albada SB, 2007, PLOS COMPUT BIOL, V3, P1925, DOI 10.1371/journal.pcbi.0030195; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yokoyama H, 2008, J CELL BIOL, V180, P867, DOI 10.1083/jcb.200706189	25	62	62	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1243	1247		10.1126/science.1161820	http://dx.doi.org/10.1126/science.1161820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948504				2022-12-24	WOS:000261033400041
J	Gavathiotis, E; Suzuki, M; Davis, ML; Pitter, K; Bird, GH; Katz, SG; Tu, HC; Kim, H; Cheng, EHY; Tjandra, N; Walensky, LD				Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.; Tjandra, Nico; Walensky, Loren D.			BAX activation is initiated at a novel interaction site	NATURE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; STABILIZED ALPHA-HELICES; BCL-X-L; BH3-ONLY PROTEINS; CELL-DEATH; INTRACELLULAR-LOCALIZATION; PROAPOPTOTIC ACTIVITY; BH3 DOMAINS; APOPTOSIS; FAMILY	BAX is a pro- apoptotic protein of the BCL- 2 family that is stationed in the cytosol until activated by a diversity of stress stimuli to induce cell death. Anti- apoptotic proteins such as BCL- 2 counteract BAX- mediated cell death. Although an interaction site that confers survival functionality has been defined for anti- apoptotic proteins, an activation site has not been identified for BAX, rendering its explicit trigger mechanism unknown. We previously developed stabilized alpha- helix of BCL- 2 domains ( SAHBs) that directly initiate BAX- mediated mitochondrial apoptosis. Here we demonstrate by NMR analysis that BIM SAHB binds BAX at an interaction site that is distinct from the canonical binding groove characterized for anti- apoptotic proteins. The specificity of the human BIM- SAHB - BAX interaction is highlighted by point mutagenesis that disrupts functional activity, confirming that BAX activation is initiated at this novel structural location. Thus, we have now defined a BAX interaction site for direct activation, establishing a new target for therapeutic modulation of apoptosis.	[Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Tu, Ho-Chou; Kim, Hyungjin; Cheng, Emily H. -Y.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Suzuki, Motoshi; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Walensky, Loren D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Gavathiotis, Evripidis; Davis, Marguerite L.; Pitter, Kenneth; Bird, Gregory H.; Katz, Samuel G.; Walensky, Loren D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov; loren_walensky@dfci.harvard.edu		Pitter, Kenneth/0000-0002-9450-313X; Suzuki, Motoshi/0000-0002-4346-7677; Gavathiotis, Evripidis/0000-0001-6319-8331	National Cancer Institute [5P01CA92625, 5RO1CA50239, 5RO1CA125562]; Burroughs Wellcome Fund Career Award; Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute; Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Culpeper Scholarship in Medical Science; American Society of Hematology Junior Faculty Scholar Award; William Lawrence Children's Foundation; Intramural Research Program of the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Searle Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E. Smith for editorial and graphics assistance, W. Beavers for amino acid analyses, A. Perry for technical assistance, C. Turner and A. Bielecki of the MIT/Harvard Center for Magnetic Resonance for NMR technical advice, and R. Youle for feedback on the manuscript. We acknowledge the indelible contributions of the late S.J. Korsmeyer, who inspired this work. L.D.W. is supported by National Cancer Institute (NCI) grant 5P01CA92625, a Burroughs Wellcome Fund Career Award in the Biomedical Sciences, a Culpeper Scholarship in Medical Science from the Goldman Philanthropic Partnerships, an American Society of Hematology Junior Faculty Scholar Award, and a grant from the William Lawrence Children's Foundation. This research was also supported by NCI grant 5RO1CA50239. N.T. is supported by the Intramural Research Program of the National Heart, Lung and Blood Institute, NIH. E.H.-Y.C. is supported by the Searle Scholars Program and NCI grant 5RO1CA125562.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P619; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Pitter K, 2008, METHOD ENZYMOL, V446, P387, DOI 10.1016/S0076-6879(08)01623-6; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	50	534	574	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1076	U6		10.1038/nature07396	http://dx.doi.org/10.1038/nature07396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948948	Green Accepted			2022-12-24	WOS:000260252600037
J	Hamilton, EE; Kay, SA				Hamilton, Elizabeth E.; Kay, Steve A.			SnapShot: Circadian Clock Proteins	CELL			English	Editorial Material									[Hamilton, Elizabeth E.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hamilton, EE (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878				Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Hardin PE, 2006, CURR OPIN NEUROBIOL, V16, P686, DOI 10.1016/j.conb.2006.09.001; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030	10	20	21	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					368	U16	368.e1	10.1016/j.cell.2008.09.042	http://dx.doi.org/10.1016/j.cell.2008.09.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957209	Bronze			2022-12-24	WOS:000260130400027
J	Sugarman, J; Siegel, AW				Sugarman, Jeremy; Siegel, Andrew W.			When embryonic stem cell lines fail to meet consent standards	SCIENCE			English	Editorial Material									[Sugarman, Jeremy; Siegel, Andrew W.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	Johns Hopkins University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.	jsugarm1@jhmi.edu		Sugarman, Jeremy/0000-0001-7022-8332				BAKER M, 2008, N NEWS          0728; *COMM GUID EMBR ST, 2005, GUID HUMAN EMBR STEM; *HUM EMBR STEM CEL, 2007, AM NAT AC GUID HUM E; *ISSCR, 2006, GUID COND HUM EMBR S; KELLER J, 2008, CHRON HIGHER ED 0728; Lyerly AD, 2007, SCIENCE, V317, P46, DOI 10.1126/science.1145067; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; National Institute of Health, 1994, REP HUM EMBR RES PAN; *NIH, 2000, FED REGISTER, V65, P51976; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; WEISS R, 2008, ETHICALLY CHALLENGED	12	11	11	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					379	379		10.1126/science.1164441	http://dx.doi.org/10.1126/science.1164441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927375				2022-12-24	WOS:000260094500025
J	Donovan, CA				Donovan, Cory A.			Babies having babies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												coryadonovan@gmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1739	1740		10.1001/jama.300.15.1739	http://dx.doi.org/10.1001/jama.300.15.1739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854523				2022-12-24	WOS:000260002000001
J	Holman, CM				Holman, Christopher M.			Trends in human gene patent litigation	SCIENCE			English	Editorial Material									[Holman, Christopher M.] Univ Missouri, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Holman, CM (corresponding author), Univ Missouri, Kansas City, MO 64110 USA.	holmancm@umkc.edu						Barton JH, 2006, NAT BIOTECHNOL, V24, P939, DOI 10.1038/nbt0806-939; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Crichton M, 2007, NY TIMES, pA23; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; HOLMAN CM, 2007, UMKC L REV, V76, P295; Hopkins MM, 2007, NAT BIOTECHNOL, V25, P185, DOI 10.1038/nbt0207-185; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Lemley MA, 2005, J ECON PERSPECT, V19, P75, DOI 10.1257/0895330054048650; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Williams-Jones Bryn, 2002, Health Law J, V10, P123	12	25	25	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					198	199		10.1126/science.1160687	http://dx.doi.org/10.1126/science.1160687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	358FK	18845733				2022-12-24	WOS:000259902300024
J	Hou, XG; Siveter, DJ; Aldridge, RJ; Siveter, DJ				Hou, Xian-Guang; Siveter, Derek J.; Aldridge, Richard J.; Siveter, David J.			Collective behavior in an early Cambrian arthropod	SCIENCE			English	Article									[Hou, Xian-Guang] Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China; [Siveter, Derek J.] Univ Oxford, Univ Museum, Oxford, England; [Siveter, Derek J.] Univ Oxford, Dept Earth Sci, Oxford, England; [Aldridge, Richard J.; Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	Yunnan University; University of Oxford; University of Oxford; University of Leicester	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Paleobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn			National Natural Foundation [40730211]; 973 Program of China [2006CB806400]; Science and Technology Department of Yunnan [2005D0002Z]; Royal Society	National Natural Foundation(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Science and Technology Department of Yunnan; Royal Society(Royal Society of London)	Thanks to National Natural Foundation (40730211) and 973 Program of China (2006CB806400); Science and Technology Department of Yunnan (2005D0002Z); the Royal Society; and G. Boxshall, S. de Grave, G. McGavin, and A. Parker for discussion.	BONE Q, 1998, BIOL PELAGIC TUNICAT, P5; CHATTERTON BDE, 2008, ADV TRILOBITE RES CU, V9, P73; HERRNKIN.W, 1969, SCIENCE, V164, P1425, DOI 10.1126/science.164.3886.1425; Holldobler B., 1990, pi; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733	6	25	31	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					224	224		10.1126/science.1162794	http://dx.doi.org/10.1126/science.1162794			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845748				2022-12-24	WOS:000259902300038
J	Sander, PM; Clauss, M				Sander, P. Martin; Clauss, Marcus			Sauropod gigantism	SCIENCE			English	Editorial Material							GROWTH-RATES; EVOLUTION; PHYSIOLOGY; HISTOLOGY; DINOSAURS		[Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland	University of Bonn; University of Zurich	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de; mclauss@vetclinics.uzh.ch	Clauss, Marcus/A-4710-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Christian Andreas, 2007, Fossil Record, V10, P38; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow J.O., 1990, P43; Gaudin Timothy J., 2006, P1; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Hummel J, 2008, EVOL ECOL RES, V10, P925; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; PERRY SF, J EXP ZOOL A; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763	24	79	79	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					200	201		10.1126/science.1160904	http://dx.doi.org/10.1126/science.1160904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845734				2022-12-24	WOS:000259902300025
J	Curran, DP				Curran, Dennis P.			Chemistry - Fluorous tags unstick messy chemical biology problems	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY; MICROARRAYS		[Curran, Dennis P.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Curran, DP (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA.	curran@pitt.edu						Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Jaipuri FA, 2008, ANGEW CHEM INT EDIT, V47, P1707, DOI 10.1002/anie.200704262; Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k; KOBOS RK, 1989, TRENDS BIOTECHNOL, V7, P101, DOI 10.1016/0167-7799(89)90008-5; Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105; Vegas AJ, 2007, ANGEW CHEM INT EDIT, V46, P7960, DOI 10.1002/anie.200703198; Zhang W, 2006, TETRAHEDRON, V62, P11837, DOI 10.1016/j.tet.2006.08.051	7	51	52	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1645	1646		10.1126/science.1158721	http://dx.doi.org/10.1126/science.1158721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801990				2022-12-24	WOS:000259300400024
J	Loaiza, E; Wardlaw, T; Salama, P				Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter			Child mortality 30 years after the Alma-Ata Declaration	LANCET			English	Editorial Material							SURVIVAL; NEWBORN		[Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter] UNICEF, New York, NY 10017 USA	UNICEF	Loaiza, E (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY 10017 USA.	eloaiza@unicef.org						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bustreo F, 2008, LANCET, V371, P1221, DOI 10.1016/S0140-6736(08)60535-8; UNICEF, 2007, 6 UNICEF; *UNICEF, 2008, MON SIT CHILDR WOM; *UNICEF UNAIDS WHO, 2008, UN ACC SCAL HIV SERV; *UNICEF WHO WORLD, 2007, LEV TRENDS CHILD MOR; 2008, COUNTDOWN 2015 TRACK	7	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					874	876		10.1016/S0140-6736(08)61378-1	http://dx.doi.org/10.1016/S0140-6736(08)61378-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790298				2022-12-24	WOS:000259266900010
J	Englund, M; Guermazi, A; Gale, D; Hunter, DJ; Aliabadi, P; Clancy, M; Felson, DT				Englund, Martin; Guermazi, Ali; Gale, Daniel; Hunter, David J.; Aliabadi, Piran; Clancy, Margaret; Felson, David T.			Incidental meniscal findings on knee MRI in middle-aged and elderly persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIXED-FLEXION RADIOGRAPHY; JOINT SPACE WIDTH; IMAGING FINDINGS; CARTILAGE LOSS; LOAD-BEARING; RISK-FACTORS; FOLLOW-UP; OSTEOARTHRITIS; PREVALENCE; ABNORMALITIES	Background: Magnetic resonance imaging (MRI) of the knee is often performed in patients who have knee symptoms of unclear cause. When meniscal tears are found, it is commonly assumed that the symptoms are attributable to them. However, there is a paucity of data regarding the prevalence of meniscal damage in the general population and the association of meniscal tears with knee symptoms and with radiographic evidence of osteoarthritis. Methods: We studied persons from Framingham, Massachusetts, who were drawn from census-tract data and random-digit telephone dialing. Subjects were 50 to 90 years of age and ambulatory; selection was not made on the basis of knee or other joint problems. We assessed the integrity of the menisci in the right knee on 1.5-tesla MRI scans obtained from 991 subjects (57% of whom were women). Symptoms involving the right knee were evaluated by questionnaire. Results: The prevalence of a meniscal tear or of meniscal destruction in the right knee as detected on MRI ranged from 19% (95% confidence interval [CI], 15 to 24) among women 50 to 59 years of age to 56% (95% CI, 46 to 66) among men 70 to 90 years of age; prevalences were not materially lower when subjects who had had previous knee surgery were excluded. Among persons with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 2 or higher, on a scale of 0 to 4, with higher numbers indicating more definite signs of osteoarthritis), the prevalence of a meniscal tear was 63% among those with knee pain, aching, or stiffness on most days and 60% among those without these symptoms. The corresponding prevalences among persons without radiographic evidence of osteoarthritis were 32% and 23%. Sixty-one percent of the subjects who had meniscal tears in their knees had not had any pain, aching, or stiffness during the previous month. Conclusions: Incidental meniscal findings on MRI of the knee are common in the general population and increase with increasing age.	[Englund, Martin; Hunter, David J.; Clancy, Margaret; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Guermazi, Ali] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Gale, Daniel] Vet Affairs Med Ctr, Dept Radiol, Boston, MA USA; [Aliabadi, Piran] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Englund, Martin] Lund Univ, Dept Orthoped, Lund, Sweden	Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Lund University	Englund, M (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Suite X200, Boston, MA 02118 USA.	englund@bu.edu	Hunter, David J/A-4622-2010; Englund, Martin/J-7245-2012	Hunter, David J/0000-0003-3197-752X; Englund, Martin/0000-0003-3320-2437; Felson, David/0000-0002-2668-2447	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60 AR047785-01S1, P60 AR047785-07, P60 AR047785, AR47785] Funding Source: Medline; NIA NIH HHS [R01 AG018393-05, AG18393, R01 AG018393] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ball J, 1963, ATLAS STANDARD RADIO, V2; Beattie KA, 2005, OSTEOARTHR CARTILAGE, V13, P181, DOI 10.1016/j.joca.2004.11.001; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Boks SS, 2006, AM J SPORT MED, V34, P1984, DOI 10.1177/0363546506290189; De Smet AA, 2006, AM J ROENTGENOL, V187, P911, DOI 10.2214/AJR.05.1354; Ding CH, 2007, J RHEUMATOL, V34, P776; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; FAIRBANK HAT, 1948, J BONE JOINT SURG BR, V30, P164, DOI 10.1302/0301-620X.30B1.164; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Fox MG, 2007, RADIOL CLIN N AM, V45, P1033, DOI 10.1016/j.rcl.2007.08.009; HALL MJ, 1998, ADV DATA VITAL HLTH, V300; Hayes CW, 2005, RADIOLOGY, V237, P998, DOI 10.1148/radiol.2373041989; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; HOWELL JR, 2000, COCHRANE DB SYST REV, V2; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P795, DOI 10.1002/art.21724; Jee WH, 2003, AM J ROENTGENOL, V180, P93, DOI 10.2214/ajr.180.1.1800093; Jordan JM, 2007, J RHEUMATOL, V34, P172; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Kornaat PR, 2006, RADIOLOGY, V239, P811, DOI 10.1148/radiol.2393050253; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Link TM, 2003, RADIOLOGY, V226, P373, DOI 10.1148/radiol.2262012190; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nevitt MC, 2007, ARTHRITIS RHEUM-US, V56, P1512, DOI 10.1002/art.22557; NOBLE J, 1975, J BONE JOINT SURG BR, V57, P180, DOI 10.1302/0301-620X.57B2.180; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; POEHLING GG, 1990, CLIN SPORT MED, V9, P539; SHRIVE NG, 1978, CLIN ORTHOP RELAT R, P279; SMILLIE IS, 1962, INJURIES KNEE JOINT, P51; Vande Berg BC, 2001, AM J ROENTGENOL, V176, P771, DOI 10.2214/ajr.176.3.1760771; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Zanetti M, 2003, AM J ROENTGENOL, V181, P635, DOI 10.2214/ajr.181.3.1810635	40	587	596	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1108	1115		10.1056/NEJMoa0800777	http://dx.doi.org/10.1056/NEJMoa0800777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784100	Green Accepted			2022-12-24	WOS:000259078200006
J	Arntzen, CJ				Arntzen, Charles J.			Plant science - Using tobacco to treat cancer	SCIENCE			English	Editorial Material							NON-HODGKINS-LYMPHOMA; TRANSGENIC PLANTS		Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Arizona State Univ, Arizona Biodesign Inst, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Arntzen, CJ (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	charles.arntzen@asu.edu						CARROLL WL, 1986, J EXP MED, V164, P1566, DOI 10.1084/jem.164.5.1566; CHASE M, 2008, WALL STREET J   0223, pA3; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; McCormick AA, 2008, P NATL ACAD SCI USA, V105, P10131, DOI 10.1073/pnas.0803636105; Ries L., 2005, SEER CANC STAT REV 1; Ruffini PA, 2005, CURR GENE THER, V5, P511, DOI 10.2174/156652305774329221; Travis J, 2008, SCIENCE, V320, P473, DOI 10.1126/science.320.5875.473; TUSE D, COMMUNICATION	9	20	22	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2008	321	5892					1052	1053		10.1126/science.1163420	http://dx.doi.org/10.1126/science.1163420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719274				2022-12-24	WOS:000258594900028
J	Lazar, MA				Lazar, Mitchell A.			Developmental biology - How now, brown fat?	SCIENCE			English	Editorial Material							ADIPOCYTES; OBESITY; WHITE		Univ Penn, Inst Diabet Obes & Metab, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Lazar, MA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Dept Med, 415 Curie Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019					CRISAN M, 2008, STEM CELLS; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001	13	36	52	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1048	1049		10.1126/science.1164094	http://dx.doi.org/10.1126/science.1164094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719271				2022-12-24	WOS:000258594900025
J	Leong, KG; Wang, BE; Johnson, L; Gao, WQ				Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang			Generation of a prostate from a single adult stem cell	NATURE			English	Article							PROXIMAL REGION; MOUSE PROSTATE; C-KIT; MURINE PROSTATE; MARKER; EXPRESSION; IDENTIFICATION; REGENERATION; CANCER; TISSUE	The existence of prostate stem cells ( PSCs) was first postulated from the observation that normal prostate regeneration can occur after repeated cycles of androgen deprivation and replacement in rodents(1). Given the critical role of PSCs in maintaining prostate tissue integrity and their potential involvement in prostate tumorigenesis(2), it is important to define specific markers for normal PSCs. Several cell- surface markers have been reported to identify candidate PSCs, including stem cell antigen-1 ( Sca-1, also known as Ly6a), CD133 (Prom1) and CD44 ( refs 3-10). However, many non- PSCs in the mouse prostate also express these markers and thus identification of a more defined PSC population remains elusive. Here we identify CD117 ( c- kit, stem cell factor receptor) as a new marker of a rare adult mouse PSC population, and demonstrate that a single stem cell defined by the phenotype Lin(-) Sca-1(+)CD133(+)CD44(+)CD117(+) can generate a prostate after transplantation in vivo. CD117 expression is predominantly localized to the region of the mouse prostate proximal to the urethra and is upregulated after castration- induced prostate involution - two characteristics consistent with that of a PSC marker. CD117(+) PSCs can generate functional, secretion- producing prostates when transplanted in vivo. Moreover, CD117(+) PSCs have long- term self-renewal capacity, as evidenced by serial isolation and transplantation in vivo. Our data establish that single cells in the adult mouse prostate with multipotent, self- renewal capacity are defined by a Lin(-)Sca-1(+) CD133(+) CD44(+) CD117(+) phenotype.	[Leong, Kevin G.; Wang, Bu-Er; Johnson, Leisa; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, WQ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	gao@gene.com	Thomson, Axel/A-7893-2013; Gao, Wei/GXH-0380-2022		Genentech Laboratory Animal Resources	Genentech Laboratory Animal Resources	We thank J. Cupp, L. Gilmour and W. Tombo for FACS support, X.-D. Wang, R. Soriano and Z. Modrusan for microarray services, I. Kasman, L. Komuves and J. Eastham- Anderson for microscopy assistance, B. D. Tarlow for assistance with laser- capture microdissection and PCR- based genotyping, Genentech Laboratory Animal Resources for support services, L. Blocher and J. Simko for human clinical prostate specimens, and F. J. de Sauvage for valuable discussion, input and supervision of the project.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bonkhoff H, 1996, PROSTATE, V28, P98; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; ISAACS JT, 1987, CONTROL CELL PROLIFE, V2, P85; Johnson MA, 2000, PROSTATE, V43, P255, DOI 10.1002/1097-0045(20000601)43:4<255::AID-PROS4>3.0.CO;2-M; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; LEV S, 1994, CRIT REV ONCOGENESIS, V5, P141, DOI 10.1615/CritRevOncog.v5.i2-3.30; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Moss KG, 2003, J PHARMACOL EXP THER, V307, P476, DOI 10.1124/jpet.103.052530; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Schmelz M, 2005, EUR J CELL BIOL, V84, P341, DOI 10.1016/j.ejcb.2004.12.019; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tsujimura A, 2007, J UROLOGY, V178, P686, DOI 10.1016/j.juro.2007.03.092; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100	30	319	340	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					804	808		10.1038/nature07427	http://dx.doi.org/10.1038/nature07427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18946470				2022-12-24	WOS:000261559900052
J	Beaglehole, R; Bonita, R				Beaglehole, Robert; Bonita, Ruth			Global public health: a scorecard	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASES 1; IMPROVING HEALTH; PREVENTION; MORTALITY; COSTS; EDUCATION; PRIORITY; TOBACCO; BURDEN	Global health is attracting an unprecedented level of interest. In this paper, we summarise recent trends and identify the unfinished and new agendas in global public health. We propose a global public health scorecard as a simple way to assess progress and suggest actions by public health practitioners and their organisations for improving the effectiveness of public health. Although we find many recent positive developments in global health, the potential for global cooperation and progress is still largely untapped. Compared with other components of development, health improvement should easily foster global cooperation; strong advocacy and political will are keys to continuing progress. We view global public health as a barometer of more general development. Our responses to the current health challenges are at the forefront of the global struggle for survival.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 2007, LANCET SERIES GLOBAL; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2004, LANCET, V363, P2084, DOI 10.1016/S0140-6736(04)16461-1; Beaglehole R, 1998, LANCET, V351, P590, DOI 10.1016/S0140-6736(97)09494-4; Beaglehole R, 2003, HUM RESOUR HEALTH, V1, P4, DOI DOI 10.1186/1478-4491-1-4; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BONITA R, 2007, GLOBALIZATION HLTH; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Chen LC, 2006, LANCET, V367, P1800, DOI 10.1016/S0140-6736(06)68783-7; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; CSDH, 2008, CLOS GAP GEN HLTH EQ; Donaldson L, 2007, LANCET, V369, P857, DOI 10.1016/S0140-6736(07)60327-4; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; *EXT EV TEAM PUBL, 2001, ENH PUBL HLTH DEV CO; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; *GOYAK FRAM ACT GL, 2008, REP G8 HLTH EXP GROU; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; HORTON R, GLOBAL PUBLIC HLTH; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; IJsselmuiden C, 2007, B WORLD HEALTH ORGAN, V85, P914, DOI 10.2471/BLT.07.045526; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 SCI; JAMSION DT, 2006, DIS CONTROL PRIORITI; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; MacDonald R, 2008, LANCET, V372, P99, DOI 10.1016/S0140-6736(08)61004-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; MATHERS CD, GLOBAL PUBL IN PRESS; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCurry J, 2008, LANCET, V372, P191, DOI 10.1016/S0140-6736(08)61054-5; MCKEE M, GLOBAL PUBL IN PRESS; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJI, PLOS MED, V3, pe260; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Sachs J., 2005, END POVERTY CAN WE M; Sadana R, 2007, B WORLD HEALTH ORGAN, V85, P902, DOI 10.2471/BLT.07.049247; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Silberschmidt G, 2008, LANCET, V371, P1483, DOI 10.1016/S0140-6736(08)60634-0; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, LANCET IN PRESS; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; *UN ENV PROGR, 2007, GLOB ENV OUTL 2007; *UNAIDS WHO, 2007, AIDS EP UPD DEC 2007; United Nations, MILL DEV GOALS REP; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; *WHO, HLTH MILL DEV GOALS; WHO, 2007, EV BUS STRENGTH HLTH; *WHO, 2008, UPD GLOB BURD DIS 20; Woodward D, 2008, LANCET, V372, P186, DOI 10.1016/S0140-6736(08)61051-X; World Health Organization, 2004, EST US DED TAX HLTH; *WORLD TRAD ORG, LAM WARNS PROT AM FI; 2008, LANCET, V372, P345; 2008, LANCET, V371, P2145; 2008, LANCET, V372, P178; [No title captured]; 2006, LANCET, V367, P1549; 2007, LANCET, V370, P801; 2008, LANCET, V372, P346	68	130	134	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1988	1996		10.1016/S0140-6736(08)61558-5	http://dx.doi.org/10.1016/S0140-6736(08)61558-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18945485				2022-12-24	WOS:000261471600025
J	Hejnol, A; Martindale, MQ				Hejnol, Andreas; Martindale, Mark Q.			Acoel development indicates the independent evolution of the bilaterian mouth and anus	NATURE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; GASTRULATION; BRACHYURY; DROSOPHILA; FLATWORMS; SUGGESTS; ORIGINS; PATTERN	Most bilaterian animals possess a through gut with a separate mouth and anus(1). It is commonly believed that during the transition from radial to bilateral symmetry, both openings evolved simultaneously by the lateral closure of a slit- like blastopore(1-4). Molecular phylogenies however, place the acoel flatworms, which have only one opening to their digestive system, as the sister group to all remaining Bilateria(5-7). To address how this single body opening is related to the mouth and anus of the protostomes and deuterostomes, we studied the expression of genes involved in bilaterian foregut and hindgut patterning during the development of the acoel Convolutriloba longifissura. Here we show that the genes brachyury and goosecoid are expressed in association with the acoel mouth, suggesting that this single opening is homologous to the mouth of other bilaterians(8). In addition, we find that the genes caudal, orthopedia and brachyury - which are expressed in various bilaterian hindguts(8-10) - are expressed in a small region at the posterior end of the animal, separated from the anterior oral brachyury- expressing region by a dorsal domain of ectodermal bmp2/4 expression. These results contradict the hypothesis that the bilaterian mouth and anus evolved simultaneously from a common blastoporal opening, and suggest that a through gut might have evolved independently in different animal lineages.	[Hejnol, Andreas; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, PBRC, Honolulu, HI 96813 USA	University of Hawaii System	Hejnol, A (corresponding author), Univ Hawaii, Kewalo Marine Lab, PBRC, 41 Ahui St, Honolulu, HI 96813 USA.	hejnol@hawaii.edu	Hejnol, Andreas/C-5577-2012	Hejnol, Andreas/0000-0003-2196-8507	National Science Foundation; AToL program [EF05-31558]; NASA; Deutsche Forschungsgemeinschaft [HE5183/2-1]	National Science Foundation(National Science Foundation (NSF)); AToL program; NASA(National Aeronautics & Space Administration (NASA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by the National Science Foundation under the AToL program (EF05-31558) and NASA to M. Q. M. A. H. received further support from the Deutsche Forschungsgemeinschaft (HE5183/2-1). We thank K. Pang for improving the manuscript and A. Okuso for the drawings of the cnidarian and annelid.	Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Graff Ludwig von, 1891, ORG TURBELLARIA ACOE; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Haeckel E., 1874, JENAISCHE Z NATURWIS, P1; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hyman L., 1951, INVERTEBRATES, VII; JAGERSTEN GOSTA, 1955, ZOOL BIDRAG UPPSALA, V30, P321; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Marcellini S, 2006, BIOESSAYS, V28, P413, DOI 10.1002/bies.20387; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Neidert AH, 2000, EVOL DEV, V2, P303, DOI 10.1046/j.1525-142x.2000.00073.x; Nielsen C, 2001, ANIMAL EVOLUTION, VSecond; Reisinger E., 1961, FORTSCHR ZOOL, V13, P1; Remane A., 1950, ZOOL ANZ, V14, P18; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; SEDGWICK W, 1884, Q J MICROSC SCI, V24, P43; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; Wu LH, 1998, DEVELOPMENT, V125, P2433	30	99	102	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					382	U45		10.1038/nature07309	http://dx.doi.org/10.1038/nature07309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18806777				2022-12-24	WOS:000261039600042
J	de Lusignan, S; Buxton, N; Kent, A				de Lusignan, Simon; Buxton, Nicola; Kent, Andy			10-MINUTE CONSULTATION New patient asking for a benzodiazepine prescription	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[de Lusignan, Simon; Buxton, Nicola] Univ London St Georges Hosp, Div Community Hlth Sci, London SW17 0RE, England; [Kent, Andy] Univ London St Georges Hosp, Div Mental Hlth, London SW17 0RE, England	St Georges University London; St Georges University London	de Lusignan, S (corresponding author), Univ London St Georges Hosp, Div Community Hlth Sci, London SW17 0RE, England.	slusigna@sgul.ac.uk	de Lusignan, Simon/A-6609-2011; de Lusignan, Simon/A-4125-2009; de Lusignan, Smion/S-7838-2019	de Lusignan, Simon/0000-0002-8553-2641; de Lusignan, Smion/0000-0002-8553-2641					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2008	337								a658	10.1136/bmj.a658	http://dx.doi.org/10.1136/bmj.a658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18755766	Green Submitted			2022-12-24	WOS:000260593700035
J	Ganzini, L; Goy, ER; Dobscha, SK				Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.			Prevalence of depression and anxiety in patients requesting physicians' aid in dying: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							MENTAL STATUS QUESTIONNAIRE; REDUCING SUICIDAL IDEATION; TERMINALLY-ILL PATIENTS; PRIMARY-CARE PATIENTS; ASSISTED SUICIDE; HASTENED DEATH; OLDER PATIENTS; CANCER; HOPELESSNESS; DESIRE	Objective To determine the prevalence of depression and anxiety in terminally ill patients pursuing aid in dying from physicians. Design Cross sectional survey. Setting State of Oregon, USA. Participants 58 Oregonians, most terminally ill with cancer or amyotrophic lateral sclerosis, who had either requested aid in dying from a physician or contacted an aid in dying advocacy organisation. Main outcome measures Diagnosis of depression or anxiety according to the hospital anxiety and depression scale and the structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders. Results 15 study participants met "caseness" criteria for depression, and 13 met criteria for anxiety. 42 patients died by the end of the study; 18 received a prescription fora lethal drug under the Death with Dignity Act, and nine died by lethal ingestion. 15 participants who received a prescription for a lethal drug did not meet criteria for depression; three did. All three depressed participants died by legal ingestion within two months of the research interview. Conclusion Although most terminally ill Oregonians who receive aid in dying do not have depressive disorders, the current practice of the Death with Dignity Act may fail to protect some patients whose choices are influenced by depression from receiving a prescription for a lethal drug.	[Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, Portland, OR 97239 USA; [Ganzini, Linda; Goy, Elizabeth R.; Dobscha, Steven K.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Ganzini, L (corresponding author), Portland VA Med Ctr, Columbia Ctr Study Chron Comorbid Mental & Phys D, Hlth Serv Res & Dev, POB 1034, Portland, OR 97239 USA.	Linda.Ganzini@va.gov			Northwest Health Foundation	Northwest Health Foundation	Northwest Health Foundation. The funding source had no role in any aspect of the study or this paper.	Appelbaum P.S., 2001, MACARTHUR COMPETENCE; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Blank K, 2001, J AM GERIATR SOC, V49, P153, DOI 10.1046/j.1532-5415.2001.49036.x; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Carlson B, 2005, J PALLIAT MED, V8, P1160, DOI 10.1089/jpm.2005.8.1160; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Conwell Y, 2000, J AM GERIATR SOC, V48, P23, DOI 10.1111/j.1532-5415.2000.tb03024.x; Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1; Emanuel EJ, 2005, J CLIN ONCOL, V23, P6456, DOI 10.1200/JCO.2005.06.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; First MB., 1997, USERS GUIDE STRUCTUR; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434; Ganzini L, 2006, J CLIN ETHIC, V17, P27; Ganzini L, 1996, AM J PSYCHIAT, V153, P1469; Ganzini L, 2000, AM J PSYCHIAT, V157, P595, DOI 10.1176/appi.ajp.157.4.595; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Henriksson MM, 1995, J AFFECT DISORDERS, V36, P11, DOI 10.1016/0165-0327(95)00047-X; Hotopf M, 2002, PALLIATIVE MED, V16, P81, DOI 10.1191/02169216302pm507oa; MINKOFF K, 1973, AM J PSYCHIAT, V130, P455; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; PEREZSTABLE EJ, 1990, ARCH INTERN MED, V150, P1083, DOI 10.1001/archinte.150.5.1083; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rosenfeld B, 2006, PSYCHOSOMATICS, V47, P504, DOI 10.1176/appi.psy.47.6.504; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; SMYER MA, 1979, J AM GERIATR SOC, V27, P263, DOI 10.1111/j.1532-5415.1979.tb06128.x; Tolle SW, 2004, J CLIN ETHIC, V15, P111; Unutzer J, 2006, J AM GERIATR SOC, V54, P1550, DOI 10.1111/j.1532-5415.2006.00882.x; Werth JL, 2004, BEHAV SCI LAW, V22, P627, DOI 10.1002/bsl.616; Wilson KG, 2007, HEALTH PSYCHOL, V26, P314, DOI 10.1037/0278-6133.26.3.314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 2007, COMPASSION CHOICES O	37	87	88	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1682	10.1136/bmj.a1682	http://dx.doi.org/10.1136/bmj.a1682			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	363WS	18842645	Green Published, hybrid			2022-12-24	WOS:000260298800034
J	Rasmussen, B; Fletcher, IR; Brocks, JJ; Kilburn, MR				Rasmussen, Birger; Fletcher, Ian R.; Brocks, Jochen J.; Kilburn, Matt R.			Reassessing the first appearance of eukaryotes and cyanobacteria	NATURE			English	Article							ISOTOPIC RATIO MEASUREMENTS; PROTEROZOIC MCARTHUR BASIN; MOUNT BRUCE SUPERGROUP; GREAT OXIDATION EVENT; ATMOSPHERIC OXYGEN; MOLECULAR FOSSILS; WESTERN-AUSTRALIA; NORTHERN AUSTRALIA; PETROLEUM GEOLOGY; FLUID INCLUSIONS	The evolution of oxygenic photosynthesis had a profound impact on the Earth's surface chemistry, leading to a sharp rise in atmospheric oxygen between 2.45 and 2.32 billion years (Gyr) ago(1,2) and the onset of extreme ice ages(3). The oldest widely accepted evidence for oxygenic photosynthesis has come from hydrocarbons extracted from similar to 2.7-Gyr-old shales in the Pilbara Craton, Australia, which contain traces of biomarkers ( molecular fossils) indicative of eukaryotes and suggestive of oxygen- producing cyanobacteria(4-7). The soluble hydrocarbons were interpreted to be indigenous and syngenetic despite metamorphic alteration and extreme enrichment ( 10-20 parts per thousand) of (13)C relative to bulk sedimentary organic matter(5,8). Here we present micrometre-scale, in situ (13)C/(12)C measurements of pyrobitumen ( thermally altered petroleum) and kerogen from these metamorphosed shales, including samples that originally yielded biomarkers. Our results show that both kerogen and pyrobitumen are strongly depleted in (13)C, indicating that indigenous petroleum is 10-20 parts per thousand lighter than the extracted hydrocarbons(5). These results are inconsistent with an indigenous origin for the biomarkers. Whatever their origin, the biomarkers must have entered the rock after peak metamorphism 2.2 Gyr ago(9) and thus do not provide evidence for the existence of eukaryotes and cyanobacteria in the Archaeaneon. The oldest fossil evidence for eukaryotes and cyanobacteria therefore reverts to 1.78-1.68 Gyr ago and similar to 2.15 Gyr ago(10,11), respectively. Our results eliminate the evidence for oxygenic photosynthesis similar to 2.7 Gyr ago and exclude previous biomarker evidence for a long delay (similar to 300 million years) between the appearance of oxygen- producing cyanobacteria and the rise in atmospheric oxygen 2.45-2.32 Gyr ago(1).	[Rasmussen, Birger; Fletcher, Ian R.] Curtin Univ Technol, Dept Appl Geol, Bentley, WA 6102, Australia; [Brocks, Jochen J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Brocks, Jochen J.] Australian Natl Univ, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Nedlands, WA 6009, Australia	Curtin University; Australian National University; Australian National University; University of Western Australia	Rasmussen, B (corresponding author), Curtin Univ Technol, Dept Appl Geol, Kent St, Bentley, WA 6102, Australia.	B.Rasmussen@curtin.edu.au	Brocks, Jochen/E-3920-2012; Kilburn, Matthew R/C-4515-2011	Brocks, Jochen/0000-0002-8430-8744; Kilburn, Matthew R/0000-0002-1858-8485; Rasmussen, Birger/0000-0002-2745-0904	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis; University of Western Australia; University, State and Commonwealth Governments	We thank S. Bengtson, G.A. Logan, J.R. Muhling, S. Revets and S. Sheppard for discussion and comments; and A.C. Cook for organic reflectivity measurements. We acknowledge the facilities of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, University of Western Australia, a facility funded by the University, State and Commonwealth Governments.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; [Anonymous], 1995, PETROLEUM GEOCHEMIST; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4321, DOI 10.1016/S0016-7037(03)00209-6; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P871, DOI 10.1016/j.gca.2007.11.028; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; CRICK IH, 1988, AAPG BULL, V72, P1495; Des Marais DJ, 2001, REV MINERAL GEOCHEM, V43, P555, DOI 10.2138/gsrmg.43.1.555; Dutkiewicz A, 2006, GEOLOGY, V34, P437, DOI 10.1130/G22360.1; FLETCHER IR, INT J MASS IN PRESS; George SC, 2008, GEOCHIM COSMOCHIM AC, V72, P844, DOI 10.1016/j.gca.2007.11.021; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HAYES JM, 1994, EARLY LIFE EARTH, P220; Hillion F, 2008, GEOCHIM COSMOCHIM AC, V72, pA377; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; HOEFS J, 2004, STABLE ISOTOPE GEOCH, P158; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Konhauser KO, 2002, GEOLOGY, V30, P1079, DOI 10.1130/0091-7613(2002)030<1079:CBHFTP>2.0.CO;2; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Rasmussen B, 2005, GEOLOGY, V33, P773, DOI 10.1130/G21666.1; Rasmussen B, 2005, GEOLOGY, V33, P497, DOI 10.1130/G21316.1; Rasmussen B, 2007, EARTH PLANET SC LETT, V258, P249, DOI 10.1016/j.epsl.2007.03.033; Sherman LS, 2007, ORG GEOCHEM, V38, P1987, DOI 10.1016/j.orggeochem.2007.08.012; Slodzian G, 2004, APPL SURF SCI, V231, P874, DOI 10.1016/j.apsusc.2004.03.155; Slodzian G, 2001, EUR PHYS J-APPL PHYS, V14, P199, DOI 10.1051/epjap:2001160; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; SUMMONS RE, 1988, GEOCHIM COSMOCHIM AC, V52, P1747, DOI 10.1016/0016-7037(88)90001-4	33	360	380	3	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1101	U9		10.1038/nature07381	http://dx.doi.org/10.1038/nature07381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948954				2022-12-24	WOS:000260252600043
J	Dartington, T; Brennan, M; Sampson, EL; Coupe, K; Malloy, L				Dartington, Tim; Brennan, Mary; Sampson, Elizabeth L.; Coupe, Kate; Malloy, Lynn			Dying from dementia - a patient's journey	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sampson, Elizabeth L.] UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England; [Dartington, Tim] Tavistock Inst, London EC2A 4UE, England; [Coupe, Kate; Malloy, Lynn] Bamet Enfield & Haringey Mental Hlth Trust, London N15 3TH, England	University of London; University College London; UCL Medical School	Sampson, EL (corresponding author), UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England.	mary.brennan@nmh.nhs.uk; e.sampson@medsch.ucl.ac.uk; Kate.coupe@beh-mht.nhs.uk; lynn.malloy@beh-mht.nhs.uk	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362					0	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1712	10.1136/bmj.a1712	http://dx.doi.org/10.1136/bmj.a1712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18818258				2022-12-24	WOS:000260093900041
J	Keshavjee, S; Gelmanova, IY; Farmer, PE; Mishustin, SP; Strelis, AK; Andreev, YG; Pasechnikov, AD; Atwood, S; Mukherjee, JS; Rich, ML; Furin, JJ; Nardell, EA; Kim, JY; Shin, SS				Keshavjee, Salmaan; Gelmanova, Irina Y.; Farmer, Paul E.; Mishustin, Sergey P.; Strelis, Aivar K.; Andreev, Yevgeny G.; Pasechnikov, Alexander D.; Atwood, Sidney; Mukherjee, Joia S.; Rich, Michael L.; Furin, Jennifer J.; Nardell, Edward A.; Kim, Jim Y.; Shin, Sonya S.			Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study	LANCET			English	Article							SHORT-COURSE CHEMOTHERAPY; TREATMENT OUTCOMES; MANAGEMENT; SURGERY; THERAPY; PRISON; LIMA	Background Mycobacterium tuberculosis strains that cause untreatable drug-resistant disease are a threat worldwide. We describe the treatment, management, and outcomes of patients with extensively drug-resistant tuberculosis in Tomsk, Russia. Methods We undertook a retrospective cohort study of 608 patients with multidrug resistant tuberculosis who had treatment in civilian or prison services, between Sept 10, 2000, and Nov 1, 2004, according to the treatment strategy recommended by WHO. Clinical characteristics, management practices, and treatment outcomes of patients with extensively drug-resistant (XDR) tuberculosis and non-extensively drug-resistant (non-XDR) tuberculosis are described. The main outcome was the frequency of poor and favourable outcomes at the end of treatment. Findings Of 608 patients with multidrug resistant tuberculosis, 29 (4.8%) patients had baseline XDR tuberculosis. Treatment failure was more common in patients with XDR tuberculosis than in those with non-XDR tuberculosis (31% vs 8.5%, p=0.0008). 48.3% of patients with XDR tuberculosis and 66.7% of patients with non-XDR tuberculosis had treatment cure or completion (p=0.04). The frequency and management of adverse events did not differ between patients with XDR and non-XDR tuberculosis. Interpretation The chronic features of tuberculosis in these patients suggest that extensively drug-resistant tuberculosis may be acquired through previous treatments that include second-line drugs. Aggressive management of this infectious disease is feasible and can prevent high mortality rates and further transmission of drug-resistant strains of Mycobacterium tuberculosis. Funding Bill & Melinda Gates Foundation, Eli Lilly Foundation, The Open Society Institute, Frank Hatch Fellowships in Global Health Equity at the Brigham & Women's Hospital, Infectious Disease Society of America, the Heiser Foundation, the United States National Institutes of Health, and the John D and Catherine T MacArthur Foundation.	[Keshavjee, Salmaan; Farmer, Paul E.; Nardell, Edward A.; Kim, Jim Y.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.; Atwood, Sidney; Mukherjee, Joia S.; Rich, Michael L.; Furin, Jennifer J.; Nardell, Edward A.; Kim, Jim Y.; Shin, Sonya S.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Keshavjee, Salmaan; Gelmanova, Irina Y.; Farmer, Paul E.; Mukherjee, Joia S.; Rich, Michael L.; Furin, Jennifer J.; Nardell, Edward A.; Kim, Jim Y.; Shin, Sonya S.] Partners Hlth, Boston, MA USA; [Gelmanova, Irina Y.; Pasechnikov, Alexander D.] Partners Hlth, Moscow, Russia; [Mishustin, Sergey P.] Tomsk Oblast TB Serv, Tomsk, Russia; [Strelis, Aivar K.] Siberia State Med Univ, Tomsk, Russia; [Strelis, Aivar K.] Tomsk Oblast TB Hosp, Tomsk, Russia; [Andreev, Yevgeny G.] Minist Justice, Tomsk Penitentiary Serv, Tomsk, Russia; [Nardell, Edward A.; Kim, Jim Y.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Siberian State Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	skeshavjee@partners.org	Mishustin, Sergey/AAI-4202-2020	Keshavjee, Salmaan/0000-0002-6967-3305; Atwood, Sidney/0000-0001-8865-6300; Mishustin, Sergey/0000-0002-4414-460X	Bill & Melinda Gates Foundation; Eli Lilly Foundation; Frank Hatch Fellowships in Global Health Equity at the Brigham & Women's Hospital; Infectious Disease Society of America; Heiser Foundation; US National Institutes of Health; John D and Catherine T MacArthur Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Eli Lilly Foundation(Eli Lilly); Frank Hatch Fellowships in Global Health Equity at the Brigham & Women's Hospital; Infectious Disease Society of America; Heiser Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D and Catherine T MacArthur Foundation	JJF, IYG, SK, EAN, SSS, ADP, and MLR received partial salary and/or travel support from the Bill & Melinda Gates Foundation and Eli Lilly Foundation. JJF, SK, MLR, and SSS received salary support also from the Frank Hatch Fellowships in Global Health Equity at the Brigham & Women's Hospital. S S S received additional salary support from the Infectious Disease Society of America, the Heiser Foundation, and the US National Institutes of Health. SK received travel and research funding from the John D and Catherine T MacArthur Foundation.	Bender D. A., 1997, NUTR REFERENCE HDB; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Farmer P, 1999, INT J TUBERC LUNG D, V3, P365; FARMER PE, 2000, J RESP DIS, V21, P53; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Keshavjee S., 2007, Innovations: Technology / Governance / Globalisation, V2, P87, DOI 10.1162/itgg.2007.2.4.87; KESHAVJEE S, 2007, ANN NY ACAD SCI, V1136, P1; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Kir A, 1997, EUR J CARDIO-THORAC, V12, P531, DOI 10.1016/S1010-7940(97)00230-3; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Li X, 2007, J INFECT DIS, V195, P864, DOI 10.1086/511985; Masjedi MR, 2006, CLIN INFECT DIS, V43, P841, DOI 10.1086/507542; Mawer C, 2001, LANCET, V358, P445, DOI 10.1016/S0140-6736(01)05621-5; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858; MIGLIORI GB, 2008, EUR RESPIR J, V31, P1; Migliori GB, 2008, CLIN INFECT DIS, V46, P958, DOI 10.1086/528875; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339; POMERANTZ M, 1991, ANN THORAC SURG, V52, P1108, DOI 10.1016/0003-4975(91)91289-8; Saravia JC, 2005, INT J TUBERC LUNG D, V9, P421; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Somocurcio JG, 2007, THORAX, V62, P416, DOI 10.1136/thx.2005.051961; *WHO, WHOHTMTB2007387; *WHO, 2006, WHOHTMTB2007374; *WHO, GREEN LIGHT COMM GLC; *WHO INT UN TUB LU, 2008, 4 WHO INT UN TUB LUN; World Health Organization, 2006, WHOHTMTB2006362; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; 2006, MMWR MORB MORTAL WKL, V56, P250	41	137	144	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1403	1409		10.1016/S0140-6736(08)61204-0	http://dx.doi.org/10.1016/S0140-6736(08)61204-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18723218				2022-12-24	WOS:000260228200026
J	Bowman, GR; Comolli, LR; Zhu, J; Eckart, M; Koenig, M; Downing, KH; Moerner, WE; Earnest, T; Shapiro, L				Bowman, Grant R.; Comolli, Luis R.; Zhu, Jian; Eckart, Michael; Koenig, Marcelle; Downing, Kenneth H.; Moerner, W. E.; Earnest, Thomas; Shapiro, Lucy			A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole	CELL			English	Article							BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; ACTIN HOMOLOG; SEGREGATION; CYCLE; MREB; MORPHOGENESIS; LOCALIZATION; DIVISION; POLARITY	Bacterial replication origins move towards opposite ends of the cell during DNA segregation. We have identified a proline-rich polar protein, PopZ, required to anchor the separated Caulobacter crescentus chromosome origins at the cell poles, a function that is essential for maintaining chromosome organization and normal cell division. PopZ interacts directly with the ParB protein bound to specific DNA sequences near the replication origin. As the origin/ParB complex is being replicated and moved across the cell, PopZ accumulates at the cell pole and tethers the origin in place upon arrival. The polar accumulation of PopZ occurs by a diffusion/capture mechanism that requires the MreB cytoskeleton. High molecular weight oligomers of PopZ assemble in vitro into a filamentous network with trimer junctions, suggesting that the PopZ network and ParB-bound DNA interact in an adhesive complex, fixing the chromosome origin at the cell pole.	[Bowman, Grant R.; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Comolli, Luis R.; Downing, Kenneth H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zhu, Jian; Earnest, Thomas] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Eckart, Michael] Stanford Univ, Stanford Prot & Nucle Acid Facil, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Koenig, Marcelle; Moerner, W. E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Moerner, William E/C-3260-2008; Comolli, Luis Raul/C-5907-2017	Moerner, William E/0000-0002-2830-209X; Zhu, Jian/0000-0001-6679-8498; Comolli, Luis Raul/0000-0002-9313-6550; Bowman, Grant/0000-0002-8817-8262	National Institutes of Health [GM32506, GM051426, 5R24GM73011-3, F32GM080008, 5 P20 HG003638-02]; Department of Energy [DE-AC02-05CH11231, DE-FG02-01ER63219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R24GM073011, R01GM051426, F32GM080008, R01GM032506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Balaji Srinivasan and Esteban Toro for developing bioinformatics tools. We thank Martin Thanbichler for purified ParB. Mike Fero designed software used for fluorescence microscopy, Bob Glaeser and Byong-Gyoon Han provided advice on EM sample preparation, Greg Hura assisted in SAXS analysis, and James Gober and Christine Jacobs-Wagner provided antibodies and strains. This work is supported by National Institutes of Health grants GM32506, GM051426, and 5R24GM73011-3 to L. S., F32GM080008 to G. B., and 5 P20 HG003638-02 to M. K. and W. E. M.; and Department of Energy grants DE-AC02-05CH11231 to L. R. C., J.X., and T. E., and DE-FG02-01ER63219 to L. S.	Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perry SE, 2006, J BACTERIOL, V188, P6039, DOI 10.1128/JB.01750-05; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Srinivasan BS, 2006, LECT NOTES COMPUT SC, V3909, P1, DOI 10.1007/11732990_1; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	34	226	226	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					945	955		10.1016/j.cell.2008.07.015	http://dx.doi.org/10.1016/j.cell.2008.07.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805088	Green Accepted, Bronze			2022-12-24	WOS:000259318100015
J	Yauch, RL; Gould, SE; Scales, SJ; Tang, T; Tian, H; Ahn, CP; Marshall, D; Fu, L; Januario, T; Kallop, D; Nannini-Pepe, M; Kotkow, K; Marsters, JC; Rubin, LL; de Sauvage, FJ				Yauch, Robert L.; Gould, Stephen E.; Scales, Suzie J.; Tang, Tracy; Tian, Hua; Ahn, Christina P.; Marshall, Derek; Fu, Ling; Januario, Thomas; Kallop, Dara; Nannini-Pepe, Michelle; Kotkow, Karen; Marsters, James C., Jr.; Rubin, Lee L.; de Sauvage, Frederic J.			A paracrine requirement for hedgehog signalling in cancer	NATURE			English	Article							SONIC HEDGEHOG; PANCREATIC-CANCER; GROWTH-FACTOR; STROMAL FIBROBLASTS; MESENCHYMAL CELLS; PATHWAY; MEDULLOBLASTOMA; RENEWAL; TRACT	Ligand- dependent activation of the hedgehog (Hh) signalling pathway has been associated with tumorigenesis in a number of human tissues(1-7). Here we show that, although previous reports have described a cell- autonomous role for Hh signalling in these tumours(1-7), Hh ligands fail to activate signalling in tumour epithelial cells. In contrast, our data support ligand- dependent activation of the Hh pathway in the stromal microenvironment. Specific inhibition of Hh signalling using small molecule inhibitors, a neutralizing anti- Hh antibody or genetic deletion of smoothened ( Smo) in the mouse stroma results in growth inhibition in xenograft tumour models. Taken together, these studies demonstrate a paracrine requirement for Hh ligand signalling in the tumorigenesis of Hh- expressing cancers and have important implications for the development of Hh pathway antagonists in cancer.	[Yauch, Robert L.; Gould, Stephen E.; Scales, Suzie J.; Tang, Tracy; Tian, Hua; Ahn, Christina P.; Marshall, Derek; Fu, Ling; Januario, Thomas; Kallop, Dara; Nannini-Pepe, Michelle; Marsters, James C., Jr.; de Sauvage, Frederic J.] Genentech Inc, San Francisco, CA 94080 USA; [Kotkow, Karen; Rubin, Lee L.] Curis Inc, Cambridge, MA 02138 USA	Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	sauvage@gene.com	Scales, Suzie J./H-4507-2019; de Sauvage, Frederic/ABE-8400-2020	Scales, Suzie J./0000-0003-2544-0283; de Sauvage, Frederic/0000-0002-5275-2584; Rubin, Lee/0000-0002-8658-841X	National Cancer Institute; National Center for Research Resources; National Institutes of Health	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. McMahon and M. Scott for providing transgenic mice; T. Holcomb, K. Wagner, D. Lee and P. Wen for their assistance in cell line screening; J. Ernst for rSHH, M. Cole for assistance with imaging; S. Louie for assistance with graphics; P. Haverty for assistance with gene expression data; and M. Evangelista, C. Callahan and V. Dixit for comments and discussions. Tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute, and the National Center for Research Resources, which is supported by the National Institutes of Health. Other investigators may have received samples from these same tissues.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BERGMANN U, 1995, CANCER RES, V55, P2007; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Duda DG, 2004, CANCER RES, V64, P5920, DOI 10.1158/0008-5472.CAN-04-1268; Durai R, 2005, INT J COLORECTAL DIS, V20, P203, DOI 10.1007/s00384-004-0675-4; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kayed H, 2004, INT J CANCER, V110, P668, DOI 10.1002/ijc.20194; Long FX, 2001, DEVELOPMENT, V128, P5099; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; YONEDA T, 1981, SCIENCE, V213, P563, DOI 10.1126/science.7017936; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	30	762	803	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					406	U61		10.1038/nature07275	http://dx.doi.org/10.1038/nature07275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18754008				2022-12-24	WOS:000259265200048
J	Mak, TK; Hesseling, AC; Hussey, GD; Cotton, MF				Mak, Tippi K.; Hesseling, Anneke C.; Hussey, Gregory D.; Cotton, Mark F.			Making BCG vaccination programmes safer in the HIV era	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; CLINICS; HEALTH		[Mak, Tippi K.] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Hesseling, Anneke C.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Hesseling, Anneke C.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Hussey, Gregory D.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Childrens Infect Dis Clin Res Unit, Dept Pediat & Child Hlth, ZA-7505 Tygerberg, South Africa	University of Basel; Swiss Tropical & Public Health Institute; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Stellenbosch University	Mak, TK (corresponding author), Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland.	tippi.mak@unibas.ch	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034				Chersich MF, 2008, INT J STD AIDS, V19, P42, DOI 10.1258/ijsa.2007.007117; Enserink M, 2007, SCIENCE, V318, P1059, DOI 10.1126/science.318.5853.1059; FALLO A, 2005, INT AIDS SOC C RIO J; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Infuso A, 2006, Euro Surveill, V11, P6, DOI 10.2807/esm.11.03.00604-en; Lotte A, 1988, Bull Int Union Tuberc Lung Dis, V63, P47; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; SALISBURY D, 2006, TUBERCULOSIS IMMUNIS, pCH32; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; *UNAIDS WHO, AIDS EP UPD DEC 2007, P1; VIOLARI A, 2007, 4 INT AIDS SOC C JUL; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; *WHO, 2007, REV BCG VACC GUID IN, V82, P193; *WHO UNAIDS, 2007, GUID PROV IN HIV TES; World Health Organization, 2008, PAED HIV ART CAR GUI	15	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					786	787		10.1016/S0140-6736(08)61318-5	http://dx.doi.org/10.1016/S0140-6736(08)61318-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774406				2022-12-24	WOS:000259124900008
J	Farmer, SR				Farmer, Stephen R.			Brown fat and skeletal muscle: Unlikely cousins?	CELL			English	Editorial Material							ADIPOSE-TISSUE; WHITE FAT; ADIPOCYTES; MICE	Although the functions of white fat and brown fat are increasingly well understood, their developmental origins remain unclear. A recent study published in Nature (Seale et al., 2008) identifies a population of progenitor cells that gives rise to brown fat and skeletal muscle but not white fat.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	farmer@biochem.bumc.bu.edu		Farmer, Stephen/0000-0003-2483-2795				Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104	10	42	68	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					726	727		10.1016/j.cell.2008.08.018	http://dx.doi.org/10.1016/j.cell.2008.08.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775306	Bronze			2022-12-24	WOS:000258947500013
J	Bartlett, JG; Branson, BM; Fenton, K; Hauschild, BC; Miller, V; Mayer, KH				Bartlett, John G.; Branson, Bernard M.; Fenton, Kevin; Hauschild, Benjamin C.; Miller, Veronica; Mayer, Kenneth H.			Opt-out testing for human immunodeficiency virus in the United States - Progress and challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; HIV-INFECTION; RISK; HEALTH; CARE; DIAGNOSIS; IMPROVE	The Centers for Disease Control and Prevention ( CDC) has recommended human immunodeficiency virus ( HIV) testing for all persons aged 13 to 64 years in all health care settings. Signed consent would not be required and counseling with referral would be managed as it is for other serious conditions. The goal of the recommendations is to promote earlier entry into care to reduce unnecessary mortality and facilitate prevention by behavioral changes that accompany knowledge of serostatus. Concerns about the change include laws in some states that mandate signed consent and counseling, a perception that counseling is an effective prevention strategy, variability in payment coverage for the test, concerns about the stigma and discrimination that may accompany the HIV diagnosis, and the possibility that other testing policies would be more effective. Eleven of 16 states have changed legislation to reduce barriers to testing, 35 of 74 national professional societies have endorsed the new recommendations, and multiple demonstration projects have shown feasibility. Metrics to evaluate the health outcomes of the CDC's recommendations for HIV testing have been defined, but the data necessary to determine the effects on early entry into care, the actual reduction in disease incidence, and the unanticipated consequences are not yet available.	[Bartlett, John G.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Branson, Bernard M.; Fenton, Kevin] Ctr Dis Control & Prevent, Atlanta, GA USA; [Hauschild, Benjamin C.; Miller, Veronica] Forum Collaborat HIV Res, Washington, DC USA; [Hauschild, Benjamin C.; Miller, Veronica] George Washington Univ, Washington, DC USA; [Mayer, Kenneth H.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Miriam Hosp, Providence, RI 02906 USA	Johns Hopkins University; Centers for Disease Control & Prevention - USA; George Washington University; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Room 447, Baltimore, MD 21205 USA.	jb@jhmi.edu						Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; Bartlett JG, 2007, CLIN INFECT DIS, V45, pS203, DOI 10.1086/522539; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Calderon Y, 2006, ANN EMERG MED, V48, P21, DOI 10.1016/j.annemergmed.2006.01.003; Centers for Disease Control and Prevention, 2003, MMWR MORB MORTAL WKL, V52, P581; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1110; *DEP HHS, HIV AIDS SURV REP 20; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Fenton KA, 2007, CLIN INFECT DIS, V45, pS213, DOI 10.1086/522615; Gostin LO, 2006, JAMA-J AM MED ASSOC, V296, P2023, DOI 10.1001/jama.296.16.2023; Gruskin S, 2008, DEV WORLD BIOETH, V8, P23, DOI 10.1111/j.1471-8847.2007.00222.x; Hanssens C, 2007, CLIN INFECT DIS, V45, pS232, DOI 10.1086/522543; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Holtgrave DR, 2007, PLOS MED, V4, P1011, DOI 10.1371/journal.pmed.0040194; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kates J, 2007, CLIN INFECT DIS, V45, pS255, DOI 10.1086/522547; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Lee LM, 2007, PUBLIC HEALTH REP, V122, P72, DOI 10.1177/00333549071220S111; Lifson AR, 2007, LANCET, V369, P539, DOI 10.1016/S0140-6736(07)60249-9; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; McCaig LF, ADV DATA VITAL HLTH; McQuillan GM, 2006, JAIDS-J ACQ IMM DEF, V41, P651, DOI 10.1097/01.qai.0000194235.31078.f6; Mollen C, 2008, AIDS PATIENT CARE ST, V22, P505, DOI 10.1089/apc.2007.0098; MOORE R, 2008, 15 C RETR OPP INF FE; *NAT HIV AIDS CLIN, 2008, STAT HIV TEST LAWS; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Rothman RE, 2004, ANN EMERG MED, V44, P31, DOI 10.1016/j.annemergmed.2004.01.016; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sullivan PS, 2004, JAIDS-J ACQ IMM DEF, V35, P511, DOI 10.1097/00126334-200404150-00009; Swamy Madhavi, 2007, HIV AIDS Policy Law Rev, V12, P39; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; VALDISERRI RO, 1993, PUBLIC HEALTH REP, V108, P12; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wynia MK, 2006, AM J BIOETHICS, V6, P5, DOI 10.1080/15265160600843536	47	90	90	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2008	300	8					945	951		10.1001/jama.300.8.945	http://dx.doi.org/10.1001/jama.300.8.945			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341AR	18728268				2022-12-24	WOS:000258687100029
J	Wang, Z; Smith, KS; Murphy, M; Piloto, O; Somervaille, TCP; Cleary, ML				Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.			Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; STEM-CELLS; BETA-CATENIN; PROTEIN; PROGENITORS; MENIN; PHOSPHORYLATES; REARRANGEMENTS; TRANSFORMATION; SPECIFICATION	Glycogen synthase kinase 3 ( GSK3) is a multifunctional serine/ threonine kinase that participates in numerous signalling pathways involved in diverse physiological processes. Several of these pathways are implicated in disease pathogenesis, which has prompted efforts to develop GSK3- specific inhibitors for therapeutic applications. However, before now, there has been no strong rationale for targeting GSK3 in malignancies. Here we report pharmacological, physiological and genetic studies that demonstrate an oncogenic requirement for GSK3 in the maintenance of a specific subtype of poor prognosis human leukaemia, genetically defined by mutations of the MLL proto- oncogene. In contrast to its previously characterized roles in suppression of neoplasia- associated signalling pathways, GSK3 paradoxically supports MLL leukaemia cell proliferation and transformation by a mechanism that ultimately involves destabilization of the cyclin- dependent kinase inhibitor p27(Kip1). Inhibition of GSK3 in a preclinical murine model of MLL leukaemia provides promising evidence of efficacy and earmarks GSK3 as a candidate cancer drug target.	[Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu		Somervaille, Tim/0000-0002-9188-4379	Children's Health Initiative of the Packard Foundation; PHS [CA55029, CA116606]; Leukemia and Lymphoma Society; Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE [R01CA055029, R01CA116606] Funding Source: NIH RePORTER	Children's Health Initiative of the Packard Foundation; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Roth for providing AKT constructs, P. J. Roach for providing GSK3 constructs, D. G. Gilliland for providing a TEL-AML1 construct, M. Iwasaki for NUP98-HOXA9 cells, M. Ambrus and C. Nicolas for technical assistance, and members of the Cleary laboratory for discussions. We acknowledge support from the Children's Health Initiative of the Packard Foundation, PHS grants CA55029 and CA116606, the Leukemia and Lymphoma Society, the Williams Lawrence Foundation and a Developmental Research Award from the Stanford Cancer Center.	AMLAK MG, 2002, BIOCHEM BIOPH RES CO, V297, P760; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; CHEN CS, 1993, BLOOD, V81, P2386; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Millar JBA, 2002, GENOME BIOL, V3; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Nickeleit I, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-13; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith KS, 1997, ONCOGENE, V14, P2917, DOI 10.1038/sj.onc.1201249; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	220	238	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1205	U29		10.1038/nature07284	http://dx.doi.org/10.1038/nature07284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18806775	Green Accepted			2022-12-24	WOS:000260462100036
J	Soukup, V; Epperlein, HH; Horacek, I; Cerny, R				Soukup, Vladimir; Epperlein, Hans-Henning; Horacek, Ivan; Cerny, Robert			Dual epithelial origin of vertebrate oral teeth	NATURE			English	Article							CRANIAL NEURAL CREST; EVOLUTIONARY ORIGINS; TOOTH; DENTITIONS; ENDODERM; GENES; MOUTH; JAWS	The oral cavity of vertebrates is generally thought to arise as an ectodermal invagination(1,2). Consistent with this, oral teeth are proposed to arise exclusively from ectoderm, contributing to tooth enamel epithelium, and from neural crest derived mesenchyme, contributing to dentin and pulp(3-5). Yet in many vertebrate groups, teeth are not restricted only to the oral cavity(6-9), but extend posteriorly as pharyngeal teeth that could be derived either directly from the endodermal epithelium, or from the ectodermal epithelium that reached this location through the mouth or through the pharyngeal slits(6). However, when the oropharyngeal membrane, which forms a sharp ecto/ endodermal border(10), is broken, the fate of these cells is poorly known. Here, using transgenic axolotls with a combination of fate- mapping approaches, we present reliable evidence of oral teeth derived from both the ectoderm and endoderm and, moreover, demonstrate teeth with a mixed ecto/ endodermal origin. Despite the enamel epithelia having a different embryonic source, oral teeth in the axolotl display striking developmental uniformities and are otherwise identical. This suggests a dominant role for the neural crest mesenchyme over epithelia in tooth initiation and, from an evolutionary point of view, that an essential factor in teeth evolution was the odontogenic capacity of neural crest cells, regardless of possible 'outside-in'(11) or 'inside-out'(12) influx of the epithelium.	[Soukup, Vladimir; Horacek, Ivan; Cerny, Robert] Charles Univ Prague, Dept Zool, CR-12844 Prague, Czech Republic; [Epperlein, Hans-Henning] Tech Univ Dresden, Dept Anat, D-01307 Dresden, Germany	Charles University Prague; Technische Universitat Dresden	Cerny, R (corresponding author), Charles Univ Prague, Dept Zool, Vinicna 7, CR-12844 Prague, Czech Republic.	cerny8@natur.cuni.cz	Cerny, Robert/H-3801-2017; Soukup, Vladimir/G-3599-2014; Horacek, Ivan/V-9741-2017	Cerny, Robert/0000-0002-0022-0199; Soukup, Vladimir/0000-0002-1914-283X; Horacek, Ivan/0000-0002-8356-5554	Ministry of Youth, Education and Sport of the Czech Republic [MSMT 0021620828]; SMWK (Dresden); COST Action B23	Ministry of Youth, Education and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); SMWK (Dresden); COST Action B23	We wish to thank E. Tanaka and H. Andreas for supplying us with GFP axolotl embryos, L. Mchedlishvili for technical advice and O. Sebesta for help with confocal microscopy. We are grateful to M. Bronner-Fraser, R. Ericsson, D. Meulemans Medeiros, L. Olsson, P. D. Polly, D. W. Stock and A. Tucker for comments on the manuscript. Grants from the Ministry of Youth, Education and Sport of the Czech Republic (MSMT 0021620828), SMWK (Dresden) and COST Action B23 'Oral facial development and regeneration' are gratefully acknowledged.	Adams AE, 1924, J EXP ZOOL, V40, P311, DOI 10.1002/jez.1400400302; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; Barlow LA, 1997, DEVELOPMENT, V124, P949; Cerny R, 2004, DEV BIOL, V276, P225, DOI 10.1016/j.ydbio.2004.08.046; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chibon P., 1966, Memoires de la Societe Zoologique de France, V36, P1; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Dickinson AJG, 2006, DEV BIOL, V295, P700, DOI 10.1016/j.ydbio.2006.03.054; Epperlein HH, 2000, DEVELOPMENT, V127, P2751; Fraser GJ, 2004, P ROY SOC B-BIOL SCI, V271, P2311, DOI 10.1098/rspb.2004.2878; HALL BK, 1947, P ROY SOC LOND B BIO, V134, P377; Huysseune A, 2002, CONNECT TISSUE RES, V43, P98, DOI 10.1080/03008200290000808; Imai H, 1998, EUR J ORAL SCI, V106, P19, DOI 10.1111/j.1600-0722.1998.tb02148.x; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; Janvier P., 1996, EARLY VERTEBRATES; Kardong K.V., 1995, VERTEBRADOSANATOMIA; Mitsiadis TA, 2006, J EXP ZOOL PART B, V306B, P227, DOI 10.1002/jez.b.21094; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; REIF WE, 1982, EVOL BIOL, V15, P287; Reiss JO, 1997, J MORPHOL, V231, P63, DOI 10.1002/(SICI)1097-4687(199701)231:1<63::AID-JMOR6>3.0.CO;2-P; Romer A.S., 1962, VERTEBRATE BODY; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 1998, EUR J ORAL SCI, V106, P482, DOI 10.1111/j.1600-0722.1998.tb02212.x; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380	31	63	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					795	U6		10.1038/nature07304	http://dx.doi.org/10.1038/nature07304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18794902				2022-12-24	WOS:000259854900046
J	Henkind, SJ; Sinnett, JC				Henkind, Steven J.; Sinnett, J. Christopher			Patient care, square-rigger sailing, and safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TEAMWORK		[Henkind, Steven J.] CCI Grp, Larchmont, NY 10538 USA; [Sinnett, J. Christopher] US Coast Guard, US Coast Guard Barque Eagle, New London, CT USA		Henkind, SJ (corresponding author), CCI Grp, 7 S Ridge Rd, Larchmont, NY 10538 USA.	sjh37@verizon.net						Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Baker DP, 2005, JT COMM J QUAL PATIE, V31, P185, DOI 10.1016/S1553-7250(05)31025-7; Gawande Atul, 2007, New Yorker, P86; Grogan EL, 2004, J AM COLL SURGEONS, V199, P843, DOI 10.1016/j.jamcollsurg.2004.08.021; *HLTH SAF EX, 1996, PUBL OTO; *JCAHO, 2006, JT PERSPECTIVES PATI, V6, P9; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; Morey JC, 2002, HEALTH SERV RES, V37, P1553, DOI 10.1111/1475-6773.01104; National Institute for Occupational Safety and Health, 2004, NIOSH PUBL, V2004-146; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; Pizzi L, 2001, AHRQ PUBLICATION; Salas E, 2001, HUM FACTORS, V43, P641, DOI 10.1518/001872001775870386; *US COAST GUARD, 1998, USCG PUBL; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	15	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1691	1693		10.1001/jama.300.14.1691	http://dx.doi.org/10.1001/jama.300.14.1691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840843				2022-12-24	WOS:000259812800031
J	Eckart, RE; Field, ME; Hruczkowski, TW; Forman, DE; Dorbala, S; Di Carli, MF; Albert, CE; Malsel, WH; Epstein, LM; Stevenson, WG				Eckart, Robert E.; Field, Michael E.; Hruczkowski, Tomasz W.; Forman, Daniel E.; Dorbala, Sharmila; Di Carli, Marcelo F.; Albert, Christine E.; Malsel, William H.; Epstein, Laurence M.; Stevenson, William G.			Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; OUTFLOW TRACT TACHYCARDIA; PROGNOSTIC VALUE; BRUGADA-SYNDROME; 12-LEAD ELECTROCARDIOGRAM; FRAGMENTED-QRS; HEART; PREDICTOR; ORIGIN; SCORE	Background: The prognostic importance of exercise-induced ventricular arrhythmia (EIVA) may be confounded by the presence of lower-risk idiopathic right ventricular outflow tract arrhythmias with left bundle-branch block (LBBB) morphology. Objective: To determine whether right bundle-branch block (RBBB)-morphology EIVA was associated with increased mortality. Design: Retrospective cohort. Setting: Academic medical center. Patients: 585 unique patients with EIVA and 2340 patients without EIVA, matched by age, sex, and risk factor, who were referred for exercise testing in an academic medical center. Measurements: Deaths and ischemia and infarction found on perfusion scan. Results: During a mean follow-up of 24 months (SD, 13), 31 deaths occurred in the EIVA group compared with 43 deaths in the group without EIVA (5.3% vs. 1.8%; P < 0.001). Worse survival in patients with RBBB-morphology or multiple-morphology EIVA (6.9%) than in patients without EIVA caused this difference. Patients with LBBB-morphology EIVAs had a mortality rate (2.5%) similar to that of patients without EIVA (P = 0.93, log-rank test). Among patients without known atherosclerotic coronary artery disease, any RBBB-morphology EIVA was associated with death (hazard ratio, 2.73 [95% CI, 1.78 to 4.13]; P < 0.001), but LBBB-morphology EIVA was not (hazard ratio, 0.82 [CI, 0.18 to 2.04]; P = 0.72). Limitations: Not all LBBB-morphology EIVA can be dismissed, and not all RBBB-morphology EIVA is high risk. Further evaluation of patients for structural heart disease was clinically driven, not protocol-driven. Conclusion: Right bundle-branch block-or multiple-morphology EIVA is associated with increased mortality. Inclusion of patients with isolated LBBB-morphology EIVA, which often is idiopathic, may contribute to differences in the prognostic importance of EIVA in previous studies.	[Eckart, Robert E.] Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, San Antonio, TX 78234 USA; Brigham & Womens Hosp, Boston Vet Adm Med Ctr, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Alberta, Edmonton, AB, Canada	San Antonio Military Medical Center; United States Department of Defense; United States Army; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of Alberta	Eckart, RE (corresponding author), Brooke Army Med Ctr, Arrhythmia Serv ATTN MCHE MDC, 3851 Roger Brooke Dr, San Antonio, TX 78234 USA.	robert.eckart@us.army.mil	Epstein, Laurence/AAQ-7571-2021; Epstein, Laurence/ABB-1592-2020	Epstein, Laurence/0000-0001-5410-0291; Albert, Christine/0000-0002-2081-1121	Medtronic; Boston Scientific; Biosense Webster	Medtronic(Medtronic); Boston Scientific(Boston Scientific); Biosense Webster	Honoraria: L. M. Epstein (Medtronic, Boston Scientific, St. Jude). Grants received: L. M. Epstein (Medtronic, Boston Scientific, Biosense Webster).	Bala R, 2007, HEART RHYTHM, V4, P366, DOI 10.1016/j.hrthm.2006.11.012; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; Cerqueira MD, 2002, J NUCL CARDIOL, V9, P240, DOI 10.1067/mnc.2002.123122; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024; Dixit S, 2003, J CARDIOVASC ELECTR, V14, P1, DOI 10.1046/j.1540-8167.2003.02404.x; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353; GOY JJ, 1990, PACE, V13, P1142, DOI 10.1111/j.1540-8159.1990.tb02172.x; Hayashi M, 2008, J AM COLL CARDIOL, V51, P1162, DOI 10.1016/j.jacc.2007.11.050; Iwai S, 2006, J CARDIOVASC ELECTR, V17, P1052, DOI 10.1111/j.1540-8167.2006.00539.x; JADONATH RL, 1995, AM HEART J, V130, P1107, DOI 10.1016/0002-8703(95)90215-5; Josephson ME, 2005, HEART RHYTHM, V2, P443, DOI 10.1016/j.hrthm.2004.12.014; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062; Kim RJ, 2007, J AM COLL CARDIOL, V49, P2035, DOI 10.1016/j.jacc.2007.01.085; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; Marchlinski FE, 2000, AM HEART J, V139, P1009, DOI 10.1067/mhj.2000.106164; MARIEB MA, 1990, AM J CARDIOL, V66, P172, DOI 10.1016/0002-9149(90)90583-M; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MONT L, 1991, AM J CARDIOL, V68, P897, DOI 10.1016/0002-9149(91)90405-A; Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x; Morshedi-Meibodi A, 2004, CIRCULATION, V109, P2417, DOI 10.1161/01.CIR.0000129762.41889.41; Nasir K, 2004, CIRCULATION, V110, P1527, DOI 10.1161/01.CIR.0000142293.60725.18; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; O'Neill JO, 2004, J AM COLL CARDIOL, V44, P820, DOI 10.1016/j.jacc.2004.02.063; OHARA GE, 1992, AM J CARDIOL, V70, P875, DOI 10.1016/0002-9149(92)90730-M; Ohkubo K, 2007, CIRC J, V71, P1258, DOI 10.1253/circj.71.1258; Tanner H, 2005, J AM COLL CARDIOL, V45, P418, DOI 10.1016/j.jacc.2004.10.037; Zweytick B, 2004, EUROPACE, V6, P123, DOI 10.1016/j.eupc.2003.11.010	31	21	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2008	149	7					451	W82		10.7326/0003-4819-149-7-200810070-00005	http://dx.doi.org/10.7326/0003-4819-149-7-200810070-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QY	18838725				2022-12-24	WOS:000260004400002
J	Wu, XY; Kodama, A; Fuchs, E				Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine			ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity	CELL			English	Article							MICROTUBULE PLUS-END; LINKING FACTOR MACF; CELL-MIGRATION; STRESS FIBERS; MOTILE CELLS; ACTIN; KINASE; PROTEINS; PROMOTES; SPECTRAPLAKINS	Coordinated interactions between microtubule (MT) and actin cytoskeletons are involved in many polarized cellular processes. Spectraplakins are enormous (>500 kDa) proteins able to bind both MTs and actin filaments (F-actin) directly. To elucidate the physiological significance and functions of mammalian spectraplakin ACF7, we've conditionally targeted it in skin epidermis. Intriguingly, ACF7 deficiency compromises the targeting of microtubules along F-actin to focal adhesions (FAs), stabilizes FA-actin networks, and impairs epidermal migration. Exploring underlying mechanisms, we show that ACF7's binding domains for F-actin, MTs, and MT plus-end proteins are not sufficient to rescue the defects in FA-cytoskeletal dynamics and migration functions of ACF7 null keratinocytes. We've uncovered an intrinsic actin-regulated ATPase domain in ACF7 and demonstrate that it is both functional and essential for these roles. Our findings provide insight into the functions of this important cytoskeletal crosslinking protein in regulating dynamic interactions between MTs and F-actin to sustain directional cell movement.	[Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Kodama, Atsuko; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		National Institutes of Health [R01-AR27883]; American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to Markus Schober, Mirna Perez-Moreno, Ellen Ezratty, and Michael Hack for discussion and helpful comments and to Ellen Wong, Maria Nikolova, June Racelis, Alison North, and Shivaprasad Bhuvanendran for their technical advice and assistance. We also thank William Earnshaw at University of Edinburgh for sharing reagents. The animal studies were performed with expert assistance from Lisa Polak and Nicole Stokes and were carried out in the Animal Lovers Against Animal Cruelty (ALAAC)-accredited LARC animal research facility at the Rockefeller University. This work was supported by a grant R01-AR27883 from the National Institutes of Health. E.F. is an investigator of the Howard Hughes Medical Institute. X.W. was an Anna D. Barker Fellow in Basic Cancer Research funded by the American Association for Cancer Research and is currently a postdoctoral fellow of the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kogan Ilana, 2002, Methods Mol Med, V70, P143; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Sun DM, 2001, J CELL SCI, V114, P161; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu XF, 2006, TRENDS CELL BIOL, V16, P135, DOI 10.1016/j.tcb.2006.01.004; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yarm F, 2001, CURR OPIN MICROBIOL, V4, P696, DOI 10.1016/S1369-5274(01)00271-5; Yvon AMC, 2000, J CELL BIOL, V151, P1003, DOI 10.1083/jcb.151.5.1003	56	211	223	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					137	148		10.1016/j.cell.2008.07.045	http://dx.doi.org/10.1016/j.cell.2008.07.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854161	Bronze, Green Accepted			2022-12-24	WOS:000259728100015
J	Medzhitov, R; Littman, D				Medzhitov, Ruslan; Littman, Dan			HIV immunology needs a new direction	NATURE			English	Editorial Material									[Medzhitov, Ruslan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Littman, Dan] NYU, New York, NY 10016 USA	Yale University; New York University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, 300 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu; dan.littman@med.nyu.edu						Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012	3	21	23	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					591	591		10.1038/455591a	http://dx.doi.org/10.1038/455591a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833256				2022-12-24	WOS:000259639700022
J	Sprake, C; Cantillon, P; Metcalf, J; Spencer, J				Sprake, Caroline; Cantillon, Peter; Metcalf, Jane; Spencer, John			Teaching rounds - Teaching in an ambulatory care setting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							12 TIPS; EDUCATION	Four third- year medical students are coming to the clinic for half a day a week. They have just finished their basic clinical skills training and the aim of their attendance is to further develop their history taking and examination skills in the maelstrom of clinical practice. What organisational issues do you need to consider?	[Sprake, Caroline; Metcalf, Jane; Spencer, John] Univ Newcastle, Sch Med Sci Educ Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Cantillon, Peter] Natl Univ Ireland Univ Coll Galway, Dept Gen Practice, Galway, Ireland	Newcastle University - UK; Ollscoil na Gaillimhe-University of Galway	Spencer, J (corresponding author), Univ Newcastle, Sch Med Sci Educ Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.a.spencer@ncl.ac.uk						*CAN I HLTH INF, 1998, NAT AMB CAR REP SYST; Dent JA, 2001, MED TEACH, V23, P345, DOI 10.1080/01421590120057012; Howe A, 2003, BRIT MED J, V327, P326, DOI 10.1136/bmj.327.7410.326; Irby DM, 2008, BRIT MED J, V336, P384, DOI 10.1136/bmj.39456.727199.AD; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; Ker JS, 2002, MED TEACH, V24, P437, DOI 10.1080/01421590220145842; Lipsky MS, 1999, MED TEACH, V21, P469; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schuwirth LWT, 2006, BMJ-BRIT MED J, V333, P544, DOI 10.1136/bmj.38952.701875.94; Smail S, 2006, EDUC PRIM CARE, V17, P171, DOI 10.1080/14739879.2006.11864055; Spencer J, 2000, MED EDUC, V34, P851, DOI 10.1046/j.1365-2923.2000.00779.x; Spencer J, 2003, BMJ-BRIT MED J, V326, P591, DOI 10.1136/bmj.326.7389.591; WOOLLISCROFT JO, 1989, ACAD MED, V64, P644, DOI 10.1097/00001888-198911000-00002	13	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2008	337	7671							a1156	10.1136/bmj.a1156	http://dx.doi.org/10.1136/bmj.a1156			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18768554				2022-12-24	WOS:000259622000036
J	Lines, J; Schapira, A; Smith, T				Lines, Jo; Schapira, Allan; Smith, Tom			Tackling malaria today	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VECTOR CONTROL; IMMUNIZATION; MORTALITY; IMPACT		[Lines, Jo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Schapira, Allan; Smith, Tom] Swiss Trop Inst, CH-4051 Basel, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute	Lines, J (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	jo.lines@lshtm.ac.uk	Smith, Thomas/B-5569-2015	Smith, Thomas/0000-0002-3650-9381; Lines, Jo/0000-0001-5380-4916				*AFR UN, 2007, 3 ORD SESS AFR UN C; [Anonymous], CONT MAL MULT RES CA; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Bill & Melinda Gates Foundation, 2007, MAL FOR COLL INN IMP; Bradley DJ., 1991, DIS MORTALITY SUBSAH, P248; Casman EA, 2002, CONTEXTUAL DETERMINA; de Savigny Don, 2008, FIXING HLTH SYSTEMS; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; GRAMICCIA G, 1988, PRINCIPLES PRACTICE, P1335; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Molineaux L, 2020, GARKI PROJECT RES EP, V8; MOUCHET J, 1953, CAHIERS ORSTOM EMP, V1, P39; Najera JA., 1998, MALARIA EPIDEMICS DE; Ottesen EA, 1997, ERADICATION INFECT D, P47; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; PAYNE D, 1976, B WORLD HEALTH ORGAN, V54, P369; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x; TATEM AJ, 2007, PLOS 1, V12, pE1298; *UN, SECR GEN ANN ROLL BA; Webster J, 2005, LANCET INFECT DIS, V5, P709, DOI 10.1016/S1473-3099(05)70269-3; *WHO, 1968, WHO TECH REP SER, P382; World Health Organization, 2007, MAL EL FIELD MAN LOW; WRIGHT JW, 1972, ANNU REV ENTOMOL, V17, P75, DOI 10.1146/annurev.en.17.010172.000451; ZAHAR AR, 1984, B WORLD HEALTH ORGAN, V62, P89	26	11	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2008	337	7667							a869	10.1136/bmj.a869	http://dx.doi.org/10.1136/bmj.a869			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346FD	18713802	Green Accepted			2022-12-24	WOS:000259053100024
J	Singh, R; Jamieson, A; Cresswell, P				Singh, Reshma; Jamieson, Amanda; Cresswell, Peter			GILT is a critical host factor for Listeria monocytogenes infection	NATURE			English	Article							THIOL REDUCTASE GILT; MATURATION; HEPATOCYTES; CYTOLYSINS; MUTANTS; PEPTIDE; COMPLEX; PREPORE; SPREAD; GROWTH	Listeria monocytogenes is a Gram- positive, intracellular, foodborne pathogen that can cause severe illness in humans and animals. On infection, it is actively phagocytosed by macrophages(1); it then escapes from the phagosome, replicates in the cytosol, and subsequently spreads from cell to cell by a non- lytic mechanism driven by actin polymerization(2). Penetration of the phagosomal membrane is initiated by the secreted haemolysin listeriolysin O ( LLO), which is essential for vacuolar escape in vitro and for virulence in animal models of infection(3). Reduction is required to activate the lytic activity of LLO in vitro(4-6), and we show here that reduction by the enzyme gamma-interferon- inducible lysosomal thiol reductase ( GILT, also called Ifi30) is responsible for the activation of LLO in vivo. GILT is a soluble thiol reductase expressed constitutively within the lysosomes of antigen- presenting cells(7,8), and it accumulates in macrophage phagosomes as they mature into phagolysosomes(9). The enzyme is delivered by a mannose-6-phosphate receptor- dependent mechanism to the endocytic pathway, where amino- and carboxy- terminal pro- peptides are cleaved to generate a 30- kDa mature enzyme(7,8,10). The active site of GILT contains two cysteine residues in a CXXC motif that catalyses the reduction of disulphide bonds(7,8). Mice lacking GILT are deficient in generating major histocompatibility complex class- II- restricted CD4(+) T-cell responses to protein antigens that contain disulphide bonds(11,12). Here we show that these mice are resistant to L. monocytogenes infection. Replication of the organism in GILT- negative macrophages, or macrophages expressing an enzymatically inactive GILT mutant, is impaired because of delayed escape from the phagosome. GILT activates LLO within the phagosome by the thiol reductase mechanism shared by members of the thioredoxin family. In addition, purified GILT activates recombinant LLO, facilitating membrane permeabilization and red blood cell lysis. The data show that GILT is a critical host factor that facilitates L. monocytogenes infection.	[Singh, Reshma; Jamieson, Amanda; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06250 USA; [Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06250 USA	Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06250 USA.	peter.cresswell@yale.edu	Jamieson, Amanda/U-7169-2019	Jamieson, Amanda/0000-0002-5781-9231	NIH [AI023081]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023081, R37AI023081] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to D. Portnoy for advice and reagents, and to N. Dometios for manuscript preparation. We acknowledge the valuable contribution of the late M. Pypaert to the electron microscopy. This work was supported by NIH AI023081 (P.C.) and the Howard Hughes Medical Institute (P.C., R.S.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; ALOUF JE, 2005, BACT TOXINS COMPREHE, P643; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; BARRY RA, 1992, INFECT IMMUN, V60, P1625, DOI 10.1128/IAI.60.4.1625-1632.1992; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bouwer HGA, 1998, INFECT IMMUN, V66, P2814, DOI 10.1128/IAI.66.6.2814-2817.1998; BRYANT RE, 1980, J INFECT DIS, V142, P594, DOI 10.1093/infdis/142.4.594; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; Haschtmann D, 2005, MICROBES INFECT, V7, P1177, DOI 10.1016/j.micinf.2005.03.031; Hastings KT, 2006, J IMMUNOL, V177, P8569, DOI 10.4049/jimmunol.177.12.8569; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Phan UT, 2002, P NATL ACAD SCI USA, V99, P12298, DOI 10.1073/pnas.182430499; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; PINKNEY M, 1989, INFECT IMMUN, V57, P2553, DOI 10.1128/IAI.57.8.2553-2558.1989; Pizarro-Cerda J, 2004, CR BIOL, V327, P521, DOI 10.1016/j.crvi.2004.05.001; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Sealy R, 2008, CLIN VACCINE IMMUNOL, V15, P713, DOI 10.1128/CVI.00412-07; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Walker KW, 1997, J BIOL CHEM, V272, P8845; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	30	112	116	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1244	U55		10.1038/nature07344	http://dx.doi.org/10.1038/nature07344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815593	Green Accepted			2022-12-24	WOS:000260462100045
J	Stice, E; Spoor, S; Bohon, C; Small, DM				Stice, E.; Spoor, S.; Bohon, C.; Small, D. M.			Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele	SCIENCE			English	Article							DOPAMINE-RECEPTOR GENE; BINDING CHARACTERISTICS; HEALTHY-VOLUNTEERS; ZUCKER RATS; REWARD; POLYMORPHISMS; REINFORCEMENT; ASSOCIATION; EXPRESSION; PREDICTION	The dorsal striatum plays a role in consummatory food reward, and striatal dopamine receptors are reduced in obese individuals, relative to lean individuals, which suggests that the striatum and dopaminergic signaling in the striatum may contribute to the development of obesity. Thus, we tested whether striatal activation in response to food intake is related to current and future increases in body mass and whether these relations are moderated by the presence of the A1 allele of the TaqIA restriction fragment length polymorphism, which is associated with dopamine D2 receptor (DRD2) gene binding in the striatum and compromised striatal dopamine signaling. Cross- sectional and prospective data from two functional magnetic resonance imaging studies support these hypotheses, which implies that individuals may overeat to compensate for a hypofunctioning dorsal striatum, particularly those with genetic polymorphisms thought to attenuate dopamine signaling in this region.	[Stice, E.; Spoor, S.; Bohon, C.] Oregon Res Inst, Eugene, OR 97403 USA; [Stice, E.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Bohon, C.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Small, D. M.] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Small, D. M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Oregon Research Institute; University of Texas System; University of Texas Austin; University of Oregon; Yale University; The John B Pierce Laboratory, Inc; Yale University	Stice, E (corresponding author), Oregon Res Inst, 1715 Franklin Blvd, Eugene, OR 97403 USA.	estice@ori.org	Kauk, Rachel C/H-3622-2012	Bohon, Cara/0000-0001-9978-3727; Small, Dana/0000-0001-7363-1100	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH081588, R01MH064560] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH064560-05, R01 MH064560, F31 MH081588-01A2, F31 MH081588] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Blum K, 1996, PHARMACOGENETICS, V6, P297, DOI 10.1097/00008571-199608000-00003; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Comings DE, 2000, PROG BRAIN RES, V126, P325; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; de Leon J, 2007, J CLIN PSYCHOPHARM, V27, P22, DOI 10.1097/JCP.0b013e31802e513a; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Leddy JJ, 2004, OBES RES, V12, P224, DOI 10.1038/oby.2004.29; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Orosco M, 1996, APPETITE, V26, P1, DOI 10.1006/appe.1996.0001; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Spitz MR, 2000, NUTR RES, V20, P371, DOI 10.1016/S0271-5317(00)00130-5; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tataranni PA, 2001, DIABETES, V50, P901, DOI 10.2337/diabetes.50.4.901; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tupala E, 2003, NEUROIMAGE, V19, P145, DOI 10.1016/S1053-8119(03)00060-0; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	33	602	614	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					449	452		10.1126/science.1161550	http://dx.doi.org/10.1126/science.1161550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927395	Green Accepted			2022-12-24	WOS:000260094500049
J	Simmons, C; Farrar, J				Simmons, Cameron; Farrar, Jeremy			Insights into inflammation and influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							H5N1 INFECTION		[Simmons, Cameron; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford	Simmons, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.		Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022	Simmons, Cameron P/0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [079864] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	5	37	40	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1621	1623		10.1056/NEJMcibr0805865	http://dx.doi.org/10.1056/NEJMcibr0805865			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843127	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000259903100015
J	Mandal, PK; Kazazian, HH				Mandal, Prabhat K.; Kazazian, Haig H., Jr.			SnapShot: Vertebrate transposons	CELL			English	Editorial Material							GENOME; ELEMENTS		[Mandal, Prabhat K.; Kazazian, Haig H., Jr.] Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mandal, PK (corresponding author), Hosp Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005	8	54	56	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1							192.e1	10.1016/j.cell.2008.09.028	http://dx.doi.org/10.1016/j.cell.2008.09.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854165	Bronze			2022-12-24	WOS:000259728100021
J	Williams, RS; Moncalian, G; Williams, JS; Yamada, Y; Limbo, O; Shin, DS; Groocock, LM; Cahill, D; Hitomi, C; Guenther, G; Moiani, D; Carney, JP; Russell, P; Tainer, JA				Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Cahill, Dana; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Carney, James P.; Russell, Paul; Tainer, John A.			Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair	CELL			English	Article							TELANGIECTASIA-LIKE DISORDER; SACCHAROMYCES-CEREVISIAE MRE11; STRUCTURAL BASIS; DAMAGE RESPONSE; PROTEIN COMPLEX; ATM ACTIVATION; REPLICATION; RECOMBINATION; BINDING; RAD50	Mre11 forms the core of the multifunctional Mre11-Rad50-Nbs1 (MRN) complex that detects DNA double-strand breaks (DSBs), activates the ATM checkpoint kinase, and initiates homologous recombination (HR) repair of DSBs. To define the roles of Mre11 in both DNA bridging and nucleolytic processing during initiation of DSB repair, we combined small-angle X-ray scattering (SAXS) and crystal structures of Pyrococcus furiosus Mre11 dimers bound to DNA with mutational analyses of fission yeast Mre11. The Mre11 dimer adopts a four-lobed U-shaped structure that is critical for proper MRN complex assembly and for binding and aligning DNA ends. Further, mutations blocking Mre11 endonuclease activity impair cell survival after DSB induction without compromising MRN complex assembly or Mre11-dependant recruitment of Ctp1, an HR factor, to DSBs. These results show how Mre11 dimerization and nuclease activities initiate repair of DSBs and collapsed replication forks, as well as provide a molecular foundation for understanding cancer-causing Mre11 mutations in ataxia telangiectasia-like disorder (ATLD).	[Williams, R. Scott; Moncalian, Gabriel; Williams, Jessica S.; Yamada, Yoshiki; Limbo, Oliver; Shin, David S.; Groocock, Lynda M.; Hitomi, Chiharu; Guenther, Grant; Moiani, Davide; Russell, Paul; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Russell, Paul] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Moncalian, Gabriel; Shin, David S.; Hitomi, Chiharu; Moiani, Davide; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cahill, Dana; Carney, James P.] Univ Maryland, Sch Med, Radiat Oncol Res Lab, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Dept Mol Biol, Berkeley, CA 94720 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB4, La Jolla, CA 92037 USA.	prussell@scripps.edu; jat@scripps.edu	Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020; Moncalian, Gabriel/K-3493-2014; moiani, davide/AAX-6790-2021; Williams, R Scott/A-6059-2015	Tainer, John/0000-0003-1659-2429; Moncalian, Gabriel/0000-0002-3007-6490; Williams, R Scott/0000-0002-4610-8397; Limbo, Oliver/0000-0003-1686-1414	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Skaggs Institute for Chemical Biology; Uehara Memorial Foundation; National Cancer Institute [CA117638, CA92584, CA77325]; U.S. Department of Energy programs IDAT; MAGGIE [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA077325, R01CA117638] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Skaggs Institute for Chemical Biology; Uehara Memorial Foundation(Uehara Memorial Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy programs IDAT(United States Department of Energy (DOE)); MAGGIE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.S.W. is supported by the Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and the Skaggs Institute for Chemical Biology fellowships. Y.Y. is supported by a Uehara Memorial Foundation fellowship. Work on the Mre11 complex in the authors' laboratories is supported in part by National Cancer Institute grants CA117638, CA92584, and CA77325. Lawrence Berkeley National Laboratory efforts are supported in part by U.S. Department of Energy programs IDAT (for Integrating crystallography and X-ray scattering) and MAGGIE (for defining Pyrococus complexes) under contract number DE-AC02-05CH11231. We thank Scott Classen, Michal Hammel, Greg Hura, and Susan Tsutakawa for assistance with SAXS and X-ray data collection at the Advanced Light Source SIBYLS beamline and Brian Chapados for discussions and comments.	Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chahwan C, 2003, MOL CELL BIOL, V23, P6564, DOI 10.1128/MCB.23.18.6564-6573.2003; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Moreau S, 2001, GENETICS, V159, P1423; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wen Q, 2008, MOL BIOL CELL, V19, P1693, DOI 10.1091/mbc.E07-09-0975; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	41	359	363	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					97	109		10.1016/j.cell.2008.08.017	http://dx.doi.org/10.1016/j.cell.2008.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854158	Green Accepted, Bronze			2022-12-24	WOS:000259728100012
J	Tang, C; Louis, JM; Aniana, A; Suh, JY; Clore, GM				Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius			Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease	NATURE			English	Article							ENCOUNTER COMPLEXES; NMR; BINDING; KINETICS; ENHANCEMENT; PRECURSOR; DYNAMICS; CLEAVAGE; ASSOCIATION; INHIBITORS	HIV- 1 protease processes the Gag and Gag- Pol polyproteins into mature structural and functional proteins, including itself, and is therefore indispensable for viral maturation(1,2). The mature protease is active only as a dimer(3-5) with each subunit contributing catalytic residues(6). The full- length transframe region protease precursor appears to be monomeric yet undergoes maturation via intramolecular cleavage of a putative precursor dimer(5,7-11), concomitant with the appearance of mature- like catalytic activity(7,9). How such intramolecular cleavage can occur when the amino and carboxy termini of the mature protease are part of an intersubunit beta-sheet located distal from the active site is unclear. Here we visualize the early events in N- terminal autoprocessing using an inactive mini- precursor with a four- residue N- terminal extension that mimics the transframe region protease precursor(5,12). Using paramagnetic relaxation enhancement, a technique that is exquisitely sensitive to the presence of minor species(13-16), we show that the mini- precursor forms highly transient, lowly populated (3-5%) dimeric encounter complexes that involve the mature dimer interface but occupy a wide range of subunit orientations relative to the mature dimer. Furthermore, the occupancy of the mature dimer configuration constitutes a very small fraction of the self- associated species ( accounting for the very low enzymatic activity of the protease precursor), and the N- terminal extension makes transient intra- and intersubunit contacts with the substrate binding site and is therefore available for autocleavage when the correct dimer orientation is sampled within the encounter complex ensemble.	[Tang, Chun; Louis, John M.; Aniana, Annie; Suh, Jeong-Yong; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500; Louis, John M/0000-0002-0052-1899	Intramural Program of the NIH; NIDDK; AIDS Targeted Antiviral program	Intramural Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AIDS Targeted Antiviral program	We thank R. Ishima for providing initial backbone assignments for the <SUP>SFNF</SUP>PR(D25N) protease construct; C. Schwieters for many discussions; Y. Sheng for help with the CS-Rosetta calculations; Y. Kim for providing the code for structure clustering and d.r.m.s. calculations; and J. Sayer for MALDI measurements. This work was supported by funds from the Intramural Program of the NIH, NIDDK and the AIDS Targeted Antiviral program of the Office of the Director of the NIH (to G.M.C.).	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; CO E, 1994, BIOCHEMISTRY-US, V33, P1248, DOI 10.1021/bi00171a027; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 1999, J BIOL CHEM, V274, P23437, DOI 10.1074/jbc.274.33.23437; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477	40	101	103	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					693	U92		10.1038/nature07342	http://dx.doi.org/10.1038/nature07342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833280	Green Accepted			2022-12-24	WOS:000259639700053
J	van Dam, RM; Li, T; Spiegelman, D; Franco, OH; Hu, FB				van Dam, Rob M.; Li, Tricia; Spiegelman, Donna; Franco, Oscar H.; Hu, Frank B.			Combined impact of lifestyle factors on mortality: prospective cohort study in US women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; ATTRIBUTABLE RISK; DIETARY-FAT; PREVENTION; METAANALYSIS; MEN; CANCER	Objective To evaluate the impact of combinations of lifestyle factors on mortality in middle aged women. Design Prospective cohort study. Setting Nurses' health study, United States. Participants 77 782 women aged 34 to 59 years and free from cardiovascular disease and cancer in 1980. Main outcome measure Relative risk of mortality during 24 years of follow- up in relation to five lifestyle factors ( cigarette smoking, being overweight, taking little moderate to vigorous physical activity, no light to moderate alcohol intake, and low diet quality score). Results 8882 deaths were documented, including 1790 from cardiovascular disease and 4527 from cancer. Each lifestyle factor independently and significantly predicted mortality. Relative risks for five compared with zero lifestyle risk factors were 3.26 ( 95% confidence interval 2.45 to 4.34) for cancer mortality, 8.17 ( 4.96 to 13.47) for cardiovascular mortality, and 4.31 ( 3.51 to 5.31) for all cause mortality. A total of 28% ( 25% to 31%) of deaths during follow- up could be attributed to smoking and 55% ( 47% to 62%) to the combination of smoking, being overweight, lack of physical activity, and a low diet quality. Additionally considering alcohol intake did not substantially change this estimate. Conclusions These results indicate that adherence to lifestyle guidelines is associated with markedly lower mortality in middle aged women. Both efforts to eradicate cigarette smoking and those to stimulate regular physical activity and a healthy diet should be intensified.	[van Dam, Rob M.; Li, Tricia; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Franco, Oscar H.] Unilever Corp Res, Sharnbrook MK44 1LQ, Beds, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Unilever	van Dam, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	van Dam, Rob M/F-9674-2010; Hu, Frank/C-1919-2013; Franco, Óscar H/ABE-2305-2020	van Dam, Rob M/0000-0002-7354-8734; Franco, Óscar H/0000-0002-4606-4929	National Institutes of Health [CA87969, HL60712]; Peanut Foundation; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peanut Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) grants CA87969 and HL60712. RMvD was partly supported by an unrestricted research grant from the Peanut Foundation. The funding sources had no role in the collection, management, analysis, or interpretation of the data and had no role in the preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Colhoun H, 1997, BRIT MED J, V314, P1164, DOI 10.1136/bmj.314.7088.1164; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Graubard BI, 2005, BIOMETRICS, V61, P847, DOI 10.1111/j.1541-0420.2005.00355.x; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; VANDERWILK EA, 2008, PREVALENCE OVERWEIGH; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Wannamethee SG, 1998, ARCH INTERN MED, V158, P2433, DOI 10.1001/archinte.158.22.2433; Willett WC, 1998, OXFORD SCHOLARSHIP O; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 1997, WHO PUBL, VWHO/NUT/NCD/98.1	42	91	93	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1440	10.1136/bmj.a1440	http://dx.doi.org/10.1136/bmj.a1440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18796495	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000259797600040
J	Muller, FJ; Laurent, LC; Kostka, D; Ulitsky, I; Williams, R; Lu, C; Park, IH; Rao, MS; Shamir, R; Schwartz, PH; Schmidt, NO; Loring, JF				Mueller, Franz-Josef; Laurent, Louise C.; Kostka, Dennis; Ulitsky, Igor; Williams, Roy; Lu, Christina; Park, In-Hyun; Rao, Mahendra S.; Shamir, Ron; Schwartz, Philip H.; Schmidt, Nils O.; Loring, Jeanne F.			Regulatory networks define phenotypic classes of human stem cell lines	NATURE			English	Article							GENE-EXPRESSION PROFILES; CLASS DISCOVERY; BIOLOGICAL NETWORKS; PROGENITOR CELLS; GENOME-WIDE; PLURIPOTENCY; DIFFERENTIATION; CANCER	Stem cells are defined as self- renewing cell populations that can differentiate into multiple distinct cell types. However, hundreds of different human cell lines from embryonic, fetal and adult sources have been called stem cells, even though they range from pluripotent cells - typified by embryonic stem cells, which are capable of virtually unlimited proliferation and differentiation - to adult stem cell lines, which can generate a far more limited repertoire of differentiated cell types. The rapid increase in reports of new sources of stem cells and their anticipated value to regenerative medicine(1,2) has highlighted the need for a general, reproducible method for classification of these cells(3). We report here the creation and analysis of a database of global gene expression profiles ( which we call the 'stem cell matrix') that enables the classification of cultured human stem cells in the context of a wide variety of pluripotent, multipotent and differentiated cell types. Using an unsupervised clustering method(4,5) to categorize a collection of similar to 150 cell samples, we discovered that pluripotent stem cell lines group together, whereas other cell types, including brain-derived neural stem cell lines, are very diverse. Using further bioinformatic analysis(6) we uncovered a protein - protein network (PluriNet) that is shared by the pluripotent cells ( embryonic stem cells, embryonal carcinomas and induced pluripotent cells). Analysis of published data showed that the PluriNet seems to be a common characteristic of pluripotent cells, including mouse embryonic stem and induced pluripotent cells and human oocytes. Our results offer a new strategy for classifying stem cells and support the idea that pluripotency and self- renewal are under tight control by specific molecular networks.	[Mueller, Franz-Josef; Laurent, Louise C.; Lu, Christina; Loring, Jeanne F.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Mueller, Franz-Josef] Univ Hosp Schleswig Holstein, Ctr Psychiat, ZIP Kiel, D-24105 Kiel, Germany; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92035 USA; [Kostka, Dennis] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Williams, Roy; Loring, Jeanne F.] Burnham Inst, La Jolla, CA 92037 USA; [Park, In-Hyun] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun] Dana Farber Canc Inst, Boston, MA 02115 USA; [Rao, Mahendra S.] Invitrogen Co, Frederick, MD 21704 USA; [Rao, Mahendra S.] Buck Inst Aging, Ctr Stem Cell Biol, Novato, CA 94945 USA; [Schwartz, Philip H.] Childrens Hosp Orange Cty, Res Inst, Ctr Res Neurosci, Orange, CA 92868 USA; [Schwartz, Philip H.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Schmidt, Nils O.] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, D-20246 Hamburg, Germany	Scripps Research Institute; University of Kiel; Schleswig Holstein University Hospital; University of California System; University of California San Diego; Max Planck Society; Tel Aviv University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Thermo Fisher Scientific; Buck Institute for Research on Aging; Childrens Hospital of Orange County; University of California System; University of California Irvine; University of Hamburg; University Medical Center Hamburg-Eppendorf	Muller, FJ (corresponding author), Scripps Res Inst, Ctr Regenerat Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fj.mueller@zip-kiel.de; jloring@scripps.edu	Müller, Franz-Josef/E-3336-2010; Ulitsky, Igor/D-4828-2009; Schmidt, Nils Ole/D-5696-2014; Loring, Jeanne F/A-1620-2011; Shamir, Ron/E-6514-2011	Müller, Franz-Josef/0000-0001-9478-8430; Schmidt, Nils Ole/0000-0001-6910-8843; Loring, Jeanne F/0000-0001-6226-9767; Shamir, Ron/0000-0003-1889-9870; Ulitsky, Igor/0000-0003-0555-6561; Williams, Roy/0000-0002-5442-9166; Laurent, Louise/0000-0002-2095-7534	Christian- Abrechts University Young Investigator Award; Hamburger Krebsgesellschaft Grant; Edmond J. Safra Bioinformatics program fellowship at Tel- Aviv University (I.U.); Converging Technologies Program of The Israel Science Foundation [1767.07]; Raymond and Beverly Sackler Chair in Bioinformatics; Reproductive Scientist Development Program Scholar Award [K12 5K12HD000849-20]; California Institute for Regenerative Medicine Clinical Scholar Award [NIH P20 GM075059-01]; Alzheimer's Association;  [SFB-654/C5]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER	Christian- Abrechts University Young Investigator Award; Hamburger Krebsgesellschaft Grant; Edmond J. Safra Bioinformatics program fellowship at Tel- Aviv University (I.U.); Converging Technologies Program of The Israel Science Foundation(Israel Science Foundation); Raymond and Beverly Sackler Chair in Bioinformatics; Reproductive Scientist Development Program Scholar Award; California Institute for Regenerative Medicine Clinical Scholar Award; Alzheimer's Association(Alzheimer's Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Stubban, H. Dittmer, S. Zapf and H. Meissner for their work with various cell cultures. We are grateful to D. Wakeman, R. Gonzalez, S. McKercher, J. P. Lee, H.- S. Park and S. Y. Moon for sharing their cell preparations for the type collection. We are also grateful to R. Wesselschmidt and M. Pera for their unique GCT lines and G. Daley for providing human iPSCs. A. M. Kocabas and J. Cibelli shared their human oocyte expression data with us. A. Barsky let us use the Cerebral 2.0 plug- in before its publication. M. Rosentraeger helped to compile the cell culture metadata. We thank J. Aldenhoff, D. Hinze- Selch, M. Westphal, K. Lamszus, U. Kehler, D. Barker and A. Fritz for their support and discussions of this project. This study has been supported by the following grants and awards: Christian- Abrechts University Young Investigator Award (F.- J.M.), SFB-654/C5 Sleep and Plasticity (F.- J. M. and D. Hinze- Selch), Hamburger Krebsgesellschaft Grant (N.O.S.), Edmond J. Safra Bioinformatics program fellowship at Tel- Aviv University (I.U.), Converging Technologies Program of The Israel Science Foundation Grant No 1767.07 (R.S.), Raymond and Beverly Sackler Chair in Bioinformatics (R.S.), Reproductive Scientist Development Program Scholar Award K12 5K12HD000849-20 (L.C.L.), California Institute for Regenerative Medicine Clinical Scholar Award (L.C.L.), NIH P20 GM075059-01 (J.F.L.), the Alzheimer's Association (J.F.L.), and anonymous donations in support of stem cell research.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Donoho D., 2003, P NIPS; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gao Y, 2005, BIOINFORMATICS, V21, P3970, DOI 10.1093/bioinformatics/bti653; Goldman B, 2008, NATURE REPORTS STEM, DOI [10.1038/stemcells.2008.26, DOI 10.1038/STEMCELLS.2008.26]; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Kornblum HI, 2001, NAT REV NEUROSCI, V2, P843, DOI 10.1038/35097597; Lacayo NJ, 2004, BLOOD, V104, P2646, DOI 10.1182/blood-2003-12-4449; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ploner A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-80; R Development Core Team, 2007, R LANG ENV STAT COMP; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng XM, 2004, RESTOR NEUROL NEUROS, V22, P421	41	263	265	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					401	U55		10.1038/nature07213	http://dx.doi.org/10.1038/nature07213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18724358	Green Accepted			2022-12-24	WOS:000259265200047
J	Power, C; Rasko, JEJ				Power, Carl; Rasko, John E. J.			Whither prometheus' liver? Greek myth and the science of regeneration	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Stem-cell biologists and those involved in regenerative medicine are fascinated by the story of Prometheus, the Greek god whose immortal liver was feasted on day after day by Zeus' eagle. This myth invariably provokes the question: Did the ancient Greeks know about the liver's amazing capacity for self-repair? The authors address this question by exploring the origins of Greek myth and medicine, adopting a 2-fold strategy. First, the authors consider what opportunities the ancient Greeks had to learn about the liver's structure and function. This involves a discussion of early battlefield surgery, the beginnings of anatomical research, and the ancient art of liver augury. In addition, the authors consider how the Greeks understood Prometheus' immortal liver. Not only do the authors examine the general theme of regeneration in Greek mythology, they survey several scholarly interpretations of Prometheus' torture.	[Rasko, John E. J.] Univ Sydney, Centenary Inst, Newtown, NSW 2042, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney	Rasko, JEJ (corresponding author), Univ Sydney, Centenary Inst, Locked Bag 6, Newtown, NSW 2042, Australia.	j.rasko@cenint.org	Rasko, John EJ/F-5754-2013	rasko, John/0000-0003-2975-807X				AESCHYLUS, 1952, COMPLETE PLAYS AESCH, P43; ALLEN DS, 2000, WORLD PROMETHEUS POL, P33; ANDRAL G, 1843, MED CLIN, V1, P345; ARISTOTLE, 1965, HIST ANIMALIUM, V1, P57; AURELIANUS C, 1950, ACUTE DIS CHRONIC DI, P752; BURKERT W, 1992, ORIENTALIZING REVOLU, P46; CALDWELL RS, 1987, HESIODS THEOGONY, P58; CHEN TSN, 1994, J ROY SOC MED, V87, P754; CRUVEILHIER LJB, 1829, ANATOMIE PATHOLOGIQU, V33, P398; Detienne, 1989, CUISINE SACRIFICE GR, P21; EDMUNDS L, 1990, APPROACHES GREEK MYT, P141; FULGENTIUS FP, 1971, FULGENTIUS MYTHOGRAP, P71; Gluck T, 1883, ARCH KLIN CHIR, V29, P139; Goss Richard J., 1991, P7; HOMER, 2003, ODYSSEY, P154; Homer, 1999, ILIAD; JASTROW M, 1907, T COLL PHYS PHILA, V29, P117; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; KORNER O, 1922, MUNCHEN MED WCHNSHCR, V69, P1484; LONGRIGG J, 1993, GREEK RATIONAL MED P, P184; LONGRIGG J, 1998, GREEK MED HEROIC HEL, P176; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Milne LS, 1909, J PATHOL BACTERIOL, V13, P127, DOI 10.1002/path.1700130121; PENGLASE C, 1994, GREEK MYTHS MESOPOTA, P197; Pistoi S, 1996, FASEB J, V10, P819, DOI 10.1096/fasebj.10.8.8666158; PONFICK E, 1889, VIRCHOWS ARCH PATH A, V118, P209; PRIORESCHI P, 1996, HIST MED, V1, P38; Reuben A, 2004, HEPATOLOGY, V39, P1460, DOI 10.1002/hep.20227; Richardson N. J., 1985, GREEK RELIG SOC, P50; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; SALAZAR CF, 2000, TREATMENT WAR WOUNDS, P20; Saunders KB, 1999, CLASSICAL QUART, V49, P345, DOI 10.1093/cq/49.2.345; Schneider MD, 2004, NATURE, V432, P451, DOI 10.1038/432451a; Spyridonidis A, 2005, STEM CELL REV, V1, P37, DOI 10.1385/SCR:1:1:037; TILLMANNS H, 1879, VIRCHOWS ARCH, V78, P437; van Gend D, 2006, HUM LIFE REV, V32, P15; Vernant Jean-Pierre, 1991, MORTALS IMMORTALS CO, P27; VONMEISTER E, 1994, BEITR PATHOL ANAT, V15, P1; VONSTADEN H, 1989, HEROPHILUS ART MED E, P162; West M. L., 1966, HESIOD THEOGONY; West Stephanie, 1994, MUSEUM HELVETICUM, V51, P129; 1931, HIPPOCRATES, P203	42	22	22	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					421	W79		10.7326/0003-4819-149-6-200809160-00009	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794562				2022-12-24	WOS:000259230200007
J	Beaglehole, R; Epping-Jordan, J; Patel, V; Chopra, M; Ebrahim, S; Kidd, M; Haines, A				Beaglehole, Robert; Epping-Jordan, JoAnne; Patel, Vikram; Chopra, Mickey; Ebrahim, Shah; Kidd, Michael; Haines, Andy			Alma-Ata: Rebirth and revision 3 - Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care	LANCET			English	Review							COMMON MENTAL-DISORDERS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; MAINTENANCE ORGANIZATION; ANTIRETROVIRAL TREATMENT; PSYCHIATRIC KNOWLEDGE; DIABETES PREVENTION; INTEGRATED CARE; HUMAN-RESOURCES; DEPRESSION	The burden of chronic diseases, such as heart disease, cancer, diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is needed in primary health care. Management of chronic diseases is fundamentally different from acute care, relying on several features: opportunistic case finding for assessment of risk factors, detection of early disease, and identification of high risk status; a combination of pharmacological and psychosocial interventions, often in a stepped-care fashion; and long-term follow-up with regular monitoring and promotion of adherence to treatment. To meet the challenge of chronic diseases, primary health care will have to be strengthened substantially. In the many countries with shortages of primary-care doctors, non-physician clinicians will have a leading role in preventing and managing chronic diseases, and these personnel need appropriate training and continuous quality assurance mechanisms. More evidence is needed about the cost-effectiveness of prevention and treatment strategies in primary health care. Research on scaling-up should be embedded in large-scale delivery programmes for chronic diseases with a strong emphasis on assessment.	[Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Patel, Vikram; Ebrahim, Shah; Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Chopra, Mickey] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Kidd, Michael] Univ Sydney, Dept Gen Practice, Sydney, NSW 2006, Australia	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz		Patel, Vikram/0000-0003-1066-8584; Haines, Andy/0000-0002-8053-4605	Wellcome Trust Senior Clinical Research Fellowship	Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust)	We thank Donna Bowers for help with references. VP is supported by a Wellcome Trust Senior Clinical Research Fellowship.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2007, LANCET; [Anonymous], INT DRUG PRIC IND GU; [Anonymous], 2005, PREV CHRON DIS VIT I; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; BABOR TF, 1994, ADDICTION, V89, P657, DOI 10.1111/j.1360-0443.1994.tb00944.x; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Berwick DM, 2004, BRIT MED J, V328, P1124, DOI 10.1136/bmj.328.7448.1124; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brownstein JN, 2007, AM J PREV MED, V32, P435, DOI 10.1016/j.amepre.2007.01.011; Chatterjee S, 2008, WORLD PSYCHIATRY, V7, P39; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Croudace T, 2003, BRIT J PSYCHIAT, V182, P20, DOI 10.1192/bjp.182.1.20; Davis RM, 2000, BRIT MED J, V320, P525, DOI 10.1136/bmj.320.7234.525; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; EBRAHIM S, 1996, HLTH PROMOTION OLDER; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk M, 2004, INT J MENT HLTH, V33, P4, DOI DOI 10.1080/00207411.2004.11043367; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Glasgow RE, 2004, AM J PREV MED, V27, P88, DOI 10.1016/j.amepre.2004.04.019; Global Health Workforce Alliance, HLTH WORK ALL ALL HL; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Henderson DC, 2005, J NERV MENT DIS, V193, P551, DOI 10.1097/01.nmd.0000172869.01711.33; Hodges B, 2001, AM J PSYCHIAT, V158, P1579, DOI 10.1176/appi.ajp.158.10.1579; Improving Chronic Illness Care, ICIC OUR WORK; *INT DIAB FED, 2007, DIAB ATL; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; *JOINT UN PROGR HI, 2003, STIGMA DISCRIMINATIO; KANER EFS, 2008, COCHRANE DB SYST REV, V2, P4148; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nash D, 2008, 15 C RETR OPP INF BO; National Health Priority Action Council, 2006, NAT CHRON DIS STRAT; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Pan American Health Organization, 2007, VER PROJ IMPR DIAB C; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V., 2003, WHERE THERE IS NO PS; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Pruitt SD, 2005, BMJ-BRIT MED J, V330, P637, DOI 10.1136/bmj.330.7492.637; Qureshi NA, 2006, EDUC HEALTH, V19, P52, DOI 10.1080/13576280500525527; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; *SCOTT GOV, PARTN CAR SCOTL HLTH; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P328, DOI 10.1016/S0163-8343(02)00201-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; Singh D, 2006, IMPROVING CARE PEOPL; Smith SM, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004910.PUB2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Stead L. F., 2008, COCHRANE DATABASE SY, V1; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Tsai AC, 2005, AM J MANAG CARE, V11, P478; UK Department of Health, 2001, EXP PAT NEW APPR CHR; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; Wagner E H, 1999, Manag Care Q, V7, P56; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; *WHO, 2004, INT MAN AD ILLN EXT; WHO, 2001, WORLD HLTH REPORT 20; *WHO, 2005, PREP WORKF 21 CENT C; WHO, 2006, WORLD HLTH REPORT 20; WHO WONCA, 2008, INT MENT HLTH PRIM C; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; World Health Organization, 1995, MENT ILLN GEN HLTH C; World Health Organization, 1998, MENT DIS PRIM CAR WH	106	367	376	5	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					940	949		10.1016/S0140-6736(08)61404-X	http://dx.doi.org/10.1016/S0140-6736(08)61404-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790317				2022-12-24	WOS:000259266900034
J	Douglas, IJ; Smeeth, L				Douglas, Ian J.; Smeeth, Liam			Exposure to antipsychotics and risk of stroke: self controlled case series study	BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; SEVERE MENTAL-ILLNESS; PRIMARY-CARE; ISCHEMIC-STROKE; PEOPLE; SIMULATION; MORTALITY; DEMENTIA; TRIAL; DRUGS	Objectives To investigate the association between use of typical and atypical antipsychotic drugs and incidence of stroke in patients with and without dementia. Design Self controlled case series. Setting UK based electronic primary care records in the general practice research database ( GPRD). Participants All patients registered in the database with a recorded incident stroke and at least one prescription for any antipsychotic drug before the end of 2002: 6790 eligible participants were identified and included in the final analysis. Main outcome measures Rate ratio for stroke in periods of time exposed to antipsychotics compared with unexposed periods. Results Use of any antipsychotic drug was associated with a rate ratio for stroke of 1.73 ( 95% confidence interval 1.60 to 1.87): 1.69 ( 1.55 to 1.84) for typical antipsychotics and 2.32 ( 1.73 to 3.10) for atypical antipsychotics. In patients receiving any antipsychotic drug, the rate ratios were 3.50 ( 2.97 to 4.12) for those with dementia and 1.41 ( 1.29 to 1.55) for those without dementia. Conclusions All antipsychotics are associated with an increased risk of stroke, and the risk might be higher in patients receiving atypical antipsychotics than those receiving typical antipsychotics. People with dementia seem to be at a higher risk of an associated stroke than people without dementia and use of antipsychotics should, when possible, be avoided in these patients.	[Douglas, Ian J.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, IJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust [082178] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; *COMM SAF MED, 2006, AT ANT DRUGS STROK M; *EUR PHARM WORK PA, 2006, PUBL ASS REP ANT CER; Gibbs RGJ, 2001, STROKE, V32, P1085, DOI 10.1161/01.STR.32.5.1085; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Health Canada, 2002, IMP DRUG SAF INF RIS; Herrmann N, 2004, AM J PSYCHIAT, V161, P1113, DOI 10.1176/appi.ajp.161.6.1113; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Liebetrau M, 2003, STROKE, V34, P2617, DOI 10.1161/01.STR.0000094420.80781.A9; *MED HEALTHC PROD, 2004, SUMM CLIN TRIAL DAT; Mowat D, 2004, BRIT MED J, V328, P1262, DOI 10.1136/bmj.328.7450.1262-b; Mulnier HE, 2006, DIABETOLOGIA, V49, P2859, DOI 10.1007/s00125-006-0493-z; *OFF NAT STAT, 2000, KEY HLTH STAT GE MB6, V2, P149; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Osborn DPJ, 2006, BRIT J PSYCHIAT, V188, P271, DOI 10.1192/bjp.bp.104.008060; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Tannen RL, 2007, J CLIN EPIDEMIOL, V60, P686, DOI 10.1016/j.jclinepi.2006.10.012; Tannen RL, 2006, J CLIN EPIDEMIOL, V59, P254, DOI 10.1016/j.jclinepi.2005.08.008; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	20	190	192	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2008	337	7670							a1227	10.1136/bmj.a1227	http://dx.doi.org/10.1136/bmj.a1227			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354DT	18755769	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000259619800038
J	Hochberg, LR				Hochberg, Leigh R.			Turning thought into action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CORTICAL CONTROL; DEVICES; ARM		[Hochberg, Leigh R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hochberg, Leigh R.] Dept Vet Affairs Rehabil Res & Dev Serv, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University	Hochberg, LR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273				GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996	6	12	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1175	1177		10.1056/NEJMcibr0805122	http://dx.doi.org/10.1056/NEJMcibr0805122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784110				2022-12-24	WOS:000259078200016
J	Crawford, F				Crawford, Fay			Uncertainties page - How can we best prevent new foot ulcers in people with diabetes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Crawford, Fay] Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH3 8DE, Midlothian, Scotland	University of Edinburgh	Crawford, F (corresponding author), Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH3 8DE, Midlothian, Scotland.	fay.crawford@ed.ac.uk		Crawford, Fay/0000-0002-0473-9959				BOULTON AJ, EFFICACY PADDED HOSI; Boyko EJ, 2006, DIABETES CARE, V29, P2563, DOI 10.2337/dc06-1661; Crawford F, 2007, QJM-INT J MED, V100, P65; International Working Group on the Diabetic Foot, 1999, INT CONS DIAB FOOT; Mason J, 1999, DIABETIC MED, V16, P801, DOI 10.1046/j.1464-5491.1999.00133.x; McCabe CJ, 1998, DIABETIC MED, V15, P80, DOI 10.1002/(SICI)1096-9136(199801)15:1<80::AID-DIA517>3.0.CO;2-K; McIntosh AP, 2003, PREVENTION MANAGEMEN; Plank J, 2003, DIABETES CARE, V26, P1691, DOI 10.2337/diacare.26.6.1691; *SCOTT INT GUID NE, 2001, MAN DIAB SIGN 55; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; *SPENCER S, 2000, COCHRANE DB SYST REV; VALK GD, 2001, COCHRANE DB SYST REV	12	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2008	337	7669							a1234	10.1136/bmj.a1234	http://dx.doi.org/10.1136/bmj.a1234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351JP	18768555				2022-12-24	WOS:000259420900039
J	Mu, TW; Ong, DST; Wang, YJ; Balch, WE; Yates, JR; Segatori, L; Kelly, JW				Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Balch, William E.; Yates, John R.; Segatori, Laura; Kelly, Jeffery W.			Chemical and biological approaches synergize to ameliorate protein-folding diseases	CELL			English	Article							HEAT-SHOCK RESPONSE; LYSOSOMAL STORAGE DISORDERS; GAUCHER-DISEASE; ENDOPLASMIC-RETICULUM; PROTEASOME INHIBITION; PHARMACOLOGICAL CHAPERONE; MOLECULAR CHAPERONES; ENZYME REPLACEMENT; ER STRESS; GLUCOCEREBROSIDASE	Loss-of-function diseases are often caused by a mutation in a protein traversing the secretory pathway that compromises the normal balance between protein folding, trafficking, and degradation. We demonstrate that the innate cellular protein homeostasis, or proteostasis, capacity can be enhanced to fold mutated enzymes that would otherwise misfold and be degraded, using small molecule proteostasis regulators. Two proteostasis regulators are reported that alter the composition of the proteostasis network in the endoplasmic reticulum through the unfolded protein response, increasing the mutant folded protein concentration that can engage the trafficking machinery, restoring function to two nonhomologous mutant enzymes associated with distinct lysosomal storage diseases. Coapplication of a pharmacologic chaperone and a proteostasis regulator exhibits synergy because of the former's ability to further increase the concentration of trafficking-competent mutant folded enzymes. It may be possible to ameliorate loss-of-function diseases by using proteostasis regulators alone or in combination with a pharmacologic chaperone.	[Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wang, Ya-Juan; Balch, William E.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, 6100 Main St,MS-362, Houston, TX 77005 USA.	segatori@rice.edu; jkelly@scripps.edu	Mu, Tingwei/AAU-8596-2020; Longo, Kenneth A/A-5631-2010	Mu, Tingwei/0000-0002-6419-9296; Wang, Yajuan (Megan)/0000-0002-3284-9012	NIH [DK75295]; Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the reviewers for their insight, Professors Jonathan Weissman and Ernest Beutler for helpful discussions, Professor Evan Powers for the latter and for creating the three-dimensional plots used herein, and Jonathan Zhu for significant help with the figures. This work was supported by the NIH (DK75295), the Skaggs Institute of Chemical Biology, and the Lita Annenberg Hazen Foundation and is dedicated to Ernest Beutler on the occasion of his upcoming 80th birthday. J. W. K. is a founder of, has equity in, and has a paid consulting relationship with two biotechnology companies: FoldRx Pharmaceuticals Inc., which specializes in the development of drug therapies for diseases of protein misfolding and amyloidosis, and Proteostasis Therapeutics Inc., which is focused on understanding the proteostasis network for the development of therapeutics for diseases associated with a loss of proteostasis. Neither company is currently pursuing therapies for lysosomal storage diseases, although this could change in the future.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Awasthi N, 2005, INVEST OPHTH VIS SCI, V46, P2082, DOI 10.1167/iovs.05-0002; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BEUTLER E, 1977, P NATL ACAD SCI USA, V74, P4620, DOI 10.1073/pnas.74.10.4620; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; Beutler E, 2006, MOL GENET METAB, V88, P208, DOI 10.1016/j.ymgme.2006.01.010; Bouvier M, 2007, CHEM BIOL, V14, P241, DOI 10.1016/j.chembiol.2007.03.004; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; HORWICH AL, 2004, ENCY BIOL CHEM, V1, P393; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moyer B D, 2001, Expert Opin Ther Targets, V5, P165, DOI 10.1517/14728222.5.2.165; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i	54	301	310	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					769	781		10.1016/j.cell.2008.06.037	http://dx.doi.org/10.1016/j.cell.2008.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775310	Green Accepted, Bronze			2022-12-24	WOS:000258947500017
J	Majo, F; Rochat, A; Nicolas, M; Abou Jaoude, G; Barrandon, Y				Majo, Francois; Rochat, Ariane; Nicolas, Michael; Abou Jaoude, Georges; Barrandon, Yann			Oligopotent stem cells are distributed throughout the mammalian ocular surface	NATURE			English	Article							HAIR-FOLLICLES; CORNEAL EPITHELIUM; BASAL CELLS; RENEWAL; LOCATION; KERATINOCYTE; CULTURE; REPAIR	The integrity of the cornea, the most anterior part of the eye, is indispensable for vision. Forty- five million individuals worldwide are bilaterally blind and another 135 million have severely impaired vision in both eyes because of loss of corneal transparency(1); treatments range from local medications to corneal transplants, and more recently to stem cell therapy(2). The corneal epithelium is a squamous epithelium that is constantly renewing, with a vertical turnover of 7 to 14 days in many mammals(3). Identification of slow cycling cells ( label- retaining cells) in the limbus of the mouse has led to the notion that the limbus is the niche for the stem cells responsible for the long- term renewal of the cornea(4); hence, the corneal epithelium is supposedly renewed by cells generated at and migrating from the limbus, in marked opposition to other squamous epithelia in which each resident stem cell has in charge a limited area of epithelium(5,6). Here we show that the corneal epithelium of the mouse can be serially transplanted, is self- maintained and contains oligopotent stem cells with the capacity to generate goblet cells if provided with a conjunctival environment. Furthermore, the entire ocular surface of the pig, including the cornea, contains oligopotent stem cells (holoclones)(7,8) with the capacity to generate individual colonies of corneal and conjunctival cells. Therefore, the limbus is not the only niche for corneal stem cells and corneal renewal is not different from other squamous epithelia. We propose a model that unifies our observations with the literature and explains why the limbal region is enriched in stem cells.	[Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Abou Jaoude, Georges] Ecole Polytech Fed Lausanne, Lab Informat & Visualizat, CH-1015 Lausanne, Switzerland; [Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Univ Lausanne Hosp, CHU Vaudois, Dept Expt Surg, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Barrandon, Y (corresponding author), Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland.	yann.barrandon@epfl.ch			Swiss National Science Foundation [3100A0-104160]; EPFL; CHUV; EuroStemCell; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer; Association Francaise contre les Myopathies; Federation des Aveugles et Handicapes Visuels de France; INSERM	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; CHUV; EuroStemCell(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Federation des Aveugles et Handicapes Visuels de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to F. Radtke and S. Vauclair for Notch1<SUP>lox/lox</SUP> K14Cre ROSA26R mice, to A. Smith for critical reading of the manuscript, to T. Hoang-Xuan, L. Zografos, F. Munier and S. Kinoshita for continuous support and to L. Schnell, J. Vannod and S. Vermot for excellent technical help. The work was supported by grants to Y. B. from the Swiss National Science Foundation (grant 3100A0-104160), the EPFL, the CHUV and EuroStemCell. The early part of the work was supported by grants to Y. B. from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer and the Association Francaise contre les Myopathies. F. M. was supported by fellowships from the Federation des Aveugles et Handicapes Visuels de France, the INSERM and then the CHUV.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; BUCK RC, 1979, INVEST OPHTH VIS SCI, V18, P767; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Ferraris C, 2000, DEVELOPMENT, V127, P5487; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1395-3907.2004.00285.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SHAPIRO MS, 1981, INVEST OPHTH VIS SCI, V21, P135; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; THOFT RA, 1984, AM J OPHTHALMOL, V97, P1; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214	35	297	307	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					250	U51		10.1038/nature07406	http://dx.doi.org/10.1038/nature07406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18830243				2022-12-24	WOS:000261039300042
J	Wang, YL; Sheng, G; Juranek, S; Tuschl, T; Patel, DJ				Wang, Yanli; Sheng, Gang; Juranek, Stefan; Tuschl, Thomas; Patel, Dinshaw J.			Structure of the guide-strand-containing argonaute silencing complex	NATURE			English	Article							A-AEOLICUS ARGONAUTE; CRYSTAL-STRUCTURE; RNA RECOGNITION; RISC; SLICER; SPECIFICITY; CLEAVAGE; INSIGHTS; DISEASE	The slicer activity of the RNA- induced silencing complex is associated with argonaute, the RNase H- like PIWI domain of which catalyses guide- strand- mediated sequence- specific cleavage of target messenger RNA. Here we report on the crystal structure of Thermus thermophilus argonaute bound to a 5 '- phosphorylated 21- base DNA guide strand, thereby identifying the nucleic- acid- binding channel positioned between the PAZ- and PIWI- containing lobes, as well as the pivot- like conformational changes associated with complex formation. The bound guide strand is anchored at both of its ends, with the solvent- exposed Watson - Crick edges of stacked bases 2 to 6 positioned for nucleation with the mRNA target, whereas two critically positioned arginines lock bases 10 and 11 at the cleavage site into an unanticipated orthogonal alignment. Biochemical studies indicate that key amino acid residues at the active site and those lining the 5 '- phosphate- binding pocket made up of the Mid domain are critical for cleavage activity, whereas alterations of residues lining the 2- nucleotide 39- end- binding pocket made up of the PAZ domain show little effect.	[Wang, Yanli; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org	wang, yanli/G-3306-2010	Wang, Yanli/0000-0002-5969-1745	NIH; US Department of Energy; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by funds from the NIH to D.J.P. and T.T. We thank the staff of NE-CAT beam line at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, for assistance with data collection.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Yuan YR, 2006, STRUCTURE, V14, P1557, DOI 10.1016/j.str.2006.08.009	39	353	371	4	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					209	U34		10.1038/nature07315	http://dx.doi.org/10.1038/nature07315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18754009	Green Accepted			2022-12-24	WOS:000261039300033
J	Zauber, AG; Lansdorp-Vogelaar, I; Knudsen, AB; Wilschut, J; van Ballegooijen, M; Kuntz, KM				Zauber, Ann G.; Lansdorp-Vogelaar, Iris; Knudsen, Amy B.; Wilschut, Janneke; van Ballegooijen, Marjolein; Kuntz, Karen M.			Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; CLINICAL GUIDELINES; COST-EFFECTIVENESS; POLYPS; SURVEILLANCE; COLONOSCOPY; MORTALITY; PREVALENCE; CAPACITY	Background: The U. S. Preventive Services Task Force requested a decision analysis to inform their update of recommendations for colorectal cancer screening. Objective: To assess life-years gained and colonoscopy requirements for colorectal cancer screening strategies and identify a set of recommendable screening strategies. Design: Decision analysis using 2 colorectal cancer microsimulation models from the Cancer Intervention and Surveillance Modeling Network. Data Sources: Derived from the literature. Target Population: U. S. average-risk 40-year-old population. Perspective: Societal. Time Horizon: Lifetime. Interventions: Fecal occult blood tests (FOBTs), flexible sigmoidoscopy, or colonoscopy screening beginning at age 40, 50, or 60 years and stopping at age 75 or 85 years, with screening intervals of 1, 2, or 3 years for FOBT and 5, 10, or 20 years for sigmoidoscopy and colonoscopy. Outcome Measures: Number of life-years gained compared with no screening and number of colonoscopies and noncolonoscopy tests required. Results of Base-Case Analysis: Beginning screening at age 50 years was consistently better than at age 60. Decreasing the stop age from 85 to 75 years decreased life-years gained by 1% to 4%, whereas colonoscopy use decreased by 4% to 15%. Assuming equally high adherence, 4 strategies provided similar life-years gained: colonoscopy every 10 years, annual Hemoccult SENSA (Beckman Coulter, Fullerton, California) testing or fecal immunochemical testing, and sigmoidoscopy every 5 years with midinterval Hemoccult SENSA testing. Annual Hemoccult II and flexible sigmoidoscopy every 5 years alone were less effective. Results of Sensitivity Analysis: The results were most sensitive to beginning screening at age 40 years. Limitation: The stop age for screening was based only on chronologic age. Conclusion: The findings support colorectal cancer screening with the following: colonoscopy every 10 years, annual screening with a sensitive FOBT, or flexible sigmoidoscopy every 5 years with a midinterval sensitive FOBT from age 50 to 75 years.	[Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; Erasmus MC, Rotterdam, Netherlands; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Minnesota, Minneapolis, MN USA	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities	Zauber, AG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10065 USA.	zaubera@mskcc.org		Wilschut, Janneke/0000-0002-4921-227X	National Cancer Institute [U01-CA-088204, U01-CA-097426, U01-CA-115953]; Agency for Healthcare Research and Quality [HHSP233200700350P, HHSP233200700210P, HHSP233200700196P]; NATIONAL CANCER INSTITUTE [U01CA097426, U01CA115953, U01CA088204, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953) and the Agency for Healthcare Research and Quality (HHSP233200700350P, HHSP233200700210P, and HHSP233200700196P).	*AM CANC SOC, CANC FACTS FIG 2008; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Breslow RA, 2008, AM J PREV MED, V35, pS14, DOI 10.1016/j.amepre.2008.04.005; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZAUBER AG, COST EFFECTIVENESS D	38	448	451	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 4	2008	149	9					659	+		10.7326/0003-4819-149-9-200811040-00244	http://dx.doi.org/10.7326/0003-4819-149-9-200811040-00244			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XK	18838717	Green Accepted			2022-12-24	WOS:000260585700006
J	Cisse, B; Caton, ML; Lehner, M; Maeda, T; Scheu, S; Locksley, R; Holmberg, D; Zweier, C; den Hollander, NS; Kant, SG; Holter, W; Rauch, A; Zhuang, YA; Reizis, B				Cisse, Babacar; Caton, Michele L.; Lehner, Manfred; Maeda, Takahiro; Scheu, Stefanie; Locksley, Richard; Holmberg, Dan; Zweier, Christiane; den Hollander, Nicolette S.; Kant, Sarina G.; Holter, Wolfgang; Rauch, Anita; Zhuang, Yuan; Reizis, Boris			Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development	CELL			English	Article							T-LYMPHOCYTE DEVELOPMENT; PITT-HOPKINS-SYNDROME; I INTERFERON; AUTOIMMUNE-DISEASES; BONE-MARROW; E2A; PROGENITORS; ACTIVATION; PROTEINS; RECEPTOR	Plasmacytoid dendritic cells (PDCs) represent a unique immune cell type specialized in type I interferon (IFN) secretion in response to viral nucleic acids. The molecular control of PDC lineage specification has been poorly understood. We report that basic helix-loop-helix transcription factor (E protein) E2-2/Tcf4 is preferentially expressed in murine and human PDCs. Constitutive or inducible deletion of murine E2-2 blocked the development of PDCs but not of other lineages and abolished IFN response to unmethylated DNA. Moreover, E2-2 haploinsufficiency in mice and in human Pitt-Hopkins syndrome patients was associated with aberrant expression profile and impaired IFN response of the PDC. E2-2 directly activated multiple PDC-enriched genes, including transcription factors involved in PDC development (SpiB, Irf8) and function (Irf7). These results identify E2-2 as a specific transcriptional regulator of the PDC lineage in mice and humans and reveal a key function of E proteins in the innate immune system.	[Cisse, Babacar; Caton, Michele L.; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Lehner, Manfred; Holter, Wolfgang] Univ Erlangen Nurnberg, Childrens Univ Hosp, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8538691, Japan; [Scheu, Stefanie; Locksley, Richard] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med & Microbiol Immunol, San Francisco, CA 94143 USA; [Scheu, Stefanie] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Scheu, Stefanie] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Holmberg, Dan] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden; [Zweier, Christiane; Rauch, Anita] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [den Hollander, Nicolette S.; Kant, Sarina G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Zhuang, Yuan] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA	Columbia University; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Nagasaki University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Umea University; University of Erlangen Nuremberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Duke University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Zweier, Christiane/F-2202-2015; Scheu, Stefanie/H-3670-2019; Rauch, Anita/C-5568-2014; Kant, Sarina/F-8596-2010	Zweier, Christiane/0000-0001-8002-2020; Scheu, Stefanie/0000-0002-9707-8191; Rauch, Anita/0000-0003-2930-3163; zhuang, yuan/0000-0002-2964-3654; Reizis, Boris/0000-0003-1140-7853; Lehner, Manfred/0000-0002-5776-4218	National Institutes of Health (NIH) [AI072571]; Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH [AI007525, HD055165, GM007367, AI080184, AI078869]; Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI066459, R37AI026918, R01AI072571, T32AI007525, R21AI085439, F31AI080184, P01AI078869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; American Society of Hematology Junior Faculty Scholar; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Daisy Soros Fellowship for New Americans; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Flora, H. Zoghbi, E. Mercer, C. Murre, and T. Ludwig for animals and reagents, B. Jones for help with E2a/HEB strain analysis, B. Kee for communicating data prior to publication, all members of the Reizis lab for helpful discussions, and J. Galan for invaluable help with expression analysis and ChIP. This work was supported by National Institutes of Health (NIH) grant AI072571, the Sandler Program for Asthma Research award, and the American Society of Hematology Junior Faculty Scholar award (B.R.), NIH training grants AI007525 and HD055165 (M.L.C.), NIH training grant GM007367, NIH fellowship AI080184, and the Paul and Daisy Soros Fellowship for New Americans (B.C.), Deutsche Forschungsgemeinschaft (A.R.), and the Howard Hughes Medical Institute and NIH grant AI078869 (R.L.).	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lazorchak A, 2005, TRENDS IMMUNOL, V26, P334, DOI 10.1016/j.it.2005.03.011; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Quong MW, 2004, J EXP MED, V199, P1101, DOI 10.1084/jem.20031180; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; Reizis B, 2001, J EXP MED, V194, P979, DOI 10.1084/jem.194.7.979; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Wikstrom I, 2006, J IMMUNOL, V177, P6723, DOI 10.4049/jimmunol.177.10.6723; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	44	458	469	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					37	48		10.1016/j.cell.2008.09.016	http://dx.doi.org/10.1016/j.cell.2008.09.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854153	Bronze, Green Accepted			2022-12-24	WOS:000259728100007
J	Paux, E; Sourdille, P; Salse, J; Saintenac, C; Choulet, F; Leroy, P; Korol, A; Michalak, M; Kianian, S; Spielmeyer, W; Lagudah, E; Somers, D; Kilian, A; Alaux, M; Vautrin, S; Berges, H; Eversole, K; Appels, R; Safar, J; Simkova, H; Dolezel, J; Bernard, M; Feuillet, C				Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Korol, Abraham; Michalak, Monika; Kianian, Shahryar; Spielmeyer, Wolfgang; Lagudah, Evans; Somers, Daryl; Kilian, Andrzej; Alaux, Michael; Vautrin, Sonia; Berges, Helene; Eversole, Kellye; Appels, Rudi; Safar, Jan; Simkova, Hana; Dolezel, Jaroslav; Bernard, Michel; Feuillet, Catherine			A physical map of the 1-gigabase bread wheat chromosome 3B	SCIENCE			English	Article							RUST RESISTANCE GENE; HEXAPLOID WHEAT; RICE; GENOMES; SR2	As the staple food for 35% of the world's population, wheat is one of the most important crop species. To date, sequence- based tools to accelerate wheat improvement are lacking. As part of the international effort to sequence the 17- billion- base- pair hexaploid bread wheat genome ( 2n = 6x = 42 chromosomes), we constructed a bacterial artificial chromosome ( BAC)based integrated physical map of the largest chromosome, 3B, that alone is 995 megabases. A chromosome- specific BAC library was used to assemble 82% of the chromosome into 1036 contigs that were anchored with 1443 molecular markers, providing a major resource for genetic and genomic studies. This physical map establishes a template for the remaining wheat chromosomes and demonstrates the feasibility of constructing physical maps in large, complex, polyploid genomes with a chromosome- based approach.	[Paux, Etienne; Sourdille, Pierre; Salse, Jerome; Saintenac, Cyrille; Choulet, Frederic; Leroy, Philippe; Bernard, Michel; Feuillet, Catherine] Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France; [Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Michalak, Monika; Kianian, Shahryar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Spielmeyer, Wolfgang; Lagudah, Evans] CSIRO, Canberra, ACT, Australia; [Somers, Daryl] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kilian, Andrzej] Divers Arrays Technol, Canberra, ACT, Australia; [Alaux, Michael] INRA, Unite Rech Genom Info, F-78026 Versailles, France; [Vautrin, Sonia; Berges, Helene] INRA, Ctr Natl Ressources Genom Vegetales, F-31931 Toulouse, France; [Eversole, Kellye] Eversole Assoc, Int Wheat Genome Sequencing Consortium, Bethesda, MD USA; [Appels, Rudi] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Safar, Jan; Simkova, Hana; Dolezel, Jaroslav] Inst Expt Bot, Lab Mol Cytogenet & Cytometry, Olomouc, Czech Republic	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Clermont Auvergne (UCA); University of Haifa; North Dakota State University Fargo; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Agriculture & Agri Food Canada; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Murdoch University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Paux, E (corresponding author), Univ Blaise Pascal, INRA, UMR 1095, Clermont Ferrand, France.		Sourdille, Pierre/CAF-2780-2022; Simkova, Hana/F-7734-2014; Spielmeyer, Wolfgang/M-3254-2018; Safar, Jan/G-1038-2014; Lagudah, Evans/A-2007-2010; Dolezel, Jaroslav/B-7716-2008; Eversole, Kellye/AAN-6141-2020	Simkova, Hana/0000-0003-4159-7619; Spielmeyer, Wolfgang/0000-0002-5115-7820; Lagudah, Evans/0000-0002-6234-1789; Dolezel, Jaroslav/0000-0002-6263-0492; Eversole, Kellye/0000-0002-8784-4913; Sourdille, Pierre/0000-0002-1027-2224; BERGES, Helene/0000-0002-5492-1062; Paux, Etienne/0000-0002-3094-7129; Alaux, Michael/0000-0001-9356-4072; Choulet, Frederic/0000-0003-1788-7288; Kilian, Andrzej/0000-0002-2730-7462	Agence Nationale de la Recherche [ANR-05-BLANC-0258-01]; INRA	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA	We thank D. Boyer, K. Paux, and members of the GENTYANE platform for technical assistance; M. Ganal (Trait Genetics), P. Jack (RAGT), and F. Azanza (Syngenta) for providing SSR markers and genotyping data; the support of F. Legeai and D. Steinbach from Unit, de Recherche en Genomique-Info in establishing the Gbrowse display of the integrated physical map; A. Kumar (Choudhury Charan Singh University Meerut), O. Riera-Lizarazu (Oregon State University), and Y. Gu (U. S. Department of Agriculture- Agricultural Research Service) for significant contributions to the RH mapping work; and F. Quetier ( gence Nationale de la Recherche) for support and discussions. Supported by the Agence Nationale de la Recherche (grant ANR-05-BLANC-0258-01) and the INRA.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cone KC, 2002, PLANT PHYSIOL, V130, P1598, DOI 10.1104/pp.012245; Dilbirligi M, 2004, GENETICS, V166, P461, DOI 10.1534/genetics.166.1.461; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; GILL BS, 1991, GENOME, V34, P830, DOI 10.1139/g91-128; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Hossain KG, 2004, GENETICS, V168, P415, DOI 10.1534/genetics.103.022590; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; Kota R, 2006, THEOR APPL GENET, V112, P492, DOI 10.1007/s00122-005-0151-8; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; McNeil MD, 2008, MOL BREEDING, V22, P15, DOI 10.1007/s11032-007-9152-4; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Warren RL, 2006, GENOME RES, V16, P768, DOI 10.1101/gr.5090606; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wollenweber B, 2005, CURR OPIN PLANT BIOL, V8, P337, DOI 10.1016/j.pbi.2005.03.001	23	301	325	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					101	104		10.1126/science.1161847	http://dx.doi.org/10.1126/science.1161847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832645				2022-12-24	WOS:000259680200047
J	Arnone, JA; Verburg, PSJ; Johnson, DW; Larsen, JD; Jasoni, RL; Lucchesi, AJ; Batts, CM; von Nagy, C; Coulombe, WG; Schorran, DE; Buck, PE; Braswell, BH; Coleman, JS; Sherry, RA; Wallace, LL; Luo, YQ; Schimel, DS				Arnone, John A., III; Verburg, Paul S. J.; Johnson, Dale W.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.; Braswell, Bobby H.; Coleman, James S.; Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi; Schimel, David S.			Prolonged suppression of ecosystem carbon dioxide uptake after an anomalously warm year	NATURE			English	Article							WATER-VAPOR EXCHANGE; TEMPERATE GRASSLAND; TERRESTRIAL ECOSYSTEMS; TALLGRASS PRAIRIE; PLANT-GROWTH; CO2; VARIABILITY; FLUXES; PRODUCTIVITY; RESPIRATION	Terrestrial ecosystems control carbon dioxide fluxes to and from the atmosphere(1,2) through photosynthesis and respiration, a balance between net primary productivity and heterotrophic respiration, that determines whether an ecosystem is sequestering carbon or releasing it to the atmosphere. Global(1,3-5) and site-specific(6) data sets have demonstrated that climate and climate variability influence biogeochemical processes that determine net ecosystem carbon dioxide exchange (NEE) at multiple timescales. Experimental data necessary to quantify impacts of a single climate variable, such as temperature anomalies, on NEE and carbon sequestration of ecosystems at interannual timescales have been lacking. This derives from an inability of field studies to avoid the confounding effects of natural intra- annual and interannual variability in temperature and precipitation. Here we present results from a four-year study using replicate 12,000-kg intact tallgrass prairie monoliths located in four 184-m(3) enclosed lysimeters(7). We exposed 6 of 12 monoliths to an anomalously warm year in the second year of the study(8) and continuously quantified rates of ecosystem processes, including NEE. We find that warming decreases NEE in both the extreme year and the following year by inducing drought that suppresses net primary productivity in the extreme year and by stimulating heterotrophic respiration of soil biota in the subsequent year. Our data indicate that two years are required for NEE in the previously warmed experimental ecosystems to recover to levels measured in the control ecosystems. This time lag caused net ecosystem carbon sequestration in previously warmed ecosystems to be decreased threefold over the study period, compared with control ecosystems. Our findings suggest that more frequent anomalously warm years(9), a possible consequence of increasing anthropogenic carbon dioxide levels(10), may lead to a sustained decrease in carbon dioxide uptake by terrestrial ecosystems.	[Arnone, John A., III; Verburg, Paul S. J.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.] Univ Nevada, Desert Res Inst, Reno, NV 89512 USA; [Johnson, Dale W.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Braswell, Bobby H.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Coleman, James S.] Rice Univ, Res Off, Houston, TX 77251 USA; [Coleman, James S.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Schimel, David S.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University System Of New Hampshire; University of New Hampshire; Rice University; Rice University; University of Oklahoma System; University of Oklahoma - Norman; National Center Atmospheric Research (NCAR) - USA	Arnone, JA (corresponding author), Univ Nevada, Desert Res Inst, Reno, NV 89512 USA.	jarnone@dri.edu	Verburg, Paul/B-6351-2014; Braswell, Bobby H/D-6411-2016	Braswell, Bobby H/0000-0002-4061-9516	US National Science Foundation's Integrated Research Challenges in Environmental Biology program; Desert Research Institute (DRI)	US National Science Foundation's Integrated Research Challenges in Environmental Biology program(National Science Foundation (NSF)); Desert Research Institute (DRI)	We thank E. Kessler and the University of Oklahoma for the use of the Kessler Farm Field Laboratory; R. Kreidberg for editorial assistance; and J. Amthor, M. Bahn, C. Korner, D. Obrist and G. Wohlfahrt, for critical review of an early draft of this manuscript. This study was funded by the US National Science Foundation's Integrated Research Challenges in Environmental Biology program, with additional support from the Desert Research Institute (DRI) for necessary upgrades to the EcoCELL facility. We are very grateful to DRI, the University of Oklahoma, and the University of Nevada-Reno teams for technical assistance, facilities support, and administrative expertise (also see Supplementary Information).	350-368, 2005, HIST ATMOSPHERIC CO2, P350; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; BUNCE JA, 1982, OECOLOGIA, V54, P233, DOI 10.1007/BF00378397; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Grace J, 1998, AUST J PLANT PHYSIOL, V25, P519, DOI 10.1071/PP97120; Griffin KL, 1996, PLANT CELL ENVIRON, V19, P1210, DOI 10.1111/j.1365-3040.1996.tb00437.x; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Korner Ch, 1994, ECOPHYSIOLOGY PHOTOS, P463; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Novick KA, 2004, OECOLOGIA, V138, P259, DOI 10.1007/s00442-003-1388-z; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Verburg PSJ, 2005, GLOBAL CHANGE BIOL, V11, P1720, DOI 10.1111/j.1365-2486.2005.001032.x; Vourlitis GL, 1999, ECOLOGY, V80, P686, DOI 10.1890/0012-9658(1999)080[0686:ECMOCA]2.0.CO;2; Vukicevic T, 2001, TELLUS B, V53, P150, DOI 10.1034/j.1600-0889.2001.d01-13.x; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2	26	121	122	10	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					383	386		10.1038/nature07296	http://dx.doi.org/10.1038/nature07296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800137				2022-12-24	WOS:000259265200043
J	Roy, K				Roy, Kaustuv			Evolution - Dynamics of body size evolution	SCIENCE			English	Editorial Material							COPES RULE; CLIMATE-CHANGE; EXTINCTION; DISTRIBUTIONS; TEMPERATURE; SELECTIVITY; PATTERNS		[Roy, Kaustuv] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Roy, K (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kroy@ucsd.edu						Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x	16	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1451	1452		10.1126/science.1163097	http://dx.doi.org/10.1126/science.1163097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787156	Green Submitted			2022-12-24	WOS:000259121800026
J	Schmidt, D				Schmidt, Dieter			Antiepileptic drug withdrawal in seizure-free patients	LANCET			English	Editorial Material							EPILEPSY		Epilepsy Res Grp Berlin, D-14163 Berlin, Germany	Epilepsy Research Group	Schmidt, D (corresponding author), Epilepsy Res Grp Berlin, D-14163 Berlin, Germany.	dbschmidt@t-online.de						CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; CHADWICK D, 1991, LANCET, V337, P1175; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Gowers WR, 1885, EPILEPSY OTHER CHRON, P210; JACOBY A, 1992, EPILEPSIA, V33, P1123, DOI 10.1111/j.1528-1157.1992.tb01769.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lossius MI, 2008, EPILEPSIA, V49, P455, DOI 10.1111/j.1528-1167.2007.01323.x; OVERWEG J, 1987, EPILEPSY RES, V1, P272, DOI 10.1016/0920-1211(87)90002-7; Sieveking E.H, 1857, LANCET, Vi, P527; Specchio LM, 2002, J NEUROL NEUROSUR PS, V72, P22, DOI 10.1136/jnnp.72.1.22	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 23	2008	372	9639					610	612		10.1016/S0140-6736(08)61256-8	http://dx.doi.org/10.1016/S0140-6736(08)61256-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340BX	18722852				2022-12-24	WOS:000258622200008
J	Wang, LD; Utzinger, J; Zhou, XN				Wang, Longde; Utzinger, Juerg; Zhou, Xiao-Nong			Schistosomiasis control: experiences and lessons from China	LANCET			English	Editorial Material							METAANALYSIS		[Zhou, Xiao-Nong] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Utzinger, Juerg] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Zhou, XN (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.	ipdzhouxn@sh163.net						BIAN Y, 2004, INT J HLTH PLANN S1, V19, P79; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guo JG, 2005, ACTA TROP, V96, P177, DOI 10.1016/j.actatropica.2005.07.012; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Liang S, 2006, B WORLD HEALTH ORGAN, V84, P139, DOI 10.2471/BLT.05.025031; Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; WANG LD, 2008, N ENGL J ME IN PRESS; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	12	167	209	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2008	372	9652					1793	1795		10.1016/S0140-6736(08)61358-6	http://dx.doi.org/10.1016/S0140-6736(08)61358-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	375KG	18930529	Green Published, Bronze			2022-12-24	WOS:000261112000009
J	Hoshida, Y; Villanueva, A; Kobayashi, M; Peix, J; Chiang, DY; Camargo, A; Gupta, S; Moore, J; Wrobel, MJ; Lerner, J; Reich, M; Chan, JA; Glickman, JN; Ikeda, K; Hashimoto, M; Watanabe, G; Daidone, MG; Roayaie, S; Schwartz, M; Thung, S; Salvesen, HB; Gabriel, S; Mazzaferro, V; Bruix, J; Friedman, SL; Kumada, H; Llovet, JM; Golub, TR				Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Glickman, Jonathan N.; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Daidone, Maria G.; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Salvesen, Helga B.; Gabriel, Stacey; Mazzaferro, Vincenzo; Bruix, Jordi; Friedman, Scott L.; Kumada, Hiromitsu; Llovet, Josep M.; Golub, Todd R.			Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED-TRIAL; LIVER-CANCER; RECURRENCE; RESECTION; INTERFERON; PREVENTION; MANAGEMENT; TUMOR; RISK	Background: It is a challenge to identify patients who, after undergoing potentially curative treatment for hepatocellular carcinoma, are at greatest risk for recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissue. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed, paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of tissue samples from 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (P=0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlated with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma.	[Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] MIT, Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Hoshida, Yujin; Chiang, Derek Y.; Camargo, Amy; Gupta, Supriya; Moore, Jamie; Wrobel, Matthew J.; Lerner, Jim; Reich, Michael; Chan, Jennifer A.; Gabriel, Stacey; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Golub, Todd R.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Hoshida, Yujin; Chiang, Derek Y.; Golub, Todd R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Villanueva, Augusto; Peix, Judit; Roayaie, Sasan; Schwartz, Myron; Thung, Swan; Friedman, Scott L.; Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, Div Liver Dis, New York, NY 10029 USA; [Kobayashi, Masahiro; Ikeda, Kenji; Hashimoto, Masaji; Watanabe, Goro; Kumada, Hiromitsu] Toranomon Gen Hosp, Tokyo, Japan; [Daidone, Maria G.; Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Salvesen, Helga B.] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Bruix, Jordi; Llovet, Josep M.] Hosp Clin Barcelona, Ctr Invest Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona Clin Liver Canc Grp, Barcelona, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Toranomon Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Bergen; Haukeland University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Golub, TR (corresponding author), MIT, Broad Inst, Canc Program, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	josep.llovet@mssm.edu; golub@broad.mit.edu	Augusto, Villanueva/F-9378-2012; Hoshida, Yujin/R-7513-2019; salvesen, Helga B/C-1187-2017; Mazzaferro, Vincenzo/AAL-4707-2020; Llovet, Josep M/D-4340-2014; Daidone, Maria Grazia/E-9232-2017; Llovet, Josep M/ABB-6264-2021; Chiang, Derek/L-6452-2019; Mazzaferro, Vincenzo/C-2726-2017	Augusto, Villanueva/0000-0003-3585-3727; salvesen, Helga B/0000-0002-4438-8831; Llovet, Josep M/0000-0003-0547-2667; Daidone, Maria Grazia/0000-0002-4786-1321; Llovet, Josep M/0000-0003-0547-2667; Mazzaferro, Vincenzo/0000-0002-4013-8085; Chiang, Derek/0000-0002-1131-6065; Reich, Michael/0000-0003-4735-5514; Bruix, Jordi/0000-0002-9826-0753	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK076986-01]; National Cancer Institute [5U54 CA112962-03]; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF2007-61898]; Institucio Catalana de Recerca i Estudis Avancats; Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III [PI05-0150]; National Institutes of Health [DK37340]; Italian Association for Cancer Research; Norwegian Cancer Society; Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; NATIONAL CANCER INSTITUTE [U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076986, R01DK037340] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Institucio Catalana de Recerca i Estudis Avancats(ICREA); Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas; Fund for Health of Spain of the Institute of Health Carlos III(Instituto de Salud Carlos III); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Norwegian Cancer Society(Norwegian Cancer Society); Harald Andersens grant; Charles A. King Trust fellowship; Fundacion Pedro Barri, de la Maza; Sheila Sherlock Fellowship; National Cancer Center Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICREA(ICREA)	Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK076986-01, to Dr. Llovet), the National Cancer Institute (5U54 CA112962-03, to Dr. Golub), the Samuel Waxman Cancer Research Foundation (to Dr. Llovet), the Spanish National Health Institute (SAF2007-61898, to Dr. Llovet), Institucio Catalana de Recerca i Estudis Avancats (to Dr. Llovet), Centro de Investigaciones en Red de Enfermedades Hepaticas y Digestivas (to Drs. Llovet and Bruix), the Fund for Health of Spain of the Institute of Health Carlos III (PI05-0150, to Dr. Bruix), the National Institutes of Health (DK37340, to Dr. Friedman), the Italian Association for Cancer Research (to Dr. Mazzaferro), Helse Vest and Norwegian Cancer Society, Harald Andersens grant (to Dr. Salvesen), the Charles A. King Trust fellowship (to Dr. Hoshida), and Fundacion Pedro Barri, de la Maza, the Sheila Sherlock Fellowship, and the National Cancer Center Fellowship (all to Dr. Villanueva).	Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takayama T, 2000, LANCET, V356, P1690; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	22	960	996	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1995	2004		10.1056/NEJMoa0804525	http://dx.doi.org/10.1056/NEJMoa0804525			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923165	Green Accepted			2022-12-24	WOS:000260632700004
J	Zheng, XW; Pontes, O; Zhu, JH; Miki, D; Zhang, F; Li, WX; Iida, K; Kapoor, A; Pikaard, CS; Zhu, JK				Zheng, Xianwu; Pontes, Olga; Zhu, Jianhua; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Pikaard, Craig S.; Zhu, Jian-Kang			ROS3 is an RNA-binding protein required for DNA demethylation in Arabidopsis	NATURE			English	Article							GLYCOSYLASE/LYASE ROS1; METHYLATION PATTERNS; ABSCISIC-ACID; HUMAN-CELLS; PLANTS; PATHWAYS; REPLICATION; MICRORNAS; DEMETER; TARGETS	DNA methylation is an important epigenetic mark for transcriptional gene silencing ( TGS) in diverse organisms(1-6). Recent studies suggest that the methylation status of a number of genes is dynamically regulated by methylation and demethylation(7-10). In Arabidopsis, active DNA demethylation is mediated by the ROS1 ( repressor of silencing 1) subfamily of 5- methylcytosine DNA glycosylases through a base excision repair pathway(8,10-13). These demethylases have critical roles in erasing DNA methylation and preventing TGS of target genes(7,8,10). However, it is not known how the demethylases are targeted to specific sequences. Here we report the identification of ROS3, an essential regulator of DNA demethylation that contains an RNA recognition motif. Analysis of ros3 mutants and ros1ros3 double mutants suggests that ROS3 acts in the same genetic pathway as ROS1 to prevent DNA hypermethylation and TGS. Gel mobility shift assays and analysis of ROS3 immunoprecipitate from plant extracts shows that ROS3 binds to small RNAs in vitro and in vivo. Immunostaining shows that ROS3 and ROS1 proteins co-localize in discrete foci dispersed throughout the nucleus. These results demonstrate a critical role for ROS3 in preventing DNA hypermethylation and suggest that DNA demethylation by ROS1 may be guided by RNAs bound to ROS3.	[Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zhu, Jianhua] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Zhang, Fei] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200240, Peoples R China	University of California System; University of California Riverside; University of California System; University of California Riverside; Washington University (WUSTL); University System of Maryland; University of Maryland College Park; Shanghai Jiao Tong University	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Pikaard, Craig S/K-8772-2012; Zhu, Jianhua/F-7127-2013; Pontes, Olga MF/F-9768-2011; Grieshaber-Bouyer, Ricardo/R-7512-2016; Zhu, Jian-Kang/F-7658-2011	Pikaard, Craig S/0000-0001-8204-7459; Pontes, Olga MF/0000-0003-3316-1145; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Zhu, Jian-Kang/0000-0001-5134-731X; IIDA, Kei/0000-0001-7130-8705; Miki, Daisuke/0000-0001-6066-3357	National Institutes of Health [R01GM070795, R01GM059138, R01GM077590, 1R01GM060380]; Edward Mallinckrodt Foundation; China Scholarship Council [2007104542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380, R01GM059138, R01GM077590, R01GM070795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Foundation; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 (J.-K.Z.), R01GM077590 and 1R01GM060380 (C.S.P.), Edward Mallinckrodt Foundation (O.P.) and China Scholarship Council scholarship 2007104542 (F.Z.).	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	34	112	123	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1259	U70		10.1038/nature07305	http://dx.doi.org/10.1038/nature07305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815596	Green Accepted			2022-12-24	WOS:000260462100049
J	Giezen, TJ; Mantel-Teeuwisse, AK; Straus, SMJM; Schellekens, H; Leufkens, HGM; Egberts, ACG				Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Schellekens, Huub; Leufkens, Hubert G. M.; Egberts, Antoine C. G.			Safety-related regulatory actions for biologicals approved in the United States and the European Union	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; INFECTIONS; BIOPHARMACEUTICALS; PHARMACOVIGILANCE; IMMUNOGENICITY	Context Biologicals are a relatively new class of medicines that carry specific risks (eg, immunogenicity). However, limited information is available on the nature and timing of safety problems with their use that were identified after approval. Objective To determine the nature, frequency, and timing of safety-related regulatory actions for biologicals following approval in the United States and/or the European Union. Design and Setting Follow-up of a group of biologicals approved in the United States and/or European Union between January 1995 and June 2007. Vaccines, allergenic products, and products for further manufacture and transfusion purposes were excluded. Main Outcome Measures Nature, frequency, and timing of safety-related regulatory actions defined as (1) dear healthcare professional letters (United States) and direct healthcare professional communications (European Union), (2) black box warnings (United States), and (3) safety-related marketing withdrawals (United States and European Union) issued between January 1995 and June 2008. Results A total of 174 biologicals were approved (136 in the United States and 105 in the European Union, of which 67 were approved in both regions). Eighty-two safety-related regulatory actions (46 dear healthcare professional letters, 17 direct healthcare professional communications, 19 black box warnings, and no withdrawals) were issued for 41 of the 174 different biologicals (23.6%). The probability of a first safety-related regulatory action, derived from Kaplan-Meier analyses, was 14% (95% confidence interval [CI], 9%-19%) 3 years after approval and 29% (95% CI, 20%-37%) 10 years after approval. Biologicals first in class to obtain approval had a higher risk for a first safety-related regulatory action compared with later approved products in that class (12.0/1000 vs 2.9/1000 months, respectively; hazard ratio, 3.7 [95% CI, 1.5- 9.5]). Warnings mostly concerned the classes general disorders and administration site conditions, infections and infestations, immune system disorders and neoplasms benign, malignant, and unspecified. Conclusions The nature of safety problems identified after approval for biologicals is often related to the immunomodulatory effect (infections). Because the biologicals first to be approved in a class were more likely to be subjected to regulatory action, close monitoring is recommended.	[Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G. M.; Egberts, Antoine C. G.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Div Pharmaceut, NL-3508 TB Utrecht, Netherlands; [Schellekens, Huub] Univ Utrecht, Dept Innovat Sci, NL-3508 TB Utrecht, Netherlands; [Egberts, Antoine C. G.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands; [Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Straus, Sabine M. J. M.; Leufkens, Hubert G. M.] Med Evaluat Board, The Hague, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Mantel-Teeuwisse, AK (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Pharmacotherapy, POB 80082, NL-3508 TB Utrecht, Netherlands.	A.K.Mantel@uu.nl	Egberts, Toine/K-4579-2019; Mantel-Teeuwisse, Aukje/I-8902-2016; Egberts, Toine/A-6625-2012	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	GlaxoSmithKline; Organon; Merck; Novo Nordisk; Roche; Merck-Serono	GlaxoSmithKline(GlaxoSmithKline); Organon; Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Roche(Roche Holding); Merck-Serono(Merck & Company)	The department employing Drs Giezen, Mantel-Teeuwisse, Leufkens, and Egberts has received unrestricted research grants from GlaxoSmithKline, Organon, Merck, and Novo Nordisk for the conduct of pharmacoepidemiological research. Dr Schellekens reported receiving research grants from Organon, Roche, and Merck-Serono. Dr Straus did not report any financial disclosures.	Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; Aksamit AJ, 2006, NEUROLOGIST, V12, P293, DOI 10.1097/01.nrl.0000250948.04681.96; BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; Baumann A, 2006, CURR DRUG METAB, V7, P15, DOI 10.2174/138920006774832604; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Botsios C, 2005, AUTOIMMUN REV, V4, P162, DOI 10.1016/j.autrev.2004.09.001; Brennan FR, 2004, MOL BIOTECHNOL, V27, P59, DOI 10.1385/MB:27:1:59; Brune K, 2007, RHEUMATOLOGY, V46, P911, DOI 10.1093/rheumatology/kem070; Crommelin DJA, 2003, INT J PHARMACEUT, V266, P3, DOI 10.1016/S0378-5173(03)00376-4; *EUR COMM, 2007, VOL 9A RUL GOV MED P; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; Hamilton CD, 2004, CURR OPIN RHEUMATOL, V16, P393, DOI 10.1097/01.bor.0000127594.92432.7c; Hartford CG, 2006, DRUG SAFETY, V29, P657, DOI 10.2165/00002018-200629080-00003; Kessler M, 2006, NEPHROL DIAL TRANSPL, V21, P9, DOI 10.1093/ndt/gfl476; Kromminga A, 2005, ANN NY ACAD SCI, V1050, P257, DOI 10.1196/annals.1313.027; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Meyboom RHB, 1996, CLIN DRUG INVEST, V12, P207, DOI 10.2165/00044011-199612040-00006; Nieminen O, 2005, EUR J PHARM BIOPHARM, V60, P319, DOI 10.1016/j.ejpb.2005.01.013; Ryff JC, 2002, TRENDS PHARMACOL SCI, V23, P254, DOI 10.1016/S0165-6147(02)02024-2; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P31, DOI 10.1093/ndt/gfh1085; Schellekens H, 2005, BEST PRACT RES CL HA, V18, P473, DOI 10.1016/j.beha.2005.01.016; Schellekens H, 2002, TRENDS PHARMACOL SCI, V23, P119, DOI 10.1016/S0165-6147(00)01967-2; SCHELLEKENS H, 2001, MED BIOTECHNOLOGIE; Schellekens H, 2006, NAT BIOTECHNOL, V24, P613, DOI 10.1038/nbt0606-613; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Sims J, 2001, TOXICOL LETT, V120, P59, DOI 10.1016/S0378-4274(01)00310-1; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Temple RJ, 2002, JAMA-J AM MED ASSOC, V287, P2273, DOI 10.1001/jama.287.17.2273; *US FDA, 2007, DRUG SAF INF FDAS CO; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Walsh G, 2006, NAT BIOTECHNOL, V24, P769, DOI 10.1038/nbt0706-769; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	34	172	178	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1887	1896		10.1001/jama.300.16.1887	http://dx.doi.org/10.1001/jama.300.16.1887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940975				2022-12-24	WOS:000260223100018
J	Whitelaw, A				Whitelaw, Andrew			Collapse of GMC hearing into research misconduct	LANCET			English	Editorial Material							NEGATIVE EXTRATHORACIC PRESSURE; FAILURE; TRIAL		[Whitelaw, Andrew] Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England	University of Bristol	Whitelaw, A (corresponding author), Univ Bristol, Dept Clin Sci, Bristol BS10 5NB, Avon, England.	andrew.whitelaw@bris.ac.uk						Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Chalmers I, 2001, BRIT MED J, V323, P280, DOI 10.1136/bmj.323.7307.280; Farthing M, 2000, BRIT MED J, V321, P1485, DOI 10.1136/bmj.321.7275.1485; *GEN MED COUNC, 2008, FITN PRACT PAN; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Hey E, 2006, PEDIATRICS, V117, P2244, DOI 10.1542/peds.2006-0819; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; Jenny C, 2007, PEDIATRICS, V119, P797, DOI 10.1542/peds.2006-2472; Samuels MP, 1996, PEDIATRICS, V98, P1154; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	11	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1283	1284		10.1016/S0140-6736(08)61532-9	http://dx.doi.org/10.1016/S0140-6736(08)61532-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929890				2022-12-24	WOS:000260060500009
J	Shaaban, R; Zureik, M; Soussan, D; Neukirch, C; Heinrich, J; Sunyer, J; Wjst, M; Cerveri, I; Pin, I; Bousquet, J; Jarvis, D; Burney, PG; Neukirch, F; Leynaert, B				Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Heinrich, Joachim; Sunyer, Jordi; Wjst, Matthias; Cerveri, Isa; Pin, Isabelle; Bousquet, Jean; Jarvis, Deborah; Burney, Peter G.; Neukirch, Francoise; Leynaert, Benedicte			Rhinitis and onset of asthma: a longitudinal population-based study	LANCET			English	Article							ASYMPTOMATIC AIRWAY HYPERRESPONSIVENESS; INDEPENDENT RISK-FACTOR; ALLERGIC RHINITIS; BRONCHIAL HYPERRESPONSIVENESS; FOLLOW-UP; PERENNIAL RHINITIS; LUNG-FUNCTION; HEALTH; SENSITIZATION; PERSISTENCE	Background A close relation between asthma and allergic rhinitis has been reported by several epidemiological and clinical studies. However, the nature of this relation remains unclear. We used the follow-up data from the European Community Respiratory Health Survey to investigate the onset of asthma in patients with allergic and non-allergic rhinitis during an 8 . 8-year period. Methods We did a longitudinal population-based study, which included 29 centres (14 countries) mostly in western Europe. Frequency of asthma was studied in 6461 participants, aged 20-44 years, without asthma at baseline. incident asthma was defined as reporting ever having had asthma confirmed by a physician between the two surveys. Atopy was defined as a positive skin-prick test to mites, cat, Alternaria, Cladosporium, grass, birch, Parietaria, olive, or 44 ragweed. Participants were classified into four groups at baseline: controls (no atopy, no rhinitis; n=3163), atopy only (atopy, no rhinitis; n=704), non-allergic rhinitis (rhinitis, no atopy; n=1377), and allergic rhinitis (atopy+rhinitis; 49 n=1217). Cox proportional hazards models were used to study asthma onset in the four groups. Findings The 8.8-year cumulative incidence of asthma was 2.2% (140 events), and was different in the four groups (1 . 1% (36), 1.9% (13), 3.1% (42), and 4.0% (49), respectively; p<0 . 0001). After controlling for country, sex, baseline age, body-mass index, forced expiratory volume in 1 s (FEV1), log total IgE, family history of asthma, and smoking, the adjusted relative risk for asthma was 1.63 (95% CI 0.82-3.24) for atopy only, 2.71 (1.64-4.46) for non-allergic rhinitis, and 3.53 (2.11-5.91) for allergic rhinitis. Only allergic rhinitis with sensitisation to mite was associated with increased risk of asthma independently of other allergens (2.79 [1.57-4.96]). Interpretation Rhinitis, even in the absence of atopy, is a powerful predictor of adult-onset asthma Funding UCB Institute of Allergy and Agence Nationale de la Recherche.	[Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Neukirch, Francoise; Leynaert, Benedicte] Univ Paris 07, Fac Med, Unite 700, INSERM, F-75870 Paris 18, France; [Neukirch, Catherine] Bichat Teaching Hosp, Dept Pneumol, Paris, France; [Heinrich, Joachim; Wjst, Matthias] Natl Res Ctr Environm & Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Sunyer, Jordi] Inst Municipal Invest Med, CREAL, E-08003 Barcelona, Spain; [Jarvis, Deborah; Burney, Peter G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Cerveri, Isa] Univ Pavia, I-27100 Pavia, Italy; [Pin, Isabelle] INSERM, Natl Inst Hlth & Med Res, Unit 823, Grenoble, France; [Pin, Isabelle] Grenoble Teaching Hosp, Grenoble, France; [Bousquet, Jean] Hosp Arnaud De Villeneuve, Dept Pneumol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Imperial College London; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes	Zureik, M (corresponding author), Univ Paris 07, Fac Med, Unite 700, INSERM, Site Bichat,BP 416, F-75870 Paris 18, France.	mahmoud.zureik@inserm.fr	Jarvis, Deborah/E-6494-2011; PIN, Isabelle/N-3020-2013; Heinrich, Joachim/N-1720-2013; Leynaert, Benedicte/N-5251-2018; Sunyer, Jordi/G-6909-2014; Zureik, Mahmoud/F-7855-2018	Heinrich, Joachim/0000-0002-9620-1629; Sunyer, Jordi/0000-0002-2602-4110; Jarvis, Deborah/0000-0002-1753-3896; Leynaert, Benedicte/0000-0001-5045-2492; Cerveri, Isa/0000-0003-0337-043X; Burney, Peter/0000-0001-8635-5678; Zureik, Mahmoud/0000-0002-8393-4217	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission; Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]; Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium [G.0402.00]; University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service [ROI HL62633-01]; CIRIT [1999SGR 00241]; Swiss National Science Foundation [4026-28099]; Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA); Norwegian Research Council; Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft [FR 1526/1-1, MA 711/4-1]; Basque Health Dept; Swedish Heart Lung Foundation; Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 [2610]; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health; Asthma UK (formerly known as National Asthma Campaign); Aventis (France); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy; Italian Ministry of University and Scientific and Technological Research (MURST); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical; Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT [901MR/10, 91AF/6]; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; CNR; Regione Veneto grant [RSF n. 381/05.93]; Norwegian Research Council [101422/310]; Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS [#91/0016060/00E-05E, #93/0393]; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council; Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service [#2 S07 RR05521-28]	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission(European CommissionEuropean Commission Joint Research Centre); Fondo de Investigaciones Santarias(Instituto de Salud Carlos III); Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium(FWO); University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CIRIT; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA)(Swiss National Science Foundation (SNSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Basque Health Dept; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health(German Research Foundation (DFG)); Asthma UK (formerly known as National Asthma Campaign); Aventis (France)(Sanofi-Aventis); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France)(UCB Pharma SA); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy(GlaxoSmithKline); Italian Ministry of University and Scientific and Technological Research (MURST)(Ministry of Education, Universities and Research (MIUR)); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical(Merck & Company); Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy)(Ministry of Education, Universities and Research (MIUR)); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); CNR(Consiglio Nazionale delle Ricerche (CNR)); Regione Veneto grant; Norwegian Research Council(Research Council of NorwayEuropean Commission); Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands(Netherlands Government); Ministero, Sanidad y Consumo FIS; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by an Educational Grant From the UCB Institute, and by the Agence Nationale de la Recherche (ANR-SEST). MZ of Allergy is a recipient of a Contrat d'Interface grant from Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris. The coordination of ECRHS II was supported by the European Commission, as part of their Quality of Life programme. The following bodies funded the local studies in ECRHS II included in this paper Albacete: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02), Hospital Universitario de Albacete, Consejeria de Sanidad; Antwerp: FWO (Fund for Scientific Research)-Flanders Belgium (grant code: G.0402.00), University of Antwerp, Flemish Health Ministry; Barcelona: SEPAR, Public Health Service (grant code: ROI HL62633-01), Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02) CIRIT (grant code: 1999SGR 00241); Basel: Swiss National Science Foundation. Swiss Federal Office for Education & Science, Swiss National Accident Insurance Fund (SUVA); Bergen: Norwegian Research Council, Norwegian Asthma & Allergy Association (NAAF), Glaxo Wellcome AS, Norway Research Fund; Bordeaux: Institut Pneurnologique d'Aquitaine; Erfurt: GSF-NationaI Research Centre for Environment & Health, Deutsche Forschungsgerneinschaft (DFG) (grant code FR 1526/1-1); Galdakao: Basque Health Dept: Goteborg: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Reserch, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Grenoble: Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, CHU de Grenoble, Comite des Maladies Respiratoires de l'lsere, Hamburg: GSF-National Reasearch Centre for Environment & Health. Deutsche Forschungsgemeinschaft (DFG) (grant code MA 711/4-1); Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign); Huelva: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Montpellier, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, Aventis (France), Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; Oviedo: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Paris: Ministere de l'Emploi et de la Solidarite, Direction Generale de la Same, UCB-Pharma (France), Aventis (France), Glaxo France, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no.; 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; Pavia: GlaxoSmithKline Italy, Italian Ministry of University and Scientific and Technological Research (MURST), Local University Funding for research 1998 & 1999 (Pavia, Italy); Portland: American Lung Association of Oregon, Northwest Health Foundation, Collins Foundation, Merck Pharmaceutical; Reykjavik: Icelandic Research Council, Icelandic University Hospital Fund; Tartu: Estonian Science Foundation: Turin: ASL 4 Regione Piemonte (Italy), AO CTO/ICORMA Regione Piemonte (Italy), Ministero dell' Universita e della Ricerca Scientifica (Italy), Glaxo Wellcome spa (Verona, Italy); Umea: Swedis Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Verona: University of Verona; Italian Ministry of University and Scientific and Technological Research (MURST); GlaxoSmith Kline Italy. Financial support for ECRHS I for centres in ECRHS II: Belgian Science Policy Office, National Fund for Scientific Research; Ministere de la Sante Glaxo France, Insitut Pneumologique d'Aquitaine, Contrat de Plan Etat-Region Languedoc-Rousillon, CNMATS, CNMRT (901MR/10, 91AF/6), Ministre delegue de la sante, RNSP, France; GSF, and the Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93, Italy; Norwegian Research Council project no. 101422/310; Dutch Ministry of Wellbeing, Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS (grants #91/0016060/00E-05E and #93/0393), and grants from Hospital General de Albacete, Hospital General Juan Ramon Jimenenz, Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy; Swiss national Science Foundation grant 4026-28099; National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service (grant #2 S07 RR05521-28).	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARDIN PG, 1990, J ALLERGY CLIN IMMUN, V86, P82, DOI 10.1016/S0091-6749(05)80126-5; Boulet LP, 2003, AM J RESP CRIT CARE, V167, P371, DOI 10.1164/rccm.200111-084PP; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bousquet PJ, 2007, CLIN EXP ALLERGY, V37, P780, DOI 10.1111/j.1365-2222.2007.02714.x; Braunstahl GJ, 2005, J ALLERGY CLIN IMMUN, V115, P142, DOI 10.1016/j.jaci.2004.10.041; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BUCCA C, 1995, LANCET, V346, P791, DOI 10.1016/S0140-6736(95)91617-2; Burgess JA, 2007, J ALLERGY CLIN IMMUN, V120, P863, DOI 10.1016/j.jaci.2007.07.020; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Chinn S, 1996, EUR J EPIDEMIOL, V12, P155, DOI 10.1007/BF00145501; Colantonio D, 2002, CLIN EXP ALLERGY, V32, P698, DOI 10.1046/j.1365-2222.2002.01379.x; Corren J, 1997, J ALLERGY CLIN IMMUN, V99, pS781, DOI 10.1016/S0091-6749(97)70127-1; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Durham SR, 1999, ALLERGY, V54, P124, DOI 10.1111/j.1398-9995.1999.tb04414.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fontanari P, 1997, EUR RESPIR J, V10, P2250, DOI 10.1183/09031936.97.10102250; GLINDMEYER HW, 1995, AM J RESP CRIT CARE, V151, P412, DOI 10.1164/ajrccm.151.2.7842200; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greisner WA, 1998, ALLERGY ASTHMA PROC, V19, P185, DOI 10.2500/108854198778557836; Grossman J, 1997, CHEST, V111, pS11, DOI 10.1378/chest.111.2_Supplement.11S; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; Huovinen E, 1999, CHEST, V115, P928, DOI 10.1378/chest.115.4.928; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; MCNICHOL KN, 1973, BRIT MED J, V4, P12, DOI 10.1136/bmj.4.5883.12; Molgaard E, 2007, ALLERGY, V62, P1033, DOI 10.1111/j.1398-9995.2007.01355.x; Panettieri RA, 2008, J ALLERGY CLIN IMMUN, V121, P607, DOI 10.1016/j.jaci.2008.01.006; Plaschke PP, 2000, AM J RESP CRIT CARE, V162, P920, DOI 10.1164/ajrccm.162.3.9912030; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Riccioni G, 2002, INT J IMMUNOPATH PH, V15, P69, DOI 10.1177/039463200201500110; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Shaaban R, 2007, AM J RESP CRIT CARE, V176, P659, DOI 10.1164/rccm.200703-427OC; Stirling RG, 2001, AM J RESP CRIT CARE, V164, P1403, DOI 10.1164/ajrccm.164.8.2010002; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Undem BJ, 1999, ALLERGY, V54, P81, DOI 10.1111/j.1398-9995.1999.tb04409.x; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Wang J, 1998, J CLIN INVEST, V102, P1132, DOI 10.1172/JCI2686; ZHONG NS, 1992, CHEST, V102, P1104, DOI 10.1378/chest.102.4.1104	52	404	440	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1049	1057		10.1016/S0140-6736(08)61446-4	http://dx.doi.org/10.1016/S0140-6736(08)61446-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805333				2022-12-24	WOS:000259648500031
J	Salay, R; Lincoln, P				Salay, Rebecca; Lincoln, Paul			Health impact assessments in the European Union	LANCET			English	Editorial Material									[Salay, Rebecca; Lincoln, Paul] Natl Heart Forum, London WC1H 9LG, England		Salay, R (corresponding author), Natl Heart Forum, Tavistock House,S Tavistock Sq, London WC1H 9LG, England.	rebecca.salay@heartforum.org.uk						European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO	1	18	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					860	861		10.1016/S0140-6736(08)61337-9	http://dx.doi.org/10.1016/S0140-6736(08)61337-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18774419				2022-12-24	WOS:000259124900028
J	Lantieri, L; Meningaud, JP; Grimbert, P; Bellivier, F; Lefaucheur, JP; Ortonne, N; Benjoar, MD; Lang, P; Wolkenstein, P				Lantieri, Laurent; Meningaud, Jean-Paul; Grimbert, Philippe; Bellivier, Frank; Lefaucheur, Jean-Pascal; Ortonne, Nicolas; Benjoar, Marc-David; Lang, Philippe; Wolkenstein, Pierre			Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study	LANCET			English	Article							HUMAN HAND TRANSPLANTATION; ALLOGRAFT; TYPE-1; REJECTION; TOLERANCE; TUMORS	Background The risk to benefit ratio of face transplantation with a composite tissue allograft remains debatable, although this procedure is technically feasible. We report here a 1-year follow-up of a patient who underwent face transplantation with a composite tissue allograft. Methods On Jan 21, 2007, a 29-year-old man with neurofibromatosis type 1 underwent resection of a massive plexiform neurofibroma diffusely infiltrating the middle and lower part of his face. The main goal was to restore both the cutaneous appearance and function of the face, including, in particular, control of orbicularis oculi and oris muscle contraction. The issues of immunosuppressive therapy, psychological outcome, and social reintergration were addressed, together with the monitoring of graft rejection by biopsies of the skin and mucosa. Findings The initial postoperative course was uncomplicated. Two episodes of clinical rejection occurred on days 28 and 64. The second episode was associated with cytomegalovirus infection. Both episodes resolved favourably, with no further clinical signs of rejection, making the reduction of immunosuppressive treatment possible. A year after surgery, the functional outcome was very good, with successful sensory and motor reinnervation in the transplanted territory. Psychological recovery was excellent, with complete social reintegration. Interpretation This case demonstrates the feasibility of surgically removing a large part of the face and replacing it with a composite tissue allograft. This facial repair procedure, which seems to have a satisfactory risk to benefit ratio, could be offered in rare and selected cases.	[Lantieri, Laurent; Meningaud, Jean-Paul; Grimbert, Philippe; Bellivier, Frank; Lefaucheur, Jean-Pascal; Ortonne, Nicolas; Benjoar, Marc-David; Lang, Philippe; Wolkenstein, Pierre] Univ Paris 12, Fac Med, IFR10, INSERM U 841, Creteil, France; [Lantieri, Laurent; Meningaud, Jean-Paul; Benjoar, Marc-David] Serv Chirurg Plast Reconstruct & Esthet, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Grimbert, Philippe; Lang, Philippe] Serv Nephrol & Transplantat, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Bellivier, Frank] Psychiat Serv, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Lefaucheur, Jean-Pascal] Serv Physiol Explorat Fonctionnelles, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Ortonne, Nicolas] Serv Anat, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Wolkenstein, Pierre] Serv Dermatol, AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lantieri, L (corresponding author), CHU Henri Mondor, Dept Plast & Reconstruct Surg, F-94010 Creteil, France.	laurent.lantieri@hmn.aphp.fr	grimbert, philippe/Q-5337-2018; BELLIVIER, FRANK/H-5197-2012; Lantieri, Laurent/AAD-2025-2019	BELLIVIER, FRANK/0000-0002-3660-6640				Barr ML, 1998, NEW ENGL J MED, V339, P1744, DOI 10.1056/NEJM199812103392404; BOUHANNA E, 2004, ALLOTRANSPLANTATION; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; JACKSON IT, 1995, CLIN PLAST SURG, V22, P513; Kanitakis J, 2006, TRANSPLANTATION, V82, P1610, DOI 10.1097/01.tp.0000248780.55263.33; Kasiske BL, 2005, AM J TRANSPLANT, V5, P1405, DOI 10.1111/j.1600-6143.2005.00853.x; Lantieri LA, 2006, SOUTH MED J, V99, P421, DOI 10.1097/01.smj.0000210143.28625.21; Lanzetta M, 2004, TRANSPL P, V36, P664, DOI 10.1016/j.transproceed.2004.03.006; Merlo CA, 2004, J HEART LUNG TRANSPL, V23, P774, DOI 10.1016/S1053-2498(03)00265-1; Nett PC, 2004, TRANSPLANTATION, V78, P1036, DOI 10.1097/01.TP.0000137105.92464.F3; Nopajaroonsri C, 1996, HUM PATHOL, V27, P982, DOI 10.1016/S0046-8177(96)90229-4; Paraskevas A, 2007, ANN CHIR PLAST ESTH, V52, P485, DOI 10.1016/j.anplas.2007.06.003; Petit F, 2004, AM J BIOETHICS, V4, P14, DOI 10.1080/15265160490496868; Petit F, 2004, PLAST RECONSTR SURG, V113, P1429, DOI 10.1097/01.PRS.0000112747.85388.39; Prabhune KA, 2003, TRANSPLANTATION, V76, P1548, DOI 10.1097/01.TP.0000085288.12571.65; Schneeberger S, 2005, TRANSPLANTATION, V80, P441, DOI 10.1097/01.tp.0000168454.68139.0a; Starzl TE, 2008, NEW ENGL J MED, V358, P407, DOI 10.1056/NEJMe0707578; Taure G, 2006, J ORAL MAXIL SURG, V64, P789, DOI 10.1016/j.joms.2006.01.010; Wolkenstein P, 2001, ARCH DERMATOL, V137, P1421, DOI 10.1001/archderm.137.11.1421; Wolkenstein P, 2001, ARCH DERMATOL, V137, P233	23	235	242	2	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2008	372	9639					639	645		10.1016/S0140-6736(08)61277-5	http://dx.doi.org/10.1016/S0140-6736(08)61277-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340BX	18722868				2022-12-24	WOS:000258622200027
J	Difilippantonio, S; Gapud, E; Wong, N; Huang, CY; Mahowald, G; Chen, HT; Kruhlak, MJ; Callen, E; Livak, F; Nussenzweig, MC; Sleckman, BP; Nussenzweig, A				Difilippantonio, Simone; Gapud, Eric; Wong, Nancy; Huang, Ching-Yu; Mahowald, Grace; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Livak, Ferenc; Nussenzweig, Michel C.; Sleckman, Barry P.; Nussenzweig, Andre			53BP1 facilitates long-range DNA end-joining during V(D)J recombination	NATURE			English	Article							SWITCH REGION RECOMBINATION; GENOMIC INSTABILITY; CHROMOSOME BREAKS; IN-VIVO; DAMAGE; ATM; H2AX; P53; METHYLATION; PREVENTS	Variable, diversity and joining (V(D)J) recombination and class-switch recombination use overlapping but distinct non- homologous end joining pathways to repair DNA double- strand- break intermediates. 53BP1 is a DNA- damage- response protein that is rapidly recruited to sites of chromosomal double- strand breaks, where it seems to function in a subset of ataxia telangiectasia mutated ( ATM) kinase-, H2A histone family member X ( H2AX, also known as H2AFX)- and mediator of DNA damage checkpoint 1 (MDC1)- dependent events(1,2). A 53BP1- dependent end- joining pathway has been described that is dispensable for V( D) J recombination but essential for class- switch recombination(3,4). Here we report a previously unrecognized defect in the joining phase of V( D) J recombination in 53BP1- deficient lymphocytes that is distinct from that found in classical non- homologous- end- joining-, H2ax-, Mdc1- and Atm- deficient mice. Absence of 53BP1 leads to impairment of distal V - DJ joining with extensive degradation of unrepaired coding ends and episomal signal joint reintegration at V( D) J junctions. This results in apoptosis, loss of T- cell receptor a locus integrity and lymphopenia. Further impairment of the apoptotic checkpoint causes propagation of lymphocytes that have antigen receptor breaks. These data suggest a more general role for 53BP1 in maintaining genomic stability during long- range joining of DNA breaks.	[Difilippantonio, Simone; Wong, Nancy; Chen, Hua Tang; Kruhlak, Michael J.; Callen, Elsa; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Gapud, Eric; Huang, Ching-Yu; Mahowald, Grace; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Rockefeller University; Howard Hughes Medical Institute	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Huang, Ching-Yu/E-3981-2010; Nussenzweig, Michel/AAE-7292-2019	Huang, Ching-yu/0000-0002-5758-281X; Mahowald, Grace/0000-0003-4541-4920	NIH [R01AI074953]; Cancer Research Institute; Intramural Research Program; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC010915, ZICBC009255, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Intramural Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to M. McAuliffe and co-workers for developing the three- dimensional- FISH measurement algorithm; D.G. Schatz and J. Haber for discussions; A. Wynshaw-Boris for Atm<SUP>-/-</SUP> mice and J. Chen for 53BP1<SUP>-/-</SUP> and Mdc1<SUP>-/-</SUP> mice; D. Venzon for help with statistical analysis; and numbers of the A. Nussenzweig laboratory (J. Daniel and A. Celeste) for comments on the manuscript. B.P.S. is supported by NIH grant R01AI074953. E.G. is supported by pre-doctoral fellowship from the Cancer Research Institute. M.C.N. is a HHMI investigator. A.N. is supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Huang CY, 2007, J IMMUNOL, V179, P449, DOI 10.4049/jimmunol.179.1.449; Huang CY, 2007, J EXP MED, V204, P1371, DOI 10.1084/jem.20061460; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021	30	228	231	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					529	U57		10.1038/nature07476	http://dx.doi.org/10.1038/nature07476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18931658	Green Accepted			2022-12-24	WOS:000261170500044
J	Pearce, MJ; Mintseris, J; Ferreyra, J; Gygi, SP; Darwin, KH				Pearce, Michael J.; Mintseris, Julian; Ferreyra, Jessica; Gygi, Steven P.; Darwin, K. Heran			Ubiquitin-Like Protein Involved in the Proteasome Pathway of Mycobacterium tuberculosis	SCIENCE			English	Article							NUCLEAR-PORE COMPLEX; 20S PROTEASOME; RESOLUTION; PROGRAMS; RANGAP1; SYSTEM	The protein modifier ubiquitin is a signal for proteasome-mediated degradation in eukaryotes. Proteasome- bearing prokaryotes have been thought to degrade proteins via a ubiquitinin-dependent pathway. We have identified a prokaryotic ubiquitin- like protein, Pup ( Rv2111c), which was specifically conjugated to proteasome substrates in the pathogen Mycobacterium tuberculosis. Pupylation occurred on lysines and required proteasome accessory factor A (PafA). In a pafA mutant, pupylated proteins were absent and substrates accumulated, thereby connecting pupylation with degradation. Although analogous to ubiquitylation, pupylation appears to proceed by a different chemistry. Thus, like eukaryotes, bacteria may use a small- protein modifier to control protein stability.	[Pearce, Michael J.; Ferreyra, Jessica; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	New York University; Harvard University; Harvard Medical School	Darwin, KH (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	NIH [AI065437, HL092774, GM67945, HG3456, HG3616];  [5T32AI07189-25]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003616, R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI007189, R56AI065437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ehrt, D. Ladant, V. Miller, and A. Steyn for plasmids used in this study. We are grateful to C. Arias and C. Perez for advice on pulse- labeling experiments and to T. Huang, I. Mohr, and M. Pagano for helpful discussions. We thank A. Darwin and M. Pagano for critical review of this manuscript. This work was supported by NIH grants AI065437 and HL092774 ( to K. H. D.) and GM67945, HG3456, and HG3616 ( to S. P. G.). M. J. P. was supported by grant 5T32AI07189-25.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7	22	290	318	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1104	1107		10.1126/science.1163885	http://dx.doi.org/10.1126/science.1163885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18832610	Green Accepted			2022-12-24	WOS:000260867700038
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Structural insights into amino acid binding and gene control by a lysine riboswitch	NATURE			English	Article							CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; RNA; EXPRESSION; REFINEMENT; BIOSYNTHESIS; RECOGNITION; BACTERIA; ANALOGS; DOMAIN	In bacteria, the intracellular concentration of several amino acids is controlled by riboswitches(1-4). One of the important regulatory circuits involves lysine- specific riboswitches, which direct the biosynthesis and transport of lysine and precursors common for lysine and other amino acids(1-3). To understand the molecular basis of amino acid recognition by riboswitches, here we present the crystal structure of the 174- nucleotide sensing domain of the Thermotoga maritima lysine riboswitch in the lysine- bound (1.9 angstrom (angstrom)) and free (3.1 angstrom) states. The riboswitch features an unusual and intricate architecture, involving three-helical and two- helical bundles connected by a compact five- helical junction and stabilized by various long- range tertiary interactions. Lysine interacts with the junctional core of the riboswitch and is specifically recognized through shape- complementarity within the elongated binding pocket and through several direct and K(+)-mediated hydrogen bonds to its charged ends. Our structural and biochemical studies indicate preformation of the riboswitch scaffold and identify conformational changes associated with the formation of a stable lysine- bound state, which prevents alternative folding of the riboswitch and facilitates formation of downstream regulatory elements. We have also determined several structures of the riboswitch bound to different lysine analogues(5), including antibiotics, in an effort to understand the ligand-binding capabilities of the lysine riboswitch and understand the nature of antibiotic resistance. Our results provide insights into a mechanism of lysine- riboswitch- dependent gene control at the molecular level, thereby contributing to continuing efforts at exploration of the pharmaceutical and biotechnological potential of riboswitches.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank personnel of beamline X29 at the Brookhaven National Laboratory and beamlines 24-ID-C/E at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank O. Ouerfelli for the synthesis of iridium hexamine. D.J.P. was supported by funds from the National Institutes of Health.	Ataide SF, 2007, ACS CHEM BIOL, V2, P819, DOI 10.1021/cb7002253; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Feig A. L., 1999, RNA WORLD, P287; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; LU Y, 1992, FEMS MICROBIOL LETT, V92, P23, DOI 10.1016/0378-1097(92)90536-W; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Patte JC, 1998, FEMS MICROBIOL LETT, V169, P165, DOI 10.1016/S0378-1097(98)00479-0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	32	185	190	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1263	U76		10.1038/nature07326	http://dx.doi.org/10.1038/nature07326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784651	Green Accepted			2022-12-24	WOS:000260462100050
J	Sarkar, M; Hennessy, S; Yang, YX				Sarkar, Monika; Hennessy, Sean; Yang, Yu-Xiao			Proton-pump inhibitor use and the risk for community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION; DRUGS; CANCER	Background: Recent studies suggest that proton-pump inhibitors (PPIs) may increase the risk for community-acquired pneumonia (CAP). Objective: To examine the association between PPI use and CAP in adults followed in general practices in the United Kingdom. Design: Nested case-control study. Setting: The General Practice Research Database (1987 to 2002) in the United Kingdom. Participants: Patients age 18 years or older with at least 6 months of initial pneumonia-free follow-up in the database. Case patients (n = 80 066) were defined as those who received an incident diagnosis of CAP. Control participants (n = 799 881) were selected by using incidence density sampling, matching on practice site, calendar period, and follow-up duration. Measurements: Use of PPIs within 30 days before the index date. Adjusted odds ratios (ORs) were estimated by using conditional logistic regression, adjusting for potential confounders. Results: Overall, current PPI use was not associated with an increased risk for CAP (adjusted OR, 1.02 [95% CI, 0.97 to 1.08]) or risk for CAP that required hospitalization (adjusted OR, 1.01 [CI, 0.91 to 1.12]). There was a strong increase in risk for CAP associated with current use of PPI therapy that was started within the previous 2 days (adjusted OR, 6.53 [CI, 3.95 to 10.80]), 7 days (adjusted OR, 3.79 [CI, 2.66 to 5.42]), and 14 days (adjusted OR, 3.21 [CI, 2.46 to 4.18]), but there was no statistically significant association for longer-term current PPI therapy. A separate matched case-control analysis, which included the 3 strongest confounders as additional matching factors, yielded similar results as the primary analysis (adjusted OR, 0.96 [CI, 0.91 to 1.02]). Limitations: Adherence to PPI prescription was assumed to be 100%. No radiographic evidence was available to corroborate a diagnosis of CAP. Conclusion: Proton-pump inhibitor therapy started within the past 30 days was associated with an increased risk for CAP, whereas longer-term current use was not.	[Yang, Yu-Xiao] Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Yang, YX (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, 722 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	yangy@mail.med.upenn.edu	yang, yx/GZM-0464-2022		the Department of Medicine, University of Pennsylvania	the Department of Medicine, University of Pennsylvania	By an Academic Development Fund by the Department of Medicine, University of Pennsylvania (Dr. Yang).	Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hartmann M, 1996, ALIMENT PHARM THERAP, V10, P359, DOI 10.1111/j.0953-0673.1996.00359.x; Hollowell J, 1997, Popul Trends, P36; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Ip S, 2005, COMP EFFECTIVENESS R, V1; Irwin RS, 2006, CHEST, V129, p80S, DOI 10.1378/chest.129.1_suppl.80S; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Martin RM, 1998, ALIMENT PHARM THERAP, V12, P797; Meier CR, 2002, PHARMACOTHERAPY, V22, P303, DOI 10.1592/phco.22.5.303.33189; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; *NAT I HEALTH CAR, 2008, PRESCR DRUG EXP 2001; Perry J, 1978, OXMIS PROBLEM CODES; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WESSLING A, 1990, EUR J CLIN PHARMACOL, V39, P207, DOI 10.1007/BF00315097; Yang YX, 2007, GASTROENTEROLOGY, V133, P748, DOI 10.1053/j.gastro.2007.06.022; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	27	202	215	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					391	W75		10.7326/0003-4819-149-6-200809160-00005	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794558				2022-12-24	WOS:000259230200003
J	Meltzer, MI				Meltzer, Martin I.			Health economics and prioritising health care	LANCET			English	Editorial Material							COST-EFFECTIVENESS; INFORMATION		Ctr Dis Control & Prevent, Div Emerging Dis & Surveillance Syst, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Meltzer, MI (corresponding author), Ctr Dis Control & Prevent, Div Emerging Dis & Surveillance Syst, Atlanta, GA 30333 USA.	qzm4@cdc.gov	Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472				[Anonymous], REC GUID ADV COMM IM; Blumstein JF, 1997, SOC SCI MED, V45, P545, DOI 10.1016/S0277-9536(96)00395-4; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Grosse SD, 2007, ANNU REV PUBL HEALTH, V28, P365, DOI 10.1146/annurev.publhealth.28.021406.144046; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; LIEU T, 2008, ADV COMM IMM PRACT F; Meltzer MI, 2001, LANCET, V358, P993, DOI 10.1016/S0140-6736(01)06107-4; Neumann PJ, 2005, VALUE HEALTH, V8, P3, DOI 10.1111/j.1524-4733.2005.04010.x; Wilensky GR, 2008, ANN INTERN MED, V148, P967, DOI 10.7326/0003-4819-148-12-200806170-00224; Williams I, 2008, HEALTH TECHNOL ASSES, V12, P1	11	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2008	372	9639					612	613		10.1016/S0140-6736(08)61257-X	http://dx.doi.org/10.1016/S0140-6736(08)61257-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340BX	18722853				2022-12-24	WOS:000258622200009
J	Kaiser, TE; Intine, RV; Dundr, M				Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav			De Novo Formation of a Subnuclear Body	SCIENCE			English	Article							CAJAL BODIES; IN-VIVO; SMN; PROTEIN; ORGANIZATION; RNA; EXPRESSION; ORGANELLES; DYNAMICS; GENOME	The mammalian cell nucleus contains structurally stable functional compartments. We show here that one of them, the Cajal body ( CB), can be formed de novo. Immobilization on chromatin of both CB structural components, such as coilin, and functional components of the CB, such as the SMN complex, spliceosomal small nuclear ribonucleoproteins ( RNPs), small nucleolar RNPs, and small Cajal body- specific RNPs, is sufficient for the formation of a morphologically normal and apparently functional CB. Biogenesis of the CB does not follow a hierarchical assembly pathway and exhibits hallmarks of a self- organizing structure.	[Kaiser, Trish E.; Intine, Robert V.; Dundr, Miroslav] Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA; [Intine, Robert V.] Rosalind Franklin Univ Med & Sci, Dr William M Scholl Coll Podiat Med, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Dundr, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA.	mirek.dundr@rosalindfranklin.edu			Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	Schweppe Career Development Award (the Schweppe Foundation); Rosalind Franklin University of Medicine and Science	We thank A. Belmont, E. Bertrand, J. Gall, M. Hastings, P. Hemmerich, T. Kiss, I. Lemm, R. Luhrmann, G. Matera, T. Meier, T. Misteli, S. Sharma, E. Soutoglou, C. Verheggen, and P. Young for reagents; S. Shevtsov for technical assistance; and T. Misteli for helpful suggestions and critical reading of the manuscript. This research was supported by Schweppe Career Development Award (the Schweppe Foundation) to M.D. and by startup funds from the Rosalind Franklin University of Medicine and Science to M. D.	Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Carrero G, 2006, J THEOR BIOL, V239, P298, DOI 10.1016/j.jtbi.2005.07.019; Dundr M, 2004, J CELL BIOL, V164, P831, DOI 10.1083/jcb.200311121; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Isaac C, 1998, J CELL BIOL, V142, P319, DOI 10.1083/jcb.142.2.319; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Matera AG, 2006, CURR OPIN CELL BIOL, V18, P317, DOI 10.1016/j.ceb.2006.03.005; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2008, HISTOCHEM CELL BIOL, V129, P5, DOI 10.1007/s00418-007-0355-x; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morse R, 2007, HUM MOL GENET, V16, P2349, DOI 10.1093/hmg/ddm192; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Querido E, 2008, METHOD CELL BIOL, V85, P273; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Sleeman JE, 2001, J CELL SCI, V114, P4407; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083	25	184	184	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2008	322	5908					1713	1717		10.1126/science.1165216	http://dx.doi.org/10.1126/science.1165216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382LU	18948503				2022-12-24	WOS:000261608300051
J	Boisvert, CA; Mark-Kurik, E; Ahlberg, PE				Boisvert, Catherine A.; Mark-Kurik, Elga; Ahlberg, Per E.			The pectoral fin of Panderichthys and the origin of digits	NATURE			English	Article							TETRAPOD LIMB; EVOLUTION; FISH; EXPRESSION	One of the identifying characteristics of tetrapods ( limbed vertebrates) is the presence of fingers and toes. Whereas the proximal part of the tetrapod limb skeleton can easily be homologized with the paired fin skeletons of sarcopterygian ( lobe- finned) fish, there has been much debate about the origin of digits. Early hypotheses(1) interpreted digits as derivatives of fin radials, but during the 1990s the idea gained acceptance that digits are evolutionary novelties without direct equivalents in fish fin skeletons. This was partly based on developmental genetic data(2), but also substantially on the pectoral fin skeleton of the elpistostegid ( transitional fish/ tetrapod) Panderichthys, which appeared to lack distal digit- like radials(3). Here we present a CT scan study of an undisturbed pectoral fin of Panderichthys demonstrating that the plate- like 'ulnare' of previous reconstructions is an artefact and that distal radials are in fact present. This distal portion is more tetrapod- like than that found in Tiktaalik(4) and, in combination with new data about fin development in basal actinopterygians(5), sharks(6) and lungfish(7), makes a strong case for fingers not being a novelty of tetrapods but derived from pre- existing distal radials present in all sarcopterygian fish.	[Boisvert, Catherine A.; Ahlberg, Per E.] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mark-Kurik, Elga] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	Uppsala University; Tallinn University of Technology	Boisvert, CA (corresponding author), Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, Norbyvagen 18A, S-75236 Uppsala, Sweden.	catherine.boisvert@ebc.uu.se	Boisvert, Catherine A/A-9782-2019; Ahlberg, Per/E-8086-2013	Boisvert, Catherine A/0000-0002-0618-7270; Ahlberg, Per/0000-0001-9054-2900	Vetenskapsradet	Vetenskapsradet(Swedish Research Council)	We thank P. Ross and the team at East-Tallinn Central Hospital, Estonia for the CT-scanning, E. Vorobyeva for permission to examine the Panderichthys material in her care, N. Shubin for access to Tiktaalik, and M.I. Coates for valuable discussions. C.A.B. and P.E.A. are supported by Vetenskapsradet.	ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; BOISVERT CA, 40 YEARS EARLY VERTE; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Gegenbaur C., 1874, GRUNDRISS VERGLEICHE; GREGORY WILLIAM K., 1941, ANN NEW YORK ACAD SCI, V42, P273, DOI 10.1111/j.1749-6632.1941.tb55396.x; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; VOROBYEVA EI, 1992, ZH OBSHCH BIOL, V53, P149; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P373, DOI 10.1098/rspb.1943.0013	21	91	93	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					636	638		10.1038/nature07339	http://dx.doi.org/10.1038/nature07339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18806778	Green Published			2022-12-24	WOS:000261340000040
J	Reynolds-Wooding, A				Reynolds-Wooding, Abigail			A patient's journey - Common variable immunodeficiency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Stanley.notoes@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1855	10.1136/bmj.a1855	http://dx.doi.org/10.1136/bmj.a1855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18930972				2022-12-24	WOS:000260298800040
J	Mercer, SW; Lean, MEJ				Mercer, S. W.; Lean, M. E. J.			Request for slimming tablets	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mercer, S. W.] Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland; [Lean, M. E. J.] Univ Glasgow, Fac Med, Div Dev Med, Glasgow G12 9LX, Lanark, Scotland	University of Glasgow; University of Glasgow	Mercer, SW (corresponding author), Univ Glasgow, Fac Med, Div Community Based Sci, Glasgow G12 9LX, Lanark, Scotland.	s.mercer@clinmed.gla.ac.uk		Mercer, Stewart William/0000-0002-1703-3664					0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 24	2008	337								a1287	10.1136/bmj.a1287	http://dx.doi.org/10.1136/bmj.a1287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FQ	18952680				2022-12-24	WOS:000261029000004
J	Li, F; Huarte, M; Zaratiegui, M; Vaughn, MW; Shi, Y; Martienssen, R; Cande, WZ				Li, Fei; Huarte, Maite; Zaratiegui, Mikel; Vaughn, Matthew W.; Shi, Yang; Martienssen, Rob; Cande, W. Zacheus			Lid2 Is Required for Coordinating H3K4 and H3K9 Methylation of Heterochromatin and Euchromatin	CELL			English	Article							HISTONE LYSINE METHYLATION; CHROMATIN-BINDING; RNA INTERFERENCE; FISSION; GENE; INTERACT; PROTEINS; RITS	In most eukaryotes, histone methylation patterns regulate chromatin architecture and function: methylation of histone H3 lysine-9 (H3K9) demarcates heterochromatin, whereas H3K4 methylation demarcates euchromatin. We show here that the S. pombe JmjC-domain protein Lid2 is a trimethyl H3K4 demethylase responsible for H3K4 hypomethylation in heterochromatin. Lid2 interacts with the histone lysine-9 methyltransferase, Clr4, through the Dos1/Clr8-Rik1 complex, which also functions in the RNA interference pathway. Disruption of the JmjC domain alone results in severe heterochromatin defects and depletion of siRNA, whereas overexpressing Lid2 enhances heterochromatin silencing. The physical and functional link between H3K4 demethylation and H3K9 methylation suggests that the two reactions act in a coordinated manner. Surprisingly, crossregulation of H3K4 and H3K9 methylation in euchromatin also requires Lid2. We suggest that Lid2 enzymatic activity in euchromatin is regulated through a dynamic interplay with other histone-modification enzymes. Our findings provide mechanistic insight into the coordination of H3K4 and H3K9 methylation.	[Li, Fei; Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Huarte, Maite; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zaratiegui, Mikel; Vaughn, Matthew W.; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Cold Spring Harbor Laboratory	Li, F (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	feili@nature.berkeley.edu; zcande@berkeley.edu	Hu, Ruogu/B-2203-2008; Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Li, Fei/0000-0002-1206-9684; Vaughn, Matthew/0000-0002-1384-4283; Zaratiegui, Mikel/0000-0002-0342-0268	National Institutes of Health [RO1GM076396, NCI118487]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067992, R01GM076396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Zac Cande laboratory, especially Xie Tang, for kind help and valuable discussions; Michael Myers and the Cold Spring Harbor Laboratory mass spectrometry facility for the mass spectrometry analysis; Erin Osborne for critical reading of the manuscript; and Amikam Cohen, Stephen Kearsey, Jun-ichi Nakayama, and Mitsuhiro Yanagida for kindly providing strains. This work was supported by grants from the National Institutes of Health (RO1GM076396 to W. Z. C. and R. M., and NCI118487 to Y. S.).	Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huarte M, 2007, J BIOL CHEM, V282, P21662, DOI 10.1074/jbc.M703897200; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lachner M, 2004, COLD SPRING HARB SYM, V69, P209, DOI 10.1101/sqb.2004.69.209; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh G, 2008, YEAST, V25, P117, DOI 10.1002/yea.1569; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	34	108	109	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					272	283		10.1016/j.cell.2008.08.036	http://dx.doi.org/10.1016/j.cell.2008.08.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957202	Green Accepted, Bronze			2022-12-24	WOS:000260130400017
J	Huang, TTK; Glass, TA				Huang, Terry T. -K.; Glass, Thomas A.			Transforming research strategies for understanding and preventing obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Huang, Terry T. -K.] NICHHD, Obes Res Strateg Core, NIH, Bethesda, MD 20892 USA; [Glass, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Huang, TTK (corresponding author), NICHHD, Obes Res Strateg Core, NIH, 6100 Execut Blvd,4B11, Bethesda, MD 20892 USA.	huangter@mail.nih.gov		Glass, Thomas/0000-0003-4399-612X; Huang, Terry/0000-0001-5544-5187				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; BRATTEBO G, 1990, SCAND J SOC MED, V18, P225, DOI 10.1177/140349489001800312; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Drewnowski A, 2007, SOC SCI MED, V65, P2458, DOI 10.1016/j.socscimed.2007.07.001; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; World Health Organization, SOC DET HLTH; 2003, PROGR GROCER    0813	15	104	104	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1811	1813		10.1001/jama.300.15.1811	http://dx.doi.org/10.1001/jama.300.15.1811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854544				2022-12-24	WOS:000260002000034
J	Thingstad, TF; Bellerby, RGJ; Bratbak, G; Borsheim, KY; Egge, JK; Heldal, M; Larsen, A; Neill, C; Nejstgaard, J; Norland, S; Sandaa, RA; Skjoldal, EF; Tanaka, T; Thyrhaug, R; Topper, B				Thingstad, T. F.; Bellerby, R. G. J.; Bratbak, G.; Borsheim, K. Y.; Egge, J. K.; Heldal, M.; Larsen, A.; Neill, C.; Nejstgaard, J.; Norland, S.; Sandaa, R. -A.; Skjoldal, E. F.; Tanaka, T.; Thyrhaug, R.; Topper, B.			Counterintuitive carbon-to-nutrient coupling in an Arctic pelagic ecosystem	NATURE			English	Article							ALGAL-BACTERIAL COMPETITION; ORGANIC-CARBON; SPRING BLOOM; RATES; PHOSPHORUS; LIMITATION; MARINE; GROWTH; ACCUMULATION; RESPIRATION	Predicting the ocean's role in the global carbon cycle requires an understanding of the stoichiometric coupling between carbon and growth- limiting elements in biogeochemical processes. A recent addition to such knowledge is that the carbon/nitrogen ratio of inorganic consumption and release of dissolved organic matter may increase in a high-CO2 world(1). This will, however, yield a negative feedback on atmospheric CO2 only if the extra organic material escapes mineralization within the photic zone. Here we show, in the context of an Arctic pelagic ecosystem, how the fate and effects of added degradable organic carbon depend critically on the state of the microbial food web. When bacterial growth rate was limited by mineral nutrients, extra organic carbon accumulated in the system. When bacteria were limited by organic carbon, however, addition of labile dissolved organic carbon reduced phytoplankton biomass and activity and also the rate at which total organic carbon accumulated, explained as the result of stimulated bacterial competition for mineral nutrients. This counterintuitive 'more organic carbon gives less organic carbon' effect was particularly pronounced in diatom- dominated systems where the carbon/ mineral nutrient ratio in phytoplankton production was high. Our results highlight how descriptions of present and future states of the oceanic carbon cycle require detailed understanding of the stoichiometric coupling between carbon and growth- limiting mineral nutrients in both autotrophic and heterotrophic processes.	[Thingstad, T. F.; Bratbak, G.; Egge, J. K.; Heldal, M.; Larsen, A.; Nejstgaard, J.; Norland, S.; Sandaa, R. -A.; Skjoldal, E. F.; Thyrhaug, R.; Topper, B.] Univ Bergen, Dept Biol, N-5020 Bergen, Norway; [Bellerby, R. G. J.; Neill, C.] Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Bellerby, R. G. J.] Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; [Borsheim, K. Y.] Inst Marine Res, N-5817 Bergen, Norway; [Tanaka, T.] CNRS, Lab Oceanog & Biogeochim, UMR6535, F-13288 Marseille 09, France	University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Institute of Marine Research - Norway; Centre National de la Recherche Scientifique (CNRS)	Thingstad, TF (corresponding author), Univ Bergen, Dept Biol, Jahnebakken 5,POB 7800, N-5020 Bergen, Norway.	frede.thingstad@bio.uib.no	Thingstad, Tron Frede/B-2254-2008; Bellerby, Richard/ABD-6590-2021; Bratbak, Gunnar/N-8786-2015; Tanaka, Tsuneo/G-3751-2011; Nejstgaard, Jens/ABB-8903-2020; Bellerby, Richard/B-5277-2012	Thingstad, Tron Frede/0000-0002-5593-819X; Bellerby, Richard/0000-0003-3598-4006; Bratbak, Gunnar/0000-0001-8388-4945; Nejstgaard, Jens/0000-0003-1236-0647; 	Research Council of Norway [175939/S30]; strategic institution project [158936/I10]; Bjerknes Centre of Climate Research Centre of Excellence [146003/V30, 178441/S40 Interact, 184860/S30 MERCLIM]; Norsk Hydro Produksjon AS [5404889]; Svalbard Science Forum as Arktisstipend	Research Council of Norway(Research Council of Norway); strategic institution project; Bjerknes Centre of Climate Research Centre of Excellence; Norsk Hydro Produksjon AS(Norsk Hydro ASA); Svalbard Science Forum as Arktisstipend	This work was financed by the Research Council of Norway through the International Polar Year project 175939/S30 'PAME-Nor' (IPY activity ID no. 71), with additional support from the strategic institution project 158936/I10 'Patterns in microbial diversity', Bjerknes Centre of Climate Research Centre of Excellence Project 146003/V30, project 178441/S40 'Interact' and project 184860/S30 'MERCLIM'. Support was received also from Norsk Hydro Produksjon AS project number 5404889, and from the Svalbard Science Forum as 'Arktisstipend'. We thank Kings Bay A/S and the staff at Ny Alesund for help with logistics.	Bellerby RGJ, 2005, GEOPH MONOG SERIES, V158, P189; Borsheim KY, 2005, J PLANKTON RES, V27, P743, DOI 10.1093/plankt/fbi047; Borsheim KY, 2000, AQUAT MICROB ECOL, V21, P115, DOI 10.3354/ame021115; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Church MJ, 2000, APPL ENVIRON MICROB, V66, P455, DOI 10.1128/AEM.66.2.455-466.2000; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Ducklow HW, 2000, DEEP-SEA RES PT II, V47, P3227, DOI 10.1016/S0967-0645(00)00066-7; Eriksen NT, 2007, J APPL PHYCOL, V19, P161, DOI 10.1007/s10811-006-9122-y; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Graneli W, 2004, DEEP-SEA RES PT II, V51, P2569, DOI 10.1016/j.dsr2.2001.01.003; Havskum H, 2003, LIMNOL OCEANOGR, V48, P129, DOI 10.4319/lo.2003.48.1.0129; HOBBIE JE, 1969, VERH INT VEREIN LIMN, V17, P725; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Holmes RM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032837; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MARTINUSSEN I, 1987, MAR ECOL PROG SER, V37, P285, DOI 10.3354/meps037285; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50034-7, DOI 10.1016/B978-0-08-030287-4.50034-7, DOI 10.1016/C2009-0-07774-5]; POMEROY LR, 1986, SCIENCE, V233, P359, DOI 10.1126/science.233.4761.359; REY F, 1987, MAR ECOL PROG SER, V36, P307, DOI 10.3354/meps036307; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rivkin RB, 1997, LIMNOL OCEANOGR, V42, P730, DOI 10.4319/lo.1997.42.4.0730; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Stets EG, 2008, LIMNOL OCEANOGR, V53, P137, DOI 10.4319/lo.2008.53.1.0137; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; THINGSTAD TF, 1993, MAR ECOL PROG SER, V99, P239, DOI 10.3354/meps099239; Thingstad TF, 2002, MAR ECOL PROG SER, V228, P15, DOI 10.3354/meps228015; Thingstad TF, 1997, LIMNOL OCEANOGR, V42, P398, DOI 10.4319/lo.1997.42.2.0398; VALDERRAMA JC, 1995, MANUAL HARMFUL MARIN, P262; Wassmann P, 1999, MAR ECOL-P S Z N I, V20, P321, DOI 10.1046/j.1439-0485.1999.2034081.x	32	134	135	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					387	U37		10.1038/nature07235	http://dx.doi.org/10.1038/nature07235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18716617				2022-12-24	WOS:000259265200044
J	Herzing, AA; Kiely, CJ; Carley, AF; Landon, P; Hutchings, GJ				Herzing, Andrew A.; Kiely, Christopher J.; Carley, Albert F.; Landon, Philip; Hutchings, Graham J.			Identification of active gold nanoclusters on iron oxide supports for CO oxidation	SCIENCE			English	Article							CATALYTIC-ACTIVITY; NANOPARTICLES; OXYGEN; TIO2(110); CHEMISTRY; CLUSTERS; TITANIA	Gold nanocrystals absorbed on metal oxides have exceptional properties in oxidation catalysis, including the oxidation of carbon monoxide at ambient temperatures, but the identification of the active catalytic gold species among the many present on real catalysts is challenging. We have used aberration- corrected scanning transmission electron microscopy to analyze several iron oxide- supported catalyst samples, ranging from those with little or no activity to others with high activities. High catalytic activity for carbon monoxide oxidation is correlated with the presence of bilayer clusters that are similar to 0.5 nanometer in diameter and contain only similar to 10 gold atoms. The activity of these bilayer clusters is consistent with that demonstrated previously with the use of model catalyst systems.	[Herzing, Andrew A.; Kiely, Christopher J.] Lehigh Univ, Ctr Adv Mat & Nanotechnol, Bethlehem, PA 18015 USA; [Herzing, Andrew A.] Natl Inst Stand & Technol, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA; [Carley, Albert F.; Landon, Philip; Hutchings, Graham J.] Cardiff Univ, Cardiff Catalysis Inst Sch Chem, Cardiff CF10 3AT, Wales	Lehigh University; National Institute of Standards & Technology (NIST) - USA; Cardiff University	Kiely, CJ (corresponding author), Lehigh Univ, Ctr Adv Mat & Nanotechnol, 5 E Packer Ave, Bethlehem, PA 18015 USA.	chk5@lehigh.edu; hutch@cardiff.ac.uk	Carley, Albert/A-7372-2010; Herzing, Andrew/D-6239-2012; Tong, Sherry/C-4462-2015	Kiely, Christopher/0000-0001-5412-0970	Engineering and Physical Sciences Research Council; NSF; NASA,; National Research Council Postdoctoral Associate	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); NASA,(National Aeronautics & Space Administration (NASA)); National Research Council Postdoctoral Associate	We thank the Athena project of the Engineering and Physical Sciences Research Council, NSF, NASA, and the National Research Council Postdoctoral Associate program for funding this work.	Abu Haija M, 2006, SURF SCI, V600, P1497, DOI 10.1016/j.susc.2006.02.003; Bondzie VA, 1999, CATAL LETT, V63, P143, DOI 10.1023/A:1019012903936; Bongiorno A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106102; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; Guzman J, 2005, J AM CHEM SOC, V127, P3286, DOI 10.1021/ja043752s; Guzman J, 2004, J AM CHEM SOC, V126, P2672, DOI 10.1021/ja039426e; Hakkinen H, 2003, ANGEW CHEM INT EDIT, V42, P1297, DOI 10.1002/anie.200390334; Haruta M, 2004, GOLD BULL, V37, P27, DOI 10.1007/BF03215514; Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Hodge NA, 2002, CATAL TODAY, V72, P133, DOI 10.1016/S0920-5861(01)00487-4; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Hutchings GJ, 2006, J CATAL, V242, P71, DOI 10.1016/j.jcat.2006.06.001; Janssens TVW, 2007, TOP CATAL, V44, P15, DOI 10.1007/s11244-007-0335-3; Matthey D, 2007, SCIENCE, V315, P1692, DOI 10.1126/science.1135752; MAYS CW, 1968, SURF SCI, V12, P134, DOI 10.1016/0039-6028(68)90119-2; Meyer R, 2004, GOLD BULL, V37, P72, DOI 10.1007/BF03215519; Pietron JJ, 2002, NANO LETT, V2, P545, DOI 10.1021/nl025536s; Rashkeev SN, 2007, PHYS REV B, V76, DOI [10.1103/PhysRevB.76.035438, 10.1103/physRevB.76.035438]; Schubert MM, 2001, J CATAL, V197, P113, DOI 10.1006/jcat.2000.3069; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Varela M, 2005, ANNU REV MATER RES, V35, P539, DOI 10.1146/annurev.matsci.35.102103.090513; Wang SW, 2004, NAT MATER, V3, P143, DOI 10.1038/nmat1077; Yan WF, 2005, J PHYS CHEM B, V109, P10676, DOI 10.1021/jp044091o; Yoon B, 2005, SCIENCE, V307, P403, DOI 10.1126/science.1104168	28	1288	1294	36	1148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1331	1335		10.1126/science.1159639	http://dx.doi.org/10.1126/science.1159639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772433				2022-12-24	WOS:000258914300043
J	Lyon, BE; Chaine, AS; Winkler, DW				Lyon, Bruce E.; Chaine, Alexis S.; Winkler, David W.			Ecology - A matter of timing	SCIENCE			English	Editorial Material							WILD BIRD POPULATION; CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; GONADAL CYCLES; EVOLUTION		[Lyon, Bruce E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Chaine, Alexis S.] CNRS, Moulis USR 2936, Stn Ecol Expt, F-09200 Moulis, France; [Winkler, David W.] Cornell Univ, Museum Vertebrates, Ithaca, NY 14853 USA; [Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); Cornell University; Cornell University	Lyon, BE (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lyon@biology.ucsc.edu	Lyon, Bruce E/E-8491-2011; Chaine, Alexis S/B-4062-2012					Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Coppack T, 2007, J ORNITHOL, V148, pS459, DOI 10.1007/s10336-007-0158-9; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dunn P, 2004, ADV ECOL RES, V35, P69, DOI 10.1016/S0065-2504(04)35004-X; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Lessells CM, 2008, PHILOS T R SOC B, V363, P1589, DOI 10.1098/rstb.2007.0008; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Silverin B, 2008, HORM BEHAV, V54, P60, DOI 10.1016/j.yhbeh.2008.01.015; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; WINGFIELD JC, 1992, J EXP ZOOL, V261, P214, DOI 10.1002/jez.1402610212	15	42	42	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1051	1052		10.1126/science.1159822	http://dx.doi.org/10.1126/science.1159822			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719273				2022-12-24	WOS:000258594900027
J	Criqui, MH; Golomb, BA				Criqui, Michael H.; Golomb, Beatrice A.			Lipid lowering: what and when to monitor	LANCET			English	Editorial Material							MAJOR CORONARY EVENTS; CHOLESTEROL; RISK; PREVENTION; IDENTIFY		[Criqui, Michael H.] Univ Calif San Diego, Dept Family & Prevent Med, Div Prevent Med, La Jolla, CA 92093 USA; [Golomb, Beatrice A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Criqui, MH (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, Div Prevent Med, La Jolla, CA 92093 USA.	mcriqui@ucsd.edu						ALSHEIKHALI AA, 2004, CIRCULATION S3, V110, P813; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Criqui MH, 1998, AM J MED, V105, p48S, DOI DOI 10.1016/S0002-9343(98)00212-5; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; IRIBARREN C, 1995, CIRCULATION, V92, P2396, DOI 10.1161/01.CIR.92.9.2396; KINOSIAN B, 1995, J INVEST MED, V43, P443; Natarajan S, 2003, AM J PREV MED, V25, P50, DOI 10.1016/S0749-3797(03)00092-8; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Sniderman AD, 2006, J INTERN MED, V259, P455, DOI 10.1111/j.1365-2796.2006.01649.x; Superko HR, 2008, CIRCULATION, V117, P560, DOI 10.1161/CIRCULATIONAHA.106.667428; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	14	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2008	372	9638					516	517		10.1016/S0140-6736(08)61213-1	http://dx.doi.org/10.1016/S0140-6736(08)61213-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339MS	18707970				2022-12-24	WOS:000258582300008
J	Lin, GA; Dudley, RA; Lucas, FL; Malenka, DJ; Vittinghoff, E; Redberg, RF				Lin, Grace A.; Dudley, R. Adams; Lucas, F. L.; Malenka, David J.; Vittinghoff, Eric; Redberg, Rita F.			Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; 3 THERAPEUTIC STRATEGIES; OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; UNITED-STATES; MASS-II; ANGINA-PECTORIS; HEART-DISEASE; RITA-2 TRIAL	Context Guidelines call for documenting ischemia in patients with stable coronary artery disease prior to elective percutaneous coronary intervention ( PCI). Objective To determine the frequency and predictors of stress testing prior to elective PCI in a Medicare population. Design, Setting, and Patients Retrospective, observational cohort study using claims data from a 20% random sample of 2004 Medicare fee- for- service beneficiaries aged 65 years or older who had an elective PCI ( N= 23 887). Main Outcome Measures Percentage of patients who underwent stress testing within 90 days prior to elective PCI; variation in stress testing prior to PCI across 306 hospital referral regions; patient, physician, and hospital characteristics that predicted the appropriate use of stress testing prior to elective PCI. Results In the United States, 44.5% ( n= 10 629) of patients underwent stress testing within the 90 days prior to elective PCI. There was wide regional variation among the hospital referral regions with stress test rates ranging from 22.1% to 70.6% ( national mean, 44.5%; interquartile range, 39.0%- 50.9%). Female sex ( adjusted odds ratio [ AOR], 0.91; 95% confidence interval [ CI], 0.86- 0.97), age of 85 years or older ( AOR, 0.83; 95% CI, 0.72- 0.95), a history of congestive heart failure ( AOR, 0.85; 95% CI, 0.79- 0.92), and prior cardiac catheterization ( AOR, 0.45; 95% CI, 0.38- 0.54) were associated with a decreased likelihood of prior stress testing. A history of chest pain ( AOR, 1.28; 95% CI, 1.09- 1.54) and black race ( AOR, 1.26; 95% CI, 1.09- 1.46) increased the likelihood of stress testing prior to PCI. Patients treated by physicians performing 150 or more PCIs per year were less likely to have stress testing prior to PCI ( AOR, 0.84; 95% CI, 0.77- 0.93). No hospital characteristics were associated with receipt of stress testing. Conclusion The majority of Medicare patients with stable coronary artery disease do not have documentation of ischemia by noninvasive testing prior to elective PCI.	[Redberg, Rita F.] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA; [Lin, Grace A.] Univ Calif San Francisco, Sch Med, Div Gen Internal Med, San Francisco, CA 94143 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Sch Med, Div Epidemiol & Biostat, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Lucas, F. L.] Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, OR USA; [Malenka, David J.] Dartmouth Hitchcock Med Ctr, Div Cardiol, Lebanon, NH 03766 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Dartmouth College	Redberg, RF (corresponding author), Univ Calif San Francisco, Sch Med, Div Cardiol, 505 Parnassus Ave,Ste M-1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu			Blue Shield of California Foundation; Robert Wood Johnson Foundation	Blue Shield of California Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was funded by the Blue Shield of California Foundation. A portion of Dr Dudley's work was supported by an Investigator Award in Health Policy from the Robert Wood Johnson Foundation.	Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campione Joanne R, 2005, Am J Geriatr Pharmacother, V3, P229, DOI 10.1016/j.amjopharm.2005.12.001; Favarato ME, 2007, INT J CARDIOL, V116, P364, DOI 10.1016/j.ijcard.2006.06.001; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Folland ED, 1997, J AM COLL CARDIOL, V29, P1505, DOI 10.1016/S0735-1097(97)00097-1; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hannan EL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-35; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lucas F L, 1999, Eff Clin Pract, V2, P71; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Lucas FL, 2007, AM HEART J, V154, P502, DOI 10.1016/j.ahj.2007.04.044; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; Poses RM, 2002, CHEST, V122, P122, DOI 10.1378/chest.122.1.122; Rogers AM, 2007, AM HEART J, V154, P461, DOI 10.1016/j.ahj.2007.05.003; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Shaw LJ, 2008, J NUCL CARDIOL, V15, P762, DOI 10.1007/BF03007357; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 1999, J AM COLL CARDIOL, V33, P661, DOI 10.1016/S0735-1097(98)00606-8; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Spertus JA, 2004, CIRCULATION, V110, P3789, DOI 10.1161/01.CIR.0000150392.70749.C7; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; STRAUSS WE, 1995, CIRCULATION, V92, P1710, DOI 10.1161/01.CIR.92.7.1710; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; TOPOL EJ, 1993, CIRCULATION, V87, P1489, DOI 10.1161/01.CIR.87.5.1489; Wennberg D, 1997, J Health Serv Res Policy, V2, P75; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; Wennberg DE, 1997, J GEN INTERN MED, V12, P172; Wennberg J. E., 1996, DARTMOUTH ATLAS HLTH; Zellweger MJ, 2003, J AM COLL CARDIOL, V42, P33, DOI 10.1016/S0735-1097(03)00557-6	50	185	188	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1765	1773		10.1001/jama.300.15.1765	http://dx.doi.org/10.1001/jama.300.15.1765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854538	Bronze			2022-12-24	WOS:000260002000028
J	Ludwig, DS; Nestle, M				Ludwig, David S.; Nestle, Marion			Can the food industry play a constructive role in the obesity epidemic?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSULIN		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Nestle, Marion] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA	Harvard University; Boston Children's Hospital; New York University	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				*AM DIET ASS, AM DIET ASS WELC COC; *COC COL CO, CORP RESP ACT LIF; HABER GB, 1977, LANCET, V2, P679; *KRAFT, HLTH WELLN; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lewin A, 2006, J PUBLIC HEALTH POL, V27, P327, DOI 10.1057/palgrave.jphp.3200098; *MCD CORP, BAL ACT LIF 2006 WOR; *PEPSICO, PEPSICO JOINS AM YMC; *PEPSICO, HLTH WELLN PEPSICOS; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; SARGENT G, AM PROSPECT BERMANS; Simon M., 2006, LOYOLA LOS ANGELES L, V39, P169; WOOTAN MG, STUDY SHOWS PROGR GE	13	151	152	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 15	2008	300	15					1808	1811		10.1001/jama.300.15.1808	http://dx.doi.org/10.1001/jama.300.15.1808			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	359QA	18854543				2022-12-24	WOS:000260002000033
J	Qu, LT; Dai, LM; Stone, M; Xia, ZH; Wang, ZL				Qu, Liangti; Dai, Liming; Stone, Morley; Xia, Zhenhai; Wang, Zhong Lin			Carbon nanotube arrays with strong shear binding-on and easy normal lifting-off	SCIENCE			English	Article							GECKO FOOT-HAIR; DRY ADHESIVES; MECHANICS; FRICTION; BIOLOGY; GROWTH; FORCE	The ability of gecko lizards to adhere to a vertical solid surface comes from their remarkable feet with aligned microscopic elastic hairs. By using carbon nanotube arrays that are dominated by a straight body segment but with curly entangled top, we have created gecko-foot-mimetic dry adhesives that show macroscopic adhesive forces of similar to 100 newtons per square centimeter, almost 10 times that of a gecko foot, and a much stronger shear adhesion force than the normal adhesion force, to ensure strong binding along the shear direction and easy lifting in the normal direction. This anisotropic force distribution is due to the shear-induced alignments of the curly segments of the nanotubes. The mimetic adhesives can be alternatively binding-on and lifting-off over various substrates for simulating the walking of a living gecko.	[Qu, Liangti; Dai, Liming] Univ Dayton, Dept Chem & Mat Engn, Sch Engn, Dayton, OH 45469 USA; [Stone, Morley] USAF, Res Lab, Human Effectiveness Directorate, AFRL RH, Wright Patterson AFB, OH 45433 USA; [Xia, Zhenhai] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University of Dayton; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University System of Ohio; University of Akron; University System of Georgia; Georgia Institute of Technology	Dai, LM (corresponding author), Univ Dayton, Dept Chem & Mat Engn, Sch Engn, 300 Coll Pk, Dayton, OH 45469 USA.	ldai@udayton.edu; zlwang@gatech.edu	Dai, Liming/AAV-4376-2020; Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022	Dai, Liming/0000-0001-7536-160X; Wang, Zhong Lin/0000-0002-5530-0380; Xia, Zhenhai/0000-0002-0881-2906	AFRL/Air Force Office of Scientific Research; NSF [CMS-0609077]	AFRL/Air Force Office of Scientific Research(United States Department of DefenseUS Air Force Research LaboratoryAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	L.D., Z.L.W., and M.S. thank AFRL/Air Force Office of Scientific Research for financial support. L.D. also thanks T. Yamada, S. Sangwook, A. Roy, J. Baur, and T. Benson-Tolle for useful discussions as well as financial support from NSF (grant CMS-0609077).	Akita S, 2002, JPN J APPL PHYS 1, V41, P4242, DOI 10.1143/JJAP.41.4242; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Dickrell PL, 2005, TRIBOL LETT, V18, P59, DOI 10.1007/s11249-004-1752-0; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Huang SM, 1999, J PHYS CHEM B, V103, P4223, DOI 10.1021/jp990342v; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jin MHC, 2006, CARBON NANOTECHNOLOGY: RECENT DEVELOPMENTS IN CHEMISTRY, PHYSICS, MATERIALS SCIENCE AND DEVICE APPLICATIONS, P611, DOI 10.1016/B978-044451855-2/50020-6; Kinoshita H, 2004, APPL PHYS LETT, V85, P2780, DOI 10.1063/1.1804254; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee J, 2008, J R SOC INTERFACE, V5, P835, DOI 10.1098/rsif.2007.1308; Lu XK, 1999, APPL PHYS LETT, V75, P193, DOI 10.1063/1.124316; Majidi CS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2128697; Qu L, 2007, ADV MATER, V19, P3844, DOI 10.1002/adma.200700023; Qu L, 2007, J MATER CHEM, V17, P3401, DOI 10.1039/b703046k; Sitti M, 2003, J ADHES SCI TECHNOL, V17, P1055, DOI 10.1163/156856103322113788; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Yao H, 2006, J MECH PHYS SOLIDS, V54, P1120, DOI 10.1016/j.jmps.2006.01.002; Yu MF, 2001, PHYS REV LETT, V86, P87, DOI 10.1103/PhysRevLett.86.87; Yurdumakan B, 2005, CHEM COMMUN, P3799, DOI 10.1039/b506047h; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhao Y, 2006, J VAC SCI TECHNOL B, V24, P331, DOI 10.1116/1.2163891	27	580	645	13	601	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					238	242		10.1126/science.1159503	http://dx.doi.org/10.1126/science.1159503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845750				2022-12-24	WOS:000259902300042
J	Qi, H; Cannons, JL; Klauschen, F; Schwartzberg, PL; Germain, RN				Qi, Hai; Cannons, Jennifer L.; Klauschen, Frederick; Schwartzberg, Pamela L.; Germain, Ronald N.			SAP-controlled T-B cell interactions underlie germinal centre formation	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; HUMORAL IMMUNITY; DENDRITIC CELLS; IN-VIVO; LYMPH-NODES; CYTOKINE REGULATION; ANTIBODY-RESPONSES; GENE-PRODUCT; ACTIVATION; INFECTION	Generation of long- term antibody- mediated immunity depends on the germinal centre reaction, which requires cooperation between antigen- specific T and B lymphocytes. In human X- linked lymphoproliferative disease and its gene- targeted mouse model, loss- of- function mutations in signalling lymphocyte activation molecule- associated protein ( SAP, encoded by SH2D1a) cause a profound defect in germinal centre formation by an as yet unknown mechanism. Here, using two- photon intravital imaging, we show that SAP deficiency selectively impairs the ability of CD4(+) T cells to stably interact with cognate B cells but not antigen- presenting dendritic cells. This selective defect results in a failure of antigen- specific B cells to receive adequate levels of contact- dependent T- cell help to expand normally, despite Sap(-/-) T cells exhibiting the known characteristics of otherwise competent helper T cells. Furthermore, the lack of stable interactions with B cells renders Sap(-/-) T cells unable to be efficiently recruited to and retained in a nascent germinal centre to sustain the germinal centre reaction. These results offer an explanation for the germinal centre defect due to SAP deficiency and provide new insights into the bi- directional communication between cognate T and B cells in vivo.	[Qi, Hai; Klauschen, Frederick; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Cannons, Jennifer L.; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pams@nhgri.nih.gov; rgermain@niaid.nih.gov	Qi, Hai/A-3955-2009; Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Klauschen, Frederick/C-5637-2015	Klauschen, Frederick/0000-0002-9131-2389; Qi, Hai/0000-0001-5475-3989	National Institute of Allergy and Infectious Disease; National Human Genome Research Institute; National Institutes of Health, USA.; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, USA.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H. Q. is in debt to Y. Hong for support, encouragement and inspiration. This work was funded by the intramural research programs of the National Institute of Allergy and Infectious Disease and National Human Genome Research Institute, National Institutes of Health, USA.	ABBAS AK, 1985, J IMMUNOL, V135, P1661; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Andoh A, 2000, IMMUNOL LETT, V73, P35, DOI 10.1016/S0165-2478(00)00202-9; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; COICO RF, 1983, J IMMUNOL, V131, P2254; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Huang AYC, 2004, IMMUNITY, V21, P331, DOI 10.1016/S1074-7613(04)00235-3; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KELSOE G, 1993, CURR OPIN IMMUNOL, V5, P418, DOI 10.1016/0952-7915(93)90062-W; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; MacLennan ICM, 1997, IMMUNOL REV, V156, P53, DOI 10.1111/j.1600-065X.1997.tb00958.x; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Morra M, 2005, P NATL ACAD SCI USA, V102, P4819, DOI 10.1073/pnas.0408681102; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; PURTILO D T, 1975, Lancet, V1, P935; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Raff M C, 1970, Nature, V226, P1257, DOI 10.1038/2261257a0; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	44	468	489	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					764	U2		10.1038/nature07345	http://dx.doi.org/10.1038/nature07345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18843362	Green Accepted			2022-12-24	WOS:000259854900039
J	Lee, TA; Pickard, AS; Au, DH; Bartle, B; Weiss, KB				Lee, Todd A.; Pickard, A. Simon; Au, David H.; Bartle, Brian; Weiss, Kevin B.			Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED CORTICOSTEROIDS; BIASED SELECTION; MORTALITY; COPD; HEALTH; HOSPITALIZATIONS; EXACERBATIONS; METAANALYSIS; FLUTICASONE; IPRATROPIUM	Background: Concerns exist regarding increased risk for mortality associated with some chronic obstructive pulmonary disease (COPD) medications. Objective: To examine the association between various respiratory medications and risk for death in veterans with newly diagnosed COPD. Design: Nested case - control study in a cohort identified between 1 October 1999 and 30 September 2003 and followed through 30 September 2004 by using National Veterans Affairs inpatient, outpatient, pharmacy, and mortality databases; Centers for Medicare & Medicaid Services databases; and National Death Index Plus data. Cause of death was ascertained for a random sample of 40% of those who died during follow-up. Case patients were categorized on the basis of all-cause, respiratory, or cardiovascular death. Mortality risk associated with medications was assessed by using conditional logistic regression adjusted for comorbid conditions, health care use, and markers of COPD severity. Setting: U. S. Veterans Health Administration health care system. Participants: 32 130 case patients and 320 501 control participants in the all-cause mortality analysis. Of 11 897 patients with cause-of-death data, 2405 case patients had respiratory deaths and 3159 case patients had cardiovascular deaths. Measurements: All-cause mortality; respiratory and cardiovascular deaths; and exposure to COPD medications, inhaled corticosteroids, ipratropium, long-acting beta-agonists, and theophylline in the 6 months preceding death. Results: Adjusted odds ratios (ORs) for all-cause mortality were 0.80 (95% CI, 0.78 to 0.83) for inhaled corticosteroids, 1.11 ( CI, 1.08 to 1.15) for ipratropium, 0.92 (CI, 0.88 to 0.96) for long-acting beta-agonists, and 1.05 (CI, 0.99 to 1.10) for theophylline. Ipratropium was associated with increased cardiovascular deaths (OR, 1.34 [CI, 1.22 to 1.47]), whereas inhaled corticosteroids were associated with reduced risk for cardiovascular death ( OR, 0.80 [ CI, 0.72 to 0.88]). Results were consistent across sensitivity analyses. Limitations: Current smoking status and lung function were not measured. Misclassification of cause-specific mortality is unknown. Conclusion: The possible association between ipratropium and elevated risk for all-cause and cardiovascular death needs further study.	[Lee, Todd A.] Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; NW Univ Feinberg, Sch Med, Chicago, IL USA; Univ Illinois, Chicago, IL USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; Amer Board Med Specialties, Evanston, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Lee, TA (corresponding author), Vet Affairs Edward Hines Jr Hosp, 5000 S 5th Ave,151-H, Hines, IL 60141 USA.	todd.lee@va.gov		Pickard, A. Simon/0000-0001-5645-7091; Lee, Todd/0000-0003-3619-5367	the U. S. Department of Veterans Affairs Health Services Research and Development [IIR 03-307]	the U. S. Department of Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs)	By the U. S. Department of Veterans Affairs Health Services Research and Development (IIR 03-307).	[Anonymous], 2000, PHARMACOEPIDEM DR S; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; *CTR DRUG EV RES, 2008, EARL COMM ONG SAF RE; de Luise C, 2007, EUR J EPIDEMIOL, V22, P267, DOI 10.1007/s10654-007-9106-5; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Gartlehner G, 2006, ANN FAM MED, V4, P253, DOI 10.1370/afm.517; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gudmundsson G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-109; HOSMER DW, 1989, APPL LOGISTIC REGRES, P187; Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205; JOO MJ, 2008, PATTERNS HEALTHCARE; Lee TA, 2007, ANN EPIDEMIOL, V17, P380, DOI 10.1016/j.annepidem.2007.01.033; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Ringbaek T, 2003, RESP MED, V97, P264, DOI 10.1053/rmed.2003.1423; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Salpeter SR, 2006, CLIN REV ALLERG IMMU, V31, P219, DOI 10.1385/CRIAI:31:2:219; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sin DD, 2000, THORAX, V55, P194, DOI 10.1136/thorax.55.3.194; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Sullivan SD, 2000, CHEST, V117, P5; Travers J, 2007, RESP MED, V101, P1313, DOI 10.1016/j.rmed.2006.10.011; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	38	146	153	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					380	W73		10.7326/0003-4819-149-6-200809160-00004	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794557				2022-12-24	WOS:000259230200002
J	Dietrich, LEP; Teal, TK; Price-Whelan, A; Newman, DK				Dietrich, Lars E. P.; Teal, Tracy K.; Price-Whelan, Alexa; Newman, Dianne K.			Redox-active antibiotics control gene expression and community behavior in divergent bacteria	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA PA14; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; PHENAZINE ANTIBIOTICS; SUPEROXIDE STRESS; SOXR; BIOSYNTHESIS; PYOCYANIN; VIRULENCE; PARADIGM	It is thought that bacteria excrete redox- active pigments as antibiotics to inhibit competitors. In Pseudomonas aeruginosa, the endogenous antibiotic pyocyanin activates SoxR, a transcription factor conserved in Proteo- and Actinobacteria. In Escherichia coli, SoxR regulates the superoxide stress response. Bioinformatic analysis coupled with gene expression studies in P. aeruginosa and Streptomyces coelicolor revealed that the majority of SoxR regulons in bacteria lack the genes required for stress responses, despite the fact that many of these organisms still produce redox- active small molecules, which indicates that redox- active pigments play a role independent of oxidative stress. These compounds had profound effects on the structural organization of colony biofilms in both P. aeruginosa and S. coelicolor, which shows that "secondary metabolites" play important conserved roles in gene expression and development.	[Dietrich, Lars E. P.; Price-Whelan, Alexa; Newman, Dianne K.] MIT, Dept Biol, Cambridge, MA 01239 USA; [Newman, Dianne K.] MIT, Dept Earth & Planetary Sci, Cambridge, MA 01239 USA; [Dietrich, Lars E. P.; Newman, Dianne K.] MIT, Howard Hughes Med Inst, Cambridge, MA 01239 USA; [Teal, Tracy K.; Price-Whelan, Alexa] CALTECH, Div Biol, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); California Institute of Technology	Newman, DK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 01239 USA.	dkn@mit.edu	Price-Whelan, Alexa/B-6045-2009	Price-Whelan, Alexa/0000-0001-7587-7534; Dietrich, Lars/0000-0003-2049-1137	EMBO Long Term Fellowship; Packard Foundation and Howard Hughes Medical Institute	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Packard Foundation and Howard Hughes Medical Institute	We thank P. Straight (Harvard University); M. Bibb and A. Hesketh (John Innes Centre, UK) for providing S. coelicolor A3(2) strains M145 and M512; and N. C. Caiazza, C. T. Brown, and B. Wold for helpful discussions. This work was supported by an EMBO Long Term Fellowship (L.E.P.D.) and grants from the Packard Foundation and Howard Hughes Medical Institute (D.K.N.).	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hernandez ME, 2004, APPL ENVIRON MICROB, V70, P921, DOI 10.1128/AEM.70.2.921-928.2004; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Hopwood DA, 2007, STREPTOMYCES NATURE; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Li XZ, 2000, J ANTIMICROB CHEMOTH, V46, P885, DOI 10.1093/jac/46.6.885; Liochev SI, 1999, J BIOL CHEM, V274, P9479, DOI 10.1074/jbc.274.14.9479; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; TSANEVA IR, 1990, J BACTERIOL, V172, P4197, DOI 10.1128/jb.172.8.4197-4205.1990; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; WILLIAMS RP, 1956, BACTERIOL REV, V20, P282, DOI 10.1128/MMBR.20.4.282-284.1956; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	29	300	312	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1203	1206		10.1126/science.1160619	http://dx.doi.org/10.1126/science.1160619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755976	Green Accepted			2022-12-24	WOS:000258754400043
J	Grosshans, H; Filipowicz, W				Grosshans, Helge; Filipowicz, Witold			Proteomics joins the search for microRNA targets	CELL			English	Editorial Material							CELLS	Two recent studies published in Nature (Baek et al. 2008; Selbach et al., 2008) analyze changes in the proteome in response to individual microRNAs (miRNAs). This approach is a powerful means to identify miRNA targets and to quantify the contribution of translational repression to post-transcriptional gene silencing by miRNAs.	[Grosshans, Helge; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Grosshans, H (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland.	helge.grosshans@fmi.ch; witold.filipowicz@fmi.ch	Grosshans, Helge/W-8931-2019	Grosshans, Helge/0000-0002-8169-6905				BAEK D, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07242; Bellare P, 2007, NAT STRUCT MOL BIOL, V14, P684, DOI 10.1038/nsmb0807-684; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; SELBACH M, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07228; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590	10	37	43	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 22	2008	134	4					560	562		10.1016/j.cell.2008.08.008	http://dx.doi.org/10.1016/j.cell.2008.08.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724926	Bronze			2022-12-24	WOS:000258665800006
J	Holden, LG; Prochnow, C; Chang, YP; Bransteitter, R; Chelico, L; Sen, U; Stevens, RC; Goodman, MF; Chen, XJS				Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Stevens, Raymond C.; Goodman, Myron F.; Chen, Xiaojiang S.			Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications	NATURE			English	Article							DNA DEAMINASE DOMAIN; RESTRICTION; MODEL	The APOBEC family members are involved in diverse biological functions. APOBEC3G restricts the replication of human immunodeficiency virus (HIV), hepatitis B virus and retroelements by cytidine deamination on single- stranded DNA or by RNA binding(1-4). Here we report the high- resolution crystal structure of the carboxy- terminal deaminase domain of APOBEC3G (APOBEC3G-CD2) purified from Escherichia coli. The APOBEC3G-CD2 structure has a five- stranded beta- sheet core that is common to all known deaminase structures and closely resembles the structure of another APOBEC protein, APOBEC2 ( ref. 5). A comparison of APOBEC3G-CD2 with other deaminase structures shows a structural conservation of the active- site loops that are directly involved in substrate binding. In the X- ray structure, these APOBEC3G active- site loops form a continuous 'substrate groove' around the active centre. The orientation of this putative substrate groove differs markedly ( by 90 degrees) from the groove predicted by the NMR structure(6). We have introduced mutations around the groove, and have identified residues involved in substrate specificity, single- stranded DNA binding and deaminase activity. These results provide a basis for understanding the underlying mechanisms of substrate specificity for the APOBEC family.	[Holden, Lauren G.; Prochnow, Courtney; Chang, Y. Paul; Bransteitter, Ronda; Chelico, Linda; Sen, Udayaditya; Goodman, Myron F.; Chen, Xiaojiang S.] Univ So Calif, Los Angeles, CA 90089 USA; [Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Southern California; Scripps Research Institute	Chen, XJS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu	Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725; Sen, Udayaditya/0000-0001-5742-2907; Chelico, Linda/0000-0003-4673-8978; Holden, Lauren/0000-0001-8014-4503	CBM; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087986] Funding Source: NIH RePORTER	CBM; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Berkeley Laboratory's Advanced Light Source (ALS) BL8.2.1 and Advanced Photon Source 19ID in Argonne National Laboratory for assistance in data collection, and M. Klein and other members of the X.S.C. laboratory for help and discussion. This work is supported in part by CBM graduate training grants to L.G.H. and Y.P.C., and by National Institutes of Health grants to M.F.G. and X.S.C.	Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678	15	182	205	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					121	U13		10.1038/nature07357	http://dx.doi.org/10.1038/nature07357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18849968	Green Accepted			2022-12-24	WOS:000260674000053
J	Yamasaki, M; Li, W; Johnson, DJD; Huntington, JA				Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.			Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization	NATURE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE-CENTER LOOP; HUMAN ALPHA(1)-ANTITRYPSIN; MECHANISM; SERPINOPATHIES; DENATURATION; ANTITHROMBIN; DEFICIENCY; PEPTIDES; DEMENTIA	Repeating intermolecular protein association by means of beta-sheet expansion is the mechanism underlying a multitude of diseases including Alzheimer's, Huntington's and Parkinson's and the prion encephalopathies(1). A family of proteins, known as the serpins, also forms large stable multimers by ordered beta-sheet linkages leading to intracellular accretion and disease(2). These 'serpinopathies' include early- onset dementia caused by mutations in neuroserpin, liver cirrhosis and emphysema caused by mutations in alpha(1)- antitrypsin (alpha(1)AT), and thrombosis caused by mutations in antithrombin(3). Serpin structure and function are quite well understood, and the family has therefore become a model system for understanding the beta-sheet expansion disorders collectively known as the conformational diseases(4). To develop strategies to prevent and reverse these disorders, it is necessary to determine the structural basis of the intermolecular linkage and of the pathogenic monomeric state. Here we report the crystallographic structure of a stable serpin dimer which reveals a domain swap of more than 50 residues, including two long antiparallel beta-strands inserting in the centre of the principal b-sheet of the neighbouring monomer. This structure explains the extreme stability of serpin polymers, the molecular basis of their rapid propagation, and provides critical new insights into the structural changes which initiate irreversible beta-sheet expansion.	[Yamasaki, Masayuki; Li, Wei; Johnson, Daniel J. D.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk			National Institutes of Health (USA); Uehara Memorial Foundation Japan	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation Japan(Uehara Memorial Foundation)	We thank R. Carrell, D. Crowther and D. Lomas for their comments on the manuscript. We are also grateful to J. Lowe for access to the robotic crystallisation facility in the MRC-LMB, and to M. Weldon for N- terminal sequencing. This work was supported by the National Institutes of Health ( USA) and the Uehara Memorial Foundation (Japan, to M.Y.), and J.A.H. is a senior MRC non- clinical fellow. Data were collected at beamlines I02 and I04 at the Diamond Light Source and we acknowledge the support of L. Duke, G. Evans, R. Flaig, J. Sandy and T. Sorensen.	Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Im H, 2000, PROTEIN SCI, V9, P1497, DOI 10.1110/ps.9.8.1497; James EL, 1998, ARCH BIOCHEM BIOPHYS, V356, P296, DOI 10.1006/abbi.1998.0751; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Jung CH, 2004, PROTEIN SCI, V13, P694, DOI 10.1110/ps.03356604; Kim DY, 1996, BIOCHEM BIOPH RES CO, V226, P378, DOI 10.1006/bbrc.1996.1364; Kjoller L, 1996, EUR J BIOCHEM, V241, P38, DOI 10.1111/j.1432-1033.1996.0038t.x; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Lomas DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2873, DOI 10.2741/1444; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Pearce MC, 2007, FEBS J, V274, P3622, DOI 10.1111/j.1742-4658.2007.05897.x; Pedersen KE, 2003, BIOCHEM J, V372, P747, DOI 10.1042/BJ20021868; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Tew DJ, 2001, J MOL BIOL, V313, P1161, DOI 10.1006/jmbi.2001.5104; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	39	197	198	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1255	U65		10.1038/nature07394	http://dx.doi.org/10.1038/nature07394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18923394				2022-12-24	WOS:000260462100048
J	Aiga, H				Aiga, Hirotsugu			How many people are really hungry?	LANCET			English	Editorial Material									[Aiga, Hirotsugu] Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan; [Aiga, Hirotsugu] UN World Food Programme, Program Design & Support Div, Rome, Italy; [Aiga, Hirotsugu] George Washington Univ, Dept Global Hlth, Washington, DC USA; [Aiga, Hirotsugu] Univ Tokyo, Dept Hlth Policy & Planning, Tokyo, Japan	George Washington University; University of Tokyo	Aiga, H (corresponding author), Japan Int Cooperat Agcy, Dept Human Dev, Shibuya Ku, Tokyo 1518558, Japan.	aiga.hirotsugu@jica.go.jp						Aiga H, 2006, HUMANITARIAN EXCHANG, V36, P36; *FOOD AGR ORG UN, 2003, FAO METH MEAS FOOD D, P2; *FOOD AGR ORG UN, 2006, STAT FOOD INS WORLD, P32; *FOOD AGR ORG UN, 2008, HIGH LEV C WORLD FOO; Food And Agriculture Organisation Of The United Nations-FAO, 1996, ROM DECL WORLD FOOD; LANJOUW JO, 2000, DEMYSTIFYING POVERTY, P4; *MIN FOR AFF JAP, G8 LEAD STAT GLOB FO; STIGLITZ JE, 2003, GLOBALIZATION ITS DI; SVEDBERG P, 1999, POVERTY UNDERNUTRITI, P298; UNICEF, 1990, STRAT IMPR NUTR CHIL, P18; 2008, ECONOMIST       0605, P61; 2007, GOAL 1 ERADICATE EXT	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1367	1369		10.1016/S0140-6736(08)61568-8	http://dx.doi.org/10.1016/S0140-6736(08)61568-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940453				2022-12-24	WOS:000260228200007
J	Zimmer, J; Nam, YS; Rapoport, TA				Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.			Structure of a complex of the ATPase SecA and the protein-translocation channel	NATURE			English	Article							SIGNAL-SEQUENCE RECOGNITION; X-RAY-STRUCTURE; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; DIMERIC SECA; DENSITY-MODIFICATION; CRYSTAL-STRUCTURES; SECYEG; MEDIATE; EXPORT	Most proteins are secreted from bacteria by the interaction of the cytoplasmic SecA ATPase with a membrane channel, formed by the heterotrimeric SecY complex. Here we report the crystal structure of SecA bound to the SecY complex, with a maximum resolution of 4.5 angstrorm ( A), obtained for components from Thermotoga maritima. One copy of SecA in an intermediate state of ATP hydrolysis is bound to one molecule of the SecY complex. Both partners undergo important conformational changes on interaction. The polypeptide- cross- linking domain of SecA makes a large conformational change that could capture the translocation substrate in a 'clamp'. Polypeptide movement through the SecY channel could be achieved by the motion of a 'two-helix finger' of SecA inside the cytoplasmic funnel of SecY, and by the coordinated tightening and widening of SecA's clamp above the SecY pore. SecA binding generates a 'window' at the lateral gate of the SecY channel and it displaces the plug domain, preparing the channel for signal sequence binding and channel opening.	[Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zimmer, Jochen; Nam, Yunsun; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Nam, Yunsun/0000-0002-7939-8626; Zimmer, Jochen/0000-0002-8423-2882	National Institutes of Health; Damon Runyon Cancer Research Foundation [DRG-#1953-07]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation	We thank B. van den Berg and P. Bendapudi for initial experiments with the B. subtilis SecA and T. maritima SecY complex, G. Skiniotis for electron microscopy analysis, W. Li for his help with data processing, the staff at Advanced Photon Source beamlines ID- 19 and 24ID and at Brookhaven National Laboratory beamline X29, and the SB Grid consortium at Harvard Medical School. We thank A. Brunger and S. Harrison for comments, and A. Brunger, B. van den Berg, W. Li, A. Osborne and S. Schulman for critical reading of the manuscript. The work was supported by a National Institutes of Health grant. T. A. R. is an HHMI investigator. Y.N. is supported by the Damon Runyon Cancer Research Foundation (DRG-#1953-07).	AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2002, J BIOL CHEM, V277, P48550, DOI 10.1074/jbc.M204436200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Prinz WA, 1996, EMBO J, V15, P5209, DOI 10.1002/j.1460-2075.1996.tb00906.x; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7434, DOI 10.1021/bi034331a; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	62	342	354	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					936	U32		10.1038/nature07335	http://dx.doi.org/10.1038/nature07335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923516	Green Accepted			2022-12-24	WOS:000260038300043
J	Fischer, SEJ; Butler, MD; Pan, Q; Ruvkun, G				Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary			Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; DROSOPHILA; PROTEIN; ARGONAUTE; HELICASE; IDENTIFICATION; PATHWAYS; REVEALS; ENCODES	Mutations that enhance the response to double- stranded RNA ( dsRNA) have revealed components of the RNA interference ( RNAi) pathway or related small RNA pathways. To explore these small RNA pathways, we screened for Caenorhabditis elegans mutants displaying an enhanced response to exogenous dsRNAs. Here we describe the isolation of mutations in two adjacent, divergently transcribed open reading frames ( eri-6 and eri-7) that fail to complement. eri-6 and eri- 7 produce separate pre- messenger RNAs ( pre- mRNAs) that are trans- spliced to form a functional mRNA, eri- 6/ 7. Trans- splicing of eri6/7 is mediated by a direct repeat that flanks the eri- 6 gene. Adenosine to inosine editing within untranslated regions of eri- 6 and eri- 7 pre- mRNAs reveals a double- stranded pre- mRNA intermediate, forming in the nucleus before splicing occurs. The ERI-6/7 protein is a superfamily I helicase that both negatively regulates the exogenous RNAi pathway and functions in an endogenous RNAi pathway.	[Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu			Leukemia and Lymphoma Society; EMBO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: S. Kennedy for advice and initiating the enhanced RNAi screen; M. Finney for advice on advanced PCR; C. Zhang for mg441 Eri characterization; Y. Kohara, D. Thierry-Mieg and J. Thierry-Mieg for EST sequences and clones; the Mitani laboratory for deletion strains; the Caenorhabditis Genetics Center for strains; Ruvkun laboratory members for reading the manuscript and many discussions; the laboratories of J. Kaplan and F. Ausubel for discussions; and the Leukemia and Lymphoma Society, and EMBO for funding to S.E.J.F.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2002, HUM MOL GENET, V11, P175, DOI 10.1093/hmg/11.2.175; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Felix MA, 2004, CURR BIOL, V14, pR75, DOI 10.1016/j.cub.2003.12.050; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Labrador M, 2001, NATURE, V409, P1000, DOI 10.1038/35059000; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; *WORMBASE, 2007, WORMBASE REL WS170; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	43	70	83	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					491	U23		10.1038/nature07274	http://dx.doi.org/10.1038/nature07274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18784652	Green Accepted			2022-12-24	WOS:000259449600037
J	Nott, A; Watson, PM; Robinson, JD; Crepaldi, L; Riccio, A				Nott, Alexi; Watson, P. Marc; Robinson, James D.; Crepaldi, Luca; Riccio, Antonella			S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons	NATURE			English	Article							NITRIC-OXIDE; SIGNALING PATHWAY; EXPRESSION; ROLES	Brain- derived neurotrophic factor ( BDNF) and other neurotrophins have a vital role in the development of the rat and mouse nervous system by influencing the expression of many specific genes that promote differentiation, cell survival, synapse formation and, later, synaptic plasticity(1). Although nitric oxide ( NO) is known to be an important mediator of BDNF signalling in neurons(2), the mechanisms by which neurotrophins influence gene expression during development and plasticity remain largely unknown. Here we show that BDNF triggers NO synthesis and S- nitrosylation of histone deacetylase 2 ( HDAC2) in neurons, resulting in changes to histone modifications and gene activation. S- nitrosylation of HDAC2 occurs at Cys 262 and Cys 274 and does not affect deacetylase activity. In contrast, nitrosylation of HDAC2 induces its release from chromatin, which increases acetylation of histones surrounding neurotrophin- dependent gene promoters and promotes transcription. Notably, nitrosylation of HDAC2 in embryonic cortical neurons regulates dendritic growth and branching, possibly by the activation of CREB ( cyclic- AMP-responsive-element- binding protein)- dependent genes. Thus, by stimulating NO production and S- nitrosylation of HDAC2, neurotrophic factors promote chromatin remodelling and the activation of genes that are associated with neuronal development.	[Nott, Alexi; Watson, P. Marc; Robinson, James D.; Crepaldi, Luca; Riccio, Antonella] UCL, MRC, Lab Mol & Cell Biol, London WC1E 6BT, England; [Nott, Alexi; Watson, P. Marc; Robinson, James D.; Crepaldi, Luca; Riccio, Antonella] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Riccio, A (corresponding author), UCL, MRC, Lab Mol & Cell Biol, Mortimer St, London WC1E 6BT, England.	a.riccio@ucl.ac.uk	Nott, Alexi/K-6103-2019	Nott, Alexi/0000-0002-2029-7193	Medical Research Council [G0500792]; European Research Council [MIRG-CT-2005-016501]; MRC Career Development Fellowship [G117/533]; MRC Career Development Award; Medical Research Council [MC_U122663296, G120/934] Funding Source: researchfish; MRC [G0500792, G120/934, MC_U122663296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC Career Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. D. Ginty, A. Lloyd, M. Raff and A. Saiardi for comments and to all members of the Riccio laboratory for discussion. Wethank E. Seto for providing HDAC plasmids and A. Chittka for help with the purification of recombinant HDAC2. We also thank C. Andreassi for help with cell lines and molecular biology techniques. This work was supported by the Medical Research Council (MRC; grant G0500792), and the European Research Council (Marie Curie International Reintegration grant MIRG-CT-2005-016501). A. R. is a recipient of an MRC Career Development Fellowship (G117/533) and P. M. W. of an MRC Career Development Award.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BREDT DS, 1994, NEURON, V13, P301, DOI 10.1016/0896-6273(94)90348-4; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Mallis RJ, 2001, BIOCHEM J, V355, P145, DOI 10.1042/bj3550145; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wink DA, 1999, METHOD ENZYMOL, V301, P201; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	33	327	334	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					411	U67		10.1038/nature07238	http://dx.doi.org/10.1038/nature07238			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18754010				2022-12-24	WOS:000259265200049
J	Lang, IA; Galloway, TS; Scarlett, A; Henley, WE; Depledge, M; Wallace, RB; Melzer, D				Lang, Iain A.; Galloway, Tamara S.; Scarlett, Alan; Henley, William E.; Depledge, Michael; Wallace, Robert B.; Melzer, David			Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN EXPOSURE; ENDOCRINE DISRUPTORS; US POPULATION; HEALTH; LIVER; METABOLISM; MECHANISMS; REGRESSION; BINDING; OBESITY	Context Bisphenol A ( BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low- level chronic exposures in humans. Objective To examine associations between urinary BPA concentrations and adult health status. Design, Setting, and Participants Cross- sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003- 2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios ( ORs) of 1.4 for diagnoses of 5% prevalence per 1- SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P <. 05. Main Outcome Measures Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes. Results Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.18- 1.63; P=. 001 with full adjustment). Higher BPA concentrations were also associated with diabetes ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.21- 1.60; P <. 001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma- glutamyltransferase ( OR per 1- SD increase in BPA concentration, 1.29; 95% CI, 1.14- 1.46; P <. 001) and alkaline phosphatase ( OR per 1- SD increase in BPA concentration, 1.48; 95% CI, 1.18- 1.85; P=. 002). Conclusion Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community- dwelling adult population.	[Lang, Iain A.; Melzer, David] Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter EX2 5DW, Devon, England; [Depledge, Michael] Peninsula Med Sch, Environm & Human Hlth Grp, Exeter EX2 5DW, Devon, England; [Galloway, Tamara S.; Scarlett, Alan] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA	University of Exeter; University of Exeter; University of Exeter; University of Plymouth; University of Iowa	Melzer, D (corresponding author), Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Barrack Rd, Exeter EX2 5DW, Devon, England.	david.melzer@pms.ac.uk	Galloway, Tamara/C-1662-2009; Lang, Iain A/B-8255-2008; Rose, Rebecca J/B-7812-2011; Scarlett, Alan G/M-3235-2017	Scarlett, Alan G/0000-0002-9559-2154; Lang, Iain/0000-0002-8473-2350; Melzer, David/0000-0002-0170-3838; Depledge, Michael/0000-0002-7216-0439	United Kingdom National Health Service South West Region Public Health Training Scheme	United Kingdom National Health Service South West Region Public Health Training Scheme	Resources for this analysis were provided by the Peninsula College of Medicine and Dentistry. Dr Lang is an Academic Specialty Trainee in Public Health supported by the United Kingdom National Health Service South West Region Public Health Training Scheme.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Birnbaum LS, 2018, TESTIMONY FEDERAL RO; Burridge E., 2003, EUR CHEM NEWS, V78, P17; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; *CDCP, 2005, 20032004 NHANES CDCP; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2005, 3 CDCP; Centers for Disease Control and Prevention (CDC), 2004, NAT HLTH NUTR EX SUR; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; KORN EL, 1995, J ROY STAT SOC A STA, V158, P263, DOI 10.2307/2983292; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Matsumoto J, 2002, ENVIRON HEALTH PERSP, V110, P193, DOI 10.1289/ehp.02110193; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; *U OXF DIAB TRIALS, 2007, HOMA CALC; *VAN U, PS POW SAMPL SIZ CAL; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047	43	960	997	5	257	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1303	1310		10.1001/jama.300.11.1303	http://dx.doi.org/10.1001/jama.300.11.1303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799442	Green Published			2022-12-24	WOS:000259231100025
J	Brantley, SL				Brantley, Susan L.			Geology - Understanding soil time	SCIENCE			English	Editorial Material							CHEMISTRY; FOREST		[Brantley, Susan L.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Brantley, SL (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.	brantley@eesi.psu.edu	Brantley, Susan L/ABE-4479-2020					Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; Fletcher RC, 2006, EARTH PLANET SC LETT, V244, P444, DOI 10.1016/j.epsl.2006.01.055; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; TURNER MG, 1993, LANDSCAPE ECOL, V8, P213, DOI 10.1007/BF00125352; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White AF, 2003, CHEM GEOL, V202, P479, DOI 10.1016/j.chemgeo.2003.03.001; WHITE AF, 2008, KINETICS WATER ROCK, P463; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	17	50	57	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1454	1455		10.1126/science.1161132	http://dx.doi.org/10.1126/science.1161132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787158				2022-12-24	WOS:000259121800028
J	Brody, DL; Magnoni, S; Schwetye, KE; Spinner, ML; Esparza, TJ; Stocchetti, N; Zipfel, GJ; Holtzman, DM				Brody, David L.; Magnoni, Sandra; Schwetye, Kate E.; Spinner, Michael L.; Esparza, Thomas J.; Stocchetti, Nino; Zipfel, Gregory J.; Holtzman, David M.			Amyloid-beta dynamics correlate with neurological status in the injured human brain	SCIENCE			English	Article							IN-VIVO; INTRACEREBRAL MICRODIALYSIS; CEREBRAL MICRODIALYSIS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; HEAD-INJURY; OLIGOMERS; MEMORY; DEPOSITION	The amyloid-beta peptide (A beta) plays a central pathophysiological role in Alzheimer's disease, but little is known about the concentration and dynamics of this secreted peptide in the extracellular space of the human brain. We used intracerebral microdialysis to obtain serial brain interstitial fluid (ISF) samples in 18 patients who were undergoing invasive intracranial monitoring after acute brain injury. We found a strong positive correlation between changes in brain ISF A beta concentrations and neurological status, with A beta concentrations increasing as neurological status improved and falling when neurological status declined. Brain ISF A beta concentrations were also lower when other cerebral physiological and metabolic abnormalities reflected depressed neuronal function. Such dynamics fit well with the hypothesis that neuronal activity regulates extracellular A beta concentration.	[Brody, David L.; Schwetye, Kate E.; Spinner, Michael L.; Esparza, Thomas J.; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Brody, David L.; Schwetye, Kate E.; Spinner, Michael L.; Esparza, Thomas J.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Magnoni, Sandra; Stocchetti, Nino] Osped Maggiore, Policlin Mangiagalli & Regina Elena, Dept Anesthesia & Intens Care, Fdn Ist Ricovero & Cura Carattere Sci, I-20100 Milan, Italy; [Stocchetti, Nino] Univ Milan, Milan, Italy; [Zipfel, Gregory J.] Washington Univ, Dept Neurol Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Milan; Washington University (WUSTL)	Brody, DL (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu	Stocchetti, Nino/O-7444-2017; Magnoni, Sandra/AAC-7479-2022	Stocchetti, Nino/0000-0003-3250-6834; Magnoni, Sandra/0000-0002-1723-0844	NIH [NS049237, AG13956]; Burroughs Wellcome Career Award in the Biomedical Sciences; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS049237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the participants and their families for their invaluable contributions. We appreciate the assistance of our neurosurgical colleagues for referring patients; M. Pluderi for placing several microdialysis catheters; and P. Bianchi, G. Brandi, M. Carbonara, U. Deledda, B. Hall, L. Magni, E. Milner, J. Sagar, and T. Zoerle for help collecting samples. Valuable discussions with R. Bateman, R. Bullock, J. Cirrito, R. Dacey, M. Diringer, L. Hillered, P. Hutchinson, J. Ladensen, N. Temkin, and W. Powers are acknowledged. We are grateful to Eli Lilly and Co. for providing the antibodies used in the Ab ELISAs. This work was supported by NIH grant NS049237 (D.L.B.), a Burroughs Wellcome Career Award in the Biomedical Sciences (D.L.B.), NIH grant AG13956 ( D.M.H.), and Cure Alzheimer's Fund (D.M.H.).	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Corbett R, 1997, J CEREBR BLOOD F MET, V17, P363, DOI 10.1097/00004647-199704000-00001; Games D, 2006, J ALZHEIMERS DIS, V9, P133; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; TEASDALE G, 1974, LANCET, V2, P81; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	28	250	260	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2008	321	5893					1221	1224		10.1126/science.1161591	http://dx.doi.org/10.1126/science.1161591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755980	Green Accepted			2022-12-24	WOS:000258754400048
J	Rougemaille, M; Dieppois, G; Kisseleva-Romanova, E; Gudipati, RK; Lemoine, S; Blugeon, C; Boulay, J; Jensen, TH; Stutz, F; Devaux, F; Libri, D				Rougemaille, Mathieu; Dieppois, Guennaelle; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Jensen, Torben Heick; Stutz, Francoise; Devaux, Frederic; Libri, Domenico			THO/Sub2p Functions to Coordinate 3 '-End Processing with Gene-Nuclear Pore Association	CELL			English	Article							MESSENGER-RNA EXPORT; QUALITY-CONTROL; COTRANSCRIPTIONAL RECRUITMENT; TRANSCRIPTION ELONGATION; YEAST-CELLS; THO COMPLEX; MRNP; MEX67P; LOCALIZATION; SUB2P	During transcription, proteins assemble sequentially with nascent RNA to generate a messenger ribonucleoprotein particle (mRNP). The THO complex and its associated Sub2p helicase are functionally implicated in both transcription and mRNP biogenesis but their precise function remains elusive. We show here that THO/Sub2p mutation leads to the accumulation of a stalled intermediate in mRNP biogenesis that contains nuclear pore components and polyadenylation factors in association with chromatin. Microarray analyses of genomic loci that are aberrantly docked to the nuclear pore in mutants allowed the identification of approximately 400 novel validated target genes that require THO /Sub2p for efficient expression. Our data strongly suggests that the THO complex/Sub2p function is required to coordinate events leading to the acquisition of export competence at a step that follows commitment to 30-processing.	[Rougemaille, Mathieu; Kisseleva-Romanova, Elena; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, F-91190 Gif Sur Yvette, France; [Dieppois, Guennaelle; Stutz, Francoise] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Lemoine, Sophie; Blugeon, Corinne; Devaux, Frederic] Ecole Normale Super, IFR36, F-75231 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Lemoine, Sophie; Blugeon, Corinne; Boulay, Jocelyne; Devaux, Frederic] Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, F-75006 Paris, France; [Rougemaille, Mathieu; Gudipati, Rajani Kanth; Boulay, Jocelyne; Jensen, Torben Heick; Libri, Domenico] Aarhus Univ, Dept Mol Biol, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus C, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Aarhus University	Libri, D (corresponding author), CNRS, Ctr Genet Mol, LEA Lab Nucl RNA Metab, UPR2167, 1 Av Terrasse, F-91190 Gif Sur Yvette, France.	libri@cgm.cnrs-gif.fr	Jensen, Torben H/G-2954-2017; Stutz, Françoise C/N-4329-2017; DEVAUX, Frédéric/N-2288-2019	DEVAUX, Frédéric/0000-0002-0039-9096; Rougemaille, Mathieu/0000-0002-9675-3888; gudipati, Rajani Kanth/0000-0002-7364-9279				Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Cui YJ, 2003, MOL CELL BIOL, V23, P7887, DOI 10.1128/MCB.23.21.7887-7901.2003; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jensen TH, 2004, MOL CELL, V16, P235, DOI 10.1016/j.molcel.2004.09.019; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	47	115	117	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					308	321		10.1016/j.cell.2008.08.005	http://dx.doi.org/10.1016/j.cell.2008.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957205	Bronze			2022-12-24	WOS:000260130400020
J	Robertson, GP; Dale, VH; Doering, OC; Hamburg, SP; Melillo, JM; Wander, MM; Parton, WJ; Adler, PR; Barney, JN; Cruse, RM; Duke, CS; Fearnside, PM; Follett, RF; Gibbs, HK; Goldemberg, J; Mladenoff, DJ; Ojima, D; Palmer, MW; Sharpley, A; Wallace, L; Weathers, KC; Wiens, JA; Wilhelm, WW				Robertson, G. Philip; Dale, Virginia H.; Doering, Otto C.; Hamburg, Steven P.; Melillo, Jerry M.; Wander, Michele M.; Parton, William J.; Adler, Paul R.; Barney, Jacob N.; Cruse, Richard M.; Duke, Clifford S.; Fearnside, Philip M.; Follett, Ronald F.; Gibbs, Holly K.; Goldemberg, Jose; Mladenoff, David J.; Ojima, Dennis; Palmer, Michael W.; Sharpley, Andrew; Wallace, Linda; Weathers, Kathleen C.; Wiens, John A.; Wilhelm, Wallace W.			Agriculture - Sustainable biofuels Redux	SCIENCE			English	Editorial Material							CORN STOVER; LAND; BIOMASS; CARBON		[Robertson, G. Philip] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Robertson, G. Philip] Michigan State Univ, Dept Crop & Soil Sci, Hickory Corners, MI 49060 USA; [Dale, Virginia H.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Doering, Otto C.] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Hamburg, Steven P.] Brown Univ, Ctr Environm Studies, Providence, RI 02906 USA; [Hamburg, Steven P.] Environm Def Fund, Boston, MA 01028 USA; [Melillo, Jerry M.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Wander, Michele M.] Univ Illinois, Urbana, IL 61801 USA; [Parton, William J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Adler, Paul R.] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Barney, Jacob N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Cruse, Richard M.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Duke, Clifford S.] Ecol Soc Amer, Washington, DC 20036 USA; [Fearnside, Philip M.] Natl Inst Res Amazon INPA, BR-69011970 Manaus, Amazonas, Brazil; [Follett, Ronald F.] USDA ARS, Ft Collins, CO 80526 USA; [Gibbs, Holly K.] Univ Wisconsin, Ctr Sustainabil & Global Environm SAGE, Nelson Inst Environm Studies, Madison, WI 53726 USA; [Goldemberg, Jose] Univ Sao Paulo, Inst Eletrotecn & Energia, Sao Paulo, Brazil; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Ojima, Dennis] H John Heinz Ctr Sci Econ & Environm, Washington, DC 20006 USA; [Palmer, Michael W.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Sharpley, Andrew] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Wallace, Linda] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Weathers, Kathleen C.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Wiens, John A.] PRBO Conservat Sci, Petaluma, CA 94954 USA; [Wilhelm, Wallace W.] Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Brown University; Environmental Defense Fund; Marine Biological Laboratory - Woods Hole; University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; Iowa State University; Institute Nacional de Pesquisas da Amazonia; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Oklahoma State University System; Oklahoma State University - Stillwater; University of Arkansas System; University of Arkansas Fayetteville; University of Oklahoma System; University of Oklahoma - Norman; Cary Institute of Ecosystem Studies; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Robertson, GP (corresponding author), Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	robertson@kbs.msu.edu	/AAD-2154-2020; Fearnside, Philip M/D-6559-2011; Palmer, Michael W/A-2519-2008; Ojima, Dennis/C-5272-2016; Robertson, G Philip/H-3885-2011; Barney, Jacob/C-2412-2008; Dale, Virginia H/GSO-3448-2022; Dale, Virginia H/ABI-6672-2020; Fearnside, Philip M/GQA-6023-2022; Dale, Virginia H/B-6023-2009; Noojipady, Praveen/B-2511-2010	Fearnside, Philip M/0000-0003-3672-9082; Robertson, G Philip/0000-0001-9771-9895; Barney, Jacob/0000-0003-2949-5003; Dale, Virginia H/0000-0002-4123-7202; Fearnside, Philip M/0000-0003-3672-9082; Adler, Paul/0000-0002-6787-631X				Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; KANTER J, 2008, NY TIMES        0912; Kline KL, 2008, SCIENCE, V321, P199, DOI 10.1126/science.321.5886.199; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150	10	290	299	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					49	50		10.1126/science.1161525	http://dx.doi.org/10.1126/science.1161525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832631				2022-12-24	WOS:000259680200028
J	Delgado, MR; Schotter, A; Ozbay, EY; Phelps, EA				Delgado, Mauricio R.; Schotter, Andrew; Ozbay, Erkut Y.; Phelps, Elizabeth A.			Understanding overbidding: using the neural circuitry of reward to design economic auctions	SCIENCE			English	Article							DECISION; BRAIN; NEUROECONOMICS; PUNISHMENT; TRUST; TASK	We take advantage of our knowledge of the neural circuitry of reward to investigate a puzzling economic phenomenon: Why do people overbid in auctions? Using functional magnetic resonance imaging (fMRI), we observed that the social competition inherent in an auction results in a more pronounced blood oxygen level- dependent ( BOLD) response to loss in the striatum, with greater overbidding correlated with the magnitude of this response. Leveraging these neuroimaging results, we design a behavioral experiment that demonstrates that framing an experimental auction to emphasize loss increases overbidding. These results highlight a role for the contemplation of loss in understanding the tendency to bid "too high." Current economic theories suggest overbidding may result from either "joy of winning" or risk aversion. By combining neuroeconomic and behavioral economic techniques, we find that another factor, namely loss contemplation in a social context, may mediate overbidding in auctions.	[Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Schotter, Andrew] NYU, Dept Econ, New York, NY 10003 USA; [Schotter, Andrew] Ctr Expt Social Sci, New York, NY 10003 USA; [Ozbay, Erkut Y.] Univ Maryland, Dept Econ, College Pk, MD 20742 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick; New York University; University System of Maryland; University of Maryland College Park	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			James S. McDonnell Foundation; National Insttute of Mental Health; NIH [MH62104]; Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Insttute of Mental Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge support from the James S. McDonnell Foundation and National Insttute of Mental Health, NIH (MH62104) to E. A. P. and the support of the Seaver Foundation to NYU's Center for Brain Imaging. We also thank the Center for Experimental Social Science for its support. We are grateful to D. Schwarz for his efforts in the initial stages of collection and analysis of neuroimaging data. We thank J. Zakrzewski and K. Nearing for their assistance during data collection, M. Niznikiewicz for assistance during data analysis, and R. Advani for his programming help on the behavioral experiment.	Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Cassidy Ralph, 1967, AUCTIONS AUCTIONEERI; Cox J., 1982, RES EXPT EC, P1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goeree JK, 2002, J ECON THEORY, V104, P247, DOI 10.1006/jeth.2001.2914; GUL F, HDB EC METH IN PRESS, V1; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; HUETTEL SA, 2004, FUNCTIONAL MAGNETIC, pR18; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Phelps Elizabeth A., 1999, P295; Rubinstein A., 2006, ADV EC THEORY, P246; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029	22	118	119	7	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1849	1852		10.1126/science.1158860	http://dx.doi.org/10.1126/science.1158860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818362	Green Accepted			2022-12-24	WOS:000259501300042
J	Dhalla, IA; Detsky, AS				Dhalla, Irfan A.; Detsky, Allan S.			Risks and benefits of importing prescription medications from lower-income countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						AUSTIN I, 2007, NY TIMES        1213; Choudhry NK, 2005, JAMA-J AM MED ASSOC, V293, P358, DOI 10.1001/jama.293.3.358; DECKER S, 2008, RANBAXY DELAY GENERI; *GREENE W, 2007, 200705A US INT TRAD; Hopkins-Tanne J, 2008, BRIT MED J, V336, P1266, DOI 10.1136/bmj.39601.618241.DB; Ricardo David, 1821, PRINCIPLES POLITICAL, V3rd; STAGNITTI MN, STAT BRIEF 205 TREND; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; ZAMISKA N, 2007, WALL STREET J   1009; ZHANG D, 2007, SOFTWOOD LUMBAR WAR; 2007, MED AD NEWS      SEP	12	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1453	1455		10.1001/jama.300.12.1453	http://dx.doi.org/10.1001/jama.300.12.1453			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812537				2022-12-24	WOS:000259410400024
J	Stern, DA; Morgan, WJ; Halonen, M; Wright, AL; Martinez, FD				Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.			Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study	LANCET			English	Article							1ST 6 YEARS; RISK-FACTORS; FOLLOW-UP; POPULATION; ILLNESS; ALLERGEN; CHILDREN; RATIO; LIFE	Background Incidence of asthma increases during early adulthood. We aimed to estimate the contributions of sex and early life factors to asthma diagnosed in young adults. Methods 1246 healthy newborn babies were enrolled in the Tucson Children's Respiratory Study. Parental characteristics, early-life wheezing phenotypes, airway function, and bronchial hyper-responsiveness to cold dry air and sensitisation to Alternaria alternata were determined before age 6 years. Physician-diagnosed asthma, both chronic and newly diagnosed, and airway function were recorded at age 22 years. Findings Of 1246 babies enrolled, 849 had follow-up data at 22 years. Average incidence of asthma at age 16-22 years was 12.6 per thousand person-years. 49 (27%) of all 181 cases of active asthma at 22 years were newly diagnosed, of which 35 (71%) were women. Asthma remittance by 22 years was higher in men than in women (multinomial odds ratio [M-OR] 2.0, 95% CI 1.2-3.2, p=0 . 008). Age at diagnosis was linearly associated with the ratio of forced expiratory volume at 1 s to forced vital capacity at age 22 years. Factors independently associated with chronic asthma at 22 years included onset at 6 years (7.4, 3 . 9-14. 0) and persistent wheezing (14.0, 6.8-28 . 0) in early life, sensitisation to A alternata (3.6, 2.1-6.4), low airway function at age 6 years (2.1, 1.1-3.9.), and bronchial hyper-responsiveness at 6 years (4 . 5, 1.9-10 . 0). Bronchial hyper-responsiveness (6.9, 2.3-21 . 0), low airway function at 6 years (2.8, 1.1-6.9), and late-onset (4 . 6, 1.7-12 . 0) and persistent wheezing (4 . 0, 1.2-14. 0) predicted newly diagnosed asthma at age 22 years. Interpretation Asthma with onset in early adulthood has its origins in early childhood. Funding National Heart Lung and Blood Institute.	[Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.] Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Morgan, Wayne J.; Wright, Anne L.] Univ Arizona, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu		Halonen, Marilyn/0000-0001-9606-935X	National Heart Lung and Blood Institute [HL-56177]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grant HL-56177 from the National Heart Lung and Blood Institute. We gratefully acknowledge the contributions of Lynn Taussig who started the Tucson Children's Respiratory Study in 1980 We thank Bruce Saul for data management and our study nurses, Marilyn Lindell and Lydia de la Ossa, for data collection and participant follow-LIP.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; ANDERSON HR, 1992, THORAX, V47, P537, DOI 10.1136/thx.47.7.537; Avila L, 2005, J ASTHMA, V42, P543, DOI 10.1080/02770900500214791; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; King ME, 2004, PANMINERVA MED, V46, P97; LARSSON L, 1995, THORAX, V50, P260, DOI 10.1136/thx.50.3.260; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Martinez FD, 2003, NEW ENGL J MED, V349, P1473, DOI 10.1056/NEJMe030041; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Nicolai T, 2003, PEDIATR ALLERGY IMMU, V14, P280, DOI 10.1034/j.1399-3038.2003.00047.x; Ownby DR, 1996, ANN ALLERG ASTHMA IM, V77, P304, DOI 10.1016/S1081-1206(10)63325-X; PATTEMORE PK, 1990, AM REV RESPIR DIS, V142, P549, DOI 10.1164/ajrccm/142.3.549; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Strachan DP, 1996, BRIT MED J, V312, P1195; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TOELLE BG, 1992, AM REV RESPIR DIS, V146, P633, DOI 10.1164/ajrccm/146.3.633; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373; Xuan W, 2000, AM J RESP CRIT CARE, V161, P1820, DOI 10.1164/ajrccm.161.6.9809118	27	276	281	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1058	1064		10.1016/S0140-6736(08)61447-6	http://dx.doi.org/10.1016/S0140-6736(08)61447-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805334	Green Accepted			2022-12-24	WOS:000259648500032
J	Costello, C; Gaines, SD; Lynham, J				Costello, Christopher; Gaines, Steven D.; Lynham, John			Can catch shares prevent fisheries collapse?	SCIENCE			English	Article							BIODIVERSITY LOSS; PROPERTY; IMPACTS	Recent reports suggest that most of the world's commercial fisheries could collapse within decades. Although poor fisheries governance is often implicated, evaluation of solutions remains rare. Bioeconomic theory and case studies suggest that rights- based catch shares can provide individual incentives for sustainable harvest that is less prone to collapse. To test whether catch- share fishery reforms achieve these hypothetical benefits, we have compiled a global database of fisheries institutions and catch statistics in 11,135 fisheries from 1950 to 2003. Implementation of catch shares halts, and even reverses, the global trend toward widespread collapse. Institutional change has the potential for greatly altering the future of global fisheries.	[Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Gaines, Steven D.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lynham, John] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Costello, C (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, 4410 Bren Hall, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019	Lynham, John/0000-0002-5816-9648	Paul G. Allen Family Foundation; Sea Around Us Project	Paul G. Allen Family Foundation; Sea Around Us Project	We thank the Paul G. Allen Family Foundation for generous financial support; the Sea Around Us Project for making the catch data publicly available; C. Wong and T. Kidman for helping to compile the database; B. Hansen for helpful comments; and J. Prince, K. Bonzon, and J. Toth for assisting with verifying the catch-share database.	Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; CLARK CW, 1973, J POLIT ECON, V81, P950, DOI 10.1086/260090; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; Festa D, 2008, ISSUES SCI TECHNOL, V24, P75; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Grafton RQ, 2000, J LAW ECON, V43, P679, DOI 10.1086/467469; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Griffith DR, 2008, FRONT ECOL ENVIRON, V6, P191, DOI 10.1890/050060; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newell RG, 2005, J ENVIRON ECON MANAG, V49, P437, DOI 10.1016/j.jeem.2004.06.005; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanchirico James N., 2007, International Journal of Global Environmental Issues, V7, P106, DOI 10.1504/IJGENVI.2007.013569; Scott A, 1955, J POLIT ECON, V63, P116, DOI 10.1086/257653; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	19	570	575	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1678	1681		10.1126/science.1159478	http://dx.doi.org/10.1126/science.1159478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801999				2022-12-24	WOS:000259300400036
J	Sawaya, MR; Wojtowicz, WM; Andre, I; Qian, B; Wu, W; Baker, D; Eisenberg, D; Zipursky, SL				Sawaya, Michael R.; Wojtowicz, Woj M.; Andre, Ingemar; Qian, Bin; Wu, Wei; Baker, David; Eisenberg, David; Zipursky, S. Lawrence			A double S shape provides the structural basis for the extraordinary binding specificity of Dscam isoforms	CELL			English	Article							MOLECULAR DIVERSITY; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; AXON GUIDANCE; DROSOPHILA DSCAM; SELF-AVOIDANCE; RECOGNITION; REFINEMENT; SOFTWARE; ADHESION	Drosophila Dscam encodes a vast family of immunoglobulin (Ig)-containing proteins that exhibit isoform-specific homophilic binding. This diversity is essential for cell recognition events required for wiring the brain. Each isoform binds to itself but rarely to other isoforms. Specificity is determined by "matching'' of three variable Ig domains within an similar to 220 kD ectodomain. Here, we present the structure of the homophilic binding region of Dscam, comprising the eight N-terminal Ig domains (Dscam(1-8)). Dscam(1-8) forms a symmetric homodimer of S-shaped molecules. This conformation, comprising two reverse turns, allows each pair of the three variable domains to "match'' in an antiparallel fashion. Structural, genetic, and biochemical studies demonstrate that, in addition to variable domain "matching,'' intramolecular interactions between constant domains promote homophilic binding. These studies provide insight into how "matching'' at all three pairs of variable domains in Dscam mediates isoform-specific recognition.	[Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Wojtowicz, Woj M.; Wu, Wei; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Andre, Ingemar; Qian, Bin; Baker, David] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu; lzipursky@mednet.ucla.edu	André, Ingemar/O-4777-2014; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Baker, David/0000-0001-7896-6217; Sawaya, Michael/0000-0003-0874-9043; Zipursky, Stephen/0000-0001-5630-7181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2007, NAT REV NEUROSCI, V8, P915, DOI 10.1038/nrn2256; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	26	84	85	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					1007	1018		10.1016/j.cell.2008.07.042	http://dx.doi.org/10.1016/j.cell.2008.07.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805093	Green Accepted, Bronze			2022-12-24	WOS:000259318100020
J	Yamagishi, Y; Sakuno, T; Shimura, M; Watanabe, Y				Yamagishi, Yuya; Sakuno, Takeshi; Shimura, Mari; Watanabe, Yoshinori			Heterochromatin links to centromeric protection by recruiting shugoshin	NATURE			English	Article							PROTEIN PHOSPHATASE 2A; FISSION YEAST; CELL-CYCLE; MEIOSIS-I; COHESION; HP1; PHOSPHORYLATION; LOCALIZATION; CHROMOSOME; METHYLATION	The centromere of a chromosome is composed mainly of two domains, a kinetochore assembling core centromere and pericentromeric heterochromatin regions(1,2). The crucial role of centromeric heterochromatin is still unknown, because even in simpler unicellular organisms such as the fission yeast Schizosaccharomyces pombe, the heterochromatin protein Swi6 ( HP1 homologue) has several functions at centromeres, including silencing gene expression and recombination, enriching cohesin, promoting kinetochore assembly, and, ultimately, preventing erroneous microtubule attachment to the kinetochores(1,3-6). Here we show that the requirement of heterochromatin for mitotic chromosome segregation is largely replaced by forcibly enriching cohesin at centromeres in fission yeast. However, this enrichment of cohesin is not sufficient to replace the meiotic requirement for heterochromatin. We find that the heterochromatin protein Swi6 associates directly with meiosis- specific shugoshin Sgo1, a protector of cohesin at centromeres. A point mutation of Sgo1 (V242E), which abolishes the interaction with Swi6, impairs the centromeric localization and function of Sgo1. The forced centromeric localization of Sgo1 restores proper meiotic chromosome segregation in swi6 Delta cells. We also show that the direct link between HP1 and shugoshin is conserved in human cells. Taken together, our findings suggest that the recruitment of shugoshin is the important primary role for centromeric heterochromatin in ensuring eukaryotic chromosome segregation.	[Yamagishi, Yuya; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Yamagishi, Yuya; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Grad Program Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan; [Shimura, Mari] Int Med Ctr Japan, Dept Intractable Dis, Tokyo 1628655, Japan	University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Global COE programme (Integrative life Science Based on the Study of Biosignaling Mechanisms); MEXT, Japan; Toray Science Foundation; Grants-in-Aid for Research on Advanced Medical Technology; Ministry of Health, Labour and Welfare	Global COE programme (Integrative life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Grants-in-Aid for Research on Advanced Medical Technology(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank S. Hauf for reading the manuscript critically; R. Allshire, S. Grewal and the Yeast Genetic Resource Center (YGRC) for yeast strains; J.-i. Nakayama for Swi6 antibody; and all the members of our laboratory for their valuable support and discussion. This work was supported in part by the Global COE programme (Integrative life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan, the Toray Science Foundation (to Y.W.), Special Coordination Funds for Promoting Science and Technology (to T. S.) and Grants-in-Aid for Research on Advanced Medical Technology, Ministry of Health, Labour and Welfare (to M. S.) and for Specially Promoted Research, MEXT, Japan ( to Y.W.).	Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Sugimoto K, 2001, CELL STRUCT FUNCT, V26, P705, DOI 10.1247/csf.26.705; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089	29	142	144	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					251	U79		10.1038/nature07217	http://dx.doi.org/10.1038/nature07217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18716626				2022-12-24	WOS:000259090800053
J	Li, H; Wang, JL; Mor, G; Sklar, J				Li, Hui; Wang, Jinglan; Mor, Gil; Sklar, Jeffrey			A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells	SCIENCE			English	Article							PRE-MESSENGER-RNAS; ACUTE LEUKEMIAS; TRANSCRIPTION; TRANSLOCATIONS; SEQUENCE; CANCER; TESTIS	Chromosomal rearrangements that create gene fusions are common features of human tumors. The prevailing view is that the resultant chimeric transcripts and proteins are abnormal, tumor- specific products that provide tumor cells with a growth and/ or survival advantage. We show that normal endometrial stromal cells contain a specific chimeric RNA joining 5' exons of the JAZF1 gene on chromosome 7p15 to 3' exons of the Polycomb group gene JJAZ1/SUZ12 on chromosome 17q11 and that this RNA is translated into JAZF1-JJAZ1, a protein with anti- apoptotic activity. The JAZF1-JJAZ1 RNA appears to arise from physiologically regulated trans- splicing between precursor messenger RNAs for JAZF1 and JJAZ1. The chimeric RNA and protein are identical to those produced from a gene fusion found in human endometrial stromal tumors. These observations suggest that certain gene fusions may be pro- neoplastic owing to constitutive expression of chimeric gene products normally generated by trans- splicing of RNAs in developing tissues.	[Li, Hui; Wang, Jinglan; Sklar, Jeffrey] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Mor, Gil] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA	Yale University; Yale University	Sklar, J (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	jeffrey.sklar@yale.edu			National Cancer Institute [R01 CA85995]; NATIONAL CANCER INSTITUTE [R01CA085995] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute (grant R01 CA85995) and a generous gift from the Burnstein-Turnbull family. We thank M. Martel for assistance in the histologic evaluation of tissue samples; R. Means for providing the rhesus fibroblast cell line RF; P. Li for cytogenetic analysis; V. Patriub for technical assistance; and H. Taylor, J. Steitz, D. Mishler, E. Ullu, and A. Krensky for helpful discussion.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Akopian AN, 1999, FEBS LETT, V445, P177, DOI 10.1016/S0014-5793(99)00126-X; BERNARD O, 1991, ONCOGENE, V6, P1477; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Flouriot G, 2002, J BIOL CHEM, V277, P26244, DOI 10.1074/jbc.M203513200; Frantz SA, 1999, P NATL ACAD SCI USA, V96, P5400, DOI 10.1073/pnas.96.10.5400; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Janz S, 2003, GENE CHROMOSOME CANC, V36, P211, DOI 10.1002/gcc.10178; Jehan Z, 2007, GENOME RES, V17, P433, DOI 10.1101/gr.5155706; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Takahara T, 2000, J BIOL CHEM, V275, P38067, DOI 10.1074/jbc.M002010200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Zhang C, 2003, DNA CELL BIOL, V22, P303, DOI 10.1089/104454903322216653	27	206	221	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1357	1361		10.1126/science.1156725	http://dx.doi.org/10.1126/science.1156725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772439				2022-12-24	WOS:000258914300051
J	Wofford, B				Wofford, Ben			One hundred thousand cows - A fable	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jbenwofford@charter.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2008	300	9					1005	1005		10.1001/jama.300.9.1005	http://dx.doi.org/10.1001/jama.300.9.1005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342YN	18768405				2022-12-24	WOS:000258819600001
J	Guo, SZ; Han, Y; Zhang, XD; Lu, BL; Yi, CG; Zhang, H; Ma, XJ; Wang, DT; Yang, L; Fan, X; Liu, YJ; Lu, KH; Li, HY				Guo, Shuzhong; Han, Yon; Zhang, Xudong; Lu, Binglun; Yi, Chenggang; Zhang, Hui; Ma, Xianjie; Wang, Datai; Yang, Li; Fan, Xing; Liu, Yunjing; Lu, Kaihua; Li, Huiyuan			Human facial allotransplantation: a 2-year follow-up study	LANCET			English	Article							ALLOGRAFT TRANSPLANTATION; FACE TRANSPLANTATION; KIDNEY-TRANSPLANTATION; SCALP TRANSPLANTATION; TOLERANCE INDUCTION; DIABETES-MELLITUS; RAT MODEL; REJECTION; TACROLIMUS; REPLANTATION	Background Progress in composite tissue allotransplantation could provide a new treatment for patients with severe facial disfigurements. We did a partial facial allotransplantation in 2006, and report here the 2 year follow-up of the patient. Methods The recipient, a 30-year-old man from China, had his face severely injured by a bear in October, 2004. Allograft composite tissue transplantation was done in April, 2006, after careful systemic preparation. The surgery included anastomosis of the right mandibular artery and anterior facial vein, whole repair of total nose, upper lip, parotid gland, front wall of the maxillary sinus, part of the infraorbital wall, and zygomatic bone. Facial nerve anastomosis was done during the surgery. Quadruple inummomodulatory therapy was used, containing tacrolimus, mycophenolate mofetil, corticosteroids, and humanised IL-2 receptor monoclonal antibody. Follow-up included T lymphocyte subgroups in peripheral blood, pathological and immunohistochemical examinations, functional progress, and psychological support. Findings Composite tissue flap survived well. There were three acute rejection episodes at 3, 5, and 17 months after transplantation, but these were controlled by adjustment of the tacrolimus dose or the application of methylprednisolone pulse therapy. Hepatic and renal functions were normal, and there was no infection. The patient developed hyperglycaemia on day 3 after transplantation, which was controlled by medication. Interpretation Facial transplantation could be successful in the short term, but the procedure was not without complications. However, promising results could mean that this procedure might be an option for long-term restoration of severe facial disfigurement. Funding New Clinical Technique Foundation of Xijing Hospital.	[Guo, Shuzhong; Han, Yon; Zhang, Xudong; Lu, Binglun; Yi, Chenggang; Zhang, Hui; Ma, Xianjie; Wang, Datai; Yang, Li; Fan, Xing; Liu, Yunjing; Lu, Kaihua; Li, Huiyuan] Fourth Mil Med Univ, Inst Plast Surg, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Guo, SZ (corresponding author), Fourth Mil Med Univ, Inst Plast Surg, Xijing Hosp, Xian 710032, Peoples R China.	mzf0709@fmmu.edu.cn			New Clinical Technique Foundation of Xjjing Hospital [XJGX0605M02]; National Nature Science Foundation of China [30672189]	New Clinical Technique Foundation of Xjjing Hospital; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was completely funded by the New Clinical Technique Foundation of Xjjing Hospital (grant number XJGX0605M02). The animal studies were funded by the National Nature Science Foundation of China (number 30672189). We thank the following specialists or teams for their close cooperation in this facial transplantation: Zhang Yongsheng, Zhang Yingzhi, Li Xiangdong, Li Xiaokang, Guo Minghua, and Fan Daiming; Xiong Lize, Chen Shaoyang, and their team; Wang He, Don Kefeng, Yi Dinghua, Zhao Qingquan, Tao Kaishan, and their teams; Wen Aidong, and his team; Ji Qiuhe and his team; Liu Baolin; Lin Maochang; Hao Xiaoke, Ding Zhenruo, and their team; Shi Mei and her team; Fu Jufang, Bian Dongmei, and their teams; Xu Fuming. And we especially thank the people who have worked on this study, but are not mentioned here.	Ahsan N, 2002, AM J TRANSPLANT, V2, P568, DOI 10.1034/j.1600-6143.2002.20612.x; Bhorade SM, 2003, AM J TRANSPLANT, V3, P1570, DOI 10.1046/j.1600-6135.2003.00260.x; Brown Charles S, 2007, Int J Surg, V5, P353, DOI 10.1016/j.ijsu.2006.06.019; Copstein LA, 2004, TRANSPL P, V36, P882, DOI 10.1016/j.transproceed.2004.04.008; Demir Y, 2004, PLAST RECONSTR SURG, V114, P1790, DOI 10.1097/01.PRS.0000142414.92308.AB; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; DEZ LEB, 2002, PLAST RECONSTR SURG, V110, P1374; Dubernard J M, 1999, Chirurgie, V124, P358, DOI 10.1016/S0001-4001(00)80007-0; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Hettiaratchy S, 2006, PLAST RECONSTR SURG, V117, P1043, DOI 10.1097/01.prs.0000201204.57587.e8; Hettiaratchy S, 2002, LANCET, V360, P5, DOI 10.1016/S0140-6736(02)09361-3; ISHIDA H, 2004, TRANSPLANTATION, V78, P54; Kanitakis J, 2005, EUR J DERMATOL, V15, P235; Kaplan B, 2008, CLIN TRANSPLANT, V22, P250, DOI 10.1111/j.1399-0012.2007.00757.x; Kerman RH, 1996, TRANSPLANTATION, V62, P201, DOI 10.1097/00007890-199607270-00009; Kvernmo HD, 2005, ACTA ORTHOP, V76, P14, DOI 10.1080/00016470510030283; Lee KW, 2004, TRANSPL P, V36, P2009, DOI 10.1016/j.transproceed.2004.08.137; Light JA, 2002, CLIN TRANSPLANT, V16, P30, DOI 10.1034/j.1399-0012.16.s7.4.x; Ma Zhong-Li, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P509; Moore R, 2006, CLIN TRANSPLANT, V20, P755, DOI 10.1111/j.1399-0012.2006.00565.x; Morris P, 2007, TRANSPLANTATION, V83, P109, DOI 10.1097/01.tp.0000254201.89012.ae; Mottershead M, 2007, EXPERT OPIN BIOL TH, V7, P1583, DOI 10.1517/14712598.7.10.1583; Okie S, 2006, NEW ENGL J MED, V354, P889, DOI 10.1056/NEJMp068005; Pei G, 2000, Zhonghua Yi Xue Za Zhi, V80, P417; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P876, DOI 10.1097/01.prs.0000204876.27481.fc; Siemionow M, 2005, TRANSPLANTATION, V79, P558, DOI 10.1097/01.TP.0000152799.16035.B7; Siemionow M, 2004, PLAST RECONSTR SURG, V113, P1421, DOI 10.1097/01.PRS.0000112792.44312.A5; Siemionow M, 2006, J RECONSTR MICROSURG, V22, P329, DOI 10.1055/s-2006-946709; Siemionow MZ, 2005, TRANSPL P, V37, P201, DOI 10.1016/j.transproceed.2004.12.055; Singh D, 2003, TRANSPL P, V35, P2395, DOI 10.1016/j.transproceed.2003.08.007; Tanaka Y, 2005, TRANSPLANTATION, V79, P1262, DOI 10.1097/01.TP.0000161667.99145.20; Thomas A, 1998, PLAST RECONSTR SURG, V102, P2085, DOI 10.1097/00006534-199811000-00041; Ulusal AE, 2005, PLAST RECONSTR SURG, V116, P811, DOI 10.1097/01.prs.0000176249.27930.38; Ulusal BG, 2003, PLAST RECONSTR SURG, V112, P1302, DOI 10.1097/01.PRS.0000079823.84984.BB; Wilhelmi BJ, 2003, ANN PLAS SURG, V50, P535, DOI 10.1097/01.SAP.0000037875.69379.56; Yagmurdur MC, 2004, TRANSPL P, V36, P144, DOI 10.1016/j.transproceed.2003.11.044; Zhou Y C, 1991, Clin Transpl, P313	37	205	222	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2008	372	9639					631	638		10.1016/S0140-6736(08)61276-3	http://dx.doi.org/10.1016/S0140-6736(08)61276-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340BX	18722867				2022-12-24	WOS:000258622200026
J	Watts, G; Greenwood, B				Watts, Geoff; Greenwood, Brian			Tightening the net around malaria	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 23	2008	337	7667							a1267	10.1136/bmj.a1267	http://dx.doi.org/10.1136/bmj.a1267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346FD	18713800				2022-12-24	WOS:000259053100022
J	McIntosh, JR; Grishchuk, EL; Morphew, MK; Efremov, AK; Zhudenkov, K; Volkov, VA; Cheeseman, IM; Desai, A; Mastronarde, DN; Ataullakhanov, FI				McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Cheeseman, Iain M.; Desai, Arshad; Mastronarde, David N.; Ataullakhanov, Fazly I.			Fibrils Connect Microtubule Tips with Kinetochores: A Mechanism to Couple Tubulin Dynamics to Chromosome Motion	CELL			English	Article							FISSION YEAST; IN-VITRO; MOLECULAR ARCHITECTURE; DISTINCT MECHANISMS; FORCE PRODUCTION; RING COMPLEX; DASH COMPLEX; DEPOLYMERIZATION; DAM1; ENDS	Kinetochores of mitotic chromosomes are coupled to spindle microtubules in ways that allow the energy from tubulin dynamics to drive chromosome motion. Most kinetochore-associated microtubule ends display curving "protofilaments,'' strands of tubulin dimers that bend away from the microtubule axis. Both a kinetochore "plate'' and an encircling, ring-shaped protein complex have been proposed to link protofilament bending to poleward chromosome motion. Here we show by electron tomography that slender fibrils connect curved protofilaments directly to the inner kinetochore. Fibril-protofilament associations correlate with a local straightening of the flared protofilaments. Theoretical analysis reveals that protofilament-fibril connections would be efficient couplers for chromosome motion, and experimental work on two very different kinetochore components suggests that filamentous proteins can couple shortening microtubules to cargo movements. These analyses define a ring-independent mechanism for harnessing microtubule dynamics directly to chromosome movement.	[McIntosh, J. Richard; Grishchuk, Ekaterina L.; Morphew, Mary K.; Efremov, Artem K.; Volkov, Vladimir A.; Mastronarde, David N.] Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA; [Grishchuk, Ekaterina L.] Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; [Efremov, Artem K.; Zhudenkov, Kirill; Volkov, Vladimir A.; Ataullakhanov, Fazly I.] Natl Res Ctr Hematol, Moscow 117513, Russia; [Cheeseman, Iain M.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ataullakhanov, Fazly I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia; [Ataullakhanov, Fazly I.] RAS, Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia	University of Colorado System; University of Colorado Boulder; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Massachusetts Institute of Technology (MIT); Whitehead Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Lomonosov Moscow State University; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences	McIntosh, JR (corresponding author), Univ Colorado, Dept MCD Biol, Boulder, CO 80309 USA.	richard.mcintosh@colorado.edu	McIntosh, Richard/GLN-3533-2022; Volkov, Vladimir/N-8746-2013; Zhudenkov, Kirill/AGG-2014-2022; Ataullakhanov, Fazoil/J-8076-2012	Volkov, Vladimir/0000-0002-5407-3366; Efremov, Artem/0000-0002-1603-610X; Cheeseman, Iain/0000-0002-3829-5612; Zhudenkov, Kirill/0000-0003-2991-6189	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033787] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR000592, RR000592, P41 RR000592-35] Funding Source: Medline; NIGMS NIH HHS [R01 GM033787, GM033787, R01 GM033787-24] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gachet Y, 2008, MOL BIOL CELL, V19, P1646, DOI 10.1091/mbc.E07-09-0910; Ganem NJ, 2006, CELL CYCLE, V5, P481, DOI 10.4161/cc.5.5.2519; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Heermann D.W., 1990, COMPUTER SIMULATION; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Morphew MK, 2003, J MICROSC-OXFORD, V212, P21, DOI 10.1046/j.1365-2818.2003.01231.x; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; VandenBeldt KJ, 2006, CURR BIOL, V16, P1217, DOI 10.1016/j.cub.2006.04.046; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	47	156	157	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					322	333		10.1016/j.cell.2008.08.038	http://dx.doi.org/10.1016/j.cell.2008.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957206	Green Accepted, Bronze			2022-12-24	WOS:000260130400021
J	Knickelbein, JE; Khanna, KM; Yee, MB; Baty, CJ; Kinchington, PR; Hendricks, RL				Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Baty, Catherine J.; Kinchington, Paul R.; Hendricks, Robert L.			Noncytotoxic lytic granule-mediated CD8(+) T cell inhibition of HSV-1 reactivation from neuronal latency	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN TRIGEMINAL GANGLIA; GAMMA-INTERFERON; INSITU HYBRIDIZATION; TYPE-1 REACTIVATION; SENSORY GANGLIA; NERVOUS SYSTEMS; INFECTION; EXPRESSION; GRANZYME	Reactivation of herpes simplex virus type 1 (HSV-1) from neuronal latency is a common and potentially devastating cause of disease worldwide. CD8(+) T cells can completely inhibit HSV reactivation in mice, with interferon-gamma affording a portion of this protection. We found that CD8(+) T cell lytic granules are also required for the maintenance of neuronal latency both in vivo and in ex vivo ganglia cultures and that their directed release to the junction with neurons in latently infected ganglia did not induce neuronal apoptosis. Here, we describe a nonlethal mechanism of viral inactivation in which the lytic granule component, granzyme B, degrades the HSV-1 immediate early protein, ICP4, which is essential for further viral gene expression.	[Knickelbein, Jared E.; Khanna, Kamal M.; Yee, Michael B.; Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Baty, Catherine J.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Hendricks, Robert L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA; [Knickelbein, Jared E.] Univ Pittsburgh, Sch Med, Med Sci Training Program, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA.	hendricksrr@upmc.edu	Yee, Michael/AAI-4164-2020	Yee, Michael/0000-0002-6296-7757	NIH [F30NS061471, R01EY05945, R01EY015291, P30EY08098]; Research to Prevent Blindness Medical Student Eye Research Fellowship; Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE [P30EY008098, R01EY005945, R01EY015291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS061471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Medical Student Eye Research Fellowship(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Lathrop and J. Karlsson for assistance with microscopy and preparation of figures and N. Zurowski for assistance with flow cytometry. We have no conflicting financial interests. This work was supported by NIH grants F30NS061471 (J.E.K.), R01EY05945 (R.L.H.), R01EY015291 (P.R.K.), and P30EY08098 (R.L.H.); a Research to Prevent Blindness Medical Student Eye Research Fellowship (J.E.K.); and unrestricted grants from Research to Prevent Blindness and the Eye and Ear Foundation of Pittsburgh (R.L.H.).	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Derfuss T, 2007, BRAIN PATHOL, V17, P389, DOI 10.1111/j.1750-3639.2007.00088.x; Freeman ML, 2007, J IMMUNOL, V179, P322, DOI 10.4049/jimmunol.179.1.322; Hoshino Y, 2007, J VIROL, V81, P8157, DOI 10.1128/JVI.00474-07; Hufner K, 2006, J NEUROPATH EXP NEUR, V65, P1022, DOI 10.1097/01.jnen.0000235852.92963.bf; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Sheridan BS, 2007, EXPERT OPIN BIOL TH, V7, P1323, DOI 10.1517/14712598.7.9.1323; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; STROOP WG, 1987, ACTA NEUROPATHOL, V74, P124, DOI 10.1007/BF00692842; Telford WG, 2002, CYTOMETRY, V47, P81, DOI 10.1002/cyto.10052; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104	25	251	257	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					268	271		10.1126/science.1164164	http://dx.doi.org/10.1126/science.1164164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845757	Green Accepted			2022-12-24	WOS:000259902300051
J	Paddock, M; O'Neil, B; Holwell, A				Paddock, Michael; O'Neil, Bernadette; Holwell, Andy			Actions speak louder than words	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Paddock, Michael; O'Neil, Bernadette] Kings Coll London, Sch Med, London WC2R 2LS, England; [Holwell, Andy] SW London & St Georges Mental Hlth NHS Trust, London, England	University of London; King's College London	Paddock, M (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.	michael.paddock@kcl.ac.uk	Paddock, Michael/HDN-7032-2022; Paddock, Michael/AAF-4175-2020	Paddock, Michael/0000-0003-4508-8803; Paddock, Michael/0000-0003-4508-8803					0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1882	10.1136/bmj.a1882	http://dx.doi.org/10.1136/bmj.a1882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SN	18826973				2022-12-24	WOS:000259798000048
J	Blow, N				Blow, Nathan			Biochemistry's new look	NATURE			English	Editorial Material							METABOLOMICS											May P, 2008, GENETICS, V179, P157, DOI 10.1534/genetics.108.088336; Northen TR, 2007, NATURE, V449, P1033, DOI 10.1038/nature06195; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001	4	93	94	5	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					697	700		10.1038/455697a	http://dx.doi.org/10.1038/455697a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833281	Bronze			2022-12-24	WOS:000259639700054
J	Bush, A; Hedlin, G; Carlsen, KH; de Benedictis, F; Lodrup-Carlsen, K; Wilson, N				Bush, Andrew; Hedlin, Gunillo; Carlsen, Kai-Hon; de Benedictis, Fernando; Lodrup-Carlsen, Karin; Wilson, Nicola			Severe childhood asthma: a common international approach?	LANCET			English	Editorial Material							RECEPTOR-BINDING AFFINITY; TO-TREAT ASTHMA; MONOCLONAL-ANTIBODY; CHILDREN; HYPERRESPONSIVENESS; RESPONSIVENESS; EXPOSURE		[Bush, Andrew; Wilson, Nicola] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England; [Hedlin, Gunillo] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Hedlin, Gunillo] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Carlsen, Kai-Hon] Rikshosp Univ Hosp, Div Paediat, Voksentoppen, Oslo, Norway; [Carlsen, Kai-Hon; Lodrup-Carlsen, Karin] Univ Oslo, Fac Med, Oslo, Norway; [de Benedictis, Fernando] Salesi Childrens Hosp, Dept Paediat, Ancona, Italy; [Lodrup-Carlsen, Karin] Ullevaal Univ Hosp, Dept Paediat, Oslo, Norway	Royal Brompton Hospital; Karolinska Institutet; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Bush, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England.	a.bush@imperial.ac.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bracken M, 2007, THORAX, V62, pA21; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Chinn S, 2007, AM J RESP CRIT CARE, V176, P20, DOI 10.1164/rccm.200612-1840OC; Chipps BE, 2007, J ALLERGY CLIN IMMUN, V119, P1156, DOI 10.1016/j.jaci.2006.12.668; Chung KF, 1999, EUR RESPIR J, V13, P1198; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; KAM JC, 1993, J IMMUNOL, V151, P3460; Langley SJ, 2005, THORAX, V60, P17, DOI 10.1136/thx.2004.027839; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Nimmagadda SR, 1997, AM J RESP CRIT CARE, V155, P87, DOI 10.1164/ajrccm.155.1.9001294; Saglani S, 2006, EUR RESPIR J, V27, P29, DOI 10.1183/09031936.06.00030605; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; WARNER JO, 1995, BRIT MED J, V311, P663, DOI 10.1136/bmj.311.7006.663; World Health Organization, GLOB ALL CHRON RESP	16	70	70	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1019	1021		10.1016/S0140-6736(08)61422-1	http://dx.doi.org/10.1016/S0140-6736(08)61422-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805316				2022-12-24	WOS:000259648500009
J	Zieg, J; Greer, PL; Greenberg, ME				Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.			SnapShot: Ca2+-dependent transcription in neurons	CELL			English	Editorial Material									[Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zieg, J (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.							Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462	10	15	15	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6							1080.e2	10.1016/j.cell.2008.09.010	http://dx.doi.org/10.1016/j.cell.2008.09.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805099	Bronze			2022-12-24	WOS:000259318100026
J	Olive, DL				Olive, David L.			Gonadotropin-releasing hormone agonists for endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEUPROLIDE ACETATE; ADD-BACK; DEPOT LEUPROLIDE; GNRH AGONIST; PELVIC PAIN; THERAPY; ESTROGEN; TRIAL; MANAGEMENT; NAFARELIN	A 36- year- old woman presents with long- standing pelvic pain, including dysmenorrhea and pain with intercourse. She has previously received oral contraceptives and depot medroxyprogesterone for presumed endometriosis. This regimen has not relieved her pain, and she has had side effects, including continual abnormal uterine bleeding and fluid retention. She is referred to a reproductive endocrinologist for further investigation and treatment. After a careful review and examination to rule out other explanations for the patient's symptoms, the endocrinologist recommends the use of a gonadotropin- releasing hormone agonist combined with norethindrone acetate as empirical treatment for endometriosis.	[Olive, David L.] Wisconsin Fertil Inst, Middleton, WI 53562 USA		Olive, DL (corresponding author), Wisconsin Fertil Inst, 3146 Deming Way, Middleton, WI 53562 USA.	dlolive1@aol.com			Nobelpharma; Procter Gamble	Nobelpharma; Procter Gamble(Procter & Gamble)	Dr. Olive reports receiving lecture fees from Nobelpharma and consulting fees from Procter & Gamble. No other potential conflict of interest relevant to this article was reported.	*AG HLTH CAR POL R, 1995, AHCPR PUBL; *AM COLL OBST GYN, 1999, ACOG PRACT B, V11; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; DiVasta AD, 2007, J PEDIATR ADOL GYNEC, V20, P293, DOI 10.1016/j.jpag.2007.04.008; DLUGI AM, 1990, FERTIL STERIL, V54, P419; DOSWELL L, 1992, FERTIL STERIL, V57, P514; Duleba A J, 1996, J Am Assoc Gynecol Laparosc, V3, P205, DOI 10.1016/S1074-3804(96)80004-1; Hornstein MD, 1998, OBSTET GYNECOL, V91, P16, DOI 10.1016/S0029-7844(97)00620-0; HORNSTEIN MD, 1995, FERTIL STERIL, V63, P955, DOI 10.1016/S0015-0282(16)57530-X; Hornstein MD, 1997, FERTIL STERIL, V68, P860, DOI 10.1016/S0015-0282(97)00360-9; KODAMAN PH, 2005, ENDOMETRIOSIS CLIN P, P13; LEMAY A, 1984, FERTIL STERIL, V41, P863; Ling FW, 1999, OBSTET GYNECOL, V93, P51, DOI 10.1016/S0029-7844(98)00341-X; MAHUTTE NG, 2005, ENDOMETRIOSIS CLIN P, P79; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; Newton C, 1996, FERTIL STERIL, V65, P1253, DOI 10.1016/S0015-0282(16)58351-4; Olive D, 2005, FUJITSU SCI TECH J, V41, P10; Olive DL, 2005, DRUGS TODAY, V40, P23; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; OLIVE DL, 2003, J IRISH SOC PHYS SUR, V32, P9; Oral E, 1997, OBSTET GYN CLIN N AM, V24, P219, DOI 10.1016/S0889-8545(05)70301-6; PARAZZINI F, 1994, AM J OBSTET GYNECOL, V171, P1205, DOI 10.1016/0002-9378(94)90133-3; Pierce SJ, 2000, FERTIL STERIL, V74, P964, DOI 10.1016/S0015-0282(00)01537-5; POKRAS R, 1997, VITAL HLTH STAT, V13; PRENTICE A, 2000, COCHRANE DB SYST REV, V2; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Schlaff WD, 2006, FERTIL STERIL, V85, P314, DOI 10.1016/j.fertnstert.2005.07.1315; SCHRIOCK E, 1985, FERTIL STERIL, V44, P583; SHAW RW, 1983, BRIT MED J, V287, P1667, DOI 10.1136/bmj.287.6406.1667; Sherwin BB, 1997, NEUROLOGY, V48, pS21, DOI 10.1212/WNL.48.5_Suppl_7.21S; Sherwin BB, 1996, J CLIN ENDOCR METAB, V81, P2545, DOI 10.1210/jc.81.7.2545; Shi ZQ, 2006, BIOL REPROD, V74, P850, DOI 10.1095/biolreprod.105.044917; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Vercellini P, 1999, BRIT J OBSTET GYNAEC, V106, P672, DOI 10.1111/j.1471-0528.1999.tb08366.x; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; WHEELER JM, 1989, J REPROD MED, V34, P41; WITZ CA, 2005, ENDOMETRIOSIS CLIN P, P61	37	30	35	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1136	1142		10.1056/NEJMct0803719	http://dx.doi.org/10.1056/NEJMct0803719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784103				2022-12-24	WOS:000259078200009
J	Tseng, YH; Kokkotou, E; Schulz, TJ; Huang, TL; Winnay, JN; Taniguchi, CM; Tran, TT; Suzuki, R; Espinoza, DO; Yamamoto, Y; Ahrens, MJ; Dudley, AT; Norris, AW; Kulkarni, RN; Kahn, CR				Tseng, Yu-Hua; Kokkotou, Efi; Schulz, Tim J.; Huang, Tian Lian; Winnay, Jonathon N.; Taniguchi, Cullen M.; Tran, Thien T.; Suzuki, Ryo; Espinoza, Daniel O.; Yamamoto, Yuji; Ahrens, Molly J.; Dudley, Andrew T.; Norris, Andrew W.; Kulkarni, Rohit N.; Kahn, C. Ronald			New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure	NATURE			English	Article							ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; GLUCOSE-UPTAKE; INSULIN; FAT; STIMULATION; CELLS; COMMITMENT; EXPRESSION; C3H10T1/2	Adipose tissue is central to the regulation of energy balance. Two functionally different types of fat are present in mammals: white adipose tissue, the primary site of triglyceride storage, and brown adipose tissue, which is specialized in energy expenditure and can counteract obesity61. Factors that specify the developmental fate and function of white and brown adipose tissue remain poorly understood(2,3). Here we demonstrate that whereas some members of the family of bone morphogenetic proteins ( BMPs) support white adipocyte differentiation, BMP7 singularly promotes differentiation of brown preadipocytes even in the absence of the normally required hormonal induction cocktail. BMP7 activates a full program of brown adipogenesis including induction of early regulators of brown fat fate PRDM16 ( PR- domain- containing 16; ref. 4) and PGC-1 alpha ( peroxisome proliferator- activated receptor-gamma ( PPAR gamma) coactivator-1 alpha; ref. 5), increased expression of the brown- fat- defining marker uncoupling protein 1 ( UCP1) and adipogenic transcription factors PPAR gamma and CCAAT/ enhancer- binding proteins ( C/ EBPs), and induction of mitochondrial biogenesis via p38 mitogen- activated protein ( MAP) kinase-( also known as Mapk14) and PGC- 1- dependent pathways. Moreover, BMP7 triggers commitment of mesenchymal progenitor cells to a brown adipocyte lineage, and implantation of these cells into nude mice results in development of adipose tissue containing mostly brown adipocytes. Bmp7 knockout embryos show a marked paucity of brown fat and an almost complete absence of UCP1. Adenoviral-ediated expression of BMP7 in mice results in a significant increase in brown, but not white, fat mass and leads to an increase in energy expenditure and a reduction in weight gain. These data reveal an important role of BMP7 in promoting brown adipocyte differentiation and thermogenesis in vivo and in vitro, and provide a potential new therapeutic approach for the treatment of obesity.	[Tseng, Yu-Hua; Schulz, Tim J.; Huang, Tian Lian; Winnay, Jonathon N.; Taniguchi, Cullen M.; Tran, Thien T.; Suzuki, Ryo; Espinoza, Daniel O.; Yamamoto, Yuji; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Obes & Hormone Act, Boston, MA 02215 USA; [Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Cell & Mol Physiol, Boston, MA 02215 USA; [Kokkotou, Efi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Ahrens, Molly J.; Dudley, Andrew T.] Northwestern Univ, Dept Biochem, Evanston, IL 60208 USA; [Norris, Andrew W.] Univ Iowa, Childrens Hosp, Div Pediat Endocrinol, Iowa City, IA 52242 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; University of Iowa	Tseng, YH (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Obes & Hormone Act, Boston, MA 02215 USA.	yu-hua.tseng@joslin.harvard.edu	Suzuki, Ryo/AAA-2736-2019; Tseng, Yu-Hua/AAE-6471-2021; Norris, Andrew W/O-5499-2018; Kahn, Ronald/AAY-2435-2021; Schulz, Tim/F-4842-2013	Suzuki, Ryo/0000-0002-2965-6906; Tseng, Yu-Hua/0000-0003-2053-9559; Norris, Andrew W/0000-0001-8396-9543; Kahn, Ronald/0000-0002-7583-9228; Schulz, Tim/0000-0002-8413-3972; Taniguchi, Cullen/0000-0002-8052-3316	National Institutes of Health [R01 DK077097, R21 DK070722, P30 DK46200, P30 DK040561, R01 DK67536, K08 DK64906, R01 DK 060837]; Tanita Healthy Weight Community; Eleanor and Miles Shore 50th Anniversary Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077097, K08DK064906, R01DK060837, R01DK067536, P30DK046200, R21DK070722, P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tanita Healthy Weight Community; Eleanor and Miles Shore 50th Anniversary Scholar Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge T.-C. He for providing adenoviruses expressing BMPs. We thank M. Rourk and L. Mazzola for help with the animal experiments, J. Hu, C. Cahill, A. McSweeney, L. Polivy and R. Bronson for technical assistance, and P. Zhang for statistical consultation. We thank A. Butte and P. Laustsen for inputs on initiation of this project. We thank M. Uldry and B. Spiegelman for providing the PGC- 1 null cells. This work was supported in part by the National Institutes of Health grants R01 DK077097, R21 DK070722, P30 DK46200 and P30 DK040561 ( to Y.- H. T.), R01 DK67536 ( to R. N. K.), K08 DK64906 ( to A. W. N.) and R01 DK 060837 ( to C. R. K), the Tanita Healthy Weight Community, and the Eleanor and Miles Shore 50th Anniversary Scholar Program from Harvard Medical School ( to Y.- H. T.).	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Godin RE, 1998, DEVELOPMENT, V125, P3473; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nedergaard J., 1986, BROWN ADIPOSE TISSUE, P152; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2007, CELL SCI REV, V3, P342; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	36	790	878	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 21	2008	454	7207					1000	U44		10.1038/nature07221	http://dx.doi.org/10.1038/nature07221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18719589	Green Accepted			2022-12-24	WOS:000258591000040
J	Wang, SY; Li, YH; Chi, GB; Xiao, SY; Ozanne-Smith, J; Stevenson, M; Phillips, MR				Wang, S. Y.; Li, Y. H.; Chi, G. B.; Xiao, S. Y.; Ozanne-Smith, J.; Stevenson, M.; Phillips, M. R.			Health System Reform in China 4 Injury-related fatalities in China: an under-recognised public-health problem	LANCET			English	Article							RISK-FACTORS; SUICIDE; MORTALITY	The May 2008 earthquake in Wenchuan drew attention to the important but largely unrecognised public-health problem of injury-related mortality and morbidity in China. Injuries account for more than 10% of all deaths and more than 30% of all potentially productive years of life lost due to premature mortality in China. Traffic-related injuries (mainly among cyclists and pedestrians), suicide, drowning, and falls account for 79% of all injury deaths. Rural injury death rates are double those of urban rates and male rates are double those of female rates. Despite an 81% increase in the traffic-related mortality from 1987 to 2006-associated with rapid motorisation-the overall injury mortality decreased by 17%, largely due to a surprising (and unexplained) 57% reduction in the suicide rate. Low-cost prevention measures that are most likely to produce large reductions in injury deaths include enforcement of laws for drinking and driving and for seat belt and helmet use, restriction of access to the most potent pesticides, and teaching children to swim. China needs to improve monitoring of fatal and non-fatal injuries, promote intersectoral collaboration, build institutional capacities, and, most importantly, mobilise community support and political will for investment in prevention.	[Phillips, M. R.] Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; [Wang, S. Y.; Chi, G. B.] Jinan Univ, Coll Med, Ctr Injury Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Li, Y. H.] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Xiao, S. Y.] Cent S Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Ozanne-Smith, J.] Monash Univ, Accident Res Ctr, Clayton, Vic 3800, Australia; [Ozanne-Smith, J.] Monash Univ, Dept Forens Med, Clayton, Vic 3800, Australia; [Stevenson, M.] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Stevenson, M.] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing 100871, Peoples R China; [Phillips, M. R.] Columbia Univ, Dept Psychiat, New York, NY USA; [Phillips, M. R.] Columbia Univ, Dept Epidemiol, New York, NY USA	Jinan University; Shanghai Center for Disease Control & Prevention; Central South University; Monash University; Monash University; University of Sydney; Peking University; Columbia University; Columbia University	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, WHO Coordinating Ctr Res & Training Suicide Preve, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.	phillipschina@yahoo.com	Phillips, Michael Robert/AAE-7585-2021; stevenson, mark/AAE-9706-2019	Phillips, Michael Robert/0000-0002-5973-2439; stevenson, mark/0000-0003-3166-5876				Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; BRENNER RA, ARCH PEDIAT IN PRESS; *CHIN IND RES MARK, 2008, AUT PARTS ACC MAN IN; *CHIN MIN HLTH, 2003, ANN REP CHIN HLTH ST; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Conner KR, 2007, AM J PUBLIC HEALTH, V97, P1842, DOI 10.2105/AJPH.2005.077420; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; *DIS PREV CONTR BU, 2007, REP INJ PREV CHIN; Dollar D, 2007, 4253 WORLD BANK; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Fahquist JN, 2006, ACCIDENT ANAL PREV, V38, P1113, DOI 10.1016/j.aap.2006.04.020; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; JING RW, 2004, BEIJING INJURY SURVE; [李献云 Li Xianyun], 2005, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V31, P272; [李献云 Li Xianyun], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P27; [刘娜 Liu Na], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P746; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mathers CD, 2003, GLOBAL BURDEN DIS 20; Moniruzzaman S, 2004, PUBLIC HEALTH, V118, P346, DOI 10.1016/j.puhe.2003.10.004; Murray C. J. L., 1996, GLOBAL BURDEN DIS; *NAT BUR STAT CHIN, 1996, B 1995 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2007, B 2005 NAT 1 SAMPL S; *NAT BUR STAT CHIN, 2006, B MAIN RES 2005 1 SA; National Bureau of Statistics of China, 1988, CHIN STAT YB; OZANNESMITH J, 2008, WORLD REPOR IN PRESS; Passmore J, 2006, Int J Inj Contr Saf Promot, V13, P187, DOI 10.1080/17457300500248444; Peden M., 2004, WORLD REPORT ROAD TR; PERREMENT M, 2006, DROWNING IS NUMBER 1; Phillips M. R., 2004, Morbidity and Mortality Weekly Report, V53, P481; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Phillips MR, 1998, CHINA J, V39, P1, DOI 10.2307/2667691; RAHMIN A, 2005, BANGLADESH HLTH INJU; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Routley V, 2007, INJURY PREV, V13, P388, DOI 10.1136/ip.2007.015701; Shi Qi-chang, 2005, Zhonghua Yufang Yixue Zazhi, V39, P229; STAINES C, CHILD EARLY ADOLESCE; *STAT COUNC INF OF, LAT DEV WENCH EARTHQ; STEVENSON M, INJ PREV IN PRESS; United Nations, 1996, PREV SUIC GUID FORM; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61365-3; Wang Li-Jun, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P889; [王艳红 WANG Yanhong], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P195; Wasserman D., 2016, SUICIDE UNNECESSARY; *WHO, 2008, WORLD HLTH STAT REP; WHO, 2006, SAF ACC PEST COMM IN; WHO, 2002, INJ CHARTB GRAPH OV; *WHO, HUM AN RAB; World Health Organization, INT STAT CLASS DIS R; World Health Organization, WHO MORT DAT; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; ZHANG KL, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61357-4; Zhou Y, 2003, INJ PREV, V9, P124, DOI 10.1136/ip.9.2.124	55	202	274	2	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1765	1773		10.1016/S0140-6736(08)61367-7	http://dx.doi.org/10.1016/S0140-6736(08)61367-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18930527				2022-12-24	WOS:000261077900026
J	Hammond, P				Hammond, Phil			(Not) warts and all	BRITISH MEDICAL JOURNAL			English	Editorial Material												hamm82@msn.com						2008, SEXUALLY TRANSMITTED, V84, P251, DOI DOI 10.1136/STI.2008.032755	1	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2186	10.1136/bmj.a2186	http://dx.doi.org/10.1136/bmj.a2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18948345				2022-12-24	WOS:000260298800050
J	Disson, O; Grayo, S; Huillet, E; Nikitas, G; Langa-Vives, F; Dussurget, O; Ragon, M; Le Monnier, A; Babinet, C; Cossart, P; Lecuit, M				Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Langa-Vives, Francina; Dussurget, Olivier; Ragon, Marie; Le Monnier, Alban; Babinet, Charles; Cossart, Pascale; Lecuit, Marc			Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis	NATURE			English	Article							SURFACE PROTEIN; E-CADHERIN; MONOCYTOGENES; INTERNALIN; RECEPTOR; ENTRY; MODEL; INIB; SUFFICIENT; PREGNANCY	The ability to cross host barriers is an essential virulence determinant of invasive microbial pathogens. Listeria monocytogenes is a model microorganism that crosses human intestinal and placental barriers, and causes severe maternofetal infections by an unknown mechanism(1). Several studies have helped to characterize the bacterial invasion proteins InlA and InlB(2). However, their respective species specificity has complicated investigations on their in vivo role(3,4). Here we describe two novel and complementary animal models for human listeriosis: the gerbil, a natural host for L. monocytogenes, and a knock- in mouse line ubiquitously expressing humanized E- cadherin. Using these two models, we uncover the essential and interdependent roles of InlA and InlB in fetoplacental listeriosis, and thereby decipher the molecular mechanism underlying the ability of a microbe to target and cross the placental barrier.	[Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Dussurget, Olivier; Cossart, Pascale; Lecuit, Marc] Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Disson, Olivier; Grayo, Solene; Nikitas, Georgios; Lecuit, Marc] Inserm Avenir, U604, F-75015 Paris, France; [Grayo, Solene; Ragon, Marie; Le Monnier, Alban; Lecuit, Marc] Inst Pasteur, Ctr Natl Reference Listeria, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Langa-Vives, Francina] Inst Pasteur, Ctr Ingn Genet Murine, F-75015 Paris, France; [Babinet, Charles] Inst Pasteur, Dev Biol Unit, F-75015 Paris, France; [Lecuit, Marc] Univ Paris 05, Ctr Infectiol Necker Pasteur, Serv Malad Infect & Trop, Hop Necker Enfants Malad,Assistance Publ Hop Pari, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecuit, M (corresponding author), Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France.	mlecuit@pasteur.fr	Disson, Olivier/H-6359-2016; Disson, Olivier/P-9935-2019; Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013	Disson, Olivier/0000-0002-7791-9782; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; LE MONNIER, Alban/0000-0001-6181-281X; Dussurget, Olivier/0000-0001-9924-0837	Institut Pasteur, Inserm; INRA; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute international research scholar	Institut Pasteur, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute international research scholar(Howard Hughes Medical Institute)	This paper is dedicated to the memory of Charles Babinet, our friend and colleague, who died a few days before the submission of thismanuscript. We thank his collaborators S. Vandormael- Pournin, C. Kress and M. Cohen- Tannoudji, as well as L. Larue and S. Tajbakhsh for help in generating the knock- in mice. We thank C. Hill for the gift of the pPL2lux- P<INF>hlyA</INF> plasmid, M.-A. Nahori for help with animal experiments, P. Roux for help with confocal imaging, P.- M. Lledo and M. Gabellec for help with vibratome sectioning, V. Masse for help with statistical analysis and O. Lortholary for his support. We also thank S. Mostowy for reading the paper. This work received financial support from the Institut Pasteur, Inserm and INRA. O. Disson received financial support from the Fondation pour la Recherche Medicale (FRM) and Inserm, P.C. is an Howard Hughes Medical Institute international research scholar and M.L. is a recipient of an Inserm interface contract.	Abram M, 2003, FEMS IMMUNOL MED MIC, V35, P177, DOI 10.1016/S0928-8244(02)00449-2; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Bierne H, 2002, J CELL SCI, V115, P3357; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Glaser P, 2001, SCIENCE, V294, P849; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Perez-Garcia CC, 2003, LAB ANIM-UK, V37, P68, DOI 10.1258/002367703762226719; Pirie JHH., 1927, PUBLICATIONS S AFRIC, V3, P163; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	30	184	190	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1114	1118		10.1038/nature07303	http://dx.doi.org/10.1038/nature07303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806773				2022-12-24	WOS:000260252600046
J	Goodyear, LJ				Goodyear, Laurie J.			The exercise pill - Too good to be true?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC ACTIVATION; GLYCOGEN; MUSCLE		[Goodyear, Laurie J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goodyear, Laurie J.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goodyear, LJ (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.							Barre L, 2007, AM J PHYSIOL-ENDOC M, V292, pE802, DOI 10.1152/ajpendo.00369.2006; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Leff T, 2003, BIOCHEM SOC T, V31, P224; Musi Nicolas, 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P119; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051	5	76	82	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1842	1844		10.1056/NEJMcibr0806723	http://dx.doi.org/10.1056/NEJMcibr0806723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946072				2022-12-24	WOS:000260245800015
J	Zheng, HW; Ying, HQ; Yan, HY; Kimmelman, AC; Hiller, DJ; Chen, AJ; Perry, SR; Tonon, G; Chu, GC; Ding, ZH; Stommel, JM; Dunn, KL; Wiedemeyer, R; You, MJJ; Brennan, C; Wang, YA; Ligon, KL; Wong, WH; Chin, L; DePinho, RA				Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Hiller, David J.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Brennan, Cameron; Wang, Y. Alan; Ligon, Keith L.; Wong, Wing H.; Chin, Lynda; DePinho, Ronald A.			p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation	NATURE			English	Article							CANCER STEM-CELLS; SELF-RENEWAL; INITIATING CELLS; C-MYC; TUMORS; GLIOBLASTOMA; EXPRESSION; RECEPTOR; PATHWAYS; BIOLOGY	Glioblastoma ( GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF ( also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low- grade disease that classically possesses PDGF and TP53 events(1-3). Here we show that concomitant central nervous system (CNS)- specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute- onset high- grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells ( NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/ promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/ progenitor cell differentiation, self- renewal and tumorigenic potential.	[Zheng, Hongwu; Ying, Haoqiang; Yan, Haiyan; Kimmelman, Alec C.; Chen, An-Jou; Perry, Samuel R.; Tonon, Giovanni; Chu, Gerald C.; Ding, Zhihu; Stommel, Jayne M.; Dunn, Katherine L.; Wiedemeyer, Ruprecht; You, Mingjian J.; Wang, Y. Alan; Ligon, Keith L.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Perry, Samuel R.; Chu, Gerald C.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Ctr Appl Canc Sci, Belfer Fdn Inst Innovat Canc Sci, Boston, MA 02115 USA; [Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Kimmelman, Alec C.] Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Chu, Gerald C.; Ligon, Keith L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Div Neuropathol, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hiller, David J.; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Brennan, Cameron] Weill Cornell Med Coll, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Tonon, Giovanni/J-9804-2018; Brennan, Cameron/R-7082-2019; Ying, Haoqiang/AAK-4325-2020; Stommel, Jayne M/M-3439-2017	Tonon, Giovanni/0000-0003-2973-5038; Brennan, Cameron/0000-0003-4064-8891; Zheng, Hongwu/0000-0002-5823-4913; DePinho, Ronald/0000-0002-5625-577X	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship; Mildred Scheel Fellowship (Deutsche Krebshilfe); Goldhirsh Foundation; NIH [U01 CA84313, RO1CA99041, 5P01CA95616]; Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE [R01CA099041, U01CA084313, P01CA095616] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Marsha Mae Moeslein Fellowship; American Brain Tumor Association; Leonard B. Holman Research Pathway Fellowship; Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mildred Scheel Fellowship (Deutsche Krebshilfe)(Deutsche Krebshilfe); Goldhirsh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Berns for providing p53 L mice; S. Zhou and S. Jiang for mouse husbandry and care; R. T. Bronson for discussion on pathology analysis; K. Montgomery for discussion on sequencing; and Y.- H. Xiao, B. Feng and J. Zhang for bioinformatic help. H. Z. was supported by Helen Hay Whitney Foundation. H. Ying is a recipient of the Marsha Mae Moeslein Fellowship from the American Brain Tumor Association. A. C. K. is a recipient of the Leonard B. Holman Research Pathway Fellowship. Z. D. is supported by the Damon Runyon Cancer Research Foundation. J. M. S. is supported by a Ruth L. Kirschstein National Research Service Award Fellowship. R. W. is supported by a Mildred Scheel Fellowship ( Deutsche Krebshilfe). Grant support comes from the Goldhirsh Foundation (R.A.D.), and NIH grants U01 CA84313 (R.A.D.), RO1CA99041 ( L. C.) and 5P01CA95616 (R.A.D., L.C., W.H.W., C.B. and K.L.L.). R.A.D. is an American Cancer Society Research Professor supported by the Robert A. and Renee E. Belfer Foundation Institute for Innovative Cancer Science.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Fukushima T, 2006, J NEUROPATH EXP NEUR, V65, P12, DOI 10.1097/01.jnen.0000196132.66464.96; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; The WHO, 2020, CLASSIFICATION TUMOU; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	35	534	547	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1129	U13		10.1038/nature07443	http://dx.doi.org/10.1038/nature07443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948956	Green Accepted, Green Submitted			2022-12-24	WOS:000260252600049
J	Mathew-Fenn, RS; Das, R; Harbury, PAB				Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.			Remeasuring the double helix	SCIENCE			English	Article							PROTEIN-DNA COMPLEXES; OPTICAL TWEEZERS; NUCLEIC-ACIDS; STRANDED-DNA; SINGLE; DISTANCES; FLUCTUATIONS; TRANSITIONS; ELASTICITY; MICROSCOPY	DNA is thought to behave as a stiff elastic rod with respect to the ubiquitous mechanical deformations inherent to its biology. To test this model at short DNA lengths, we measured the mean and variance of end-to-end length for a series of DNA double helices in solution, using small-angle x-ray scattering interference between gold nanocrystal labels. In the absence of applied tension, DNA is at least one order of magnitude softer than measured by single-molecule stretching experiments. Further, the data rule out the conventional elastic rod model. The variance in end-to-end length follows a quadratic dependence on the number of base pairs rather than the expected linear dependence, indicating that DNA stretching is cooperative over more than two turns of the DNA double helix. Our observations support the idea of long-range allosteric communication through DNA structure.	[Mathew-Fenn, Rebecca S.; Harbury, Pehr A. B.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Mathew-Fenn, Rebecca S.; Das, Rhiju; Harbury, Pehr A. B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Harbury, PAB (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu		Das, Rhiju/0000-0001-7497-0972	NIH [GM068126-01, DP OD000429-01]; NSF; U.S. Department of Energy [W-31-109 Eng-438]; Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068126] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Stanford Synchrotron Radiation Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C.J. Ackerson for discussions on nanocrystal synthesis; R.L. Baldwin, F.E. Boas, Z.D. Bryant, L.S. Churchman, A.R. Dunn, D.R. Halpin, D. Herschlag, W.L. Martin, B.H. Robinson, J.M. Schurr, A.L. Smith, R.M. Weisinger, and S.J. Wrenn for insights into DNA; Y. Bai, S. Doniach, K. Ito, J. Lipfert, I. S. Millett, S. Seifert, P. Thiyagarajan and H. Tsuruta for assistance and advice on x-ray scattering; T.D. Fenn for writing code that was used to calculate crystallographic dispersion values and for valuable discussions throughout this work; P.A. Walker for expert assistance with DNA synthesis; and P. Bradley and D. Baker for permitting use of unpublished code to prepare Fig. 4. Supported by NIH grants GM068126-01 and DP OD000429-01 (P.A.B.H.), an NIH training grant fellowship (R.S.F.), an NSF graduate fellowship (R.D.), and the U.S. Department of Energy (contract W-31-109 Eng-438 to the Advanced Photon Source, and support of Stanford Synchrotron Radiation Laboratory).	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Cai Q, 2006, NUCLEIC ACIDS RES, V34, P4722, DOI 10.1093/nar/gkl546; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gore J, 2006, NATURE, V442, P836, DOI 10.1038/nature04974; GRIFFITH JD, 1978, SCIENCE, V201, P525, DOI 10.1126/science.663672; HARBURY PAB, 2008, PLOS 1, V3, pE3329; Hillisch A, 2001, CURR OPIN STRUC BIOL, V11, P201, DOI 10.1016/S0959-440X(00)00190-1; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Liu YX, 2001, J BIOMOL STRUCT DYN, V18, P505, DOI 10.1080/07391102.2001.10506684; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Sakata-Sogawa K, 1998, EUR BIOPHYS J BIOPHY, V27, P55, DOI 10.1007/s002490050110; Schurr JM, 2000, BIOPOLYMERS, V54, P561, DOI 10.1002/1097-0282(200012)54:7<561::AID-BIP80>3.0.CO;2-M; Schurr JM, 1997, BIOPOLYMERS, V44, P283, DOI 10.1002/(SICI)1097-0282(1997)44:3<283::AID-BIP7>3.0.CO;2-R; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Ulyanov NB, 1995, METHOD ENZYMOL, V261, P90; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Zhu PZ, 2005, BIOPHYS J, V89, pL37, DOI 10.1529/biophysj.105.071027; ZIMMERMAN SB, 1979, J MOL BIOL, V135, P1023, DOI 10.1016/0022-2836(79)90526-6	31	167	168	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					446	449		10.1126/science.1158881	http://dx.doi.org/10.1126/science.1158881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927394	Green Accepted			2022-12-24	WOS:000260094500048
J	Oard, DW				Oard, Douglas W.			Social science - Unlocking the potential of the spoken word	SCIENCE			English	Editorial Material									[Oard, Douglas W.] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA; [Oard, Douglas W.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Oard, DW (corresponding author), Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA.	oard@umd.edu						Bell G, 2007, SCI AM, V296, P58, DOI 10.1038/scientificamerican0307-58; HACKFORD R, 1952, PLATOS PHAEDRUS; HOOKER FJ, 1996, READING PAST ANCIENT; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; LIN WH, 2002, JOINT C DIG LIB JCDL; ROSEN J, 2008, NY TIMES        0327	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1787	1788		10.1126/science.1157353	http://dx.doi.org/10.1126/science.1157353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818348				2022-12-24	WOS:000259501300024
J	Morris, EJ; Ji, JY; Yang, FJ; Di Stefano, L; Herr, A; Moon, NS; Kwon, EJ; Haigis, KM; Naar, AM; Dyson, NJ				Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Kwon, Eun-Jeong; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.			E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8	NATURE			English	Article							COLON-CANCER; EXPRESSION; ACTIVATION; PROTEIN; GENE; APC; P53; SPECIFICITY; DROSOPHILA; MEDIATOR	The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumour suppressor protein ( pRB). Here we show that E2F1 is a potent and specific inhibitor of beta-catenin/T-cell factor (TCF)- dependent transcription, and that this function contributes to E2F1- induced apoptosis. E2F1 deregulation suppresses beta-catenin activity in an adenomatous polyposis coli ( APC)/glycogen synthase kinase- 3 ( GSK3)- independent manner, reducing the expression of key beta-catenin targets including c- MYC. This interaction explains why colorectal tumours, which depend on beta- catenin transcription for their abnormal proliferation, keep RB1 intact. Remarkably, E2F1 activity is also repressed by cyclin- dependent kinase- 8 ( CDK8), a colorectal oncoprotein(1). Elevated levels of CDK8 protect beta-catenin/TCF-dependent transcription from inhibition by E2F1. Thus, by retaining RB1 and amplifying CDK8, colorectal tumour cells select conditions that collectively suppress E2F1 and enhance the activity of beta-catenin.	[Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, Charlestown, MA 02129 USA; [Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Yang, Fajun; Naar, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kwon, Eun-Jeong] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kwon, Eun-Jeong] Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Canc, Lab Mol Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Dyson, NJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, 13th St,Bldg 149, Charlestown, MA 02129 USA.	dyson@helix.mgh.harvard.edu	Di Stefano, Luisa/ABB-6457-2020	Di Stefano, Luisa/0000-0003-3437-9066; Morris, Erick/0000-0002-3566-5630; Ji, Jun-yuan/0000-0002-4483-4336; Moon, Nam-Sung/0000-0002-0455-927X	Ruth L. Kirschstein Award; Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence [P50-CA127003]; Saltonstall Foundation; National Institutes of Health [GM81607, GM053203, GM071449]; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449, R01GM081607, R01GM053203] Funding Source: NIH RePORTER	Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence; Saltonstall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank many investigators for their gifts of cell lines, plasmids and fly stocks, especially S. Artavanis-Tsakonas. We thank D. Rennie and the Massachusetts General Hospital Cutaneous Biology Research Center Transgenic Fly Core for embryo injections, and B. Fowle for his help with SEM imaging. We thank A. McClatchey, J. Settleman, C. Seum and T. Orr-Weaver for their gifts of antibodies. We thank our colleagues at the Massachusetts General Hospital (MGH) Cancer Center for discussions. E.J.M. and J.-Y.J. are supported in part by a Ruth L. Kirschstein Award and a Tosteson Postdoctoral Fellowship, respectively. L. D. S. is supported by the MGH ECOR Fund for Medical Discovery. N.-S.M. is a Leukemia and Lymphoma Society Special Fellow. K.M.H. was supported by a Career Development award from the Harvard Gastrointestinal Specialized Program of Research Excellence (GI-SPORE) (P50-CA127003). N.J.D. was supported by a scholarship from the Saltonstall Foundation. This study was supported by grants from the National Institutes of Health to N.J.D. (GM81607, GM053203) and A. M. N. (GM071449).	Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; GOPE R, 1990, J NATL CANCER I, V82, P310, DOI 10.1093/jnci/82.4.310; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hughes TA, 2005, BIOCHEM BIOPH RES CO, V329, P1267, DOI 10.1016/j.bbrc.2005.02.102; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Ueda Y, 2001, BIOCHEM BIOPH RES CO, V283, P327, DOI 10.1006/bbrc.2001.4788; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006	29	234	238	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					552	U67		10.1038/nature07310	http://dx.doi.org/10.1038/nature07310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794899	Green Accepted, Green Submitted			2022-12-24	WOS:000259449600050
J	Pavord, ID; Shaw, DE; Gibson, PG; Taylor, DR				Pavord, Ian D.; Shaw, Dominick E.; Gibson, Peter G.; Taylor, D. Robin			Inflammometry to assess airway diseases	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC ASTHMA; INFLAMMATION; SPUTUM; EXACERBATIONS; CHILDREN; PREDNISOLONE; COUNTS; ADULTS		[Pavord, Ian D.; Shaw, Dominick E.] Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England; [Gibson, Peter G.] John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, New Lambton, NSW, Australia; [Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Otago	Pavord, ID (corresponding author), Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk	shaw, dominick/N-1293-2014; gibson, peter/G-6194-2014	shaw, dominick/0000-0003-4106-8469; gibson, peter/0000-0001-5865-489X; Pavord, Ian/0000-0002-4288-5973				Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; BROWN HM, 1958, LANCET, V2, P1245; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hunter CJ, 2002, CHEST, V121, P1051, DOI 10.1378/chest.121.4.1051; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Pavord ID, 2006, EUR RESPIR J, V27, P884, DOI 10.1183/09031936.06.00128105; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC	17	65	68	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1017	1019		10.1016/S0140-6736(08)61421-X	http://dx.doi.org/10.1016/S0140-6736(08)61421-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805315				2022-12-24	WOS:000259648500008
J	Del Bene, F; Wehman, AM; Link, BA; Baier, H				Del Bene, Filippo; Wehman, Ann M.; Link, Brian A.; Baier, Herwig			Regulation of neurogenesis by interkinetic nuclear migration through an apical-basal Notch gradient	CELL			English	Article							CELL-FATE DETERMINATION; RETINAL GANGLION-CELL; ZEBRAFISH; PROGENITOR; NUMB; GLIOGENESIS; EXPRESSION; DIVISION; MUTATION; REVEALS	The different cell types in the central nervous system develop from a common pool of progenitor cells. The nuclei of progenitors move between the apical and basal surfaces of the neuroepithelium in phase with their cell cycle, a process termed interkinetic nuclear migration (INM). In the retina of zebrafish mikre oko (mok) mutants, in which the motor protein Dynactin-1 is disrupted, interkinetic nuclei migrate more rapidly and deeply to the basal side and more slowly to the apical side. We found that Notch signaling is predominantly activated on the apical side in both mutants and wild-type. Mutant progenitors are, thus, less exposed to Notch and exit the cell cycle prematurely. This leads to an overproduction of early-born retinal ganglion cells (RGCs) at the expense of later-born interneurons and glia. Our data indicate that the function of INM is to balance the exposure of progenitor nuclei to neurogenic versus proliferative signals.	[Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA	Medical College of Wisconsin; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Link, BA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	blink@mcw.edu; herwig.baier@ucsf.edu	Wehman, Ann M/J-7860-2019; del bene, filippo/D-1245-2010	Wehman, Ann M/0000-0001-9826-4132; del bene, filippo/0000-0001-8551-2846	NEI NIH HHS [R01 EY012406-09, EY012406, R01 EY013855, R01 EY013855-04, R01 EY012406-05, R01 EY012406, EY01467, R01 EY013855-06, EY013855] Funding Source: Medline; NINDS NIH HHS [R01 NS053358-02, R01 NS053358] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Baye LM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-28; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Doerre G, 2001, J NEUROSCI, V21, P6745, DOI 10.1523/JNEUROSCI.21-17-06745.2001; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fan SS, 1997, DEVELOPMENT, V124, P1497; Frade JM, 2002, PROG BRAIN RES, V136, P67; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; Meng A, 1999, METHOD CELL BIOL, V60, P133; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Passini MA, 1997, J COMP NEUROL, V388, P495, DOI 10.1002/(SICI)1096-9861(19971124)388:3<495::AID-CNE11>3.0.CO;2-L; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Poggi L, 2005, CURR OPIN CELL BIOL, V17, P676, DOI 10.1016/j.ceb.2005.09.004; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Scheer N, 2001, DEVELOPMENT, V128, P1099; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Takke C, 1999, DEVELOPMENT, V126, P1811; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Wehman AM, 2007, DEV BIOL, V303, P144, DOI 10.1016/j.ydbio.2006.10.043; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yan RT, 2005, MOL NEUROBIOL, V32, P157, DOI 10.1385/MN:32:2:157; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	68	238	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1055	1065		10.1016/j.cell.2008.07.017	http://dx.doi.org/10.1016/j.cell.2008.07.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805097	Green Accepted, Bronze			2022-12-24	WOS:000259318100024
J	Inomata, H; Haraguchi, T; Sasai, Y				Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki			Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation	CELL			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; SPEMANN ORGANIZER; NEURAL INDUCTION; XENOPUS EMBRYOS; GASTRULATION; INHIBITION; MOVEMENTS; CLEAVAGE; SIGNALS; BIOLOGY	Dorsal axial formation during vertebrate embryogenesis exhibits robust resistance to perturbations in patterning signals. However, how such stability is supported at the molecular level remains largely elusive. Here we show that Xenopus ONT1, an Olfactomedin-class secreted protein, stabilizes axial formation by restricting Chordin activity on the dorsal side. When ONT1 function is attenuated, the embryo becomes hyperdorsalized by a normally subeffective dose of Chordin. ONT1 binds Chordin and BMP1/Tolloid-class proteinases (B1TP) via distinct domains and acts as a secreted scaffold that enhances B1TP-mediated Chordin degradation by facilitating enzyme-substrate association. ONT1 is indispensable for fine-tuning BMP signaling in the axial tissue, and a similar role has been suggested for dorsally expressed BMPs such as ADMP. Simultaneous inhibition of ONT1 and dorsally expressed BMPs (ADMP and BMP2) synergistically caused drastic dorsalization. These results indicate that stable axial formation depends on two compensatory regulatory pathways involving ONT1/B1TP and dorsally expressed BMPs.	[Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Inomata, Hidehiko/N-7390-2015		MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We would like to thank Drs. M. Hibi and G. Sheng for invaluable comments, Dr. L. Dale for the Xlr plasmid, Drs. N. Sasai and M. Ikeya for critical reading, Dr. M. Sakuragi for chick ONT1 information, and Ms. M. Suzuki for Xenopus husbandry. This work was supported by grants in aid from MEXT, the Kobe Cluster Project, and the Leading Project (Y. S.).	Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; COOKE J, 1975, J EMBRYOL EXP MORPH, V33, P147; COOKE J, 1973, J EMBRYOL EXP MORPH, V30, P49; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; FERRELL JE, 2000, SCI STKE, pPE1; GALLERA J, 1974, EXPERIENTIA, V30, P183, DOI 10.1007/BF01927723; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Moos M, 1995, DEVELOPMENT, V121, P4293; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Plouhinec JL, 2007, MOL BIOSYST, V3, P454, DOI 10.1039/b701571b; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sakuragi M, 2006, MECH DEVELOP, V123, P114, DOI 10.1016/j.mod.2005.11.005; Salic AN, 1997, DEVELOPMENT, V124, P4739; Spemann H, 1903, ARCH ENTWICKLUNG ORG, V16, P551, DOI 10.1007/BF02301267; Spemann H, 2001, INT J DEV BIOL, V45, P13; Tsuda H, 2002, NEURON, V33, P515, DOI 10.1016/S0896-6273(02)00590-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064	34	86	92	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					854	865		10.1016/j.cell.2008.07.008	http://dx.doi.org/10.1016/j.cell.2008.07.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775317	Bronze			2022-12-24	WOS:000258947500024
J	Aiello, LP				Aiello, Lloyd Paul			Targeting intraocular neovascularization and edema - One drop at a time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VASCULAR-PERMEABILITY; KINASE INHIBITOR		[Aiello, Lloyd Paul] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA; [Aiello, Lloyd Paul] Joslin Diabet Ctr, Sect Eye Res, Boston, MA 02215 USA; [Aiello, Lloyd Paul] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Aiello, LP (corresponding author), Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA 02215 USA.							Doukas J, 2008, J CELL PHYSIOL, V216, P29, DOI 10.1002/jcp.21426; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773	5	31	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2008	359	9					967	969		10.1056/NEJMcibr0804551	http://dx.doi.org/10.1056/NEJMcibr0804551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341IU	18753655				2022-12-24	WOS:000258708300014
J	Loeb, M; Hanna, S; Nicolle, L; Eyles, J; Elliott, S; Rathbone, M; Drebot, M; Neupane, B; Fearon, M; Mahony, J				Loeb, Mark; Hanna, Steven; Nicolle, Lindsay; Eyles, John; Elliott, Susan; Rathbone, Michel; Drebot, Michael; Neupane, Binod; Fearon, Margaret; Mahony, James			Prognosis after west nile virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							FATIGUE SEVERITY SCALE; PSYCHOMETRIC PROPERTIES; UNITED-STATES; FOLLOW-UP; NEW-YORK; DEPRESSION; ENCEPHALITIS; EPIDEMIC; OUTCOMES; FEVER	Background: The long-term prognosis of patients infected with West Nile virus is not well understood. Objective: To describe the patterns of physical and mental function after infection with West Nile virus and to determine factors associated with recovery. Design: Longitudinal cohort study. Setting: Data were collected during home visits and from ambulatory clinics in 4 Canadian provinces. Participants: 156 persons with West Nile virus infection. Measurements: Scores on the Physical Component Summary and Mental Component Summary of the Short Form-36, Depression Anxiety Stress Scale, and Fatigue Severity Scale. Results: Physical and mental function, as well as mood and fatigue, seemed to return to normal within 1 year of symptom onset. Participants with neuroinvasive disease took slightly longer to recover. Maximum predicted recovery or rate of recovery in any domain did not differ between participants with meningoencephalitis and those with encephalitis. Lack of preexisting comorbid conditions was associated with faster recovery of physical function, whereas lack of comorbid conditions and male sex were associated with faster recovery of mental function. Limitations: The analysis excluded 7 patients who died shortly after diagnosis, so the study's estimates of prognosis may be over-optimistic. The authors did not formally assess neuropsychological difficulties. The estimates of recovery are relative to the U. S. population, not to participants' function levels before West Nile virus infection. Conclusion: Physical and mental outcome measures seem to normalize within approximately 1 year in patients with West Nile virus. The presence of preexisting comorbid conditions is associated with longer recovery.	[Loeb, Mark] McMaster Univ, Hamilton, ON L8N 3Z5, Canada	McMaster University	Loeb, M (corresponding author), McMaster Univ, MDCL 3200,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	loebm@mcmaster.ca		Hanna, Steven/0000-0003-3120-9600	Canadian Institutes of Health Research [69010]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research (grant no. 69010).	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Berner YN, 2002, J AM GERIATR SOC, V50, P1844, DOI 10.1046/j.1532-5415.2002.505402.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Gottfried K, 2005, SOUTH MED J, V98, P603, DOI 10.1097/01.SMJ.0000155633.43244.AC; Haaland KY, 2006, EMERG INFECT DIS, V12, P1260, DOI 10.3201/eid1708.060097; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hayes EB, 2006, PEDIATR INFECT DIS J, V25, P1065, DOI 10.1097/01.inf.0000243324.14658.58; Klee AL, 2004, EMERG INFECT DIS, V10, P1405, DOI 10.3201/eid1008.030879; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murray KO, 2007, EMERG INFECT DIS, V13, P479, DOI 10.3201/eid1303.060602; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Ou Alan C, 2005, J La State Med Soc, V157, P42; Patnaik JL, 2006, EMERG INFECT DIS, V12, P1129, DOI 10.3201/eid1207.051399; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sejvar JJ, 2006, EMERG INFECT DIS, V12, P514, DOI 10.3201/eid1203.050643; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Voelker R, 2008, JAMA-J AM MED ASSOC, V299, P2135, DOI 10.1001/jama.299.18.2135; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Watson JT, 2004, ANN INTERN MED, V141, P360, DOI 10.7326/0003-4819-141-5-200409070-00010	26	41	41	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2008	149	4					232	+		10.7326/0003-4819-149-4-200808190-00004	http://dx.doi.org/10.7326/0003-4819-149-4-200808190-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338RQ	18711153				2022-12-24	WOS:000258526700002
J	Provan, D; Chapel, HM; Sewell, WAC; O'Shaughnessy, D				Provan, Drew; Chapel, Helen M.; Sewell, W. A. Carrock; O'Shaughnessy, Denise		UK Immunoblobulin Expert Working G	Guidelines - Prescribing intravenous immunoglobulin: summary of Department of Health guidelines	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Provan, Drew] Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England; [Chapel, Helen M.] Univ Oxford, Nuffield Dept Med, Oxford OX3 9DU, England; [Chapel, Helen M.] Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Sewell, W. A. Carrock] Scunthorpe Gen Hosp, N Lincolnshire & Goole NHS Trust, Scunthorpe DN15 7BH, N Lincs, England; [O'Shaughnessy, Denise] Dept Hlth, Blood Policy Unit, London SE13 6LH, England	Barts Health NHS Trust; Royal London Hospital; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Provan, D (corresponding author), Royal London Hosp, Dept Haematol, Barts & London NHS Trust, London E1 2ES, England.	a.provan@virgin.net	Provan, Drew/AAF-2766-2021	Provan, Drew/0000-0002-5110-8455	Department of Health Funding Source: Medline	Department of Health		[Anonymous], 2008, DEM MAN PLAN IMM US; Boulis A, 2002, J HEALTH POLIT POLIC, V27, P977, DOI 10.1215/03616878-27-6-977; Darabi K, 2006, TRANSFUSION, V46, P741, DOI 10.1111/j.1537-2995.2006.00792.x; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Pendergrast JM, 2005, VOX SANG, V89, P150, DOI 10.1111/j.1423-0410.2005.00670.x; Provan D., 2008, IVIG GUIDELINE DEV G, V2nd; *US DEP HHS, 1993, AHCPR PUBL, V1	7	15	16	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1831	10.1136/bmj.a1831	http://dx.doi.org/10.1136/bmj.a1831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18936060				2022-12-24	WOS:000260298800038
J	Berger, SP				Berger, S. Paul			Brain science and addiction	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; EXPOSURE THERAPY; D-CYCLOSERINE; DISORDER		[Berger, S. Paul] Dept Vet Affairs Med Ctr, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Berger, SP (corresponding author), Dept Vet Affairs Med Ctr, Portland, OR 97239 USA.	bergerp@ohsu.edu						Academy of Medical Sciences, 2008, BRAIN SCI ADD DRUGS; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; BENDER E, 2003, PSYCHIAT NEWS, V38, P12; Berger SP, 2007, NATURE, V449, P972, DOI 10.1038/449972a; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P544, DOI 10.1016/j.biopsych.2007.11.011; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Pucci E, 2007, COCHRANE DB SYST REV, V1; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1280	1281		10.1016/S0140-6736(08)61530-5	http://dx.doi.org/10.1016/S0140-6736(08)61530-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929888				2022-12-24	WOS:000260060500007
J	Buis, J; Wu, YP; Deng, YB; Leddon, J; Westfield, G; Eckersdorff, M; Sekiguchi, JM; Chang, S; Ferguson, DO				Buis, Jeffrey; Wu, Yipin; Deng, Yibin; Leddon, Jennifer; Westfield, Gerwin; Eckersdorff, Mark; Sekiguchi, JoAnn M.; Chang, Sandy; Ferguson, David O.			Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation	CELL			English	Article							DOUBLE-STRAND BREAKS; END-JOINING PATHWAY; SACCHAROMYCES-CEREVISIAE; V(D)J RECOMBINATION; LIGASE IV; MEIOTIC RECOMBINATION; EMBRYONIC LETHALITY; DAMAGE RESPONSES; HUMAN TELOMERES; COMPLEX	The Mre11/Rad50/NBS1 (MRN) complex maintains genomic stability by bridging DNA ends and initiating DNA damage signaling through activation of the ATM kinase. Mre11 possesses DNA nuclease activities that are highly conserved in evolution but play unknown roles in mammals. To define the functions of Mre11, we engineered targeted mouse alleles that either abrogate nuclease activities or inactivate the entire MRN complex. Mre11 nuclease deficiency causes a striking array of phenotypes indistinguishable from the absence of MRN, including early embryonic lethality and dramatic genomic instability. We identify a crucial role for the nuclease activities in homology-directed double-strand-break repair and a contributing role in activating the ATR kinase. However, the nuclease activities are not required to activate ATM after DNA damage or telomere deprotection. Therefore, nucleolytic processing by Mre11 is an essential function of fundamental importance in DNA repair, distinct from MRN control of ATM signaling.	[Buis, Jeffrey; Wu, Yipin; Leddon, Jennifer; Eckersdorff, Mark; Ferguson, David O.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Deng, Yibin; Chang, Sandy] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Westfield, Gerwin; Sekiguchi, JoAnn M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ferguson, DO (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	daviferg@umich.edu		Deng, Yibin/0000-0001-5711-3565; Westfield, Gerwin/0000-0001-9634-2336; Sekiguchi, JoAnn/0000-0002-7178-4258	National Institutes of Health (NIH) [HL079118]; Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center [5-P30-CA46592]; Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH [AG028888, CA129037, AI063058]; Pew Foundation Scholars Award;  [K08 HL067580];  [1K01CA124461-01]; NATIONAL CANCER INSTITUTE [T32CA009676, R01CA129037, P30CA016672, K01CA124461, P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079118, K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028888] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; University of Michigan Cancer Center(University of Michigan System); Munn Endowment; Cure foundations, the Michael Kadoorie Cancer Genetics Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation Scholars Award; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this work to D.O.F. was provided by the National Institutes of Health (NIH) (HL079118), Sidney Kimmel Cancer Research Foundation, University of Michigan Cancer Center Support Grant 5-P30-CA46592, and Munn Endowment, and by K08 HL067580 under initial mentorship of Frederick W. Alt. D.O.F. thanks John Moran, Tom Wilson, Mats Ljungman, Chris Canman, and Tobias Else for advice on the manuscript and experiments. S.C. acknowledges M.D. Anderson Cancer Center's Molecular Cytogenetics Core (CA016672) and support from the Welch, Elsa U. Pardee, and Abraham and Phyllis Katz, and Susan G. Komen for the Cure foundations, the Michael Kadoorie Cancer Genetics Research Program, and the NIH (AG028888, CA129037). Y.D. supported by 1K01CA124461-01. J.M.S. is supported by NIH AI063058 and Pew Foundation Scholars Award.	Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Bressan DA, 1998, GENETICS, V150, P591; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Moreau S, 1999, MOL CELL BIOL, V19, P556; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2005, MOL CELL, V19, P724, DOI 10.1016/j.molcel.2005.07.006; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	52	239	244	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					85	96		10.1016/j.cell.2008.08.015	http://dx.doi.org/10.1016/j.cell.2008.08.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854157	Green Accepted, Bronze			2022-12-24	WOS:000259728100011
J	de Ferranti, S; Ludwig, DS				de Ferranti, Sarah; Ludwig, David S.			Storm over statins - The controversy surrounding pharmacologic treatment of children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[de Ferranti, Sarah] Childrens Hosp, Prevent Cardiol Clin, Boston, MA 02115 USA; [de Ferranti, Sarah; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	de Ferranti, S (corresponding author), Childrens Hosp, Prevent Cardiol Clin, 300 Longwood Ave, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004	5	53	55	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1309	1312		10.1056/NEJMp0805953	http://dx.doi.org/10.1056/NEJMp0805953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815394				2022-12-24	WOS:000259440900001
J	Arora, VM; Georgitis, E; Siddique, J; Vekhter, B; Woodruff, JN; Humphrey, HJ; Meltzer, DO				Arora, Vineet M.; Georgitis, Emily; Siddique, Juned; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.			Association of workload of on-call medical interns with on-call sleep duration, shift duration, and participation in educational activities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENT DUTY HOURS; HOUR REGULATIONS; DELICATE BALANCE; PATIENT-CARE; TIME; ACTIGRAPHY; OUTCOMES; SERVICE; RISK; MORTALITY	Context Further restrictions in resident duty hours are being considered, and it is important to understand the association between workload, sleep loss, shift duration, and the educational time of on-call medical interns. Objective To assess whether increased on- call intern workload, as measured by the number of new admissions on- call and the number of previously admitted patients remaining on the service, was associated with reductions in on- call sleep, increased total shift duration, and lower likelihood of participation in educational activities. Design, Setting, and Participants Prospective cohort study of medical interns at a single US academic medical center from July 1, 2003, through June 24, 2005. Of the 81 interns, 56 participated ( 69%), for a total of 165 general medicine inpatient months resulting in 1100 call nights. Main Outcome Measures On- call sleep duration, estimated by wrist watch actigraphy; total shift duration, measured from paging logs; and participation in educational activities ( didactic lectures or bedside teaching), measured by experience sampling method via a personal digital assistant. Results Mean ( SD) sleep duration on- call was 2.8 ( 1.5) hours and mean ( SD) shift duration was 29.9 ( 1.7) hours. Interns reported spending 11% of their time in educational activities. Early in the academic year ( July to October), each new on- call admission was associated with less sleep (- 10.5 minutes [ 95% confidence interval {CI}, - 16.8 to - 4.2 minutes]; P <. 001) and a longer shift duration ( 13.2 minutes [ 95% CI, 3.2- 23.3 minutes]; P=. 01). A higher number of previously admitted patients remaining on the service was associated with a lower odds of participation in educational activities ( odds ratio, 0.82 [ 95% CI, 0.70- 0.96]; P=. 01]. Call nights during the week and early in the academic year were associated with the most sleep loss and longest shift durations. Conclusion In this study population, increased on- call workload was associated with more sleep loss, longer shift duration, and a lower likelihood of participation in educational activities.	[Arora, Vineet M.; Georgitis, Emily; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Siddique, Juned] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Meltzer, David O.] Univ Chicago, Dept Econ & Publ Policy Studies, Chicago, IL 60637 USA; [Arora, Vineet M.; Humphrey, Holly J.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Arora, VM (corresponding author), 5841 S Maryland Ave,MC 2007,AMB B217, Chicago, IL 60637 USA.	varora@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Arora, Vineet/0000-0002-4745-7599	Department of Medicine, Pritzker School of Medicine, University of Chicago	Department of Medicine, Pritzker School of Medicine, University of Chicago(University of Chicago)	This study was funded by the Department of Medicine, Pritzker School of Medicine, University of Chicago.	*ACCR COUNC GRAD M, ACGME PROGR REQ RES; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], 2006, SAS MIXED MODELS; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BELLINI LM, APDIM LEARNING ENV T; Dawson D, 2005, JAMA-J AM MED ASSOC, V294, P1104, DOI 10.1001/jama.294.9.1104; Dresselhaus TR, 1998, J GEN INTERN MED, V13, P534, DOI 10.1046/j.1525-1497.1998.00164.x; GUARISCO S, 1994, J GEN INTERN MED, V9, P272, DOI 10.1007/BF02599655; HEDEKER D, 2006, LONGITUDINAL DATA AN; Hektner JM, 2007, EXPERIENCE SAMPLING; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; *I MED, OPT GRAD MED TRAIN R; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Myers JS, 2006, ACAD MED, V81, P1052, DOI 10.1097/01.ACM.0000246687.03462.59; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Ong M, 2007, ARCH INTERN MED, V167, P47, DOI 10.1001/archinte.167.1.47; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Reed DA, 2007, ARCH INTERN MED, V167, P1487, DOI 10.1001/archinte.167.14.1487; Reid K, 1999, SLEEP, V22, P378, DOI 10.1093/sleep/22.3.378; Rubin DB, 2004, MULTIPLE IMPUTATION; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schuberth JL, 2008, CIRCULATION, V117, P2637, DOI 10.1161/CIRCULATIONAHA.107.740357; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Volpp KG, 2008, CIRCULATION, V117, P2580, DOI 10.1161/CIRCULATIONAHA.108.777508; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Wayne DB, 2008, J GEN INTERN MED, V23, P1120, DOI 10.1007/s11606-008-0671-4; Wilde G J, 1998, Inj Prev, V4, P89	37	84	85	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1146	1153		10.1001/jama.300.10.1146	http://dx.doi.org/10.1001/jama.300.10.1146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780843	Bronze			2022-12-24	WOS:000259038700007
J	Koglin, A; Lohr, F; Bernhard, F; Rogov, VV; Frueh, DP; Strieter, ER; Mofid, MR; Guntert, P; Wagner, G; Walsh, CT; Marahiel, MA; Dotsch, V				Koglin, Alexander; Loehr, Frank; Bernhard, Frank; Rogov, Vladimir V.; Frueh, Dominique P.; Strieter, Eric R.; Mofid, Mohammad R.; Guentert, Peter; Wagner, Gerhard; Walsh, Christopher T.; Marahiel, Mohamed A.; Doetsch, Volker			Structural basis for the selectivity of the external thioesterase of the surfactin synthetase	NATURE			English	Article							ACYL CARRIER PROTEIN; PEPTIDE SYNTHETASES; CHEMICAL-SHIFT; POLYKETIDE; BIOSYNTHESIS; MACROCYCLIZATION; RESTRAINTS; DYNAMICS; SYNTHASE; DATABASE	Non-ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) found in bacteria, fungi and plants use two different types of thioesterases for the production of highly active biological compounds(1,2). Type I thioesterases (TEI) catalyse the release step from the assembly line(3) of the final product where it is transported from one reaction centre to the next as a thioester linked to a 4 '-phosphopantetheine (4 '-PP) cofactor that is covalently attached to thiolation (T) domains(4-9). The second enzyme involved in the synthesis of these secondary metabolites, the type II thioesterase (TEII), is a crucial repair enzyme for the regeneration of functional 4 '-PP cofactors of holo-T domains of NRPS and PKS systems(10-12). Mispriming of 4 '-PP cofactors by acetyl- and short-chain acyl-residues interrupts the biosynthetic system. This repair reaction is very important, because roughly 80% of CoA, the precursor of the 4 '-PP cofactor, is acetylated in bacteria(13). Here we report the three-dimensional structure of a type II thioesterase from Bacillus subtilis free and in complex with a T domain. Comparison with structures of TEI enzymes(3,14) shows the basis for substrate selectivity and the different modes of interaction of TEII and TEI enzymes with T domains. Furthermore, we show that the TEII enzyme exists in several conformations of which only one is selected on interaction with its native substrate, a modified holo-T domain.	[Koglin, Alexander; Loehr, Frank; Bernhard, Frank; Rogov, Vladimir V.; Guentert, Peter; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Koglin, Alexander; Loehr, Frank; Bernhard, Frank; Rogov, Vladimir V.; Guentert, Peter; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance & Cluster Excellence, D-60438 Frankfurt, Germany; [Koglin, Alexander; Frueh, Dominique P.; Strieter, Eric R.; Wagner, Gerhard; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rogov, Vladimir V.] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Russia; [Mofid, Mohammad R.; Marahiel, Mohamed A.] Univ Marburg, Dept Chem Biochem, D-35032 Marburg, Germany; [Guentert, Peter] Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Harvard University; Harvard Medical School; Russian Academy of Sciences; Philipps University Marburg	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany.	Christopher_Walsh@hms.harvard.edu; Marahiel@chemie.uni-marburg.de; VDoetsch@em.uni-frankfurt.de	Güntert, Peter/L-5577-2013; Doetsch, Volker/D-5697-2011; Frueh, Dominique P/A-6462-2008	Güntert, Peter/0000-0002-2911-7574; Frueh, Dominique P/0000-0003-4605-3776; Bernhard, Frank/0000-0002-4860-1783; mofid, mohammad reza/0000-0002-0347-8152; Dotsch, Volker/0000-0001-5720-212X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467, R01GM049338, R01GM020011] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042738-09, R01 AI042738] Funding Source: Medline; NIBIB NIH HHS [P41 EB002026-29, P41 EB002026-30, P41 EB002026-32, P41 EB002026-33, P41 EB002026-31, P41 EB002026] Funding Source: Medline; NIGMS NIH HHS [R01 GM020011-32, P01 GM047467, R01 GM020011, P01 GM047467-170012, R01 GM020011-30, P01 GM047467-15, P01 GM047467-17, P01 GM047467-14, R01 GM020011-37, R01 GM020011-31, P01 GM047467-12, R01 GM049338-17, R01 GM020011-28, R01 GM020011-29, P01 GM047467-16, R01 GM049338, P01 GM047467-160010, R01 GM020011-38, P01 GM047467-110009, P01 GM047467-13, P01 GM047467-160012] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cobas JC, 2003, CONCEPT MAGN RESON A, V19A, P80, DOI 10.1002/cmr.a.10089; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Frueh DP, 2006, J BIOMOL NMR, V34, P31, DOI 10.1007/s10858-005-5338-4; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Johnson MA, 2006, PROTEIN SCI, V15, P1030, DOI 10.1110/ps.051964606; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Kopp F, 2007, NAT PROD REP, V24, P735, DOI 10.1039/b613652b; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; Meier JL, 2006, J AM CHEM SOC, V128, P12174, DOI 10.1021/ja063217n; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Sieber SA, 2003, J AM CHEM SOC, V125, P10862, DOI 10.1021/ja0361852; Steller S, 2004, BIOCHEMISTRY-US, V43, P11331, DOI 10.1021/bi0493416; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	40	101	111	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2008	454	7206					907	U68		10.1038/nature07161	http://dx.doi.org/10.1038/nature07161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336XH	18704089	Green Accepted			2022-12-24	WOS:000258398600041
J	Huang, J; Lesser, CF; Lory, S				Huang, Jin; Lesser, Cammie F.; Lory, Stephen			The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth	NATURE			English	Article							III SECRETION; SACCHAROMYCES-CEREVISIAE; INFECTED CELLS; HELA-CELLS; YEAST; EXPRESSION; BACTERIAL; IDENTIFICATION; TRANSLOCATION; APOPTOSIS	Bacterial virulence determinants can be identified, according to the molecular Koch's postulates(1), if inactivation of a gene associated with a suspected virulence trait results in a loss in pathogenicity. This approach is commonly used with genetically tractable organisms. However, the current lack of tools for targeted gene disruptions in obligate intracellular microbial pathogens seriously hampers the identification of their virulence factors. Here we demonstrate an approach to studying potential virulence factors of genetically intractable organisms, such as Chlamydia. Heterologous expression of Chlamydia pneumoniae CopN in yeast and mammalian cells resulted in a cell cycle arrest, presumably owing to alterations in the microtubule cytoskeleton. A screen of a small molecule library identified two compounds that alleviated CopN-induced growth inhibition in yeast. These compounds interfered with C. pneumoniae replication in mammalian cells, presumably by 'knocking out' CopN function, revealing an essential role of CopN in the support of C. pneumoniae growth during infection. This work demonstrates the role of a specific chlamydial protein in virulence. The chemical biology approach described here can be used to identify virulence factors, and the reverse chemical genetic strategy can result in the identification of lead compounds for the development of novel therapeutics.	[Huang, Jin; Lesser, Cammie F.; Lory, Stephen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lesser, Cammie F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lory, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	stephen_lory@hms.harvard.edu			NIAID NIH HHS [R01 AI064285-03, R01 AI064285] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064285] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2003, METH MOL B; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; CROCKER TT, 1965, J INFECT DIS, V115, P105, DOI 10.1093/infdis/115.2.105; Cross NA, 1999, ANTIMICROB AGENTS CH, V43, P2311, DOI 10.1128/AAC.43.9.2311; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guichon A, 2001, J BACTERIOL, V183, P1269, DOI 10.1128/JB.183.4.1269-1276.2001; Hackstadt T, 1999, CHLAMYDIA, P101; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HOROSCHAK KD, 1978, INFECT IMMUN, V19, P281, DOI 10.1128/IAI.19.1.281-286.1978; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2002, P NATL ACAD SCI USA, V99, P3914, DOI 10.1073/pnas.062578399; Khan MA, 1996, J ANTIMICROB CHEMOTH, V37, P677, DOI 10.1093/jac/37.4.677; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Li D, 2005, J MICROBIOL METH, V61, P17, DOI 10.1016/j.mimet.2004.10.020; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; MILLER RK, 2003, METH MOL B, V241, P341; MOULDER JW, 1982, CHLAMYDIA INFECTI S1, V10, pS10; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Perkins E, 2001, CANCER RES, V61, P4175; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tugendreich S, 2001, GENOME RES, V11, P1899, DOI 10.1101/gr.191601; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Zhang Hong, 2004, Methods Mol Biol, V241, P77	38	52	54	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					112	U10		10.1038/nature07355	http://dx.doi.org/10.1038/nature07355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18830244	Green Accepted			2022-12-24	WOS:000260674000051
J	Feehally, J; Griffith, KE; Lamb, EJ; O'Donoghue, DJ; Tomson, CRV				Feehally, J.; Griffith, K. E.; Lamb, E. J.; O'Donoghue, D. J.; Tomson, C. R. V.			Early detection of chronic kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; POPULATION; MANAGEMENT; EQUATIONS		[Feehally, J.] Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England; [Griffith, K. E.] Wenlock Terrace Surg, York, N Yorkshire, England; [Lamb, E. J.] E Kent Hosp NHS Trust, Canterbury, Kent, England; [O'Donoghue, D. J.] Dept Hlth, London SE1 6TE, England; [O'Donoghue, D. J.] Salford Royal Hosp NHS Trust, Salford, Lancs, England; [Tomson, C. R. V.] N Bristol Hosp NHS Trust, Bristol, Avon, England	University Hospitals of Leicester NHS Trust; University of Leicester; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Feehally, J (corresponding author), Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England.	jf27@le.ac.uk		Tomson, Charles/0000-0002-0224-8726				[Anonymous], 2003, EPIDEMIOLOGY UNINITI; *DEP HLTH, 2004, NAT QUAL REQ DEL OUT, P1; Department of Health, 2005, NAT SERV FRAM LONG T, P1; Giles PD, 2007, BMJ-BRIT MED J, V334, P1198, DOI 10.1136/bmj.39226.400694.80; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; *INF CTR, 2007, NAT QUAL OUTC FRAM S; Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association and the Royal College of General Practitioners, 2006, CHRON KIDN DIS AD UK; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; *KIDN DIS QUAL OUT, 2002, K DOQI CLIN PRACT GU; Klebe B, 2007, NEPHROL DIAL TRANSPL, V22, P2504, DOI 10.1093/ndt/gfm248; Lamb EJ, 2007, AGE AGEING, V36, P689, DOI 10.1093/ageing/afm121; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mathew TH, 2007, MED J AUSTRALIA, V187, P459, DOI 10.5694/j.1326-5377.2007.tb01357.x; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; *NHS EMPL, 2008, QUAL OUTC FRAM; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; Quinn MP, 2008, NEPHROL DIAL TRANSPL, V23, P542, DOI 10.1093/ndt/gfm599; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P549, DOI 10.1093/ndt/gfm857; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; *SCOTT INT GUID NE, 2008, DIAGN MAN CHRON KIDN	21	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1618	10.1136/bmj.a1618	http://dx.doi.org/10.1136/bmj.a1618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18829639				2022-12-24	WOS:000259903300031
J	Holt, TA; Holt, CJ				Holt, Tim A.; Holt, Claire J.			10-minute consultation - Raised blood glucose concentration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Holt, Tim A.] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Holt, Claire J.] Kenyon Med Ctr, Coventry CV3 3AD, W Midlands, England	University of Warwick	Holt, TA (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	tim.holt@warwick.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1073	10.1136/bmj.a1073	http://dx.doi.org/10.1136/bmj.a1073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18818257				2022-12-24	WOS:000259903300039
J	Vakil, N; Vaira, D				Vakil, Nimish; Vaira, Dino			Sequential therapy for Helicobacter pylori - Time to consider making the switch?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIPLE THERAPY; ERADICATION; MANAGEMENT; METAANALYSIS		[Vakil, Nimish] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Vaira, Dino] Univ Bologna, Bologna, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Bologna	Vakil, N (corresponding author), Aurora Med Ctr, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu						Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Duck WM, 2004, EMERG INFECT DIS, V10, P1088, DOI 10.3201/eid1006.030744; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Rinaldi V, 1997, ALIMENT PHARM THERAP, V11, P929, DOI 10.1046/j.1365-2036.1997.00228.x; SANCHEZDELGADO J, AM J GASTROENTEROL, DOI DOI 10.1111/J.1572-0241.2008.01924X; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Vakil N, 2004, ALIMENT PHARM THERAP, V20, P99, DOI 10.1111/j.1365-2036.2004.02029.x; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Van Der Poorten D, 2007, ALIMENT PHARM THER, V26, P1537, DOI 10.1111/j.1365-2036.2007.03531.x; Wu DC, 2008, GASTROENTEROLOGY, V134, pA24; Zullo A, 2007, GUT, V56, P1353, DOI 10.1136/gut.2007.125658	15	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1346	1347		10.1001/jama.300.11.1346	http://dx.doi.org/10.1001/jama.300.11.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799448				2022-12-24	WOS:000259231100031
J	Goldfine, AB				Goldfine, Allison B.			Assessing the cardiovascular safety of diabetes therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldfine, Allison B.] Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goldfine, AB (corresponding author), Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA.			Goldfine, Allison/0000-0002-0345-1048				Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; KLIMT CR, 1970, DIABETES, V19, P747; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987	5	85	86	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1092	1095		10.1056/NEJMp0805758	http://dx.doi.org/10.1056/NEJMp0805758			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784098				2022-12-24	WOS:000259078200004
J	Wheeler, TD; Stroock, AD				Wheeler, Tobias D.; Stroock, Abraham D.			The transpiration of water at negative pressures in a synthetic tree	NATURE			English	Article							SYSTEM; CAVITATION; RESISTANCE; CAPILLARY; TRANSPORT; SUCTION; PLANTS	Plant scientists believe that transpiration - the motion of water from the soil, through a vascular plant, and into the air - occurs by a passive, wicking mechanism. This mechanism is described by the cohesion- tension theory: loss of water by evaporation reduces the pressure of the liquid water within the leaf relative to atmospheric pressure; this reduced pressure pulls liquid water out of the soil and up the xylem to maintain hydration(1-3). Strikingly, the absolute pressure of the water within the xylem is often negative, such that the liquid is under tension and is thermodynamically metastable with respect to the vapour phase(1,4). Qualitatively, this mechanism is the same as that which drives fluid through the synthetic wicks that are key elements in technologies for heat transfer(5), fuel cells(6,7) and portable chemical systems(8-10). Quantitatively, the differences in pressure generated in plants to drive flow can be more than a hundredfold larger than those generated in synthetic wicks. Here we present the design and operation of a microfluidic system formed in a synthetic hydrogel. This synthetic 'tree' captures the main attributes of transpiration in plants: transduction of subsaturation in the vapour phase of water into negative pressures in the liquid phase, stabilization and flow of liquid water at large negative pressures (-1.0 MPa or lower), continuous heat transfer with the evaporation of liquid water at negative pressure, and continuous extraction of liquid water from subsaturated sources. This development opens the opportunity for technological uses of water under tension and for new experimental studies of the liquid state of water.	[Wheeler, Tobias D.; Stroock, Abraham D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University	Stroock, AD (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	ads10@cornell.edu		Stroock, Abraham/0000-0002-8145-9977	Office of Naval Research Young Investigator Program; Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF); Nanobiotechnology Center; STC Program of the NSF [ECS-98767710]; Cornell Center for Materials Research; NSF [DMR- 0520404]	Office of Naval Research Young Investigator Program(Office of Naval Research); Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); Nanobiotechnology Center; STC Program of the NSF; Cornell Center for Materials Research; NSF(National Science Foundation (NSF))	We thank M. A. Zwieniecki, N. M. Holbrook, P. J. Melcher, C. Cohen, K. J. Niklas, C. Cottin- Bizonne, A. Lassiter and F. Caupin for discussions and suggestions. Wethank G. Swan and E. Velez- Rosa for technical assistance with experiments. Support was provided by the Office of Naval Research Young Investigator Program and the Camille and Henry Dreyfus Foundation. T. D. W. acknowledges partial support by a graduate fellowship from the Corning Foundation. The experiments made use of the following facilities: Cornell NanoScale Science and Technology Facility (a member of the National Nanotechnology Infrastructure Network, supported by the National Science Foundation (NSF)), the Nanobiotechnology Center ( supported by the STC Program of the NSF under Agreement No. ECS-98767710) and the Cornell Center for Materials Research ( supported by the NSF under Award No. DMR- 0520404).	Arce A, 2004, PHYS CHEM CHEM PHYS, V6, P103, DOI 10.1039/b307996a; ASKENASY E, 1896, VERH NATURH MED VER, V5, P429; Aybar HS, 2005, DESALINATION, V180, P285, DOI 10.1016/j.desal.2005.01.009; Bohm, 1893, BER DEUT BOT GES, V11, P203; BRINKER CJ, 1989, SOL GEL SCI PHYS CHE; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Chen J, 2004, J POWER SOURCES, V131, P155, DOI 10.1016/j.jpowsour.2004.01.007; De Paula J., 2002, ATKINS PHYS CHEM; Debenedetti P. G., 1996, METASTABLE LIQUIDS; Dixon H., 1894, PHILOS T ROYAL SOC B, V186, P563, DOI DOI 10.1098/RSTB.1895.0012; Effenhauser CS, 2002, BIOMED MICRODEVICES, V4, P27, DOI 10.1023/A:1014215728074; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; Flory P, 1955, PRINCIPLES POLYM CHE; Guan Y, 1997, CAN GEOTECH J, V34, P604, DOI 10.1139/t97-014; Guan YX, 2006, TALANTA, V68, P1384, DOI 10.1016/j.talanta.2005.08.021; HAYWARD ATJ, 1970, NATURE, V225, P376, DOI 10.1038/225376b0; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449; Karan K, 2007, ELECTROCHEM SOLID ST, V10, pB34, DOI 10.1149/1.2398728; Machin WD, 1998, CAN J CHEM, V76, P1578, DOI 10.1139/cjc-76-11-1578; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nobel P., 1999, PHYSICOCHEMICAL ENV, V2nd; Peterson G.P., 1994, INTRO HEAT PIPES; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; THUT HIRAM F., 1928, OHIO JOUR SCI, V28, P292; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175	28	340	350	21	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					208	212		10.1038/nature07226	http://dx.doi.org/10.1038/nature07226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784721				2022-12-24	WOS:000259090800043
J	Mukhopadhyay, J; Das, K; Ismail, S; Koppstein, D; Jang, MY; Hudson, B; Sarafianos, S; Tuske, S; Patel, J; Jansen, R; Irschik, H; Arnold, E; Ebright, RH				Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Jansen, Rolf; Irschik, Herbert; Arnold, Eddy; Ebright, Richard H.			The RNA Polymerase "Switch Region" Is a Target for Inhibitors	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; MYXOPYRONIN-B ANALOGS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GLIDING BACTERIA; BINDING; HOLOENZYME; ANTIBIOTICS; ELONGATION; INITIATION	The alpha-pyrone antibiotic myxopyronin (Myx) inhibits bacterial RNA polymerase (RNAP). Here, through a combination of genetic, biochemical, and structural approaches, we show that Myx interacts with the RNAP "switch region''-the hinge that mediates opening and closing of the RNAP active center cleft-to prevent interaction of RNAP with promoter DNA. We define the contacts between Myx and RNAP and the effects of Myx on RNAP conformation and propose that Myx functions by interfering with opening of the RNAP active-center cleft during transcription initiation. We further show that the structurally related alpha-pyrone antibiotic corallopyronin (Cor) and the structurally unrelated macrocyclic-lactone antibiotic ripostatin (Rip) function analogously to Myx. The RNAP switch region is distant from targets of previously characterized RNAP inhibitors, and, correspondingly, Myx, Cor, and Rip do not exhibit crossresistance with previously characterized RNAP inhibitors. The RNAP switch region is an attractive target for identification of	[Das, Kalyan; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Mukhopadhyay, Jayanta; Das, Kalyan; Ismail, Sajida; Koppstein, David; Jang, Minyoung; Hudson, Brian; Sarafianos, Stefan; Tuske, Steven; Patel, Jay; Arnold, Eddy; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Jansen, Rolf; Irschik, Herbert] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Rutgers State University New Brunswick; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Helmholtz Association; Helmholtz-Center for Infection Research	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	arnold@cabm.rutgers.edu; ebright@mbcl.rutgers.edu	Das, Kalyan/O-9224-2019; Jansen, Rolf/C-1570-2011; Das, Kalyan/B-2967-2018; Ebright, Richard/O-3321-2019	Das, Kalyan/0000-0002-8897-324X; Jansen, Rolf/0000-0002-3592-4807; Das, Kalyan/0000-0002-8897-324X; Ebright, Richard/0000-0001-8915-7140; Sarafianos, Stefan G/0000-0002-5840-154X; Koppstein, David/0000-0002-8618-7237	NIH [AI072766, GM41376]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041376, R01GM041376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Chakraborty, N. Connell, S. Darst, Y. Korlann, C. Self, Y. Sun, G. Olson, M. Talaue, D. Wang, X. Wang, A. Wasmuth, and S. Weiss for unpublished data and G. Hofle, M. Kalesse, and E. Sineva for discussion. This work was supported by NIH grant AI072766 to R. H. E. and E. A., NIH grant GM41376 to R. H. E., and a Howard Hughes Medical Investigatorship to R. H.	AUGUSTINIAK H, 1996, LIEBIGS ANN CHEM, V10, P1657; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2007, CURR OPIN INVEST DR, V8, P600; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2004, TRENDS BIOCHEM SCI, V29, P159, DOI 10.1016/j.tibs.2004.02.005; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Doundoulakis T, 2004, BIOORG MED CHEM LETT, V14, P5667, DOI 10.1016/j.bmcl.2004.08.045; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; Hu T, 1998, J ORG CHEM, V63, P2401, DOI 10.1021/jo9721610; IRSCHIK H, 1995, J ANTIBIOT, V48, P787, DOI 10.7164/antibiotics.48.787; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; IRSCHIK H, 1985, J ANTIBIOT, V38, P145, DOI 10.7164/antibiotics.38.145; JANSEN R, 1985, LIEBIGS ANN CHEM, P822; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KOHL W, 1983, LIEBIGS ANN CHEM, P1656; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; O'Neill A, 2000, ANTIMICROB AGENTS CH, V44, P3163, DOI 10.1128/AAC.44.11.3163-3166.2000; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; TRIPATARA A, 1993, J MOL BIOL, V233, P349, DOI 10.1006/jmbi.1993.1516; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	38	178	197	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					295	307		10.1016/j.cell.2008.09.033	http://dx.doi.org/10.1016/j.cell.2008.09.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957204	Green Accepted, Bronze			2022-12-24	WOS:000260130400019
J	Graves, N; McGowan, JE				Graves, Nicholas; McGowan, John E., Jr.			Nosocomial Infection, the Deficit Reduction Act, and incentives for hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; PREVENTION; ECONOMICS; SAFETY		[Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [McGowan, John E., Jr.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Queensland University of Technology (QUT); Emory University; Rollins School Public Health	Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave,Kelvin Grove Urban Village, Kelvin Grove, Qld 4059, Australia.	n.graves@qut.edu.au	Graves, Nicholas/A-3052-2011; mcgowan, john e/G-5404-2011	Graves, Nicholas/0000-0002-5559-3267				Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P767, DOI 10.1086/518518; [Anonymous], 2007, EXTENDING CURE POLIC; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Centers for Medicare and Medicaid Services, 2008, FED REGISTER, V73, P48434; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Davis MM, 2008, INFECT CONT HOSP EP, V29, P395, DOI 10.1086/587966; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Persson U, 1999, ACTA ORTHOP SCAND, V70, P163, DOI 10.3109/17453679909011256; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Zell BL, 2007, INFECT CONT HOSP EP, V28, P261, DOI 10.1086/513722	14	33	34	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1577	1579		10.1001/jama.300.13.1577	http://dx.doi.org/10.1001/jama.300.13.1577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827214				2022-12-24	WOS:000259617700022
J	Hochman, M; Hochman, S; Bor, D; McCormick, D				Hochman, Michael; Hochman, Steven; Bor, David; McCormick, Danny			News media coverage of medication research - Reporting pharmaceutical company funding and use of generic medication names	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	New England Regional Meeting of the Society-General-Internal-Medicine	APR   14, 2008	Worcester, MA	Soc Gen Internal Med, New England Reg			CONFLICTS-OF-INTEREST; BIOMEDICAL-RESEARCH; DRUG NAMES; TRIALS; BRAND; SUBSTITUTION; ASSOCIATION; CONCLUSIONS; DISCLOSURE; JOURNALS	Context The news media are an important source of information about medical research for patients and even some physicians. Little is known about how frequently news articles report when medication research has received funding from pharmaceutical companies or how frequently news articles use generic vs brand medication names. Objectives To assess the reporting of pharmaceutical company funding and generic medication name use in news articles about medication studies and to determine the views of newspaper editors about these issues. Design, Setting, and Participants We reviewed US news articles from newspaper and online sources about all pharmaceutical company - funded medication studies published in the 5 most prominent general medical journals between April 1, 2004, and April 30, 2008. We also surveyed editors at the 100 most widely circulated newspapers in the United States. Main Outcome Measures The percentage of news articles indicating when studies have been pharmaceutical company - funded and the percentage that refer to medications by their generic vs brand names. Also the percentage of newspaper editors who indicate that their articles report pharmaceutical company funding; the percentage of editors who indicate that their articles refer to medications by generic names; and the percentage of newspapers with policies about these issues. Results Of the 306 news articles about medication research identified, 130 ( 42%; 95% confidence interval [ CI], 37%- 48%) did not report that the research had received company funding. Of the 277 of these articles reporting on medications with both generic and brand names, 186 ( 67%; 95% CI, 61%- 73%) referred to the study medications by their brand names in at least half of the medication references. Eighty-two of the 93 ( 88%) newspaper editors who responded to our survey reported that articles from their publications always or often indicated when studies had received company funding ( 95% CI, 80%- 94%), and 71 of 92 ( 77%) responding editors also reported that articles from their publications always or often referred to medications by the generic names ( 95% CI, 67%- 85%). However, only 3 of 92 newspapers ( 3%) had written policies stating that company funding sources of medical studies be reported ( 95% CI 1%- 9%), and 2 of 93 ( 2%) newspapers had written policies stating that medications should be referred to by their generic names ( 95% CI 1%- 8%). Conclusion News articles reporting on medication studies often fail to report pharmaceutical company funding and frequently refer to medications by their brand names despite newspaper editors' contention that this is not the case.	[Hochman, Michael; Bor, David; McCormick, Danny] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; [Hochman, Michael; Bor, David; McCormick, Danny] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Hochman, Steven] Pomona Coll, Claremont, CA 91711 USA	Harvard University; Cambridge Health Alliance; Harvard University; Claremont Colleges; Pomona College	Hochman, M (corresponding author), Cambridge Hosp, Dept Med, 1493 Cambridge St, Cambridge, MA 02139 USA.	miehochman@challiance.org						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P305; Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; *ASS HLTH CAR JOUR, STAT PRINC; *AUD BUR CIRC, 2006, FAS FAX REP MAJ US N; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bromley J, 2006, MED J AUSTRALIA, V185, P687, DOI 10.5694/j.1326-5377.2006.tb00767.x; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V286, P89, DOI 10.1001/jama.286.1.89; Gundersen L, 1998, ANN INTERN MED, V129, P677, DOI 10.7326/0003-4819-129-8-199810150-00042; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; HENRY J, 2001, PRESCRIPTION DRUG TR; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; *I SAF MED PRACT, 2003, DRAFT GUID SAF EL CO, V8; *INT COMM MED J ED, 2007, UN REQ MAN SUBM BIOM; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; *LEAD DIR INC, 2007, NEWS MED YELL BOOK; Li M, 2008, HEALTH EDUC RES, V23, P543, DOI 10.1093/her/cym028; LIEBERMAN T, 2005, COLUMBIA JOURNAL JUL; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *NAT I HLTH CAR MA, 2002, PRIM GEN DRUGS PAT P; PARKER WA, 1983, AM J HOSP PHARM, V40, P38, DOI 10.1093/ajhp/40.1.38; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Schwab M, 2002, ARCH INTERN MED, V162, P1065, DOI 10.1001/archinte.162.9.1065; Schwartz RS, 2008, NEW ENGL J MED, V358, P1850, DOI 10.1056/NEJMe0802618; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Steinman MA, 2007, J GEN INTERN MED, V22, P645, DOI 10.1007/s11606-006-0074-3; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; 2006, NATL J CITATION REPO	34	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1544	1550		10.1001/jama.300.13.1544	http://dx.doi.org/10.1001/jama.300.13.1544			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827211				2022-12-24	WOS:000259617700018
J	Brusatte, SL; Benton, MJ; Ruta, M; Lloyd, GT				Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.			Superiority, competition, and opportunism in the evolutionary radiation of dinosaurs	SCIENCE			English	Article							TRIASSIC-JURASSIC BOUNDARY; DISPARITY; DIVERSIFICATION; PATTERNS	The rise and diversification of the dinosaurs in the Late Triassic, from 230 to 200 million years ago, is a classic example of an evolutionary radiation with supposed competitive replacement. A comparison of evolutionary rates and morphological disparity of basal dinosaurs and their chief "competitors," the crurotarsan archosaurs, shows that dinosaurs exhibited lower disparity and an indistinguishable rate of character evolution. The radiation of Triassic archosaurs as a whole is characterized by declining evolutionary rates and increasing disparity, suggesting a decoupling of character evolution from body plan variety. The results strongly suggest that historical contingency, rather than prolonged competition or general " superiority," was the primary factor in the rise of dinosaurs.	[Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Brusatte, SL (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	brusatte@uchicago.edu	Lloyd, Graeme/F-6677-2010; Lloyd, Graeme/E-1798-2011; Benton, Michael J/A-5639-2008; Brusatte, Stephen/O-9663-2014	Benton, Michael J/0000-0002-4323-1824; Brusatte, Stephen/0000-0001-7525-7319; Ruta, Marcello/0000-0002-6151-0704	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council; Royal Society; Natural Environment Research Council [NE/C518973/1] Funding Source: researchfish; NERC [NE/C518973/1] Funding Source: UKRI	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Benson, M. Coates, P. Donoghue, M. Foote, M. LaBarbera, and S. Wang for discussion. Supported by the Marshall Scholarship and Paleontological Society (S.L.B.), the UK Natural Environment Research Council (M.J.B., M.R., G.T.L.), and the Royal Society (M.J.B., M.R.).	BAKKER RT, 1971, EVOLUTION, V25, P636, DOI 10.1111/j.1558-5646.1971.tb01922.x; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; BENTON MJ, 1987, BIOL REV, V62, P305, DOI 10.1111/j.1469-185X.1987.tb00666.x; CHARIG AJ, 1984, S ZOOL SOC LONDON, V52, P597; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; FOOTE M, 1996, EVOLUTIONARY PALEOBI; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Wagner PJ, 1997, PALEOBIOLOGY, V23, P115, DOI 10.1017/S0094837300016675; Weishampel DB., 2004, DINOSAURIA; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	21	316	322	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1485	1488		10.1126/science.1161833	http://dx.doi.org/10.1126/science.1161833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787166	Green Submitted, Green Accepted			2022-12-24	WOS:000259121800039
J	Lette, F; Dwyer, JP				Lette, Francois; Dwyer, Jamie P.			The fluid craze	LANCET			English	Editorial Material							HYPONATREMIA		[Lette, Francois; Dwyer, Jamie P.] Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA	Mayo Clinic	Lette, F (corresponding author), Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA.	lette.francois@mayo.edu	Dwyer, Jamie/A-4799-2015	Dwyer, Jamie/0000-0002-8402-8961				Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Bleser S, 2005, J FAM PRACTICE, V54, P691; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Chung BD, 1999, J CLIN GASTROENTEROL, V28, P29, DOI 10.1097/00004836-199901000-00006; COLERIDGESMITH PD, 1990, BRIT J SURG, V77, P1055, DOI 10.1002/bjs.1800770933; COMEROTA AJ, 1989, SURGERY, V106, P301; Decaux G, 2006, AM J MED, V119, pS79, DOI 10.1016/j.amjmed.2006.05.013; *I MED, 2005, DIET REF INT DRI WAT; JANVRIN SB, 1980, BRIT J SURG, V67, P690, DOI 10.1002/bjs.1800671004; Kurlansky M, 2003, SALT WORLD HIST; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; Lindeman RD, 2000, J GERONTOL A-BIOL, V55, pM361, DOI 10.1093/gerona/55.7.M361; Longe AC, 1997, E AFR MED J, V74, P487; Negoianu D, 2008, J AM SOC NEPHROL, V19, P1041, DOI 10.1681/ASN.2008030274; Noakes TD, 2006, BRIT J SPORT MED, V40, P567, DOI 10.1136/bjsm.2005.020354; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003	17	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					782	784		10.1016/S0140-6736(08)61316-1	http://dx.doi.org/10.1016/S0140-6736(08)61316-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774404				2022-12-24	WOS:000259124900006
J	Bouzigon, E; Corda, E; Aschard, H; Dizier, MH; Boland, A; Bousquet, J; Chateigner, N; Gormand, F; Just, J; Le Moual, N; Scheinmann, P; Siroux, V; Vervloet, D; Zelenika, D; Pin, I; Kauffmann, F; Lathrop, M; Demenais, F				Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Dizier, Marie-Helene; Boland, Anne; Bousquet, Jean; Chateigner, Nicolas; Gormand, Frederic; Just, Jocelyne; Le Moual, Nicole; Scheinmann, Pierre; Siroux, Valerie; Vervloet, Daniel; Zelenika, Diana; Pin, Isabelle; Kauffmann, Francine; Lathrop, Mark; Demenais, Florence			Effect of 17q21 Variants and Smoking Exposure in Early-Onset Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CHILDHOOD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; ORMDL3 EXPRESSION; CHILDRENS HEALTH; LUNG-FUNCTION; GENE; ASSOCIATION; LIFE; POLYMORPHISM	Background: A genomewide association study has shown an association between variants at chromosome 17q21 and an increased risk of asthma. To elucidate the relationship between this locus and disease, we examined a large, family-based data set that included extensive phenotypic and environmental data from the Epidemiological Study on the Genetics and Environment of Asthma. Methods: We tested 36 single-nucleotide polymorphisms (SNPs) in the 17q21 region in 1511 subjects from 372 families for an association with asthma. We also tested for genetic heterogeneity according to the age at the onset of asthma and exposure to environmental tobacco smoke in early life. Results: Eleven SNPs were significantly associated with asthma (P<0.01), of which three (rs8069176, rs2305480, and rs4795400) were strongly associated (P<0.001). Ordered-subset regression analysis led us to select an onset at 4 years of age or younger to classify patients as having early-onset asthma. Association with early-onset asthma was highly significant (P<10(-5) for four SNPs), whereas no association was found with late-onset asthma. With respect to exposure to environmental tobacco smoke in early life, we observed a significant association with early-onset asthma only in exposed subjects (P<5 x 10(-5) for six SNPs). Under the best-fitting recessive model, homozygous status (GG) at the most strongly associated SNP (rs8069176) conferred an increase in risk by a factor of 2.9, as compared with other genotypes (AG and AA) in the group exposed to environmental tobacco smoke (P=2.8 x 10(-6); P=0.006 for the test for heterogeneity of the SNP effect on early-onset asthma between groups with tobacco exposure and those without such exposure). Conclusions: This study shows that the increased risk of asthma conferred by 17q21 genetic variants is restricted to early-onset asthma and that the risk is further increased by early-life exposure to environmental tobacco smoke. These findings provide a greater understanding of the functional role of the 17q21 variants in the pathophysiology of asthma.	[Bouzigon, Emmanuelle; Corda, Eve; Aschard, Hugues; Chateigner, Nicolas; Lathrop, Mark; Demenais, Florence] Fdn Jean Dausset, CEPH, INSERM, U794, F-75010 Paris, France; [Bouzigon, Emmanuelle; Aschard, Hugues; Chateigner, Nicolas; Demenais, Florence] Univ Evry, Evry, France; [Dizier, Marie-Helene] INSERM, U535, Villejuif, France; [Dizier, Marie-Helene; Le Moual, Nicole; Kauffmann, Francine] Univ Paris 11, Villejuif, France; [Boland, Anne; Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, CEA, Inst Genom, Evry, France; [Bousquet, Jean] Hop Arnaud de Villeneuve, Montpellier, France; [Gormand, Frederic] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France; [Just, Jocelyne] Hop Enfants Armand Trousseau, Paris, France; [Le Moual, Nicole; Kauffmann, Francine] INSERM, U780, Villejuif, France; [Scheinmann, Pierre] Hop Necker Enfants Malad, Paris, France; [Siroux, Valerie; Pin, Isabelle] INSERM, U823, Grenoble, France; [Vervloet, Daniel] Hop St Marguerite, Marseille, France; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France	Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite de Montpellier; CHU de Montpellier; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Demenais, F (corresponding author), Fdn Jean Dausset, CEPH, INSERM, U794, 27 Rue Juliette Dodu, F-75010 Paris, France.	demenais@inserm.fr	Le Moual, Nicole/GNP-5114-2022; siroux, valerie/N-1865-2013; Bouzigon, Emmanuelle/L-2766-2017; GORMAND, FREDERIC/I-1414-2017; PIN, Isabelle/N-3020-2013; Le Moual, Nicole/R-8976-2016; Dizier, Marie-Hélène/K-8463-2018; Demenais, Florence/G-3298-2013	Le Moual, Nicole/0000-0002-2723-5569; siroux, valerie/0000-0001-7329-7237; Bouzigon, Emmanuelle/0000-0001-5756-4286; Le Moual, Nicole/0000-0002-2723-5569; Dizier, Marie-Hélène/0000-0001-8460-7667; Demenais, Florence/0000-0001-8361-0936	INSERM; French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research [ANR 05-SEST-020-02/05-9-97, ANR 06-CEBS]; European Commission as part of the Global Allergy and Asthma European Network [FOOD-CT-2004-506378]; GABRIEL consortium; Glaxo SmithKline; Stallergenes; Allerbio; Astra Zeneca; UCB	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Higher Education and Research; University of Evry; French Agency for Environmental and Occupational Health Safety; Afsset-APR-SE-2004; French National Agency for Research(French National Research Agency (ANR)); European Commission as part of the Global Allergy and Asthma European Network(European CommissionEuropean Commission Joint Research Centre); GABRIEL consortium; Glaxo SmithKline(GlaxoSmithKline); Stallergenes; Allerbio; Astra Zeneca(AstraZeneca); UCB(UCB Pharma SA)	Supported by INSERM, the French Ministry of Higher Education and Research, and the University of Evry and by grants from the French Agency for Environmental and Occupational Health Safety (Afsset-APR-SE-2004), the French National Agency for Research (ANR 05-SEST-020-02/05-9-97 and ANR 06-CEBS), and the European Commission as part of the Global Allergy and Asthma European Network (FOOD-CT-2004-506378) and the GABRIEL consortium (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community; HEALTH-LSH-2005-018996). Dr. Vervloet reports receiving lecture fees from Glaxo SmithKline, Stallergenes, and Allerbio and consulting fees from Astra Zeneca, GlaxoSmithKline, Allerbio, and UCB. No other potential conflict of interest relevant to this article was reported.	Barrett R, 2008, J MOTOR BEHAV, V40, P62, DOI 10.3200/JMBR.40.1.62-70; Choudhry S, 2005, AM J RESP CRIT CARE, V172, P173, DOI 10.1164/rccm.200409-1232OC; Colilla S, 2003, J ALLERGY CLIN IMMUN, V111, P840, DOI 10.1067/mai.2003.170; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dizier MH, 2007, EUR J HUM GENET, V15, P810, DOI 10.1038/sj.ejhg.5201830; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Hashimoto Shu, 2008, Allergol Int, V57, P21, DOI 10.2332/allergolint.R-07-156; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Holgate ST, 2007, EUR RESPIR J, V29, P793, DOI 10.1183/09031936.00087506; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Katoh M, 2003, INT J MOL MED, V12, P399; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Kurukulaaratchy RJ, 2004, PEDIATRICS, V113, P345, DOI 10.1542/peds.113.2.345; Kurukulaaratchy RJ, 2003, CLIN EXP ALLERGY, V33, P573, DOI 10.1046/j.1365-2222.2003.01657.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lowe LA, 2005, AM J RESP CRIT CARE, V171, P231, DOI 10.1164/rccm.200406-695OC; Madore AM, 2008, HUM GENET, V123, P93, DOI 10.1007/s00439-007-0444-x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Meyers DA, 2005, J ALLERGY CLIN IMMUN, V115, P1169, DOI 10.1016/j.jaci.2005.01.070; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; Schmitt C, 2002, APOPTOSIS, V7, P277, DOI 10.1023/A:1015372322419; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Siroux V, 2004, EUR J EPIDEMIOL, V19, P841, DOI 10.1023/B:EJEP.0000040528.89863.59; Stein Renato T, 2004, Paediatr Respir Rev, V5, P155, DOI 10.1016/j.prrv.2004.01.007; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Toren K, 2006, J CLIN EPIDEMIOL, V59, P90, DOI 10.1016/j.jclinepi.2005.03.019; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Wang ZX, 2001, AM J RESP CRIT CARE, V163, P1404, DOI 10.1164/ajrccm.163.6.2001101; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	38	275	285	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 6	2008	359	19					1985	1994		10.1056/NEJMoa0806604	http://dx.doi.org/10.1056/NEJMoa0806604			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368OW	18923164				2022-12-24	WOS:000260632700003
J	He, WZ; Ladinsky, MS; Huey-Tubman, KE; Jensen, GJ; McIntosh, JR; Bjorkman, PJ				He, Wanzhong; Ladinsky, Mark S.; Huey-Tubman, Kathryn E.; Jensen, Grant J.; McIntosh, J. Richard; Bjorkman, Pamela J.			FcRn-mediated antibody transport across epithelial cells revealed by electron tomography	NATURE			English	Article							CLATHRIN-COATED VESICLES; RAT-KIDNEY CELL; INTESTINAL TRANSPORT; FREEZE-SUBSTITUTION; IMMUNOGLOBULIN-G; NEONATAL RAT; 3 DIMENSIONS; YOUNG-RAT; RECEPTOR; FUSION	The neonatal Fc receptor ( FcRn) transports maternal IgG across epithelial barriers(1,2), thereby providing the fetus or newborn with humoral immunity before its immune system is fully functional. In newborn rats, FcRn transfers IgG from milk to blood by apical-to-basolateral transcytosis across intestinal epithelial cells. The pH difference between the apical ( pH 6.0-6.5) and basolateral ( pH 7.4) sides of intestinal epithelial cells facilitates the efficient unidirectional transport of IgG, because FcRn binds IgG at pH 6.0-6.5 but not at pH 7 or more(1,2). As milk passes through the neonatal intestine, maternal IgG is removed by FcRn-expressing cells in the proximal small intestine ( duodenum and jejunum); remaining proteins are absorbed and degraded by FcRn- negative cells in the distal small intestine ( ileum)(3-6). Here we use electron tomography to make jejunal transcytosis visible directly in space and time, developing new labelling and detection methods to map individual nanogold-labelled Fc within transport vesicles(7) and simultaneously to characterize these vesicles by immunolabelling. Combining electron tomography with a nonperturbing endocytic label allowed us to conclusively identify receptor- bound ligands, resolve interconnecting vesicles, determine whether a vesicle was microtubule- associated, and accurately trace FcRn- mediated transport of IgG. Our results present a complex picture in which Fc moves through networks of entangled tubular and irregular vesicles, only some of which are microtubuleassociated, as it migrates to the basolateral surface. New features of transcytosis are elucidated, including transport involving multivesicular body inner vesicles/ tubules and exocytosis through clathrin- coated pits. Markers for early, late and recycling endosomes each labelled vesicles in different and overlapping morphological classes, revealing spatial complexity in endo- lysosomal trafficking.	[He, Wanzhong; Huey-Tubman, Kathryn E.; Jensen, Grant J.; Bjorkman, Pamela J.] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; [Huey-Tubman, Kathryn E.; Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [He, Wanzhong] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ladinsky, Mark S.; McIntosh, J. Richard] Univ Colorado, Boulder Lab 3D Elect Microscopy Cells, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; National University of Singapore; University of Colorado System; University of Colorado Boulder	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	McIntosh, Richard/GLN-3533-2022		National Institutes of Health [2 R37 AI041239-06A1, RR000592]; Max Planck Research Award; Gordon and Betty Moore Foundation; Agouron Institute; Caltech; National University of Singapore [R-154-000-339-133]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Research Award(Max Planck Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Agouron Institute(Pfizer); Caltech; National University of Singapore(National University of Singapore); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Mastronarde for advice about setting up SerialEM on the Caltech microscopes and three- dimensional modelling; C. Kivork for preparing Au-Fc and Au-dextran; B. Tivol for assistance with electron microscopes; M. Murphy for help with schematic figures; M. Morphew for contributions to silver enhancement methods; Y. Nie, A. Feuerabendt, A. Kules, C. Luna, K. McKenzie, R. Sander and L. Zinn-Bjorkman for segmenting tomograms; J. Vielmetter for SPR studies of Au-Fc; and F. Brodsky, F. Maxfield, S. Schmid and D. Tesar for discussions. This work was supported by the National Institutes of Health (2 R37 AI041239-06A1 to P.J.B. and RR000592 to J.R.M.), a Max Planck Research Award (P.J.B.), gifts from the Gordon and Betty Moore Foundation and the Agouron Institute to support electron microscopy at Caltech, and National University of Singapore AcRF start-up funds (R-154-000-339-133 to W.H.).	ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V143, P408, DOI 10.1098/rspb.1955.0020; He WZ, 2007, J STRUCT BIOL, V160, P103, DOI 10.1016/j.jsb.2007.07.004; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 2007, METHOD CELL BIOL, V79, P543, DOI 10.1016/S0091-679X(06)79021-5; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCarthy KM, 2000, J CELL SCI, V113, P1277; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Morphew M, 2008, J MICROSC-OXFORD, V230, P263, DOI 10.1111/j.1365-2818.2008.01983.x; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1970, J CELL BIOL, V45, P635, DOI 10.1083/jcb.45.3.635; RODEWALD R, 1973, J CELL BIOL, V58, P189, DOI 10.1083/jcb.58.1.189; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x	37	122	131	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					542	U53		10.1038/nature07255	http://dx.doi.org/10.1038/nature07255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818657	Green Accepted			2022-12-24	WOS:000259449600048
J	Heidemann, C; Sun, Q; van Dam, RM; Meigs, JB; Zhang, CL; Tworoger, SS; Mantzoros, CS; Hu, FB				Heidemann, Christin; Sun, Qi; van Dam, Rob M.; Meigs, James B.; Zhang, Cuilin; Tworoger, Shelley S.; Mantzoros, Christos S.; Hu, Frank B.			Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; SERUM RESISTIN; PLASMA RESISTIN; ADIPOSE-TISSUE; OLDER MEN; MELLITUS; OBESITY; HUMANS	Background: Adiponectin and resistin are recently discovered adipokines that may provide a molecular link between adiposity and type 2 diabetes. Objective: To evaluate whether total and high-molecular-weight adiponectin and resistin are associated with future risk for type 2 diabetes, independent of obesity and other known diabetes risk factors. Design: Prospective, nested, case - control study. Setting: United States. Participants: 1038 initially healthy women of the Nurses' Health Study who developed type 2 diabetes after blood sampling (1989 to 1990) through 2002 and 1136 matched control participants. Measurements: Plasma concentrations of total and high-molecular-weight adiponectin and resistin. Results: In multivariate models including body mass index, higher total and high-molecular-weight adiponectin levels were associated with a substantially lower risk for type 2 diabetes (odds ratio [OR] comparing the highest with the lowest quintiles, 0.17 [95% CI, 0.12 to 0.25] for total adiponectin and 0.10 [CI, 0.06 to 0.15] for high-molecular-weight adiponectin). A higher ratio of high-molecular-weight to total adiponectin was associated with a statistically significantly lower risk even after adjustment for total adiponectin (OR, 0.45 [CI, 0.31 to 0.65]). In the multivariate model without body mass index, higher resistin levels were associated with a higher risk for diabetes (OR, 1.68 [CI, 1.25 to 2.25]), but the association was no longer statistically significant after adjustment for body mass index (OR, 1.28 [CI, 0.93 to 1.76]). Limitation: The findings apply mainly to white women and could be partly explained by residual confounding from imperfectly measured or unmeasured variables. Conclusion: Adiponectin is strongly and inversely associated with risk for diabetes, independent of body mass index, whereas resistin is not. The ratio of high-molecular-weight to total adiponectin is related to risk for diabetes independent of total adiponectin, suggesting an important role of the relative proportion of high-molecular-weight adiponectin in diabetes pathogenesis.	Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02215 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013; van Dam, Rob M/F-9674-2010; Mantzoros, Christos/Y-2902-2019; Meigs, James/P-3927-2019	van Dam, Rob M/0000-0002-7354-8734; Meigs, James/0000-0002-2439-2657; Tworoger, Shelley/0000-0002-6986-7046; Zhang, Cuilin/0000-0002-8014-2708	National Institute of Child Health & Human Development [CA87969, DK58845, DK58785]; German Academic Exchange Service; Hans & Eugenia Juetting Foundation; American Diabetes; Tanita Corporation; Beth Israel Deaconess Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, R56DK058785, R01DK058785, K24DK080140] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Hans & Eugenia Juetting Foundation; American Diabetes(American Diabetes Association); Tanita Corporation; Beth Israel Deaconess Medical Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health and the Intramural Research Program of the National Institute of Child Health & Human Development (grants CA87969, DK58845 and DK58785). Dr. Heidemann was supported by fellowships of the German Academic Exchange Service and the Hans & Eugenia Juetting Foundation. Dr. Meigs received a Career Development Award from the American Diabetes. Dr. Mantzoros was supported by discretionary grants from the Tanita Corporation and Beth Israel Deaconess Medical Center.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Harithy RN, 2005, ANN SAUDI MED, V25, P283, DOI 10.5144/0256-4947.2005.283; Bayes B, 2007, AM J TRANSPLANT, V7, P416, DOI 10.1111/j.1600-6143.2006.01646.x; Bluher M, 2007, DIABETES CARE, V30, P280, DOI 10.2337/dc06-1362; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chanchay S, 2006, INT J VITAM NUTR RES, V76, P125, DOI 10.1024/0300-9831.76.3.125; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; de Courten BV, 2004, DIABETES, V53, P1279, DOI 10.2337/diabetes.53.5.1279; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P201; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Heilbronn LK, 2004, J CLIN ENDOCR METAB, V89, P1844, DOI 10.1210/jc.2003-031410; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Knobler H, 2006, EUR J ENDOCRINOL, V154, P87, DOI 10.1530/eje.1.02054; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Lu HL, 2006, WORLD J GASTROENTERO, V12, P1747, DOI 10.3748/wjg.v12.i11.1747; McTernan PG, 2006, CURR OPIN LIPIDOL, V17, P170, DOI 10.1097/01.mol.0000217899.59820.9a; Mitchell M, 2005, REPRODUCTION, V130, P583, DOI 10.1530/rep.1.00521; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Norata GD, 2007, EUR J ENDOCRINOL, V156, P279, DOI 10.1530/eje.1.02338; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Schulze MB, 2005, DIABETIC MED, V22, P1178, DOI 10.1111/j.1464-5491.2005.01585.x; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Snijder MB, 2006, DIABETES CARE, V29, P2498, DOI 10.2337/dc06-0952; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tokuyama Y, 2007, METABOLISM, V56, P693, DOI 10.1016/j.metabol.2006.12.019; Utzschneider KM, 2005, DIABETOLOGIA, V48, P2330, DOI 10.1007/s00125-005-1932-y; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Yaturu S, 2006, CYTOKINE, V34, P219, DOI 10.1016/j.cyto.2006.05.005; Youn BS, 2004, J CLIN ENDOCR METAB, V89, P150, DOI 10.1210/jc.2003-031121	48	163	174	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 2	2008	149	5					307	W66		10.7326/0003-4819-149-5-200809020-00005	http://dx.doi.org/10.7326/0003-4819-149-5-200809020-00005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SD	18765700	Green Accepted			2022-12-24	WOS:000259229300003
J	Fosarelli, P				Fosarelli, Pat			Medicine, spirituality, and patient care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Ecumen Inst Theol, Baltimore, MD 21210 USA		Fosarelli, P (corresponding author), Ecumen Inst Theol, 5400 Roland Ave, Baltimore, MD 21210 USA.	pfosarelli@stmarys.edu						Curlin FA, 2007, ARCH INTERN MED, V167, P649, DOI 10.1001/archinte.167.7.649; *JOINT COMM, 2004, SPIR ASS; KOENIG H, 2007, SPIRITUALITY PATIENT, pCH1; Koenig HG, 2002, JAMA-J AM MED ASSOC, V288, P487, DOI 10.1001/jama.288.4.487; Mueller PS, 2001, MAYO CLIN PROC, V76, P1225, DOI 10.4065/76.12.1225; Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129; Silverman M. E., 2003, THE QUOTABLE OSLER	7	16	18	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2008	300	7					836	838		10.1001/jama.300.7.836	http://dx.doi.org/10.1001/jama.300.7.836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338VM	18714065				2022-12-24	WOS:000258537500025
J	Hopkins, BB; Paull, TT				Hopkins, Ben B.; Paull, Tanya T.			The P-furiosus Mre11/Rad50 Complex Promotes 5 ' Strand Resection at a DNA Double-Strand Break	CELL			English	Article							HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITIES; MRE11 COMPLEX; RECBCD ENZYME; SBCCD PROTEIN; REPAIR; RAD50; HELICASE; CHECKPOINT; BINDING	The Mre11/Rad50 complex has been implicated in the early steps of DNA double-strand break (DSB) repair through homologous recombination in several organisms. However, the enzymatic properties of this complex are incompatible with the generation of 30 single-stranded DNA for recombinase loading and strand exchange. In thermophilic archaea, the Mre11 and Rad50 genes cluster in an operon with genes encoding a helicase, HerA, and a 50 to 30 exonuclease, NurA, suggesting a common function. Here we show that purified Mre11 and Rad50 from Pyrococcus furiosus act cooperatively with HerA and NurA to resect the 50 strand at a DNA end under physiological conditions in vitro. The 30 single-stranded DNA generated by these enzymes can be utilized by the archaeal RecA homolog RadA to catalyze strand exchange. This work elucidates how the conserved Mre11/Rad50 complex promotes DNA end resection in archaea and may serve as a model for DSB processing in eukaryotes.	[Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Hopkins, Ben B.; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu		Paull, Tanya/0000-0002-2991-651X	NIH [R01 CA094008]; DOD; NATIONAL CANCER INSTITUTE [R01CA094008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to J. Carney for the P. furiosus Mre11/Rad50 expression plasmid, to L. Symington for personal communication of unpublished results, and to members of the Paull lab for comments about this project. This work was supported by NIH grant R01 CA094008 and DOD predoctoral fellowship to B. B.	ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arthur LM, 2004, NUCLEIC ACIDS RES, V32, P1886, DOI 10.1093/nar/gkh343; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Doherty AJ, 2001, FEBS LETT, V500, P186, DOI 10.1016/S0014-5793(01)02589-3; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Kondo N, 2008, EXTREMOPHILES, V12, P217, DOI 10.1007/s00792-007-0118-6; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Seitz EM, 2001, ADV APPL MICROBIOL, V50, P101, DOI 10.1016/S0065-2164(01)50005-2; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Zhang ST, 2008, DNA REPAIR, V7, P380, DOI 10.1016/j.dnarep.2007.10.010; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	49	125	129	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					250	260		10.1016/j.cell.2008.09.054	http://dx.doi.org/10.1016/j.cell.2008.09.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957200	Green Accepted, Bronze			2022-12-24	WOS:000260130400015
J	Tsukazaki, T; Mori, H; Fukai, S; Ishitani, R; Mori, T; Dohmae, N; Perederina, A; Sugita, Y; Vassylyev, DG; Ito, K; Nureki, O				Tsukazaki, Tomoya; Mori, Hiroyuki; Fukai, Shuya; Ishitani, Ryuichiro; Mori, Takaharu; Dohmae, Naoshi; Perederina, Anna; Sugita, Yuji; Vassylyev, Dmitry G.; Ito, Koreaki; Nureki, Osamu			Conformational transition of Sec machinery inferred from bacterial SecYE structures	NATURE			English	Article							TRANSLOCATION ATPASE SECA; PROTEIN-TRANSLOCATION; PREPROTEIN TRANSLOCATION; MEMBRANE; CHANNEL; COMPLEX; COMPONENTS; PARALLEL; DOMAIN; PHASE	Over 30% of proteins are secreted across or integrated into membranes. Their newly synthesized forms contain either cleavable signal sequences or non- cleavable membrane anchor sequences, which direct them to the evolutionarily conserved Sec translocon (SecYEG in prokaryotes and Sec61, comprising alpha-, gamma- and beta-subunits, in eukaryotes). The translocon then functions as a protein-conducting channel(1). These processes of protein localization occur either at or after translation. In bacteria, the SecA ATPase(2,3) drives post- translational translocation. The only high- resolution structure of a translocon available so far is that for SecYE beta from the archaeon Methanococcus jannaschii(4), which lacks SecA. Here we present the 3.2- A-resolution crystal structure of the SecYE translocon from a SecA- containing organism, Thermus thermophilus. The structure, solved as a complex with an anti- SecY Fab fragment, revealed a 'pre-open' state of SecYE, in which several transmembrane helices are shifted, as compared to the previous SecYEb structure(4), to create a hydrophobic crack open to the cytoplasm. Fab and SecA bind to a common site at the tip of the cytoplasmic domain of SecY. Molecular dynamics and disulphide mapping analyses suggest that the pre- open state might represent a SecYE conformational transition that is inducible by SecA binding. Moreover, we identified a SecA - SecYE interface that comprises SecA residues originally buried inside the protein, indicating that both the channel and the motor components of the Sec machinery undergo cooperative conformational changes on formation of the functional complex.	[Tsukazaki, Tomoya; Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Kanagawa 2268501, Japan; [Mori, Hiroyuki; Ito, Koreaki] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Div Struct Biol, Dept Basic Med Sci, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Dohmae, Naoshi] RIKEN, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, CREST JST, Wako, Saitama 3510198, Japan; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Tokyo Institute of Technology; Kyoto University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); RIKEN; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nureki, O (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	Koreaki.Ito@ky5.ecs.kyoto-u.ac.jp; nureki@ims.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; Vassylyev, Dmitry/A-9005-2008; Mori, Takaharu/AAH-1234-2021; Tsukazaki, Tomoya/N-2299-2019; Sugita, Yuji/L-6726-2014; Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014	Dohmae, Naoshi/0000-0002-5242-9410; Tsukazaki, Tomoya/0000-0002-6386-723X; Sugita, Yuji/0000-0001-9738-9216; Fukai, Shuya/0000-0002-1241-1443; Mori, Hiroyuki/0000-0002-0429-1269	SORST program; CREST; BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine); National Project on Protein Structural and Functional Analyses; NIH; MEXT; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [20247020] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840, R01GM074252] Funding Source: NIH RePORTER	SORST program; CREST(Core Research for Evolutional Science and Technology (CREST)); BIRD; Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Inaba, Y. Akiyama and M. Hattori for useful suggestions about sample preparation and crystallization; T. Sakamoto and T. Saika for their assistance in the purification of T. thermophilus SecYE; K. Mochizuki, M. Sano, K. Yoshikaie, T. Adachi and Y. Echizen for technical support; and the beamline staff members at BL41XU of SPring- 8 ( Sayo, Japan) and NW12 of PF ( Tsukuba, Japan) for technical help during data collection. We also thank I. Artsimovitch for critically reading the manuscript. This work was supported by a SORST program grant from JST ( Japan Science and Technology) to O. N., by a CREST grant from JST to K. I. and N. D., by a BIRD grant from JST to H. M. and Y. S., by Global COE Program (Center of Education and Research for Advanced Genome-Based Medicine) and a grant for the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology ( MEXT) to O. N., by NIH grants to D. G. V., by grants from MEXT to H.M, S.F., R.I., K.I. and O.N., and by Mitsubishi Foundation grants to O.N.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2003, J BACTERIOL, V185, P405, DOI 10.1128/JB.185.2.405-412.2003; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Shindo N, 1997, ANAL BIOCHEM, V249, P79, DOI 10.1006/abio.1997.2155; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Vassylyeva MN, 2006, ACTA CRYSTALLOGR F, V62, P909, DOI 10.1107/S1744309106030843; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	43	177	184	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					988	U72		10.1038/nature07421	http://dx.doi.org/10.1038/nature07421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923527	Green Accepted			2022-12-24	WOS:000260038300055
J	Watts, G				Watts, Geoff			What happened to the polypill?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE					geoff@scileg.freeserve.co.uk						Rodgers A, 2003, BMJ-BRIT MED J, V326, P1407, DOI 10.1136/bmj.326.7404.1407; *U AUCKL CLIN TRIA, 2008, PILL PIL PROGR IMPR; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	3	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1822	10.1136/bmj.a1822	http://dx.doi.org/10.1136/bmj.a1822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18819953				2022-12-24	WOS:000259798000030
J	Katz, MH				Katz, Mitchell H.			Banning tobacco sales in pharmacies - The right prescription	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING; ACCEPTABILITY; CIGARETTES; ADULTS		[Katz, Mitchell H.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	mitch.katz@sfdph.org						Albers AB, 2004, TOB CONTROL, V13, P347, DOI 10.1136/tc.2003.007336; Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; BRANDECKER M, NY PHARM COULD BANNE; *CAL MED ASS FDN, 2000, PRESCR CHANG CAL REA; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; DAVIS RM, 1992, TOB CONTROL, V1, P84; Eule B, 2004, TOB CONTROL, V13, P429, DOI 10.1136/tc.2004.007872; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; Fong, 2008, WALL STREET J, pB1; Hudmon KS, 2006, TOB CONTROL, V15, P35, DOI 10.1136/tc.2005.012278; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; NATION NI, 2008, MARIN INDEPENDE 0801; *NCI, MON NCI, V19; SCHROEDER SA, 1978, AM J PUBLIC HEALTH, V68, P494, DOI 10.2105/AJPH.68.5.494; TAYLOR MC, BANNING CIGARETTE SA	15	24	24	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1451	1453		10.1001/jama.300.12.1451	http://dx.doi.org/10.1001/jama.300.12.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812536				2022-12-24	WOS:000259410400023
J	Clark, AM; Thompson, DR				Clark, Alexander M.; Thompson, David R.			The future of management programmes for heart failure	LANCET			English	Editorial Material									[Clark, Alexander M.] Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada; [Thompson, David R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Thompson, David R.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Alberta; University of Leicester; University of Leicester	Clark, AM (corresponding author), Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada.	Alex.Clark@ualberta.ca	Thompson, David R/C-6320-2009; Thompson, David R/E-2431-2018	Thompson, David R/0000-0001-8518-6307; Clark, Alexander/0000-0002-2860-0492				Clark AM, 2007, HEALTH-LONDON, V11, P513, DOI 10.1177/1363459307080876; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Holland R, 2007, BRIT MED J, V334, P1098, DOI 10.1136/bmj.39164.568183.AE; Jaarsma T, 2008, ARCH INTERN MED, V168, P316, DOI 10.1001/archinternmed.2007.83; Ledwidge M, 2005, EUR J HEART FAIL, V7, P385, DOI 10.1016/j.ejheart.2004.10.022; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Nguyen V, 2007, J CARD FAIL, V13, P287, DOI 10.1016/j.cardfail.2007.01.002; Nucifora G, 2006, J CARDIOVASC MED, V7, P614, DOI 10.2459/01.JCM.0000237910.34000.58; Smith B, 2005, AM J MANAG CARE, V11, P701; Taylor S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub2; Tilley, 1997, REALISTIC EVALUATION; Yu DSF, 2006, EUR HEART J, V27, P596, DOI 10.1093/eurheartj/ehi656	13	36	41	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					784	786		10.1016/S0140-6736(08)61317-3	http://dx.doi.org/10.1016/S0140-6736(08)61317-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774405				2022-12-24	WOS:000259124900007
J	Ogata, H; Claverie, JM				Ogata, Hiroyuki; Claverie, Jean-Michel			Microbiology - How to infect a mimivirus	SCIENCE			English	Editorial Material							VIRUSES; PATTERN		[Ogata, Hiroyuki; Claverie, Jean-Michel] Univ Aix Marseille 2, Struct & Genom Informat Lab, CNRS, UPR 2589,IFR 88, FR-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ogata, H (corresponding author), Univ Aix Marseille 2, Struct & Genom Informat Lab, CNRS, UPR 2589,IFR 88, Parc Sci Luminy, FR-13288 Marseille, France.	ogata@igs.cnrs-mrs.fr; jean-michel.claverie@univmed.fr	Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019	Claverie, Jean-Michel/0000-0003-1424-0315				Abergel C, 2007, J VIROL, V81, P12406, DOI 10.1128/JVI.01107-07; Allen MJ, 2006, J VIROL, V80, P7699, DOI 10.1128/JVI.00491-06; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; Claverie JM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-110; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; La Scola B, 2003, SCIENCE, V299, P2033; LASCOLA B, 2008, NATURE; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3599, DOI 10.1128/AEM.71.7.3599-3607.2005; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Ogata H, 2007, GENOME RES, V17, P1353, DOI 10.1101/gr.6358607; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114	14	11	11	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1305	1306		10.1126/science.1164839	http://dx.doi.org/10.1126/science.1164839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772426				2022-12-24	WOS:000258914300036
J	Holtzer, R; Verghese, J; Wang, CL; Hall, CB; Lipton, RB				Holtzer, Roee; Verghese, Joe; Wang, Cuiling; Hall, Charles B.; Lipton, Richard B.			Within-person across-neuropsychological test variability and incident dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD COGNITIVE IMPAIRMENT; INTRAINDIVIDUAL VARIABILITY; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; PERFORMANCE; DIAGNOSIS; GAIT; PREVALENCE; PREDICTION; INCREASES	Context Neuropsychological tests are used to predict and diagnose dementia. However, to our knowledge, no studies to date have examined whether within-person across-neuropsychological test variability predicts dementia. Objective To examine whether within-person across-neuropsychological test variability predicts future dementia. Design The Einstein Aging Study (EAS) is a population-based longitudinal study of aging and dementia located in Bronx County, New York. We used Cox proportional hazards models using age as the time scale to estimate hazard ratios (HRs) for performance on individual neuropsychological tests (Free and Cued Selective Reminding Test, Digit Symbol Substitution subtest of the Wechsler Adult Intelligence Scale Revised, and the Vocabulary subtest of the Wechsler Adult Intelligence Scale Revised) and for within-person across-neuropsychological test variability as predictors of incident dementia. Analyses were stratified by sex, and controlled for education and medical illness. Setting and Participants A total of 1797 participants (age >= 70 years) enrolled in the EAS between October 1993 and December 2007. Participants seen for the baseline visit only (n = 750), prevalent dementia cases (n = 72), and those with missing follow-up information (n = 78) were excluded. A total of 897 individuals were included in this investigation. Participants had follow-up visits every 12 to 18 months. Main Outcome Measure Incident dementia. Results Sixty-one cases of incident dementia were identified during follow-up (mean [SD], 3.3 [2.4] years), of which 26 were in the highest quartile of within-person across-neuropsychological test variability. Adjusting for sex, education, and medical illness, variability was associated with incident dementia (HR for 1-point difference in variability, 3.93 [95% confidence interval {Cl}, 2.04-7.56]). The association persisted even after adjusting for level of performance on individual neuropsychological tests (HR for 1-point difference in variability, 2.10 [95% Cl, 1.04-4.23]). Comparing Cox models using neuropsychological tests with and without within-person across-neuropsychological test variablity showed that the former improved the prediction of dementia. Sensitivity in a model predicting dementia at 1 year also improved when neuropsychological test variability was included. Conclusions In this population, within-person across-neuropsychological test variability was associated with development of incident dementia independent of neuropsychological test performance. This finding needs to be confirmed in future studies.	[Holtzer, Roee; Verghese, Joe; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wang, Cuiling; Hall, Charles B.; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Holtzer, Roee] Yeshiva Univ Albert Einstein Coll Med, Ferkauf Grad Sch Psychol, Bronx, NY 10461 USA; [Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Holtzer, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Rousso Bldg,Room 306,1165 Morris Pk Ave, Bronx, NY 10461 USA.	rholtzer@aecom.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Lipton, Richard B/B-5060-2011; Hall, Charles B./AAX-8216-2020	Hall, Charles/0000-0001-9982-8120; Holtzer, Roee/0000-0001-6639-0724	National Institute on Aging [AGO3949, K23 AG030857, AG025119]; NATIONAL INSTITUTE ON AGING [K23AG030857, P01AG003949, R01AG025119] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Einstein Aging Study is supported by the National Institute on Aging program project grant AGO3949. Dr Holtzer is supported by the National Institute on Aging Paul B. Beeson Award K23 AG030857. Dr Verghese is supported by the National Institute on Aging grant AG025119.	Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bischkopf J, 2002, ACTA PSYCHIAT SCAND, V106, P403, DOI 10.1034/j.1600-0447.2002.01417.x; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Collie A, 2002, J CLIN EXP NEUROPSYC, V24, P720, DOI 10.1076/jcen.24.6.720.8397; Crystal HA, 2000, ARCH NEUROL-CHICAGO, V57, P713, DOI 10.1001/archneur.57.5.713; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuld PA., 1978, ALZHEIMERS DIS SENIL, V7, P185; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Grober E, 2000, NEUROLOGY, V54, P827, DOI 10.1212/WNL.54.4.827; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hall CB, 2001, STAT MED, V20, P3695, DOI 10.1002/sim.1113; Hall CB, 2003, COMPUT STAT DATA AN, V42, P91, DOI 10.1016/S0167-9473(02)00148-2; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kliegel M, 2004, GERONTOLOGY, V50, P39, DOI 10.1159/000074388; KNOTEK PC, 1990, BRAIN LANG, V38, P465, DOI 10.1016/0093-934X(90)90131-Y; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li SC, 2004, GERONTOLOGY, V50, P28, DOI 10.1159/000074386; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; MASUR DM, 1994, NEUROLOGY, V44, P1427, DOI 10.1212/WNL.44.8.1427; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McPherson SE, 1996, BRAIN COGNITION, V31, P269, DOI 10.1006/brcg.1996.0045; Mitrushina M., 2005, HDB NORMATIVE DATA N; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Potter G.G., 2006, GERIATRIC NEUROPSYCH, P5; Prifitera A., 1989, PSYCHOL ASSESSMENT J, V1, P186, DOI [https://doi.org/10.1037/1040-3590.1.3.186, DOI 10.1037/1040-3590.1.3.186]; Salthouse TA, 2007, NEUROPSYCHOLOGY, V21, P401, DOI 10.1037/0894-4105.21.4.401; Sarazin M, 2007, NEUROLOGY, V69, P1859, DOI 10.1212/01.wnl.0000279336.36610.f7; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Silvey S.D., 1975, REPRINTING MONOGRAPH; Sliwinski M, 1997, J Int Neuropsychol Soc, V3, P317; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Stuss DT, 1999, NEUROPSYCHOLOGIA, V37, P1005, DOI 10.1016/S0028-3932(98)00158-4; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Verghese J, 1999, NEUROLOGY, V53, P1974, DOI 10.1212/WNL.53.9.1974; Verghese J, 2004, AGE AGEING, V33, P628, DOI 10.1093/ageing/afh210; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; West R, 2001, EUR J COGN PSYCHOL, V13, P91, DOI 10.1080/09541440042000232	56	155	154	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2008	300	7					823	830		10.1001/jama.300.7.823	http://dx.doi.org/10.1001/jama.300.7.823			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338VM	18714062	Bronze, Green Accepted			2022-12-24	WOS:000258537500022
J	Okita, K; Nakagawa, M; Hong, HJ; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Nakagawa, Masato; Hong, Hyenjong; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; EFFICIENT; MYC	Induced pluripotent stem ( iPS) cells have been generated from mouse and human somatic cells by introducing Oct3/4 and Sox2 with either Klf4 and c-Myc or Nanog and Lin28 using retroviruses or lentiviruses. Patient- specific iPS cells could be useful in drug discovery and regenerative medicine. However, viral integration into the host genome increases the risk of tumorigenicity. Here, we report the generation of mouse iPS cells without viral vectors. Repeated transfection of two expression plasmids, one containing the complementary DNAs ( cDNAs) of Oct3/4, Sox2, and Klf4 and the other containing the c- Myc cDNA, into mouse embryonic fibroblasts resulted in iPS cells without evidence of plasmid integration, which produced teratomas when transplanted into mice and contributed to adult chimeras. The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine.	[Okita, Keisuke; Nakagawa, Masato; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Nakagawa, Masato; Hong, Hyenjong; Yamanaka, Shinya] Kyoto Univ, Dept Stem Cell Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Project, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp		Okita, Keisuke/0000-0001-5806-1090				Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	1439	1737	5	581	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					949	953		10.1126/science.1164270	http://dx.doi.org/10.1126/science.1164270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18845712				2022-12-24	WOS:000260674100049
J	Keown, P; Mercer, G; Scott, J				Keown, Patrick; Mercer, Gavin; Scott, Jan			Retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and number of psychiatric beds in England 1996-2006	BRITISH MEDICAL JOURNAL			English	Article							CARE; REINSTITUTIONALISATION	Objective To analyse the number of voluntary and involuntary (detentions under the Mental Health Act 1983) admissions for mental disorders between 1996 and 2006 in England. Design Retrospective analysis. Setting England. Main outcome measures Number of voluntary and involuntary admissions for mental disorders in England's health service, number of involuntary admissions to private beds, and number of NHS beds for patients with mental disorders or learning disabilities. Results Admissions for mental disorders in the NHS in England peaked in 1998 and then started to fall. Reductions in admissions were confined to patients with depression, learning disabilities, or dementia. Admissions for schizophrenic and manic disorders did not change whereas those for drug and alcohol problems increased. The number of NHS psychiatric beds decreased by 29%. The total number of involuntary admissions per annum increased by 20%, with a threefold increase in the likelihood of admission to a private facility. Patients admitted involuntarily occupied 23% of NHS psychiatric beds in 1996 but 36% in 2006. Conclusions Psychiatric inpatient care changed considerably in the decade from 1996 to 2006, with more involuntary admissions to fewer NHS beds. The case mix has shifted further towards psychotic and substance misuse disorders, which has changed the milieu of inpatient wards. Increasing proportions of involuntary patients were admitted to private facilities.	[Keown, Patrick; Mercer, Gavin] NHS Ctr, E Community Mental Hlth Team, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England; [Scott, Jan] Royal Victoria Infirm, Univ Dept Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Keown, P (corresponding author), NHS Ctr, E Community Mental Hlth Team, Molineux St, Newcastle Upon Tyne NE6 1SG, Tyne & Wear, England.	p.j.keown@newcastle.ac.uk	Scott, Jan/F-2966-2010	Scott, Jan/0000-0002-7203-8601				Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; *DEP HLTH, 2006, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; *INF CTR, 2007, INP FORM DET HOSP ME; JOHNSON S, 2005, BRIT MED J, V331, P4; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Priebe S, 2003, BRIT MED J, V326, P175, DOI 10.1136/bmj.326.7382.175; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520	9	48	48	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1837	10.1136/bmj.a1837	http://dx.doi.org/10.1136/bmj.a1837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18845592	Green Published, hybrid			2022-12-24	WOS:000260298800035
J	Boyer, P				Boyer, Pascal			Religion: Bound to believe?	NATURE			English	Editorial Material									[Boyer, Pascal] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Boyer, Pascal] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Boyer, P (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	pboyer@wustl.edu							0	102	104	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1038	1039		10.1038/4551038a	http://dx.doi.org/10.1038/4551038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	363FG	18948934	Bronze			2022-12-24	WOS:000260252600019
J	Galiana, G; Branca, RT; Jenista, ER; Warren, WS				Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren			Accurate temperature imaging based on intermolecular coherences in magnetic resonance	SCIENCE			English	Article							PROTON CHEMICAL-SHIFT; SOLUTION NMR; INHOMOGENEOUS FIELDS; QUANTUM COHERENCES; HIGH-RESOLUTION; HYPERTHERMIA; WATER; SPECTROSCOPY; THERMOMETRY; LIPOSOMES	Conventional magnetic resonance methods that provide interior temperature profiles, which find use in clinical applications such as hyperthermic therapy, can develop inaccuracies caused by the inherently inhomogeneous magnetic field within tissues or by probe dynamics, and work poorly in important applications such as fatty tissues. We present a magnetic resonance method that is suitable for imaging temperature in a wide range of environments. It uses the inherently sharp resonances of intermolecular zero-quantum coherences, in this case flipping up a water spin while flipping down a nearby fat spin. We show that this method can rapidly and accurately assign temperatures in vivo on an absolute scale.	[Galiana, Gigi; Branca, Rosa T.; Jenista, Elizabeth R.; Warren, S. Warren] Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA; [Galiana, Gigi] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Duke University; Princeton University	Warren, WS (corresponding author), Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA.	warren.warren@duke.edu		Branca, Rosa Tamara/0000-0002-6871-1824	NIH [EB2122, EB5979]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122, F31EB005979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH grants EB2122 and EB5979. We thank M. Dewhirst for useful discussions.	Boss A, 2005, J MAGN RESON IMAGING, V22, P813, DOI 10.1002/jmri.20438; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; De Senneville BD, 2005, INT J HYPERTHER, V21, P515, DOI 10.1080/02656730500133785; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Faber C, 2003, J MAGN RESON, V161, P265, DOI 10.1016/S1090-7807(03)00006-5; Gaber MH, 1996, INT J RADIAT ONCOL, V36, P1177, DOI 10.1016/S0360-3016(96)00389-6; Galiana G, 2005, J AM CHEM SOC, V127, P17574, DOI 10.1021/ja054463m; Gellermann J, 2005, INT J HYPERTHER, V21, P497, DOI 10.1080/02656730500070102; HE QH, 1993, J CHEM PHYS, V98, P6779, DOI 10.1063/1.464770; Hehr T, 2003, ONKOLOGIE, V26, P295, DOI 10.1159/000071628; Hekmatyar SK, 2005, MAGN RESON MED, V53, P294, DOI 10.1002/mrm.20345; HINDMAN JC, 1966, J CHEM PHYS, V44, P4582, DOI 10.1063/1.1726676; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Jones EL, 2005, J CLIN ONCOL, V23, P3079, DOI 10.1200/JCO.2005.05.520; Kong G, 2000, CANCER RES, V60, P4440; Kuroda K, 2000, MAGNET RESON MED, V43, P220, DOI 10.1002/(SICI)1522-2594(200002)43:2<220::AID-MRM8>3.0.CO;2-9; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Lin YY, 2000, SCIENCE, V290, P118, DOI 10.1126/science.290.5489.118; McDannold N, 2004, RADIOLOGY, V230, P743, DOI 10.1148/radiol.2303021713; Needham D, 2000, CANCER RES, V60, P1197; Peters RD, 1999, MAGNET RESON MED, V41, P909, DOI 10.1002/(SICI)1522-2594(199905)41:5<909::AID-MRM9>3.0.CO;2-N; Raaphorst GP, 1990, INTRO PRACTICAL ASPE, P10; Rieke V, 2004, MAGNET RESON MED, V51, P1223, DOI 10.1002/mrm.20090; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; WARREN WS, 1993, SCIENCE, V262, P2005, DOI 10.1126/science.8266096; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652; [No title captured]; [No title captured]	32	54	56	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					421	424		10.1126/science.1163242	http://dx.doi.org/10.1126/science.1163242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927389	Green Accepted, Green Submitted			2022-12-24	WOS:000260094500041
J	Erlandson, KJ; Miller, SBM; Nam, Y; Osborne, AR; Zimmer, J; Rapoport, TA				Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.			A role for the two-helix finger of the SecA ATPase in protein translocation	NATURE			English	Article							ESCHERICHIA-COLI; PORE RESIDUES; CHANNEL; MEMBRANE; COMPLEX; MEDIATE; RECOGNITION; PROTEOLYSIS; HYDROLYSIS; PEPTIDASE	An important step in the biosynthesis of many proteins is their partial or complete translocation across the plasma membrane in prokaryotes or the endoplasmic reticulum membrane in eukaryotes(1). In bacteria, secretory proteins are generally translocated after completion of their synthesis by the interaction of the cytoplasmic ATPase SecA and a protein- conducting channel formed by the SecY complex(2). How SecA moves substrates through the SecY channel is unclear. However, a recent structure of a SecA - SecY complex raises the possibility that the polypeptide chain is moved by a two- helix finger domain of SecA that is inserted into the cytoplasmic opening of the SecY channel(3). Here we have used disulphide- bridge cross-linking to show that the loop at the tip of the two- helix finger of Escherichia coli SecA interacts with a polypeptide chain right at the entrance into the SecY pore. Mutagenesis demonstrates that a tyrosine in the loop is particularly important for translocation, but can be replaced by some other bulky, hydrophobic residues. We propose that the two- helix finger of SecA moves a polypeptide chain into the SecY channel with the tyrosine providing the major contact with the substrate, a mechanism analogous to that suggested for hexameric, protein- translocating ATPases.	[Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Erlandson, Karl J.; Miller, Stephanie B. M.; Nam, Yunsun; Osborne, Andrew R.; Zimmer, Jochen; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Zimmer, Jochen/0000-0002-8423-2882; Nam, Yunsun/0000-0002-7939-8626	NIH; Damon Runyon Cancer Research Foundation [DRG 1953-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. DeLaBarre and B. Burton for critical reading of the manuscript, and R. Sauer, T. Baker and A. Horwich for discussion. The work was supported by an NIH grant. T.A.R. is a HHMI investigator. Y.N. was supported by the Damon Runyon Cancer Research Foundation (DRG 1953-07)	Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; JAROSIK GP, 1991, J BACTERIOL, V173, P860, DOI 10.1128/jb.173.2.860-868.1991; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; MATSUYAMA S, 1990, J BIOL CHEM, V265, P8760; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	27	105	107	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					984	U67		10.1038/nature07439	http://dx.doi.org/10.1038/nature07439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923526	Green Accepted, Green Submitted			2022-12-24	WOS:000260038300054
J	Walsh, M; Spurling, G				Walsh, Maie; Spurling, Geoffrey			Aspirin in type 2 diabetes: is there any evidence base?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; PRIMARY PREVENTION; RANDOMIZED TRIALS; METAANALYSIS; MELLITUS; DISEASE		[Spurling, Geoffrey] Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia; [Walsh, Maie] Univ Queensland, Royal Brisbane Hosp, Herston, Qld 4029, Australia	Royal Brisbane & Women's Hospital; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Spurling, G (corresponding author), Univ Queensland, Royal Brisbane Hosp, Discipline Gen Practice, Brisbane, Qld 4072, Australia.	g.spurling@uq.edu.au	Spurling, Geoffrey K/F-1783-2010	Spurling, Geoffrey K/0000-0002-3525-4663				Ajjan R, 2008, DIABETOLOGIA, V51, P385, DOI 10.1007/s00125-007-0898-3; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BUSE J, 1997, DIABETES CARE, V20, P1767; De Berardis G, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-21; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; Halushka MK, 2002, CIRCULATION, V105, P1620, DOI 10.1161/01.CIR.0000015422.86569.52; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; *MACR DIS EXP WORK, 2001, PREV DET MACR DIS TY; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; RYDEN L, EUR HEART J, V28, P88; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265	14	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2008	337								a1902	10.1136/bmj.a1902	http://dx.doi.org/10.1136/bmj.a1902			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374FF	18927174				2022-12-24	WOS:000261027900002
J	Jacobsen, SJ; Cheetham, TC; Haque, R; Shi, JM; Loo, RK				Jacobsen, Steven J.; Cheetham, T. Craig; Haque, Reina; Shi, Jiaxiao M.; Loo, Ronald K.			Association between 5-alpha reductase inhibition and risk of hip fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; BENIGN PROSTATIC HYPERPLASIA; FINASTERIDE; MEN; TESTOSTERONE	Context For more than 15 years, 5-alpha reductase inhibitors, which block the conversion of testosterone to dihydrotestosterone, have been used in the treatment of benign prostatic hyperplasia ( BPH). Short- term studies show no effects of these agents on bone metabolism, but long- term data are not available. Objective To assess the association between use of 5-alpha reductase inhibitors ( eg, finasteride) for BPH and occurrence of hip fracture. Design, Setting, and Patients Population- based case- control study using data from Kaiser Permanente Southern California, a managed care organization with more than 3 million members. Case patients included 7076 men 45 years and older with incident hip fracture from 1997- 2006. Control patients were 7076 men without incident hip fracture, optimally matched at a 1: 1 ratio to case patients on age and medical center. Electronic information on pharmaceutical use was used to identify use of finasteride from 1991 forward. Results Overall, 2547 ( 36%) and 2488 ( 35%) case and control patients, respectively, had a diagnosis of BPH ( P=. 30), and 109 ( 1.5%) and 141 ( 2.0%) of case and control patients, respectively, had been exposed to finasteride prior to the index date ( matched odds ratio, 0.77; 95% confidence interval, 0.59- 1.00; P=. 04). There was no suggestion of a dose- response relationship between exposure to 5- alpha reductase inhibitors when the exposure was stratified into tertiles of total exposure ( P=. 12). By contrast, there was a slightly higher prevalence of alpha-blocker use in case vs control patients ( 32% vs 30%, respectively; P=. 04). Conclusions Exposure to 5-alpha reductase inhibitors was not associated with increased risk of hip fracture. The reduction in risk observed with exposure to 5-alpha reductase inhibitors and the modest increase in risk associated with exposure to alpha-blockers require replication and warrant further investigation.	[Jacobsen, Steven J.; Haque, Reina; Shi, Jiaxiao M.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA 91101 USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Downey, CA USA; [Loo, Ronald K.] Kaiser Permanente So Calif, Dept Urol, Bellflower Med Ctr, Bellfower, CA USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Jacobsen, SJ (corresponding author), Kaiser Permanente So Calif, Dept Res & Evaluat, 100 S Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	steven.j.jacobsen@kp.org		Jacobsen, Steven/0000-0002-8174-8533	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	Kaiser Foundation Community Benefit; Southern California Permanente Medical Group	This study was supported through the Kaiser Foundation Community Benefit fund and the Southern California Permanente Medical Group.	Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Andriole G, 2004, J UROLOGY, V172, P1399, DOI 10.1097/01.ju.0000139539.94828.29; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Bergstralh EJ, 1996, EPIDEMIOLOGY, V7, P331; CastroMagana M, 1996, J ANDROL, V17, P516; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayman Ralph V, 2005, J Urol, V173, P1200; COLVARD DS, 1989, P NATL ACAD SCI USA, V86, P854, DOI 10.1073/pnas.86.3.854; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Djavan B, 1999, EUR UROL, V36, P1, DOI 10.1159/000019919; Issa S, 2002, J CLIN ENDOCR METAB, V87, P5401, DOI 10.1210/jc.2001-011902; JACOBSEN SJ, 1995, ARCH INTERN MED, V155, P477, DOI 10.1001/archinte.155.5.477; JACOBSEN SJ, 1990, AM J PUBLIC HEALTH, V80, P871, DOI 10.2105/AJPH.80.7.871; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Matsumoto AM, 2002, J UROLOGY, V167, P2105, DOI 10.1016/S0022-5347(05)65095-1; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; SANDLER RB, 1987, CALCIFIED TISSUE INT, V41, P65; Sobel V, 2006, J CLIN ENDOCR METAB, V91, P3017, DOI 10.1210/jc.2005-2809; Somjen D, 2007, J STEROID BIOCHEM, V107, P238, DOI 10.1016/j.jsbmb.2007.03.048; Tollin SR, 1996, J CLIN ENDOCR METAB, V81, P1031, DOI 10.1210/jc.81.3.1031; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe	22	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1660	1664		10.1001/jama.300.14.1660	http://dx.doi.org/10.1001/jama.300.14.1660			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356YF	18840839	Bronze			2022-12-24	WOS:000259812800027
J	Blau, HM				Blau, Helen M.			Cell therapies for muscular dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; TRANSPLANTATION		[Blau, Helen M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282	5	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1403	1405		10.1056/NEJMcibr0805708	http://dx.doi.org/10.1056/NEJMcibr0805708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815403				2022-12-24	WOS:000259440900015
J	Tzemos, N; Therrien, J; Yip, J; Thanassoulis, G; Tremblay, S; Jamorski, MT; Webb, GD; Siu, SC				Tzemos, Nikolaos; Therrien, Judith; Yip, James; Thanassoulis, George; Tremblay, Sonia; Jamorski, Michal T.; Webb, Gary D.; Siu, Samuel C.			Outcomes in adults with bicuspid aortic valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASCENDING AORTA; NATURAL-HISTORY; HEART-DISEASE; FOLLOW-UP; STENOSIS; DILATATION; COARCTATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS	Context Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population. Cardiac outcomes in a contemporary population of adults with bicuspid aortic valve have not been systematically determined. Objective To determine the frequency and predictors of cardiac outcomes in a large consecutive series of adults with bicuspid aortic valve. Design, Setting, and Participants Cohort study examining cardiac outcomes in 642 consecutive ambulatory adults ( mean [ SD] age, 35 [ 16] years; 68% male) with bicuspid aortic valve presenting to a Canadian congenital cardiac center from 1994 through 2001 and followed up for a mean ( SD) period of 9 ( 5) years. Frequency and predictors of major cardiac events were determined by multivariate analysis. Mortality rate in the study group was compared with age- and sex- matched population estimates. Main Outcome Measures Mortality and cause of death were determined. Primary cardiac events were defined as the occurrence of any of the following complications: cardiac death, intervention on the aortic valve or ascending aorta, aortic dissection or aneurysm, or congestive heart failure requiring hospital admission during the follow- up period. Results During the follow- up period, there were 28 deaths ( mean [ SD], 4% [ 1%]). One or more primary cardiac events occurred in 161 patients ( mean [ SD], 25% [ 2%]), which included cardiac death in 17 patients ( mean [ SD], 3% [ 1%]), intervention on aortic valve or ascending aorta in 142 patients ( mean [ SD], 22% [ 2%]), aortic dissection or aneurysm in 11 patients ( mean [ SD], 2% [ 1%]), or congestive heart failure requiring hospital admission in 16 patients ( mean [ SD], 2% [ 1%]). Independent predictors of primary cardiac events were age older than 30 years ( hazard ratio [ HR], 3.01; 95% confidence interval [ CI], 2.15- 4.19; P <. 001), moderate or severe aortic stenosis ( HR, 5.67; 95% CI, 4.16- 7.80; P <. 001), and moderate or severe aortic regurgitation ( HR, 2.68; 95% CI, 1.93- 3.76; P <. 001). The 10- year survival rate of the study group ( mean [ SD], 96% [ 1%]) was not significantly different from population estimates ( mean [ SD], 97% [ 1%]; P=. 71). At last follow- up, 280 patients ( mean [ SD], 45% [ 2%]) had dilated aortic sinus and/ or ascending aorta. Conclusions In this study population of young adults with bicuspid aortic valve, age, severity of aortic stenosis, and severity of aortic regurgitation were independently associated with primary cardiac events. Over the mean follow- up duration of 9 years, survival rates were not lower than for the general population.	[Siu, Samuel C.] Univ Western Ontario Hosp, Div Cardiol, London, ON N6A 5A5, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Toronto Congenital Cardiac Ctr Adults, Toronto, ON, Canada; [Yip, James] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Therrien, Judith; Thanassoulis, George; Tremblay, Sonia] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada; [Webb, Gary D.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia Adult Congenital Heart Ctr, Dept Med, Philadelphia, PA 19104 USA; [Siu, Samuel C.] Univ Western Ontario, Div Cardiol, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto; National University of Singapore; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Western University (University of Western Ontario)	Siu, SC (corresponding author), Univ Western Ontario Hosp, Div Cardiol, C6-005,339 Windermere Rd, London, ON N6A 5A5, Canada.	Samuel.Siu@lhsc.on.ca	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669	University of Toronto Department of Medicine; Fonds de Recherche en Sante du Quebec; Canadian Institutes of Health Research [53130]; Heart and Stroke Foundation of Canada [NA5662]	University of Toronto Department of Medicine(University of Toronto); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Dr Tzemos was partially supported by a fellowship grant from the University of Toronto Department of Medicine. Dr Thanassoulis was supported by a research fellowship from the Fonds de Recherche en Sante du Quebec. The study was supported by operating grants from the Canadian Institutes of Health Research (grant 53130) and the Heart and Stroke Foundation of Canada (grant NA5662).	Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089; Bireley WR, 2007, J MAGN RESON IMAGING, V26, P1480, DOI 10.1002/jmri.21085; Bonderman D, 1999, CIRCULATION, V99, P2138, DOI 10.1161/01.CIR.99.16.2138; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; FENOGLIO JJ, 1977, AM J CARDIOL, V39, P164, DOI 10.1016/S0002-9149(77)80186-0; Ferencik M, 2003, AM J CARDIOL, V92, P43, DOI 10.1016/S0002-9149(03)00462-4; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Gurvitz M, 2004, AM J CARDIOL, V94, P1337, DOI 10.1016/j.amjcard.2004.07.130; Hager A, 2004, CHEST, V126, P1169, DOI 10.1378/chest.126.4.1169; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Keane MG, 2000, CIRCULATION, V102, P35; Konen E, 2004, AM J ROENTGENOL, V182, P1333, DOI 10.2214/ajr.182.5.1821333; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Manuel DG, 2003, CAN J CARDIOL, V19, P997; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; MILLS P, 1978, BRIT HEART J, V40, P951; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; THANASSOULIS G, IN PRESS NAT CLIN PR; Therrien J, 2001, CAN J CARDIOL, V17, P1029; Tutar E, 2005, AM HEART J, V150, P513, DOI 10.1016/j.ahj.2004.10.036; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Weyman AE, 1994, PRINCIPLES PRACTICE, P1289; Yap SC, 2007, INT J CARDIOL, V122, P224, DOI 10.1016/j.ijcard.2006.11.092; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	392	415	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1317	1325		10.1001/jama.300.11.1317	http://dx.doi.org/10.1001/jama.300.11.1317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799444				2022-12-24	WOS:000259231100027
J	Ramachandran, V; Chen, XM				Ramachandran, Vanitharani; Chen, Xuemei			Degradation of microRNAs by a family of exoribonucleases in Arabidopsis	SCIENCE			English	Article							RIBOSOMAL-RNA; 5.8S; METHYLATION; PROTEIN; YEAST; ERI1	microRNAs ( miRNAs) play crucial roles in numerous developmental and metabolic processes in plants and animals. The steady- state levels of miRNAs need to be properly controlled to ensure normal development. Whereas the framework of miRNA biogenesis is established, factors involved in miRNA degradation remain unknown. Here, we show that a family of exoribonucleases encoded by the SMALL RNA DEGRADING NUCLEASE ( SDN) genes degrades mature miRNAs in Arabidopsis. SDN1 acts specifically on single- stranded miRNAs in vitro and is sensitive to the 2'-O-methyl modification on the 3' terminal ribose of miRNAs. Simultaneous knockdown of three SDN genes in vivo results in elevated miRNA levels and pleiotropic developmental defects. Therefore, we have uncovered the enzymes that degrade miRNAs and demonstrated that miRNA turnover is crucial for plant development.	[Ramachandran, Vanitharani; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu		Chen, Xuemei/0000-0002-5209-1157	NSF [MCB-0718029]; NIH [GM61146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bi for technical assistance and T. Dinh, L. Ji, B. Yu, and B. Zheng for helpful discussions and careful reading of the manuscript. This work was supported by grants from NSF (MCB-0718029) and NIH (GM61146) to X. C.	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Faber AW, 2004, RNA, V10, P1946, DOI 10.1261/rna.7155904; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	17	307	324	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1490	1492		10.1126/science.1163728	http://dx.doi.org/10.1126/science.1163728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787168	Green Accepted			2022-12-24	WOS:000259121800041
J	Williams, TM; Selegue, JE; Werner, T; Gompel, N; Kopp, A; Carroll, SB				Williams, Thomas M.; Selegue, Jane E.; Werner, Thomas; Gompel, Nicolas; Kopp, Artyom; Carroll, Sean B.			The regulation and evolution of a genetic switch controlling sexually dimorphic traits in Drosophila	CELL			English	Article							DNA-BINDING; TRANSCRIPTIONAL REGULATION; SEX-DETERMINATION; DOUBLESEX; MELANOGASTER; PROTEINS; DIFFERENTIATION; RECOGNITION; MAB-3	Sexually dimorphic traits play key roles in animal evolution and behavior. Little is known, however, about the mechanisms governing their development and evolution. One recently evolved dimorphic trait is the male-specific abdominal pigmentation of Drosophila melanogaster, which is repressed in females by the Bric-a-brac (Bab) proteins. To understand the regulation and origin of this trait, we have identified and traced the evolution of the genetic switch controlling dimorphic bab expression. We show that the HOX protein Abdominal-B (ABD-B) and the sex-specific isoforms of Doublesex (DSX) directly regulate a bab cis-regulatory element (CRE). In females, ABD-B and DSX F activate bab expression whereas in males DSX M directly represses bab, which allows for pigmentation. A new domain of dimorphic bab expression evolved through multiple fine-scale changes within this CRE, whose ancestral role was to regulate other dimorphic features. These findings reveal how new dimorphic characters can emerge from genetic networks regulating pre-existing dimorphic traits.	[Williams, Thomas M.; Selegue, Jane E.; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Williams, Thomas M.; Selegue, Jane E.; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Gompel, Nicolas] CNRS, IBDML, UMR 6216, F-13288 Marseille 9, France; [Kopp, Artyom] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Davis	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Gompel, Nicolas/0000-0003-3358-7963	National Institutes of Health [GM076935]; Human Frontiers Science Program Fellowship [LT00640/2005-L]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program Fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Kassner, C. Walsh, M. Rebeiz, K. Vaccaro, and B. Prud'homme for technical assistance; J.-L. Couderc for technical advice; K. Venken for providing genomic attP docking site lines; F. Karch for providing germ-line-specific fC31 integrase lines, and T. Shirangi for comments on the manuscript. This work was supported by National Institutes of Health Postdoctoral fellowship (GM076935) to T. M. W., a Human Frontiers Science Program Fellowship (LT00640/2005- L) to T. W., and the Howard Hughes Medical Institute (S. B. C.).	AN WQ, 1995, EMBO J, V14, P1221, DOI 10.1002/j.1460-2075.1995.tb07105.x; Andersson Malte, 1994; Balhoff JP, 2005, P NATL ACAD SCI USA, V102, P8591, DOI 10.1073/pnas.0409638102; Bannina O, 2007, DEV BIOL, V311, P277, DOI 10.1016/j.ydbio.2007.07.030; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CELNIKER SE, 1987, GENE DEV, V1, P111, DOI 10.1101/gad.1.2.111; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Couderc JL, 2002, DEVELOPMENT, V129, P2419; Coyne JA, 2008, EVOLUTION, V62, P214, DOI 10.1111/j.1558-5646.2007.00254.x; Darwin Charles, 1871, DESCENT MAN; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; DUNCAN IW, 1975, GENETICS, V80, P733; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; Erdman SE, 1996, GENETICS, V144, P1639; Fisher R.A., 1930, GENETICAL THEORY NAT; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; JURSNICH VA, 1993, DEV BIOL, V155, P235, DOI 10.1006/dbio.1993.1021; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kopp A, 2002, DEV BIOL, V242, P15, DOI 10.1006/dbio.2001.0529; Lours C, 2003, NUCLEIC ACIDS RES, V31, P5389, DOI 10.1093/nar/gkg724; Robins Diane M, 2005, Novartis Found Symp, V268, P42; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Wilkins AS, 2004, BIOESSAYS, V26, P116, DOI 10.1002/bies.10414; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Yi W, 2000, DEVELOPMENT, V127, P4469; Yi WS, 1999, DEVELOPMENT, V126, P873; Yoder JH, 2006, EVOL DEV, V8, P241, DOI 10.1111/j.1525-142X.2006.00095.x; Zauner H, 2003, EVOL DEV, V5, P466, DOI 10.1046/j.1525-142X.2003.03053.x	36	214	217	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					610	623		10.1016/j.cell.2008.06.052	http://dx.doi.org/10.1016/j.cell.2008.06.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724934	Green Accepted, Bronze			2022-12-24	WOS:000258665800015
J	Navas-Acien, A; Silbergeld, EK; Pastor-Barriuso, R; Guallar, E				Navas-Acien, Ana; Silbergeld, Ellen K.; Pastor-Barriuso, Roberto; Guallar, Eliseo			Arsenic exposure and prevalence of type 2 diabetes in US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PANCREATIC BETA-CELLS; DRINKING-WATER; EPIDEMIOLOGIC EVIDENCE; HUMAN URINE; MELLITUS; TRANSCRIPTION; GLUCOSE; DISEASES; TAIWAN; TRANSLOCATION	Context High chronic exposure to inorganic arsenic in drinking water has been related to diabetes development, but the effect of exposure to low to moderate levels of inorganic arsenic on diabetes risk is unknown. In contrast, arsenobetaine, an organic arsenic compound derived from seafood intake, is considered nontoxic. Objective To investigate the association of arsenic exposure, as measured in urine, with the prevalence of type 2 diabetes in a representative sample of US adults. Design, Setting, and Participants Cross-sectional study in 788 adults aged 20 years or older who participated in the 2003-2004 National Health and Nutrition Examination Survey (NHANES) and had urine arsenic determinations. Main Outcome Measure Prevalence of type 2 diabetes across intake of arsenic. Results The median urine levels of total arsenic, dimethylarsinate, and arsenobetaine were 7.1, 3.0, and 0.9 mu g/L, respectively. The prevalence of type 2 diabetes was 7.7%. After adjustment for diabetes risk factors and markers of seafood intake, participants with type 2 diabetes had a 26% higher level of total arsenic (95% confidence interval [Cl], 2.0%-56.0%) and a nonsignificant 10% higher level of dimethylarsinate (95% Cl, -8.0% to 33.0%) than participants without type 2 diabetes, and levels of arsenobetaine were similar to those of participants without type 2 diabetes. After similar adjustment, the odds ratios for type 2 diabetes comparing participants at the 80th vs the 20th percentiles were 3.58 for the level of total arsenic (95% Cl, 1.18-10.83), 1.57 for dimethylarsinate (95% Cl, 0.89-2.76), and 0.69 for arsenobetaine (95% Cl, 0.33-1.48). Conclusions After adjustment for biomarkers of seafood intake, total urine arsenic was associated with increased prevalence of type 2 diabetes. This finding supports the hypothesis that low levels of exposure to inorganic arsenic in drinking water, a widespread exposure worldwide, may play a role in diabetes prevalence. Prospective studies in populations exposed to a range of inorganic arsenic levels are needed to establish whether this association is causal.	[Navas-Acien, Ana; Silbergeld, Ellen K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Navas-Acien, Ana; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Navas-Acien, Ana; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Pastor-Barriuso, Roberto] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain; [Pastor-Barriuso, Roberto] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Guallar, Eliseo] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Johns Hopkins University; Johns Hopkins Medicine	Navas-Acien, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 N Wolfe St,Room W7033B, Baltimore, MD 21205 USA.	anavas@jhsph.edu	Guallar, Eliseo/D-3807-2014; Pastor-Barriuso, Roberto/AAA-6746-2019	Guallar, Eliseo/0000-0002-4471-9565; Pastor-Barriuso, Roberto/0000-0002-7325-3960	National Institute of Environmental Health Sciences Center in Urban Environmental Health [P30 ES 03819]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences Center in Urban Environmental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant P30 ES 03819 from the National Institute of Environmental Health Sciences Center in Urban Environmental Health.	Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Bazuine M, 2003, EUR J BIOCHEM, V270, P3891, DOI 10.1046/j.1432-1033.2003.03771.x; Calderon RL, 1999, ENVIRON HEALTH PERSP, V107, P663, DOI 10.2307/3434459; CALDWELL KL, 2008, J EXPO SCI ENV EPID, P1, DOI DOI 10.1038/JES.2008.32; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; Coronado-Gonzalez JA, 2007, ENVIRON RES, V104, P383, DOI 10.1016/j.envres.2007.03.004; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Del Razo LM, 2002, FOOD CHEM TOXICOL, V40, P1423, DOI 10.1016/S0278-6915(02)00074-1; Diaz-Villasenor A, 2006, TOXICOL APPL PHARM, V214, P30, DOI 10.1016/j.taap.2005.11.015; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Focazio M.J., 2000, RETROSPECTIVE ANAL O; Francesconi KA, 1997, ADV INORG CHEM, V44, P147; Francesconi KA, 2002, CLIN CHEM, V48, P92; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans World Health Organization & International Agency for Research on Cancer, 2004, SOM DRINK WAT DIS CO; Izquierdo-Vega JA, 2006, TOXICOL LETT, V160, P135, DOI 10.1016/j.toxlet.2005.06.018; Jensen GE, 1998, ANALYST, V123, P77, DOI 10.1039/a705699k; Karagas M R, 2001, Int J Occup Med Environ Health, V14, P171; LAI MS, 1994, AM J EPIDEMIOL, V139, P484, DOI 10.1093/oxfordjournals.aje.a117031; Lamm SH, 2006, J OCCUP ENVIRON MED, V48, P1001, DOI 10.1097/01.jom.0000237359.75757.25; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Longnecker MP, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454649; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; *NAT CTR ENV HLTH, LAB PROC MAN TOT ARS; *NAT CTR ENV HLTH, 2004, LAB PROC MAN ARS ARS; National Center for Health Statistics, DOC COD FREQ LAB COM; National Research Council, 1999, ARS DRINK WAT; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; Paul DS, 2007, ENVIRON HEALTH PERSP, V115, P734, DOI 10.1289/ehp.9867; Rahman M, 1998, AM J EPIDEMIOL, V148, P198, DOI 10.1093/oxfordjournals.aje.a009624; Raml R, 2005, CHEM RES TOXICOL, V18, P1444, DOI 10.1021/tx050111h; Ruiz-Navarro ML, 1998, SCI TOTAL ENVIRON, V216, P55, DOI 10.1016/S0048-9697(98)00136-3; Ryan PB, 2000, ENVIRON HEALTH PERSP, V108, P731, DOI 10.2307/3434726; SABBIONI E, 1991, CARCINOGENESIS, V12, P1287, DOI 10.1093/carcin/12.7.1287; Salazard B, 2004, CELL BIOL TOXICOL, V20, P375, DOI 10.1007/s10565-004-1471-1; Schoof RA, 1999, FOOD CHEM TOXICOL, V37, P839, DOI 10.1016/S0278-6915(99)00073-3; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Steinmaus CM, 2005, ENVIRON RES, V99, P164, DOI 10.1016/j.envres.2004.10.003; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; US Environmental Protection Agency (EPA), 2001, FED REGISTER, V66, P6976; USDA, FOOD NUTR DAT DIET S; Walton FS, 2004, TOXICOL APPL PHARM, V198, P424, DOI 10.1016/j.taap.2003.10.026; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; Wang SL, 2007, ENVIRON INT, V33, P805, DOI 10.1016/j.envint.2007.03.004; Wang SL, 2003, ENVIRON HEALTH PERSP, V111, P155, DOI 10.1289/ehp.5457; Wauson EM, 2002, TOXICOL SCI, V65, P211, DOI 10.1093/toxsci/65.2.211; Yost LJ, 1998, HUM ECOL RISK ASSESS, V4, P137, DOI 10.1080/1080703031877131; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	50	328	340	1	41	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2008	300	7					814	822		10.1001/jama.300.7.814	http://dx.doi.org/10.1001/jama.300.7.814			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338VM	18714061	Bronze			2022-12-24	WOS:000258537500021
J	Bakir, M; Millington, KA; Soysal, A; Deeks, JJ; Efee, S; Aslan, Y; Dosanjh, DPS; Lalvani, A				Bakir, Mustafa; Millington, Kerry A.; Soysal, Ahmet; Deeks, Jonathan J.; Efee, Serpil; Aslan, Yasemin; Dosanjh, Davinder P. S.; Lalvani, Ajit			Prognostic Value of a T-Cell-Based, Interferon-gamma Biomarker in Children with Tuberculosis Contact	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; SKIN-TEST; CHILDHOOD TUBERCULOSIS; PREDICTIVE-VALUE; RAPID DETECTION; INFECTION; DIAGNOSIS; ENUMERATION	Background: Enzyme-linked immunospot (ELISpot) assay is an increasingly widely used, T-cell-based, interferon-gamma-release assay for diagnosing tuberculosis infection, but whether positive results are prognostic of active tuberculosis is not known. Objective: To determine whether ELISpot results predict the development of active tuberculosis among persons with recent tuberculosis exposure. Design: Longitudinal cohort study of children and adolescents with tuberculosis contact recruited from October 2002 to April 2004. Setting: Community-based contact investigations in Turkey. Patients: 908 children and adolescents with recent household tuberculosis exposure. Intervention: Enzyme-linked immunospot assay, incorporating early secretory antigenic target-6 and culture filtrate protein-10, and tuberculin skin test were done at baseline. Measurements: Incidence rates ratios of progression to active tuberculosis for contacts with positive tuberculin skin test and ELISpot results, and relative incidence rates comparing contacts with positive and negative test results. Results: Isoniazid preventive therapy was given to 688 (76%) contacts according to local guidelines. Fifteen contacts developed active tuberculosis over 1201 person-years of follow-up. Of 381 contacts with positive ELISpot results, 11 developed active tuberculosis over 536 person-years of follow-up ( incidence rate, 21 per 1000 person-years [95% CI, 10.2 to 36.7 per 1000 person-years]), a statistically significant 3- to 4-fold increased risk for progression relative to ELISpot-negative contacts. Of 550 contacts with positive tuberculin skin test results, 12 developed active tuberculosis over 722 person-years of follow-up ( incidence rate, 17 per 1000 person-years [CI, 8.6 to 29.0 per 1000 person-years]). Limitation: Only 3 of the 15 incident cases were confirmed by culture. Conclusion: Positive ELISpot results predict subsequent development of active tuberculosis in recent tuberculosis contacts. Although tuberculosis contacts with positive ELISpot results have an incidence rate of tuberculosis similar to that of contacts with positive tuberculin skin test results, ELISpot testing could allow more focused targeting of preventive therapy to fewer contacts.	[Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, London W2 1PG, England; Marmara Univ, Sch Med, Istanbul, Turkey; Univ Birmingham, Birmingham, W Midlands, England	Imperial College London; Marmara University; University of Birmingham	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, TB Immunol Grp, Dept Resp Med, Natl Heart & Lung Inst, Norfolk Pl, London W2 1PG, England.	a.lalvani@imperial.ac.uk	Dosanjh, Davinder/ABD-8895-2021; ASLAN, YASEMİN/AAP-7409-2020; Deeks, Jon/AAV-5745-2020; Aslan, Yasemin/AAP-7713-2020	Dosanjh, Davinder/0000-0002-9169-5607; Deeks, Jon/0000-0002-8850-1971; Aslan, Yasemin/0000-0001-6292-2332; Lalvani, Ajit/0000-0002-2396-246X	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization; UK Department of Health; Centre for Respiratory Infection, Imperial College London	Trust and the United Nations; (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization(World Health Organization); UK Department of Health; Centre for Respiratory Infection, Imperial College London	By the Wellcome Trust and the United Nations (International) Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases, a UK Department of Health Senior Fellowship in Evidence Synthesis (Dr. Deeks), and the Sir Halley Stewart Trust ( Dr. Dosanjh's PhD studentship). Dr. Lalvani is a Wellcome Senior Research Fellow in Clinical Science, and Dr. Millington was a Wellcome Trust Prize PhD student. Both are members of the Wellcome Trust-funded Centre for Respiratory Infection, Imperial College London.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2000, AM J RESP CRIT CARE, V161, pS221; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Fourth report to the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee, 1972, B WHO, V46, P371; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; HSU KHK, 1984, JAMA-J AM MED ASSOC, V251, P1283, DOI 10.1001/jama.251.10.1283; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lalvani A, 2001, AM J RESP CRIT CARE, V163, P824, DOI 10.1164/ajrccm.163.4.2009100; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; LALVANI A, 2008, EUR RESP J IN PRESS; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; *NAT CTR HIV STD T, 2005, MMWR RECOMM REP, V54, P49; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; Schluger Neil W, 2003, Semin Respir Infect, V18, P241; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Starke JR, 2006, PEDIATR INFECT DIS J, V25, P941, DOI 10.1097/01.inf.0000239685.49999.d3; Sterling TR, 2006, NEW ENGL J MED, V355, P118, DOI 10.1056/NEJMp068015; Stout JE, 2008, AM J RESP CRIT CARE, V177, P1055, DOI 10.1164/rccm.200802-251ED; *TURK CUMH SAGL BA, 2003, TURK TUB KONTR BASV; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; *WHO, 2007, WHO PUBL; Zellweger JP, 2005, INT J TUBERC LUNG D, V9, P1242	50	127	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2008	149	11					777	W163		10.7326/0003-4819-149-11-200812020-00248	http://dx.doi.org/10.7326/0003-4819-149-11-200812020-00248			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383AA	18936496	Green Accepted			2022-12-24	WOS:000261645300001
J	Stathopulos, PB; Zheng, L; Li, GY; Plevin, MJ; Ikura, M				Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko			Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; SAM DOMAIN; CA2+ ENTRY; CRAC CHANNELS; POINT MUTATIONS; I-CRAC; STIM1; PROTEIN; BINDING; ER	Stromal interaction molecule-1 (STIM1) activates store-operated Ca2+ entry (SOCE) in response to diminished luminal Ca2+ levels. Here, we present the atomic structure of the Ca2+-sensing region of STIM1 consisting of the EF-hand and sterile a motif (SAM) domains (EF-SAM). The canonical EF-hand is paired with a previously unidentified EF-hand. Together, the EF-hand pair mediates mutually indispensable hydrophobic interactions between the EF-hand and SAM domains. Structurally critical mutations in the canonical EF-hand, "hidden'' EF-hand, or SAM domain disrupt Ca2+ sensitivity in oligomerization via destabilization of the entire EF-SAM entity. In mammalian cells, EF-SAM destabilization mutations within full-length STIM1 induce punctae formation and activate SOCE independent of luminal Ca2+. We provide atomic resolution insight into the molecular basis for STIM1-mediated SOCE initiation and show that the folded/unfolded state of the Ca2+-sensing region of STIM is crucial to SOCE regulation.	[Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Stathopulos, Peter B.; Zheng, Le; Li, Guang-Yao; Plevin, Michael J.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto Med Discovery Tower,MaRS Ctr,101 Coll St, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca		Stathopulos, Peter B./0000-0002-0536-6656; Plevin, Michael/0000-0003-2057-8291	Canadian Institutes of Health Research; Canadian Foundation for Innovation [800 MHz NMR]; Natural Sciences and Engineering Research Council of Canada; Ontario Cancer Institute Knudson	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Cancer Institute Knudson	We thank N. Ishiyama for his EM assistance, R.S. Lewis (Stanford University) for providing cherryFP-STIM1, and Bruker Biospin Corporation (Fremont, CA) for 900 MHz NMR time. This research was made possible through a Canadian Institutes of Health Research operating grant, a Canadian Foundation for Innovation grant for an 800 MHz NMR spectrometer, and Natural Sciences and Engineering Research Council of Canada and Ontario Cancer Institute Knudson fellowships (to P.B.S.). M.I. holds the Canada Research Chair in Cancer Structural Biology.	ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; IKURA M, 1985, BIOCHEMISTRY-US, V24, P4264, DOI 10.1021/bi00337a002; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; KASS GEN, 1990, J BIOL CHEM, V265, P17486; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strange K, 2007, CELL CALCIUM, V42, P193, DOI 10.1016/j.ceca.2007.02.007; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wojcik J, 1997, BIOCHEMISTRY-US, V36, P680, DOI 10.1021/bi961821c; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	56	343	354	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					110	122		10.1016/j.cell.2008.08.006	http://dx.doi.org/10.1016/j.cell.2008.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854159	Bronze			2022-12-24	WOS:000259728100013
J	Stuber, GD; Klanker, M; de Ridder, B; Bowers, MS; Joosten, RN; Feenstra, MG; Bonci, A				Stuber, Garret D.; Klanker, Marianne; de Ridder, Bram; Bowers, M. Scott; Joosten, Ruud N.; Feenstra, Matthijs G.; Bonci, Antonello			Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; COCAINE-SEEKING; GLUTAMATE; LTP; AMPHETAMINE; DEPRESSION; RATS	Using sensory information for the prediction of future events is essential for survival. Midbrain dopamine neurons are activated by environmental cues that predict rewards, but the cellular mechanisms that underlie this phenomenon remain elusive. We used in vivo voltammetry and in vitro patch- clamp electrophysiology to show that both dopamine release to reward predictive cues and enhanced synaptic strength onto dopamine neurons develop over the course of cue- reward learning. Increased synaptic strength was not observed after stable behavioral responding. Thus, enhanced synaptic strength onto dopamine neurons may act to facilitate the transformation of neutral environmental stimuli to salient reward- predictive cues.	[Stuber, Garret D.; de Ridder, Bram; Bowers, M. Scott; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Klanker, Marianne; Joosten, Ruud N.; Feenstra, Matthijs G.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	antonello.bonci@ucsf.edu	Stuber, Garret/E-1160-2011	Bowers, M Scott/0000-0003-0047-6765; Stuber, Garret/0000-0003-1730-4855	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO;  [DA021937];  [DA015096]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021937, R01DA015096] Funding Source: NIH RePORTER	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Fields, F. W. Hopf, P. Janak, and K. Tye for helpful comments and R. Sadler and L. Wang for technical assistance. This work was supported by DA021937 (G.D.S.), DA015096 (A.B.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (A.B.), the Van Den Houtenfonds (M.G.F.), and the Netherlands Organisation for Scientific Research, NWO (M.G.F.).	Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Cheng JJ, 2003, EUR J NEUROSCI, V18, P1306, DOI 10.1046/j.1460-9568.2003.02849.x; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2004, EUR J NEUROSCI, V19, P1661, DOI 10.1111/j.1460-9568.2004.03232.x; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARNELI M, 2007, SCIENCE, V317, P530; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Schuchard M, 1998, NEUROMODULATION, V1, P46, DOI 10.1111/j.1525-1403.1998.tb00029.x; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; You ZB, 2007, J NEUROSCI, V27, P10546, DOI 10.1523/JNEUROSCI.2967-07.2007; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	23	223	224	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1690	1692		10.1126/science.1160873	http://dx.doi.org/10.1126/science.1160873			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802002	Green Accepted			2022-12-24	WOS:000259300400040
J	Vasquez, V; Sotomayor, M; Cordero-Morales, J; Schulten, K; Perozo, E				Vasquez, Valeria; Sotomayor, Marcos; Cordero-Morales, Julio; Schulten, Klaus; Perozo, Eduardo			A structural mechanism for MscS gating in lipid bilayers	SCIENCE			English	Article							MECHANOSENSITIVE CHANNEL; MOLECULAR-DYNAMICS; ION-CHANNEL; PORE; CONDUCTION; PRESSURE	The mechanosensitive channel of small conductance (MscS) is a key determinant in the prokaryotic response to osmotic challenges. We determined the structural rearrangements associated with MscS activation in membranes, using functorial measurements, electron paramagnetic resonance spectroscopy, and computational analyses. MscS was trapped in its open conformation after the transbilayer pressure profile was modified through the asymmetric incorporation of lysophospholipids. The transition from the closed to the open state is accompanied by the downward tilting of the transmembrane TM1-TM2 hairpin and by the expansion, tilt, and rotation of the TM3 helices. These movements expand the permeation pathway, leading to an increase in accessibility to water around TM3. Our open MscS model is compatible with single- channel conductance measurements and supports the notion that helix tilting is associated with efficient pore widening in mechanosensitive channels.	[Vasquez, Valeria; Cordero-Morales, Julio; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; [Vasquez, Valeria; Cordero-Morales, Julio] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Sotomayor, Marcos] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sotomayor, Marcos] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Schulten, Klaus] Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Chicago; University of Virginia; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu	Schulten, Klaus/D-5561-2009; Sotomayor, Marcos/T-2411-2019; Sotomayor, Marcos/J-4898-2012	Sotomayor, Marcos/0000-0002-3333-1805; Sotomayor, Marcos/0000-0002-3333-1805; Cordero Morales, Julio/0000-0002-6505-5403; Vasquez, Valeria/0000-0001-8494-1534	NIH grants [GM063617, P41-RR05969, 1 R01 GM067887]; NSF grant [LRAC MCA93S028]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063617, R01GM067887] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF grant(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Jogini, S. Chakrapani, H. Raghuraman, and D. M. Cortes for providing comments and experimental advice and G. R. Meyer for EPR data analysis script. M. S. is an associate of the Howard Hughes Medical Institute in the laboratory of David Corey. This work was supported by NIH grants GM063617 (E. P.), P41-RR05969 (K.S.), and 1 R01 GM067887 (K.S.). Supercomputer time was provided through NSF grant LRAC MCA93S028.	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Gullingsrud J, 2001, BIOPHYS J, V80, P2074, DOI 10.1016/S0006-3495(01)76181-4; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Koprowski P, 1998, J MEMBRANE BIOL, V164, P253, DOI 10.1007/s002329900410; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Markin VS, 2007, CURR TOP MEMBR, V58, P87, DOI 10.1016/S1063-5823(06)58004-4; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Martinac B, 2001, CELL PHYSIOL BIOCHEM, V11, P61, DOI 10.1159/000047793; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sompornpisut P, 2008, BIOPHYS J, V95, P5349, DOI 10.1529/biophysj.108.142984; Sotomayor M, 2006, BIOPHYS J, V90, P3496, DOI 10.1529/biophysj.105.080069; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Sotomayor M, 2007, BIOPHYS J, V92, P886, DOI 10.1529/biophysj.106.095232; Spronk SA, 2006, BIOPHYS J, V90, P3555, DOI 10.1529/biophysj.105.080432; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Yoshimura K, 2004, BIOPHYS J, V86, P2113, DOI 10.1016/S0006-3495(04)74270-8	41	136	139	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1210	1214		10.1126/science.1159674	http://dx.doi.org/10.1126/science.1159674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755978	Green Accepted			2022-12-24	WOS:000258754400045
J	Strate, LL; Liu, YL; Syngal, S; Aldoori, WH; Giovannucci, EL				Strate, Lisa L.; Liu, Yan L.; Syngal, Sapna; Aldoori, Walid H.; Giovannucci, Edward L.			Nut, corn, and popcorn consumption and the incidence of diverticular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER RISK; NATURAL-HISTORY; PROSTATE-CANCER; ANTIINFLAMMATORY DRUGS; MAGNESIUM INTAKE; HEART-DISEASE; COLON; EPIDEMIOLOGY; PATHOGENESIS; REAPPRAISAL	Context Patients with diverticular disease are frequently advised to avoid eating nuts, corn, popcorn, and seeds to reduce the risk of complications. However, there is little evidence to support this recommendation. Objective To determine whether nut, corn, or popcorn consumption is associated with diverticulitis and diverticular bleeding. Design and Setting The Health Professionals Follow- up Study is a cohort of US men followed up prospectively from 1986 to 2004 via self- administered questionnaires about medical ( biennial) and dietary ( every 4 years) information. Men reporting newly diagnosed diverticulosis or diverticulitis were mailed supplemental questionnaires. Participants The study included 47 228 men aged 40 to 75 years who at baseline were free of diverticulosis or its complications, cancer, and inflammatory bowel disease and returned a food- frequency questionnaire. Main Outcome Measures Incident diverticulitis and diverticular bleeding. Results During 18 years of follow- up, there were 801 incident cases of diverticulitis and 383 incident cases of diverticular bleeding. We found inverse associations between nut and popcorn consumption and the risk of diverticulitis. The multivariate hazard ratios for men with the highest intake of each food ( at least twice per week) compared with men with the lowest intake ( less than once per month) were 0.80 ( 95% confidence interval, 0.63- 1.01; P for trend=. 04) for nuts and 0.72 ( 95% confidence interval, 0.56- 0.92; P for trend=. 007) for popcorn. No associations were seen between corn consumption and diverticulitis or between nut, corn, or popcorn consumption and diverticular bleeding or uncomplicated diverticulosis. Conclusions In this large, prospective study of men without known diverticular disease, nut, corn, and popcorn consumption did not increase the risk of diverticulosis or diverticular complications. The recommendation to avoid these foods to prevent diverticular complications should be reconsidered.	[Strate, Lisa L.] Harborview Med Ctr, Div Gastroenterol, Dept Med, Seattle, WA 98104 USA; [Strate, Lisa L.] Univ Washington, Sch Med, Seattle, WA USA; [Liu, Yan L.; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Syngal, Sapna; Giovannucci, Edward L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Syngal, Sapna] Brigham & Womens Hosp, Dept Med, Div Gastroenterol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02115 USA; [Aldoori, Walid H.] Wyeth Consumer Healthcare Inc, Mississauga, ON, Canada	Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Pfizer	Strate, LL (corresponding author), Harborview Med Ctr, Div Gastroenterol, Dept Med, 325 9th Ave,Box 359773, Seattle, WA 98104 USA.	lstrate@u.washington.edu			Agency for Healthcare Research and Quality [K08 HS14062]; National Cancer Institute [P01 CA055075, K24CA113433]; National Heart, Lung, and Blood Institute [R01HL035464]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS014062] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K24CA113433, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grant K08 HS14062 from the Agency for Healthcare Research and Quality (Dr Strate); grants P01 CA055075 (Dr Giovannucci) and K24CA113433(Dr Syngal) from the National Cancer Institute; and grant R01HL035464 from the National Heart, Lung, and Blood Institute (Dr Giovannucci).	Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Aldoori WH, 1998, J NUTR, V128, P714, DOI 10.1093/jn/128.4.714; Aldoori WH, 1998, ARCH FAM MED, V7, P255, DOI 10.1001/archfami.7.3.255; ALDOORI WH, 1994, AM J CLIN NUTR, V60, P757, DOI 10.1093/ajcn/60.5.757; ALDOORI WH, 1995, GUT, V36, P276, DOI 10.1136/gut.36.2.276; ALMY TP, 1980, NEW ENGL J MED, V302, P324, DOI 10.1056/NEJM198002073020605; BERMAN LG, 1968, SURG GYNECOL OBSTETR, V127, P481; Bogardus ST, 2006, J CLIN GASTROENTEROL, V40, pS108, DOI 10.1097/01.mcg.0000212603.28595.5c; COX DR, 1972, J R STAT SOC B, V34, P187; Dobbins C, 2006, COLORECTAL DIS, V8, P37, DOI 10.1111/j.1463-1318.2005.00847.x; FLEISCHN.FG, 1965, RADIOLOGY, V84, P599, DOI 10.1148/84.4.599; Floch MH, 2004, J CLIN GASTROENTEROL, V38, pS2, DOI 10.1097/01.mcg.0000124003.07433.ee; Folsom AR, 2006, AM J EPIDEMIOL, V163, P232, DOI 10.1093/aje/kwj037; Hebert JR, 1998, JNCI-J NATL CANCER I, V90, P1637, DOI 10.1093/jnci/90.21.1637; HORNER JL, 1958, AM J DIG DIS, V3, P343, DOI 10.1007/BF02232401; Hu F B, 1999, Curr Atheroscler Rep, V1, P204, DOI 10.1007/s11883-999-0033-7; Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341; HUGHES LE, 1969, GUT, V10, P344, DOI 10.1136/gut.10.5.344; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Jain MG, 1999, NUTR CANCER, V34, P173, DOI 10.1207/S15327914NC3402_8; Jenab M, 2004, CANCER EPIDEM BIOMAR, V13, P1595; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Korzenik JR, 2006, J CLIN GASTROENTEROL, V40, pS112, DOI 10.1097/01.mcg.0000225503.59923.6c; Laine L, 2006, ALIMENT PHARM THER, V24, P751, DOI 10.1111/j.1365-2036.2006.03043.x; Laine L, 2003, GASTROENTEROLOGY, V124, P288, DOI 10.1053/gast.2003.50054; MCGUIRE HH, 1994, ANN SURG, V220, P653, DOI 10.1097/00000658-199411000-00008; MEYERS MA, 1976, GASTROENTEROLOGY, V71, P577; MEYERS MA, 1976, AM J ROENTGENOL, V127, P901, DOI 10.2214/ajr.127.6.901; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; Mimura T, 2004, DIS COLON RECTUM, V47, P371, DOI 10.1007/s10350-003-0050-5; Morris CR, 2003, GUT, V52, P1734, DOI 10.1136/gut.52.12.1734; Morris CR, 2003, BRIT J SURG, V90, P1267, DOI 10.1002/bjs.4221; Morris CR, 2002, POSTGRAD MED J, V78, P654, DOI 10.1136/pmj.78.925.654; MORSON BC, 1963, P ROY SOC MED, V56, P798, DOI 10.1177/003591576305600916; PARKS TG, 1968, P ROY SOC MED, V61, P932, DOI 10.1177/003591576806100931; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rosemar A, 2008, DIS COLON RECTUM, V51, P450, DOI 10.1007/s10350-007-9172-5; Sabate J, 1999, AM J CLIN NUTR, V70, p500S, DOI 10.1093/ajcn/70.3.500s; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schechter S, 1999, DIS COLON RECTUM, V42, P470, DOI 10.1007/BF02234169; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Stumpf M, 2001, INT J COLORECTAL DIS, V16, P271, DOI 10.1007/s003840100310; Tsai CJ, 2004, AM J EPIDEMIOL, V160, P961, DOI 10.1093/aje/kwh302; *US FDA, QUAL HLTH CLAIMS LET; van den Brandt PA, 2007, BRIT J CANCER, V96, P510, DOI 10.1038/sj.bjc.6603577; WELCH CE, 1953, ANN SURG, V138, P332, DOI 10.1097/00000658-195313830-00005	48	144	149	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 27	2008	300	8					907	914		10.1001/jama.300.8.907	http://dx.doi.org/10.1001/jama.300.8.907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341AR	18728264	Green Accepted, Bronze			2022-12-24	WOS:000258687100025
J	Zhang, KL; Detels, R; Liao, SS; Cohen, M; Yu, DB				Zhang, Kong-Lai; Detels, Roger; Liao, Susu; Cohen, Myron; Yu, Dong-Bao			China's HIV/AIDS epidemic: continuing challenges	LANCET			English	Editorial Material							HIV		[Zhang, Kong-Lai] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Cohen, Myron] Univ N Carolina, Chapel Hill, NC USA; [Liao, Susu] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China; [Yu, Dong-Bao] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization	Zhang, KL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	Konglai_Zhang@163.com						*CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gill B, 2007, NEW ENGL J MED, V356, P1801, DOI 10.1056/NEJMp078010; Li L, 2007, INT J EPIDEMIOL, V36, P178, DOI 10.1093/ije/dyl256; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; UNAIDS, 2008, REP GLOB EP; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8	8	31	34	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 22	2008	372	9652					1791	1793		10.1016/S0140-6736(08)61357-4	http://dx.doi.org/10.1016/S0140-6736(08)61357-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	375KG	18930521				2022-12-24	WOS:000261112000008
J	Yang, GH; Kong, LZ; Zhao, WH; Wan, X; Zhai, Y; Chen, LC; Koplan, JP				Yang, Gonghuan; Kong, Lingzhi; Zhao, Wenhua; Wan, Xia; Zhai, Yi; Chen, Lincoln C.; Koplan, Jeffrey P.			Health System Reform in China 3 Emergence of chronic non-communicable diseases in China	LANCET			English	Article							VERBAL AUTOPSY PROCEDURES; OF-DEATH STATISTICS; VALIDATION; PREVALENCE; SMOKING	China has experienced an epidemiological transition shifting from the infectious to the chronic diseases in much shorter time than many other countries. The pace and spread of behavioural changes, including changing diets, decreased physical activity high rates of male smoking, and other high risk behaviours, has accelerated to an unprecedented degree. As a result, the burden of chronic diseases, preventable morbidity and mortality and associated health-care costs could now increase substantially. China already has 177 million adults with hypertension; furthermore, 303 million adults smoke, which is a third of the world's total number of smokers, and 530 million people in China are passively exposed to second-hand smoke. The prevalence of overweight people and obesity is increasing in Chinese adults and children, because of dietary changes and reduced physical activity. Emergence of chronic diseases presents special challenges for China's ongoing reform of health care, given the large numbers who require curative treatment and the narrow window of opportunity for timely prevention of disease.	[Yang, Gonghuan; Zhao, Wenhua; Zhai, Yi] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Kong, Lingzhi] Minist Hlth, Bur Dis Prevent & Control, Beijing, Peoples R China; [Yang, Gonghuan; Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Yang, Gonghuan; Wan, Xia] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Chen, Lincoln C.] China Med Board, Cambridge, MA USA; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA	Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Emory University	Yang, GH (corresponding author), Chinese Ctr Dis Control & Prevent, 27 Nan Wei Rd, Beijing 100050, Peoples R China.	yanggh@chinacdc.cn		Zhai, Yi/0000-0002-1779-6645				Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; *CHIN AC PREV MED, 1997, SER REP CHIN DIS SUR; *CHIN INT INF CTR, 2008, ISS PROM 3 SURV CAUS; Chinese Academy of Preventive Medicine, 1997, SMOK HLTH CHIN 1996; Chinese Nutrition Society, 2008, CHIN DIET GUID; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; *COMM REV CHIN GUI, 2006, CHIN HYP GUID; GE KY, 1996, J HYGIENE RES S29, V25, P54; HU SL, 2003, CHIN HLTH EC MAG, V22, P18; HUA XL, 2006, CHINA TOBACCO HIST; HUANG R, 1995, MORTALITY DATA CHINA; HUANG XQ, 2008, CHINA TOBACCO, V3, P59; International Institute for Applied Systems Analysis, CHIN POP AG SEX 1950; Li J, 2000, CELL BIOL INT, V24, P9, DOI 10.1006/cbir.1999.0438; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; *MIN HLTH, 2005, ANN CHIN HLTH YB; *MIN HLTH CANC PRE, 1979, STUD CANC DEATH SURV; *MIN HLTH COMM NAT, 1987, 1984 NAT PREV SURV S; *MIN HLTH CTR HLTH, 2004, AN REP NAT HLTH SERV; *MIN HLTH DEP DIS, 2006, REP CHRON DIS CHIN; *MIN HLTH MIN PUBL, 1992, MED CERT DEATH STREN; Population Census Office under the State Council and Department of Population Social Science and Technology Statistics, 2002, TAB 2000 POP CENS PE; Population Census Office under the State Council Department of Population and Employment Statistics of National Bureau of Statistics, 1993, TAB 1990 POP CENS PE; PUSKA P, 1988, EURO REPORTS STUDIES, V106; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; *STAT STAT BUR PEO, 1996, 1982 POP CENS CHIN; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/S0140-6736(08)61364-1; UN Department of Economic and Social Affairs Population Division, 2006, WORLD POP PROSP 2006; Wang LD, 2005, COMPREHENSIVE REPORT; Wang LJ, 2007, J EPIDEMIOL COMMUN H, V61, P519, DOI 10.1136/jech.2005.043927; WANG WZ, 2002, CHIN J GERIATR CARDI, V4, P30; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; WHO, 2008, REP GLOB TOB EP 2008; *WHO, 2002, PREV CHRON DIS VIT I; World Health Organization, 1986, 1 INT C HLTH PROM OT; World Health Organization, 1993, MORT GUID CERT RUL C, V2, P30; World Health Organization, 1997, OB PREV MAN GLOB EP; World Health Organization, 1983, WHOSMO834; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xie Gaoqiang, 2008, Wei Sheng Yan Jiu, V37, P33; Yang, 2005, DEATHS THEIR RISK FA; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; YANG GH, 2004, TOBACCO SCI POLICY P, P215; YANG GH, 1992, J CHIN EPIDEMIOL, V13, P79; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; [No title captured]; 2007, PERIODIC REPORT IMPL	52	373	418	6	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2008	372	9650					1697	1705		10.1016/S0140-6736(08)61366-5	http://dx.doi.org/10.1016/S0140-6736(08)61366-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	372KG	18930526				2022-12-24	WOS:000260899900034
J	Krukowski, ZH; Bruce, J				Krukowski, Zygmunt H.; Bruce, Julie			Commentary: Controversies in NICE guidance on surgical site infection	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bruce, Julie] Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland; [Krukowski, Zygmunt H.] Aberdeen Royal Infirm, Ward 31, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Bruce, J (corresponding author), Univ Aberdeen, Sect Populat Hlth, Aberdeen AB25 2ZD, Scotland.	j.bruce@abdn.ac.uk	Bruce, Julie/G-7588-2014	Bruce, Julie/0000-0002-8462-7999	MRC [G106/1178] Funding Source: UKRI; Medical Research Council [G106/1178] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		CRUSE PJE, 1980, SURG CLIN N AM, V60, P27; *HLTH PROT AG, SURG SIT INF SURV EN; *HLTH PROT SCOTL, 2007, SURG SIT INF SURV SC; KRUKOWSKI ZH, 1988, BRIT J SURG, V75, P857, DOI 10.1002/bjs.1800750909; National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Taylor EW, 2004, BRIT J SURG, V91, P105, DOI 10.1002/bjs.4365	6	10	10	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a2120	10.1136/bmj.a2120	http://dx.doi.org/10.1136/bmj.a2120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957456				2022-12-24	WOS:000260593700033
J	Bayne, EH; Portoso, M; Kagansky, A; Kos-Braun, IC; Urano, T; Ekwall, K; Alves, F; Rappsilber, J; Allshire, RC				Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Urano, Takeshi; Ekwall, Karl; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.			Splicing factors facilitate RNAi-directed silencing in fission yeast	SCIENCE			English	Article							PRE-MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; CENTROMERE FUNCTION; HETEROCHROMATIN; MUTANTS; RITS; ESTABLISHMENT; TRANSCRIPTION; INTERFERENCE; CHROMATIN	Heterochromatin formation at fission yeast centromeres is directed by RNA interference (RNAi). Noncoding transcripts derived from centromeric repeats are processed into small interfering RNAs (siRNAs) that direct the RNA-induced transcriptional silencing (RITS) effector complex to engage centromer transcripts, resulting in recruitment of the histone H3 lysine 9 methyltransferase Clr4, and hence silencing. We have found that defects in specific splicing factors, but not splicing itself, affect the generation of centromeric siRNAs and consequently centromeric heterochromatin integrity. Moreover, splicing factors physically associate with Cid12, a component of the RNAi machinery, and with centromeric chromatin, consistent with a direct role in RNAi. We propose that spliceosomal complexes provide a platform for siRNA generation and hence facilitate effective centromere repeat silencing.	[Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Bayne, Elizabeth H.; Portoso, Manuela; Kagansky, Alexander; Kos-Braun, Isabelle C.; Alves, Flavia; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6938501, Japan; [Ekwall, Karl] Univ Coll Sodertorn, Karolinska Inst, Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden	University of Edinburgh; University of Edinburgh; Shimane University; Karolinska Institutet; Sodertorn University	Allshire, RC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Kagansky, Alexander/B-3137-2011; Rappsilber, Juri/B-7265-2015; /C-3697-2019; Bayne, Elizabeth H/G-5411-2010	Kagansky, Alexander/0000-0002-6219-6892; Rappsilber, Juri/0000-0001-5999-1310; Bayne, Elizabeth H/0000-0001-8775-999X; Urano, Takeshi/0000-0003-3383-3554; Allshire, Robin/0000-0002-8005-3625; Kos-Braun, Isabelle/0000-0002-2380-5720; Ekwall, Karl/0000-0002-3029-4041	Epigenome Network of Excellence [EC-FP6/Contract/LSHG-CT2004-503433]; UK Medical Research Council [G0301153/ID:69173]; Wellcome Trust Prize Studentship [067844]; Marie Curie Excellence Grant [MEXT-CT-014171]; Wellcome Trust Principal Research Fellowship [065061/Z]; Medical Research Council [G0301153] Funding Source: researchfish; MRC [G0301153] Funding Source: UKRI	Epigenome Network of Excellence; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Prize Studentship(Wellcome Trust); Marie Curie Excellence Grant(European Commission); Wellcome Trust Principal Research Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Beggs, E. S. Chin, A. Pidoux, F. Simmer, I. Stancheva, and D. Tollervey for comments; N. Kaufer, D. Moazed, and T. Tani for materials; and the Allshire lab for support. Supported by Epigenome Network of Excellence (EC-FP6/Contract/LSHG-CT2004-503433), of which R.C.A. and K.E. are members (E.B.); UK Medical Research Council grant G0301153/ID:69173 (A.K.); Wellcome Trust Prize Studentship 067844 (M.P.); Marie Curie Excellence Grant MEXT-CT-014171 from the European Commission (I.R.); and Wellcome Trust Principal Research Fellowship grant 065061/Z (R.C.A.).	Bartels C, 2002, EMBO REP, V3, P875, DOI 10.1093/embo-reports/kvf172; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ekwall K, 1999, GENETICS, V153, P1153; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Goymer P, 2007, NAT REV MOL CELL BIO, V8, P597, DOI 10.1038/nrm2225; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; LOCKHART SR, 1994, MOL CELL BIOL, V14, P3623, DOI 10.1128/MCB.14.6.3623; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; VOLPE TA, 2002, SCIENCE, V297, P18533, DOI DOI 10.1112/SCIENCE.1074973	25	99	98	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					602	606		10.1126/science.1164029	http://dx.doi.org/10.1126/science.1164029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948543	Green Accepted			2022-12-24	WOS:000260299100047
J	Schwander, T; Keller, L				Schwander, Tanja; Keller, Laurent			Genetic compatibility affects queen and worker caste determination	SCIENCE			English	Article									[Schwander, Tanja; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Lausanne	Schwander, T (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tanja.schwander@gmail.com	keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953; Schwander, Tanja/0000-0003-1945-5374	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Campbell for help in the field; F. Dessimoz and C. Ohayon for ant care and laboratory work; B.J. Crespi, P. Chnste, M. Chapunsat, and D. Queler for comments; and K. Parker and D. Arbuthnott for help with English. Supported by the Swiss National Science Foundation.	Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508	4	42	42	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					552	552		10.1126/science.1162590	http://dx.doi.org/10.1126/science.1162590			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948532	Green Submitted			2022-12-24	WOS:000260299100032
J	Silberstein, SD				Silberstein, Stephen D.			Recent developments in migraine	LANCET			English	Editorial Material							DOUBLE-BLIND; CONTROLLED-TRIAL; RISK; INTERVENTION; CGRP		[Silberstein, Stephen D.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Jefferson University	Silberstein, SD (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.	stephen.silberstein@jefferson.edu						Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Diener HC, 2007, LANCET NEUROL, V6, P1054, DOI 10.1016/S1474-4422(07)70272-7; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; HO TW, 2008, HEADACHE S1, V48, P7; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Lipton RB, 2005, HEADACHE, V45, P792; MATCHAR DB, 2008, HEADACHE        0610, DOI DOI 10.1111/J.1526-4610.2007.01148.X; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094; Silberstein S, 2008, NEUROLOGY, V70, P548, DOI 10.1212/01.wnl.0000297551.27191.70; Silberstein SD, 2008, NEUROLOGY, V71, P114, DOI 10.1212/01.wnl.0000316800.22949.20; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486	16	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1369	1371		10.1016/S0140-6736(08)61569-X	http://dx.doi.org/10.1016/S0140-6736(08)61569-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940454				2022-12-24	WOS:000260228200008
J	Win, MN; Smolke, CD				Win, Maung Nyan; Smolke, Christina D.			Higher-order cellular information processing with synthetic RNA devices	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; MAMMALIAN-CELLS; RIBOSWITCHES; BINDING	The engineering of biological systems is anticipated to provide effective solutions to challenges that include energy and food production, environmental quality, and health and medicine. Our ability to transmit information to and from living systems, and to process and act on information inside cells, is critical to advancing the scale and complexity at which we can engineer, manipulate, and probe biological systems. We developed a general approach for assembling RNA devices that can execute higher-order cellular information processing operations from standard components. The engineered devices can function as logic gates (AND, NOR, NAND, or OR gates) and signal filters, and exhibit cooperativity. RNA devices process and transmit molecular inputs to targeted protein outputs, linking computation to gene expression and thus the potential to control cellular function.	[Win, Maung Nyan; Smolke, Christina D.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Smolke, CD (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 210-41, Pasadena, CA 91125 USA.	smolke@cheme.caltech.edu			Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086663, R21GM074767] Funding Source: NIH RePORTER	Center for Biological Circuit Design at the California Institute of Technology; Arnold and Mabel Beckman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Chen, J. Liang, and D. Endy for critical reading of the manuscript and A. Babiskin for pRzS. This work was supported by the Center for Biological Circuit Design at the California Institute of Technology, the Arnold and Mabel Beckman Foundation, and the NIH. The authors declare competing financial interests in the form of a pending patent application.	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; NELSON DL, 2005, LEHNINGER PRINCIPLES, P167; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Suess B, 2008, RNA BIOL, V5, P24, DOI 10.4161/rna.5.1.5955; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	25	401	434	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					456	460		10.1126/science.1160311	http://dx.doi.org/10.1126/science.1160311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927397	Green Accepted			2022-12-24	WOS:000260094500051
J	Avorn, J				Avorn, Jerry			Drug warnings that can cause fits - Communicating risks in a data-poor environment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Avorn, Jerry] Harvard Interfac Initiat Medicat & Soc, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							2008, JOINT M PER CENTR NE	1	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2008	359	10					991	994		10.1056/NEJMp0805922	http://dx.doi.org/10.1056/NEJMp0805922			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	343KN	18768941				2022-12-24	WOS:000258852500002
J	Belcher, CM; McElwain, JC				Belcher, C. M.; McElwain, J. C.			Limits for combustion in low O-2 redefine paleoatmospheric predictions for the mesozoic	SCIENCE			English	Article							OXYGEN; FIRE; MODEL; EVOLUTION; RISE	Several studies have attempted to determine the lower limit of atmospheric oxygen under which combustion can occur; however, none have been conducted within a fully controlled and realistic atmospheric environment. We performed experimental burns ( using pine wood, moss, matches, paper, and a candle) at 20 degrees C in O-2 concentrations ranging from 9 to 21% and at ambient and high CO2 (2000 parts per million) in a controlled environment room, which was equipped with a thermal imaging system and full atmospheric, temperature, and humidity control. Our data reveal that the lower O-2 limit for combustion should be increased from 12 to 15%. These results, coupled with a record of Mesozoic paleowildfires, are incompatible with the prediction of prolonged intervals of low atmospheric O-2 levels (10 to 12%) in the Mesozoic.	[Belcher, C. M.; McElwain, J. C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland	University College Dublin	Belcher, CM (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland.	claire.belcher@ucd.ie	McElwain, Jennifer/AAX-1605-2020; McElwain, Jennifer/B-1735-2009	McElwain, Jennifer/0000-0002-1729-6755	European Union Marie Curie Excellence Grant [MEXT-CT-2006-042531]	European Union Marie Curie Excellence Grant(European Commission)	We acknowledge funding through a European Union Marie Curie Excellence Grant (MEXT-CT-2006-042531). We thank T. Gallagher for the use of the thermal imaging camera; M. Haworth, R. O'Hare, and D. Martin for much help and assistance in setting up the UCD Peac facility; J. Hunt and C. Hunt for supplying the moss; T. Lenton and two anonymous reviewers for improving the manuscript; L. Mander for insightful comments throughout; and M. Haworth, L. Mander, and M. Steinthorsdottir for safety supervision while working in subambient O<INF>2</INF> conditions.	Agee JK, 2002, FOREST ECOL MANAG, V167, P57, DOI 10.1016/S0378-1127(01)00690-9; ALBINI FA, 1976, INT30 USDA FOR SER; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; COPE MJ, 1980, NATURE, V283, P647, DOI 10.1038/283647a0; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Huey RB, 2005, SCIENCE, V308, P398, DOI 10.1126/science.1108019; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P249, DOI 10.1029/1999GB900076; Lenton TM, 2001, GLOBAL CHANGE BIOL, V7, P613, DOI 10.1046/j.1354-1013.2001.00429.x; LENTON TM, 2003, EVOLUTION PLANET EAR, P33; RASBASH DJ, 1968, COMBUST FLAME, V12, P33, DOI 10.1016/0010-2180(68)90006-0; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P281, DOI 10.1016/S0031-0182(00)00192-9; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6; Watson A.J., 1978, THESIS U READING; Wildman RA, 2004, GEOLOGY, V32, P457, DOI 10.1130/G20255.1	20	128	139	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1197	1200		10.1126/science.1160978	http://dx.doi.org/10.1126/science.1160978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755974				2022-12-24	WOS:000258754400041
J	Bercovich, D; Ganmore, I; Scott, LM; Wainreb, G; Birger, Y; Elimelech, A; Chen, SC; Cazzaniga, G; Biondi, A; Basso, G; Cario, G; Schrappe, M; Stanulla, M; Strehl, S; Haas, OA; Mann, G; Binder, V; Borkhardt, A; Kempski, H; Trka, J; Bielorei, B; Avigad, S; Stark, B; Smith, O; Dastugue, N; Bourquin, JP; Ben Tal, N; Green, AR; Izraeli, S				Bercovich, Dani; Ganmore, Ithamar; Scott, Linda M.; Wainreb, Gilad; Birger, Yehudit; Elimelech, Arava; Chen, Shochat; Cazzaniga, Giovanni; Biondi, Andrea; Basso, Giuseppe; Cario, Gunnar; Schrappe, Martin; Stanulla, Martin; Strehl, Sabine; Haas, Oskar A.; Mann, Georg; Binder, Vera; Borkhardt, Arndt; Kempski, Helena; Trka, Jan; Bielorei, Bella; Avigad, Smadar; Stark, Batia; Smith, Owen; Dastugue, Nicole; Bourquin, Jean-Pierre; Ben Tal, Nir; Green, Anthony R.; Izraeli, Shai			Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome	LANCET			English	Article							MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; MEGAKARYOBLASTIC LEUKEMIA; ACQUIRED MUTATIONS; GATA1; EXPRESSION; CHILDREN; RECEPTOR	Background Children with Down's syndrome have a greatly increased risk of acute megakaryoblastic and acute lymphoblastic leukaemias. Acute megakaryoblastic leukaemia in Down's syndrome is characterised by a somatic mutation in GATA1. Constitutive activation of the JAK/STAT (Janus kinase and signal transducer and activator of transcription) pathway occurs in several haematopoietic malignant diseases. We tested the hypothesis that mutations in JAK2 might be a common molecular event in acute lymphoblastic leukaemia associated with Down's syndrome. Methods JAK2 DNA mutational analysis was done on diagnostic bone marrow samples obtained from 88 patients with Down's syndrome-associated acute lymphoblastic: leukaemia; and 216 patients with sporadic acute lymphoblastic: leukaemia, Down's syndrome-associated acute megakaryoblastic leukaemia, and essential thrombocythaemia. Functional consequences of identified mutations were studied in mouse haematopoietic progenitor cells. Findings Somatically acquired JAK2 mutations were identified in 16 (18%) patients with Down's syndrome-associated acute lymphoblastic leukaemia. The only patient with non-Down's syndrome-associated leukaemia but with a JAK2 mutation had an isochromosome 21q. Children with a JAK2 mutation were younger (mean [SE] age 4.5 years [0 . 86] vs 8.6 years [0 . 59], p<0 . 0001) at diagnosis. Five mutant alleles were identified, each affecting a highly conserved arginine residue (R683). These mutations immortalised primary mouse haematopoietic progenitor cells in vitro, and caused constitutive Jak/Stat activation and cytokine-independent growth of BaF3 cells, which was sensitive to pharmacological inhibition with JAK inhibitor 1. In modelling studies of the JAK2 pseudokinase domain, R683 was situated in an exposed conserved region separated from the one implicated in myeloproliferative disorders. Interpretation A specific genotype- phenotype association exists between the type of somatic mutation within the JAK2 pseudokinase domain and the development of B-lymphoid or myeloid neoplasms. Somatically acquired R683 JAK2 mutations define a distinct acute lymphoblastic leukaemia subgroup that is uniquely associated with trisomy 21. JAK2 inhibitors could be useful for treatment of this leukaemia. Funding Israel Trade Ministry, Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association, Curtis Katz, Constantiner Institute for Molecular Genetics, German-Israel Foundation, and European Commission FP6 Integrated Project EUROHEAR.	[Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel; [Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Migal Galilee Biotechnol Ctr, Human Mol Genet & Pharmacogenet Lab, Kiryat Shmona, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Tel Hai Acad Coll, Tel Hai, Israel; [Wainreb, Gilad; Ben Tal, Nir] Tel Aviv Univ, Dept Biochem, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Scott, Linda M.; Green, Anthony R.] Cambridge Inst Med Res, Cambridge, England; [Cazzaniga, Giovanni; Biondi, Andrea] Univ Milano Bicocca, Hosp San Gerardo, Res Ctr Tettamanti, Paediat Clin, Monza, Italy; [Basso, Giuseppe] Univ Padua, Dept Paediat, Lab Oncohaematol, Padua, Italy; [Cario, Gunnar; Schrappe, Martin] Univ Hosp Schleswig Holstein, Dept Paediat, Kiel, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Paediat Haematol & Oncol, D-3000 Hannover, Germany; [Strehl, Sabine; Haas, Oskar A.; Mann, Georg] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Binder, Vera; Borkhardt, Arndt] Univ Dusseldorf, Clin Paediat Oncol Haematol & Clin Immunol, Childrens Univ Hosp, Dusseldorf, Germany; [Kempski, Helena] Great Ormond St Hosp Sick Children, Inst Child Hlth, London WC1N 3JH, England; [Trka, Jan] Charles Univ Prague, Sch Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Trka, Jan] Univ Hosp Motol, Motol, Czech Republic; [Avigad, Smadar; Stark, Batia] Schneider Childrens Hosp, Dept Paediat Haematooncol, Petah Tiqwa, Israel; [Smith, Owen] Univ Dublin Trinity Coll, Dept Haematol, Dublin 2, Ireland; [Dastugue, Nicole] Univ Hosp Ctr Toulouse, Toulouse, France; [Bourquin, Jean-Pierre] Univ Zurich, Dept Paediat Oncol, Univ Childrens Hosp, Zurich, Switzerland	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Hai Academy College; Tel Aviv University; University of Cambridge; University of Milano-Bicocca; University of Padua; University of Kiel; Schleswig Holstein University Hospital; Hannover Medical School; Saint Anna Children's Hospital; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Charles University Prague; Motol University Hospital; Trinity College Dublin; CHU de Toulouse; University Children's Hospital Zurich; University of Zurich	Izraeli, S (corresponding author), Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel.	sizraeli@sheba.health.gov.il	Schrappe, Martin/ABA-6144-2020; Binder, Vera/N-2078-2015; Trka, Jan/Y-4820-2019; Smith, Owen/AAU-8929-2020; Stanulla, Martin/N-4674-2017; Schrappe, Martin/A-8109-2010; Scott, Linda/D-9777-2012; Bourquin, Jean-Pierre/C-2802-2011; Biondi, Andrea/K-9997-2016; Stanulla, Martin/D-2528-2010; Biondi, Andrea/AAX-1865-2020; Cario, Gunnar/D-2535-2010; Haas, Oskar/AAM-5794-2020; Cazzaniga, Giovanni/K-6338-2016	Stanulla, Martin/0000-0002-3834-0727; Scott, Linda/0000-0003-0334-1479; Bourquin, Jean-Pierre/0000-0001-6571-6227; Biondi, Andrea/0000-0002-6757-6173; Ben-Tal, Nir/0000-0001-6901-832X; Cazzaniga, Giovanni/0000-0003-2955-4528; Green, Anthony/0000-0002-9795-0218; Strehl, Sabine/0000-0002-0179-0628; BASSO, GIUSEPPE/0000-0002-2634-9302	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation; Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation; European Commission FP6 Integrated Project EURCHEAR [LSHG-CT-20054-512063]; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G0300723B] Funding Source: researchfish	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); European Commission FP6 Integrated Project EURCHEAR(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is an international BFM study. This study has been done as part fulfilment of the requirement for a PhD degree by IG at the Faculty ofmedicine, Tel-Aviv University. We thank Wei Tong, Drorit Neuman, Connie Eavs, and James Griffin for the gifts of reagents; and Inna Muler, Cohava Cohen, Gil Smooha, Nir Gefen, Itamar Goldstein, and Dasa Janousek for their assistance. This study was partly funded by grants from Israel Trade Ministry (to DB) and Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association (to S I), Curtis Katz (to SI), Constantiner Institute for Molecular Genetics (to IG), and German-Israel Foundation (to Sl and AB). NBT received support from the European Commission FP6 Integrated Project EURCHEAR, LSHG-CT-20054-512063.	Bercovich D, 2003, GENET TEST, V7, P189, DOI 10.1089/109065703322537197; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Izraeli S, 2007, BLOOD CELL MOL DIS, V39, P156, DOI 10.1016/j.bcmd.2007.04.004; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Norton A, 2007, BLOOD, V110, P1077, DOI 10.1182/blood-2007-03-080374; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; PRIEST JH, 1988, HUM GENET, V81, P1, DOI 10.1007/BF00283718; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Vyas P, 2006, EARLY HUM DEV, V82, P767, DOI 10.1016/j.earlhumdev.2006.09.016; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Whitlock JA, 2005, BLOOD, V106, P4043, DOI 10.1182/blood-2003-10-3446	29	249	253	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1484	1492		10.1016/S0140-6736(08)61341-0	http://dx.doi.org/10.1016/S0140-6736(08)61341-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18805579				2022-12-24	WOS:000260801300025
J	Perrotta, S; Gallagher, PG; Mohandas, N				Perrotta, Silverio; Gallagher, Patrick G.; Mohandas, Narla			Hereditary spherocytosis	LANCET			English	Review							RED-CELL SKELETON; INCREASED OSMOTIC FRAGILITY; ANEMIA TYPE-II; BAND-3 DEFICIENCY; ANKYRIN GENE; SUBTOTAL SPLENECTOMY; SPECTRIN DEFICIENCY; FRAMESHIFT MUTATION; HEMOLYTIC-ANEMIA; MOLECULAR-BASIS	Hereditary spherocytosis is a common inherited disorder that is characterised by anaemia, jaundice, and splenomegaly. It is reported worldwide and is the most common inherited anaemia in individuals of northern European ancestry. Clinical severity is variable with most patients having a well-compensated haemolytic anaemia. Some individuals are asymptomatic, whereas others have severe haemolytic anaemia requiring erythrocyte transfusion. The primary lesion in hereditary spherocytosis is loss of membrane surface area, leading to reduced deformability due to defects in the membrane proteins ankyrin, band 3, beta spectrin, alpha spectrin, or protein 4.2. Many isolated mutations have been identified in the genes encoding these membrane proteins; common hereditary spherocytosis-associated mutations have not been identified. Abnormal spherocytes are trapped and destroyed in the spleen and this is the main cause of haemolysis in this disorder. Common complications are cholelithiasis, haemolytic episodes, and aplastic crises. Splenectomy is curative but should be undertaken only after careful assessment of the risks and benefits.	[Perrotta, Silverio] Univ Naples 2, Dipartimento Pediat, I-80138 Naples, Italy; [Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA	Universita della Campania Vanvitelli; Yale University; New York Blood Center	Perrotta, S (corresponding author), Univ Naples 2, Dipartimento Pediat, Via S Andrea Dame 4, I-80138 Naples, Italy.	silverio.perrotta@unina2.it		Perrotta, Silverio/0000-0001-6149-6845	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania [LR 5/02, 2005, DK62039, HK65488, DK26263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263, R01DK062039] Funding Source: NIH RePORTER	Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was partly provided by grants from Progetti di Rilevante Interesse Nazionale, Agenzia Italiana del Farmaco, and Regione Campania (LR 5/02, 2005) to SP, DK62039 and HK65488 to PGG, and DK26263 to NM.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; Akar N, 2002, PEDIATR HEMAT ONCOL, V19, P569, DOI 10.1080/08880010290097431; Alloisio N, 1997, BLOOD, V90, P414; Alloisio N, 1996, BLOOD, V88, P1062; An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; Bader-Meunier B, 2001, BLOOD, V97, P399, DOI 10.1182/blood.V97.2.399; Balaguer EJ, 2006, J SURG RES, V134, P68, DOI 10.1016/j.jss.2006.02.053; BECKER PS, 1993, J CLIN INVEST, V92, P612, DOI 10.1172/JCI116628; Bellows CF, 2005, AM FAM PHYSICIAN, V72, P637; Berardi A, 2006, BIOL NEONATE, V90, P243, DOI 10.1159/000093668; Boguslawska DM, 2004, ANN HEMATOL, V83, P28, DOI 10.1007/s00277-003-0739-5; Bolton-Maggs PHB, 2004, BRIT J HAEMATOL, V126, P455, DOI 10.1111/j.1365-2141.2004.05052.x; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Bracher NA, 2001, BRIT J HAEMATOL, V113, P689, DOI 10.1046/j.1365-2141.2001.02800.x; Brown KE, 2000, BEST PRACT RES CL HA, V13, P245, DOI 10.1053/beha.1999.0071; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Calhoun SK, 2001, PEDIATR RADIOL, V31, P879, DOI 10.1007/s002470100011; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Cartron JP, 2001, LANCET, pS57, DOI 10.1016/S0140-6736(01)07069-6; Castagnola E, 2003, EUR J HAEMATOL, V71, P319, DOI 10.1034/j.1600-0609.2003.00158.x; Caterino M, 2006, FEBS LETT, V580, P6527, DOI 10.1016/j.febslet.2006.10.070; Cavill I, 1996, BRIT MED J, V312, P430; CHASIS JA, 1988, J CLIN INVEST, V82, P617, DOI 10.1172/JCI113640; Cherif-Zahar B, 1998, BLOOD, V92, P2535, DOI 10.1182/blood.V92.7.2535.2535_2535_2540; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; Curro G, 2006, SURG ENDOSC, V20, P252, DOI 10.1007/s00464-005-0318-z; Cynober T, 1996, J LAB CLIN MED, V128, P259, DOI 10.1016/S0022-2143(96)90027-X; Da Costa L, 2001, BLOOD, V98, P2894, DOI 10.1182/blood.V98.10.2894; DACIE J, 1985, HAEMOLYTIC ANAEMIA, P134; Dacie JV, 1991, PRACTICAL HAEMATOLOG, P195; Danise P, 2001, CLIN LAB HAEMATOL, V23, P7, DOI 10.1046/j.1365-2257.2001.00354.x; Davies JM, 2002, CLIN MED, V2, P440, DOI 10.7861/clinmedicine.2-5-440; del Giudice EM, 2001, BRIT J HAEMATOL, V112, P42; del Giudice EM, 1999, BLOOD, V94, P2259, DOI 10.1182/blood.V94.7.2259.419k42_2259_2262; del Giudice EM, 1998, BRIT J HAEMATOL, V101, P251, DOI 10.1046/j.1365-2141.1998.00688.x; del Giudice EM, 1998, J PEDIATR-US, V132, P117; Delaunay J, 2004, BRIT J HAEMATOL, V127, P118, DOI 10.1111/j.1365-2141.2004.05160.x; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; delGiudice EM, 1997, HAEMATOLOGICA, V82, P332; DELGIUDICE EM, 1994, BRIT J HAEMATOL, V88, P52; Delhommeau F, 2000, BLOOD, V95, P393, DOI 10.1182/blood.V95.2.393; Dhermy D, 1997, BRIT J HAEMATOL, V98, P32, DOI 10.1046/j.1365-2141.1997.1893005.x; Dhermy D, 2000, CLIN LAB HAEMATOL, V22, P329, DOI 10.1046/j.1365-2257.2000.00319.x; Discher DE, 2001, CELL MOL BIOL LETT, V6, P593; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; EBER SW, 1992, ANN HEMATOL, V64, P88, DOI 10.1007/BF01715351; Eber SW, 1999, ANN HEMATOL, V78, P524, DOI 10.1007/s002770050550; EBER SW, 1990, J PEDIATR-US, V117, P409, DOI 10.1016/S0022-3476(05)81081-9; Edelman EJ, 2007, BLOOD, V109, P5491, DOI 10.1182/blood-2006-09-046573; Farah RA, 1997, J PEDIATR-US, V131, P41, DOI 10.1016/S0022-3476(97)70122-7; Gallagher P., 2003, HEMATOLOGY INFANCY C, P560; Gallagher P. G., 2005, HEMATOLOGY BASIC PRI, P669; Gallagher Patrick G, 2004, Curr Hematol Rep, V3, P85; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Gallagher PG, 2005, HUM MOL GENET, V14, P2501, DOI 10.1093/hmg/ddi254; Gallagher PG, 2001, J BIOL CHEM, V276, P41683, DOI 10.1074/jbc.M105844200; GALLAGHER PG, 1995, J CLIN INVEST, V95, P1174, DOI 10.1172/JCI117766; Gallagher PG, 2000, BRIT J HAEMATOL, V111, P1190, DOI 10.1046/j.1365-2141.2000.02441.x; GALLAGHER PG, 2005, HEMATOLOGY BASIC PRI, P576; Giraldi S, 2003, PEDIATR DERMATOL, V20, P427, DOI 10.1046/j.1525-1470.2003.20512.x; GODAL HC, 1981, SCAND J HAEMATOL, V27, P30; Guarnone R, 1996, BRIT J HAEMATOL, V92, P150, DOI 10.1046/j.1365-2141.1996.00285.x; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; HANSPAL M, 1991, BLOOD, V77, P165; Hassoun H, 1997, BLOOD, V90, P398; Heimpel H, 2003, BLOOD, V102, P4576, DOI 10.1182/blood-2003-02-0613; Hery G, 2008, SURG ENDOSC, V22, P45, DOI 10.1007/s00464-007-9509-0; Huang CH, 2000, SEMIN HEMATOL, V37, P150, DOI 10.1016/S0037-1963(00)90040-4; Iolascon A, 1998, BLOOD, V91, P1093, DOI 10.1182/blood.V91.3.1093; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Jalbert F, 2005, J NEUROSURG-SPINE, V2, P491, DOI 10.3171/spi.2005.2.4.0491; Jardine DL, 2004, INTERN MED J, V34, P214, DOI 10.1111/j.1444-0903.2004.00580.x; Jarolim P, 1996, BLOOD, V88, P4366; JAROLIM P, 1994, J CLIN INVEST, V93, P121, DOI 10.1172/JCI116935; JAROLIM P, 1995, BLOOD, V85, P3278, DOI 10.1182/blood.V85.11.3278.bloodjournal85113278; JENSSON O, 1977, ACTA MED SCAND, V201, P187; Jugenburg M, 1999, J PEDIATR SURG, V34, P1064, DOI 10.1016/S0022-3468(99)90565-1; Kaplinsky C, 2006, PEDIATR BLOOD CANCER, V47, P740, DOI 10.1002/pbc.21014; Kedar PS, 2004, CLIN CHIM ACTA, V344, P221, DOI 10.1016/j.cccn.2004.02.021; Kerr R, 2000, CLIN LAB HAEMATOL, V22, P365, DOI 10.1046/j.1365-2257.2000.00338.x; Kimura F, 2003, AM J ROENTGENOL, V181, P1021, DOI 10.2214/ajr.181.4.1811021; King MJ, 2004, BRIT J HAEMATOL, V124, P106, DOI 10.1046/j.1365-2141.2003.04730.x; KORONES D, 1989, J PEDIATR-US, V114, P264, DOI 10.1016/S0022-3476(89)80794-2; Kutter Dolphe, 2002, Clin Lab, V48, P163; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; Lima PRM, 2005, EUR J HAEMATOL, V74, P396, DOI 10.1111/j.1600-0609.2004.00405.x; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; MACKENZIE FA, 1962, LANCET, V1, P1102; MARTINEZCLIMENT JA, 1995, EUR J PEDIATR, V154, P753, DOI 10.1007/BF02276723; MCLANE NJ, 1984, AM J OPHTHALMOL, V97, P444, DOI 10.1016/S0002-9394(14)76127-6; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1986, BLOOD, V68, P506; Mohler PJ, 2005, FRONT BIOSCI, V10, P2832, DOI 10.2741/1739; MOTTA M, 1999, SURG LAPARO ENDO PER, V9, P203; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Ozcan R, 2003, BRIT J HAEMATOL, V122, P669, DOI 10.1046/j.1365-2141.2003.04479.x; PAJOR A, 1993, ARCH GYNECOL OBSTET, V253, P37, DOI 10.1007/BF02770632; PEKRUN A, 1993, ANN HEMATOL, V67, P89, DOI 10.1007/BF01788132; Perrotta S, 2005, BLOOD, V106, P4359, DOI 10.1182/blood-2005-07-2806; Perrotta S, 1999, HAEMATOLOGICA, V84, P660; Perrotta S, 1999, BLOOD, V93, P2131; Peters LL, 2004, BLOOD, V103, P3233, DOI 10.1182/blood-2003-08-2813; PINTO L, 1995, INT J PEDIAT HEM ONC, V2, P43; Premetis EVANGELOS, 1999, Hematology, V4, P361; Price VE, 2006, PEDIATR BLOOD CANCER, V46, P597, DOI 10.1002/pbc.20477; Reliene R, 2002, BLOOD, V100, P2208, DOI 10.1182/blood.V100.6.2208.h81802002208_2208_2215; Rescorla FJ, 2002, AM SURGEON, V68, P297; Rescorla FJ, 2007, ANN SURG, V246, P683, DOI 10.1097/SLA.0b013e318155abb9; Ribeiro ML, 2000, BLOOD, V96, P1602; Ricard MP, 2000, HAEMATOLOGICA, V85, P994; Ricard MP, 1996, CLIN LAB HAEMATOL, V18, P75, DOI 10.1046/j.1365-2257.1996.00157.x; Rice HE, 2003, ANN SURG, V237, P281, DOI 10.1097/00000658-200302000-00019; Saada V, 2006, PEDIATR HEMAT ONCOL, V23, P387, DOI 10.1080/08880010600646662; Sanchez-Lopez JY, 2003, BLOOD CELL MOL DIS, V31, P357, DOI 10.1016/S1079-9796(03)00207-9; Sandler A, 1999, J PEDIATR SURG, V34, P1077, DOI 10.1016/S0022-3468(99)90569-9; SAVVIDES P, 1993, BLOOD, V82, P2953; SCHILLING RF, 1995, ANN INTERN MED, V122, P187, DOI 10.7326/0003-4819-122-3-199502010-00005; Schilling RF, 1997, LANCET, V350, P1677, DOI 10.1016/S0140-6736(05)64276-6; Schilling RF, 2006, AM J HEMATOL, V81, P315, DOI 10.1002/ajh.20566; SCHROTER W, 1983, J PEDIATR-US, V103, P460, DOI 10.1016/S0022-3476(83)80428-4; Shatz DV, 2005, EXPERT REV VACCINES, V4, P27, DOI 10.1586/14760584.4.1.27; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P791, DOI 10.1111/j.1365-2141.2005.05956.x; Stoehr GA, 2006, BRIT J HAEMATOL, V132, P788, DOI 10.1111/j.1365-2141.2005.05918.x; Stoya G, 2006, ACTA HAEMATOL-BASEL, V116, P186, DOI 10.1159/000094679; SUMMERFIELD GP, 1985, LANCET, V2, P1070; Tamary H, 2003, J PEDIAT HEMATOL ONC, V25, P952, DOI 10.1097/00043426-200312000-00009; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Tchernia G, 2000, Hematol J, V1, P146, DOI 10.1038/sj.thj.6200022; TCHERNIA G, 1993, BLOOD, V81, P2014; Tewari M, 2006, J SURG ONCOL, V93, P629, DOI 10.1002/jso.20529; Toye AM, 2005, BLOOD, V105, P4088, DOI 10.1182/blood-2004-05-1895; Troendle SB, 2007, PEDIATR BLOOD CANCER, V49, P781, DOI 10.1002/pbc.21319; Ustun C, 2003, ACTA HAEMATOL-BASEL, V109, P46, DOI 10.1159/000067273; Van Dort HM, 2001, J BIOL CHEM, V276, P46968, DOI 10.1074/jbc.M107855200; Vasilescu C, 2006, SURG ENDOSC, V20, P748, DOI 10.1007/s00464-005-0429-6; Vermeulen S, 2002, AM J MED GENET, V108, P315, DOI 10.1002/ajmg.10295; Wandersee NJ, 2004, BLOOD, V103, P710, DOI 10.1182/blood-2003-02-0492; WHITFIELD CF, 1991, BLOOD, V78, P3043; Wichterle H, 1996, J CLIN INVEST, V98, P2300, DOI 10.1172/JCI119041; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Yawata Y, 2000, INT J HEMATOL, V71, P118	147	384	403	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1411	1426		10.1016/S0140-6736(08)61588-3	http://dx.doi.org/10.1016/S0140-6736(08)61588-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18940465				2022-12-24	WOS:000260228200028
J	Bakal, C; Linding, R; Llense, F; Heffern, E; Martin-Blanco, E; Pawson, T; Perrimon, N				Bakal, Chris; Linding, Rune; Llense, Flora; Heffern, Elleard; Martin-Blanco, Enrique; Pawson, Tony; Perrimon, Norbert			Phosphorylation networks regulating JNK activity in diverse genetic backgrounds	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CELL POLARITY; DORSAL CLOSURE; DROSOPHILA; PATHWAY; PHOSPHATASE; MOVEMENT; INVASION; ENCODES; PROTEIN	Cellular signaling networks have evolved to enable swift and accurate responses, even in the face of genetic or environmental perturbation. Thus, genetic screens may not identify all the genes that regulate different biological processes. Moreover, although classical screening approaches have succeeded in providing parts lists of the essential components of signaling networks, they typically do not provide much insight into the hierarchical and functional relations that exist among these components. We describe a high-throughput screen in which we used RNA interference to systematically inhibit two genes simultaneously in 17,724 combinations to identify regulators of Drosophila JUN NH(2)-terminal kinase (JNK). Using both genetic and phosphoproteomics data, we then implemented an integrative network algorithm to construct a JNK phosphorylation network, which provides structural and mechanistic insights into the systems architecture of JNK signaling.	[Bakal, Chris; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Bakal, Chris; Heffern, Elleard; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02215 USA; [Linding, Rune] Inst Canc Res, Cellular & Mol Log Team, London SW3 6JB, England; [Llense, Flora; Martin-Blanco, Enrique] CSIC, Spanish Council Sci Res, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bakal, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02215 USA.	cbakal@receptor.med.harvard.edu	Pawson, Tony J/E-4578-2013; Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X; Perrimon, Norbert/0000-0001-7542-472X; Linding, Rune/0000-0003-0420-4839; Bakal, Chris/0000-0002-0413-6744	Genome Canada; Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007); European Union (FP6)	Genome Canada(Genome Canada); Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (FP6)(European Commission)	We are deeply indebted to the Drosophila RNAi Screening Center and to J. Aach, S. Lee, C. Jorgensen, B. Mathey-Prevot, and B. Bodenmiller. The NetworKIN and NetPhorest algorithms are available at http://networkin.info and http://NetPhorest.info, respectively. This work is supported by Genome Canada through the Ontario Genomics Institute, the Spanish Ministerio de Ciencia e Innovacion (BFU/Consolider 2007), and the European Union (FP6). C.B. is a Fellow of the Leukemia and Lymphoma Society. N.P. is an Investigator of the Howard Hughes Medical Institute.	AFFOLTER M, 1994, DEVELOPMENT, V120, P3105; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Chiariello M, 1998, ONCOGENE, V16, P2435, DOI 10.1038/sj.onc.1201778; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Massimi P, 2003, EXP CELL RES, V290, P265, DOI 10.1016/S0014-4827(03)00317-3; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005	23	99	101	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					453	456		10.1126/science.1158739	http://dx.doi.org/10.1126/science.1158739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927396	Green Accepted			2022-12-24	WOS:000260094500050
J	Cheng, MH				Cheng, Margaret Harris			Nigeria struggles to contain poliomyelitis	LANCET			English	News Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1287	1290		10.1016/S0140-6736(08)61534-2	http://dx.doi.org/10.1016/S0140-6736(08)61534-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18946911	Bronze			2022-12-24	WOS:000260060500011
J	Wright, AA; Zhang, BH; Ray, A; Mack, JW; Trice, E; Balboni, T; Mitchell, SL; Jackson, VA; Block, SD; Maciejewski, PK; Prigerson, HG				Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Mack, Jennifer W.; Trice, Elizabeth; Balboni, Tracy; Mitchell, Susan L.; Jackson, Vicki A.; Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.			Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVANCED CANCER-PATIENTS; TREATMENT PREFERENCES; FAMILY CAREGIVERS; IMMINENT DEATH; SERIOUSLY ILL; BAD-NEWS; COMMUNICATION; PROGNOSIS; PHYSICIANS; ILLNESS	Context Talking about death can be difficult. Without evidence that end- of- life discussions improve patient outcomes, physicians must balance their desire to honor patient autonomy against a concern of inflicting psychological harm. Objective To determine whether end- of- life discussions with physicians are associated with fewer aggressive interventions. Design, Setting, and Participants A US multisite, prospective, longitudinal cohort study of patients with advanced cancer and their informal caregivers ( n= 332 dy-ads), September 2002- February 2008. Patients were followed up from enrollment to death, a median of 4.4 months later. Bereaved caregivers' psychiatric illness and quality of life was assessed a median of 6.5 months later. Main Outcome Measures Aggressive medical care ( eg, ventilation, resuscitation) and hospice in the final week of life. Secondary outcomes included patients' mental health and caregivers' bereavement adjustment. Results One hundred twenty- three of 332 ( 37.0%) patients reported having end-of-life discussions before baseline. Such discussions were not associated with higher rates of major depressive disorder ( 8.3% vs 5.8%; adjusted odds ratio [ OR], 1.33; 95% confidence interval [ CI], 0.54- 3.32), or more worry ( mean McGill score, 6.5 vs 7.0; P=. 19). After propensity- score weighted adjustment, end- of- life discussions were associated with lower rates of ventilation ( 1.6% vs 11.0%; adjusted OR, 0.26; 95% CI, 0.08- 0.83), resuscitation ( 0.8% vs 6.7%; adjusted OR, 0.16; 95% CI, 0.03- 0.80), ICU admission ( 4.1% vs 12.4%; adjusted OR, 0.35; 95% CI, 0.14- 0.90), and earlier hospice enrollment ( 65.6% vs 44.5%; adjusted OR, 1.65; 95% CI, 1.04- 2.63). In adjusted analyses, more aggressive medical care was associated with worse patient quality of life ( 6.4 vs 4.6; F= 3.61, P=. 01) and higher risk of major depressive disorder in bereaved caregivers ( adjusted OR, 3.37; 95% CI, 1.12- 10.13), whereas longer hospice stays were associated with better patient quality of life ( mean score, 5.6 vs 6.9; F= 3.70, P=. 01). Better patient quality of life was associated with better caregiver quality of life at follow- up (beta=. 20; P=. 001). Conclusions End- of- life discussions are associated with less aggressive medical care near death and earlier hospice referrals. Aggressive care is associated with worse patient quality of life and worse bereavement adjustment.	[Wright, Alexi A.; Trice, Elizabeth] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wright, Alexi A.; Zhang, Baohui; Ray, Alaka; Trice, Elizabeth; Balboni, Tracy; Block, Susan D.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, Boston, MA 02115 USA; [Mack, Jennifer W.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; [Ray, Alaka; Jackson, Vicki A.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Balboni, Tracy] Harvard Univ, Harvard Radiat Oncol Program, Boston, MA USA; [Jackson, Vicki A.; Block, Susan D.; Prigerson, Holly G.] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Block, Susan D.; Maciejewski, Paul K.; Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 550 Shields Warren,44 Binney St, Boston, MA 02115 USA.	awright2@partners.org	Wright, Alexi/T-5793-2019; Prigerson, Holly/L-3800-2019; Prigerson, Holly/GWV-3283-2022; Balboni, Tracy/AAH-4490-2020	Prigerson, Holly/0000-0002-7075-4268; 	National Cancer Institute [CA 106370]; National Institute of Mental Health [MH63892]; National Cancer Institute's "Program in Cancer Outcomes Research Training" [CA 92044343]; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG033640] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute's "Program in Cancer Outcomes Research Training"; Dana-Farber Cancer Institute's Friends Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants CA 106370 from the National Cancer Institute and MH63892 from the National Institute of Mental Health. Dr Wright was supported, in part, by grant CA 92044343, which is part of the National Cancer Institute's "Program in Cancer Outcomes Research Training" and by the Dana-Farber Cancer Institute's Friends Fellowship.	Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; [Anonymous], 1999, DEATH FORETOLD PROPH; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baile WF, 2002, J CLIN ONCOL, V20, P2189, DOI 10.1200/JCO.2002.08.004; Balboni TA, 2007, J CLIN ONCOL, V25, P555, DOI 10.1200/JCO.2006.07.9046; CARALIS PV, 1993, J CLIN ETHIC, V4, P155; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cherlin E, 2005, J PALLIAT MED, V8, P1176, DOI 10.1089/jpm.2005.8.1176; Chu KC, 2007, J NATL MED ASSOC, V99, P1092; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; ENDICOTT J, 1984, CANCER, V53, P2243; First M. B., 2002, STRUCTURED CLIN INTE; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Gessert Charles E., 2001, Ethnicity and Disease, V11, P97; Gordon EJ, 2003, BIOETHICS, V17, P142, DOI 10.1111/1467-8519.00330; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Hancock K, 2007, PALLIATIVE MED, V21, P507, DOI 10.1177/0269216307080823; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Helft PR, 2005, J CLIN ONCOL, V23, P3146, DOI 10.1200/JCO.2005.07.003; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Lamont E B, 2000, J Palliat Med, V3, P27, DOI 10.1089/jpm.2000.3.27; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lehmann L, 2007, J CLIN ONCOL, V25; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Mack JW, 2008, CANCER-AM CANCER SOC, V112, P2509, DOI 10.1002/cncr.23476; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; PRIGERSON HG, 1992, J HEALTH SOC BEHAV, V33, P378, DOI 10.2307/2137315; Ptacek JT, 2001, J BEHAV MED, V24, P205, DOI 10.1023/A:1010766732373; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ray A, 2006, J PALLIAT MED, V9, P1359, DOI 10.1089/jpm.2006.9.1359; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Siegel MD, 2008, CRIT CARE MED, V36, P1722, DOI 10.1097/CCM.0b013e318174da72; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Sullivan AM, 2007, J PALLIAT MED, V10, P882, DOI 10.1089/jpm.2007.0189; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; The AM, 2001, WESTERN J MED, V174, P247, DOI 10.1136/ewjm.174.4.247; Trice ED, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.6506; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	49	1788	1796	7	156	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 8	2008	300	14					1665	1673		10.1001/jama.300.14.1665	http://dx.doi.org/10.1001/jama.300.14.1665			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356YF	18840840	Bronze, Green Accepted			2022-12-24	WOS:000259812800028
J	Hampton, T				Hampton, Tracy			Researchers devise innovative method to overcome cancer-related drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; PARK IH, 2008, CELL            0807; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1507	1508		10.1001/jama.300.13.1507	http://dx.doi.org/10.1001/jama.300.13.1507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827202				2022-12-24	WOS:000259617700004
J	Kaklamani, VG; Wisinski, KB; Sadim, M; Gulden, C; Do, A; Offit, K; Baron, JA; Ahsan, H; Mantzoros, C; Pasche, B				Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Do, Albert; Offit, Kenneth; Baron, John A.; Ahsan, Habibul; Mantzoros, Christos; Pasche, Boris			Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-I; CORONARY-ARTERY-DISEASE; IGF-I; PLASMA ADIPONECTIN; METABOLIC SYNDROME; BINDING PROTEIN-3; RECTAL-CANCER; COLON-CANCER; APM1 GENE; C-PEPTIDE	Context Current epidemiological evidence suggests an association between obesity, hyperinsulinemia, and colorectal cancer risk. Adiponectin is a hormone secreted by the adipose tissue, and serum levels are inversely correlated with obesity and hyperinsulinemia. While there is evidence of an association between circulating adiponectin levels and colorectal cancer risk, no association between genes of the adiponectin pathway and colorectal cancer have been reported to date. Objective To determine the association of 10 haplotype-tagging single-nucleotide polymorphisms (SNPs) of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes with colorectal cancer risk. Design, Setting, and Patients Two case-control studies including patients with a diagnosis of colorectal cancer and controls were recruited between 2000 and 2007. Case-control study 1 included a total of 441 patients with a diagnosis of colorectal cancer and 658 controls; both groups were of Ashkenazi Jewish ancestry and from new York, New York. Case-control study 2 included 199 patients with a diagnosis of colorectal cancer and 199 controls from Chicago, Illinois, matched 1:1 for sex, age, and ethnicity. Main Outcome Measures ADIPOQ and ADIPOR1 SNP frequency among cases and controls. Results In study 1, after adjustment for age, sex, and SNPs from the same gene, 3 ADIPOQ SNPs and 1 ADIPOR1 SNP were associated with colorectal cancer risk: rs266729 (adjusted odds ratio [AOR], 0.72; 95% confidence interval [CI], 0.55-0.95) and rs822396 (AOR, 0.37; 95% CI, 0.14-1.00) were associated with decreased risk whereas rs822395 (AOR, 1.76; 95% CI, 1.09-2.84) and rs1342387 (AOR, 1.79; 95% CI, 1.18-2.72) were associated with increased risk. In study 2, after adjustment for age, sex, race, and SNPs from the same gene, the ADIPOQ SNP rs266729 was associated with a decreased colorrectal cancer risk of similar magnitude as in study 1 (AOR, 0.52; 95% CI, 0.34-0.78). Combined analysis of both studies shows an association of rs266729 with decreased colorectal cancer risk (AOR, 0.73; 95% Ci, 0.53-0.99). Conclusion The SNP rs266729, which tags the 5' flanking region of the ADIPOQ gene, is associated with decreased colorectal cancer risk. .	[Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Canc Genet Program, Div Hematol & Oncol, Dept Med, Chicago, IL 60611 USA; [Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Do, Albert; Mantzoros, Christos] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab,Dept Med, Boston, MA USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Baron, John A.] Dartmouth Med Sch, Dept Med & Community, Hanover, NH USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Dartmouth College; Dartmouth College; University of Chicago	Pasche, B (corresponding author), Univ Alabama Birmingham, Div Hematol Oncol, 1802 6th Ave S,NP 2666, Birmingham, AL 35294 USA.	Boris.Pasche@ccc.uab.edu	Mantzoros, Christos/Y-2902-2019		Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health [CA112520, CA108741, DK081913, DK79929, DK 58785]; American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE [R01CA112520, R01CA108741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058785, R01DK058785, R01DK079929, K24DK081913] Funding Source: NIH RePORTER	Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Walter S. Mander Foundation (Chicago, Illinois); grants CA112520, CA108741, DK081913, DK79929, DK 58785 from the National Institutes of Health; the Jeannik M. Littlefield-AACR Grant in Metastatic Colon Cancer Research from the American Institute for Cancer Research; a discretionary grant from Beth Israel Deaconess Medical Center; the Lynn Sage Foundation and the American Society of Clinical Oncology Career Development Award; and the Niehaus Clinical Cancer Genetics Initiative.	Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Crimmins NA, 2007, OBES REV, V8, P419, DOI 10.1111/j.1467-789X.2007.00348.x; Drew JE, 2007, AM J PHYSIOL-GASTR L, V293, pG682, DOI 10.1152/ajpgi.00231.2007; Fenton JI, 2008, INT J CANCER, V122, P2437, DOI 10.1002/ijc.23436; Filippi E, 2005, J MOL MED, V83, P711, DOI 10.1007/s00109-005-0667-z; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230; Pischon T, 2007, OBESITY, V15, P2051, DOI 10.1038/oby.2007.244; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qi L, 2006, DIABETES, V55, P1512, DOI 10.2337/db05-1520; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197	31	105	111	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1523	1531		10.1001/jama.300.13.1523	http://dx.doi.org/10.1001/jama.300.13.1523			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827209	Green Accepted, Bronze			2022-12-24	WOS:000259617700016
J	Hiratsuka, T; Furihata, K; Ishikawa, J; Yamashita, H; Itoh, N; Seto, H; Dairi, T				Hiratsuka, Tomoshige; Furihata, Kazuo; Ishikawa, Jun; Yamashita, Haruyuki; Itoh, Nobuya; Seto, Haruo; Dairi, Tohru			An alternative menaquinone biosynthetic pathway operating in microorganisms	SCIENCE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOMYCES-COELICOLOR A3(2); HELICOBACTER-PYLORI; VITAMIN-K; METABOLISM	In microorganisms, menaquinone is an obligatory component of the electron- transfer pathway. It is derived from chorismate by seven enzymes in Escherichia coli. However, a bioinformatic analysis of whole genome sequences has suggested that some microorganisms, including pathogenic species such as Helicobacter pylori and Campylobacter jejuni, do not have orthologs of the men genes, even though they synthesize menaquinone. We deduced the outline of this alternative pathway in a nonpathogenic strain of Streptomyces by bioinformatic screening, gene knockouts, shotgun cloning with isolated mutants, and in vitro studies with recombinant enzymes. As humans and commensal intestinal bacteria, including lactobacilli, lack this pathway, it represents an attractive target for the development of chemotherapeutics.	[Hiratsuka, Tomoshige; Itoh, Nobuya; Dairi, Tohru] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Furihata, Kazuo] Univ Tokyo, Div Agr & Agr Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Shinjuku Ku, Dept Bioact Mol, Tokyo 1628640, Japan; [Yamashita, Haruyuki] ADEKA Corp, Adv Mat Res & Dev Lab, Arakawa Ku, Tokyo 1168553, Japan; [Seto, Haruo] Tokyo Univ Agr, Setagaya Ku, Fac Appl Biosci, Tokyo 1568502, Japan	Toyama Prefectural University; University of Tokyo; National Institute of Infectious Diseases (NIID); Tokyo University of Agriculture	Dairi, T (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	dairi@pu-toyama.ac.jp	Dairi, Tohru/A-5448-2012; Hiratsuka, Tomoshige/C-7447-2017	Dairi, Tohru/0000-0002-3406-7970	Grant-in-Aid for Scientific Research (B); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"; Ministry of Education, Culture, Sports, Science and Technology of Japan; Urakami Foundation; Skylark Food Science Institute	Grant-in-Aid for Scientific Research (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation); Skylark Food Science Institute	This work was supported in part by a Grant-in-Aid for Scientific Research (B) to S. H. and by a Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Urakami Foundation, and the Skylark Food Science Institute to T.D. Author contributions: T.H., H.S., and T.D. conceived and designed the experiments; T.H., K.F., J.I., H.S., and T. D. performed the experiments; T.H., K.F., H.Y., N.I., H.S., and T.D. analyzed the data; and H.S. and T.D. wrote the paper. The DNA sequences determined and characterized in this study have been deposited in the DDBJ, EMBL, and GenBank data banks as follows: SCO4506, AB447888; SCO4327, AB447889; SCO4550, AB447890; SCO4326, AB447891; TTHA0556, AB447892; TTHA1568, AB447893.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HOPWOOD DA, 1985, GENE MANIPULATION ST; Hosokawa N, 1999, CHEM PHARM BULL, V47, P1032; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Marcelli SW, 1996, FEMS MICROBIOL LETT, V138, P59; Meganathan R, 2001, VITAM HORM, V61, P173; MOSS CW, 1990, J CLIN MICROBIOL, V28, P395, DOI 10.1128/JCM.28.2.395-397.1990; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Plaza SM, 2005, ALTERN MED REV, V10, P24; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	22	177	188	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1670	1673		10.1126/science.1160446	http://dx.doi.org/10.1126/science.1160446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801996				2022-12-24	WOS:000259300400033
J	Turnbaugh, PJ; Gordon, JI				Turnbaugh, Peter J.; Gordon, Jeffrey I.			An invitation to the marriage of metagenomics and metabolomics	CELL			English	Article							MICROBIOME	Metagenomics seeks to characterize the composition of microbial communities, their operations, and their dynamically coevolving relationships with the habitats they occupy without having to culture community members. Uniting metagenomics with analyses of the products of microbial community metabolism (metabolomics) will shed light on how microbial communities function in a variety of environments, including the human body.	[Turnbaugh, Peter J.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu		Turnbaugh, Peter/0000-0002-0888-2875				DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DRAKE HL, 2006, PROKARYOTES, V2, P354, DOI DOI 10.1007/0-387-30742-7_13; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godzik A, 2007, CELL MOL LIFE SCI, V64, P2505, DOI 10.1007/s00018-007-7211-y; Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Prentice AM, 2008, J CLIN INVEST, V118, P1322, DOI 10.1172/JCI34034; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	32	168	179	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					708	713		10.1016/j.cell.2008.08.025	http://dx.doi.org/10.1016/j.cell.2008.08.025			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775300	Bronze			2022-12-24	WOS:000258947500007
J	Leaper, D; Burman-Roy, S; Palanca, A; Cullen, K; Worster, D; Gautam-Aitken, E; Whittle, M				Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin		Guideline Dev Grp	GUIDELINES Prevention and treatment of surgical site infection: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Leaper, David; Burman-Roy, Shona; Palanca, Ana; Cullen, Katherine; Worster, Danielle; Gautam-Aitken, Eva; Whittle, Martin] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Leaper, David] Cardiff Univ, Dept Wound Healing, Cardiff, S Glam, Wales	Cardiff University	Leaper, D (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, Kings Court,2-16 Goodge St, London W1T 2QA, England.	profdavidleaper@doctors.org.uk	Palanca, Ana/E-1541-2018	Palanca, Ana/0000-0003-3513-4458; Cullen, Katherine/0000-0002-3704-4598	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	National Institute for Health and Clinical Excellence, 2008, SURG SIT INF; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020	2	67	71	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2008	337								a1924	10.1136/bmj.a1924	http://dx.doi.org/10.1136/bmj.a1924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368AM	18957455				2022-12-24	WOS:000260593700032
J	Williams, LE; Bargh, JA				Williams, Lawrence E.; Bargh, John A.			Experiencing physical warmth promotes interpersonal warmth	SCIENCE			English	Article							UNIVERSAL DIMENSIONS; SOCIAL-PERCEPTION; 1ST IMPRESSIONS	"Warmth" is the most powerful personality trait in social judgment, and attachment theorists have stressed the importance of warm physical contact with caregivers during infancy for healthy relationships in adulthood. Intriguingly, recent research in humans points to the involvement of the insula in the processing of both physical temperature and interpersonal warmth (trust) information. Accordingly, we hypothesized that experiences of physical warmth (or coldness) would increase feelings of interpersonal warmth (or coldness), without the person's awareness of this influence. In study 1, participants who briefly held a cup of hot (versus iced) coffee judged a target person as having a "warner" personality (generous, caring); in study 2, participants holding a hot (versus cold) therapeutic pad were more likely to choose a gift for a friend instead of for themselves.	[Williams, Lawrence E.] Univ Colorado, Leeds Sch Business, Boulder, CO 80309 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	University of Colorado System; University of Colorado Boulder; Yale University	Williams, LE (corresponding author), Univ Colorado, Leeds Sch Business, UCB 419, Boulder, CO 80309 USA.	lawrence.williams@colorado.edu	Williams, Lawrence/AAE-1725-2021		National Institute of Mental Health [MH-R01-60767]; NSF Graduate Research Fellowship; Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Yale International Center for Finance Whitebox Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Bloom, J. Gray, F. Keil, E. Morsella, A. Poehlman, P. Winkielman, S. Gottlieb, K Connolly, S. Hennessey, and funding from National Institute of Mental Health (grant MH-R01-60767), a NSF Graduate Research Fellowship, and a Yale International Center for Finance Whitebox Fellowship.	Asch S., 1958, PERSON PERCEPTION IN, P86; ASCH SE, 1946, J ABNORM SOC PSYCH, V41, P258, DOI 10.1037/h0055756; Balter M, 2007, SCIENCE, V315, P1208, DOI 10.1126/science.315.5816.1208; Bowlby J., 1969, ATTACHMENT AND LOSS; Clark H.H., 1973, COGNITIVE DEV ACQUIS, P27; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Higgins E.T., 1996, SOCIAL PSYCHOL HDB B, P133; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson M., 1987, BODY MIND BODILY BAS; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Lorenz K., 1966, AGGRESSION; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meyer-Lindenberg A, 2008, SCIENCE, V321, P778, DOI 10.1126/science.1162908; Niedenthal PM, 1999, PSYCHOL REV, V106, P337, DOI 10.1037/0033-295X.106.2.337; NISBETT RE, 1977, J PERS SOC PSYCHOL, V35, P250, DOI 10.1037//0022-3514.35.4.250; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sweetser E.E., 1990, ETYMOLOGY PRAGMATICS; TAIMY L, 1988, COGNITIVE SCI, V12, P49; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001	26	629	665	19	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					606	607		10.1126/science.1162548	http://dx.doi.org/10.1126/science.1162548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948544	Green Accepted, Green Submitted			2022-12-24	WOS:000260299100048
J	Yawar, A				Yawar, Athar			Can doctors think?	LANCET			English	Editorial Material									[Yawar, Athar] The Lancet, London NW1 7BY, England		Yawar, A (corresponding author), The Lancet, London NW1 7BY, England.							Borges Jorge Luis, 1970, ALEPH OTHER STORIES; DEIKMAN A, 1982, OBSERVING SELF; Evans-Pritchard E E, 1951, WITCHCRAFT ORACLES M; Illich I., 1995, LIMITS MED; Illich I., 1970, DESCHOOLING SOC; Kingsley P., 2003, REALITY INVERNESS; LESSING D, 1994, PRISONS WE CHOOSE LI; Littlewood R., 2000, CULTURAL PSYCHIAT ME; Micale Mark, 1995, APPROACHING HYSTERIA; Owen GS, 2007, BRIT J PSYCHIAT, V191, P453, DOI 10.1192/bjp.bp.107.037309; Polanyi M., 1962, PERSONAL KNOWLEDGE; RAHNEMA M, 1997, POST DEV READER; SHAH I, 1982, SEEKER TRUTH	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1285	1286		10.1016/S0140-6736(08)61533-0	http://dx.doi.org/10.1016/S0140-6736(08)61533-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929891				2022-12-24	WOS:000260060500010
J	Montalvo, G; Avanzini, F; Anselmi, M; Prandi, R; Ibarra, S; Marquez, M; Armani, D; Moreira, JM; Caicedo, C; Roncaglioni, MC; Colombo, F; Camisasca, P; Milani, V; Quimi, S; Gonzabay, F; Tognoni, G				Montalvo, Gregorio; Avanzini, Fausto; Anselmi, Mariella; Prandi, Rosanna; Ibarra, Samuel; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola; Milani, Valentina; Quimi, Simon; Gonzabay, Felix; Tognoni, Gianni			Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ADULT DEATHS; DISABILITY; MORTALITY; PREVENTION; INTERHEART; MANAGEMENT	Objectives To explore the predictive power of a risk stratification method for people with hypertension based on "essential" procedures ( that is, available in economically less developed areas of the world), comparing it in the same population with the results given by the method suggested by the 1999 World Health Organization-International Society of Hypertension ( WHO-ISH) guidelines. Design Prospective cohort study of outcomes according to cardiovascular risk profile at baseline. Setting Primary care in a poor rural area of the Ecuadorian forest. Participants 504 people with hypertension prospectively monitored for a mean of 6.7 ( SD 2.3) years. Interventions Essential data included blood pressure, medical history, smoking, age, sex, and diagnosis of diabetes; the WHO- ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and the incidence of cardiovascular events and of total deaths: up to three quarters of all cardiovascular events and two thirds of all deaths were reported among people classified as at high or very high risk with either method. The predictive discrimination of the essential method is comparable with the WHO- ISH with C statistics ( 95% confidence interval) of 0.788 ( 0.721 to 0.855) and 0.744 ( 0.673 to 0.815), respectively, for cardiovascular events and 0.747 ( 0.678 to 0.816) and 0.705 ( 0.632 to 0.778) for total mortality. Conclusions The risk stratification of patients with hypertension with an essential package of variables ( that is, available and practicable even in the economically less developed areas of the world) serves at least as well as the more comprehensive method proposed by WHO- ISH.	[Montalvo, Gregorio; Anselmi, Mariella; Prandi, Rosanna; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia] Ctr Epidemiol Comunitaria & Med Trop CECOMET, Esmeraldas, Ecuador; [Avanzini, Fausto; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola] Ist Ric Farmacol Mario Negri, Lab Ric Med Gen, I-20156 Milan, Italy; [Anselmi, Mariella] Osped S Cuore, Ctr Malatt Trop, I-37034 Verona, Italy; [Ibarra, Samuel; Caicedo, Cynthia; Quimi, Simon; Gonzabay, Felix] Minist Salud Publ, Sist Local Salud, Borbon, Ecuador; [Milani, Valentina] Ist Ric Farmacol Mario Negri, Lab Stat Med, I-20156 Milan, Italy; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Avanzini, F (corresponding author), Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Via Masa 19, I-20156 Milan, Italy.	avanzini@marionegri.it	roncaglioni, maria carla/AAB-1875-2020; Milani, Valentina/AAB-5367-2019	roncaglioni, maria carla/0000-0002-2029-7847; Milani, Valentina/0000-0002-2989-981X; Avanzini, Fausto/0000-0002-4029-2891				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 1996, World Health Organ Tech Rep Ser, V862, P1; [Anonymous], 1977, World Health Organ Tech Rep Ser, P1; Anselmi M, 2003, LANCET, V361, P1186, DOI 10.1016/S0140-6736(03)12918-2; Chalmers J, 1999, J HYPERTENS, V17, P151; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Charlton RW, 2001, S AFR MED J, V91, P163; Cuspidi C, 2001, Ital Heart J, V2, P702; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gajalakshmi V, 2006, INT J EPIDEMIOL, V35, P748, DOI 10.1093/ije/dyl112; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lemogoum D, 2003, J HYPERTENS, V21, P1993, DOI 10.1097/00004872-200311000-00003; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *PREV CARD DIS, 2007, GUID ASS MAN CARD RI; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; *WHO, 2002, INT MAN CARD RISK RE; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	33	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1387	10.1136/bmj.a1387	http://dx.doi.org/10.1136/bmj.a1387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18805835	hybrid, Green Published			2022-12-24	WOS:000259797600039
J	Nichol, G; Thomas, E; Callaway, CW; Hedges, J; Powell, JL; Aufderheide, TP; Rea, T; Lowe, R; Brown, T; Dreyer, J; Davis, D; Idris, A; Stiell, I				Nichol, Graham; Thomas, Elizabeth; Callaway, Clifton W.; Hedges, Jerris; Powell, Judy L.; Aufderheide, Tom P.; Rea, Tom; Lowe, Robert; Brown, Todd; Dreyer, John; Davis, Dan; Idris, Ahamed; Stiell, Ian			Regional variation in out-of-hospital cardiac arrest incidence and outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; AMERICAN-HEART-ASSOCIATION; MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; COMATOSE SURVIVORS; DISEASE; CARE; RESUSCITATION; MORTALITY; COMMITTEE	Context The health and policy implications of regional variation in incidence and outcome of out-of-hospital cardiac arrest remain to be determined. Objective To evaluate whether cardiac arrest incidence and outcome differ across geographic regions. Design, Setting, and Patients Prospective observational study ( the Resuscitation Outcomes Consortium) of all out- of- hospital cardiac arrests in 10 North American sites ( 8 US and 2 Canadian) from May 1, 2006, to April 30, 2007, followed up to hospital discharge, and including data available as of June 28, 2008. Cases ( aged 0- 108 years) were assessed by organized emergency medical services ( EMS) personnel, did not have traumatic injury, and received attempts at external defibrillation or chest compressions or resuscitation was not attempted. Census data were used to determine rates adjusted for age and sex. Main Outcome Measures Incidence rate, mortality rate, case- fatality rate, and survival to discharge for patients assessed or treated by EMS personnel or with an initial rhythm of ventricular fibrillation. Results Among the 10 sites, the total catchment population was 21.4 million, and there were 20 520 cardiac arrests. A total of 11 898 ( 58.0%) had resuscitation attempted; 2729 ( 22.9% of treated) had initial rhythm of ventricular fibrillation or ventricular tachycardia or rhythms that were shockable by an automated external defibrillator; and 954 ( 4.6% of total) were discharged alive. The median incidence of EMS- treated cardiac arrest across sites was 52.1 ( interquartile range [ IQR], 48.0- 70.1) per 100 000 population; survival ranged from 3.0% to 16.3%, with a median of 8.4% ( IQR, 5.4%- 10.4%). Median ventricular fibrillation incidence was 12.6 ( IQR, 10.6- 5.2) per 100 000 population; survival ranged from 7.7% to 39.9%, with a median of 22.0% ( IQR, 15.0%- 24.4%), with significant differences across sites for incidence and survival ( P <. 001). Conclusion In this study involving 10 geographic regions in North America, there were significant and important regional differences in out- of- hospital cardiac arrest incidence and outcome.	[Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Seattle, WA 98104 USA; [Nichol, Graham; Thomas, Elizabeth; Powell, Judy L.] Univ Washington, Clin Trial Ctr, Dept Biostat, Seattle, WA 98195 USA; [Rea, Tom] Seattle King Cty Dept Publ Hlth, Seattle, WA USA; [Callaway, Clifton W.] Univ Pittsburgh, Pittsburgh, PA USA; [Hedges, Jerris; Lowe, Robert] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brown, Todd] Univ Alabama Birmingham, Birmingham, AL USA; [Dreyer, John] Univ Western Ontario, London, ON, Canada; [Davis, Dan] Univ Calif San Diego, San Diego, CA 92103 USA; [Idris, Ahamed] SW Texas State Univ, Dallas, TX USA; [Stiell, Ian] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Western University (University of Western Ontario); University of California System; University of California San Diego; Texas State University System; Texas State University San Marcos; University of Ottawa	Nichol, G (corresponding author), Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Box 359727,325 9th Ave, Seattle, WA 98104 USA.	nichol@u.washington.edu	Nichol, Graham/Z-4996-2019; Lowe, Robert A/A-4926-2008; Hedges, Jerris/AAC-1847-2021	Lowe, Robert A/0000-0002-4732-9634; Idris, Ahamed/0000-0001-7113-6499; Callaway, Clifton/0000-0002-3309-1573; Stiell, Ian/0000-0002-2583-6408	National Heart, Lung, and Blood Institute [5U01 HL077863, 5U01 HL077881, 5U01 HL077871, 5U01 HL077873, 5U01 HL077872, 5U01 HL077866, 5U01 HL077908, 5U01 HL077867, 5U01 HL077885]; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077872, U01HL077871, U01HL077867, U01HL077866, U01HL077863, U01HL077873, U01HL077908, U01HL077881, U01HL077885] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a cooperative agreement (grants 5U01 HL077863, HL077881, HL077871, HL077873, HL077872, HL077866, HL077908, HL077867, HL077885, and HL077885) with the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada. Medtronic Physio-Control Inc loaned equipment to several EMS agencies participating in the Alabama ROC site. These devices were used routinely in the course of the EMS duties and were not exclusively for ROC, but they were also used with ROC patients.	BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Bergner L, 1983, Am J Emerg Med, V1, P259, DOI 10.1016/0735-6757(83)90101-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brooks SC, 2007, CIRCULATION, V116, P934; Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EKSTROM L, 1994, RESUSCITATION, V27, P181, DOI 10.1016/0300-9572(94)90031-0; FRANDSEN F, 1991, CARDIOLOGY, V79, P256, DOI 10.1159/000174888; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan A, 2003, ANN EMERG MED, V41, P481, DOI 10.1067/mem.2003.108; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; GRAY AJ, 1987, BRIT MED J, V294, P1133, DOI 10.1136/bmj.294.6580.1133; Grmec S, 2007, RESUSCITATION, V72, P404, DOI 10.1016/j.resuscitation.2006.07.012; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Herlitz J, 2003, HEART, V89, P25, DOI 10.1136/heart.89.1.25; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; Institute of Medicine, 2006, EM MED SERV CROSSR; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Knafelj R, 2007, RESUSCITATION, V74, P227, DOI 10.1016/j.resuscitation.2007.01.016; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Little R. J. A., 1987, STAT ANAL MISSING DA; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Menon V, 2006, AM J MED, V119, P584, DOI 10.1016/j.amjmed.2006.01.018; Mitchell LB, 2003, J AM COLL CARDIOL, V42, P81, DOI 10.1016/S0735-1097(03)00498-4; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; PEDERSEN TR, 1994, LANCET, V344, P1383; Rea TD, 2004, AM J CARDIOL, V93, P1455, DOI 10.1016/j.amjcard.2004.03.002; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Rubin DB, 2004, MULTIPLE IMPUTATION; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Soo LH, 1999, EUR HEART J, V20, P535, DOI 10.1053/euhj.1998.1334; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stiell IG, 2009, ANN EMERG MED, V53, P241, DOI 10.1016/j.annemergmed.2008.03.018; Stiell IG, 1998, ANN EMERG MED, V32, P180, DOI 10.1016/S0196-0644(98)70135-0; TILLINGHAST SJ, 1991, AM J EPIDEMIOL, V134, P851, DOI 10.1093/oxfordjournals.aje.a116160; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; VANDERHOEVEN JG, 1995, NETH J MED, V46, P123, DOI 10.1016/0300-2977(94)00106-J; Wilkins R., 2002, HLTH REP S, V13, P45	50	1448	1513	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1423	1431		10.1001/jama.300.12.1423	http://dx.doi.org/10.1001/jama.300.12.1423			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812533	Green Accepted, Bronze			2022-12-24	WOS:000259410400020
J	Cox, P; Jones, C				Cox, Peter; Jones, Chris			Climate change - Illuminating the modern dance of climate and CO2	SCIENCE			English	Editorial Material							CARBON-CYCLE FEEDBACKS		[Cox, Peter] Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England; [Jones, Chris] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	University of Exeter; Met Office - UK; Hadley Centre	Cox, P (corresponding author), Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk; chris.d.jones@metoffice.gov.uk	Jones, Chris/I-2983-2014; Cox, Peter Michae;/B-3299-2012	Jones, Chris/0000-0002-7141-9285; Cox, Peter Michae;/0000-0002-0679-2219	Natural Environment Research Council [earth010002, earth010004] Funding Source: researchfish; NERC [earth010004, earth010002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Archer D, 1997, GEOPHYS RES LETT, V24, P405, DOI 10.1029/97GL00168; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; ETHERIDGE DM, 1993, J GEOPHYS RES, V101, P4115; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; Jones CD, 2001, J CLIMATE, V14, P4113, DOI 10.1175/1520-0442(2001)014<4113:TCCRTE>2.0.CO;2; Jones CD, 2006, TELLUS B, V58, P603, DOI 10.1111/j.1600-0889.2006.00215.x; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Scheffer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025044; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	12	69	70	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1642	1644		10.1126/science.1158907	http://dx.doi.org/10.1126/science.1158907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801988				2022-12-24	WOS:000259300400022
J	Oxley, DR; Smith, KB; Alford, JR; Hibbing, MV; Miller, JL; Scalora, M; Hatemi, PK; Hibbing, JR				Oxley, Douglas R.; Smith, Kevin B.; Alford, John R.; Hibbing, Matthew V.; Miller, Jennifer L.; Scalora, Mario; Hatemi, Peter K.; Hibbing, John R.			Political attitudes vary with physiological traits	SCIENCE			English	Article							DISEASE-AVOIDANCE; GENETIC-VARIATION; AMYGDALA; FEAR; ANXIETY; SUPPORT; THREAT	Although political views have been thought to arise largely from individuals' experiences, recent research suggests that they may have a biological basis. We present evidence that variations in political attitudes correlate with physiological traits. In a group of 46 adult participants with strong political beliefs, individuals with measurably lower physical sensitivities to sudden noises and threatening visual images were more likely to support foreign aid, liberal immigration policies, pacifism, and gun control, whereas individuals displaying measurably higher physiological reactions to those same stimuli were more likely to favor defense spending, capital punishment, patriotism, and the Iraq War. Thus, the degree to which individuals are physiologically responsive to threat appears to indicate the degree to which they advocate policies that protect the existing social structure from both external ( outgroup) and internal ( norm- violator) threats.	[Oxley, Douglas R.; Smith, Kevin B.; Miller, Jennifer L.; Hibbing, John R.] Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA; [Alford, John R.] Rice Univ, Dept Polit Sci, Houston, TX 77251 USA; [Hibbing, Matthew V.] Univ Illinois, Dept Polit Sci, Urbana, IL 61801 USA; [Scalora, Mario] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Hatemi, Peter K.] Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA	University of Nebraska System; University of Nebraska Lincoln; Rice University; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln; Virginia Commonwealth University	Hibbing, JR (corresponding author), Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA.	jhibbing@unl.edu	Alford, John R/A-2561-2009; sarinopoulos, isidoros/B-5453-2010; Hibbing, Matthew/AAF-3930-2020	Hatemi, Peter/0000-0001-6514-2614; Oxley, Douglas/0000-0003-2258-2112	NSF [SES-0721378, SES-0721707]; ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	NSF(National Science Foundation (NSF)); ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	We thank E. Whitaker, C. Jacobs, B. Sexton, K. A. Espy, J. Brehm, D. Bulling, and the James Long Company for their invaluable assistance. Financial support was provided by the NSF (SES-0721378 and SES-0721707), the ManTech Corporation, and the University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; [Anonymous], 1915, BODILY CHANGES PAIN; Bracha HS, 2005, J AFFECT DISORDERS, V88, P119, DOI 10.1016/j.jad.2005.05.013; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; CAMPBELL A, 1960, AM VOETER; Converse P.E, 1964, IDEOLOGY DISCONTENT; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/twin.2.2.62; Fahmy S, 2006, VIS COMMUN Q, V13, P4, DOI 10.1207/s15551407vcq1301_2; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; GROSSER GH, 1971, THREAT IMPENDING DIS; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Huddy L, 2005, AM J POLIT SCI, V49, P593, DOI 10.2307/3647734; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Larson CL, 2006, BIOL PSYCHIAT, V60, P410, DOI 10.1016/j.biopsych.2006.03.079; Lemche E, 2006, HUM BRAIN MAPP, V27, P623, DOI 10.1002/hbm.20206; Lodge M, 2005, POLIT PSYCHOL, V26, P455, DOI 10.1111/j.1467-9221.2005.00426.x; Mainen ZF, 2007, NAT NEUROSCI, V10, P1511, DOI 10.1038/nn1207-1511; Marcus G.E., 2000, AFFECTIVE INTELLIGEN; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; McDermott R., 2004, PERSPECT POLIT, V2, P691, DOI DOI 10.1017/S1537592704040459; MILLER A, 2007, DEV PSYCHOPHYSIOLOGY; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Page B, 1992, RATIONAL PUBLIC; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Stenner K., 2005, AUTHORITARIAN DYNAMI; Thase M.E., 1995, HDB DEPRESSION; Westen D., 2007, PUBLIC AFFAIRS; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Zaller J., 1992, NATURE ORIGINS MASS	38	303	307	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1667	1670		10.1126/science.1157627	http://dx.doi.org/10.1126/science.1157627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801995	Green Published			2022-12-24	WOS:000259300400032
J	Trumbore, SE; Czimczik, CI				Trumbore, Susan E.; Czimczik, Claudia I.			Geology - An uncertain future for soil carbon	SCIENCE			English	Editorial Material							ORGANIC-MATTER; CYCLE FEEDBACK; DYNAMICS; RELEASE; STORAGE; MODEL		[Trumbore, Susan E.; Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Trumbore, SE (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	setrumbo@uci.edu; czimczik@uci.edu	Trumbore, Susan/B-1948-2013	Czimczik, Claudia/0000-0002-8251-6603				Brantley SL, 2008, SCIENCE, V321, P1454, DOI 10.1126/science.1161132; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Holmes KW, 2005, BIOGEOCHEMISTRY, V74, P173, DOI 10.1007/s10533-004-3544-x; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260	16	165	177	25	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1455	1456		10.1126/science.1160232	http://dx.doi.org/10.1126/science.1160232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787159				2022-12-24	WOS:000259121800029
J	Pan, WJ; Choi, SC; Wang, H; Qin, YB; Volpicelli-Daley, L; Swan, L; Lucast, L; Khoo, C; Zhang, XW; Li, L; Abrams, CS; Sokol, SY; Wu, DQ				Pan, Weijun; Choi, Sun-Cheol; Wang, He; Qin, Yuanbo; Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise; Khoo, Cynthia; Zhang, Xiaowu; Li, Lin; Abrams, Charles S.; Sokol, Sergei Y.; Wu, Dianqing			Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation	SCIENCE			English	Article							WNT SIGNALING PATHWAY; DOMAIN; MEMBRANE	The canonical Wnt-beta-catenin signaling pathway is initiated by inducing phosphorylation of one of the Wnt receptors, low- density lipoprotein receptor- related protein 6 ( LRP6), at threonine residue 1479 ( Thr(1479)) and serine residue 1490 (Ser(1490)). By screening a human kinase small interfering RNA library, we identified phosphatidylinositol 4- kinase type II alpha and phosphatidylinositol- 4- phosphate 5- kinase type I (PIP5KI) as required for Wnt3a-induced LRP6 phosphorylation at Ser1490 in mammalian cells and confirmed that these kinases are important for Wnt signaling in Xenopus embryos. Wnt3a stimulates the formation of phosphatidylinositol 4,5-bisphosphates [PtdIns (4,5)P-2] through frizzled and dishevelled, the latter of which directly interacted with and activated PIP5KI. In turn, PtdIns (4,5)P-2 regulated phosphorylation of LRP6 at Thr(1479) and Ser(1490). Therefore, our study reveals a signaling mechanism for Wnt to regulate LRP6 phosphorylation.	[Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Choi, Sun-Cheol; Sokol, Sergei Y.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Wang, He; Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Wang, He; Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Cell Signaling, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Khoo, Cynthia; Abrams, Charles S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Zhang, Xiaowu] Cell Signaling Technol, Danvers, MA 01923 USA	Yale University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Howard Hughes Medical Institute; Yale University; University of Pennsylvania	Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	dan.wu@yale.edu		Swan, Laura/0000-0002-6312-6263; Sokol, Sergei/0000-0002-3963-9202	NIH [AR051476, CA132317, HL080706, NS36251, DA018343]; National Institute on Drug Abuse to Yale Neuroproteomics Center; Ministry of Science and Technology of China [2002CB513000]; National Science Foundation of China [30521005]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse to Yale Neuroproteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. De Camilli for making available resources from his lab in connection to this work, discussion, and critical reading of the manuscript; Z. Li, M. Orsulak, Y. Zhang, L. Tang, W. Liu, Y. Xi, F. Nie, Y. Wu, and X. Gan for technical assistance; and D. Sussman, C. Carpenter, R. Grosschedl, T. Balla, B. Williams, M. F. Roussel, X. He, C. Niehrs, R. Nusse, and J. Nathans for providing experimental materials. This work was supported by grants from NIH (AR051476, CA132317, HL080706, NS36251, and DA018343), the National Institute on Drug Abuse to Yale Neuroproteomics Center, the Ministry of Science and Technology of China (2002CB513000), and the National Science Foundation of China (30521005).	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hsuan JJ, 1998, ADV CANCER RES, V74, P167, DOI 10.1016/S0065-230X(08)60767-8; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, NATURE, V438, P747, DOI 10.1038/438747a; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	22	147	152	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1350	1353		10.1126/science.1160741	http://dx.doi.org/10.1126/science.1160741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772438	Green Accepted			2022-12-24	WOS:000258914300049
J	Rasko, DA; Moreira, CG; Li, DR; Reading, NC; Ritchie, JM; Waldor, MK; Williams, N; Taussig, R; Wei, SG; Roth, M; Hughes, DT; Huntley, JF; Fina, MW; Falck, JR; Sperandio, V				Rasko, David A.; Moreira, Cristiano G.; Li, De Run; Reading, Nicola C.; Ritchie, Jennifer M.; Waldor, Matthew K.; Williams, Noelle; Taussig, Ron; Wei, Shuguang; Roth, Michael; Hughes, David T.; Huntley, Jason F.; Fina, Maggy W.; Falck, John R.; Sperandio, Vanessa			Targeting QseC signaling and virulence for antibiotic development	SCIENCE			English	Article							BACTERIA; COMMUNICATION; INHIBITION; SENSOR	Many bacterial pathogens rely on a conserved membrane histidine sensor kinase, QseC, to respond to host adrenergic signaling molecules and bacterial signals in order to promote the expression of virulence factors. Using a high- throughput screen, we identified a small molecule, LED209, that inhibits the binding of signals to QseC, preventing its autophosphorylation and consequently inhibiting QseC- mediated activation of virulence gene expression. LED209 is not toxic and does not inhibit pathogen growth; however, this compound markedly inhibits the virulence of several pathogens in vitro and in vivo in animals. Inhibition of signaling offers a strategy for the development of broad- spectrum antimicrobial drugs.	[Rasko, David A.; Moreira, Cristiano G.; Reading, Nicola C.; Hughes, David T.; Huntley, Jason F.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Li, De Run; Williams, Noelle; Wei, Shuguang; Roth, Michael; Falck, John R.; Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ritchie, Jennifer M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Taussig, Ron; Fina, Maggy W.; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	vanessa.sperandio@utsouthwestern.edu	Falck, John R/B-3030-2011; Huntley, Jason F/N-3848-2015; Moreira, Cristiano/D-8694-2014; Moreira, Cristiano Gallina/AHB-1469-2022	Falck, John R/0000-0002-9219-7845; Huntley, Jason F/0000-0002-0501-6103; Moreira, Cristiano/0000-0002-0689-4119; Moreira, Cristiano Gallina/0000-0002-0689-4119; Waldor, Matthew/0000-0003-1843-7000; Roth, Michael/0000-0002-9056-332X; Ritchie, Jennifer/0000-0002-1244-3082; David, Rasko/0000-0002-7337-7154	NIH [RO3 NS053582, RO1 AI053067, RO1 GM31278, PO1-AI055637-03, UO1-AI77853, R21 AI067827]; Ellison Medical Foundation; Burroughs Wellcome Fund; Robert A. Welch Foundation; UT Southwestern Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055637, R21AI067827, R01AI053067, U01AI077853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS053582] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); UT Southwestern Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. V. Norgard, E. Vitetta, V. Miller, and S. L. McKnight for comments and J. Richardson for pathological review of tissues from LED209- treated mice. This work was supported by NIH grants RO3 NS053582, RO1 AI053067, RO1 GM31278, PO1- AI055637- 03, UO1- AI77853, and R21 AI067827; the Ellison Medical Foundation; the Burroughs Wellcome Fund; the Robert A. Welch Foundation; and a High Impact High Risk grant from UT Southwestern Medical Center. M. K. W. is a Howard Hughes Medical Institute investigator. This work yielded the provisional patent application UTSD: 1854USP1.	Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lyon GJ, 2003, CHEM BIOL, V10, P1007, DOI 10.1016/j.chembiol.2003.11.003; Merighi M, 2006, J BACTERIOL, V188, P141, DOI 10.1128/JB.188.1.141-149.2006; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; ROYCHOUDHURY S, 1993, P NATL ACAD SCI USA, V90, P965, DOI 10.1073/pnas.90.3.965; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Tarr PI, 2002, NEW ENGL J MED, V347, P2171; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	17	371	387	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1078	1080		10.1126/science.1160354	http://dx.doi.org/10.1126/science.1160354			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	339RL	18719281	Green Accepted			2022-12-24	WOS:000258594900037
J	Wang, LD; Wang, Y; Jin, SG; Wu, ZY; Chin, DP; Koplan, JP; Wilson, ME				Wang, Longde; Wang, Yu; Jin, Shuigao; Wu, Zunyou; Chin, Daniel P.; Koplan, Jeffrey P.; Wilson, Mary Elizabeth			Health system reform in China 2 Emergence and control of infectious diseases in China	LANCET			English	Article							STREPTOCOCCUS-SUIS; AVIAN INFLUENZA; SARS; BATS; CORONAVIRUSES; TRANSMISSION; OUTBREAK; VIRUS	Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.	[Wang, Yu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China; [Wang, Longde] Minist Hlth, Beijing, Peoples R China; [Jin, Shuigao] Chinese Ctr Dis Control & Prevent, Natl Ctr Publ Hlth Surveillance & Informat Serv, Beijing 100050, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Wilson, Mary Elizabeth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	wuzy@263.net			FOGARTY INTERNATIONAL CENTER [U2RTW006918] Funding Source: NIH RePORTER; FIC NIH HHS [U2R TW06918, U2R TW006918-05, U2R TW006918-04, U2R TW006918] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Chen SL, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/11/010; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; *CHIN CTR DIS CONT, NAT DAT NOT DIS CHIN; *CHIN MIN HLTH, 2006, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2005, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2007, NOT DIS CHIN 2006; *CHIN MIN HLTH, 2007, CHIN ANN HLTH STAT 2; Cook IG, 2004, HEALTH POLICY, V67, P329, DOI 10.1016/j.healthpol.2003.07.005; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Feng Ping, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P874; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI [10.1162/1535351041747905, DOI 10.1162/1535351041747905]; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Hampton T, 2005, JAMA-J AM MED ASSOC, V294, P2291, DOI 10.1001/jama.294.18.2291; Ho G, 2006, NURS INQ, V13, P2, DOI 10.1111/j.1440-1800.2006.00301.x; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lim W, 2006, ANN ACAD MED SINGAP, V35, P354; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Matsui S, 2005, WATER SCI TECHNOL, V51, P91, DOI 10.2166/wst.2005.0234; Mcfee RB, 2007, DM-DIS MON, V53, P343, DOI 10.1016/j.disamonth.2007.05.005; *NAT TECHN STEER G, 2002, CHIN J TUBERC RESP D, V25, P3; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Normile D, 2005, SCIENCE, V309, P1308; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; RANDS G, 1989, J ROY SOC HEALTH, V109, P79, DOI 10.1177/146642408910900302; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shao C, 1996, Chin Med Sci J, V11, P252; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; *STAT COUNC AIDS W, 2007, UN THEM GROUP AIDS C; TANG S, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)6134-1; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; United Nations Commission on Human Security, 2007, HUM DEV REP 2007 200; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; WANG L, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61358-6; Wang LF, 2007, CURR TOP MICROBIOL, V315, P325; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Watts J, 2004, LANCET, V363, P1370, DOI 10.1016/S0140-6736(04)16087-X; WHO, 2021, CUM NUMB CONF HUM CA; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang FJ, 2006, CHINESE MED J-PEKING, V119, P1999, DOI 10.1097/00029330-200612010-00010; ZHANG K, 2008, LANCET          1020, DOI DOI 10.1016/SO140-6736(08)61357-4; Zhang XB, 1996, ARS COMBINATORIA, V42, P3; ZHENG LQ, 2007, HLTH NEWS BEIJI 0608; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	51	262	292	7	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2008	372	9649					1598	1605		10.1016/S0140-6736(08)61365-3	http://dx.doi.org/10.1016/S0140-6736(08)61365-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367ZG	18930534	Green Published, Bronze			2022-12-24	WOS:000260590500034
J	Hawkes, N				Hawkes, Nigel			NHS dentistry: a service with teeth	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a2043	10.1136/bmj.a2043	http://dx.doi.org/10.1136/bmj.a2043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18940838				2022-12-24	WOS:000260298800030
J	Albrechtsen, S; Rasmussen, S; Thoresen, S; Irgens, LM; Iversen, OE				Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.; Iversen, Ole Erik			Pregnancy outcome in women before and after cervical conisation: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; PRETERM DELIVERY	Objectives To examine the consequences of cervical conisation in terms of adverse outcome in subsequent pregnancies. Design Population based cohort study. Data sources Data on cervical conisation derived from the Cancer Registry of Norway and on pregnancy outcome from the Medical Birth Registry of Norway, 1967- 2003. 15 108 births occurred in women who had previously undergone cervical conisation and 57 136 who subsequently underwent cervical conisation. In the same period there were 2 164 006 births to women who had not undergone relevant treatment ( control). Results The proportion of preterm delivery was 17.2% in women who gave birth after cervical conisation versus 6.7% in women who gave birth before cervical conisation and 6.2% in women who had not undergone cervical conisation. The relative risk of a late abortion (< 24 weeks' gestation) was 4.0 ( 95% confidence interval 3.3 to 4.8) in women who gave birth after cervical conisation compared with no cervical conisation. The relative risk of delivery was 4.4 ( 3.8 to 5.0) at 24- 27 weeks, 3.4 ( 3.1 to 3.7) at 28- 32 weeks, and 2.5 ( 2.4 to 2.6) at 33- 36 weeks. The relative risk of preterm delivery declined during the study period and especially of delivery before 28 weeks' gestation. Conclusion Cervical conisation influences outcome in subsequent pregnancies in terms of an increased risk of preterm delivery, especially in the early gestational age groups in which the clinical significance is highest. A careful clinical approach should be taken in the selection of women for cervical conisation and in the clinical care of pregnancies after a cervical conisation.	[Albrechtsen, Susanne; Rasmussen, Svein; Iversen, Ole Erik] Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.] Univ Bergen, Med Birth Registry Norway, Dept Publ Hlth & Primary Hlth Care, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Bergen, Norway; [Thoresen, Steinar] Canc Registry Norway, Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Oslo	Albrechtsen, S (corresponding author), Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway.	Susanne.Albrechtsen@Helse-Bergen.no	Albrechtsen, Susanne/H-4680-2019		Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	Norwegian Cancer Society.	Forsmo S, 1996, ACTA OBSTET GYN SCAN, V75, P139, DOI 10.3109/00016349609033306; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; KRISTENSEN J, 1993, ACTA OBSTET GYN SCAN, V72, P640, DOI 10.3109/00016349309021157; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LUND E, 1986, Tidsskrift for den Norske Laegeforening, V106, P543; *MED BIRTH REG NOR, 1998, BIRTH NORW 30 YEARS; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	14	118	122	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1343	10.1136/bmj.a1343	http://dx.doi.org/10.1136/bmj.a1343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18801869	hybrid, Green Published			2022-12-24	WOS:000259798000037
J	Yang, DS; Lao, CS; Zewail, AH				Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.			4D electron diffraction reveals correlated unidirectional Behavior in zinc oxide nanowires	SCIENCE			English	Article							ZNO; CRYSTALLOGRAPHY; NANOSTRUCTURES; NANOCRYSTALS; MICROSCOPY; DYNAMICS; GROWTH; ARRAYS; ROUTE	The confined electronic structure of nanoscale materials has increasingly been shown to induce behavior quite distinct from that of bulk analogs. Direct atomic- scale visualization of nanowires of zinc oxide was achieved through their unique pancake- type diffraction by using four- dimensional (4D) ultrafast electron crystallography. After electronic excitation of this wide- gap photonic material, the wires were found to exhibit colossal expansions, two orders of magnitude higher than that expected at thermal equilibrium; the expansion is highly anisotropic, a quasi- one- dimensional behavior, and is facilitated by the induced antibonding character. By reducing the density of nanowires, the expansions reach even larger values and occur at shorter times, suggesting a decrease of the structural constraint in transient atomic motions. This unanticipated ultrafast carrier- driven expansion highlights the optoelectronic consequences of nanoscale morphologies.	[Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	Zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291	NSF; Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the NSF and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech. We wish to thank Z.L. Wang for providing the samples, which were made by P. Fei and S. Xu, and K. Xu for the help with the SEM measurement in J.R. Heath's laboratory at Caltech.	Adachi S., 2004, HDB PHYS PROPERTIES; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Greene LE, 2005, NANO LETT, V5, P1231, DOI 10.1021/nl050788p; Gu B, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903576; He J, 2005, OPT EXPRESS, V13, P9235, DOI 10.1364/OPEX.13.009235; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; ICHIMIYA A, 2004, REFLECTION HIGH ENER, P20; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Lee HW, 2007, CHEM PHYS LETT, V447, P86, DOI 10.1016/j.cplett.2007.08.086; MULLER E, 2006, MICROSCOPY SEMICONDU, P303; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Si X, 2008, CHINESE PHYS B, V17, P1291, DOI 10.1088/1674-1056/17/4/024; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; Tang J, 2007, J PHYS CHEM C, V111, P8957, DOI 10.1021/jp073015t; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang ZL, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70076-7; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; WANG ZL, 1996, REFLECTION ELECT MIC; Warren B, 1990, XRAY DIFFRACTION, P253; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; Zhang CF, 2006, OPT LETT, V31, P3345, DOI 10.1364/OL.31.003345	30	62	62	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1660	1664		10.1126/science.1162049	http://dx.doi.org/10.1126/science.1162049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801993				2022-12-24	WOS:000259300400030
J	Haddad, RI; Shin, DM				Haddad, Robert I.; Shin, Dong M.			Recent advances in head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; MODULATED RADIATION-THERAPY; LYMPH-NODE METASTASIS; LOCALLY ADVANCED HEAD; MULTICENTER PHASE-II; HUMAN-PAPILLOMAVIRUS; PROTEIN-KINASE; CONCURRENT CHEMOTHERAPY; PREMALIGNANT LESIONS		[Haddad, Robert I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Haddad, Robert I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Haddad, Robert I.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shin, Dong M.] Emory Univ, Dept Hematol Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Emory University	Haddad, RI (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	robert_haddad@dfci.harvard.edu	Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013; Teh, Muy-Teck/B-9284-2016	Shin, Dong Moon/0000-0002-8245-4174; Teh, Muy-Teck/0000-0002-7725-8355; Haddad, Robert/0000-0003-1413-0079	ImClone Systems; Bristol-Myers Squibb; Sanofi-Aventis	ImClone Systems(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis)	Dr. Haddad reports receiving consulting fees from ImClone Systems and Bristol-Myers Squibb and lecture fees from Sanofi-Aventis and Bristol-Myers Squibb; and Dr. Shin, lecture fees from Bristol-Myers Squibb and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported. We thank Drs. Anthea Hammond and Souheil El-Chemaly for their critical reading of and assistance with the preparation of the manuscript.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Ang K, 2007, INT J RADIAT ONCOL, V69, pS12, DOI 10.1016/j.ijrobp.2007.07.023; Ang KK, 2002, CANCER RES, V62, P7350; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi HR, 2003, AM J SURG PATHOL, V27, P1216, DOI 10.1097/00000478-200309000-00004; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; COHEN S, 1980, J BIOL CHEM, V255, P4834; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; COPPER MP, 1995, ARCH OTOLARYNGOL, V121, P157; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Diwakar N, 2005, ORAL ONCOL, V41, P416, DOI 10.1016/j.oraloncology.2004.10.009; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Eisbruch A, 2005, NAT CLIN PRACT ONCOL, V2, P34, DOI 10.1038/ncponc0058; El-Naggar AK, 1997, DIAGN MOL PATHOL, V6, P305, DOI 10.1097/00019606-199712000-00001; ElNaggar AK, 1996, CLIN CANCER RES, V2, P903; ElNaggar AK, 1996, AM J PATHOL, V148, P2067; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FORASTIERE A, 2002, NEW ENGL J MED, V346, P788; Forastiere AA, 2006, J CLIN ONCOL, V24, p284S; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Garden AS, 2007, INT J RADIAT ONCOL, V67, P438, DOI 10.1016/j.ijrobp.2006.08.078; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gasco M, 2003, ORAL ONCOL, V39, P222, DOI 10.1016/S1368-8375(02)00163-X; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; Janot F, 1996, BRIT J CANCER, V73, P531, DOI 10.1038/bjc.1996.92; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Jin YT, 1999, ORAL ONCOL, V35, P251, DOI 10.1016/S1368-8375(98)00112-2; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; LAI SL, 1995, ONCOL REP, V2, P1115; Laird AD, 2000, CANCER RES, V60, P4152; Lee NY, 2006, INT J RADIAT ONCOL, V66, P966, DOI 10.1016/j.ijrobp.2006.06.040; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Li GJ, 2004, CARCINOGENESIS, V25, P1911, DOI 10.1093/carcin/bgh197; Li MF, 2002, CLIN CANCER RES, V8, P3570; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; MASUI H, 1984, CANCER RES, V44, P1002; MENDELSOHN J, 1988, PROG ALLERGY, V45, P147; Mendenhall WM, 2006, J CLIN ONCOL, V24, P2618, DOI 10.1200/JCO.2005.04.7225; Mosher William D, 2005, Adv Data, P1; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Papadimitrakopoulou VA, 2001, CLIN CANCER RES, V7, P3127; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perrone F, 2007, CLIN CANCER RES, V13, P4313; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Seiden MV, 2007, GYNECOL ONCOL, V104, P727, DOI 10.1016/j.ygyno.2006.10.019; SHAH JP, 1990, AM J SURG, V160, P405, DOI 10.1016/S0002-9610(05)80554-9; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; STEWART S, 2007, P AM ASS CANC RES AN; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tseng JE, 2001, CANCER-AM CANCER SOC, V92, P2364, DOI 10.1002/1097-0142(20011101)92:9<2364::AID-CNCR1584>3.0.CO;2-P; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; VERMORKEN J, 2007, EUR J CANCER, V5, P4; VERMORKEN J, 2007, 43 ANN M AM SOC CLIN; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vokes EE, 2005, J CLIN ONCOL, V23, p501S; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang XH, 2006, ORAL ONCOL, V42, P740, DOI 10.1016/j.oraloncology.2005.11.018; Weber A, 2003, PATHOL RES PRACT, V199, P391, DOI 10.1078/0344-0338-00435; WILLIAMS R, 1993, J BIOL CHEM, V268, P18213; Zhang ZD, 2004, CANCER EPIDEM BIOMAR, V13, P1081	90	688	706	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1143	1154		10.1056/NEJMra0707975	http://dx.doi.org/10.1056/NEJMra0707975			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784104				2022-12-24	WOS:000259078200010
J	Kamerow, D				Kamerow, Douglas			Jabbering about jabs	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] RTI Int, Manchester, Lancs, England	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Manchester, Lancs, England.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], 2008, MMWR-MORBID MORTAL W, V57, P893; 2008, BMJ, V337, pA1254	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2008	337	7669							a1517	10.1136/bmj.a1517	http://dx.doi.org/10.1136/bmj.a1517			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351JP	18768543				2022-12-24	WOS:000259420900029
J	Tang, JL; Liu, BY; Ma, KW				Tang, Jin-Ling; Liu, Bao-Yan; Ma, Kan-Wen			Traditional Chinese medicine	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS		[Tang, Jin-Ling] Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China; [Liu, Bao-Yan] Chinese Acad Med Sci, Beijing 100037, Peoples R China; [Ma, Kan-Wen] UCL, Wellcome Trust Ctr Hist Med, London, England	Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; University of London; University College London	Tang, JL (corresponding author), Chinese Univ Hong Kong, Hong Kong Cochrane Ctr, Sch Publ Hlth, Fac Med, Hong Kong, Peoples R China.	jltang@cuhk.edu.hk	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021; Ran, Mao-Sheng/I-7957-2013; Al-Bayati, Lubna Lubna al Bayati/E-5100-2019					*BEIJ U CHIN MED, 2006, CHIN STAT YB CHIN ME; BROWN AC, 2002, POTENTIALLY LIFE THR; European Medicines Agency, 2005, PUBL STAT RISK ASS U; Ezzo JM, 2006, COCHRANE DB SYST REV, V19, P2285, DOI DOI 10.1002/14651858.CD002285.PUB2; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; Keji C., 2003, EUR REV, V11, P225, DOI DOI 10.1017/S106279870300022X; Liang MX, 1998, PREDICAMENTS FUTURE, P1; MA KW, 1993, EW MED EXCHANGES THE, P154; *MED HEALTHC PROD, 2006, TOUGH ACT UK MED REG; Pittler MH, 1999, CLIN INFECT DIS, V28, P597, DOI 10.1086/515148; STRATHERN P, 2005, BRIEF HIST MED, P179; Tang JL, 2006, BMJ-BRIT MED J, V333, P391, DOI 10.1136/bmj.333.7564.391; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Tomlinson B, 2000, J CLIN PHARMACOL, V40, P451, DOI 10.1177/00912700022009206; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Vines G, 2004, HERBAL HARVESTS FUTU; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Zhang W, 2005, COCHRANE DB SYST REV, V2	19	305	314	8	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2008	372	9654					1938	1940		10.1016/S0140-6736(08)61354-9	http://dx.doi.org/10.1016/S0140-6736(08)61354-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380NE	18930523				2022-12-24	WOS:000261471600010
J	Kobayashi, YM; Rader, EP; Crawford, RW; Iyengar, NK; Thedens, DR; Faulkner, JA; Parikh, SV; Weiss, RM; Chamberlain, JS; Moore, SA; Campbell, KP				Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Thedens, Daniel R.; Faulkner, John A.; Parikh, Swapnesh V.; Weiss, Robert M.; Chamberlain, Jeffrey S.; Moore, Steven A.; Campbell, Kevin P.			Sarcolemma-localized nNOS is required to maintain activity after mild exercise	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ALPHA-SARCOGLYCAN; NEUROMUSCULAR DISORDERS; MICE; DEFICIENT; FATIGUE; THERAPY; COMPLEX	Many neuromuscular conditions are characterized by an exaggerated exercise- induced fatigue response that is disproportionate to activity level. This fatigue is not necessarily correlated with greater central or peripheral fatigue in patients(1), and some patients experience severe fatigue without any demonstrable somatic disease(2). Except in myopathies that are due to specific metabolic defects, the mechanism underlying this type of fatigue remains unknown(2). With no treatment available, this form of inactivity is a major determinant of disability(3). Here we show, using mouse models, that this exaggerated fatigue response is distinct from a loss in specific force production by muscle, and that sarcolemma-localized signalling by neuronal nitric oxide synthase ( nNOS) in skeletal muscle is required to maintain activity after mild exercise. We show that nNOS- null mice do not have muscle pathology and have no loss of muscle- specific force after exercise but do display this exaggerated fatigue response to mild exercise. In mouse models of nNOS mislocalization from the sarcolemma, prolonged inactivity was only relieved by pharmacologically enhancing the cGMP signal that results from muscle nNOS activation during the nitric oxide signalling response to mild exercise. Our findings suggest that the mechanism underlying the exaggerated fatigue response to mild exercise is a lack of contraction- induced signalling from sarcolemma- localized nNOS, which decreases cGMP- mediated vasomodulation in the vessels that supply active muscle after mild exercise. Sarcolemmal nNOS staining was decreased in patient biopsies from a large number of distinct myopathies, suggesting a common mechanism of fatigue. Our results suggest that patients with an exaggerated fatigue response to mild exercise would show clinical improvement in response to treatment strategies aimed at improving exercise- induced signalling.	[Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Kobayashi, Yvonne M.; Rader, Erik P.; Crawford, Robert W.; Iyengar, Nikhil K.; Parikh, Swapnesh V.; Weiss, Robert M.; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Faulkner, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chamberlain, Jeffrey S.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu		Chamberlain, Jeffrey/0000-0001-5299-0059; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051199, F32AR048742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; University of Iowa Cardiovascular Interdisciplinary Research; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senator Paul D. Wellstone Fellowship; Muscular Dystrophy Association Development Grant(Muscular Dystrophy Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Anderson and M. Henry for comments, and M. M. Kilburg, K. Uppal, B. J. Steinmann and S. Watkins and members of the Campbell laboratory for scientific contributions. This work was supported in part by a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant. Y.M.K. was supported by grants from the University of Iowa Cardiovascular Interdisciplinary Research/ National Research Service Award (NRSA) Fellowship, from an individual NRSA Fellowship from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, from the National Institutes of Health (NIH), and from a Senator Paul D. Wellstone Fellowship. E.P.R. was supported by a Muscular Dystrophy Association Development Grant. R.M.W. was supported by the NIH. K.P.C. is an investigator of the Howard Hughes Medical Institute.	Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bloom TJ, 2005, CAN J PHYSIOL PHARM, V83, P1055, DOI 10.1139/Y05-085; Bloom TJ, 2002, CAN J PHYSIOL PHARM, V80, P1132, DOI 10.1139/Y02-149; Chao DS, 1998, J NEUROCHEM, V71, P784; Consolino CM, 2005, PHYSIOL GENOMICS, V22, P244, DOI 10.1152/physiolgenomics.00311.2004; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Imamura M, 2005, HUM MOL GENET, V14, P775, DOI 10.1093/hmg/ddi072; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kalkman JS, 2007, J PSYCHOSOM RES, V62, P571, DOI 10.1016/j.jpsychores.2006.11.014; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Persson J, 2003, J VASC RES, V40, P538, DOI 10.1159/000075677; Phillips BA, 2000, CURR OPIN NEUROL, V13, P547, DOI 10.1097/00019052-200010000-00007; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; Schillings ML, 2007, CLIN NEUROPHYSIOL, V118, P292, DOI 10.1016/j.clinph.2006.10.018; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Torelli S, 2004, NEUROPATH APPL NEURO, V30, P540, DOI 10.1111/j.1365-2990.2004.00561.x; Yokoyama T, 2007, J PAIN, V8, P692, DOI 10.1016/j.jpain.2007.05.008; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	25	210	219	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2008	456	7221					511	515		10.1038/nature07414	http://dx.doi.org/10.1038/nature07414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18953332	Green Published, Green Accepted			2022-12-24	WOS:000261170500040
J	Jackevicius, CA; Tu, JV; Demers, V; Melo, M; Cox, J; Rinfret, S; Kalavrouziotis, D; Johansen, H; Behlouli, H; Newman, A; Pilote, L				Jackevicius, Cynthia A.; Tu, Jack V.; Demers, Virginie; Melo, Magda; Cox, Jafna; Rinfret, Stephane; Kalavrouziotis, Dimitri; Johansen, Helen; Behlouli, Hassan; Newman, Alice; Pilote, Louise			Cardiovascular outcomes after a change in prescription policy for clopidogrel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PRIOR-AUTHORIZATION PROGRAMS; ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; TIME-SERIES; PREMATURE DISCONTINUATION; STENT IMPLANTATION; HEART-ASSOCIATION; AMERICAN-COLLEGE; PREVALENCE	Background: Drug-reimbursement policies may have an adverse effect on patient outcomes if they interfere with timely access to efficacious medications for acute medical conditions. Clopidogrel in combination with aspirin is the recommended standard of care for patients receiving coronary stents to prevent thrombosis. We examined the population-level effect of a change by a Canadian provincial government in a pharmacy-benefits program from a prior-authorization policy to a less restrictive, limited-use policy on access to clopidogrel among patients undergoing percutaneous coronary intervention (PCI) with stenting after acute myocardial infarction. Methods: We conducted a population-based, retrospective, time-series analysis from April 1, 2000, to March 31, 2005, of all patients 65 years of age or older with acute myocardial infarction who underwent PCI with stenting in Ontario, Canada. The primary outcome was the composite rate of death, recurrent acute myocardial infarction, PCI, and coronary-artery bypass grafting at 1 year, with adjustment for sex and age. The secondary outcome was major bleeding. Results: The rate of clopidogrel use within 30 days after hospital discharge following myocardial infarction increased from 35% in the prior-authorization period to 88% in the limited-use period. The median time to the first dispensing of a clopidogrel prescription decreased from 9 days in the first period to 0 days in the second period. The 1-year composite cardiovascular outcome significantly decreased from 15% in the prior-authorization group to 11% in the limited-use group (P=0.02). Rates of bleeding in the two groups did not change. Conclusions: The removal of a prior-authorization program led to improvement in timely access to clopidogrel for coronary stenting and improved cardiovascular outcomes.	[Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.; Melo, Magda; Newman, Alice] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Demers, Virginie; Behlouli, Hassan; Pilote, Louise] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Rinfret, Stephane] Univ Montreal, Montreal, PQ, Canada; [Cox, Jafna; Kalavrouziotis, Dimitri] Dalhousie Univ, Halifax, NS, Canada; [Johansen, Helen] STAT Canada, Ottawa, ON, Canada	Western University of Health Sciences; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McGill University; Universite de Montreal; Dalhousie University; Statistics Canada	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu		Cox, Jafna/0000-0001-7908-5323; Pilote, Louise/0000-0002-6159-0628; Tu, Jack/0000-0003-0111-722X	Canadian Institutes for Health Research; Canada Research Chair in Health Services Research, Ottawa; Heart and Stroke Foundation of Ontario; Ontario Ministry of Health and Long-Term Care, Toronto; Fonds de la Recherche en Sant, du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research, Ottawa(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); Fonds de la Recherche en Sant, du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	Supported by a Team Grant in Cardiovascular Outcomes Research to the Canadian Cardiovascular Outcomes Research Team (CCORT) from the Canadian Institutes for Health Research; by a Canada Research Chair in Health Services Research, Ottawa, and a Career Investigator Award from the Heart and Stroke Foundation of Ontario (to Dr. Tu); by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto, to the Institute for Clinical Evaluative Sciences; by a CCORT Summer Student Award (to Dr. Demers); by the Fonds de la Recherche en Sant, du Quebec (FRSQ) (to Dr. Rinfret); by a CCORT master's student fellowship (to Dr. Kalavrouziotis); and by a James McGill chair and the FRSQ (to Dr. Pilote). Dr. Cox reports receiving consulting and lecture fees from Bristol-Myers Squibb, Merck, Pfizer, Sanofi-Aventis, and GlaxoSmithKline and research support from Merck and Pfizer and being a site investigator for a clinical trial sponsored by Sanofi-Aventis; and Dr. Rinfret, receiving consulting and lecture fees from Pfizer, Bristol-Myers Squibb, Sanofi-Aventis, and Abbott Vascular. No other potential conflict of interest relevant to this article was reported. We thank the Cardiac Care Network of Ontario for providing data regarding types of stents from its clinical registry.	Ackman ML, 2006, CAN J CARDIOL, V22, P1205, DOI 10.1016/S0828-282X(06)70960-6; *CAN I HLTH INF, 2007, DRUG EXP CAN 1985 20; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fischer MA, 2004, NEW ENGL J MED, V351, P2187, DOI 10.1056/NEJMsa042770; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Hamel MB, 2004, NEW ENGL J MED, V351, P2156, DOI 10.1056/NEJMp048294; JACKEVICIUS CA, 2006, CCORT CANADIAN CARDI, P180; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; Jackevicius CA, 2007, PHARMACOEPIDEM DR S, V16, P207, DOI 10.1002/pds.1289; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; McCombs JS, 2002, CLIN THER, V24, P1939, DOI 10.1016/S0149-2918(02)80090-X; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; PHILLIPS CR, 1997, J MANAGE CARE PHARM, V3, P699; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S; Schneeweiss S, 2003, CLIN PHARMACOL THER, V74, P388, DOI 10.1016/S0009-9236(03)00227-3; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; SMALLEY WE, 1995, NEW ENGL J MED, V332, P1612, DOI 10.1056/NEJM199506153322406; Smith SC, 2006, J AM COLL CARDIOL, V47, P216, DOI 10.1016/j.jacc.2005.11.025; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tran CTT, 2003, CAN J CARDIOL, V19, P38; Tricoci P, 2006, ARCH INTERN MED, V166, P806, DOI 10.1001/archinte.166.7.806; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; TU JV, 1999, CARDIOVASCULAR HLTH, P25; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yaffee R.A., 2000, INTRO TIME SERIES AN	32	57	57	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 23	2008	359	17					1802	1810		10.1056/NEJMsa0803410	http://dx.doi.org/10.1056/NEJMsa0803410			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363DJ	18946065				2022-12-24	WOS:000260245800007
J	Hyman, SE				Hyman, Steven E.			A glimmer of light for neuropsychiatric disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NATIONAL COMORBIDITY SURVEY; ALZHEIMERS-DISEASE; RETT-SYNDROME; COPY NUMBER; GENETICS; SCHIZOPHRENIA; GENES; LOCI; TRANSLOCATION		[Hyman, Steven E.] Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Cambridge, MA 02138 USA	Harvard University	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Off Provost, Dept Neurobiol, Massachusetts Hall, Cambridge, MA 02138 USA.	seh@harvard.edu						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kendler KS, 1998, AM J PSYCHIAT, V155, P172; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Lewis JC, 2004, J MED GENET, V41, P203, DOI 10.1136/jmg.2003.012757; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Merikangas KR, 2003, AM J PSYCHIAT, V160, P625, DOI 10.1176/appi.ajp.160.4.625; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Murray CJ, 1996, GLOBAL BURDEN DIS; Nestler E. J., 2008, MOL NEUROPHARMACOLOG; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; Reddy Kavita S, 2005, BMC Med Genet, V6, P3, DOI 10.1186/1471-2350-6-3; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; WHO, 2001, WORLD HLTH REP MENT; Williams NM, 2006, INT REV NEUROBIOL, V73, P1, DOI 10.1016/S0074-7742(06)73001-X; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	48	81	84	1	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					890	893		10.1038/nature07454	http://dx.doi.org/10.1038/nature07454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923510	Bronze			2022-12-24	WOS:000260038300036
J	Schwalb, NK; Temps, F				Schwalb, Nina K.; Temps, Friedrich			Base sequence and higher-order structure induce the complex excited-state dynamics in DNA	SCIENCE			English	Article							MOLECULAR-SPECTROSCOPY; ENERGY-TRANSFER; FLUORESCENCE; CONVERSION; ADENINE; DELOCALIZATION; DEACTIVATION; SELECTIVITY; RELAXATION; EXCITATION	The high photostability of DNA is commonly attributed to efficient radiationless electronic relaxation processes. We used femtosecond time-resolved fluorescence spectroscopy to reveal that the ensuing dynamics are strongly dependent on base sequence and are also affected by higher-order structure. Excited electronic state lifetimes in dG-doped d(A)(20) single-stranded DNA and dG center dot dC-doped d(A)(20)center dot d(T)(20) double-stranded DNA decrease sharply with the substitution of only a few bases. In duplexes containing d(AGA) center dot d(TCT) or d(AG) center dot d(TC) repeats, deactivation of the fluorescing states occurs on the subpicosecond time scale, but the excited-state lifetimes increase again in extended d(G) runs. The results point at more complex and molecule-specific photodynamics in native DNA than may be evident in simpler model systems.	[Schwalb, Nina K.; Temps, Friedrich] Univ Kiel, Inst Chem Phys, D-24098 Kiel, Germany	University of Kiel	Schwalb, NK (corresponding author), Univ Kiel, Inst Chem Phys, Olshaussenstr 40, D-24098 Kiel, Germany.	schwalb@phc.uni-kiel.de; temps@phc.uni-kiel.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft. Furthermore, the authors thank J. Grotzinger for letting us take the CD spectra.	Abo-Riziq A, 2005, P NATL ACAD SCI USA, V102, P20, DOI 10.1073/pnas.0408574102; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Bouvier B, 2003, J PHYS CHEM B, V107, P13512, DOI 10.1021/jp036164u; Bouvier B, 2002, CHEM PHYS, V275, P75, DOI 10.1016/S0301-0104(01)00523-7; Buchvarov I, 2007, P NATL ACAD SCI USA, V104, P4794, DOI 10.1073/pnas.0606757104; Crespo-Hernandez CE, 2008, J AM CHEM SOC, V130, P10844, DOI 10.1021/ja802183s; Crespo-Hernandez CE, 2006, NATURE, V441, pE8, DOI 10.1038/nature04904; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; Crespo-Hernandez CE, 2004, J PHYS CHEM B, V108, P11182, DOI 10.1021/jp0496046; Czader A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821384; Elias B, 2008, J AM CHEM SOC, V130, P1152, DOI 10.1021/ja710358p; Emanuele E, 2005, CHEMPHYSCHEM, V6, P1387, DOI 10.1002/cphc.200500014; Groenhof G, 2007, J AM CHEM SOC, V129, P6812, DOI 10.1021/ja069176c; Gustavsson T, 2002, CHEM PHYS LETT, V351, P195, DOI 10.1016/S0009-2614(01)01375-6; Hyeon-Deuk K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2894843; Kelley SO, 1999, SCIENCE, V283, P375, DOI 10.1126/science.283.5400.375; Kwok WM, 2006, J AM CHEM SOC, V128, P11894, DOI 10.1021/ja0622002; Markovitsi D, 2005, J AM CHEM SOC, V127, P17130, DOI 10.1021/ja054955z; Markovitsi D, 2003, CHEMPHYSCHEM, V4, P303, DOI 10.1002/cphc.200390050; Markovitsi D, 2006, NATURE, V441, pE7, DOI 10.1038/nature04903; Miannay FA, 2007, J AM CHEM SOC, V129, P14574, DOI 10.1021/ja077100q; Onidas D, 2002, J PHYS CHEM B, V106, P11367, DOI 10.1021/jp026063g; Onidas D, 2007, J PHYS CHEM B, V111, P9644, DOI 10.1021/jp072508v; Pancur T, 2005, CHEM PHYS, V313, P199, DOI 10.1016/j.chemphys.2004.12.019; Pecourt JML, 2001, J AM CHEM SOC, V123, P10370, DOI 10.1021/ja0161453; Peon J, 2001, CHEM PHYS LETT, V348, P255, DOI 10.1016/S0009-2614(01)01128-9; Schwalb NK, 2007, J AM CHEM SOC, V129, P9272, DOI 10.1021/ja073448+; Sobolewski AL, 2005, P NATL ACAD SCI USA, V102, P17903, DOI 10.1073/pnas.0504087102; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297	30	126	129	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					243	245		10.1126/science.1161651	http://dx.doi.org/10.1126/science.1161651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845751				2022-12-24	WOS:000259902300043
J	Guven-Ozkan, T; Nishi, Y; Robertson, SM; Lin, RL				Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling			Global transcriptional repression in C-elegans germline precursors by regulated sequestration of TAF-4	CELL			English	Article							RNA-POLYMERASE-II; TO-EMBRYO TRANSITION; ZINC-FINGER PROTEINS; CAENORHABDITIS-ELEGANS; OOCYTE MATURATION; GENE-EXPRESSION; MATERNAL PROTEINS; PIE-1 PROTEIN; CHROMATIN; DEGRADATION	In C. elegans, four asymmetric divisions, beginning with the zygote (P0), generate transcriptionally repressed germline blastomeres (P1-P4) and somatic sisters that become transcriptionally active. The protein PIE-1 represses transcription in the later germline blastomeres but not in the earlier germline blastomeres P0 and P1. We show here that OMA-1 and OMA-2, previously shown to regulate oocyte maturation, repress transcription in P0 and P1 by binding to and sequestering in the cytoplasm TAF-4, a component critical for assembly of TFIID and the pol II pre-initiation complex. OMA-1/2 binding to TAF-4 is developmentally regulated, requiring phosphorylation by the DYRK kinase MBK-2, which is activated at meiosis II after fertilization. OMA-1/2 are normally degraded after the first mitosis, but ectopic expression of wild-type OMA-1 is sufficient to repress transcription in both somatic and later germline blastomeres. We propose that phosphorylation by MBK-2 serves as a developmental switch, converting OMA-1/2 from oocyte to embryo regulators.	[Guven-Ozkan, Tugba; Nishi, Yuichi; Robertson, Scott M.; Lin, Rueyling] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, RL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	rueyling.lin@utsouthwestern.edu	Robertson, Scott/B-9018-2013		National Institutes of Health [HD37933]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Lin lab members for discussions, Angela Collins for technical assistance in the initial isolation of taf-4 clones, Jim Priess for antibodies to MEX-5 and PIE-1, Judith Austin for AZ212, Ed Kipreos for ET113, Geraldine Seydoux for the vet-5 clone and pID3.01B, Andy Fire for vet-5 sequence information, Yuji Kohara for all yk cDNA clones, Zheng Zhou and Bob Horvitz for sharing the yeast two-hybrid library, Keith Blackwell and Amy Walker for anti-TAF-4 antibody, and Hiroyuki Kawahara for anti-OMA-1a antibody. All other strains used were provided by C. elegans Genome Center. This work was supported by a National Institutes of Health grant (HD37933) to R. L.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Deshpande G, 2005, MECH DEVELOP, V122, P645, DOI 10.1016/j.mod.2004.12.009; Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gangloff YG, 2000, MOL CELL BIOL, V20, P340, DOI 10.1128/MCB.20.1.340-351.2000; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Ghosh D, 2008, GENETICS, V178, P235, DOI 10.1534/genetics.107.083212; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; Hoffmann A, 1996, J BIOL CHEM, V271, P18194, DOI 10.1074/jbc.271.30.18194; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KOBAYASHI S, 1988, DEV GROWTH DIFFER, V30, P251; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu J, 2004, DEVELOPMENT, V131, P3513, DOI 10.1242/dev.01245; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Praitis V, 2001, GENETICS, V157, P1217; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; SCHAUER IE, 1990, DEVELOPMENT, V110, P1303; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Surani MA, 2004, COLD SPRING HARB SYM, V69, P1, DOI 10.1101/sqb.2004.69.40; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; VARNUM BC, 1989, ONCOGENE, V4, P119; Walker AK, 2004, J BIOL CHEM, V279, P15339, DOI 10.1074/jbc.M310731200; Walker AK, 2003, J BIOL CHEM, V278, P6181, DOI 10.1074/jbc.M211056200; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Walker AK, 2007, DEV BIOL, V304, P382, DOI 10.1016/j.ydbio.2006.12.039; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	61	78	92	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					149	160		10.1016/j.cell.2008.07.040	http://dx.doi.org/10.1016/j.cell.2008.07.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854162	Green Accepted, Bronze			2022-12-24	WOS:000259728100016
J	Scott, JJ; Oh, DC; Yuceer, MC; Klepzig, KD; Clardy, J; Currie, CR				Scott, Jarrod J.; Oh, Dong-Chan; Yuceer, M. Cetin; Klepzig, Kier D.; Clardy, Jon; Currie, Cameron R.			Bacterial protection of beetle-fungus mutualism	SCIENCE			English	Article							SOUTHERN PINE-BEETLE		[Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Scott, Jarrod J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yuceer, M. Cetin] Mississippi State Univ, Dept Forestry, Mississippi State, MS 39762 USA; [Klepzig, Kier D.] So Res Stn, US Dept Agr Forest Serv, Pineville, LA 71360 USA	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Mississippi State University; United States Department of Agriculture (USDA); United States Forest Service	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; currie@bact.wisc.edu		Scott, Jarrod/0000-0001-9863-1318	U. S. Department of Agriculture; NIH; NSF; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER	U. S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Adams, S. Adams, C. Booth, E. Caldera, J. Ensign, C. Hsu, Y. Kang, A. Lawrence, W. Monroe, P. Jeffreys, M. Palmisano, A. Pinto, M. Poulsen, K. Raffa, D. Stone, and E. Vallery for assistance. Support provided by the U. S. Department of Agriculture (C.R.C., K.D.K., and M.C.Y.), NIH (J.C.), and NSF (C.R.C.). We have a patent application submitted on mycangimycin.	Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Klepzig KD, 1997, APPL ENVIRON MICROB, V63, P621, DOI 10.1128/AEM.63.2.621-627.1997; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019	7	347	368	7	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					63	63		10.1126/science.1160423	http://dx.doi.org/10.1126/science.1160423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832638	Green Accepted			2022-12-24	WOS:000259680200035
J	Lu, L; Jia, MH; Ma, YL; Yang, L; Chen, ZW; Ho, DD; Jiang, Y; Zhang, LQ				Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li; Chen, Zhiwei; Ho, David D.; Jiang, Yan; Zhang, Linqi			The changing face of HIV in China	NATURE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT; INFECTION; HIV/AIDS; YUNNAN; DONORS; GENOME; STRAIN		[Lu, Lin; Jia, Manhong; Ma, Yanling; Yang, Li] Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China; [Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Hong Kong, Peoples R China; [Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Ho, David D.; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Jiang, Yan] Chinese Ctr Dis Control & Prevent, Natl AIDS Reference Lab, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhang, Linqi] Chinese Acad Med Sci, AIDS Res Ctr, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Zhang, Linqi] Peking Union Med Coll, Beijing 100021, Peoples R China	University of Hong Kong; Rockefeller University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lu, L (corresponding author), Yunnan Ctr Dis Control & Prevent, Yunnan, Peoples R China.		Chen, Zhiwei/B-7793-2019; ZHANG, LIN/GYD-9123-2022; MA, YAN/HHN-2912-2022	Chen, Zhiwei/0000-0002-4511-2888; 	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology [2006CB504200]; Tenth Five-year Key Technologies R&D Programme of China [2004BA719A14-1, 2004BA719A14-2]	National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology(National Basic Research Program of China); Tenth Five-year Key Technologies R&D Programme of China(National Key Technology R&D Program)	This work is supported by National Basic Research Program ( also called 973 Program) of Chinese Ministry of Science and Technology to L. Z. (2006CB504200) and by the Tenth Five-year Key Technologies R&D Programme of China: 2004BA719A14-1, 2004BA719A14-2. We also thank Mark Goldin for helpful suggestions.	CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; Chin KC, 2007, CHINESE CONNECTION C; Gill B, 2007, DEMOGRAPHY HIV AIDS; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *US BUR INT NARC L, 2007, INT NARC CONTR STRAT, V1; WENIGER BG, 1994, AIDS, V8, pS13; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Yang RG, 2003, J VIROL, V77, P685, DOI 10.1128/JVI.77.1.685-695.2003; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	19	228	272	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					609	611		10.1038/455609a	http://dx.doi.org/10.1038/455609a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833270	Bronze			2022-12-24	WOS:000259639700035
J	McIvor, RA; Chapman, KR				McIvor, R. Andrew; Chapman, Kenneth R.			The coming of age of asthma guidelines	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; SAFETY		[McIvor, R. Andrew] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada; [Chapman, Kenneth R.] Univ Toronto, Asthma & Airway Ctr, Univ Hlth Network, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	McIvor, RA (corresponding author), McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada.	amcivor@stjosham.on.ca						Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; *BRIT THOR SOC, 2008, BRIT GUID MAN ASTHM; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126	10	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1021	1022		10.1016/S0140-6736(08)61423-3	http://dx.doi.org/10.1016/S0140-6736(08)61423-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805317				2022-12-24	WOS:000259648500010
J	Leyland, E				Leyland, Elizabeth			Human papillomavirus vaccination: stabbing in the dark?	LANCET			English	Editorial Material									Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Leyland, E (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	lizleyland@hotmail.com						Bosch FX, 2008, ANN ONCOL, V19, P48, DOI 10.1093/annonc/mdn310; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; *CANC RES UK, 2008, ENC UPT HPV VACC TRI; *DEP HLTH, 2008, INTRO HUM PAP VACC N; *DEP HLTH, 2008, INTRO HPV VACC NAT I; *DEP HLTH, 2008, IMM INF DIS GREEN BO, pCH18A; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Kane MA, 2008, J FAM PLAN REPROD H, V34, P3, DOI 10.1783/147118908783332113; Kim J. J., 2008, BMJ-BRIT MED J, V337, P303	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2008	372	9639					614	614		10.1016/S0140-6736(08)61258-1	http://dx.doi.org/10.1016/S0140-6736(08)61258-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	340BX	18722854				2022-12-24	WOS:000258622200010
J	Manning, AL; Compton, DA				Manning, Amity L.; Compton, Duane A.			SnapShot: Nonmotor proteins in spindle assembly	CELL			English	Editorial Material							MICROTUBULE; CELL		[Manning, Amity L.] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA; Norris Cotton Canc Ctr, Lebanon, NH 03755 USA	Dartmouth College; Norris Cotton Cancer Center	Manning, AL (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH USA.		Manning, Amity/AAC-8205-2019	Manning, Amity/0000-0003-1332-9086; Compton, Duane/0000-0002-4445-9118	NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIGMS NIH HHS [R37 GM051542, GM51542, R01 GM051542] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051542, R37GM051542] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Jang CY, 2008, J CELL BIOL, V181, P255, DOI 10.1083/jcb.200711032; Johansen KM, 2007, INT REV CYTOL, V263, P155, DOI 10.1016/S0074-7696(07)63004-6; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santamaria A, 2008, CURR BIOL, V18, P723, DOI 10.1016/j.cub.2008.04.041; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	10	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 22	2008	134	4					694	U18		10.1016/j.cell.2008.08.001	http://dx.doi.org/10.1016/j.cell.2008.08.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724941	Green Accepted, Bronze			2022-12-24	WOS:000258665800022
J	Vikse, BE; Irgens, LM; Leivestad, T; Skjaerven, R; Iversen, BM				Vikse, Bjorn Egil; Irgens, Lorentz M.; Leivestad, Torbjorn; Skjaerven, Rolv; Iversen, Bjarne M.			Preeclampsia and the risk of end-stage renal disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEDICAL BIRTH REGISTRY; PREGNANCY COMPLICATIONS; IMPAIRED ANGIOGENESIS; RETROSPECTIVE COHORT; BLOOD-PRESSURE; KIDNEY; WOMEN; HYPERTENSION; PARAMETERS	Background: It is unknown whether preeclampsia is a risk marker for subsequent end-stage renal disease (ESRD). Methods: We linked data from the Medical Birth Registry of Norway, which contains data on all births in Norway since 1967, with data from the Norwegian Renal Registry, which contains data on all patients receiving a diagnosis of end-stage renal disease (ESRD) since 1980, to assess the association between preeclampsia in one or more pregnancies and the subsequent development of ESRD. The study population consisted of women who had had a first singleton birth between 1967 and 1991; we included data from up to three pregnancies. Results: ESRD developed in 477 of 570,433 women a mean (+/-SD) of 17+/-9 years after the first pregnancy (overall rate, 3.7 per 100,000 women per year). Among women who had been pregnant one or more times, preeclampsia during the first pregnancy was associated with a relative risk of ESRD of 4.7 (95% confidence interval [CI], 3.6 to 6.1). Among women who had been pregnant two or more times, preeclampsia during the first pregnancy was associated with a relative risk of ESRD of 3.2 (95% CI, 2.2 to 4.9), preeclampsia during the second pregnancy with a relative risk of 6.7 (95% CI, 4.3 to 10.6), and preeclampsia during both pregnancies with a relative risk of 6.4 (95% CI, 3.0 to 13.5). Among women who had been pregnant three or more times, preeclampsia during one pregnancy was associated with a relative risk of ESRD of 6.3 (95% CI, 4.1 to 9.9), and preeclampsia during two or three pregnancies was associated with a relative risk of 15.5 (95% CI, 7.8 to 30.8). Having a low-birth-weight or preterm infant increased the relative risk of ESRD. The results were similar after adjustment for possible confounders and after exclusion of women who had kidney disease, rheumatic disease, essential hypertension, or diabetes mellitus before pregnancy. Conclusions: Although the absolute risk of ESRD in women who have had preeclampsia is low, preeclampsia is a marker for an increased risk of subsequent ESRD.	[Vikse, Bjorn Egil; Iversen, Bjarne M.] Haukeland Hosp, Inst Med, Dept Med, Renal Res Grp, N-5021 Bergen, Norway; [Vikse, Bjorn Egil; Iversen, Bjarne M.] Univ Bergen, Inst Med, Renal Res Grp, Bergen, Norway; [Irgens, Lorentz M.; Skjaerven, Rolv] Univ Bergen, Sect Epidemiol & Med Stat, Bergen, Norway; [Vikse, Bjorn Egil; Irgens, Lorentz M.; Skjaerven, Rolv; Iversen, Bjarne M.] Univ Bergen, Locus Registry Based Epidemiol, Bergen, Norway; [Irgens, Lorentz M.; Skjaerven, Rolv] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Leivestad, Torbjorn] Univ Oslo, Rikshosp, Inst Immunol, Norwegian Renal Registry, N-0027 Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Oslo; National Hospital Norway	Vikse, BE (corresponding author), Haukeland Hosp, Inst Med, Dept Med, Renal Res Grp, N-5021 Bergen, Norway.	bjorn.vikse@med.uib.no			Western Norway Regional Health Authority; Strategic Research Program of Haukeland University Hospital	Western Norway Regional Health Authority; Strategic Research Program of Haukeland University Hospital	Supported by grants from the Western Norway Regional Health Authority and the Strategic Research Program of Haukeland University Hospital.; No potential conflict of interest relevant to this article was reported.; We thank Stein Atle Lie for valuable statistical advice.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Bar J, 1999, NEPHROL DIAL TRANSPL, V14, P1129, DOI 10.1093/ndt/14.5.1129; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Cotter AM, 2001, AM J OBSTET GYNECOL, V185, P781, DOI 10.1067/mob.2001.117304; Dahlstrom BL, 2006, ACTA OBSTET GYN SCAN, V85, P916, DOI 10.1080/00016340500442449; de Jong PE, 2004, KIDNEY INT, V66, P2109, DOI 10.1111/j.1523-1755.2004.66001.x; Hall JE, 2003, CURR OPIN NEPHROL HY, V12, P195, DOI 10.1097/00041552-200303000-00011; He S, 1999, THROMB HAEMOSTASIS, V81, P538; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kang DH, 2001, AM J KIDNEY DIS, V37, P601, DOI 10.1053/ajkd.2001.22087; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; NISELL H, 1995, BRIT J OBSTET GYNAEC, V102, P876, DOI 10.1111/j.1471-0528.1995.tb10874.x; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pouta A, 2004, HYPERTENSION, V43, P825, DOI 10.1161/01.HYP.0000120122.39231.88; Rasmussen S, 2007, HYPERTENSION, V49, P806, DOI 10.1161/01.HYP.0000259924.74947.aa; Sattar N, 2003, HYPERTENSION, V42, P39, DOI 10.1161/01.HYP.0000074428.11168.EE; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Skomsvoll JF, 2002, ACTA OBSTET GYN SCAN, V81, P831, DOI 10.1034/j.1600-0412.2002.810905.x; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Stene LC, 2007, NOR EPIDEMIOL, V17, P165; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845	35	436	469	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2008	359	8					800	809		10.1056/NEJMoa0706790	http://dx.doi.org/10.1056/NEJMoa0706790			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339HL	18716297				2022-12-24	WOS:000258568600005
J	Francois, M; Caprini, A; Hosking, B; Orsenigo, F; Wilhelm, D; Browne, C; Paavonen, K; Karnezis, T; Shayan, R; Downes, M; Davidson, T; Tutt, D; Cheah, KSE; Stacker, SA; Muscat, GEO; Achen, MG; Dejana, E; Koopman, P				Francois, Mathias; Caprini, Andrea; Hosking, Brett; Orsenigo, Fabrizio; Wilhelm, Dagmar; Browne, Catherine; Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Cheah, Kathryn S. E.; Stacker, Steven A.; Muscat, George E. O.; Achen, Marc G.; Dejana, Elisabetta; Koopman, Peter			Sox18 induces development of the lymphatic vasculature in mice	NATURE			English	Article							ENDOTHELIAL-CELLS; BOX GENE; SYSTEM; MOUSE; EXPRESSION; MUTATIONS; PROX1; LYMPHANGIOGENESIS; DIFFERENTIATION; ANGIOGENESIS	The lymphatic system plays a key role in tissue fluid regulation and tumour metastasis, and lymphatic defects underlie many pathological states including lymphoedema, lymphangiectasia, lymphangioma and lymphatic dysplasia(1-3). However, the origins of the lymphatic system in the embryo, and the mechanisms that direct growth of the network of lymphatic vessels, remain unclear. Lymphatic vessels are thought to arise from endothelial precursor cells budding from the cardinal vein under the influence of the lymphatic hallmark gene Prox1 ( prospero homeobox 1; ref. 4). Defects in the transcription factor gene SOX18 ( SRY ( sex determining region Y) box 18) cause lymphatic dysfunction in the human syndrome hypotrichosis- lymphoedema- telangiectasia(5), suggesting that Sox18 may also play a role in lymphatic development or function. Here we use molecular, cellular and genetic assays in mice to show that Sox18 acts as a molecular switch to induce differentiation of lymphatic endothelial cells. Sox18 is expressed in a subset of cardinal vein cells that later co- express Prox1 and migrate to form lymphatic vessels. Sox18 directly activates Prox1 transcription by binding to its proximal promoter. Overexpression of Sox18 in blood vascular endothelial cells induces them to express Prox1 and other lymphatic endothelial markers, while Sox18- null embryos show a complete blockade of lymphatic endothelial cell differentiation from the cardinal vein. Our findings demonstrate a critical role for Sox18 in developmental lymphangiogenesis, and suggest new avenues to investigate for therapeutic management of human lymphangiopathies.	[Francois, Mathias; Hosking, Brett; Wilhelm, Dagmar; Browne, Catherine; Downes, Meredith; Davidson, Tara; Tutt, Desmond; Muscat, George E. O.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Caprini, Andrea; Orsenigo, Fabrizio; Dejana, Elisabetta] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; [Paavonen, Karri; Karnezis, Tara; Shayan, Ramin; Stacker, Steven A.; Achen, Marc G.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia; [Shayan, Ramin] Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia; [Cheah, Kathryn S. E.] Univ Hong Kong, Dept Biochem, Hong Kong, Peoples R China; [Cheah, Kathryn S. E.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Peoples R China; [Dejana, Elisabetta] Univ Milan, Dept Biomol Sci & Biotechnol, I-20129 Milan, Italy	University of Queensland; IFOM - FIRC Institute of Molecular Oncology; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne; University of Hong Kong; University of Hong Kong; University of Milan	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	elisabetta.dejana@ifom-ieo-campus.it; p.koopman@imb.uq.edu.au	Downes, Meredith/B-7370-2013; Wilhelm, Dagmar/B-6915-2009; Stacker, Steven A/J-2205-2012; Koopman, Peter A/C-9416-2009; francois, mathias/A-9604-2014; Downes, Meredith/P-8203-2018; Muscat, George/A-6401-2017	Wilhelm, Dagmar/0000-0002-7757-4075; Stacker, Steven A/0000-0003-4096-9273; Koopman, Peter A/0000-0001-6939-0914; francois, mathias/0000-0002-9846-6882; DEJANA, ELISABETTA/0000-0002-0007-0426; Achen, Marc/0000-0002-3791-803X; Downes, Meredith/0000-0002-6517-1834; Orsenigo, Fabrizio/0000-0001-9135-8478; Muscat, George/0000-0002-5829-5695	National Health and Medical Research Council (Australia); INSERM ( France); Associazione Italiana per la Ricerca sul Cancro (Italy); European Community [LSHG-CT-2004-503573]; Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia; Australian Research Council	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); INSERM ( France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Associazione Italiana per la Ricerca sul Cancro (Italy)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Pfizer Foundation (Australia); Australia), the Research Grants Council ( Hong Kong); Research Grants Council (Hong Kong)(Hong Kong Research Grants Council); Raelene Boyle Sporting Chance Foundation (Australia); Royal Australasian College of Surgeons; Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council(Australian Research Council)	We thank A. Nagy, W. Abramow-Newerly, L. Naldini, P. Berta, A. Yap and J. Gamble for gifts of reagents. We also thank L. Bernard, L. Tizzoni and V. Dall'Olio for quantitative real- time PCR analysis, M. Chan and A. Pelling for antibody characterization, and S. Pizzi for technical assistance. Confocal microscopy was performed at the Australian Cancer Research Foundation Dynamic Imaging Centre for Cancer Biology. This work was supported by the National Health and Medical Research Council ( Australia), INSERM ( France), the Associazione Italiana per la Ricerca sul Cancro ( Italy), the European Community (LSHG-CT-2004-503573, Eustroke and Optistem networks), the Pfizer Foundation (Australia), the Research Grants Council (Hong Kong), the Raelene Boyle Sporting Chance Foundation ( Australia), the Royal Australasian College of Surgeons, the Heart Foundation of Australia, and the Australian Research Council.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; CARTER TC, 1954, J HERED, V45, P151; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Garlanda C, 1997, EUR J CELL BIOL, V73, P368; GREEN EL, 1961, J HERED, V52, P223, DOI 10.1093/oxfordjournals.jhered.a107077; Hosking BM, 2004, J BIOL CHEM, V279, P5314, DOI 10.1074/jbc.M308512200; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Hosking BM, 2001, GENE, V262, P239, DOI 10.1016/S0378-1119(00)00525-4; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Liersch R, 2006, BLOOD, V107, P1214, DOI 10.1182/blood-2005-08-3400; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pennisi D, 2000, MOL CELL BIOL, V20, P9331, DOI 10.1128/MCB.20.24.9331-9336.2000; Rodriguez-Niedenfuhr M, 2001, ANAT EMBRYOL, V204, P399, DOI 10.1007/s00429-001-0214-9; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; SLEE JOHN, 1957, JOUR GENETICS, V55, P570, DOI 10.1007/BF02984073; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4	33	377	386	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					643	669		10.1038/nature07391	http://dx.doi.org/10.1038/nature07391			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18931657				2022-12-24	WOS:000261340000042
J	Verpy, E; Weil, D; Leibovici, M; Goodyear, RJ; Hamard, G; Houdon, C; Lefevre, GM; Hardelin, JP; Richardson, GP; Avan, P; Petit, C				Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Goodyear, Richard J.; Hamard, Ghislaine; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Richardson, Guy P.; Avan, Paul; Petit, Christine			Stereocilin-deficient mice reveal the origin of cochlear waveform distortions	NATURE			English	Article							OUTER HAIR-CELLS; TECTORIAL MEMBRANE; CHINCHILLA COCHLEA; BASILAR-MEMBRANE; TUNING CURVES; MECHANICS; RESPONSES; LINKS; MUTATIONS; EMISSIONS	Although the cochlea is an amplifier and a remarkably sensitive and finely tuned detector of sounds, it also produces conspicuous mechanical and electrical waveform distortions(1). These distortions reflect nonlinear mechanical interactions within the cochlea. By allowing one tone to suppress another ( masking effect), they contribute to speech intelligibility(2). Tones can also combine to produce sounds with frequencies not present in the acoustic stimulus(3). These sounds compose the otoacoustic emissions that are extensively used to screen hearing in newborns. Because both cochlear amplification and distortion originate from the outer hair cells - one of the two types of sensory receptor cells - it has been speculated that they stem from a common mechanism. Here we show that the nonlinearity underlying cochlear waveform distortions relies on the presence of stereocilin, a protein defective in a recessive form of human deafness(4). Stereocilin was detected in association with horizontal top connectors(5-7), lateral links that join adjacent stereocilia within the outer hair cell's hair bundle. These links were absent in stereocilin- null mutant mice, which became progressively deaf. At the onset of hearing, however, their cochlear sensitivity and frequency tuning were almost normal, although masking was much reduced and both acoustic and electrical waveform distortions were completely lacking. From this unique functional situation, we conclude that the main source of cochlear waveform distortions is a deflection- dependent hair bundle stiffness resulting from constraints imposed by the horizontal top connectors, and not from the intrinsic nonlinear behaviour of the mechanoelectrical transducer channel.	[Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] INSERM, UMRS 587, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Coll France, F-75015 Paris, France; [Verpy, Elisabeth; Weil, Dominique; Leibovici, Michel; Houdon, Carine; Lefevre, Gaelle M.; Hardelin, Jean-Pierre; Petit, Christine] Univ Paris 06, F-75015 Paris, France; [Goodyear, Richard J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Hamard, Ghislaine] Inst Cochin Genet Mol, F-75014 Paris, France; [Avan, Paul] Univ Auvergne, Lab Biophys Sensorielle, F-63001 Clermont Ferrand, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Sorbonne Universite; University of Sussex; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Clermont Auvergne (UCA)	Petit, C (corresponding author), Inst Pasteur, Unite Genet & Physiol Audit, F-75015 Paris, France.	everpy@pasteur.fr; cpetit@pasteur.fr	AVAN, Paul/J-6878-2015; Leibovici, Michel/ABB-6745-2020	AVAN, Paul/0000-0003-1054-1479; Petit, Christine/0000-0002-9069-002X	European Commission FP6 Integrated Project EuroHear,; Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame); Wellcome Trust	European Commission FP6 Integrated Project EuroHear,(European CommissionEuropean Commission Joint Research Centre); Fondation Raymonde et Guy Strittmatter; Region Ile-de-France (Programme Sesame)(Region Ile-de-France); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Lenoir, S. Guadagnini and M.-C. Prevost for advice on SEM; E. Perret and P. Roux for advice on confocal microscopy, S. Chardenoux, S. Nouaille and A. Mallet for technical help, Y. Lallemand for providing us with PGK- Cre m mice, N. Michalski for help with figure drawing and J. Boutet de Monvel for critical reading of the manuscript. This work was supported by the European Commission FP6 Integrated Project EuroHear, Fondation Raymonde et Guy Strittmatter, Region Ile-de-France (Programme Sesame), and the Wellcome Trust.	ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; FLOCK A, 1984, NATURE, V310, P597, DOI 10.1038/310597a0; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; GOLDSTEIN JL, 1967, J ACOUST SOC AM, V41, P676, DOI 10.1121/1.1910396; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; KIM DO, 1980, J ACOUST SOC AM, V67, P1704, DOI 10.1121/1.384297; Kimura R S, 1966, Acta Otolaryngol, V61, P55, DOI 10.3109/00016486609127043; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lukashkin AN, 2004, J NEUROPHYSIOL, V91, P163, DOI 10.1152/jn.00680.2003; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Moore B. C. J., 1998, COCHLEAR HEARING LOS; Patuzzi R., 1996, COCHLEA, P186; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; RUGGERO MA, 1992, J NEUROPHYSIOL, V68, P1087, DOI 10.1152/jn.1992.68.4.1087; Tsuprun V, 2002, J HISTOCHEM CYTOCHEM, V50, P493, DOI 10.1177/002215540205000406; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726	34	96	98	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					255	U56		10.1038/nature07380	http://dx.doi.org/10.1038/nature07380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849963	Green Accepted			2022-12-24	WOS:000261039300043
J	Mokotoff, DM				Mokotoff, David M.			Remembering Earl	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dmok@tampabay.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 22	2008	300	16					1853	1854		10.1001/jama.300.16.1853	http://dx.doi.org/10.1001/jama.300.16.1853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362UR	18940964				2022-12-24	WOS:000260223100001
J	Sokol, DK				Sokol, Daniel K.			The harms of medicoplasty	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London, England.	daniel.sokol@talk21.com						Liao LM, 2007, BMJ-BRIT MED J, V334, P1090, DOI 10.1136/bmj.39206.422269.BE; 2008, BMJ, V337, pA1684	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1983	10.1136/bmj.a1983	http://dx.doi.org/10.1136/bmj.a1983			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18840633				2022-12-24	WOS:000259903300030
J	Song, MS; Salmena, L; Carracedo, A; Egia, A; Lo-Coco, F; Teruya-Feldstein, J; Pandolfi, PP				Song, Min Sup; Salmena, Leonardo; Carracedo, Arkaitz; Egia, Ainara; Lo-Coco, Francesco; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo			The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network	NATURE			English	Article							NUCLEAR-BODY FORMATION; PROMYELOCYTIC LEUKEMIA; TUMOR SUPPRESSION; UBIQUITIN LIGASE; EXPRESSION; MDM2; DEGRADATION; PROTEIN; MONOUBIQUITYLATION; MUTATION	Nuclear exclusion of the PTEN ( phosphatase and tensin homologue deleted in chromosome 10) tumour suppressor has been associated with cancer progression(1-6). However, the mechanisms leading to this aberrant PTEN localization in human cancers are currently unknown. We have previously reported that ubiquitinylation of PTEN at specific lysine residues regulates its nuclear cytoplasmic partitioning(7). Here we show that functional promyelocytic leukaemia protein ( PML) nuclear bodies co- ordinate PTEN localization by opposing the action of a previously unknown PTEN- deubiquitinylating enzyme, herpesvirus- associated ubiquitin- specific protease ( HAUSP, also known as USP7), and that the integrity of this molecular framework is required for PTEN to be able to enter the nucleus. We find that PTEN is aberrantly localized in acute promyelocytic leukaemia, in which PML function is disrupted by the PML - RAR alpha fusion oncoprotein. Remarkably, treatment with drugs that trigger PML - RAR alpha degradation, such as all- trans retinoic acid or arsenic trioxide, restore nuclear PTEN. We demonstrate that PML opposes the activity of HAUSP towards PTEN through a mechanism involving the adaptor protein DAXX ( death domain- associated protein). In support of this paradigm, we show that HAUSP is overexpressed in human prostate cancer and is associated with PTEN nuclear exclusion. Thus, our results delineate a previously unknown PML DAXX - HAUSP molecular network controlling PTEN deubiquitinylation and trafficking, which is perturbed by oncogenic cues in human cancer, in turn defining a new deubiquitinylation- dependent model for PTEN subcellular compartmentalization.	[Song, Min Sup; Salmena, Leonardo; Carracedo, Arkaitz; Egia, Ainara; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA; [Song, Min Sup; Salmena, Leonardo; Carracedo, Arkaitz; Egia, Ainara; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Lo-Coco, Francesco] Univ Roma Tor Vergata, Dept Biopathol, I-00133 Rome, Italy; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Rome Tor Vergata; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X	NIH; International Human Frontier Science Program Organization; European Molecular Biology Organization; NATIONAL CANCER INSTITUTE [R01CA082328, P50CA092629] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Vogelstein, K.H. Baek, M. Lanotte and X. Jiang for sharing reagents and W. Gu for critical discussions. We thank all members of the Pandolfi laboratory, in particular K. Ito, S. Majid and L. Poliseno, for technical support, advice and discussion. This work was supported by NIH grants to P.P.P.L.S. is supported by the International Human Frontier Science Program Organization, and A.C. is supported by the European Molecular Biology Organization.	Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Carracedo A, 2008, CELL, V133, P550, DOI 10.1016/j.cell.2008.04.023; CUMMINS JM, 2004, NATURE, V428; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Tallman MS, 2004, SEMIN HEMATOL, V41, P27, DOI 10.1053/j.seminhematol.2004.02.004; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	30	377	415	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					813	U11		10.1038/nature07290	http://dx.doi.org/10.1038/nature07290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18716620	Green Accepted			2022-12-24	WOS:000259854900050
J	Podsypanina, K; Du, YCN; Jechlinger, M; Beverly, LJ; Hambardzumyan, D; Varmus, H				Podsypanina, Katrina; Du, Yi-Chieh Nancy; Jechlinger, Martin; Beverly, Levi J.; Hambardzumyan, Dolores; Varmus, Harold			Seeding and propagation of untransformed mouse mammary cells in the lung	SCIENCE			English	Article							BREAST-CANCER METASTASIS; TUMOR-METASTASIS; MICE	The acquisition of metastatic ability by tumor cells is considered a late event in the evolution of malignant tumors. We report that untransformed mouse mammary cells that have been engineered to express the inducible oncogenic transgenes MYC and Kras(D12), or polyoma middle T, and introduced into the systemic circulation of a mouse can bypass transformation at the primary site and develop into metastatic pulmonary lesions upon immediate or delayed oncogene induction. Therefore, previously untransformed mammary cells may establish residence in the lung once they have entered the bloodstream and may assume malignant growth upon oncogene activation. Mammary cells lacking oncogenic transgenes displayed a similar capacity for long- term residence in the lungs but did not form ectopic tumors.	[Podsypanina, Katrina; Du, Yi-Chieh Nancy; Jechlinger, Martin; Beverly, Levi J.; Hambardzumyan, Dolores; Varmus, Harold] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Podsypanina, K (corresponding author), Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	podsypak@mskcc.org	Jechlinger, Martin/AAC-9442-2020	Jechlinger, Martin/0000-0002-3710-4466	NIH [K01 CA118731, P01 CA94060, R24 CA83084, P30-CA 08748]; Martell Foundation; U.S. Department of Defense [W81XWH-05-1-0220]; NATIONAL CANCER INSTITUTE [P01CA094060, P30CA008748, K01CA118731, R24CA083084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martell Foundation; U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. A. Melnick, G. Sanchez, A. Giannakou, and J. Demers for expert handling of the mouse colony; L. Chodosh for providing MMTV-rtTA transgenic mice; D. Felsher and J. M. Bishop for providing TetO-MYC transgenic mice; A. Olshen for assistance with statistical analysis; and L. K. Tan for assistance with histological analysis. Supported in part by awards from NIH (K01 CA118731 to K. P., P01 CA94060 to H. V., and R24 CA83084 and P30-CA 08748, which provides partial support for core facilities used in conducting this investigation), the Martell Foundation ( to H. V.), and the U.S. Department of Defense (W81XWH-05-1-0220 to M. J.).	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	17	214	220	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1841	1844		10.1126/science.1161621	http://dx.doi.org/10.1126/science.1161621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18755941	Green Accepted			2022-12-24	WOS:000259501300040
J	Lin, HH; Murray, M; Cohen, T; Colijn, C; Ezzati, M				Lin, Hsien-Ho; Murray, Megan; Cohen, Ted; Colijn, Caroline; Ezzati, Majid			Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study	LANCET			English	Article							AIR-POLLUTION; HEALTH SYSTEM; RURAL CHINA; MORTALITY; TOBACCO; BURDEN; INTERVENTIONS; CESSATION; DISEASE; IMPROVEMENT	Background Chronic obstructive pulmonary disease (COPD), lung cancer, and tuberculosis are three leading causes of death in China, where prevalences of smoking and solid-fuel use are also high. We aimed to predict the effects of risk-factor trends on COPD, lung cancer, and tuberculosis. Methods We used representative data sources to estimate past trends in smoking and household solid-fuel use and to construct a range of future scenarios. We obtained the aetiological effects of risk factors on diseases from meta-analyses of epidemiological studies and from large studies in China. We modelled future COPD and lung cancer mortality and tuberculosis incidence, taking into account the accumulation of hazardous effects of risk factors on COPD and lung cancer over time, and dependency of the risk of tuberculosis infection on the prevalence of disease. We quantified the sensitivity of our results to methods and data choices. Findings If smoking and solid-fuel use remain at current levels between 2003 and 2033, 65 million deaths from COPD and 18 million deaths from lung cancer are predicted in China; 82% of COPD deaths and 75% of lung cancer deaths will be attributable to the combined effects of smoking and solid-fuel use. Complete gradual cessation of smoking and solid-fuel use by 2033 could avoid 26 million deaths from COPD and 6.3 million deaths from lung cancer; interventions of intermediate magnitude would reduce deaths by 6-31% (COPD) and 8-26% (lung cancer). Complete cessation of smoking and solid-fuel use by 2033 would reduce the projected annual tuberculosis incidence in 2033 by 1.4-52% if 80% DOTS coverage is sustained, 27-62% if 50% coverage is sustained, or 33-71% if 20% coverage is sustained. Interpretation Reducing smoking and solid-fuel use can substantially lower predictions of COPD and lung cancer burden and would contribute to effective tuberculosis control in China. Funding International Union Against Tuberculosis and Lung Disease.	[Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho; Murray, Megan; Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lin, Hsien-Ho] Mennonite Christian Hosp, Community Hlth Soc, Hualien, Taiwan; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Murray, Megan; Cohen, Ted] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Ezzati, Majid] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Bristol; Harvard University	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	majid_ezzati@harvard.edu	Tomescu, Cleopatra M/F-5197-2011; Cohen, Ted/G-8101-2011	LIN, HSIEN-HO/0000-0002-7481-6016; Green, Jonathan/0000-0002-0143-181X; Cohen, Ted/0000-0002-8091-7198	International Union Against Tuberculosis and Lung Disease; World Bank; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985] Funding Source: NIH RePORTER	International Union Against Tuberculosis and Lung Disease; World Bank(The World Bank India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the International Union Against Tuberculosis and Lung Disease, through a grant from the World Bank. We thank Cheng-Yuan Chiang, Donald Enarson, Ems Baris, and Ziad Obermeyer for Valuable discussion on methods and models, Colin Mathers for mortality projections, Zheng Zhou for help with data on smoking and fuel use, Jonathan Sinton for discussions on fuels use trends in China, and the Chinese Ministry of Health for tuberculosis prevalence data. We thank the China Health and Nutrition Survey, Jill Boreham, Rachel Huxley, and Zhengming Chen for valuable information and data on risk factor exposure and effects.	Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; [Anonymous], 2003, TOBACCO CONTROL POLI; Baris E, 2004, BMJ-BRIT MED J, V329, P1090, DOI 10.1136/bmj.329.7474.1090; Barnes DF, 2005, URBAN HOUSEHOLD ENER; Barroso Elizabeth Clara, 2003, J. Pneumologia, V29, P89, DOI 10.1590/S0102-35862003000200008; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chapman Simon, 2003, N S W Public Health Bull, V14, P46, DOI 10.1071/NB03013; Chen XY, 2004, LANCET, V364, P417; *CHIN CDCP CAR POP, CHIN HLTH NUTR SURV; *CHIN DAT CTR, CHIN YEARL MACR STAT; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Colijn C, 2007, J THEOR BIOL, V247, P765, DOI 10.1016/j.jtbi.2007.04.015; *DEP AGR, 1997, CHIN RUR EN YB 1991; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2004, ANNU REV ENV RESOUR, V29, P383, DOI 10.1146/annurev.energy.29.062103.121246; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M, 2004, COMP QUANTIFICATION; FERNANDEZ GO, 2006, ENCUESTA NACL SALUD; Florig HK, 1997, ENVIRON SCI TECHNOL, V31, pA274, DOI 10.1021/es972315t; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; GILMORE J, 2002, REPORT SMOKING CANAD; Grimard Franque, IMPACT TUBERCULOSIS; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Hedley AJ, 2002, LANCET, V360, P1646, DOI 10.1016/S0140-6736(02)11612-6; Huxley R, 2007, AM J EPIDEMIOL, V165, P1280, DOI 10.1093/aje/kwm002; International Energy Agency, 2002, WORLD EN OUTL 2002; Jha P., 2000, TOBACCO CONTROL DEV; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Jiang L., 2004, INT J GLOBAL ENERGY, V21, P2, DOI DOI 10.1504/IJGEI.2004.004691; KOH H, 2002, TOBACCO CONTROL S11, V11, P1; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Laxminarayan R, 2007, EC BENEFIT TUBERCULO; Leung CC, 2004, AM J RESP CRIT CARE, V170, P1027, DOI 10.1164/rccm.200404-512oc; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Masera, 2005, ENERGY SUSTAIN DEV, V9, P25, DOI [10.1016/S0973-0826(08)60480-9, DOI 10.1016/S0973-0826(08)60480-9]; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; *MIN HLTH, 1994, RES NAT HLTH SERV AN; *MIN HLTH, 1999, RES NAT HLTH SERV AN; *MIN PUBL HLTH PEO, 1985, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 2000, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1979, NAT RAND SURV EP TUB; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health, 2004, RES NAT HLTH SERV AN; Onyebujoh PC, 1999, LANCET, V354, P116, DOI 10.1016/S0140-6736(98)10448-8; *POP CENS OFF, 2002, TAB 2000 POP CENS PR; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Sassi F., 2008, PREVENTION LIFESTYLE; Schneider NK, 2007, B WORLD HEALTH ORGAN, V85, P820, DOI 10.2471/BLT.07.034797; Shafey O, 2003, TOBACCO CONTROL COUN; Sinton JE, 2004, ENERGY SUSTAIN DEV, V8, P33, DOI [10.1016/S0973-0826(08)60465-2, DOI 10.1016/S0973-0826(08)60465-2]; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; SMITH KR, 1993, WORLD DEV, V21, P941, DOI 10.1016/0305-750X(93)90053-C; SPRINGETT V H, 1971, Tubercle, V52, P73, DOI 10.1016/0041-3879(71)90015-8; Squire SB, 2004, LANCET, V364, P391, DOI 10.1016/S0140-6736(04)16777-9; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Tang SL, 2005, HEALTH POLICY, V72, P93, DOI 10.1016/j.healthpol.2004.06.009; Thun MJ, 1997, NATL CANCER I MONOGR, P305; United Nations Population Division, WORLD POP PROSP 2006; *US DEP HHS, 1990, DHHS PUBL CDC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Wang Jun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P837; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; World Bank, 2007, COST POLLUTION CHINA; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19	79	184	210	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1473	1483		10.1016/S0140-6736(08)61345-8	http://dx.doi.org/10.1016/S0140-6736(08)61345-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18835640	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000260801300024
J	Kim, HJ; Oh, SA; Brownfield, L; Hong, SH; Ryu, H; Hwang, I; Twell, D; Nam, HG				Kim, Hyo Jung; Oh, Sung Aeong; Brownfield, Lynette; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Twell, David; Nam, Hong Gil			Control of plant germline proliferation by SCFFBL17 degradation of cell cycle inhibitors	NATURE			English	Article							F-BOX PROTEINS; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; EXPRESSION; SIGNAL; GENE; INSIGHTS; MUTANTS; COMPLEX; TOBACCO	Flowering plants possess a unique reproductive strategy, involving double fertilization by twin sperm cells(1). Unlike animal germ lines, the male germ cell lineage in plants only forms after meiosis and involves asymmetric division of haploid microspores, to produce a large, non- germline vegetative cell and a germ cell that undergoes one further division to produce the twin sperm cells(2). Although this switch in cell cycle control is critical for sperm cell production and delivery, the underlying molecular mechanisms are unknown. Here we identify a novel F- box protein of Arabidopsis thaliana, designated FBL17 ( F- box- like 17), that enables this switch by targeting the degradation of cyclin- dependent kinase A; 1 inhibitors specifically in male germ cells. We show that FBL17 is transiently expressed in the male germ line after asymmetric division and forms an SKP1 -Cullin1 - F- box protein ( SCF) E3 ubiquitin ligase complex (SCFFBL17) that targets the cyclin- dependent kinase inhibitors KRP6 and KRP7 for proteasome- dependent degradation. Accordingly, the loss of FBL17 function leads to the stabilization of KRP6 and inhibition of germ cell cycle progression. Our results identify SCFFBL17 as an essential male germ cell proliferation complex that promotes twin sperm cell production and double fertilization in flowering plants.	[Oh, Sung Aeong; Brownfield, Lynette; Twell, David] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; [Kim, Hyo Jung; Hong, Sung Hyun; Ryu, Hojin; Hwang, Ildoo; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	University of Leicester; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Twell, D (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	twe@le.ac.uk; nam@postech.ac.kr	Twell, David/D-8043-2011	Twell, David/0000-0003-0483-1461	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics; Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council; BK21 research fellowship for Life Science, Kyungpook National University; KRF grant; MOHERD; BBSRC [BB/E001017/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001017/1, BB/C004205/1] Funding Source: researchfish	MOST ( KOSEF) through the National Core Research Center for Systems Bio-Dynamics(Korea Science and Engineering Foundation); Crop Functional Genomics Research Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BK21 research fellowship for Life Science, Kyungpook National University; KRF grant(National Research Foundation of Korea); MOHERD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K.H. Suh, Y.S. Park and B.H. Kim for technical assistance. This work was supported by MOST (KOSEF) through the National Core Research Center for Systems Bio-Dynamics (to H.G.N.) and the Crop Functional Genomics Research Program (to H.G.N.), by the Biotechnology and Biological Sciences Research Council (to D.T.), by the BK21 research fellowship for Life Science, Kyungpook National University ( to S.A.O.), and by a KRF grant from MOHERD (to I.H.).	Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Duplakova N, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-39; Durbarry A, 2005, PLANT PHYSIOL, V137, P297, DOI 10.1104/pp.104.053165; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Howden R, 1998, GENETICS, V149, P621; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Iwakawa H, 2006, PLANT J, V45, P819, DOI 10.1111/j.1365-313X.2005.02643.x; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1046/j.1365-313X.2003.01869.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Padidam M, 2003, TRANSGENIC RES, V12, P101, DOI 10.1023/A:1022113817892; Park SK, 2004, SEX PLANT REPROD, V17, P63, DOI 10.1007/s00497-004-0216-x; Park SK, 1998, DEVELOPMENT, V125, P3789; Park SK, 2001, PLANT PHYSIOL, V126, P899, DOI 10.1104/pp.126.2.899; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Toda T, 1999, PHILOS T ROY SOC B, V354, P1551, DOI 10.1098/rstb.1999.0498; Verdaguer B, 1996, PLANT MOL BIOL, V31, P1129, DOI 10.1007/BF00040830; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192	36	147	152	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1134	U14		10.1038/nature07289	http://dx.doi.org/10.1038/nature07289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948957				2022-12-24	WOS:000260252600050
J	Kriegenburg, F; Seeger, M; Saeki, Y; Tanaka, K; Lauridsen, AMB; Hartmann-Petersen, R; Hendil, KB				Kriegenburg, Franziska; Seeger, Michael; Saeki, Yasushi; Tanaka, Keiji; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.			Mammalian 26S Proteasomes Remain Intact during Protein Degradation	CELL			English	Article							ATP-DEPENDENT PROTEASES; MULTIUBIQUITIN-CHAIN; DEUBIQUITINATING ENZYME; PROTEOLYTIC PATHWAY; REGULATORY COMPLEX; SUBSTRATE ENTRY; 20S PROTEASOME; FISSION YEAST; HELA-CELLS; UBIQUITIN	It has been suggested that degradation of polyubiquitylated proteins is coupled to dissociation of 26S proteasomes. In contrast, using several independent types of experiments, we find that mammalian proteasomes can degrade polyubiquitylated proteins without disassembling. Thus, immobilized, 35 S-labeled 26S proteasomes degraded polyubiquitylated Sic1 and c-IAP1 without releasing any subunits. In addition, it is predicted that if 26S proteasomes dissociate into 20S proteasomes and regulatory complexes during a degradation cycle, the reassembly rate would be limiting at low proteasome concentrations. However, the rate with which each proteasome degraded polyubiquitylated Sic1 was independent of the proteasome concentration. Likewise, substrate-dependent dissociation of 26S proteasomes could not be detected by nondenaturing electrophoresis. Lastly, epoxomicin-inhibited 20S proteasomes can trap released regulatory complexes, forming inactive 26S proteasomes, but addition of epoxomicin-inhibited 20S proteasomes had no effect on the degradation of either polyubiquitylated Sic1 or UbcH10 by 26S proteasomes or of endogenous substrates in cell extracts.	[Kriegenburg, Franziska; Lauridsen, Anne-Marie B.; Hartmann-Petersen, Rasmus; Hendil, Klavs B.] Dept Biol, DK-2100 Copenhagen O, Denmark; [Seeger, Michael] Charite Univ Med Berlin, Inst Biochem, D-10117 Berlin, Germany; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tokyo Metropolitan Institute of Medical Science	Hartmann-Petersen, R (corresponding author), Dept Biol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen O, Denmark.	rhpetersen@bio.ku.dk; kbhendil@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Saeki, Yasushi/AAR-8198-2021	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Saeki, Yasushi/0000-0002-9202-5453				Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kominami K, 1997, MOL BIOL CELL, V8, P171, DOI 10.1091/mbc.8.1.171; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith SE, 2005, WOMAN ART J, V26, P20, DOI 10.2307/3566530; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	64	32	34	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					355	365		10.1016/j.cell.2008.08.032	http://dx.doi.org/10.1016/j.cell.2008.08.032			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957208	Bronze			2022-12-24	WOS:000260130400024
J	Wilson, MD; Barbosa-Morais, NL; Schmidt, D; Conboy, CM; Vanes, L; Tybulewicz, VLJ; Fisher, EMC; Tavare, S; Odom, DT				Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Conboy, Caitlin M.; Vanes, Lesley; Tybulewicz, Victor L. J.; Fisher, Elizabeth M. C.; Tavare, Simon; Odom, Duncan T.			Species-specific transcription in mice carrying human chromosome 21	SCIENCE			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; HISTONE-H3 LYSINE-4; EVO-DEVO; EVOLUTION; CHROMATIN; RECOGNITION; RESOLUTION; REVEALS; DOMAIN	Homologous sets of transcription factors direct conserved tissue-specific gene expression, yet transcription factor-binding events diverge rapidly between closely related species. We used hepatocytes from an aneuploid mouse strain carrying human chromosome 21 to determine, on a chromosomal scale, whether interspecies differences in transcriptional regulation are primarily directed by human genetic sequence or mouse nuclear environment. Virtually all transcription factor-binding locations, landmarks of transcription initiation, and the resulting gene expression observed in human hepatocytes were recapitulated across the entire human chromosome 21 in the mouse hepatocyte nucleus. Thus, in homologous tissues, genetic sequence is largely responsible for directing transcriptional programs; interspecies differences in epigenetic machinery, cellular environment, and transcription factors themselves play secondary roles.	[Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Cambridge CB2 0RE, England; [Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Conboy, Caitlin M.] Univ Minnesota, Sch Med, Med Sci Training Program, Minneapolis, MN 55455 USA; [Vanes, Lesley; Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Fisher, Elizabeth M. C.] UCL, Neurol Inst, London WC1N 3BG, England; [Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities; MRC National Institute for Medical Research; University of London; University College London; University of Cambridge	Odom, DT (corresponding author), Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	duncan.odom@cancer.org.uk	Barbosa-Morais, Nuno L/I-2743-2013; Wilson, Michael D/K-6294-2014; Fisher, Elizabeth MC/C-2168-2008; Pillay, Nischalan/F-9536-2012	Barbosa-Morais, Nuno L/0000-0002-1215-0538; Wilson, Michael D/0000-0002-4015-3066; Fisher, Elizabeth MC/0000-0003-2850-9936; Tybulewicz, Victor/0000-0003-2439-0798; Conboy, Caitlin/0000-0001-8280-056X; Odom, Duncan/0000-0001-6201-5599	European Research Council; Royal Society Wolfson Research Merit Award; Hutchison Whampoa; Medical Research Council; Wellcome Trust; University of Cambridge; Cancer Research U.K.; Medical Research Council [MC_U117527252, G0601056] Funding Source: researchfish; MRC [MC_U117527252, G0601056] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Hutchison Whampoa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Cancer Research U.K.(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to E. Jacobsen, R. Stark, I. Spiteri, B. Liu, J. Marioni, A. Lynch, J. Hadfield, N. Matthews, the Cambridge Research Institute (CRI) Genomics Core, CRI Bioinformatics Core, and Camgrid for technical assistance, and B. Gottgens and J. Ferrer for insightful advice. Supported by the European Research Council (D.T.O.); Royal Society Wolfson Research Merit Award (S.T.); Hutchison Whampoa (D.T.O., ST); Medical Research Council (E.F.,VT); Wellcome Trust (E.F., V.T.); University of Cambridge (D.T.O., D.S., N.B.M., S.T.); and Cancer Research U.K. (D.T.O., M.D.W., N.B.M., S.T., D.S.). Data deposited under ArrayExpress accession numbers E-TABM-473 and E-TABM-474. M.D.W., N.B.M., D.S., D.T.O., and C.M.C. designed and performed experiments; N.B.M., M.D.W., and D.S. analyzed the data; L.V., V.T., M.D.W., and E.F. created, prepared, and provided Tc1 mouse tissues; and M.D.W., N.B.M., D.T.O., and S.T. wrote the manuscript. D.T.O. oversaw the work. The authors declare no competing interests.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Eeckhoute J, 2003, NUCLEIC ACIDS RES, V31, P6640, DOI 10.1093/nar/gkg850; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	28	214	218	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					434	438		10.1126/science.1160930	http://dx.doi.org/10.1126/science.1160930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18787134	Green Accepted			2022-12-24	WOS:000260094500045
J	Bshary, R; Grutter, AS; Willener, AST; Leimar, O				Bshary, Redouan; Grutter, Alexandra S.; Willener, Astrid S. T.; Leimar, Olof			Pairs of cooperating cleaner fish provide better service quality than singletons	NATURE			English	Article							TIT-FOR-TAT; PARTNER CONTROL; LABROIDES DIMIDIATUS; ANIMAL SOCIETIES; REEF FISH; MUTUALISM; EVOLUTION; PUNISHMENT; ECOLOGY; RATES	Service providers may vary service quality depending on whether they work alone or provide the service simultaneously with a partner. The latter case resembles a prisoner's dilemma(1-4), in which one provider may try to reap the benefits of the interaction without providing the service. Here we present a game- theory model based on the marginal value theorem(5), which predicts that as long as the client determines the duration, and the providers cooperate towards mutual gain, service quality will increase in the pair situation. This prediction is consistent with field observations and with an experiment on cleaning mutualism, in which stable male - female pairs of the cleaner wrasse Labroides dimidiatus repeatedly inspect client fish jointly. Cleaners cooperate by eating ectoparasites(6) off clients but actually prefer to cheat and eat client mucus(7). Because clients often leave in response to such cheating, the benefits of cheating can be gained by only one cleaner during a pair inspection. In both data sets, the increased service quality during pair inspection was mainly due to the smaller females behaving significantly more cooperatively than their larger male partners. In contrast, during solitary inspections, cleaning behaviour was very similar between the sexes. Our study highlights the importance of incorporating interactions between service providers to make more quantitative predictions about cooperation between species.	[Bshary, Redouan; Willener, Astrid S. T.] Univ Neuchatel, Dept Zool, CH-2009 Neuchatel, Switzerland; [Grutter, Alexandra S.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia; [Leimar, Olof] Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Neuchatel; University of Queensland; Stockholm University	Bshary, R (corresponding author), Univ Neuchatel, Dept Zool, Rue Emile Argand 11 Case Postale 158, CH-2009 Neuchatel, Switzerland.	redouan.bshary@unine.ch	Grutter, Alexandra S/J-2737-2013; Leimar, Olof/L-3781-2014	Grutter, Alexandra S/0000-0003-1688-2821; Leimar, Olof/0000-0001-8621-6977; Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council; Swiss Science Foundation; Australian Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Australian Research Council(Australian Research Council)	We thank the Egyptian Environmental Affairs Agency for permission to work at Ras Mohammed National Park, the Park Rangers and I. Riepl for local support, and M. Wurth and A. Hubl for field assistance. We further thank the Lizard Island Research Station for their support concerning the experiments. R.B. was funded by the Natural Environment Research Council and by the Swiss Science Foundation. A.S.T.W. was funded by the Swiss Science Foundation. A.S.G. was funded by the Australian Research Council. O.L. was funded by the Swedish	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bowles S, 2003, DAHL WS ENV, P153; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Bshary R, 2002, ANIM BEHAV, V63, P557, DOI 10.1006/anbe.2001.1923; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R, 2006, NATURE, V441, P975, DOI 10.1038/nature04755; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1988, BEHAV ECOL SOCIOBIOL, V23, P395, DOI 10.1007/BF00303714; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; HAMMERSTEIN P, 2003, WHY IS RECIPROCITY S, P83; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 2002, ECOL LETT, V5, P634, DOI 10.1046/j.1461-0248.2002.00358.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOE R, 1991, ETHOLOGY, V87, P97; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007	28	88	89	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					964	U46		10.1038/nature07184	http://dx.doi.org/10.1038/nature07184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923522	Green Submitted			2022-12-24	WOS:000260038300049
J	Poon, VY; Klassen, MP; Shen, K				Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang			UNC-6/netrin and its receptor UNC-5 locally exclude presynaptic components from dendrites	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; NETRIN RECEPTOR; AXON GUIDANCE; COLORECTAL-CANCER; SYNAPSE FORMATION; DROSOPHILA; ENCODES; WNT; EXPRESSION	Polarity is an essential feature of many cell types, including neurons that receive information from local inputs within their dendrites and propagate nerve impulses to distant targets through a single axon. It is generally believed that intrinsic structural differences between axons and dendrites dictate the polarized localization of axonal and dendritic proteins(1). However, whether extracellular cues also instruct this process in vivo has not been explored. Here we show that the axon guidance cue UNC-6/netrin and its receptor UNC-5 act throughout development to exclude synaptic vesicle and active zone proteins from the dendrite of the Caenorhabditis elegans motor neuron DA9, which is proximal to a source of UNC- 6/ netrin. In unc- 6/ netrin and unc- 5 loss- of-function mutants, presynaptic components mislocalize to the DA9 dendrite. In addition, ectopically expressed UNC- 6/ netrin, acting through UNC- 5, is sufficient to exclude endogenous synapses from adjacent subcellular domains within the DA9 axon. Furthermore, this anti- synaptogenic activity is interchangeable with that of LIN- 44/ Wnt despite being transduced through different receptors, suggesting that extracellular cues such as netrin and Wnts not only guide axon navigation but also regulate the polarized accumulation of presynaptic components through local exclusion.	[Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Sch Med, Neurosci Program, 300 Pasteur Dr, Stanford, CA 94305 USA.	kangshen@stanford.edu			W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W. M. Keck Foundation, the McKnight Endowment Fund, the Searle Scholar Award and the Howard Hughes Medical Institute. We thank the International Caenorhabditis Genetic Center and M. Chalfie for strains. We further thank M. Chalfie for sharing unpublished results on the silencing system. We also thank C. Gao and Y. Fu for technical assistance, and T. Clandinin, C. Bargmann, S. McConnell, and members of the Shen laboratory for comments on the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jin YS, 1999, J NEUROSCI, V19, P539; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Manitt C, 2006, J NEUROSCI RES, V84, P1808, DOI 10.1002/jnr.21070; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Su MW, 2000, DEVELOPMENT, V127, P585; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	29	102	114	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					669	U68		10.1038/nature07291	http://dx.doi.org/10.1038/nature07291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18776887	Green Accepted			2022-12-24	WOS:000259639700048
J	Munck, E; Bominaar, EL				Munck, Eckard; Bominaar, Emile L.			Chemistry - Bringing stability to highly reduced iron-sulfur clusters	SCIENCE			English	Editorial Material							AZOTOBACTER-VINELANDII; FE PROTEIN; NITROGENASE; ANALOG; MOSSBAUER; EPR		[Munck, Eckard; Bominaar, Emile L.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Munck, E (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th St, Pittsburgh, PA 15213 USA.	emunck@cmu.edu; eb7g@andrew.cmu.edu						Angove HC, 1997, J AM CHEM SOC, V119, P8730, DOI 10.1021/ja9712837; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Deng L, 2008, J AM CHEM SOC, V130, P9878, DOI 10.1021/ja802111w; Guo ML, 2002, J AM CHEM SOC, V124, P12100, DOI 10.1021/ja026478f; Hans M, 2008, J BIOL INORG CHEM, V13, P563, DOI 10.1007/s00775-008-0345-z; HERSKOVITZ T, 1972, P NATL ACAD SCI USA, V69, P2437, DOI 10.1073/pnas.69.9.2437; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; OSULLIVAN T, 1985, J AM CHEM SOC, V107, P4096, DOI 10.1021/ja00299a066; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Scott TA, 2005, P NATL ACAD SCI USA, V102, P9741, DOI 10.1073/pnas.0504258102; Strop P, 2001, BIOCHEMISTRY-US, V40, P651, DOI 10.1021/bi0016467; Yoo SJ, 1999, J AM CHEM SOC, V121, P2534, DOI 10.1021/ja9837405	13	19	19	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1452	1453		10.1126/science.1163868	http://dx.doi.org/10.1126/science.1163868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787157				2022-12-24	WOS:000259121800027
J	Law, MR; Majumdar, SR; Soumerai, SB				Law, Michael R.; Majumdar, Sumit R.; Soumerai, Stephen B.			Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROMOTION	Objective To assess the impact of direct to consumer advertising of prescription drugs in the United States on Canadian prescribing rates for three heavily marketed drugs-etanercept, mometasone, and tegaserod. Design Controlled quasi-experimental study using interrupted time series analysis. Population Representative sample of 2700 Canadian pharmacies and prescription data from 50 US Medicaid programmes. Main outcome measures Differences in number of filled prescriptions per 10000 population per month between English speaking and French speaking (control) Canadian provinces before and after the start of direct to consumer advertising in the United States. Results Spending on direct to consumer advertising for study drugs ranged from $194m to $314m (104m- pound 169m; pound ((euro)131m-(euro)212m) over the study period. Prescription rates for etanercept and mometasone did not increase in English speaking provinces relative to French speaking controls after the start of direct to consumer advertising. In contrast, tegaserod prescriptions increased 42% (0.56 prescriptions/ 10 000 residents, 95% confidence interval 0.37 to 0.76) in English speaking provinces immediately after the start of US direct to consumer advertising. Uncontrolled analysis of US Medicaid data showed a larger 56% increase in tegaserod prescriptions. However, this increase did not persist over time in either country, despite continued advertising. Conclusions Exposure to US direct to consumer advertising transiently influenced both Canadian and US prescribing rates for tegaserod, a drug later withdrawn owing to safety concerns. The impact of direct to consumer advertising on drug use seems to be highly variable and probably depends on the characteristics of the advertised drug, the level of exposure to direct to consumer advertising, and the cultural context.	[Law, Michael R.; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; [Law, Michael R.; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; [Majumdar, Sumit R.] Univ Alberta Hosp, Div Gen Internal Med, Dept Med, Walter Mackenzie Hlth Sci Ctr 2E3 07, Edmonton, AB T6G 2B7, Canada	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Alberta	Law, MR (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mlaw@post.harvard.edu			Thomas 0 Pyle Fellowship; Fellowship in Pharmaceutical Policy at Harvard Medical School; Social Sciences and Humanities Research Council of Canada; Alberta Heritage Foundation for Medical Research (health scholar); Canadian Institutes of Health Research (new investigator); Agency for Healthcare Research and Quality [U18HS010391]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010391] Funding Source: NIH RePORTER	Thomas 0 Pyle Fellowship; Fellowship in Pharmaceutical Policy at Harvard Medical School; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Alberta Heritage Foundation for Medical Research (health scholar)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (new investigator)(Canadian Institutes of Health Research (CIHR)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	MRL is supported by the Thomas 0 Pyle Fellowship and the Fellowship in Pharmaceutical Policy at Harvard Medical School and by a Social Sciences and Humanities Research Council of Canada doctoral fellowship. SRM receives salary support from the Alberta Heritage Foundation for Medical Research (health scholar) and the Canadian Institutes of Health Research (new investigator). SBS is an investigator in the HMO Research Network Centers for Education and Research on Therapeutics, supported by the Agency for Healthcare Research and Quality (grant No. U18HS010391). The funding and data sources for this study had no role in study design; in the collection, analysis, and interpretation of data: in the writing of the report: and in the decision to submit the article for publication.	*APPL MAN, 2000, CAN ACC INS PRESCR M; Bradford WD, 2006, HEALTH AFFAIR, V25, P1371, DOI 10.1377/hlthaff.25.5.1371; Calfee JE, 2002, J LAW ECON, V45, P673, DOI 10.1086/374704; Cassels A, 2006, BRIT MED J, V332, P1469, DOI 10.1136/bmj.332.7556.1469-a; *CTR MED MED SERV, 2005, MED MAN CAR ENR REP; *CTR MED MED SERV, 2007, STAT DRUG UT DAT; Donohue JM, 2004, MED CARE, V42, P1176, DOI 10.1097/00005650-200412000-00004; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Evans BW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003960.pub3; Gilbody S, 2005, QUAL SAF HEALTH CARE, V14, P246, DOI 10.1136/qshc.2004.012781; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; HOMER A, 1999, JAMA-J AM MED ASSOC, V281, P380; *IAG RES, 2006, PRESCR DRUG ADV BREA; *IAG RES, 2005, ADV PRESCR DRUGS IS; Iizuka T, 2004, J IND ECON, V52, P349, DOI 10.1111/j.0022-1821.2004.00230.x; Lexchin J, 2006, HEALTH POLICY, V79, P214, DOI 10.1016/j.healthpol.2005.12.015; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Mansfield PR, 2008, MED J AUSTRALIA, V188, P13, DOI 10.5694/j.1326-5377.2008.tb01496.x; MacKinnon BJ, 2007, CAN MED ASSOC J, V176, P1405, DOI 10.1503/cmaj.070483; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; *NEW YORK AM MARK, 2005, EFF AW BRIEF EFF ZEL; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; Rosenthal MB, 2003, FRONTIERS HLTH POLIC, V6, P1; SCHOEN C, 2004, HEALTH AFFAIR, pW4, DOI DOI 10.1377/HLTHAFF.W4.487; Shuchman M, 2007, NEW ENGL J MED, V356, P2236, DOI 10.1056/NEJMp078080; *STAT CAN, 2007, MED TOT INC FAM TYP; *STAT CAN, 2007, Q DEM EST; *STAT CAN, 2007, POP SEX AG GROUP PRO; *STAT CAN, LANG COMP CAN HIGHL; *STAT CAN, 2006, TEL VIEW DAT TABL; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WEISSMAN JS, 2003, HLTH AFF MILLWOOD S, pW3	32	40	40	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2008	337	7669							a1055	10.1136/bmj.a1055	http://dx.doi.org/10.1136/bmj.a1055			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351JP	18765444	Green Submitted, Green Published			2022-12-24	WOS:000259420900034
J	Tottey, S; Waldron, KJ; Firbank, SJ; Reale, B; Bessant, C; Sato, K; Cheek, TR; Gray, J; Banfield, MJ; Dennison, C; Robinson, NJ				Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Bessant, Conrad; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.			Protein-folding location can regulate manganese-binding versus copper- or zinc-binding	NATURE			English	Article							OXALATE DECARBOXYLASE; QUERCETIN 2,3-DIOXYGENASE; BACILLUS-SUBTILIS; SENSITIVITY; EXPRESSION; CHAPERONE; PATHWAY; YEAST; EPR	Metals are needed by at least one-quarter of all proteins(1,2). Although metallochaperones(3-8) insert the correct metal into some proteins, they have not been found for the vast majority, and the view is that most metalloproteins acquire their metals directly from cellular pools. However, some metals form more stable complexes with proteins than do others. For instance, as described in the Irving Williams series(9), Cu2+ and Zn2+ typically form more stable complexes than Mn2+. Thus it is unclear what cellular mechanisms manage metal acquisition by most nascent proteins. To investigate this question, we identified the most abundant Cu2+-protein, CucA (Cu2+- cupin A), and the most abundant Mn2+- protein, MncA (Mn2+- cupin A), in the periplasm of the cyanobacterium Synechocystis PCC 6803. Each of these newly identified proteins binds its respective metal via identical ligands within a cupin fold. Consistent with the Irving - Williams series, MncA only binds Mn2+ after folding in solutions containing at least a 10(4) times molar excess of Mn2+ over Cu2+ or Zn2+. However once MncA has bound Mn2+, the metal does not exchange with Cu2+. MncA and CucA have signal peptides for different export pathways into the periplasm, Tat and Sec respectively. Export by the Tat pathway allows MncA to fold in the cytoplasm, which contains only tightly bound copper or Zn2+ ( refs 10-12) but micromolar Mn2+ ( ref. 13). In contrast, CucA folds in the periplasm to acquire Cu2+. These results reveal a mechanism whereby the compartment in which a protein folds overrides its binding preference to control its metal content. They explain why the cytoplasm must contain only tightly bound and buffered copper and Zn2+.	[Tottey, Steve; Waldron, Kevin J.; Firbank, Susan J.; Reale, Brian; Sato, Katsuko; Cheek, Timothy R.; Gray, Joe; Banfield, Mark J.; Dennison, Christopher; Robinson, Nigel J.] Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bessant, Conrad] Cranfield Univ, Cranfield Bioinformat Grp, Cranfield MK43 0AL, Beds, England	Newcastle University - UK; Cranfield University	Robinson, NJ (corresponding author), Univ Newcastle, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@ncl.ac.uk	Robinson, Nigel J/J-6363-2012; Johnson, Michael D. L./B-4352-2012; Waldron, Kevin/J-2368-2016; Waldron, Kevin John/HHM-8983-2022; Banfield, Mark/C-7453-2013; Bessant, Conrad/E-7620-2010	Robinson, Nigel J/0000-0001-5586-1092; Waldron, Kevin/0000-0002-5577-7357; Waldron, Kevin John/0000-0002-5577-7357; Banfield, Mark/0000-0001-8921-3835; Bessant, Conrad/0000-0002-7983-1020; Dennison, Christopher/0000-0001-8665-052X; Gray, Joseph/0000-0003-2338-0301	BBSRC PMS committee [BBS/B/02576, BB/E001688/1]; J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow; BBSRC [BB/E001688/1] Funding Source: UKRI; MRC [G0600759, G0500367] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001688/1, BBS/B/02576] Funding Source: researchfish; Medical Research Council [G0600759, G0500367] Funding Source: researchfish	BBSRC PMS committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); J. Gitlin and the Children's Discovery Institute; Royal Society University Research Fellow(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the BBSRC PMS committee (BBS/B/02576 and BB/E001688/1). B. R. was supported by J. Gitlin and the Children's Discovery Institute. M. J. B. is a Royal Society University Research Fellow. J. Kotz provided advice on the draft manuscript. We thank T. Palmer, B. Ize and G. Buchanan for donating E. coli BL21 tat deletion strains and for advice.	Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A, 2007, J PHYS CHEM B, V111, P5043, DOI 10.1021/jp0715326; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Fusetti F, 2002, STRUCTURE, V10, P259, DOI 10.1016/S0969-2126(02)00704-9; Helmann JD, 2007, MOL CELL, V27, P859, DOI 10.1016/j.molcel.2007.09.002; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kooter IM, 2002, EUR J BIOCHEM, V269, P2971, DOI 10.1046/j.1432-1033.2002.02973.x; Leslie AGW, 1992, RECENT CHANGES MOSFL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmer T, 2003, MICROBIOL-SGM, V149, P547, DOI 10.1099/mic.0.25900-0; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey Stephen, 2007, V6, P3, DOI 10.1007/7171_2006_072; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Waldron KJ, 2007, J BIOL CHEM, V282, P3837, DOI 10.1074/jbc.M609916200; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	42	236	243	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1138	U17		10.1038/nature07340	http://dx.doi.org/10.1038/nature07340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948958				2022-12-24	WOS:000260252600051
J	Nishino, J; Kim, I; Chada, K; Morrison, SJ				Nishino, Jinsuke; Kim, Injune; Chada, Kiran; Morrison, Sean J.			Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16(Ink4a) and p19(Arf) Expression	CELL			English	Article							TUMOR SUPPRESSION; DEPENDENCE DISTINGUISHES; TRANSGENIC MICE; INK4A LOCUS; BMI-1; MOUSE; PROTEINS; PROLIFERATION; SENESCENCE; GENE	Stem cells persist throughout life in diverse tissues by undergoing self-renewing divisions. Self-renewal capacity declines with age, partly because of increasing expression of the tumor suppressor p16(Ink4a). We discovered that the Hmga2 transcriptional regulator is highly expressed in fetal neural stem cells but that expression declines with age. This decrease is partly caused by the increasing expression of let-7b microRNA, which is known to target HMGA2. Hmga2-deficient mice show reduced stem cell numbers and self-renewal throughout the central and peripheral nervous systems of fetal and young-adult mice but not old-adult mice. Furthermore, p16(Ink4a) and p19(Arf) expression were increased in Hmga2-deficient fetal and young-adult stem cells, and deletion of p16(Ink4a) and/or p19(Arf) partially restored self-renewal capacity. let-7b overexpression reduced Hmga2 and increased p16(Ink4a)/p19(Arf) expression. Hmga2 thus promotes fetal and young-adult stem cell self-renewal by decreasing p16(Ink4a)/p19(Arf) expression. Changes in let-7 and Hmga2 expression during aging contribute to the decline in neural stem cell function.	[Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nishino, Jinsuke; Kim, Injune; Morrison, Sean J.] Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chada, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08554 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Kim, Injune/C-1710-2011	Kim, Injune/0000-0001-9244-815X; Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; National Institute of Neurological Disorder and Stroke [R01 NS040750]; National Institute on Aging [R01 AG024945-01]; University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) [CA46592]; National Institute of Diabetes, Digestive, and Kidney Diseases [NIH5P60-DK20572]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Howard Hughes Medical Institute, the National Institute of Neurological Disorder and Stroke (R01 NS040750), and the National Institute on Aging (R01 AG024945-01). Flow cytometry was partially supported by the University of Michigan (UM) Comprehensive Cancer National Institutes of Health (NIH) CA46592. Antibody production was supported in part by National Institute of Diabetes, Digestive, and Kidney Diseases grant NIH5P60-DK20572 to the Michigan Diabetes Research and Training Center. J.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Thanks to David Adams and Martin White for flow cytometry and to Elizabeth Smith (UM Hybridoma Core) for antibody production. Thanks to Charles Sherr for providing p19<SUP>Arf-/-</SUP> mice and to Ron DePinho for providing p16<SUP>Ink4a</SUP>/p19Arf<SUP>-/-</SUP> and p16<SUP>Ink4a-/-</SUP> mice. Thanks to Scott Lowe and to Masashi Narita for providing anti-Hmga2 antibody and to Tom Lanigan in the UM Vector Core for generating	Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; BENSON KF, 1994, GENET RES, V64, P27, DOI 10.1017/S0016672300032511; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiel MJ, 2005, DEV BIOL, V283, P29, DOI 10.1016/j.ydbio.2005.03.037; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	39	471	480	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					227	239		10.1016/j.cell.2008.09.017	http://dx.doi.org/10.1016/j.cell.2008.09.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957199	Bronze, Green Accepted			2022-12-24	WOS:000260130400013
J	Karelis, AD				Karelis, Antony D.			Metabolically healthy but obese individuals	LANCET			English	Editorial Material							NORMAL-WEIGHT; WOMEN; IDENTIFICATION; POPULATION; PREVALENCE; PROFILE; RISK		[Karelis, Antony D.] Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada	University of Quebec; University of Quebec Montreal	Karelis, AD (corresponding author), Univ Quebec, Dept Kinesiol, Montreal, PQ H2X 3R9, Canada.	karelis.antony@uqam.ca						AGUILARSALINAS CA, 2008, J CLIN ENDOCRIN 0805; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Iacobellis G, 2005, OBES RES, V13, P1116, DOI 10.1038/oby.2005.130; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Perseghin G, 2008, DIABETOLOGIA, V51, P1567, DOI 10.1007/s00125-008-1077-x; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	13	191	196	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1281	1283		10.1016/S0140-6736(08)61531-7	http://dx.doi.org/10.1016/S0140-6736(08)61531-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18929889				2022-12-24	WOS:000260060500008
J	Nair, S; Schilling, TF				Nair, Sreelaja; Schilling, Thomas F.			Chemokine signaling controls endodermal migration during zebrafish gastrulation	SCIENCE			English	Article							CELL-MIGRATION; RECEPTOR CXCR4; GASTROINTESTINAL-TRACT; MYOCARDIAL MIGRATION; MESODERM MIGRATION; FIBRONECTIN; XENOPUS; EXPRESSION; ADHESION; SDF-1-ALPHA	Directed cell movements during gastrulation establish the germ layers of the vertebrate embryo and coordinate their contributions to different tissues and organs. Anterior migration of the mesoderm and endoderm has largely been interpreted to result from epiboly and convergent-extension movements that drive body elongation. We show that the chemokine Cxcl12b and its receptor Cxcr4a restrict anterior migration of the endoderm during zebrafish gastrulation, thereby coordinating its movements with those of the mesoderm. Depletion of either gene product causes disruption of integrin- dependent cell adhesion, resulting in separation of the endoderm from the mesoderm; the endoderm then migrates farther anteriorly than it normally would, resulting in bilateral duplication of endodermal organs. This process may have relevance to human gastrointestinal bifurcations and other organ defects.	[Nair, Sreelaja; Schilling, Thomas F.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Schilling, TF (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	tschilli@uci.edu			NIH [R01NS41353, R01DE13828]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041353] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Raz for cxcl12b and cxcr4a constructs; our laboratory colleagues, especially S. Piloto for help with qPCR and T. Hoffman for help with itgb1b constructs; and I. Blitz for reviewing the manuscript. Supported by NIH grants R01NS41353 and R01DE13828.	Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Dickinson K, 2006, DEV DYNAM, V235, P368, DOI 10.1002/dvdy.20636; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Fukui A, 2007, BIOCHEM BIOPH RES CO, V354, P472, DOI 10.1016/j.bbrc.2007.01.007; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; HOWARD JE, 1992, MECH DEVELOP, V38, P109, DOI 10.1016/0925-4773(92)90003-3; Jones J, 2007, EXP CELL RES, V313, P4051, DOI 10.1016/j.yexcr.2007.07.001; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Pelletier AJ, 2000, BLOOD, V96, P2682; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Roberts DJ, 2000, DEV DYNAM, V219, P109, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Stevenson R.E., 1993, HUMAN MALFORMATIONS; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Trinh LA, 2004, DEV CELL, V6, P371; Warga RM, 1999, DEVELOPMENT, V126, P827; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; Winklbauer R, 1996, DEV BIOL, V177, P413, DOI 10.1006/dbio.1996.0174; Winklbauer R, 1996, INT J DEV BIOL, V40, P305; Yusuf F, 2005, ANAT EMBRYOL, V210, P35, DOI 10.1007/s00429-005-0013-9; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011	37	96	97	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					89	92		10.1126/science.1160038	http://dx.doi.org/10.1126/science.1160038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18719251	Green Accepted			2022-12-24	WOS:000259680200044
J	Forde, SE; Beardmore, RE; Gudelj, I; Arkin, SS; Thompson, JN; Hurst, LD				Forde, Samantha E.; Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.; Thompson, John N.; Hurst, Laurence D.			Understanding the limits to generalizability of experimental evolutionary models	NATURE			English	Article							HOST-PARASITOID INTERACTION; ESCHERICHIA-COLI; BACTERIA; COEVOLUTION; PHAGE; COMMUNITIES; ADAPTATION; RESISTANCE; GENETICS; VIRUS	Given the difficulty of testing evolutionary and ecological theory in situ, in vitro model systems are attractive alternatives(1); however, can we appraise whether an experimental result is particular to the in vitro model, and, if so, characterize the systems likely to behave differently and understand why? Here we examine these issues using the relationship between phenotypic diversity and resource input in the T7 - Escherichia coli co- evolving system as a case history. We establish a mathematical model of this interaction, framed as one instance of a super- class of host - parasite co- evolutionary models, and show that it captures experimental results. By tuning this model, we then ask how diversity as a function of resource input could behave for alternative co- evolving partners ( for example, E. coli with lambda bacteriophages). In contrast to populations lacking bacteriophages, variation in diversity with differences in resources is always found for co- evolving populations, supporting the geographic mosaic theory of co- evolution(2). The form of this variation is not, however, universal. Details of infectivity are pivotal: in T7 - E. coli with a modified gene- for- gene interaction, diversity is low at high resource input, whereas, for matching- allele interactions, maximal diversity is found at high resource input. A combination of in vitro systems and appropriately configured mathematical models is an effective means to isolate results particular to the in vitro system, to characterize systems likely to behave differently and to understand the biology underpinning those alternatives.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Forde, Samantha E.; Thompson, John N.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Gudelj, Ivana] Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England	University of Bath; University of California System; University of California Santa Cruz; Imperial College London; University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	; Hurst, Laurence/F-9215-2010	Arkin, Sinan/0000-0001-7805-4015; Hurst, Laurence/0000-0002-1002-1054	NERC Advanced Fellowship; ORS award; Department of Mathematics at Imperial College London; National Science Foundation [DEB 0515598]; EPSRC [EP/F037856/1] Funding Source: UKRI; NERC [NE/E013007/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F037856/1] Funding Source: researchfish; Natural Environment Research Council [NE/B501998/2, NE/B501998/1, NE/E013007/2] Funding Source: researchfish	NERC Advanced Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ORS award; Department of Mathematics at Imperial College London; National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Buckling, S. Nuismer, K. Rich, J. Hoeksema and C. Jessup for their comments on an earlier version of this manuscript. L. D. H. is a Royal Society Wolfson Research Merit Award Holder. I. G. is supported by a NERC Advanced Fellowship. S. S. A. is funded by an ORS award and a studentship for the Department of Mathematics at Imperial College London. S. E. F. and J. N. T. are supported by the National Science Foundation DEB 0515598.	Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Forde SE, 2007, AM NAT, V169, P794, DOI 10.1086/516848; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; KRUGER DH, 1981, MICROBIOL REV, V45, P9; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455, DOI 10.1098/rspb.1999.0659; SEN K, 1991, J BACTERIOL, V173, P926, DOI 10.1128/jb.173.2.926-928.1991; SPANAKIS E, 1987, J GEN MICROBIOL, V133, P353; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Thompson J. N., 2005, INTERSPEC INTERACT; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818	21	32	33	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					220	U44		10.1038/nature07152	http://dx.doi.org/10.1038/nature07152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784724	Green Submitted			2022-12-24	WOS:000259090800046
J	Berger, JM				Berger, James M.			SnapShot: Nucleic acid helicases and translocases	CELL			English	Editorial Material							MECHANISMS		Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA.				NIGMS NIH HHS [R01 GM071747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300	10	31	34	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5							888.e1	10.1016/j.cell.2008.08.027	http://dx.doi.org/10.1016/j.cell.2008.08.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775318	Green Accepted, Bronze			2022-12-24	WOS:000258947500027
J	Ratcliffe, JM; Nydam, ML				Ratcliffe, John M.; Nydam, Marie L.			Multimodal warning signals for a multiple predator world	NATURE			English	Article							ARCTIID MOTHS; EVOLUTION; LEPIDOPTERA; GENE; BATS; DISCRIMINATION; MITOCHONDRIAL; DEFENSES; UTILITY	Aposematism is an anti- predator defence, dependent on a predator's ability to associate unprofitable prey with a prey- borne signal(1). Multimodal signals should vary in efficacy according to the sensory systems of different predators; however, until now, the impact of multiple predator classes on the evolution of these signals had not been investigated(2,3). Here, using a community- level molecular phylogeny to generate phylogenetically independent contrasts, we show that warning signals of tiger moths vary according to the seasonal and daily activity patterns of birds and bats - predators with divergent sensory capacities. Many tiger moths advertise chemical defence(4,5) using conspicuous colouration and/ or ultrasonic clicks(3,6). During spring, when birds are active and bats less so, we found that tiger moths did not produce ultrasonic clicks. Throughout both spring and summer, tiger moths most active during the day were visually conspicuous. Those species emerging later in the season produced ultrasonic clicks; those that were most nocturnal were visually cryptic. Our results indicate that selective pressures from multiple predator classes have distinct roles in the evolution of multimodal warning displays now effective against a single predator class. We also suggest that the evolution of acoustic warning signals may lack the theoretical difficulties associated with the origination of conspicuous colouration.	[Nydam, Marie L.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Ratcliffe, John M.] Univ So Denmark, Ctr Sound Commun, Inst Biol, DK-5230 Odense M, Denmark	Cornell University; University of Southern Denmark	Nydam, ML (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	jmr@biology.sdu.dk; mln32@cornell.edu			NSERC; NIDCD; DNSRC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); DNSRC(Danish Natural Science Research Council)	We thank R. Hoebeke for access to the Cornell University Insect Collection, T. Eisner for the loan of ultraviolet photography equipment, and the 15 people who scored the photographs. J. M. R. thanks M. Fitzpatrick for discussion. J. Barber, C. Beatty, I. Cuthill, T. Eisner and J. Fullard provided detailed comments that improved the manuscript. This study was funded by research grants to J. Fullard (NSERC), R. Hoy (NIDCD) and J. M. R. (NSERC and DNSRC). Molecular work was conducted at Cornell in the laboratory of R. Harrison and the Evolutionary Genetics Core Facility.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; BARCLAY RMR, 1994, ANIM BEHAV, V48, P1013, DOI 10.1006/anbe.1994.1334; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Cadman M. D., 1987, ATLAS BREEDING BIRDS; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cott H.B., 1940, ADAPTIVE COLORATION; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Dunn PO, 2001, EVOLUTION, V55, P161; FULLARD JH, 1977, NATURE, V267, P42, DOI 10.1038/267042a0; FULLARD JH, 1980, CAN J ZOOL, V58, P1745, DOI 10.1139/z80-241; Fullard JH, 2001, ANIM BEHAV, V62, P349, DOI 10.1006/anbe.2001.1753; FULLARD JH, 1977, CAN J ZOOL, V55, P1213, DOI 10.1139/z77-160; Godfrey WE, 1986, THE BIRDS OF CANADA; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Hristov N, 2005, CHEMOECOLOGY, V15, P105, DOI 10.1007/s00049-005-0301-0; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; NICOLAUS LK, 1983, SCIENCE, V220, P212, DOI 10.1126/science.220.4593.212; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; Ratcliffe JM, 2003, ANIM BEHAV, V65, P385, DOI 10.1006/anbe.2003.2059; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe C, 2002, P ROY SOC B-BIOL SCI, V269, P1353, DOI 10.1098/rspb.2002.2012; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; WARD P S, 1974, Journal of Research on the Lepidoptera, V13, P23; Weller, 2002, CLADISTIC STUDY ARCT; YACK JE, 1988, CAN J ZOOL, V66, P753, DOI 10.1139/z88-111	40	80	80	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2008	455	7209					96	U59		10.1038/nature07087	http://dx.doi.org/10.1038/nature07087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18769439				2022-12-24	WOS:000258890200044
J	Han, JC; Liu, QR; Jones, M; Levinn, RL; Menzie, CM; Jefferson-George, KS; Adler-Wailes, DC; Sanford, EL; Lacbawan, FL; Uhl, GR; Rennert, OM; Yanovski, JA				Han, Joan C.; Liu, Qing-Rong; Jones, MaryPat; Levinn, Rebecca L.; Menzie, Carolyn M.; Jefferson-George, Kyra S.; Adler-Wailes, Diane C.; Sanford, Ethan L.; Lacbawan, Felicitas L.; Uhl, George R.; Rennert, Owen M.; Yanovski, Jack A.			Brain-derived neurotrophic factor and obesity in the WAGR syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; HUMAN PLATELETS; ENERGY-BALANCE; FACTOR BDNF; HYPERPHAGIA; DELETION; CHILDREN; PATIENT; HYPOTHALAMUS; ASSOCIATION	Background: Brain-derived neurotrophic factor (BDNF) has been found to be important in energy homeostasis in animal models, but little is known about its role in energy balance in humans. Heterozygous, variably sized, contiguous gene deletions causing haploinsufficiency of the WT1 and PAX6 genes on chromosome 11p13, approximately 4 Mb centromeric to BDNF (11p14.1), result in the Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome. Hyperphagia and obesity were observed in a subgroup of patients with the WAGR syndrome. We hypothesized that the subphenotype of obesity in the WAGR syndrome is attributable to deletions that induce haploinsufficiency of BDNF. Methods: We studied the relationship between genotype and body-mass index (BMI) in 33 patients with the WAGR syndrome who were recruited through the International WAGR Syndrome Association. The extent of each deletion was determined with the use of oligonucleotide comparative genomic hybridization. Results: Deletions of chromosome 11p in the patients studied ranged from 1.0 to 26.5 Mb; 58% of the patients had heterozygous BDNF deletions. These patients had significantly higher BMI z scores throughout childhood than did patients with intact BDNF (mean [+/-SD] z score at 8 to 10 years of age, 2.08+/-0.45 in patients with heterozygous BDNF deletions vs. 0.88+/-1.28 in patients without BDNF deletions; P=0.03). By 10 years of age, 100% of the patients with heterozygous BDNF deletions (95% confidence interval [CI], 77 to 100) were obese (BMI greater/equal 95th percentile for age and sex) as compared with 20% of persons without BDNF deletions (95% CI, 3 to 56; P<0.001). The critical region for childhood-onset obesity in the WAGR syndrome was located within 80 kb of exon 1 of BDNF. Serum BDNF concentrations were approximately 50% lower among the patients with heterozygous BDNF deletions (P=0.001). Conclusions: Among persons with the WAGR syndrome, BDNF haploinsufficiency is associated with lower levels of serum BDNF and with childhood-onset obesity; thus, BDNF may be important for energy homeostasis in humans. (ClinicalTrials.gov number, NCT00006073.).	[Han, Joan C.; Levinn, Rebecca L.; Menzie, Carolyn M.; Jefferson-George, Kyra S.; Adler-Wailes, Diane C.; Sanford, Ethan L.; Yanovski, Jack A.] NIH, Unit Growth & Obes, Program Dev Endocrinol & Genet, Hatfield Clin Res Ctr, Bethesda, MD 20892 USA; [Rennert, Owen M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Clin Genom, Bethesda, MD USA; [Jones, MaryPat] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Lacbawan, Felicitas L.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Liu, Qing-Rong; Uhl, George R.] NIDA, Mol Neurobiol Branch, Baltimore, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Yanovski, JA (corresponding author), NIH, Unit Growth & Obes, Program Dev Endocrinol & Genet, Hatfield Clin Res Ctr, 10 Ctr Dr,Rm 1E-3330,MSC 1103, Bethesda, MD 20892 USA.	jy15i@nih.gov	Liu, Qing-Rong/A-3059-2012; Rennert, owen/AAI-7374-2020	Liu, Qing-Rong/0000-0001-8477-6452; Yanovski, Jack/0000-0001-8542-1637; Han, Joan/0000-0003-4252-2678; Sanford, Ethan/0000-0002-7423-6521	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH) [Z01-HD-00641]; NIH Office of Rare Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008822, ZIAHD000641] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000401, ZIADA000492] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Rare Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by grants from the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH) (Z01-HD-00641) and from the NIH Office of Rare Diseases. Dr. Uhl reports holding patents for OPRM1 and DAT (SLC6A3), which might play roles in obesity, but having no patents or other financial interests that are related to brain-derived neurotrophic factor ( BDNF); and Dr. Yanovski, receiving research support for an obesity-related clinical trial from Obecure but having no financial interests that are related to BDNF. Drs. Han and Yanovski are commissioned officers in the U. S. Public Health Service. No other potential conflict of interest relevant to this article was reported. We thank the members of International WAGR Syndrome Association for assistance in identifying families who were willing to participate in this study, Dr. Jack W. Tsao for his assistance with evaluation of nociception in our patients and review of an earlier version of the manuscript, and Chanelle Wijensinghe for administrative assistance.	Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Amor DJ, 2002, CLIN DYSMORPHOL, V11, P73, DOI 10.1097/00019605-200201000-00016; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Breau LM, 2002, PAIN, V99, P349, DOI 10.1016/S0304-3959(02)00179-3; Bremond-Gignac D, 2005, EUR J HUM GENET, V13, P409, DOI 10.1038/sj.ejhg.5201358; Breslow NE, 2003, J CLIN ONCOL, V21, P4579, DOI 10.1200/JCO.2003.06.096; Chaldakov GN, 2004, PROG BRAIN RES, V146, P279, DOI 10.1016/S0079-6123(03)46018-4; Chung WK, 2005, TRENDS ENDOCRIN MET, V16, P267, DOI 10.1016/j.tem.2005.06.009; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; DECASTRO JM, 1994, APPETITE, V23, P179, DOI 10.1006/appe.1994.1045; Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216; El-Gharbawy AH, 2006, J CLIN ENDOCR METAB, V91, P3548, DOI 10.1210/jc.2006-0658; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Fox EA, 2004, AM J PHYSIOL-REG I, V286, pR994, DOI 10.1152/ajpregu.00727.2003; Friedel S, 2005, AM J MED GENET B, V132B, P96, DOI 10.1002/ajmg.b.30090; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Gul D, 2002, AM J MED GENET, V107, P70, DOI 10.1002/ajmg.10013; Gunstad J, 2006, NEUROPSYCHOBIOLOGY, V53, P153, DOI 10.1159/000093341; Jung R, 2006, MOL GENET METAB, V88, P256, DOI 10.1016/j.ymgme.2006.02.003; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Levin BE, 2007, AM J PHYSIOL-REG I, V293, pR988, DOI 10.1152/ajpregu.00434.2007; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Marlin S, 1994, Clin Dysmorphol, V3, P255; MCGAUGHRAN JM, 1995, J MED GENET, V32, P823, DOI 10.1136/jmg.32.10.823; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ribases M, 2005, EUR J HUM GENET, V13, P428, DOI 10.1038/sj.ejhg.5201351; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Tiberio G, 2000, CLIN DYSMORPHOL, V9, P63, DOI 10.1097/00019605-200009010-00014; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1037, DOI 10.1152/ajpregu.00125.2007; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	42	208	217	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2008	359	9					918	927		10.1056/NEJMoa0801119	http://dx.doi.org/10.1056/NEJMoa0801119			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341IU	18753648	Green Accepted			2022-12-24	WOS:000258708300006
J	Bhatti, P; Sigurdson, AJ; Mabuchi, K				Bhatti, Parveen; Sigurdson, Alice J.; Mabuchi, Kiyohiko			Can low-dose radiation increase risk of cardiovascular disease?	LANCET			English	Editorial Material							INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; RADIOTHERAPY; MORTALITY; EXPOSURE; WORKERS		[Bhatti, Parveen; Sigurdson, Alice J.; Mabuchi, Kiyohiko] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mabuchi, K (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	mabuchik@mail.nih.gov		Bhatti, Parveen/0000-0003-1709-1781	NATIONAL CANCER INSTITUTE [Z01CP010133] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; McGale P, 2005, RADIAT RES, V163, P247, DOI 10.1667/RR3314; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Senkus-Konefka E, 2007, CANCER TREAT REV, V33, P578, DOI 10.1016/j.ctrv.2007.07.011; Vrijheid M, 2007, INT J EPIDEMIOL, V36, P1126, DOI 10.1093/ije/dym138	10	13	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2008	372	9640					697	699		10.1016/S0140-6736(08)61285-4	http://dx.doi.org/10.1016/S0140-6736(08)61285-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344YZ	18761208				2022-12-24	WOS:000258964500008
J	Schunemann, HJ; Woodhead, M; Anzueto, A; Buist, S; MacNee, W; Rabe, KF; Heffner, J				Schuenemann, Holger J.; Woodhead, Mark; Anzueto, Antonio; Buist, Sonia; MacNee, William; Rabe, Klaus F.; Heffner, John			A vision statement on guideline development for respiratory disease: the example of COPD	LANCET			English	Editorial Material							RECOMMENDATIONS; STRENGTH; QUALITY		[Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Schuenemann, Holger J.] SUNY Buffalo, Dept Med, Buffalo, NY USA; [Woodhead, Mark] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Woodhead, Mark] Univ Manchester, Manchester, Lancs, England; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Buist, Sonia; Heffner, John] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [MacNee, William] Queens Med Res Inst, ELEGI Colt Res Labs, UoE MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Manchester; University of Manchester; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Oregon Health & Science University; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schunemann, HJ (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Med Ctr 2C9, CLARITY Res Grp, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	schuneh@mcmaster.ca	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401; Schunemann, Holger/0000-0003-3211-8479; MacNee, William/0000-0002-3692-1448	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL090485] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R13HL 90485-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2008, COCHRANE HDB SYSTEMA; Bradbury J, 1999, LANCET, V353, P563, DOI 10.1016/S0140-6736(99)00028-8; Glasziou Paul, 2005, Evid Based Nurs, V8, P36, DOI 10.1136/ebn.8.2.36; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P12, DOI 10.1186/1478-4505-4-12; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3	11	49	53	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					774	779		10.1016/S0140-6736(08)61347-1	http://dx.doi.org/10.1016/S0140-6736(08)61347-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	18835641				2022-12-24	WOS:000263725400037
J	Grey, M; Haggart, JW; Smith, PL				Grey, Melissa; Haggart, James W.; Smith, Paul L.			Variation in Evolutionary Patterns Across the Geographic Range of a Fossil Bivalve	SCIENCE			English	Article							RANDOM-WALKS; MODE; RATES	The fossil record is the only direct source of data for studying modes ( patterns) and rates of morphological change over long periods of time. Determining modes and rates is important for understanding macroevolutionary processes, but just how modes and rates vary within a taxon, and why, remain largely unaddressed. We examined patterns of morphological change in the shell of the Mesozoic marine bivalve genus Buchia over its geographic and temporal range. Most modes conformed to either random walks or stasis, and both modes and rates showed variability between locations. For example, stasis was more common in deeper marine environments, whereas random walks occurred more often at the highest paleolatitudes studied. These results indicate that the environment can play an important role in shaping patterns of evolution.	[Grey, Melissa; Haggart, James W.; Smith, Paul L.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Haggart, James W.] Geol Survey Canada, Vancouver, BC V6B 5J3, Canada	University of British Columbia; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Grey, M (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	mgrey@eos.ubc.ca			Natural Sciences and Engineering Research of Canada (NSERC); NSERC PGS-A scholarship	Natural Sciences and Engineering Research of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-A scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by a Natural Sciences and Engineering Research of Canada (NSERC) grant (to P.L.S.) and an NSERC PGS-A scholarship (to M.G.). We are grateful to P. Alsen, T. Bogdanova, A. Crame, J.S. Crampton, J. Dougherty, J. Grant-Mackie, D.A.T. Harper, D. Hikuroa, N. Hudson, E. Kalacheva, J. Rassmussen, J. Sha, I. Sey, and F. Surlyk for use of their collections and hospitality; to P. G. Lelievre for creating the MatLab morphometrics program (MorphLab 1.0); and to G. Hunt and P. Roopnarine for help and program codes for analyzing mode. This manuscript was substantially improved by the comments and suggestions of three reviewers.	BELL MA, 2006, PALEOBIOLOGY, V58, P814; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Grey M, 2008, PALAEONTOLOGY, V51, P583, DOI 10.1111/j.1475-4983.2008.00765.x; Hannisdal B, 2007, PALEOBIOLOGY, V33, P98, DOI 10.1666/06038.1; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; JELETZKY JA, 1965, GEOL SURV CAN B, V103; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Roopnarine PD, 2001, PALEOBIOLOGY, V27, P446, DOI 10.1666/0094-8373(2001)027<0446:TDACOE>2.0.CO;2; Sey LI, 1999, PALAEOGEOGR PALAEOCL, V150, P49, DOI 10.1016/S0031-0182(99)00007-3; Sha JG, 2003, CRETACEOUS RES, V24, P715, DOI 10.1016/j.cretres.2003.07.006; Sheets HD, 2001, GENETICA, V112, P105, DOI 10.1023/A:1013308409951; SURLYK F, 1982, PALAEONTOLOGY, V25, P727	16	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 21	2008	322	5905					1238	1241		10.1126/science.1162046	http://dx.doi.org/10.1126/science.1162046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18948502				2022-12-24	WOS:000261033400039
J	Haruyama, J; Ohtake, M; Matsunaga, T; Morota, T; Honda, C; Yokota, Y; Pieters, CM; Hara, S; Hioki, K; Saiki, K; Miyamoto, H; Iwasaki, A; Abe, M; Ogawa, Y; Takeda, H; Shirao, M; Yamaji, A; Josset, JL				Haruyama, Junichi; Ohtake, Makiko; Matsunaga, Tsuneo; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Pieters, Carle M.; Hara, Seiichi; Hioki, Kazuyuki; Saiki, Kazuto; Miyamoto, Hideaki; Iwasaki, Akira; Abe, Masanao; Ogawa, Yoshiko; Takeda, Hiroshi; Shirao, Motomaro; Yamaji, Atsushi; Josset, Jean-Luc			Lack of Exposed Ice Inside Lunar South Pole Shackleton Crater	SCIENCE			English	Article							WATER ICE; DEPOSITS; HYDROGEN; SURFACE; REGIONS; MOON	The inside of Shackleton Crater at the lunar south pole is permanently shadowed; it has been inferred to hold water- ice deposits. The Terrain Camera ( TC), a 10- meter- resolution stereo camera onboard the Selenological and Engineering Explorer ( SELENE) spacecraft, succeeded in imaging the inside of the crater, which was faintly lit by sunlight scattered from the upper inner wall near the rim. The estimated temperature of the crater floor, based on the crater shape model derived from the TC data, is less than similar to 90 kelvin, cold enough to hold water- ice. However, at the TC's spatial resolution, the derived albedo indicates that exposed relatively pure water- ice deposits are not on the crater floor. Water- ice may be disseminated and mixed with soil over a small percentage of the area or may not exist at all.	[Haruyama, Junichi; Ohtake, Makiko; Morota, Tomokatsu; Honda, Chikatoshi; Yokota, Yasuhiro; Abe, Masanao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsunaga, Tsuneo; Ogawa, Yoshiko] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hara, Seiichi; Hioki, Kazuyuki] NTT DATA CCS Corp, Koto Ku, Tokyo 1360071, Japan; [Saiki, Kazuto] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Osaka 5600043, Japan; [Miyamoto, Hideaki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Iwasaki, Akira] Univ Tokyo, Dept Aerosp & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Takeda, Hiroshi] Chiba Inst Technol, Chiba 2750016, Japan; [Yamaji, Atsushi] Kyoto Univ, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Josset, Jean-Luc] Space Explorat Inst, CH-2002 Neuchatel, Switzerland	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute for Environmental Studies - Japan; Brown University; Osaka University; University of Tokyo; University of Tokyo; Chiba Institute of Technology	Haruyama, J (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.		Matsunaga, Tsuneo/H-3040-2018; Yamaji, Atsushi/ABB-2815-2021; Miyamoto, Hideaki/B-9666-2008; Miyamoto, Hideaki/E-3381-2012	Matsunaga, Tsuneo/0000-0002-3380-5230; Yamaji, Atsushi/0000-0001-8074-543X; Miyamoto, Hideaki/0000-0001-8013-6124; 	KAKENHI [20540416, 20.9211]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the contributors to the SELENE ( Kaguya) project, especially members of the project management group (Y. Takizawa, M. Kato, S. Sasaki, R. Nagashima, K. Tsuruda, and H. Mizutani) and the Lunar Imager/ Spectrometer (LISM) working group (H. Otake, H. Kawasaki, R. Nakamura, S. Kodama, S. Minami, S. Takechi, A. Akiyama, T. Yokota, T. Arai, T. Sugihara, Y. Yamaguchi, S. Sasaki, N. Asada, H. Demura, N. Hirata, J. Terazono, T. Hiroi, T. Hashimoto, T. Michikami, K. Kitazato, M. Higa, P. Pinet, T. Nimura, T. Yamamoto, N. Harada, K. Iseki, T. Hodokuma, S. Kikuchi, S. Kawabe, S. Okuno, and T. Takayama) for their efforts in the development, operation, and data processing of SELENE and LISM/TC. We thank the three anonymous reviewers for their helpful comments. This work was supported by KAKENHI (grants 20540416 to J. H. and C. H. and 20.9211 to T. Morota).	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Campbell DB, 2006, NATURE, V443, P835, DOI 10.1038/nature05167; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Hapke B., 1993, THEORY REFLECTANCE E; Haruyama J, 2008, EARTH PLANETS SPACE, V60, P243, DOI 10.1186/BF03352788; Mukai T, 1997, ADV SPACE RES-SERIES, V19, P1497, DOI 10.1016/S0273-1177(97)00348-7; *NASA, 1969, SP8023 NASA; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	14	50	54	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 7	2008	322	5903					938	939		10.1126/science.1164020	http://dx.doi.org/10.1126/science.1164020			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18948501				2022-12-24	WOS:000260674100045
J	Whitson, JA; Galinsky, AD				Whitson, Jennifer A.; Galinsky, Adam D.			Lacking control increases illusory pattern perception	SCIENCE			English	Article							SELF-AFFIRMATION; CAUSAL ATTRIBUTION; HELPLESSNESS; EVENTS; DESIRE	We present six experiments that tested whether lacking control increases illusory pattern perception, which we define as the identification of a coherent and meaningful interrelationship among a set of random or unrelated stimuli. Participants who lacked control were more likely to perceive a variety of illusory patterns, including seeing images in noise, forming illusory correlations in stock market information, perceiving conspiracies, and developing superstitions. Additionally, we demonstrated that increased pattern perception has a motivational basis by measuring the need for structure directly and showing that the causal link between lack of control and illusory pattern perception is reduced by affirming the self. Although these many disparate forms of pattern perception are typically discussed as separate phenomena, the current results suggest that there is a common motive underlying them.	[Whitson, Jennifer A.] Univ Texas Austin, Dept Management, Austin, TX 78712 USA; [Galinsky, Adam D.] Northwestern Univ, Dept Management & Org, Evanston, IL 60208 USA	University of Texas System; University of Texas Austin; Northwestern University	Whitson, JA (corresponding author), Univ Texas Austin, Dept Management, Austin, TX 78712 USA.	jennifer.whitson@mccombs.utexas.edu	sarinopoulos, isidoros/B-5453-2010		Kellogg School of Managemen	Kellogg School of Managemen	This work benefited from the generous financial support of the Dean's office of the Kellogg School of Management. We thank C. Appleton, K. Dover-Taylor, L. Howland, and A. Marfia for research help. The research was based in part on the doctoral dissertation submitted by J.W. to Northwestern University and has benefited from the comments of the committee members W. Gardner, V. Medvec, and K. Murnighan. We also thank L. Egan, Z. Kinias, G. Ku, K. Liljenquist, L. Nordgren, N. Sivanathan, C. Wang, and C. Zhong for their helpful comments.	Brehm J.W., 1966, THEORY PSYCHOL REACT; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; BURGER JM, 1988, J PERS, V56, P531, DOI 10.1111/j.1467-6494.1988.tb00901.x; CLARY EG, 1983, PERS SOC PSYCHOL B, V9, P609, DOI 10.1177/0146167283094010; Cohen S., 1986, BEHAV HLTH ENV STRES; deCharms R., 1969, PERSONAL CAUSATION; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; GLASS DC, 1972, AM SCI, V60, P457; GLASS DC, 1973, J PERS, V41, P576, DOI 10.1111/j.1467-6494.1973.tb00112.x; GMELCH G, 1971, T ACTION, V9, P39; HASTIE R, 1984, J PERS SOC PSYCHOL, V46, P44, DOI 10.1037/0022-3514.46.1.44; KANAZAWA S, 1992, PERS SOC PSYCHOL B, V18, P659, DOI 10.1177/0146167292186001; Kelley HH., 1971, ATTRIBUTION SOCIAL I; KLEIN DC, 1976, J PERS SOC PSYCHOL, V33, P508, DOI 10.1037/0022-3514.33.5.508; Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111; KRAMER RM, 1994, MOTIV EMOTION, V18, P199, DOI 10.1007/BF02249399; Levine R, 1942, J PSYCHOL, V13, P283, DOI 10.1080/00223980.1942.9917096; LIU TJ, 1986, J PERS SOC PSYCHOL, V51, P531, DOI 10.1037/0022-3514.51.3.531; Luck A, 1999, LANCET, V354, P2032, DOI 10.1016/S0140-6736(98)10495-6; Malinowski Bronislaw, 1948, MAGIC SCI RELIG OTHE; NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113; Pipes Daniel, 1997, CONSPIRACY PARANOID; PITTMAN NL, 1979, J PERS SOC PSYCHOL, V37, P39, DOI 10.1037/0022-3514.37.1.39; PITTMAN TS, 1980, J PERS SOC PSYCHOL, V39, P377, DOI 10.1037/0022-3514.39.3.377; PYSZCZYNSKI TA, 1981, J PERS SOC PSYCHOL, V40, P31, DOI 10.1037/0022-3514.40.1.31; Rosenthal R., 2008, ESSENTIALS BEHAV RES; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; SIMONOV PV, 1977, AVIAT SPACE ENVIR MD, V48, P856; STEELE CM, 1983, J PERS SOC PSYCHOL, V45, P5, DOI 10.1037/0022-3514.45.1.5; WEINER B, 1985, PSYCHOL BULL, V97, P74, DOI 10.1037/0033-2909.97.1.74; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934	32	568	590	15	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					115	117		10.1126/science.1159845	http://dx.doi.org/10.1126/science.1159845			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355AE	18832647				2022-12-24	WOS:000259680200050
J	Mallet, V; Gilgenkrantz, H; Serpaggi, J; Verkarre, V; Vallet-Pichard, A; Fontaine, H; Pol, S				Mallet, Vincent; Gilgenkrantz, Helene; Serpaggi, Jeanne; Verkarre, Virginie; Vallet-Pichard, Anais; Fontaine, Helene; Pol, Stanislas			Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-RELATED CIRRHOSIS; SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; INTERFERON-ALPHA; REVERSIBILITY; THERAPY; RIBAVIRIN; REVERSAL; MANAGEMENT	Background: The effect of regression of cirrhosis in chronic hepatitis C is unknown. Objective: To evaluate the relation between regression of cirrhosis and clinical outcome in patients with chronic hepatitis C after antiviral therapy. Design: A cohort of patients with cirrhosis treated between 1988 and 2001. Setting: Hepatology unit of a tertiary care center in France. Patients: 96 patients with chronic hepatitis C and biopsy-proven cirrhosis (METAVIR score F4) who were treated with an interferon-based regimen and had at least 1 posttreatment liver biopsy. Patients were followed until November 2006. Measurements: Occurrence of a combined end point of liver-related events (ascites, hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, hepatocellular carcinoma, or liver transplantation) and death in patients with regression of cirrhosis (defined as a decrease from 4 to <= 2 METAVIR units on post-therapy liver biopsy). Results: The median follow-up was 118 months (interquartile range, 86 to 138 months). Eighteen patients had regression of cirrhosis. The incidence of the combined end point per 100 patient-years was 0 in patients with regression of cirrhosis and 4 in patients without regression of cirrhosis (P = 0.002, log-rank test). The transplantation-free survival rate at 10 years was 100% in patients with regression of cirrhosis and 74.2% in patients without regression of cirrhosis (P = 0.025). Limitations: Selection of patients was retrospective; selection and survival biases may have influenced the estimates of the overall rate of regression of cirrhosis. The low number of patients who experienced regression of cirrhosis precludes analysis of factors that could predict regression of cirrhosis. Conclusion: Regression of cirrhosis occurs after antiviral therapy in some patients with chronic hepatitis C. Regression is associated with decreased disease-related morbidity and improved survival.	[Pol, Stanislas] Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, F-75014 Paris, France; Hop Necker Enfants Malad, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Pol, S (corresponding author), Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	stanislas.pol@cch.aphp.fr	Gilgenkrantz, Helene/G-5534-2017; Mallet, Vincent/G-4623-2011	gilgenkrantz, helene/0000-0001-6770-4561; Mallet, Vincent/0000-0003-2219-9201				BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bellentani S, 2001, J HEPATOL, V35, P531, DOI 10.1016/S0168-8278(01)00151-9; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; El Braks R, 2007, WORLD J GASTROENTERO, V13, P5648, DOI 10.3748/wjg.v13.i42.5648; Farci P, 2004, GASTROENTEROLOGY, V126, P1740, DOI 10.1053/j.gastro.2004.03.017; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fontaine H, 2000, LANCET, V356, P41, DOI 10.1016/S0140-6736(00)02434-X; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; Mallet VO, 2007, ANTIVIR THER, V12, P279; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; ORLANDO R, 1990, J CLIN GASTROENTEROL, V12, P47; Papatheodoridis GV, 2001, ALIMENT PHARM THER, V15, P689, DOI 10.1046/j.1365-2036.2001.00979.x; Pol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012; POWELL LW, 1970, AUSTRALAS ANN MED, V19, P54; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Serpaggi J, 2006, HUM PATHOL, V37, P1519, DOI 10.1016/j.humpath.2006.07.007; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; SOYER MT, 1976, SURGERY, V79, P601; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Valla DC, 1999, HEPATOLOGY, V29, P1870, DOI 10.1002/hep.510290616; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003	31	233	243	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					399	W76		10.7326/0003-4819-149-6-200809160-00006	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794559				2022-12-24	WOS:000259230200004
J	Doran, CM; Shakeshaft, AP				Doran, Christopher M.; Shakeshaft, Anthony P.			Using taxes to curb drinking in Australia	LANCET			English	Editorial Material									[Doran, Christopher M.; Shakeshaft, Anthony P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Doran, CM (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	c.doran@unsw.edu.au	Shakeshaft, Anthony/U-4637-2017	Shakeshaft, Anthony/0000-0002-5472-0930				*AIHW, 2008, DRUG STAT, V20; Australian Institute of Health and Welfare (AIHW), 2002, 2001 NAT DRUG STRAT; Euromonitor International, 2008, ALC DRINKS AUSTR; WHTIE V, 2006, AUSTR SECONDARY SCH	4	24	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2008	372	9640					701	702		10.1016/S0140-6736(08)61287-8	http://dx.doi.org/10.1016/S0140-6736(08)61287-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344YZ	18761210				2022-12-24	WOS:000258964500010
J	Moldon, A; Malapeira, J; Gabrielli, N; Gogol, M; Gomez-Escoda, B; Ivanova, T; Seidel, C; Ayte, J				Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gogol, Madelaine; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Seidel, Chris; Ayte, Jose			Promoter-driven splicing regulation in fission yeast	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; DNA-BINDING-DOMAIN; RNA-POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; BUDDING YEASTS; MEIOSIS; PROGRAM; SPORULATION; PROTEINS; ENCODES	The meiotic cell cycle is modified from the mitotic cell cycle by having a pre- meiotic S phase that leads to high levels of recombination, two rounds of nuclear division with no intervening DNA synthesis and a reductional pattern of chromosome segregation. Rem1 is a cyclin that is only expressed during meiosis in the fission yeast Schizosaccharomyces pombe. Cells in which rem1 has been deleted show decreased intragenic meiotic recombination and a delay at the onset of meiosis I ( ref. 1). When ectopically expressed in mitotically growing cells, Rem1 induces a G1 arrest followed by severe mitotic catastrophes. Here we show that rem1 expression is regulated at the level of both transcription and splicing, encoding two proteins with different functions depending on the intron retention. We have determined that the regulation of rem1 splicing is not dependent on any transcribed region of the gene. Furthermore, when the rem1 promoter is fused to other intron-containing genes, the chimaeras show a meiotic- specific regulation of splicing, exactly the same as endogenous rem1. This regulation is dependent on two transcription factors of the forkhead family, Mei4 ( ref. 2) and Fkh2 ( ref. 3). Whereas Mei4 induces both transcription and splicing of rem1, Fkh2 is responsible for the intron retention of the transcript during vegetative growth and the pre- meiotic S phase.	[Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Ayte, Jose] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona 08003, Spain; [Gogol, Madelaine] Stowers Inst, Kansas City, MO 64110 USA	Pompeu Fabra University; Stowers Institute for Medical Research	Ayte, J (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Doctor Aiguader 88, Barcelona 08003, Spain.	jose.ayte@upf.edu	Ayte, Jose/L-5217-2014; Gomez-Escoda, Blanca/T-1256-2019; Malapeira, Jordi/I-7956-2014	Ayte, Jose/0000-0002-6354-0536; Gomez Escoda, Blanca/0000-0001-9999-0806; Malapeira, Jordi/0000-0003-3503-1272; Gogol, Madelaine/0000-0002-8738-0995	Ministerio de Ciencia y Tecnologia [BFU2006-01785]; Consolider-Ingenio	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank P. Nurse, K. Gould, C. Query, N. Kaufer, H. Murakami and C. McInerny for strains and plasmids; J. Wuand Y. Zhurinskiy for help and advice on ChIPs; E. Hidalgo, J. Valcarcel, J. Vilardell and G. Gil for critical reading of the manuscript; and members of the Oxidative Stress and Cell Cycle Group at Universitat Pompeu Fabra and P. Nurse's laboratory at Rockefeller University for suggestions and comments. We acknowledge the technical support of M. Carmona and K. Zueckert-Gaudenz. J. A. is supported by a contract Ramon y Cajal from the Ministerio de Educacion y Ciencia. This work was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2006-01785) and the Consolider-Ingenio 2007-0020.	Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Newo ANS, 2007, NUCLEIC ACIDS RES, V35, P1391, DOI 10.1093/nar/gkl1144; NIELSEN O, 1990, EMBO J, V9, P1401, DOI 10.1002/j.1460-2075.1990.tb08255.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ribar B, 1997, GENE, V202, P1, DOI 10.1016/S0378-1119(97)00390-9; Sinibaldi R, 2001, Methods Mol Biol, V170, P211; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Szilagyi Z, 2005, GENE, V348, P101, DOI 10.1016/j.gene.2004.12.043	29	63	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					997	U83		10.1038/nature07325	http://dx.doi.org/10.1038/nature07325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18815595	Green Submitted, Green Published			2022-12-24	WOS:000260038300057
J	Wirtz-Peitz, F; Nishimura, T; Knoblich, JA				Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.			Linking cell cycle to asymmetric division: Aurora-A phosphorylates the par complex to regulate Numb localization	CELL			English	Article							LETHAL-GIANT-LARVAE; NEUROBLAST SELF-RENEWAL; NEURAL STEM-CELLS; TUMOR-SUPPRESSOR; DROSOPHILA NEUROBLASTS; MEMBRANE LOCALIZATION; FATE DETERMINANTS; PROTEIN; POLARITY; APKC	Drosophila neural precursor cells divide asymmetrically by segregating the Numb protein into one of the two daughter cells. Numb is uniformly cortical in interphase but assumes a polarized localization in mitosis. Here, we show that a phosphorylation cascade triggered by the activation of Aurora-A is responsible for the asymmetric localization of Numb in mitosis. Aurora-A phosphorylates Par-6, a regulatory subunit of atypical protein kinase C (aPKC). This activates aPKC, which initially phosphorylates Lethal (2) giant larvae (Lgl), a cytoskeletal protein that binds and inhibits aPKC during interphase. Phosphorylated Lgl is released from aPKC and thereby allows the PDZ domain protein Bazooka to enter the complex. This changes substrate specificity and allows aPKC to phosphorylate Numb and release the protein from one side of the cell cortex. Our data reveal a molecular mechanism for the asymmetric localization of Numb and show how cell polarity can be coupled to cell-cycle progression.	[Wirtz-Peitz, Frederik; Nishimura, Takashi; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Nishimura, Takashi/D-7672-2017; Nishimura, Takashi/AAQ-9299-2020	Knoblich, Juergen A/0000-0002-6751-3404; Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302	Boehringer Ingelheim Fonds; Human Frontiers Science Program; Austrian Academy of Sciences; Austrian Science Fund; Vienna Science and Technology Fund; European Union EUROSYSTEMS; ONCASYM	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontiers Science Program(Human Frontier Science Program); Austrian Academy of Sciences; Austrian Science Fund(Austrian Science Fund (FWF)); Vienna Science and Technology Fund; European Union EUROSYSTEMS(European Commission); ONCASYM	We thank C. Juschke and S.K. Bowman for comments on the manuscript; Y. Bellaiche, T. Hirota, Y.N. Jan, D. St Johnston, K. Kaibuchi, F. Matsuzaki, T. Murphy, S. Ohno, H. Saya, F. Schweisguth, and the Developmental Studies Hybridoma Bank for constructs, antibodies, and fly stocks; J. Betschinger, D. Berdnik, and A. Hutterer for generating transgenic fly lines and constructs; N. Nishimura and S. Farina Lopez for technical assistance; and M.P. Posti-glione, S. Goulas, and other members of our lab for discussion. F.W.P. was supported by a PhD fellowship of the Boehringer Ingelheim Fonds; T.N. is supported by a long-term fellowship of the Human Frontiers Science Program; and work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund, the Vienna Science and Technology Fund, the European Union EUROSYSTEMS, and ONCASYM.	Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dornan S, 1997, MOL BIOL CELL, V8, P1391, DOI 10.1091/mbc.8.8.1391; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Phair RD, 2004, METHOD ENZYMOL, V375, P393; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Roegiers F, 2005, MOL BIOL CELL, V16, P3480, DOI 10.1091/mbc.E05-03-0177; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938	40	272	275	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					161	173		10.1016/j.cell.2008.07.049	http://dx.doi.org/10.1016/j.cell.2008.07.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854163	Green Accepted, Bronze			2022-12-24	WOS:000259728100017
J	Han, BW; Herrin, BR; Cooper, MD; Wilson, IA				Han, Byung Woo; Herrin, Brantley R.; Cooper, Max D.; Wilson, Ian A.			Antigen recognition by variable lymphocyte receptors	SCIENCE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LAMPREY; ANTIBODY; BINDING; PROTEIN; DOMAIN; DIVERSIFICATION; DIVERSITY; EVOLUTION	Variable lymphocyte receptors ( VLRs) rather than antibodies play the primary role in recognition of antigens in the adaptive immune system of jawless vertebrates. Combinatorial assembly of leucine- rich repeat ( LRR) gene segments achieves the required repertoire for antigen recognition. We have determined a crystal structure for a VLR- antigen complex, VLR RBC36 in complex with the H- antigen trisaccharide from human blood type O erythrocytes, at 1.67 angstrom resolution. RBC36 binds the H- trisaccharide on the concave surface of the LRR modules of the solenoid structure where three key hydrophilic residues, multiple van der Waals interactions, and the highly variable insert of the carboxyl- terminal LRR module determine antigen recognition and specificity. The concave surface assembled from the most highly variable regions of the LRRs, along with diversity in the sequence and length of the highly variable insert, can account for the recognition of diverse antigens by VLRs.	[Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Scripps Research Institute; Scripps Research Institute; Emory University; Emory University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Herrin, Brantley/0000-0002-1842-6806	NIH [AI42266, AI072435]; Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, T32AI007051, R01AI072435, R01AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. L. Stanfield, X. Dai, and X. Zhu for help with data collection and analysis; M. N. Alder for help with VLR cDNA library preparation; J. Paulson and R. McBride for helpful comments and suggestions; and J. Vanhnasy, B. Droese, and H.-J. Kim for technical support and advice. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Supported by NIH grants AI42266 (I.A.W.) and AI072435 (M.D.C.), the Georgia Research Alliance (M.D.C.), and the Skaggs Institute for Chemical Biology (I.A.W.). This is Scripps Research Institute manuscript 19581-MB. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession code 3E6J.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BOFFA GA, 1967, NATURE, V214, P700, DOI 10.1038/214700b0; *CHEM COMP GROUP, 2003, MOL OP ENV MOE VERS; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; VON GARA P., 1931, Zeitschrift fur Immunitatsforschung und Experimentelle Therapie, V71, P1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; POLLARA B, 1970, J IMMUNOL, V105, P738; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	28	133	148	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1834	1837		10.1126/science.1162484	http://dx.doi.org/10.1126/science.1162484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818359	Green Accepted			2022-12-24	WOS:000259501300038
J	Hanson, JA; Chang, CB; Graves, SM; Li, ZB; Mason, TG; Deming, TJ				Hanson, Jarrod A.; Chang, Connie B.; Graves, Sara M.; Li, Zhibo; Mason, Thomas G.; Deming, Timothy J.			Nanoscale double emulsions stabilized by single-component block copolypeptides	NATURE			English	Article							MONODISPERSE DOUBLE EMULSIONS; MULTIPLE EMULSIONS; CURVATURE; DELIVERY; RELEASE	Water- in- oil- in- water emulsions are examples of double emulsions, in which dispersions of small water droplets within larger oil droplets are themselves dispersed in a continuous aqueous phase(1-3). Emulsions occur in many forms of processing and are used extensively by the foods, cosmetics and coatings industries. Because of their compartmentalized internal structure, double emulsions can provide advantages over simple oil- in- water emulsions for encapsulation, such as the ability to carry both polar and non- polar cargos, and improved control over release of therapeutic molecules(4-6). The preparation of double emulsions typically requires mixtures of surfactants for stability; the formation of double nanoemulsions, where both inner and outer droplets are under 100 nm, has not yet been achieved(7-9). Here we show that water- in- oil- in- water double emulsions can be prepared in a simple process and stabilized over many months using single- component, synthetic amphiphilic diblock copolypeptide surfactants. These surfactants even stabilize droplets subjected to extreme flow, leading to direct, mass production of robust double nanoemulsions that are amenable to nanostructured encapsulation applications in foods, cosmetics and drug delivery.	[Hanson, Jarrod A.; Li, Zhibo; Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Chang, Connie B.; Graves, Sara M.; Mason, Thomas G.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mason, Thomas G.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Mason, Thomas G.; Deming, Timothy J.] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Deming, TJ (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	mason@chem.ucla.edu; demingt@seas.ucla.edu	Li, Zhibo/K-1614-2013; Deming, Timothy/I-5411-2013	Li, Zhibo/0000-0001-9512-1507; Deming, Timothy/0000-0002-0594-5025	National Science Foundation; Human Frontiers of Science Program; University of California; National Institutes of Health; National Center for Research Resources P41 programme	National Science Foundation(National Science Foundation (NSF)); Human Frontiers of Science Program(Human Frontier Science Program); University of California(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources P41 programme(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by a grant from the National Science Foundation (T.J.D.), a grant from the Human Frontiers of Science Program (T.J.D.), and University of California start-up funds (T.J.D. and T.G.M.). Some of the work was conducted at the National Resource for Automated Molecular Microscopy (NRAMM) which is supported by the National Institutes of Health through the National Center for Research Resources P41 programme. We thank C. Potter and J. Quispe of NRAMMat the Scripps Research Institute, and S. Zhong and D. Pochan of the University of Delaware, for use of cryoelectron microscopy equipment.	Benichou A, 2004, ADV COLLOID INTERFAC, V108, P29, DOI 10.1016/j.cis.2003.10.013; Bibette J, 1999, REP PROG PHYS, V62, P969, DOI 10.1088/0034-4885/62/6/203; BREITENBACH JW, 1955, MONATSH, V86, P269; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chang CB, 2008, ACS NANO, V2, P281, DOI 10.1021/nn700385z; Dalgleish DG, 1996, FOOD RES INT, V29, P541, DOI 10.1016/S0963-9969(96)00065-8; DAVIS SS, 1987, METHOD ENZYMOL, V149, P51; DICKINSON E, 1992, J CHEM SOC FARADAY T, V88, P2973, DOI 10.1039/ft9928802973; ENSER M, 1990, INT J BIOL MACROMOL, V12, P118, DOI 10.1016/0141-8130(90)90063-G; Ficheux MF, 1998, LANGMUIR, V14, P2702, DOI 10.1021/la971271z; Garti N, 1997, COLLOID SURFACE A, V123, P233, DOI 10.1016/S0927-7757(96)03809-5; Goubault C, 2001, LANGMUIR, V17, P5184, DOI 10.1021/la010407x; Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2; KRICHELDORF HR, 1981, MAKROMOL CHEM, V182, P3077; LAPP C, 1963, J CHIM PHYS PCB, V60, P756, DOI 10.1051/jcp/1963600756; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Mason TG, 2006, J PHYS-CONDENS MAT, V18, pR635, DOI 10.1088/0953-8984/18/41/R01; Morais JM, 2008, J DISPER SCI TECHNOL, V29, P63, DOI 10.1080/01932690701688391; Niederhafner P, 2005, J PEPT SCI, V11, P757, DOI 10.1002/psc.721; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Okochi H, 2000, ADV DRUG DELIVER REV, V45, P5, DOI 10.1016/S0169-409X(00)00097-1; Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336; Pays K, 2002, J CONTROL RELEASE, V79, P193, DOI 10.1016/S0168-3659(01)00535-1; SAITO M, 1995, BIOSCI BIOTECH BIOCH, V59, P388, DOI 10.1271/bbb.59.388; STREY R, 1994, COLLOID POLYM SCI, V272, P1005, DOI 10.1007/BF00658900; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164; Wang YF, 2006, LANGMUIR, V22, P67, DOI 10.1021/la0523255; Zuidema HH, 1941, IND ENG CHEM, V13, P0312, DOI 10.1021/i560093a009	30	214	228	8	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 4	2008	455	7209					85	U54		10.1038/nature07197	http://dx.doi.org/10.1038/nature07197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343XS	18769436				2022-12-24	WOS:000258890200041
J	Phatak, PD; Bonkovsky, HL; Kowdley, KV				Phatak, Pradyumna D.; Bonkovsky, Herbert L.; Kowdley, Kris V.			Hereditary hemochromatosis: Time for targeted screening	ANNALS OF INTERNAL MEDICINE			English	Article							GENE; POPULATION; MUTATION; PENETRANCE; PREVALENCE	The discovery of the HFE gene in 1996 heralded a decade of major advances in the understanding of the mechanisms that control iron absorption and body iron stores. A genetic definition of the common form of hereditary hemochromatosis became possible, and testing for the common causative HFE mutations is now widely available in clinical laboratories. Several population screening studies have confirmed that disease penetrance in HFE-related hereditary hemochromatosis is lower than previously believed, making universal population-based screening for this disorder unattractive. However, hereditary hemochromatosis may still cause morbidity and mortality because of iron overload. Early detection and use of appropriate therapy can prevent these manifestations and can only be achieved by targeted case finding. In this article, the authors draw attention again to hereditary hemochromatosis as a cause of preventable organ dysfunction and propose targeted case finding for Caucasian men of Northern European ancestry.	Virginia Mason Med Ctr, Seattle, WA 98101 USA; Rochester Gen Hosp, Rochester, NY 14621 USA; Carolinas Hlth Care Syst, Charlotte, NC USA; Univ Washington, Sch Med, Seattle, WA USA	Virginia Mason Medical Center; Rochester General Hospital; Carolinas HealthCare System; University of Washington; University of Washington Seattle	Kowdley, KV (corresponding author), Virginia Mason Med Ctr, 1201 9th Ave, Seattle, WA 98101 USA.		Bonkovsky, Herbert L./AAH-1892-2021; Kowdley, Kris/AAF-5202-2019	Bonkovsky, Herbert L./0000-0001-7387-3230; 	National Institutes of Health [K02957, RO1-DK-38825]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	In part by the National Institutes of Health (grants K02957 and RO1-DK-38825).	Adams PC, 2007, LANCET, V370, P1855, DOI 10.1016/S0140-6736(07)61782-6; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Adams PC, 1999, AM J GASTROENTEROL, V94, P1593; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; CADMAN D, 1984, JAMA-J AM MED ASSOC, V251, P1580, DOI 10.1001/jama.251.12.1580; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Carella M, 1997, AM J HUM GENET, V60, P828; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gagne G, 2007, CLIN GENET, V71, P46, DOI 10.1111/j.1399-0004.2006.00727.x; Hall MA, 2005, GENET MED, V7, P311, DOI 10.1097/01.GIM.0000162874.58370.C0; Jacobs EMC, 2007, NETH J MED, V65, P425; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; NIEDERAU C, 1994, BAILLIERE CLIN HAEM, V7, P881, DOI 10.1016/S0950-3536(05)80129-5; Phatak PD, 1998, ANN INTERN MED, V129, P954, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00006; Powell LW, 2000, J HEPATOL, V32, P48, DOI 10.1016/S0168-8278(00)80415-8; Qaseem A, 2005, ANN INTERN MED, V143, P517, DOI 10.7326/0003-4819-143-7-200510040-00010; Robson KJH, 2000, BRIT J HAEMATOL, V108, P31; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	20	40	41	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2008	149	4					270	+		10.7326/0003-4819-149-4-200808190-00009	http://dx.doi.org/10.7326/0003-4819-149-4-200808190-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338RQ	18711158				2022-12-24	WOS:000258526700007
J	McAlonan, K; Cavanaugh, J; Wurtz, RH				McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.			Guarding the gateway to cortex with attention in visual thalamus	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; RETICULAR NUCLEUS; MACAQUE MONKEY; ORGANIZATION; NEURONS; GALAGO; SECTOR; MODULATION; PROJECTION; RESPONSES	The massive visual input from the eye to the brain requires selective processing of some visual information at the expense of other information, a process referred to as visual attention. Increases in the responses of visual neurons with attention have been extensively studied along the visual processing streams in monkey cerebral cortex, from primary visual areas to parietal and frontal cortex(1-4). Here we show, by recording neurons in attending macaque monkeys ( Macaca mulatta), that attention modulates visual signals before they even reach cortex by increasing responses of both magnocellular and parvocellular neurons in the first relay between retina and cortex, the lateral geniculate nucleus ( LGN). At the same time, attention decreases neuronal responses in the adjacent thalamic reticular nucleus ( TRN). Crick(5) argued for such modulation of the LGN by observing that it is inhibited by the TRN, and suggested that " the thalamus is the gateway to the cortex, the reticular complex might be described as the guardian of the gateway'', a reciprocal relationship we now show to be more than just hypothesis. The reciprocal modulation in LGN and TRN appears only during the initial visual response, but the modulation of LGN reappears later in the response, suggesting separate early and late sources of attentional modulation in LGN.	[McAlonan, Kerry; Cavanaugh, James; Wurtz, Robert H.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	McAlonan, K (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	km@nei.nih.gov			National Eye Institute; NATIONAL EYE INSTITUTE [Z01EY000109] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural research program of the National Eye Institute. We are grateful for the assistance of J. McClurkin, A. Nichols, M. Smith, T. Ruffner and G. Tansey.	Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Casagrande VA, 2005, PROG BRAIN RES, V149, P11, DOI 10.1016/S0079-6123(05)49002-0; CONLEY M, 1990, EUR J NEUROSCI, V2, P211, DOI 10.1111/j.1460-9568.1990.tb00414.x; CRABTREE JW, 1989, EUR J NEUROSCI, V1, P94, DOI 10.1111/j.1460-9568.1989.tb00777.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fitzgibbon T, 2007, VISUAL NEUROSCI, V24, P857, DOI 10.1017/S0952523807070770; HARTING JK, 1991, J COMP NEUROL, V310, P411, DOI 10.1002/cne.903100310; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones E. G., 2007, THALAMUS, P1270; JONES EG, 1975, J COMP NEUROL, V162, P285, DOI 10.1002/cne.901620302; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Kolmac CI, 1998, J COMP NEUROL, V396, P531; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; MONTERO VM, 1977, BRAIN RES, V138, P407, DOI 10.1016/0006-8993(77)90681-3; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roberts M, 2007, NAT NEUROSCI, V10, P1483, DOI 10.1038/nn1967; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Uhlrich DJ, 2003, J COMP NEUROL, V458, P128, DOI 10.1002/cne.10568; WILSON JR, 1995, ANAT REC, V242, P566, DOI 10.1002/ar.1092420413	30	335	337	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					391	U56		10.1038/nature07382	http://dx.doi.org/10.1038/nature07382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849967	Green Accepted			2022-12-24	WOS:000261039600044
J	Tang, W; Zeve, D; Suh, JM; Bosnakovski, D; Kyba, M; Hammer, RE; Tallquist, MD; Graff, JM				Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Hammer, Robert E.; Tallquist, Michelle D.; Graff, Jonathan M.			White fat progenitor cells reside in the adipose vasculature	SCIENCE			English	Article							STEM-CELL; GENE-EXPRESSION; OBESITY; TISSUE; DIFFERENTIATION; ADIPOCYTES; PERICYTES	White adipose (fat) tissues regulate metabolism, reproduction, and life span. Adipocytes form throughout life, with the most marked expansion of the lineage occurring during the postnatal period. Adipocytes develop in coordination with the vasculature, but the identity and location of white adipocyte progenitor cells in vivo are unknown. We used genetically marked mice to isolate proliferating and renewing adipogenic progenitors. We found that most adipocytes descend from a pool of these proliferating progenitors that are already committed, either prenatally or early in postnatal life. These progenitors reside in the mural cell compartment of the adipose vasculature, but not in the vasculature of other tissues. Thus, the adipose vasculature appears to function as a progenitor niche and may provide signals for adipocyte development.	[Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tallquist, Michelle D.; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	jon.graff@utsouthwestern.edu	Bosnakovski, Darko/T-8292-2019; Tallquist, Michelle/AAU-5277-2021; Suh, Jae Myoung/B-3268-2015	Tallquist, Michelle/0000-0002-1383-144X; Suh, Jae Myoung/0000-0001-8097-4662; Zeve, Daniel/0000-0002-4117-1282; Bosnakovski, Darko/0000-0002-7198-2019; Kyba, Michael/0000-0002-5579-7534; Hammer, Robert E./0000-0001-5487-7551	NIH; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK064261, 1R01DK066556]; University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064261, R01DK066556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kennedy, T. Wang, R. Adams, R. Evans, S. Kernie, L. Monteggia, M. Osawa, R. Perlingeiro, Q. LaPlant, and M. Iacovino, as well as members of the Graff lab. J.M.G. is a founder of Reata Pharmaceuticals, a privately held company designed to address unmet needs in cancer, neurodegenerative, and inflammatory conditions. This work was supported by NIH and the National Institute of Diabetes and Digestive and Kidney Diseases (grants 1R01DK064261 and 1R01DK066556) and the University of Texas Southwestern Medical Center Excellence in Education Fund. W.T., J.M.G., and the University of Texas Southwestern Medical Center may file. a patent application related to the work reported here.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; COOK JR, 1982, DEV BIOL, V92, P440, DOI 10.1016/0012-1606(82)90189-0; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; IYAMA KI, 1979, VIRCHOWS ARCH B, V31, P143, DOI 10.1007/BF02889932; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KLAUS S, 1991, J CELL BIOL, V115, P1783, DOI 10.1083/jcb.115.6.1783; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	28	794	817	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					583	586		10.1126/science.1156232	http://dx.doi.org/10.1126/science.1156232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18801968	Green Accepted			2022-12-24	WOS:000260299100042
J	Tay, Y; Zhang, JQ; Thomson, AM; Lim, B; Rigoutsos, I				Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing; Rigoutsos, Isidore			MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation	NATURE			English	Article							RNA INTERFERENCE; GENE-REGULATION; BINDING-SITES; ES CELLS; PLURIPOTENCY; EXPRESSION; TARGETS; IDENTIFICATION; MECHANISMS; PATHWAY	MicroRNAs ( miRNAs) are short RNAs that direct messenger RNA degradation or disrupt mRNA translation in a sequence- dependent manner(1-7). For more than a decade, attempts to study the interaction of miRNAs with their targets were confined to the 3' untranslated regions of mRNAs(1), fuelling an underlying assumption that these regions are the principal recipients of miRNA activity. Here we focus on the mouse Nanog, Oct4 ( also known as Pou5f1) and Sox2 genes(8-11) and demonstrate the existence of many naturally occurring miRNA targets in their amino acid coding sequence ( CDS). Some of the mouse targets analysed do not contain the miRNA seed, whereas others span exon - exon junctions or are not conserved in the human and rhesus genomes. miR-134, miR- 296 and miR- 470, upregulated on retinoic- acid- induced differentiation of mouse embryonic stem cells, target the CDS of each transcription factor in various combinations, leading to transcriptional and morphological changes characteristic of differentiating mouse embryonic stem cells, and resulting in a new phenotype. Silent mutations at the predicted targets abolish miRNA activity, prevent the down regulation of the corresponding genes and delay the induced phenotype. Our findings demonstrate the abundance of CDS- located miRNA targets, some of which can be species- specific, and support an augmented model whereby animal miRNAs exercise their control on mRNAs through targets that can reside beyond the 39 untranslated region.	[Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; [Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Med Ctr, Boston, MA 02215 USA	International Business Machines (IBM); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, POB 218, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com	Rigoutsos, Isidore/C-5381-2012; Kumar, Rajesh/E-7957-2010	Rigoutsos, Isidore/0000-0003-1529-8631	Agency for Science, Technology and Research of Singapore; A*STAR graduate scholarship; National Institutes of Health [DK47636, AI54973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR graduate scholarship(Agency for Science Technology & Research (A*STAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Huynh for assistance with building the rna22 pipeline that was used to make the miRNA target predictions, and H. Zhang and Y.L. Lee for their help with some of the constructs. The work of Y.T., J.Z., A.M.T. and B.L. was supported by the Agency for Science, Technology and Research of Singapore. Y.T. was the recipient of an A*STAR graduate scholarship. B.L. was also partially supported by National Institutes of Health grants DK47636 and AI54973.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200	30	1078	1157	0	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1124	U12		10.1038/nature07299	http://dx.doi.org/10.1038/nature07299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806776				2022-12-24	WOS:000260252600048
J	Janoueix-Lerosey, I; Lequin, D; Brugieres, L; Ribeiro, A; de Pontual, L; Combaret, V; Raynal, V; Puisieux, A; Schleiermacher, G; Pierron, G; Valteau-Couanet, D; Frebourg, T; Michon, J; Lyonnet, S; Amiel, J; Delattre, O				Janoueix-Lerosey, Isabelle; Lequin, Delphine; Brugieres, Laurence; Ribeiro, Agnes; de Pontual, Loic; Combaret, Valerie; Raynal, Virginie; Puisieux, Alain; Schleiermacher, Gudrun; Pierron, Gaelle; Valteau-Couanet, Dominique; Frebourg, Thierry; Michon, Jean; Lyonnet, Stanislas; Amiel, Jeanne; Delattre, Olivier			Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GENE; IDENTIFICATION; NPM; INHIBITOR; PROTEIN; FUSION; FLT3	Neuroblastoma, a tumour derived from the peripheral sympathetic nervous system, is one of the most frequent solid tumours in childhood(1,2). It usually occurs sporadically but familial cases are observed, with a subset of cases occurring in association with congenital malformations of the neural crest being linked to germline mutations of the PHOX2B gene(1-4). Here we conducted genome-wide comparative genomic hybridization analysis on a large series of neuroblastomas. Copy number increase at the locus encoding the anaplastic lymphoma kinase (ALK)(5) tyrosine kinase receptor was observed recurrently. One particularly informative case presented a high- level gene amplification that was strictly limited to ALK, indicating that this gene may contribute on its own to neuroblastoma development. Through subsequent direct sequencing of cell lines and primary tumour DNAs we identified somatic mutations of the ALK kinase domain that mainly clustered in two hotspots. Germline mutations were observed in two neuroblastoma families, indicating that ALK is a neuroblastoma predisposition gene. Mutated ALK proteins were overexpressed, hyperphosphorylated and showed constitutive kinase activity. The knockdown of ALK expression in ALK- mutated cells, but also in cell lines overexpressing a wild- type ALK, led to a marked decrease of cell proliferation. Altogether, these data identify ALK as a critical player in neuroblastomadevelopment that may hence represent a very attractive therapeutic target in this disease that is still frequently fatal with current treatments(6,7).	[Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] Inst Curie, Ctr Rech, F-94805 Villejuif, France; [Janoueix-Lerosey, Isabelle; Lequin, Delphine; Raynal, Virginie; Schleiermacher, Gudrun; Delattre, Olivier] INSERM, U830, F-94805 Villejuif, France; [Brugieres, Laurence; Valteau-Couanet, Dominique] Inst Gustave Roussy, Dept Pediat, F-94805 Villejuif, France; [Ribeiro, Agnes; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, F-75248 Paris, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Univ Paris 05, Dept Genet, Fac Med, F-75743 Paris 15, France; [de Pontual, Loic; Lyonnet, Stanislas; Amiel, Jeanne] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris 15, France; [Combaret, Valerie; Puisieux, Alain] Ctr Leon Berard, FNCLCC, Lab Rech Translat, F-69008 Lyon, France; [Puisieux, Alain] INSERM, U590, F-69008 Lyon, France; [Puisieux, Alain] Univ Lyon 1, Inst Sci Pharmaceut & Biol, F-69008 Lyon, France; [Schleiermacher, Gudrun; Michon, Jean] Inst Curie, Dept Pediat, F-75248 Paris, France; [Frebourg, Thierry] CHU Rouen, Serv Genet, F-76183 Rouen, France; [Frebourg, Thierry] Fac Med Pharm, INSERM, U614, F-76183 Rouen, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delattre, O (corresponding author), Inst Curie, Ctr Rech, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	olivier.delattre@curie.fr	Schleiermacher, Gudrun/AAN-4711-2021; Frebourg, Thierry/AAK-8390-2020; Janoueix-Lerosey, Isabelle/G-1758-2018; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017; Lyonnet, Stanislas/H-5483-2017	Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; amiel, jeanne/0000-0001-5973-4728; Lyonnet, Stanislas/0000-0001-5426-9417; delattre, olivier/0000-0002-8730-2276; DE PONTUAL, LOIC/0000-0002-3123-0453; PUISIEUX, Alain/0000-0002-9938-3798; Frebourg, Thierry/0000-0003-0399-4007	Agence Nationale pour la Recherche; Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project)(Institut National du Cancer (INCA) France); APAESIC; Association Hubert Gouin; Comite de l'Ain of the Ligue Nationale contre le Cancer	We are grateful to F. Moreau-Gachelin, I. Gallais, D. Surdez, F. Tirode, A. Fix, F. Bourdeaut, A. Almeida, C. Lucchesi, S. Roman Roman, B. Bressac, J. Benard and G. Vassal for their critical help. We thank C. Decraene, D. Gentien and B. Albaud from the translational department of Institut Curie for profiling the paediatric tumours, and P. Rosa and E. Barillot for the development of bioinformatic tools. We thank M. Lathrop and the Centre National de Genotypage for the Affymetrix 100K SNP analysis and A. Chompret for collecting families. This work was supported by grants from the Agence Nationale pour la Recherche, the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee and CIT project), the APAESIC ( Association des Parents et des Amis des Enfants Soignes a l'Institut Curie), the Association Hubert Gouin, les amis de Claire, Les Bagouz a Manon and Enfance et Sante. A. P. and V. C. are supported by the Comite de l'Ain of the Ligue Nationale contre le Cancer.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Chiarle R, 2008, NAT MED, V14, P676, DOI 10.1038/nm1769; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffin CA, 1999, CANCER RES, V59, P2776; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tonini GP, 2003, CANCER LETT, V197, P41, DOI 10.1016/S0304-3835(03)00080-6; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	27	634	666	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					967	U51		10.1038/nature07398	http://dx.doi.org/10.1038/nature07398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923523				2022-12-24	WOS:000260038300050
J	Jenkins, HE; Aylward, RB; Gasasira, A; Donnelly, CA; Abanida, EA; Koleosho-Adelekan, T; Grassly, NC				Jenkins, Helen E.; Aylward, R. Bruce; Gasasira, Alex; Donnelly, Christl A.; Abanida, Emmanuel A.; Koleosho-Adelekan, Titi; Grassly, Nicholas C.			Effectiveness of immunization against paralytic poliomyelitis in Nigeria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL POLIOVIRUS VACCINE; ACUTE FLACCID PARALYSIS; IMMUNOGENICITY; SURVEILLANCE; ERADICATION; BRAZIL; INDIA; RISK	Background: The number of cases of paralytic poliomyelitis has declined in Nigeria since the introduction of newly licensed monovalent oral poliovirus vaccines and new techniques of vaccine delivery. Understanding the relative contribution of these vaccines and the improved coverage to the decline in incident cases is essential for future planning. Methods: We estimated the field efficacies of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine, using the reported number of doses received by people with poliomyelitis and by matched controls as identified in Nigeria's national surveillance database, in which 27,379 cases of acute flaccid paralysis were recorded between 2001 and 2007. Our estimates of vaccine coverage and vaccine-induced immunity were based on the number of doses received by children listed in the database who had paralysis that was not caused by poliovirus. Results: The estimated efficacies per dose of monovalent type 1 oral poliovirus vaccine and trivalent oral poliovirus vaccine against type 1 paralytic poliomyelitis were 67% (95% confidence interval [CI], 39 to 82) and 16% (95% CI, 10 to 21), respectively, and the estimated efficacy per dose of trivalent oral poliovirus vaccine against type 3 paralytic poliomyelitis was 18% (95% CI, 9 to 26). In the northwestern region of Nigeria, which reported the majority of cases during the study period, coverage with at least one dose of vaccine increased from 59 to 78%. Between 2005 and 2007, vaccine-induced immunity levels among children under the age of 5 years more than doubled, to 56%. Conclusions: The higher efficacy of monovalent type 1 oral poliovirus vaccine (four times as effective as trivalent oral poliovirus vaccine) and the moderate gains in coverage dramatically increased vaccine-induced immunity against serotype 1 in northern Nigeria. Further increases in coverage in Nigerian states with infected populations are required to achieve the levels of vaccine-induced immunity associated with the sustained elimination achieved in other parts of the country.	[Jenkins, Helen E.; Donnelly, Christl A.; Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, London W2 1PG, England; [Aylward, R. Bruce] WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland; [Gasasira, Alex] WHO Nigeria, Abuja, Nigeria; [Abanida, Emmanuel A.; Koleosho-Adelekan, Titi] Natl Primary Hlth Care Dev Agcy, Abuja, Nigeria	Imperial College London; World Health Organization	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modeling, Dept Infect Dis Epidemiol, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	h.jenkins@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Donnelly, Christl/0000-0002-0195-2463; Jenkins, Helen/0000-0003-4749-1591	Medical Research Council [G0600719] Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish; MRC [G0600719] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; *FED REP NIG NAT P, 2006, NAT IMM COV SURV 200; *FED REP NIG NAT P, 2007, LEG NOT PUBL 2006 CE; *FED REP NIG NAT P, 2003, DEM HLTH SURV NIG 20; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; Grassly NC, 2007, LANCET, V369, P1790; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P210; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; *WHO, 2004, GLOB POL ER IN PROGR; 1999, MMWR MORB MORTAL WKL, V48, P312; 2007, MMWR MORB MORTAL WKL, V56, P996	17	43	47	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1666	U111		10.1056/NEJMoa0803259	http://dx.doi.org/10.1056/NEJMoa0803259			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18923171				2022-12-24	WOS:000260041400005
J	Dai, J; Hyland, EM; Yuan, DS; Huang, HL; Bader, JS; Boeke, JD				Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.			Probing nucleosome function: A highly versatile library of synthetic histone H3 and H4 mutants	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; LYSINE METHYLATION; H2B UBIQUITYLATION; GLOBULAR DOMAIN; GENE-EXPRESSION; MATING-TYPE; DNA-REPAIR; CELL-CYCLE; YEAST; ACETYLATION	Nucleosome structural integrity underlies the regulation of DNA metabolism and transcription. Using a synthetic approach, a versatile library of 486 systematic histone H3 and H4 substitution and deletion mutants that probes the contribution of each residue to nucleosome function was generated in Saccharomyces cerevisiae. We probed fitness contributions of each residue to perturbations of chromosome integrity and transcription, mapping global patterns of chemical sensitivities and requirements for transcriptional silencing onto the nucleosome surface. Each histone mutant was tagged with unique molecular barcodes, facilitating identification of histone mutant pools through barcode amplification, labeling, and TAG microarray hybridization. Barcodes were used to score complex phenotypes such as competitive fitness in a chemostat, DNA repair proficiency, and synthetic genetic interactions, revealing new functions for distinct histone residues and new interdependencies among nucleosome components and their modifiers.	[Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Huang, Hailiang; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Dai, Junbiao/AAB-8328-2021; Bader, Joel/A-1818-2009	Dai, Junbiao/0000-0002-5299-4700; Bader, Joel/0000-0002-6020-4625; Huang, Hailiang/0000-0003-1461-5762; Boeke, Jef/0000-0001-5322-4946	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020839, U54 RR020839-04, RR020839] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHATTOO BB, 1979, GENETICS, V93, P51; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HORIUCHI T, 1962, BIOCHIM BIOPHYS ACTA, V55, P152; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwartz BE, 2006, CURR TOP DEV BIOL, V74, P31, DOI 10.1016/S0070-2153(06)74002-9; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Yu CL, 2006, J BIOL CHEM, V281, P9755, DOI 10.1074/jbc.M513178200; Yuan DS, 2006, BIOINFORMATICS, V22, P3054, DOI 10.1093/bioinformatics/btl542; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	65	156	158	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1066	1078		10.1016/j.cell.2008.07.019	http://dx.doi.org/10.1016/j.cell.2008.07.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805098	Green Accepted, Bronze			2022-12-24	WOS:000259318100025
J	Navarro, P; Chambers, I; Karwacki-Neisius, V; Chureau, C; Morey, C; Rougeulle, C; Avner, P				Navarro, Pablo; Chambers, Ian; Karwacki-Neisius, Violetta; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip			Molecular coupling of Xist regulation and pluripotency	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; EARLY MOUSE EMBRYOS; TSIX TRANSCRIPTION; ES CELLS; NANOG; EXPRESSION; DIFFERENTIATION; DETERMINES; OCT3/4	During mouse embryogenesis, reversion of imprinted X chromosome inactivation in the pluripotent inner cell mass of the female blastocyst is initiated by the repression of Xist from the paternal X chromosome. Here we report that key factors supporting pluripotency-Nanog, Oct3/4, and Sox2-bind within Xist intron 1 in undifferentiated embryonic stem ( ES) cells. Whereas Nanog null ES cells display a reversible and moderate up- regulation of Xist in the absence of any apparent modification of Oct3/4 and Sox2 binding, the drastic release of all three factors from Xist intron 1 triggers rapid ectopic accumulation of Xist RNA. We conclude that the three main genetic factors underlying pluripotency cooperate to repress Xist and thus couple X inactivation reprogramming to the control of pluripotency during embryogenesis.	[Navarro, Pablo; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip] CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France; [Chambers, Ian; Karwacki-Neisius, Violetta] Univ Edinburgh, MRC, Ctr Dev Stem Cell Biol, Inst Stem Cell Res,Sch Biol Sci, Edinburgh EH9 3JQ, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh	Rougeulle, C (corresponding author), CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France.	rougeull@pasteur.fr; pavner@pasteur.fr	, Celine/ABB-7420-2020; Morey, Celine/N-5179-2018; Chambers, Ian/H-5416-2011	, Celine/0000-0001-9513-0278; Chambers, Ian/0000-0003-2605-1597; Rougeulle, Claire/0000-0003-3861-4940	CNRS; Institut Pasteur [05-JCJC-0166-01, 07-BLAN-0047-01]; EU Epigenome Network of Excellence; Wellcome Trust; Juvenile Diabetes Research Foundation; Biotechnological and Biological Sciences and Medical Research Councils of the UK; Medical Research Council [G0700711B] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); EU Epigenome Network of Excellence; Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Biotechnological and Biological Sciences and Medical Research Councils of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Colby for technical assistance, members of our laboratories for stimulating discussion, and A. Smith for the gift of the ZHBTc4 ES cell line. P.N., C.C., C.R., and P.A. were supported by recurrent funding from the CNRS and the Institut Pasteur, contracts 05-JCJC-0166-01 and 07-BLAN-0047-01 from the Agence Nationale de Recherche, and funding from the EU Epigenome Network of Excellence. Research in I.C.'s laboratory was supported by the Wellcome Trust, the Juvenile Diabetes Research Foundation, and the Biotechnological and Biological Sciences and Medical Research Councils of the UK.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103	24	257	263	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1693	1695		10.1126/science.1160952	http://dx.doi.org/10.1126/science.1160952			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802003				2022-12-24	WOS:000259300400041
J	Pryor, PR; Jackson, L; Gray, SR; Edeling, MA; Thompson, A; Sanderson, CM; Evans, PR; Owen, DJ; Luzio, JP				Pryor, Paul R.; Jackson, Lauren; Gray, Sally R.; Edeling, Melissa A.; Thompson, Amanda; Sanderson, Christopher M.; Evans, Philip R.; Owen, David J.; Luzio, J. Paul			Molecular basis for the sorting of the SNARE VAMP7 into endocytic clathrin-coated vesicles by the ArfGAP Hrb	CELL			English	Article							MEMBRANE-FUSION; TI-VAMP; PROTEINS; COMPLEX; DOMAIN; LOCALIZATION; SPECIFICITY; LYSOSOMES; TRANSPORT; ADAPTER	SNAREs provide the specificity and energy for the fusion of vesicles with their target membrane, but how they are sorted into the appropriate vesicles on post-Golgi trafficking pathways is largely unknown. We demonstrate that the clathrin-mediated endocytosis of the SNARE VAMP7 is directly mediated by Hrb, a clathrin adaptor and ArfGAP. Hrb wraps 20 residues of its unstructured C-terminal tail around the folded VAMP7 longin domain, demonstrating that unstructured regions of clathrin adaptors can select cargo. Disrupting this interaction by mutation of the VAMP7 longin domain or depletion of Hrb causes VAMP7 to accumulate on the cell's surface. However, the SNARE helix of VAMP7 binds back onto its longin domain, outcompeting Hrb for binding to the same groove and suggesting that Hrb-mediated endocytosis of VAMP7 occurs only when VAMP7 is incorporated into a cis-SNARE complex. These results elucidate the mechanism of retrieval of a postfusion SNARE complex in clathrin-coated vesicles.	[Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Jackson, Lauren; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Thompson, Amanda; Sanderson, Christopher M.] MRC, Rosalind Franklin Ctr Genom Res, Cambridge CB10 1SB, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk; jpl10@cam.ac.uk		Pryor, Paul Robert/0000-0001-9123-8329; Jackson, Lauren/0000-0002-3705-6126	MRC [G9310915]; Wellcome Trust [079895]; MRC [MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105178845, G9310915] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by MRC programme grant G9310915 to J. P. L., a Wellcome Trust Senior Research Fellowship to D. J. O., and Wellcome Trust Strategic Award 079895 to CIMR. We thank beamline staff at the ESRF and Maria Jose Sanchez Barena for help with data collection, Jenny Martin (IMB Brisbane) for the SNAP23 and syntaxin4 clones, Celina Whalley and Naveed Aziz of the York Technology Facility at the University of York for help with qPCR, Sally Raines and Brett Collins for technical assistance, and Andrew Peden, Katherine Bowers, Margaret Robinson, and Sean Munro for helpful discussions.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; HONG W, 2005, GENETICS, V144, P1425; KRISSINEL E, 2005, DETECTION PROTEIN AS; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Reaves BJ, 1996, J CELL SCI, V109, P749; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	39	119	119	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					817	827		10.1016/j.cell.2008.07.023	http://dx.doi.org/10.1016/j.cell.2008.07.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775314	hybrid, Green Published			2022-12-24	WOS:000258947500021
J	Kessler, D; Gase, K; Baldwin, IT				Kessler, Danny; Gase, Klaus; Baldwin, Ian T.			Field experiments with transformed plants reveal the sense of floral scents	SCIENCE			English	Article							NICOTIANA-ATTENUATA; POLLINATION; CHEMISTRY; ECOLOGY; SHIFT	Plants use many means to attract pollinators, including visual cues and odor. We investigated how nonpigment floral chemistry influences nectar removal, floral visitation, florivory, rates of outcrossing, and fitness through both male and female functions. We blocked expression of biosynthetic genes of the dominant floral attractant [ benzyl acetone (Nachal1)] and nectar repellent [ nicotine (Napmt1/2)] in all combinations in the native tobacco Nicotiana attenuata and measured their effects on plants in their native habitat. Both repellent and attractant were required to maximize capsule production and seed siring in emasculated flowers and flower visitation by native pollinators, whereas nicotine reduced florivory and nectar robbing.	[Kessler, Danny; Gase, Klaus; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, DE-07745 Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Hans Knoll Str 8, DE-07745 Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974	Max-Planck-Gesellschaft	Max-Planck-Gesellschaft(Max Planck Society)	Supported by the Max-Planck-Gesellschaft. We thank M. Baldwin, A. Kessler, and E. Wheeler for critically reading the manuscript; Brigham Young University for the use of the Lytle Ranch Preserve field station; and U. S. Department of Agriculture-Animal and Plant Health Inspection Service for constructive regulatory oversight of the genetically modified organism releases. Gene sequences have been deposited in GenBank with accession numbers EU503226 and EU503227.	Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Euler M, 1996, OECOLOGIA, V107, P102, DOI 10.1007/BF00582240; Hartmann T, 2008, P NATL ACAD SCI USA, V105, P4541, DOI 10.1073/pnas.0709231105; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Raguso RA, 2008, ENTOMOL EXP APPL, V128, P196, DOI 10.1111/j.1570-7458.2008.00683.x; Sime Karen R, 2003, BMC Ecol, V3, P6, DOI 10.1186/1472-6785-3-6; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Strauss SY, 2007, ECOLOGY EVOLUTION FL, P120; VONMARILAUN AK, 1879, SCHUTZMITTEL BLUTHEN	13	265	274	2	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 29	2008	321	5893					1200	1202		10.1126/science.1160072	http://dx.doi.org/10.1126/science.1160072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755975				2022-12-24	WOS:000258754400042
J	Mosse, YP; Laudenslager, M; Longo, L; Cole, KA; Wood, A; Attiyeh, EF; Laquaglia, MJ; Sennett, R; Lynch, JE; Perri, P; Laureys, G; Speleman, F; Kim, C; Hou, CP; Hakonarson, H; Torkamani, A; Schork, NJ; Brodeur, GM; Tonini, GP; Rappaport, E; Devoto, M; Maris, JM				Mosse, Yael P.; Laudenslager, Marci; Longo, Luca; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Perri, Patrizia; Laureys, Genevieve; Speleman, Frank; Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon; Torkamani, Ali; Schork, Nicholas J.; Brodeur, Garrett M.; Tonini, Gian P.; Rappaport, Eric; Devoto, Marcella; Maris, John M.			Identification of ALK as a major familial neuroblastoma predisposition gene	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; FUNCTIONAL-ANALYSIS; HOMEOBOX GENE; B-RAF; MUTATIONS; EXPRESSION; PHOX2B; RECEPTOR; CANCER; ACTIVATION	Neuroblastoma is a childhood cancer that can be inherited, but the genetic aetiology is largely unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired. We first identified a significant linkage signal at chromosome bands 2p23-24 using a whole- genome scan in neuroblastoma pedigrees. Resequencing of regional candidate genes identified three separate germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight separate families. Resequencing in 194 high- risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples. Nine of the ten mutations map to critical regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers. Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK messenger RNA resulted in profound inhibition of growth in all cell lines harbouring mutant or amplified ALK, as well as in two out of six wild- type cell lines for ALK. Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell- surface kinase is a tractable therapeutic target for this lethal paediatric malignancy.	[Mosse, Yael P.; Laudenslager, Marci; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Hou, Cuiping; Brodeur, Garrett M.; Rappaport, Eric; Maris, John M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Oncol, Philadelphia, PA 19104 USA; [Mosse, Yael P.; Laudenslager, Marci; Cole, Kristina A.; Wood, Andrew; Attiyeh, Edward F.; Laquaglia, Michael J.; Sennett, Rachel; Lynch, Jill E.; Hou, Cuiping; Brodeur, Garrett M.; Rappaport, Eric; Maris, John M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Longo, Luca; Perri, Patrizia; Tonini, Gian P.] Natl Inst Canc Res, Italian Neuroblastoma Fdn, I-16132 Genoa, Italy; [Perri, Patrizia] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Laureys, Genevieve; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Kim, Cecilia; Hou, Cuiping; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Torkamani, Ali; Schork, Nicholas J.] Scripps Genom Med, La Jolla, CA 92037 USA; [Torkamani, Ali; Schork, Nicholas J.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hakonarson, Hakon; Devoto, Marcella] Univ Penn, Sch Med, Div Genet, Childrens Hosp Philadelphia,Dept Pediat, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Devoto, Marcella] Univ Penn, Sch Med, CCEB, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Genoa; IRCCS AOU San Martino IST; Ghent University; Ghent University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Scripps Research Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Sapienza University Rome; University of Pennsylvania; Pennsylvania Medicine	Maris, JM (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Oncol, Philadelphia, PA 19104 USA.	maris@chop.edu	laureys, genevieve/AAG-2390-2021; Rappaport, Eric/GRO-4051-2022; Devoto, Marcella/AAP-7595-2021; Cole, Kristina/M-3922-2015; Perri, Patrizia/I-8124-2018; Perri, Patrizia/AFV-5794-2022; Longo, Luca/K-6156-2018; speleman, frank/AAR-5184-2020	Perri, Patrizia/0000-0003-2538-8278; Perri, Patrizia/0000-0003-2538-8278; Longo, Luca/0000-0002-5153-4243; speleman, frank/0000-0002-6628-8559; DEVOTO, MARCELLA/0000-0002-4431-5114; Schork, Nicholas/0000-0003-0920-5013	National Institutes of Health [K08-111733, R01-CA78454, R01-CA87847]; American Society of Clinical Oncology Career Development Award; Foerderer-Murray Fund; Carly Hillman Fund; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; Giulio D'Angio Endowed Chair; Italian Neuroblastoma Foundation; Center for Applied Genomics at the Joseph Stokes Research Institute; Scripps Genomic Medicine; Scripps Dickinson Scholarship; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [U10CA098543, R01CA078545, R01CA087847, R01CA124709, K08CA111733] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology Career Development Award; Foerderer-Murray Fund; Carly Hillman Fund; Alex's Lemonade Stand Foundation; Andrew's Army Foundation; Giulio D'Angio Endowed Chair; Italian Neuroblastoma Foundation; Center for Applied Genomics at the Joseph Stokes Research Institute; Scripps Genomic Medicine; Scripps Dickinson Scholarship; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge the families and children that participated in this research study, and the Children's Oncology Group for providing specimens. We thank W. London for providing statistical analyses related to the Children's Oncology Group tumour set, H. Rydbeck for his assistance with the linkage analysis, M. Wasik for technical assistance, and J. Felgenhauer, N. Van Roy and C. McConville for providing neuroblastoma pedigrees. This work was supported in part by National Institutes of Health grants K08-111733 (Y.P.M.), R01-CA78454 (J.M.M.), R01-CA87847 (J.M.M.), an American Society of Clinical Oncology Career Development Award (Y.P.M.), the Foerderer-Murray Fund (Y.P.M.), the Carly Hillman Fund (Y.P.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Andrew's Army Foundation (J.M.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Italian Neuroblastoma Foundation (L.L.), the Center for Applied Genomics at the Joseph Stokes Research Institute (H.H.), Scripps Genomic Medicine (A.T., N.J.S.), the Scripps Dickinson Scholarship (A.T.), and the Abramson Family Cancer Research Institute ( J. M. M.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; Friedman DL, 2005, CANCER EPIDEM BIOMAR, V14, P1922, DOI 10.1158/1055-9965.EPI-05-0066; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Griffin CA, 1999, CANCER RES, V59, P2776; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ikenoue T, 2003, CANCER RES, V63, P8132; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo L, 2007, HUM HERED, V63, P205, DOI 10.1159/000099997; Maris JM, 1997, EUR J CANCER, V33, P1923, DOI 10.1016/S0959-8049(97)00265-7; Maris JM, 2005, PEDIAT ONCOL, P21; Maris JM, 2002, CANCER RES, V62, P6651; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Perri P, 2002, ONCOGENE, V21, P8356, DOI 10.1038/sj.onc.1206009; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	50	914	976	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					930	U22		10.1038/nature07261	http://dx.doi.org/10.1038/nature07261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18724359	Green Accepted			2022-12-24	WOS:000260038300042
J	Barrett, RDH; Rogers, SM; Schluter, D				Barrett, Rowan D. H.; Rogers, Sean M.; Schluter, Dolph			Natural selection on a major armor gene in threespine stickleback	SCIENCE			English	Article							GASTEROSTEUS-ACULEATUS; PARALLEL EVOLUTION; MORPHOLOGICAL-CHANGES; PELVIC REDUCTION; FRESH-WATER; POPULATION; FITNESS; SIZE; REPRODUCTION; SPECIATION	Experimental estimates of the effects of selection on genes determining adaptive traits add to our understanding of the mechanisms of evolution. We measured selection on genotypes of the Ectodysplasin locus, which underlie differences in lateral plates in threespine stickleback fish. A derived allele (low) causing reduced plate number has been fixed repeatedly after marine stickleback colonized freshwater from the sea, where the ancestral allele (complete) predominates. We transplanted marine sticklebacks carrying both alleles to freshwater ponds and tracked genotype frequencies over a generation. The low allele increased in frequency once lateral plates developed, most likely via a growth advantage. Opposing selection at the larval stage and changing dominance for fitness throughout life suggest either that the gene affects additional traits undergoing selection or that linked loci also are affecting fitness.	[Barrett, Rowan D. H.; Rogers, Sean M.; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Barrett, Rowan D. H.; Rogers, Sean M.; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Barrett, RDH (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	rbarrett@zoology.ubc.ca	barrett, rowan/G-3906-2010	Barrett, Rowan/0000-0003-3044-2531; Schluter, Dolph/0000-0003-1683-7836	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery and Special Research Opportunity; Canada Foundation for Innovation; NSERC postdoctoral	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery and Special Research Opportunity(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NSERC postdoctoral(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank K. Marchinko, A. Paccard, M. Dosani, K. Dhahan, J.-B. Oboni, E. Sciampe, C. Verchere, J. Courchesne, E. J. Davis, F. Guillaume, J. Hill, C. Jordan, C. Spencer, M. Barrueto, M. Dionne, and S. Rogers for field and genotyping assistance and S. Otto, R. Grant, S. Barrett, and the Schluter lab group for comments on the manuscript. Supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery and Special Research Opportunity grants (D.S.), grants from the Canada Foundation for Innovation (D.S.), and NSERC postdoctoral (S.M.R.) and graduate scholarships (R.D.H.B.). Microsatellite sequences were deposited in GenBank by the Stanford Genome Research Center with the accessions BV678144, BV678119, BV678140, and BV67814.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Aebischer A, 1996, J AVIAN BIOL, V27, P143, DOI 10.2307/3677143; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BELL MA, 1977, COPEIA, P277; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; Bell MA, 2001, GENETICA, V112, P445; Bell MA, 2004, EVOLUTION, V58, P814; BELL MA, 1981, EVOLUTION INT J ORG, V38, P665; Bradshaw HD, 1998, GENETICS, V149, P367; Candolin U, 2003, EVOLUTION, V57, P862, DOI 10.1111/j.0014-3820.2003.tb00297.x; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Curry RA, 2005, ENVIRON BIOL FISH, V72, P111, DOI 10.1007/s10641-004-6582-2; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; FOSTER SA, 1988, OECOLOGIA, V74, P577, DOI 10.1007/BF00380056; GILES N, 1983, J ZOOL, V199, P535; HAGEN DW, 1973, HEREDITY, V30, P273, DOI 10.1038/hdy.1973.38; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; KLEPAKER T, 1993, CAN J ZOOL, V71, P1251, DOI 10.1139/z93-171; Kristjansson BK, 2005, ENVIRON BIOL FISH, V74, P357, DOI 10.1007/s10641-005-1487-2; Kristjansson BK, 2002, EVOL ECOL RES, V4, P659; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; Marchinko KB, 2007, EVOLUTION, V61, P1084, DOI 10.1111/j.1558-5646.2007.00103.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Reimchen TE, 2000, BEHAVIOUR, V137, P1081, DOI 10.1163/156853900502448; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; SCHULTZ ET, 1991, AM NAT, V138, P1408, DOI 10.1086/285294; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	40	285	291	5	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					255	257		10.1126/science.1159978	http://dx.doi.org/10.1126/science.1159978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18755942				2022-12-24	WOS:000259902300047
J	Gubbels, SP; Woessner, DW; Mitchell, JC; Ricci, AJ; Brigande, JV				Gubbels, Samuel P.; Woessner, David W.; Mitchell, John C.; Ricci, Anthony J.; Brigande, John V.			Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer	NATURE			English	Article							INNER-EAR DEVELOPMENT; HEARING-LOSS; MYOSIN VIIA; MATH1; MOUSE; THERAPY; MECHANOTRANSDUCTION; REPLACEMENT; EXPRESSION; GENERATION	Sensory hair cells in the mammalian cochlea convert mechanical stimuli into electrical impulses that subserve audition(1,2). Loss of hair cells and their innervating neurons is the most frequent cause of hearing impairment(3). Atonal homologue 1 ( encoded by Atoh1, also known as Math1) is a basic helix - loop - helix transcription factor required for hair- cell development(4-6), and its misexpression in vitro(7,8) and in vivo(9,10) generates hair- cell- like cells. Atoh1- based gene therapy to ameliorate auditory(10) and vestibular(11) dysfunction has been proposed. However, the biophysical properties of putative hair cells induced by Atoh1 misexpression have not been characterized. Here we show that in utero gene transfer of Atoh1 produces functional supernumerary hair cells in the mouse cochlea. The induced hair cells display stereociliary bundles, attract neuronal processes and express the ribbon synapse marker carboxyterminal binding protein 2 ( refs 12,13). Moreover, the hair cells are capable of mechanoelectrical transduction(1,2) and show basolateral conductances with age- appropriate specializations. Our results demonstrate that manipulation of cell fate by transcription factor misexpression produces functional sensory cells in the postnatal mammalian cochlea. We expect that our in utero gene transfer paradigm will enable the design and validation of gene therapies to ameliorate hearing loss in mouse models of human deafness(14,15).	[Gubbels, Samuel P.; Woessner, David W.; Brigande, John V.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97239 USA; [Mitchell, John C.] Oregon Hlth & Sci Univ, Dept Restorat Dent, Div Biomat & Biomech, Sch Dent, Portland, OR 97239 USA; [Ricci, Anthony J.] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Oregon Health & Science University; Oregon Health & Science University; Stanford University	Brigande, JV (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	brigande@ohsu.edu		ricci, anthony/0000-0002-1706-8904	National Institute on Deafness and Other Communication Disorders; McKnight Endowment Fund for Neuroscience; American Otological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008595, R01DC003896] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); McKnight Endowment Fund for Neuroscience; American Otological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Bresee and J. Jungwirth for expert technical support; C. Cepko and G. Nolan for plasmids EF1 alpha-GFP and BMN-IRES-GFP, respectively; A. Kiernan, D. Fekete, S. Heller, A. Nguyen-Huynh, C. Bresee and J. Jungwirth for critical comments that improved the manuscript; D. Trune, B. Fritzsch and N. Segil for helpful discussions; S. Griest for statistical analyses; and M. Campbell and S. Nigra for exceptional animal care. This study was supported by grants from the National Institute on Deafness and Other Communication Disorders (J.V.B. and A.J.R.), the McKnight Endowment Fund for Neuroscience (J.J.B.) and the American Otological Society (Research Training Fellowship to S.P.G.).	Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; DAVIS A, 1993, HEARING SCI HEARING; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Grant L, 2007, PFLUG ARCH EUR J PHY, V454, P793, DOI 10.1007/s00424-007-0253-z; GUBBELS S, 2007, 30 ANN MIDWINTER RES, V30, P330; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hu ZQ, 2006, STEM CELLS DEV, V15, P449, DOI 10.1089/scd.2006.15.449; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; Kawamoto K, 2003, J NEUROSCI, V23, P4395; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Li HW, 2004, TRENDS MOL MED, V10, P309, DOI 10.1016/j.molmed.2004.05.008; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Maklad A, 2003, DEV BRAIN RES, V140, P223, DOI 10.1016/S0165-3806(02)00609-0; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Self T, 1998, DEVELOPMENT, V125, P557; SHER AE, 1971, ACTA OTO-LARYNGOL, P1; Staecker H, 2007, OTOL NEUROTOL, V28, P223, DOI 10.1097/MAO.0b013e31802b3225; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	30	192	223	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					537	U47		10.1038/nature07265	http://dx.doi.org/10.1038/nature07265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18754012	Green Accepted			2022-12-24	WOS:000259449600047
J	Alexandru, G; Graumann, J; Smith, GT; Kolawa, NJ; Fang, RH; Deshaies, RJ				Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.			UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1 alpha turnover	CELL			English	Article							AAA-ATPASE CDC48/P97; RETICULUM-ASSOCIATED DEGRADATION; VALOSIN-CONTAINING PROTEIN; POLYUBIQUITIN CHAINS; TRANSCRIPTION FACTOR; SELECTIVE CHAPERONE; MEMBRANE-FUSION; 26S PROTEASOME; ER; COMPLEX	p97 is an ATP-dependent chaperone that plays an important role in endoplasmic reticulum-associated degradation but whose connections to turnover of soluble proteins remain sparse. Binding of p97 to substrates is mediated by cofactors that contain ubiquitin-binding domains. We employed "network proteomics'' to show that p97 assembles with all of the 13 mammalian UBX-domain proteins. The UBX proteins that bind ubiquitin conjugates also interact with dozens of E3 ubiquitin ligases, only one of which had been previously linked to p97. In particular, UBXD7 links p97 to the ubiquitin ligase CUL2/VHL and its substrate hypoxia-inducible factor 1 alpha (HIF1 alpha). Depletion of p97 leads to accumulation of endogenous HIF1 alpha and increased expression of a HIF1 alpha target gene. The large number of ubiquitin ligases found associated with UBX proteins suggests that p97 plays a far broader role than previously anticipated in the global regulation of protein turnover.	[Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Alexandru, G (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	galex@caltech.edu; deshaies@caltech.edu	Graumann, Johannes/C-5241-2008; Deshaies, Raymond/B-8354-2014	Graumann, Johannes/0000-0002-3015-5850; Deshaies, Raymond/0000-0002-3671-9354; Alexandru, Gabriela/0000-0002-7058-5644	Damon Runyon Cancer Research Foundation [DRG-1745-02]; Howard Hughes Medical Institute (HHMI); HHMI	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute)	We thank G. Kleiger and T. Chou for help with gel filtration, J. Quimby for help with DNA cloning, S. Schwarz for advice on cell culture, R. Oania for technical assistance, and S. Buonomo for experimental protocols. We also thank T. Nagase, G. Warren, H. Katoh, and S. Buonomo for plasmids and Millipore, J. Pastorek, S. Pastorekova, and Z. Xia for antibodies. We are grateful to A. Varshavsky and members of the Deshaies' lab for critical reading of the manuscript. G. A. was supported by DRG-1745-02 of the Damon Runyon Cancer Research Foundation and the Howard Hughes Medical Institute (HHMI). R. J. D. is an HHMI Investigator, and this work was funded by HHMI. R. J. D. is a founder, shareholder, and consultant for Proteolix.	Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carim-Todd L, 2001, BBA-GENE STRUCT EXPR, V1517, P298, DOI 10.1016/S0167-4781(00)00248-7; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parker Carol E., 2005, V301, P153; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamabe Y, 1997, GENOMICS, V39, P198, DOI 10.1006/geno.1996.4480; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	62	243	252	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					804	816		10.1016/j.cell.2008.06.048	http://dx.doi.org/10.1016/j.cell.2008.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775313	Green Accepted, Bronze			2022-12-24	WOS:000258947500020
J	Holmes, E; Wilson, ID; Nicholson, JK				Holmes, Elaine; Wilson, Ian D.; Nicholson, Jeremy K.			Metabolic phenotyping in health and disease	CELL			English	Editorial Material							GENE	Analyzing metabolites (small molecules <1 kDa) in body fluids such as urine and plasma using various spectroscopic methods provides information on the metabotype (metabolic phenotype) of individuals or populations, information that can be applied to personalized medicine or public healthcare.	[Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England; [Wilson, Ian D.] AstraZeneca, Dept Safety Med, Macclesfield SK10 4TG, Cheshire, England	Imperial College London; AstraZeneca	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020; Wilson, Ian David/ABG-4451-2021; Wilson, Ian/Z-3019-2019; Holmes, Elaine/A-2189-2015	Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; 				Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Westhoff M, 2007, J PHYSIOL PHARMACOL, V58, P739	15	537	561	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					714	717		10.1016/j.cell.2008.08.026	http://dx.doi.org/10.1016/j.cell.2008.08.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775301	Bronze			2022-12-24	WOS:000258947500008
J	Brechbuhl, J; Klaey, M; Broillet, MC				Brechbuehl, Julien; Klaey, Magali; Broillet, Marie-Christine			Grueneberg ganglion cells mediate alarm pheromone detection in mice	SCIENCE			English	Article							STRESS-INDUCED HYPERTHERMIA; OLFACTORY-BULB; PRIMARY CILIUM; RATS; RECEPTORS; MOUSE; CUES; CONSPECIFICS; COMPONENTS; GLOMERULI	Alarm pheromones ( APs) are widely used throughout the plant and animal kingdoms. Species such as fish, insects, and mammals signal danger to conspecifics by releasing volatile alarm molecules. Thus far, neither the chemicals, their bodily source, nor the sensory system involved in their detection have been isolated or identified in mammals. We found that APs are recognized by the Grueneberg ganglion ( GG), a recently discovered olfactory subsystem. We showed with electron microscopy that GG neurons bear primary cilia, with cell bodies ensheathed by glial cells. APs evoked calcium responses in GG neurons in vitro and induced freezing behavior in vivo, which completely disappeared when the GG degenerated after axotomy. We conclude that mice detect APs through the activation of olfactory GG neurons.	[Brechbuehl, Julien; Klaey, Magali; Broillet, Marie-Christine] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Broillet, MC (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Bugnon 27, CH-1005 Lausanne, Switzerland.	mbroille@unil.ch	Brechbühl, Julien/AAF-7815-2020	Brechbühl, Julien/0000-0002-2335-3058; Broillet, Marie-Christine/0000-0002-0487-6638	Department of Pharmacology and Toxicology; Swiss National Science Foundation; Leenaards Foundation	Department of Pharmacology and Toxicology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation	We thank I. Rodriguez for the OMP-GFP mice; J. and S. Fakan for their enthusiastic help with EM techniques and for analyzing EM micrographs; G. Knott, A. Mucciolo, and S. Rosset for preparing EM tissue samples; the Cellular Imaging Facility of the University of Lausanne and its coordinator J.-Y. Chatton for valuable advice; C. Lebrand for providing antibodies; N. Rosenblatt-Velin for help with animal handling; and K. Geering and R. Stoop for fruitful discussions on the manuscript. Supported by the Department of Pharmacology and Toxicology, the Swiss National Science Foundation, and the Leenaards Foundation.	ABEL EL, 1991, PHYSIOL BEHAV, V50, P723, DOI 10.1016/0031-9384(91)90009-D; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Boissy A, 1998, PHYSIOL BEHAV, V63, P489, DOI 10.1016/S0031-9384(97)00466-6; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Fleischer J, 2006, HISTOCHEM CELL BIOL, V125, P337, DOI 10.1007/s00418-005-0077-x; Fleischer J, 2007, CHEM SENSES, V32, P623, DOI 10.1093/chemse/bjm032; Fleischer J, 2006, J NEUROCHEM, V98, P543, DOI 10.1111/j.1471-4159.2006.03894.x; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; GRUENEBERG H, 1973, Zeitschrift fuer Anatomie und Entwicklungsgeschichte, V140, P39; Gutierrez-Garcia AG, 2007, PHYSIOL BEHAV, V91, P166, DOI 10.1016/j.physbeh.2007.02.006; Hauser R, 2005, FORENSIC SCI INT, V155, P226, DOI 10.1016/j.forsciint.2005.08.005; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Kikusui T, 2001, PHYSIOL BEHAV, V72, P45, DOI 10.1016/S0031-9384(00)00370-X; Kiyokawa Y, 2005, CHEM SENSES, V30, P513, DOI 10.1093/chemse/bji044; Koos DS, 2005, NEUROREPORT, V16, P1929, DOI 10.1097/01.wnr.0000186597.72081.10; Leach MC, 2002, COMPARATIVE MED, V52, P249; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; MATHES C, 1995, J GEN PHYSIOL, V106, P975, DOI 10.1085/jgp.106.5.975; Mirza RS, 2001, J CHEM ECOL, V27, P1641, DOI 10.1023/A:1010414426082; Mondor EB, 2004, P ROY SOC B-BIOL SCI, V271, pS341, DOI 10.1098/rsbl.2004.0179; Ono M, 2003, NATURE, V424, P637, DOI 10.1038/424637a; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Roppolo D, 2006, EUR J NEUROSCI, V23, P2887, DOI 10.1111/j.1460-9568.2006.04818.x; SHINODA K, 1989, J COMP NEUROL, V284, P362, DOI 10.1002/cne.902840304; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Storan MJ, 2006, J COMP NEUROL, V494, P834, DOI 10.1002/cne.20858; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; TACHIBANA T, 1990, ARCH HISTOL CYTOL, V53, P147, DOI 10.1679/aohc.53.147; Wisenden BD, 2001, ANIM BEHAV, V62, P761, DOI 10.1006/anbe.2001.1797; ZALAQUETT C, 1991, PHYSIOL BEHAV, V50, P221, DOI 10.1016/0031-9384(91)90524-R	31	147	150	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1092	1095		10.1126/science.1160770	http://dx.doi.org/10.1126/science.1160770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719286				2022-12-24	WOS:000258594900042
J	Krizhanovsky, V; Yon, M; Dickins, RA; Hearn, S; Simon, J; Miething, C; Yee, H; Zender, L; Lowe, SW				Krizhanovsky, Valery; Yon, Monica; Dickins, Ross A.; Hearn, Stephen; Simon, Janelle; Miething, Cornelius; Yee, Herman; Zender, Lars; Lowe, Scott W.			Senescence of activated stellate cells limits liver fibrosis	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; NATURAL-KILLER-CELLS; HEPATITIS-B-VIRUS; CELLULAR SENESCENCE; HETEROCHROMATIN FORMATION; TRANSGENIC MICE; P53; PATHWAY; TUMORIGENESIS; CANCER	Cellular senescence acts as a potent mechanism of tumor suppression; however, its functional contribution to noncancer pathologies has not been examined. Here we show that senescent cells accumulate in murine livers treated to produce fibrosis, a precursor pathology to cirrhosis. The senescent cells are derived primarily from activated hepatic stellate cells, which initially proliferate in response to liver damage and produce the extracellular matrix deposited in the fibrotic scar. In mice lacking key senescence regulators, stellate cells continue to proliferate, leading to excessive liver fibrosis. Furthermore, senescent activated stellate cells exhibit gene expression profile consistent with cell-cycle exit, reduced secretion of extracellular matrix components, enhanced secretion of extracellular matrix-degrading enzymes, and enhanced immune surveillance. Accordingly natural killer cells preferentially kill senescent activated stellate cells in vitro and in vivo, thereby facilitating the resolution of fibrosis. Therefore, the senescence program limits the fibrogenic response to acute tissue damage.	[Krizhanovsky, Valery; Yon, Monica; Dickins, Ross A.; Hearn, Stephen; Simon, Janelle; Miething, Cornelius; Zender, Lars; Lowe, Scott W.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Yon, Monica] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Yee, Herman] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Universidade de Sao Paulo; New York University	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Miething, Cornelius/F-9498-2014; Dickins, Ross A/K-2852-2012; Krizhanovsky, Valery/D-1336-2010	Miething, Cornelius/0000-0003-4699-3805; Dickins, Ross A/0000-0003-4112-5304; Hearn, Stephen/0000-0002-2489-2424; Krizhanovsky, Valery/0000-0002-3977-5482	Leukemia and Lymphoma Society; National Institutes of Health [AG16379]; National Council for Scientific and Technological Development (CNPq); German Research Foundation [ZE-545/2-1]; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG016379, R01AG016379] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge M. Spector for insightful suggestions and critical reading and editing of the manuscript; G. P. Amarante-Mendes for reagents and advice; M. J. Bahr for reading the manuscript; M. McCurrach for editorial advice; members of the Lowe laboratory for stimulating discussions; E. Hernando and L. Chiriboga for IHC; K. Diggins, L. Bianco, and the CSHL animal facility for help with animals; P. Moody and the CSHL Flow Cytometry facility for help with laser scanning cytometry. This work was supported by a postdoctoral fellowship from the Leukemia and Lymphoma Society (V. K.) and grant AG16379 from the National Institutes of Health (S. W. L.). M. Y. is supported by a doctoral fellowship from the National Council for Scientific and Technological Development (CNPq). L. Z. is a Seligson Clinical Fellow and supported by the German Research Foundation (Emmy Noether Programme, ZE-545/2-1 and the Excellence Cluster "Rebirth''). S. W. L. is a Howard Hughes Medical Institute investigator.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Drexler HG, 2000, LEUKEMIA, V14, P777, DOI 10.1038/sj.leu.2401778; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; *NCHS, 2004, NAT VITT STAT REP; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	35	1227	1279	4	155	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 22	2008	134	4					657	667		10.1016/j.cell.2008.06.049	http://dx.doi.org/10.1016/j.cell.2008.06.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724938	Green Accepted, Bronze			2022-12-24	WOS:000258665800018
J	Holland, MD; Hastings, A				Holland, Matthew D.; Hastings, Alan			Strong effect of dispersal network structure on ecological dynamics	NATURE			English	Article							PERSISTENCE; SYNCHRONIZATION; LANDSCAPES; PREDATORS; CORRIDORS; STABILITY	A central question in ecology with great importance for management, conservation and biological control is how changing connectivity affects the persistence and dynamics of interacting species. Researchers in many disciplines have used large systems of coupled oscillators to model the behaviour of a diverse array of fluctuating systems in nature(1-4). In the well- studied regime of weak coupling, synchronization is favoured by increases in coupling strength and large- scale network structures ( for example 'small worlds') that produce short cuts and clustering(5-9). Here we show that, by contrast, randomizing the structure of dispersal networks in a model of predators and prey tends to favour asynchrony and prolonged transient dynamics, with resulting effects on the amplitudes of population fluctuations. Our results focus on synchronization and dynamics of clusters in models, and on time-scales, more appropriate for ecology, namely smaller systems with strong interactions outside the weak- coupling regime, rather than the better- studied cases of large, weakly coupled systems. In these smaller systems, the dynamics of transients and the effects of changes in connectivity can be well understood using a set of methods including numerical reconstructions of phase dynamics, examinations of cluster formation and the consideration of important aspects of cyclic dynamics, such as amplitude.	[Holland, Matthew D.; Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis	Holland, MD (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, 1 Shields Ave, Davis, CA 95616 USA.	mdholland@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	Quantitative Environmental and Integrative Biology; National Science Foundation	Quantitative Environmental and Integrative Biology; National Science Foundation(National Science Foundation (NSF))	We thank M. Holyoak for comments on an earlier version of the manuscript and D. Wysham for discussions. M. D. H. was funded by a Quantitative Environmental and Integrative Biology grant to A. H. and M. Holyoak from the National Science Foundation.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cohen S. D., 1996, Computers in Physics, V10, P138; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Crooks K. R., 2006, CONNECTIVITY CONSERV; CROWLEY PH, 1981, AM NAT, V118, P673, DOI 10.1086/283861; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; Hudgens BR, 2003, AM NAT, V161, P808, DOI 10.1086/374343; Izhikevich E.M, 2007, DYNAMICAL SYSTEMS NE; Jansen VAA, 2001, THEOR POPUL BIOL, V59, P119, DOI 10.1006/tpbi.2000.1506; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MATTHEWS PC, 1991, PHYSICA D, V52, P293, DOI 10.1016/0167-2789(91)90129-W; McIntire EJB, 2007, J APPL ECOL, V44, P725, DOI 10.1111/j.1365-2664.2007.01326.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Smith SW, 1997, SCI ENG GUIDE DIGITA; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; WATTS D, 1999, SMALL WORLDS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3	30	136	139	1	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2008	456	7223					792	U76		10.1038/nature07395	http://dx.doi.org/10.1038/nature07395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18931656				2022-12-24	WOS:000261559900049
J	Rooker, JR; Secor, DH; De Metrio, G; Schloesser, R; Block, BA; Neilson, JD				Rooker, Jay R.; Secor, David H.; De Metrio, Gregorio; Schloesser, Ryan; Block, Barbara A.; Neilson, John D.			Natal Homing and Connectivity in Atlantic Bluefin Tuna Populations	SCIENCE			English	Article							MARINE FISH; DELTA-C-13; OTOLITHS	Atlantic bluefin tuna populations are in steep decline, and an improved understanding of connectivity between individuals from eastern ( Mediterranean Sea) and western ( Gulf of Mexico) spawning areas is needed to manage remaining fisheries. Chemical signatures in the otoliths of yearlings from regional nurseries were distinct and served as natural tags to assess natal homing and mixing. Adults showed high rates of natal homing to both eastern and western spawning areas. Trans- Atlantic movement ( east to west) was significant and size- dependent, with individuals of Mediterranean origin mixing with the western population in the U. S. Atlantic. The largest ( oldest) bluefin tuna collected near the northern extent of their range in North American waters were almost exclusively of western origin, indicating that this region represents critical habitat for the western population.	[Rooker, Jay R.; Schloesser, Ryan] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77551 USA; [Secor, David H.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [De Metrio, Gregorio] Univ Bari, Dept Anim Hlth & Well Being, I-70010 Bari, Italy; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Neilson, John D.] St Andrews Biol Stn, Populat Ecol Sect, Dept Fisheries & Oceans, St Andrews, NB, Canada	Texas A&M University System; University System of Maryland; University of Maryland Center for Environmental Science; Universita degli Studi di Bari Aldo Moro; Stanford University; Fisheries & Oceans Canada	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, 5007 Ave U, Galveston, TX 77551 USA.	rookerj@tamug.edu	Secor, David H./D-4367-2012; Rooker, Jay/M-3197-2013	Secor, David H./0000-0001-6007-4827; Rooker, Jay/0000-0002-5934-7688; Schloesser, Ryan/0000-0002-1004-554X	NOAA Observer Program; NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	NOAA Observer Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program)(National Oceanic Atmospheric Admin (NOAA) - USA); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	We thank S. Campana, J. Graves, and R. D. Wells for insightful comments on earlier versions of the manuscript. Special thanks to A. Belmonte, A. Boustany, B. Campbell, A. Corriero, M. DeFlorio, D. Dettman, J. Kaufman, M. Lutcavage, E. Rodriguez-Marin, P. Mace, E. Prince, N. Santamaria, G. Skomal, M. Stokesbury, S. Teo, P. Thompson, S. Turner, V. Ticina, R. Wingate, NOAA Observer Program, T. F. M. Tuna Farms of the Mediterraneo S. L., Tuna Graso, S. A., and Fish and Fish Ltd. for their assistance. Funding for this study was provided by NOAA ( Southeast Fisheries Science Center and Saltonstall-Kennedy Program), the International Fisheries Governance Program of Fisheries and Oceans Canada, Monterey Bay Aquarium, Tag-A-Giant Foundation, and the Large Pelagic Research Center (University of New Hampshire).	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Ashford J, 2007, GEOCHIM COSMOCHIM AC, V71, P87, DOI 10.1016/j.gca.2006.08.030; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cushing D.H., 1995, POPULATION PRODUCTIO; Fonteneau A., 2007, COL VOL SCI PAP ICCA, V60, P1027; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Maffucci F, 2006, BIOL CONSERV, V127, P183, DOI 10.1016/j.biocon.2005.08.009; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; QUINN TP, 1993, FISH RES, V18, P29, DOI 10.1016/0165-7836(93)90038-9; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; TEA SLH, 2007, MAR BIOL BERLIN, V151, P1; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297	18	227	232	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					742	744		10.1126/science.1161473	http://dx.doi.org/10.1126/science.1161473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18832611				2022-12-24	WOS:000260605200049
J	Duncan, EM; Muratore-Schroeder, TL; Cook, RG; Garcia, BA; Shabanowitz, J; Hunt, DF; Allis, CD				Duncan, Elizabeth M.; Muratore-Schroeder, Tara L.; Cook, Richard G.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Allis, C. David			Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation	CELL			English	Article							CYSTEINE PROTEINASES; NUCLEAR-LOCALIZATION; CHROMATIN; METHYLATION; INHIBITOR; MARKS; HETEROCHROMATIN; IDENTIFICATION; PLURIPOTENCY; PROTEOLYSIS	Chromatin undergoes developmentally-regulated structural and chemical changes as cells differentiate, which subsequently lead to differences in cellular function by altering patterns of gene expression. To gain insight into chromatin alterations that occur during mammalian differentiation, we turned to a mouse embryonic stem cell (ESC) model. Here we show that histone H3 is proteolytically cleaved at its N-terminus during ESC differentiation. We map the sites of H3 cleavage and identify Cathepsin L as a protease responsible for proteolytically processing the N-terminal H3 tail. In addition, our data suggest that H3 cleavage may be regulated by covalent modifications present on the histone tail itself. Our studies underscore the intriguing possibility that histone proteolysis, brought about by Cathepsin L and potentially other family members, plays a role in development and differentiation that was not previously recognized.	[Muratore-Schroeder, Tara L.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Duncan, Elizabeth M.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Cook, Richard G.] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	University of Virginia; Rockefeller University; University of Virginia; Baylor College of Medicine	Hunt, DF (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	dfh@virginia.edu; alliscd@rockefeller.edu	Hunt, Donald F/I-6936-2012; Duncan, Elizabeth/AAJ-3351-2020	Hunt, Donald F/0000-0003-2815-6368; Duncan, Elizabeth/0000-0003-2003-6417	Rockefeller University; Starr Foundation; National Institutes of Health [GM37537, GM53512]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM049351, R01GM037537, R01GM053512] Funding Source: NIH RePORTER	Rockefeller University; Starr Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wysocka, T. Swigut, A. Ruthenburg, D. Shechter, L, Banaszynski, and B. Ueberheide for their advice on biochemical and ESC methods, and J. Wysocka and D. Shechter for their critical reading of the manuscript. Peptides were synthesized at the proteomics facilities at RU and Tufts. E. M. D. is an Anderson Cancer Center fellow (The Rockefeller University). This work was funded by institutional support from The Rockefeller University and grants from the Tri-Institutional Stem Cell Initiative (funded by the Starr Foundation) and National Institutes of Health Grants GM37537 (to D.F.H.) and GM53512 (to C.D.A.).	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; Anand R, 2007, J BIOL CHEM, V282, P35425, DOI 10.1074/jbc.R700027200; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Barrett AJ, 2003, HDB PROTEOLYTIC ENZY; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Giadrossi S, 2007, CURR OPIN GENET DEV, V17, P132, DOI 10.1016/j.gde.2007.02.012; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Ishidoh K, 1998, BIOCHEM BIOPH RES CO, V252, P202, DOI 10.1006/bbrc.1998.9613; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; MASON RW, 1989, BIOCHEM J, V257, P125, DOI 10.1042/bj2570125; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morin V, 2008, J CELL PHYSIOL, V216, P790, DOI 10.1002/jcp.21459; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028	45	251	260	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					284	294		10.1016/j.cell.2008.09.055	http://dx.doi.org/10.1016/j.cell.2008.09.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957203	Green Accepted, Bronze			2022-12-24	WOS:000260130400018
J	Simonetti, A; Marzi, S; Myasnikov, AG; Fabbretti, A; Yusupov, M; Gualerzi, CO; Klaholz, BP				Simonetti, Angelita; Marzi, Stefano; Myasnikov, Alexander G.; Fabbretti, Attilio; Yusupov, Marat; Gualerzi, Claudio O.; Klaholz, Bruno P.			Structure of the 30S translation initiation complex	NATURE			English	Article							MESSENGER-RNA TRANSLATION; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; BINDING; FMET-TRNA(FMET); TERMINATION; BOOTSTRAP; MOVEMENT; REVEALS; EVENTS	Translation initiation, the rate- limiting step of the universal process of protein synthesis, proceeds through sequential, tightly regulated steps. In bacteria, the correct messenger RNA start site and the reading frame are selected when, with the help of initiation factors IF1, IF2 and IF3, the initiation codon is decoded in the peptidyl site of the 30S ribosomal subunit by the fMet-tRNA(fMet) anticodon. This yields a 30S initiation complex (30SIC) that is an intermediate in the formation of the 70S initiation complex (70SIC) that occurs on joining of the 50S ribosomal subunit to the 30SIC and release of the initiation factors(1-3). The localization of IF2 in the 30SIC has proved to be difficult so far using biochemical approaches, but could now be addressed using cryo- electron microscopy and advanced particle separation techniques on the basis of three- dimensional statistical analysis. Here we report the direct visualization of a 30SIC containing mRNA, fMet-tRNA(fMet) and initiation factors IF1 and GTP-bound IF2. We demonstrate that the fMet-tRNA(fMet) is held in a characteristic and precise position and conformation by two interactions that contribute to the formation of a stable complex: one involves the transfer RNA decoding stem which is buried in the 30S peptidyl site, and the other occurs between the carboxy- terminal domain of IF2 and the tRNA acceptor end. The structure provides insights into the mechanism of 70SIC assembly and rationalizes the rapid activation of GTP hydrolysis triggered on 30SIC-50S joining(2,3) by showing that the GTP- binding domain of IF2 would directly face the GTPase-activated centre of the 50S subunit.	[Simonetti, Angelita; Marzi, Stefano; Myasnikov, Alexander G.; Yusupov, Marat; Klaholz, Bruno P.] Inst Genet & Mol & Cellular Biol, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France; [Simonetti, Angelita; Marzi, Stefano; Myasnikov, Alexander G.; Yusupov, Marat; Klaholz, Bruno P.] INSERM, U596, F-67404 Illkirch Graffenstaden, France; [Simonetti, Angelita; Marzi, Stefano; Myasnikov, Alexander G.; Yusupov, Marat; Klaholz, Bruno P.] CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France; [Simonetti, Angelita; Marzi, Stefano; Myasnikov, Alexander G.; Yusupov, Marat; Klaholz, Bruno P.] Univ Strasbourg, F-67070 Strasbourg, France; [Marzi, Stefano] CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, UPR 9002, F-67084 Strasbourg, France; [Fabbretti, Attilio; Gualerzi, Claudio O.] Univ Camerino, Dept Biol, Genet Lab, MCA, I-62032 Camerino, MC, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Camerino	Klaholz, BP (corresponding author), Inst Genet & Mol & Cellular Biol, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France.	klaholz@igbmc.u-strasbg.fr	Fabbretti, Attilio/L-2524-2013; Yusupov, Marat/I-6126-2013; Marzi, Stefano/A-1810-2012; Myasnikov, Alexander/T-4654-2018	Fabbretti, Attilio/0000-0003-3928-2781; Yusupov, Marat/0000-0001-5544-0597; Marzi, Stefano/0000-0003-0399-4613; Simonetti, Angelita/0000-0001-7983-4945	Centre National pour la Recherche Scientifique; Ministere de la Recherche et de la Technologie; European Molecular Biology Organization Young Investigator Programme; Institut du Developpement et des Ressources en Informatique Scientifique; European Commission [LSHG-CT-2006-031220]; SPINE2; Institut National de la Sante et de la Recherche Medicale; Fondation de la Recherche Medicale; ULP,; CNRS; FRM; Alsace Regio; Association pour la Recherche sur le Cancer	Centre National pour la Recherche Scientifique; Ministere de la Recherche et de la Technologie; European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); Institut du Developpement et des Ressources en Informatique Scientifique; European Commission(European CommissionEuropean Commission Joint Research Centre); SPINE2; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); ULP,; CNRS(Centre National de la Recherche Scientifique (CNRS)); FRM(Fondation pour la Recherche Medicale); Alsace Regio; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank J. Thompson for providing IF2 strains, M. Argentini for mass spectroscopy analysis of IF1 and IF2, and P. Schultz, D. Moras, J.- C. Thierry, V. Mallouh, G. Yusupova and I. Orlov for their constant support and interest. This work was supported by grants from the Centre National pour la Recherche Scientifique (CNRS), the Ministere de la Recherche et de la Technologie, the European Molecular Biology Organization Young Investigator Programme, the Institut du Developpement et des Ressources en Informatique Scientifique, and the European Commission as SPINE2-complexes (contract n<SUP>o</SUP> LSHG-CT-2006-031220). A. S. is a PhD student in a co-tutorial between the Universite Louis Pasteur (ULP) and the Universita di Camerino, and was supported by SPINE2- complexes, by the Institut National de la Sante et de la Recherche Medicale (INSERM) and by the Fondation de la Recherche Medicale (FRM). S. M. was supported by postdoctoral fellowships from the ULP, the CNRS and from the FRM, and A. G. M. was a recipient of postdoctoral fellowships from the CNRS and the FRM. The electron microscope facility is supported by the Alsace Region, the INSERM, the CNRS and the Association pour la Recherche sur le Cancer.	Ali IK, 2006, MOL CELL, V23, P865, DOI 10.1016/j.molcel.2006.08.011; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; FECHTER P, IN PRESS METHODS MOL; Giuliodori AM, 2007, RNA, V13, P1355, DOI 10.1261/rna.455607; Grigoriadou C, 2007, J MOL BIOL, V373, P562, DOI 10.1016/j.jmb.2007.07.032; Gualerzi CO, 2001, COLD SPRING HARB SYM, V66, P363, DOI 10.1101/sqb.2001.66.363; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; HAYNOR DR, 1989, IEEE T MED IMAGING, V8, P337, DOI 10.1109/42.41486; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; Orlov IM, 2006, J STRUCT BIOL, V154, P287, DOI 10.1016/j.jsb.2006.03.007; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; RODNINA MV, 1994, ANAL BIOCHEM, V219, P380, DOI 10.1006/abio.1994.1282; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SIMONETTI A, 2008, NATURE PROTCOLS, DOI DOI 10.1038/NPROT.2008.130; Szkaradkiewicz K, 2000, EUR J BIOCHEM, V267, P4290, DOI 10.1046/j.1432-1327.2000.01480.x; Thompson J, 2004, NUCLEIC ACIDS RES, V32, P5954, DOI 10.1093/nar/gkh925; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	37	159	159	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					416	U73		10.1038/nature07192	http://dx.doi.org/10.1038/nature07192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18758445				2022-12-24	WOS:000259265200050
J	Kaser, A; Lee, AH; Franke, A; Glickman, JN; Zeissig, S; Tilg, H; Nieuwenhuis, EES; Higgins, DE; Schreiber, S; Glimcher, LH; Blumberg, RS				Kaser, Arthur; Lee, Ann-Hwee; Franke, Andre; Glickman, Jonathan N.; Zeissig, Sebastian; Tilg, Herbert; Nieuwenhuis, Edward E. S.; Higgins, Darren E.; Schreiber, Stefan; Glimcher, Laurie H.; Blumberg, Richard S.			XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; ALPHA-DEFENSINS; CROHN-DISEASE; PANETH CELLS; GENOME; ASSOCIATION; ACTIVATION; EXPRESSION	Inflammatory bowel disease (IBD) has been attributed to aberrant mucosal immunity to the intestinal microbiota. The transcription factor XBP1, a key component of the endoplasmic reticulum (ER) stress response, is required for development and maintenance of secretory cells and linked to JNK activation. We hypothesized that a stressful environmental milieu in a rapidly proliferating tissue might instigate a proinflammatory response. We report that Xbp1 deletion in intestinal epithelial cells (IECs) results in spontaneous enteritis and increased susceptibility to induced colitis secondary to both Paneth cell dysfunction and an epithelium that is overly reactive to inducers of IBD such as bacterial products (flagellin) and TNF alpha. An association of XBP1 variants with both forms of human IBD (Crohn's disease and ulcerative colitis) was identified and replicated (rs35873774; p value 1.6 x 10(-5)) with novel, private hypomorphic variants identified as susceptibility factors. Hence, intestinal inflammation can originate solely from XBP1 abnormalities in IECs, thus linking cell-specific ER stress to the induction of organ-specific inflammation.	[Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Franke, Andre; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Nieuwenhuis, Edward E. S.] Erasmus MC Sophia Childrens Hosp, Div Pediat Gastroenterol, NL-3000 GE Rotterdam, Netherlands; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Medical University of Innsbruck; Medical University of Innsbruck; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu; rblumberg@partners.org	Longo, Kenneth A/A-5631-2010; Zeissig, Sebastian/B-6297-2012; Franke, Andre/B-2151-2010	Zeissig, Sebastian/0000-0001-5124-0897; Franke, Andre/0000-0003-1530-5811	Crohn's and Colitis Foundation of America; NIH [DK44319, P30 DK034854, AI32412, P01 AI56296]; Ellison Medical Foundation [CDA 1P50CA100707]; Austrian Science Fund; Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"; German Ministry of Education and Research (BMBF); PopGen Biobank; NATIONAL CANCER INSTITUTE [P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412, P01AI056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, P30DK034854, R37DK044319] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Austrian Science Fund(Austrian Science Fund (FWF)); Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); PopGen Biobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Robine and N. Davidson for VCre-ER<SUP>T2</SUP> mice; Dr. S. Ito for help with EM; Drs. J. Rioux, A. Ouelette, and M. Starnbach for helpful discussions; P. Gupta, B. Enrich, and D. Lindenbergh-Kortleve for technical support; and Dr. S. Snapper for critical reading of the manuscript. This work was supported by grants from the Crohn's and Colitis Foundation of America (R. S. B. and A. K.), NIH grants DK44319 (R. S. B.), P30 DK034854 (R. S. B.; Harvard Digestive Diseases Center), and AI32412 and P01 AI56296 (L. H. G.), the Ellison Medical Foundation (L. H. G.), CDA 1P50CA100707(A.- H. L.), the Austrian Science Fund (A. K. and H. T.), the Max Kade Foundation (A. K.), and the DFG/BMBF Excellence Cluster "Inflammation at Interfaces" (S. S. and A. F.). The authors wish to thank the patients, families, and physicians for their cooperation. The cooperativeness of the German Crohn and Colitis patient association (Deutsche Morbus Crohn und Colitis Vereinigung e. V.) and of the German "Kompetenznetz Darmerkrankungen'' are gratefully acknowledged. Genotyping in this study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the PopGen Biobank.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Song F, 1999, J IMMUNOL, V162, P2275; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tashiro E, 2007, J ANTIBIOT, V60, P547, DOI 10.1038/ja.2007.69; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	47	1010	1051	5	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					743	756		10.1016/j.cell.2008.07.021	http://dx.doi.org/10.1016/j.cell.2008.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775308	Green Accepted, Bronze			2022-12-24	WOS:000258947500015
J	Sang, LY; Coller, HA; Roberts, JM				Sang, Liyun; Coller, Hilary A.; Roberts, James M.			Control of the reversibility of cellular quiescence by the transcriptional repressor HES1	SCIENCE			English	Article							NOTCH PATHWAY; SENESCENCE; EXPRESSION; P21; ENHANCER; CELLS; MODEL; HAIRY; P53	The mechanisms by which quiescent cells, including adult stem cells, preserve their ability to resume proliferation after weeks or even years of cell cycle arrest are not known. We report that reversibility is not a passive property of nondividing cells, because enforced cell cycle arrest for a period as brief as 4 days initiates spontaneous, premature, and irreversible senescence. Increased expression of the gene encoding the basic helix- loop- helix protein HES1 was required for quiescence to be reversible, because HES1 prevented both premature senescence and inappropriate differentiation in quiescent fibroblasts. In some human tumors, the HES1 pathway was activated, which allowed these cells to evade differentiation and irreversible cell cycle arrest. We conclude that HES1 safeguards against irreversible cell cycle exit both during normal cellular quiescence and pathologically in the setting of tumorigenesis.	[Sang, Liyun; Roberts, James M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Sang, Liyun] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Roberts, James M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Princeton University; University of Washington; University of Washington Seattle	Roberts, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	jroberts@fhcrc.org	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	Howard Hughes Medical Institute; NIH; New Jersey Commission on Cancer Research; Pharmaceutical Research and Manufacturers of America Foundation; National Institute of General Medical Sciences Center of Excellence [P50 GM071508]; NATIONAL CANCER INSTITUTE [R01CA118043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; Pharmaceutical Research and Manufacturers of America Foundation; National Institute of General Medical Sciences Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge expert advice and materials from S. Tapscott and members of the Tapscott laboratory, J. Olson and members of the Olson laboratory, members of the Galloway laboratory, S. Parkhurst, V. Vasioukhin, X. Yu, C. Civin, K. Fitzgerald, W. Chien, K. Loeb, M. Mehaffey, R. Eisenman, M. Groudine, D. Gottschling, R. Zhang, P. Adams, and members of the Roberts laboratory. L. S. acknowledges support from the Howard Hughes Medical Institute. J. M. R. was supported by grants from NIH. H. A. C. is the Milton E. Cassel scholar of the Rita Allen Foundation and acknowledges support from the New Jersey Commission on Cancer Research and the Pharmaceutical Research and Manufacturers of America Foundation. H. A. C. is supported by National Institute of General Medical Sciences Center of Excellence grant P50 GM071508.	Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; Curry CL, 2006, LAB INVEST, V86, P842, DOI 10.1038/labinvest.3700442; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hopfer O, 2005, BRIT J CANCER, V93, P709, DOI 10.1038/sj.bjc.6602719; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kwon YH, 2002, J BIOL CHEM, V277, P41417, DOI 10.1074/jbc.M203388200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	28	227	243	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2008	321	5892					1095	1100		10.1126/science.1155998	http://dx.doi.org/10.1126/science.1155998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719287	Green Accepted			2022-12-24	WOS:000258594900043
J	Moritz, CT; Perlmutter, SI; Fetz, EE				Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.			Direct control of paralysed muscles by cortical neurons	NATURE			English	Article							MOTOR CORTEX CELLS; INTRASPINAL MICROSTIMULATION; ARM MUSCLES; MOVEMENT; COMPUTER; MONKEYS; NEUROPROSTHESIS; STIMULATION; PROSTHESIS; PLASTICITY	A potential treatment for paralysis resulting from spinal cord injury is to route control signals from the brain around the injury by artificial connections. Such signals could then control electrical stimulation of muscles, thereby restoring volitional movement to paralysed limbs(1-3). In previously separate experiments, activity of motor cortex neurons related to actual or imagined movements has been used to control computer cursors and robotic arms(4-10), and paralysed muscles have been activated by functional electrical stimulation(11-13). Here we show that Macaca nemestrina monkeys can directly control stimulation of muscles using the activity of neurons in the motor cortex, thereby restoring goal-directed movements to a transiently paralysed arm. Moreover, neurons could control functional stimulation equally well regardless of any previous association to movement, a finding that considerably expands the source of control signals for brain- machine interfaces. Monkeys learned to use these artificial connections from cortical cells to muscles to generate bidirectional wrist torques, and controlled multiple neuron - muscle pairs simultaneously. Such direct transforms from cortical activity to muscle stimulation could be implemented by autonomous electronic circuitry, creating a relatively natural neuroprosthesis. These results are the first demonstration that direct artificial connections between cortical cells and muscles can compensate for interrupted physiological pathways and restore volitional control of movement to paralysed limbs.	[Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Moritz, Chet T.; Perlmutter, Steve I.; Fetz, Eberhard E.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moritz, CT (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	ctmoritz@u.washington.edu		Perlmutter, Steve/0000-0002-1149-4152	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS051013, R01NS040867, R37NS012542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Shupe for programming assistance, C. Kent and L. Miller for advice on nerve block, C. Kirby, A. Price and K. McElwain for animal care, and A. Jackson, Y. Nishimura and A. Richardson for comments on the manuscript. This work was supported by grants from the National Institutes of Health.	Batschelet E, 1981, CIRCULAR STAT BIOL; BRINKMAN C, 1983, SCIENCE, V220, P438, DOI 10.1126/science.6836289; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1975, EXP BRAIN RES, V23, P217; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Jackson A, 2007, J NEUROPHYSIOL, V97, P360, DOI 10.1152/jn.00710.2006; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; LOEB GE, 1985, J NEUROPHYSIOL, V54, P565, DOI 10.1152/jn.1985.54.3.565; Mavoori J, 2005, J NEUROSCI METH, V148, P71, DOI 10.1016/j.jneumeth.2005.04.017; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Mushahwar VK, 2002, IEEE T NEUR SYS REH, V10, P68, DOI 10.1109/TNSRE.2002.1021588; NANNINI N, 1991, IEEE T BIO-MED ENG, V38, P769, DOI 10.1109/10.83589; Nudo RJ, 1996, J NEUROSCI, V16, P785; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stein RB, 2002, ARCH ITAL BIOL, V140, P273; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238	33	392	409	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					639	U63		10.1038/nature07418	http://dx.doi.org/10.1038/nature07418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923392	Green Accepted			2022-12-24	WOS:000261340000041
J	Seehausen, O; Terai, Y; Magalhaes, IS; Carleton, KL; Mrosso, HDJ; Miyagi, R; van der Sluijs, I; Schneider, MV; Maan, ME; Tachida, H; Imai, H; Okada, N				Seehausen, Ole; Terai, Yohey; Magalhaes, Isabel S.; Carleton, Karen L.; Mrosso, Hillary D. J.; Miyagi, Ryutaro; van der Sluijs, Inke; Schneider, Maria V.; Maan, Martine E.; Tachida, Hidenori; Imai, Hiroo; Okada, Norihiro			Speciation through sensory drive in cichlid fish	NATURE			English	Article							LAKE VICTORIA CICHLIDS; TUNING SPECTRAL SENSITIVITY; OPSIN GENE-EXPRESSION; SEXUAL SELECTION; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; COLOR-VISION; DIVERGENT SELECTION; ADAPTIVE DIVERGENCE; NATURAL-SELECTION	Theoretically, divergent selection on sensory systems can cause speciation through sensory drive. However, empirical evidence is rare and incomplete. Here we demonstrate sensory drive speciation within island populations of cichlid fish. We identify the ecological and molecular basis of divergent evolution in the cichlid visual system, demonstrate associated divergence in male colouration and female preferences, and show subsequent differentiation at neutral loci, indicating reproductive isolation. Evidence is replicated in several pairs of sympatric populations and species. Variation in the slope of the environmental gradients explains variation in the progress towards speciation: speciation occurs on all but the steepest gradients. This is the most complete demonstration so far of speciation through sensory drive without geographical isolation. Our results also provide a mechanistic explanation for the collapse of cichlid fish species diversity during the anthropogenic eutrophication of Lake Victoria.	[Seehausen, Ole; Magalhaes, Isabel S.] Univ Bern, Inst Zool, CH-3012 Bern, Switzerland; [Seehausen, Ole; Magalhaes, Isabel S.; Schneider, Maria V.] Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-6047 Kastanienbaum, Switzerland; [Terai, Yohey; Miyagi, Ryutaro; Okada, Norihiro] Tokyo Inst Technol, Midori Ku, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Carleton, Karen L.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mrosso, Hillary D. J.] Mwanza Ctr, Tanzania Fisheries Res Inst, Mwanza, Tanzania; [van der Sluijs, Inke; Maan, Martine E.] Leiden Univ, Dept Anim Ecol, Inst Biol, NL-2300 RA Leiden, Netherlands; [Tachida, Hidenori] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8108560, Japan; [Imai, Hiroo] Kyoto Univ, Dept Cellular & Mol Biol, Primate Res Inst, Kyoto 4848506, Japan	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Tokyo Institute of Technology; University System of Maryland; University of Maryland College Park; Leiden University; Leiden University - Excl LUMC; Kyushu University; Kyoto University	Seehausen, O (corresponding author), Univ Bern, Inst Zool, Baltzerstr 6, CH-3012 Bern, Switzerland.	ole.seehausen@aqua.unibe.ch; nokada@bio.titech.ac.jp	Maan, Martine/B-5444-2008; Seehausen, Ole/C-8272-2011; Schneider, Maria Victoria/E-6317-2010; TATSUTA, HARUKI/F-2997-2010	Maan, Martine/0000-0003-1113-8067; Seehausen, Ole/0000-0001-6598-1434; Schneider, Maria Victoria/0000-0002-7114-2060; Okada, Norihiro/0000-0002-3655-8060; Santos Magalhaes, Isabel/0000-0003-2391-3577; Imai, Hiroo/0000-0003-0729-0322; Mrosso, Hillary Deogratias John/0000-0003-1924-7268; Carleton, Karen/0000-0001-6306-5643	Swiss National Science Foundation [3100A0-106573]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We acknowledge the Tanzania Commission for Science & Technology for research permissions, the Tanzania Fisheries Research Institute, and its Muranza Centre director E. F. B. Katunzi, for hospitality and logistical support; M. Kayeba, M. Haluna, S. Mwaiko, M. Haesler and E. Burgerhout for help with data and fish collection; H. Araki, L. Excoffier, L. Harmon, B. Ibelings, I. Keller, T. Kocher, P. Nosil, M. Pierotti, D. Schluter, A. Sivasundar and O. Svensson for comments on the manuscript; and M. Kawata, J. J. M. van Alphen, K. Young, R. Stelkens and E. Bezault for discussion. This work was supported by Swiss National Science Foundation project 3100A0-106573 (to O.S.), and by the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N.O.).	ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Belkhir K.P.B., 1996, GENETIX VERSION 4 05; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gavrilets S, 2004, FITNESS LANDSCAPES O; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Haesler MP, 2005, P ROY SOC B-BIOL SCI, V272, P237, DOI 10.1098/rspb.2004.2946; HUDSON RR, 1987, GENETICS, V116, P153; Kawata M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-99; Leimar O, 2008, EVOLUTION, V62, P807, DOI 10.1111/j.1558-5646.2008.00334.x; Levring T., 1956, OIKOS, V7, P98; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; McDonald JH, 1998, MOL BIOL EVOL, V15, P377, DOI 10.1093/oxfordjournals.molbev.a025934; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Okullo W, 2007, APPL OPTICS, V46, P8553, DOI 10.1364/AO.46.008553; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1993, P ROY SOC B-BIOL SCI, V253, P117, DOI 10.1098/rspb.1993.0089; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1998, BEHAV ECOL SOCIOBIOL, V42, P1, DOI 10.1007/s002650050405; Seehausen O., 1996, LAKE VICTORIA ROCK C; Shichida Yoshinori, 1999, P23; Smit SA, 1997, NETH J ZOOL, V47, P9; Spady TC, 2005, MOL BIOL EVOL, V22, P1412, DOI 10.1093/molbev/msi137; Stelkens RB, 2008, PHILOS T R SOC B, V363, P2861, DOI 10.1098/rstb.2008.0049; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Terai Y, 2002, P NATL ACAD SCI USA, V99, P15501, DOI 10.1073/pnas.232561099; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120; VANDERMEER HJ, 1995, ENVIRON BIOL FISH, V44, P115, DOI 10.1007/BF00005910; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Yokoyama S, 2000, GENE, V259, P17, DOI 10.1016/S0378-1119(00)00435-2	49	765	781	5	492	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					620	U23		10.1038/nature07285	http://dx.doi.org/10.1038/nature07285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18833272				2022-12-24	WOS:000259639700037
J	Hong, JW; Hendrix, DA; Levine, MS				Hong, Joung-Woo; Hendrix, David A.; Levine, Michael S.			Shadow enhancers as a source of evolutionary novelty	SCIENCE			English	Article							DROSOPHILA-EMBRYO; GENE-REGULATION; DORSAL; ELEMENTS		[Hong, Joung-Woo; Hendrix, David A.; Levine, Michael S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Hong, Joung-Woo/AAG-1173-2021	Hong, Joung-Woo/0000-0001-6511-7881; Levine, Michael/0000-0001-7629-0081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046638, R01GM046638] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046638, GM46638] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	7	309	313	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1314	1314		10.1126/science.1160631	http://dx.doi.org/10.1126/science.1160631			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772429	Green Accepted			2022-12-24	WOS:000258914300039
J	Bowler, C; Allen, AE; Badger, JH; Grimwood, J; Jabbari, K; Kuo, A; Maheswari, U; Martens, C; Maumus, F; Otillar, RP; Rayko, E; Salamov, A; Vandepoele, K; Beszteri, B; Gruber, A; Heijde, M; Katinka, M; Mock, T; Valentin, K; Verret, F; Berges, JA; Brownlee, C; Cadoret, JP; Chiovitti, A; Choi, CJ; Coesel, S; De Martino, A; Detter, JC; Durkin, C; Falciatore, A; Fournet, J; Haruta, M; Huysman, MJJ; Jenkins, BD; Jiroutova, K; Jorgensen, RE; Joubert, Y; Kaplan, A; Kroger, N; Kroth, PG; La Roche, J; Lindquist, E; Lommer, M; Martin-Jezequel, V; Lopez, PJ; Lucas, S; Mangogna, M; McGinnis, K; Medlin, LK; Montsant, A; Oudot-Le Secq, MP; Napoli, C; Obornik, M; Parker, MS; Petit, JL; Porcel, BM; Poulsen, N; Robison, M; Rychlewski, L; Rynearson, TA; Schmutz, J; Shapiro, H; Siaut, M; Stanley, M; Sussman, MR; Taylor, AR; Vardi, A; von Dassow, P; Vyverman, W; Willis, A; Wyrwicz, LS; Rokhsar, DS; Weissenbach, J; Armbrust, EV; Green, BR; Van De Peer, Y; Grigoriev, IV				Bowler, Chris; Allen, Andrew E.; Badger, Jonathan H.; Grimwood, Jane; Jabbari, Kamel; Kuo, Alan; Maheswari, Uma; Martens, Cindy; Maumus, Florian; Otillar, Robert P.; Rayko, Edda; Salamov, Asaf; Vandepoele, Klaas; Beszteri, Bank; Gruber, Ansgar; Heijde, Marc; Katinka, Michael; Mock, Thomas; Valentin, Klaus; Verret, Frederic; Berges, John A.; Brownlee, Colin; Cadoret, Jean-Paul; Chiovitti, Anthony; Choi, Chang Jae; Coesel, Sacha; De Martino, Alessandra; Detter, J. Chris; Durkin, Colleen; Falciatore, Angela; Fournet, Jerome; Haruta, Miyoshi; Huysman, Marie J. J.; Jenkins, Bethany D.; Jiroutova, Katerina; Jorgensen, Richard E.; Joubert, Yolaine; Kaplan, Aaron; Kroger, Nils; Kroth, Peter G.; La Roche, Julie; Lindquist, Erica; Lommer, Markus; Martin-Jezequel, Veronique; Lopez, Pascal J.; Lucas, Susan; Mangogna, Manuela; McGinnis, Karen; Medlin, Linda K.; Montsant, Anton; Oudot-Le Secq, Marie-Pierre; Napoli, Carolyn; Obornik, Miroslav; Parker, Micaela Schnitzler; Petit, Jean-Louis; Porcel, Betina M.; Poulsen, Nicole; Robison, Matthew; Rychlewski, Leszek; Rynearson, Tatiana A.; Schmutz, Jeremy; Shapiro, Harris; Siaut, Magali; Stanley, Michele; Sussman, Michael R.; Taylor, Alison R.; Vardi, Assaf; von Dassow, Peter; Vyverman, Wim; Willis, Anusuya; Wyrwicz, Lucjan S.; Rokhsar, Daniel S.; Weissenbach, Jean; Armbrust, E. Virginia; Green, Beverley R.; Van de Peer, Yves; Grigoriev, Igor V.			The Phaeodactylum genome reveals the evolutionary history of diatom genomes	NATURE			English	Article							RECIPROCAL GENE LOSS; THALASSIOSIRA-PSEUDONANA; BACILLARIOPHYCEAE; METABOLISM; MECHANISMS; COMPONENTS; BACTERIA; YEASTS	Diatoms are photosynthetic secondary endosymbionts found throughout marine and freshwater environments, and are believed to be responsible for around one- fifth of the primary productivity on Earth(1,2). The genome sequence of the marine centric diatom Thalassiosira pseudonana was recently reported, revealing a wealth of information about diatom biology(3-5). Here we report the complete genome sequence of the pennate diatom Phaeodactylum tricornutum and compare it with that of T. pseudonana to clarify evolutionary origins, functional significance and ubiquity of these features throughout diatoms. In spite of the fact that the pennate and centric lineages have only been diverging for 90 million years, their genome structures are dramatically different and a substantial fraction of genes (similar to 40%) are not shared by these representatives of the two lineages. Analysis of molecular divergence compared with yeasts and metazoans reveals rapid rates of gene diversification in diatoms. Contributing factors include selective gene family expansions, differential losses and gains of genes and introns, and differential mobilization of transposable elements. Most significantly, we document the presence of hundreds of genes from bacteria. More than 300 of these gene transfers are found in both diatoms, attesting to their ancient origins, and many are likely to provide novel possibilities for metabolite management and for perception of environmental signals. These findings go a long way towards explaining the incredible diversity and success of the diatoms in contemporary oceans.	[Bowler, Chris; Allen, Andrew E.; Jabbari, Kamel; Maheswari, Uma; Maumus, Florian; Rayko, Edda; Heijde, Marc; De Martino, Alessandra; Lopez, Pascal J.; Montsant, Anton; Vardi, Assaf] Ecole Normale Super, CNRS, Dept Biol, UMR8186, F-75005 Paris, France; [Bowler, Chris; Coesel, Sacha; Falciatore, Angela; Mangogna, Manuela; Montsant, Anton; Siaut, Magali] Stn Zool A Dohrn, I-80121 Naples, Italy; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Grimwood, Jane; Schmutz, Jeremy] Stanford Human Genome Ctr, Joint Genome Inst Stanford, Palo Alto, CA 94304 USA; [Kuo, Alan; Otillar, Robert P.; Salamov, Asaf; Detter, J. Chris; Lindquist, Erica; Lucas, Susan; Shapiro, Harris; Rokhsar, Daniel S.; Grigoriev, Igor V.] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Martens, Cindy; Vandepoele, Klaas; Huysman, Marie J. J.; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Beszteri, Bank; Valentin, Klaus; Medlin, Linda K.] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Gruber, Ansgar; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Katinka, Michael; Petit, Jean-Louis; Porcel, Betina M.; Weissenbach, Jean] CNRS, CEA Inst Genom, UMR 8030, F-91057 Evry, France; [Mock, Thomas; Durkin, Colleen; Parker, Micaela Schnitzler; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Verret, Frederic; Brownlee, Colin; Medlin, Linda K.; Taylor, Alison R.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Berges, John A.; Choi, Chang Jae] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Cadoret, Jean-Paul] IFREMER, PBA, F-44311 Nantes 03, France; [Chiovitti, Anthony; Willis, Anusuya] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Fournet, Jerome; Joubert, Yolaine; Martin-Jezequel, Veronique] Univ Nantes, Lab Mer Mol Sante, Fac Tech Sci, EA 2160, F-44322 Nantes 3, France; [Haruta, Miyoshi; Robison, Matthew; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Huysman, Marie J. J.; Vyverman, Wim] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Jenkins, Bethany D.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Jenkins, Bethany D.] Univ Rhode Isl, Grad Sch Oceanog, Kingston, RI 02881 USA; [Jiroutova, Katerina; Obornik, Miroslav] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Jiroutova, Katerina; Obornik, Miroslav] Univ S Bohemia, Fac Sci, CR-37005 Ceske Budejovice, Czech Republic; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Bio5 Inst, Tucson, AZ 85719 USA; [Jorgensen, Richard E.; McGinnis, Karen; Napoli, Carolyn] Univ Arizona, Dept Plant Sci, Tucson, AZ 85719 USA; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, IL-91904 Jerusalem, Israel; [Kroger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Kroger, Nils] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [La Roche, Julie; Lommer, Markus] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Oudot-Le Secq, Marie-Pierre; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Poulsen, Nicole] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Rychlewski, Leszek; Wyrwicz, Lucjan S.] BioInfoBank Inst, PL-60744 Poznan, Poland; [Rynearson, Tatiana A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Stanley, Michele] Dunstaffnage Marine Res Lab, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Taylor, Alison R.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Vardi, Assaf] Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Grp, New Brunswick, NJ 08901 USA; [von Dassow, Peter] CNRS, Biol Stn, UMR7144, F-29682 Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli; J. Craig Venter Institute; Stanford University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Flanders Institute for Biotechnology (VIB); Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Konstanz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Washington; University of Washington Seattle; Marine Biological Association United Kingdom; University of Wisconsin System; University of Wisconsin Milwaukee; Ifremer; University of Melbourne; Nantes Universite; University of Wisconsin System; University of Wisconsin Madison; Ghent University; University of Rhode Island; University of Rhode Island; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Arizona; University of Arizona; Hebrew University of Jerusalem; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of British Columbia; University System of Georgia; Georgia Institute of Technology; University of Rhode Island; UHI Millennium Institute; University of North Carolina; University of North Carolina Wilmington; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Bowler, C (corresponding author), Ecole Normale Super, CNRS, Dept Biol, UMR8186, 46 Rue Ulm, F-75005 Paris, France.	cbowler@biologie.ens.fr	Heijde, Marc/O-8958-2014; Obornik, Miroslav/G-9350-2014; Falciatore, Angela/Q-6161-2018; medlin, linda k/G-4820-2010; Kroth, Peter G/A-9728-2008; Van de Peer, Yves/D-4388-2009; Bowler, Chris/AAC-6256-2019; Stanley, Michele S/D-5859-2013; Allen, Andrew E/C-4896-2012; Wilis, Anusuya/AAV-6917-2020; Vandepoele, Klaas/E-7514-2010; Schmutz, Jeremy/N-3173-2013; Willis, Anusuya/B-6712-2013; Lopez, Pascal Jean/A-7427-2011; Grimwood, Jane/ABD-5737-2021; Beszteri, Bank M/D-1961-2010; Kaplan, Aaron/GLN-5655-2022; Green, Beverley R./AAJ-5199-2021; Wyrwicz, Lucjan/ABD-6558-2021; von Dassow, Peter/A-5399-2012; Maumus, Florian/O-5426-2016; Lopez, Pascal Jean/P-5813-2019; Dasseville, Renaat/B-3561-2010; Valentin, Klaus/G-5862-2014; LaRoche, Julie/A-1109-2010; Berges, John A/D-9520-2012; Gruber, Ansgar/B-9587-2008; Van de Peer, Yves/AAE-7666-2019; Coesel, Sacha/AAX-5588-2021; Mock, Thomas/A-3127-2008	Kroth, Peter G/0000-0003-4734-8955; Van de Peer, Yves/0000-0003-4327-3730; Allen, Andrew E/0000-0001-5911-6081; Wilis, Anusuya/0000-0003-0829-7446; Vandepoele, Klaas/0000-0003-4790-2725; Schmutz, Jeremy/0000-0001-8062-9172; Beszteri, Bank M/0000-0002-6852-1588; Green, Beverley R./0000-0002-4021-9387; Wyrwicz, Lucjan/0000-0003-0808-6892; Maumus, Florian/0000-0001-7325-0527; Lopez, Pascal Jean/0000-0002-9914-4252; Valentin, Klaus/0000-0001-7401-9423; Berges, John A/0000-0002-3124-4783; Gruber, Ansgar/0000-0002-5876-4391; Van de Peer, Yves/0000-0003-4327-3730; Coesel, Sacha/0000-0001-9422-8388; Mock, Thomas/0000-0001-9604-0362; Stanley, Michele/0000-0002-2348-3231; Shunmugam, Uma/0000-0001-7007-9234; martin-jezequel, veronique/0000-0002-6633-1334; Kaplan, Aaron/0000-0002-0815-5731; Choi, Chang Jae/0000-0002-0831-7470; von Dassow, Peter/0000-0002-1858-1953; Grigoriev, Igor/0000-0002-3136-8903; Petit, Jean-Louis/0000-0002-8566-0571; heijde, marc/0000-0002-8109-8999; Verret, Frederic/0000-0002-8175-7325; Fournet, jerome/0000-0001-8595-9971; LaRoche, Julie/0000-0003-4809-6411; Porcel, Betina/0000-0003-0169-5302; Falciatore, Angela/0000-0003-3318-9578; Cadoret, Jean-Paul/0000-0001-7542-5474; Bowler, Chris/0000-0003-3835-6187; Parker, Micaela/0000-0003-1007-4612; Poulsen, Nicole/0000-0002-4533-8860; Vardi, Assaf/0000-0002-7079-0234	EU-funded FP6 Diatomics [LSHG-CT-2004-512035]; EU-FP6 Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; ATIP 'Blanche'; CNRS (France); Agence Nationale de la Recherche (France); NERC [dml010007, mba010002] Funding Source: UKRI; Natural Environment Research Council [mba010002, dml010007] Funding Source: researchfish	EU-funded FP6 Diatomics(European Commission); EU-FP6 Marine Genomics Network of Excellence(European Commission); ATIP 'Blanche'; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Diatom genome sequencing at the JGI (USA) was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory, under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344 and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. P. tricornutum ESTs were generated at Genoscope (France). Funding for this work was also obtained from the EU-funded FP6 Diatomics project (LSHG-CT-2004-512035), the EU-FP6 Marine Genomics Network of Excellence (GOCE-CT-2004-505403), an ATIP 'Blanche' grant from the CNRS (France) and the Agence Nationale de la Recherche (France). We are grateful to M. Muffato and H.-R. Crollius for the analysis reported in Supplementary Fig. 3a.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; Carpenter EJ, 2000, J PHYCOL, V36, P540, DOI 10.1046/j.1529-8817.2000.99163.x; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kooistra Wiebe H. C. F., 2007, P207; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Martens C, 2008, P NATL ACAD SCI USA, V105, P3427, DOI 10.1073/pnas.0712248105; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schmid AMM, 2003, J PHYCOL, V39, P122, DOI 10.1046/j.1529-8817.2003.02084.x; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	30	1153	1239	19	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2008	456	7219					239	244		10.1038/nature07410	http://dx.doi.org/10.1038/nature07410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18923393	Green Published, hybrid			2022-12-24	WOS:000261039300040
J	Wing, K; Onishi, Y; Prieto-Martin, P; Yamaguchi, T; Miyara, M; Fehervari, Z; Nomura, T; Sakaguchi, S				Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon			CTLA-4 control over Foxp3(+) regulatory T cell function	SCIENCE			English	Article							DENDRITIC CELLS; COSTIMULATORY MOLECULES; TARGET GENES; ANTIGEN 4; AUTOIMMUNITY; BLOCKADE; CD25(+); INFLAMMATION; TOLERANCE; IMMUNITY	Naturally occurring Foxp3(+)CD4(+) regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell-mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs - in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.	[Wing, Kajsa; Onishi, Yasushi; Prieto-Martin, Paz; Yamaguchi, Tomoyuki; Miyara, Makoto; Fehervari, Zoltan; Nomura, Takashi; Sakaguchi, Shimon] Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Onishi, Yasushi] Tohoku Univ, Grad Sch Med, Dept Rheumatol & Haematol, Sendai, Miyagi 9808574, Japan; [Sakaguchi, Shimon] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Sakaguchi, Shimon] Osaka Univ, Expt Immunol Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Kyoto University; Tohoku University; Japan Science & Technology Agency (JST); Osaka University	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Miyara, Makoto/P-4491-2017	Miyara, Makoto/0000-0001-8743-8846; Wing, Kajsa/0000-0001-7744-4847	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency [Grants-in-Aid]; Japan Society for the Promotion of Science; Astra-Zeneca, Loughborough, UK	Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astra-Zeneca, Loughborough, UK(AstraZeneca)	We thank M. Ono for discussion and R. Ishii and M. Matsushita for technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Sports and Culture of Japan, Japan Science and Technology Agency. Z.F. was a Japan Society for the Promotion of Science fellow, and K. W. was granted a fellowship by Astra-Zeneca, Loughborough, UK.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shimizu J, 1999, J IMMUNOL, V163, P5211; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	25	2027	2139	5	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					271	275		10.1126/science.1160062	http://dx.doi.org/10.1126/science.1160062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845758				2022-12-24	WOS:000259902300052
J	Sato, Y; Yoshikawa, A; Yamagata, A; Mimura, H; Yamashita, M; Ookata, K; Nureki, O; Iwai, K; Komada, M; Fukai, S				Sato, Yusuke; Yoshikawa, Azusa; Yamagata, Atsushi; Mimura, Hisatoshi; Yamashita, Masami; Ookata, Kayoko; Nureki, Osamu; Iwai, Kazuhiro; Komada, Masayuki; Fukai, Shuya			Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains	NATURE			English	Article							SPLICING FACTOR PRP8; CRYSTAL-STRUCTURE; UBIQUITIN; DOMAIN; DEUBIQUITINATION; RECOGNITION; PROTEIN; DEGRADATION; BINDING; REFINEMENT	Deubiquitinating enzymes ( DUBs) remove ubiquitin from conjugated substrates to regulate various cellular processes. The Zn2+-dependent DUBs AMSH and AMSH- LP regulate receptor trafficking by specifically cleaving Lys 63- linked polyubiquitin chains from internalized receptors. Here we report the crystal structures of the human AMSH- LP DUB domain alone and in complex with a Lys 63- linked di- ubiquitin at 1.2 angstrom and 1.6 angstrom resolutions, respectively. The AMSH- LP DUB domain consists of a Zn2+-coordinating catalytic core and two characteristic insertions, Ins- 1 and Ins- 2. The distal ubiquitin interacts with Ins- 1 and the core, whereas the proximal ubiquitin interacts with Ins- 2 and the core. The core and Ins- 1 form a catalytic groove that accommodates the Lys 63 side chain of the proximal ubiquitin and the isopeptide- linked carboxy- terminal tail of the distal ubiquitin. This is the first reported structure of a DUB in complex with an isopeptide- linked ubiquitin chain, which reveals the mechanism for Lys 63- linkage- specific deubiquitination by AMSH family members.	[Sato, Yusuke; Yoshikawa, Azusa; Yamagata, Atsushi; Mimura, Hisatoshi; Yamashita, Masami; Fukai, Shuya] Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan; [Sato, Yusuke; Yoshikawa, Azusa; Yamagata, Atsushi; Mimura, Hisatoshi; Yamashita, Masami; Fukai, Shuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Sato, Yusuke; Yoshikawa, Azusa; Ookata, Kayoko; Nureki, Osamu] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; [Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Yamashita, Masami; Fukai, Shuya] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778501, Japan; [Iwai, Kazuhiro] Osaka Univ, Dept Biophys & Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Tokyo Institute of Technology; Tokyo Institute of Technology; University of Tokyo; Osaka University	Fukai, S (corresponding author), Univ Tokyo, Struct Biol Lab, Div Life Sci, Synchrotron Radiat Res Org, Tokyo 1130032, Japan.	fukai@iam.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; IWAI, KAZUHIRO/GSN-7385-2022; Fukai, Shuya/X-4838-2018; Sato, Yusuke/GPW-9280-2022	Fukai, Shuya/0000-0002-1241-1443; Sato, Yusuke/0000-0001-8495-8950; Iwai, Kazuhiro/0000-0001-5620-5951	MEXT; JSPS research fellowships	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS research fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank C. Toyoshima for support of this research. We thank M. Shirakawa and T. Tenno for advice about the K63-Ub<INF>2</INF> preparation. We thank S. Kaiser for critical reading and improvement of this manuscript. We thank the beam-line staffs at NW12A of PF-AR (Tsukuba, Japan) for technical help during data collection. This work was supported by grants from MEXT to S. F. and O.N. Y.S. is supported by JSPS research fellowships for young scientists.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gupta SP, 2007, CHEM REV, V107, P3042, DOI 10.1021/cr030448t; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; HOLDEN HM, 1987, BIOCHEMISTRY-US, V26, P8542, DOI 10.1021/bi00400a008; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komada Masayuki, 2008, Curr Drug Discov Technol, V5, P78, DOI 10.2174/157016308783769469; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	49	253	258	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					358	U19		10.1038/nature07254	http://dx.doi.org/10.1038/nature07254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18758443				2022-12-24	WOS:000259265200037
J	Finke, DL; Snyder, WE				Finke, Deborah L.; Snyder, William E.			Niche partitioning increases resource exploitation by diverse communities	SCIENCE			English	Article							BIODIVERSITY; NITROGEN; IMPACTS; PREY	Classical ecological theory suggests that the coexistence of consumer species is fostered by resource- use differences, leading to greater resource use in communities with more species. However, explicit empirical support for this idea is lacking, because resource use by species is generally confounded with other species- specific attributes. We overcame this obstacle by co- opting behavioral plasticity in food choice among a group of animal consumers, allowing us to manipulate patterns of resource use while controlling for the effects of species identity and diversity. Within an aphid- parasitoid- radish community, we created a fully factorial manipulation of consumer resource- use breadth ( specialist versus generalist) and species diversity ( one versus three species) and found that resource exploitation improved with greater specialist, but not generalist, diversity. Therefore, resource partitioning, and not diversity per se, fostered greater overall resource consumption in our multispecies consumer communities.	[Finke, Deborah L.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Finke, Deborah L.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Washington State University; University of Missouri System; University of Missouri Columbia	Finke, DL (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	finked@missouri.edu		Snyder, William/0000-0002-2747-3102	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service [2004-01215]	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	We thank A. Ives, J. Owen, A. Storfer, C. Straub, and anonymous reviewers for comments. This project was supported by the National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service, grant 2004-01215.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chalcraft DR, 2003, ECOLOGY, V84, P2407, DOI 10.1890/02-0550; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; May R. M., 1973, STABILITY COMPLEXITY; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; Pike KS, 2000, P ENTOMOL SOC WASH, V102, P688; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tunings T.C., 1992, INSECT LEARNING ECOL, P51; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	30	268	276	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1488	1490		10.1126/science.1160854	http://dx.doi.org/10.1126/science.1160854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787167	Green Submitted			2022-12-24	WOS:000259121800040
J	Cadwell, K; Liu, JY; Brown, SL; Miyoshi, H; Loh, J; Lennerz, JK; Kishi, C; Kc, W; Carrero, JA; Hunt, S; Stone, CD; Brunt, EM; Xavier, RJ; Sleckman, BP; Li, E; Mizushima, N; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kishi, Chieko; Kc, Wumesh; Carrero, Javier A.; Hunt, Steven; Stone, Christian D.; Brunt, Elizabeth M.; Xavier, Ramnik J.; Sleckman, Barry P.; Li, Ellen; Mizushima, Noboru; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells	NATURE			English	Article							GENOME-WIDE ASSOCIATION; MESENTERIC ADIPOSE-TISSUE; SUSCEPTIBILITY LOCI; CROHN-DISEASE; PROTEIN; PATHOGENESIS; EXPRESSION; MEMBRANE; COMPLEX	Susceptibility to Crohn's disease, a complex inflammatory disease involving the small intestine, is controlled by over 30 loci(1). One Crohn's disease risk allele is in ATG16L1, a gene homologous to the essential yeast autophagy gene ATG16 ( ref. 2). It is not known how ATG16L1 or autophagy contributes to intestinal biology or Crohn's disease pathogenesis. To address these questions, we generated and characterized mice that are hypomorphic for ATG16L1 protein expression, and validated conclusions on the basis of studies in these mice by analysing intestinal tissues that we collected from Crohn's disease patients carrying the Crohn's disease risk allele of ATG16L1. Here we show that ATG16L1 is a bona fide autophagy protein. Within the ileal epithelium, both ATG16L1 and a second essential autophagy protein ATG5 are selectively important for the biology of the Paneth cell, a specialized epithelial cell that functions in part by secretion of granule contents containing antimicrobial peptides and other proteins that alter the intestinal environment(3). ATG16L1- andATG5- deficient Paneth cells exhibited notable abnormalities in the granule exocytosis pathway. In addition, transcriptional analysis revealed an unexpected gain of function specific to ATG16L1- deficient Paneth cells including increased expression of genes involved in peroxisome proliferator- activated receptor ( PPAR) signalling and lipid metabolism, of acute phase reactants and of two adipocytokines, leptin and adiponectin, known to directly influence intestinal injury responses. Importantly, Crohn's disease patients homozygous for the ATG16L1 Crohn's disease risk allele displayed Paneth cell granule abnormalities similar to those observed in autophagy- protein- deficient mice and expressed increased levels of leptin protein. Thus, ATG16L1, and probably the process of autophagy, have a role within the intestinal epithelium of mice and Crohn's disease patients by selective effects on the cell biology and specialized regulatory properties of Paneth cells.	[Cadwell, Ken; Liu, John Y.; Brown, Sarah L.; Miyoshi, Hiroyuki; Loh, Joy; Lennerz, Jochen K.; Kc, Wumesh; Carrero, Javier A.; Brunt, Elizabeth M.; Sleckman, Barry P.; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hunt, Steven] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Stone, Christian D.; Li, Ellen] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Kishi, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Miyoshi, Hiroyuki/0000-0001-7400-0714; Cadwell, Ken/0000-0002-5860-0661; Virgin, Herbert/0000-0001-8580-7628	Broad Foundation; NIH [T32 AR07279, R01 AI062832, AI062773, DK43351]; Lallage Feazel Wall Fellowship [DRG-1972-08]; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center [P30 DK52574]; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award; Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Toray Science Foundation;  [U54 AI057160 Project 6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062832, U54AI057160, R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK052574, P30DK040561] Funding Source: NIH RePORTER	Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lallage Feazel Wall Fellowship; Damon Runyon Cancer Research Foundation; Pew Foundation; Washington University Digestive Diseases Research Core Center; Barnes Jewish Foundation; Johnson and Johnson Translational Seed Award(Johnson & JohnsonJohnson & Johnson USA); Crohn's Colitis Foundation of America; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toray Science Foundation(Toray Industries, Inc.); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Abe for technical assistance with fluorescence microscopy, V. Cavalli for microscope use, J. Eisenberg and A. Ng for help with bioinformatics analysis, A. J. Ouellette for technical advice, and I. Mysorekar and J. Mills for help with antibodies. This research was supported by grant U54 AI057160 Project 6 and the Broad Foundation (K.C., J. Loh and H.W.V.), training grant NIH T32 AR07279 (K.C.), the Lallage Feazel Wall Fellowship DRG-1972-08 (K.C.) from the Damon Runyon Cancer Research Foundation; the Pew Foundation (J. Liu, S.L.B., H.M., W.K. and T.S.S.); the Washington University Digestive Diseases Research Core Center P30 DK52574, Barnes Jewish Foundation, Johnson and Johnson Translational Seed Award, and the Crohn's Colitis Foundation of America (E.L., S.H. and C.S.); grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Toray Science Foundation (C.K. and N.M.); NIH R01 AI062832 (J.A.C.); and NIH AI062773 and DK43351 (R.J.X.).	Barbier M, 2003, GASTROEN CLIN BIOL, V27, P987; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; DVORAK AM, 1980, HUM PATHOL, V11, P561; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516	29	1093	1130	5	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					259	U62		10.1038/nature07416	http://dx.doi.org/10.1038/nature07416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849966	Green Accepted			2022-12-24	WOS:000261039300044
J	Liu, Y; Dentin, R; Chen, D; Hedrick, S; Ravnskjaer, K; Schenk, S; Milne, J; Meyers, DJ; Cole, P; Yates, J; Olefsky, J; Guarente, L; Montminy, M				Liu, Yi; Dentin, Renaud; Chen, Danica; Hedrick, Susan; Ravnskjaer, Kim; Schenk, Simon; Milne, Jill; Meyers, David J.; Cole, Phil; Yates, John, III; Olefsky, Jerrold; Guarente, Leonard; Montminy, Marc			A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange	NATURE			English	Article							TRANSCRIPTION FACTOR FOXO1; GLUCOSE-HOMEOSTASIS; CATALYTIC SUBUNIT; GENE-EXPRESSION; FACTOR FKHR; GLUCOSE-6-PHOSPHATASE; SIRT1; P300; METABOLISM; STARVATION	During early fasting, increases in skeletal muscle proteolysis liberate free amino acids for hepatic gluconeogenesis in response to pancreatic glucagon. Hepatic glucose output diminishes during the late protein- sparing phase of fasting, when ketone body production by the liver supplies compensatory fuel for glucose- dependent tissues(1-4). Glucagon stimulates the gluconeogenic program by triggering the dephosphorylation and nuclear translocation of the CREB regulated transcription coactivator 2 ( CRTC2; also known as TORC2), while parallel decreases in insulin signalling augment gluconeogenic gene expression through the dephosphorylation and nuclear shuttling of forkhead box O1 (FOXO1)(5-7). Here we show that a fasting- inducible switch, consisting of the histone acetyltransferase p300 and the nutrient- sensing deacetylase sirtuin 1 ( SIRT1), maintains energy balance in mice through the sequential induction of CRTC2 and FOXO1. After glucagon induction, CRTC2 stimulated gluconeogenic gene expression by an association with p300, which we show here is also activated by dephosphorylation at Ser 89 during fasting. In turn, p300 increased hepatic CRTC2 activity by acetylating it at Lys 628, a site that also targets CRTC2 for degradation after its ubiquitination by the E3 ligase constitutive photomorphogenic protein (COP1)(8). Glucagon effects were attenuated during late fasting, when CRTC2 was downregulated owing to SIRT1- mediated deacetylation and when FOXO1 supported expression of the gluconeogenic program. Disrupting SIRT1 activity, by liver- specific knockout of the Sirt1 gene or by administration of a SIRT1 antagonist, increased CRTC2 activity and glucose output, whereas exposure to SIRT1 agonists reduced them. In view of the reciprocal activation of FOXO1 and its coactivator peroxisome proliferator- activated receptor-gamma coactivator-1 alpha (PGC-1 alpha, encoded by Ppargc1 alpha) by SIRT1 activators(9-12), our results illustrate how the exchange of two gluconeogenic regulators during fasting maintains energy balance.	[Liu, Yi; Dentin, Renaud; Hedrick, Susan; Ravnskjaer, Kim; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Chen, Danica; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Schenk, Simon; Olefsky, Jerrold] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Milne, Jill] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Meyers, David J.; Cole, Phil] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yates, John, III] Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Johns Hopkins University; Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Montminy@salk.edu	dentin, Renaud/P-4939-2017; Dentin, Renaud/AAV-5818-2020	dentin, Renaud/0000-0003-0988-4458; Dentin, Renaud/0000-0003-0988-4458; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health; Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation, Inc; Hillblom Foundation; Kieckhefer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kahn for the gift of phospho-specific p300 antiserum and L. Vera for technical assistance. We also thank R. Shaw and M. Mihaylova for sharing results on p300 phosphorylation. This work was supported by grants from the National Institutes of Health, the Clayton Medical Research Foundation, Inc., the Hillblom Foundation (to Y.L.), and the Kieckhefer Foundation.	Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FERRE P, 1978, AM J PHYSIOL, V234, pE129, DOI 10.1152/ajpendo.1978.234.2.E129; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277; GOODMAN MN, 1981, AM J PHYSIOL, V241, pE321, DOI 10.1152/ajpendo.1981.241.4.E321; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; MARLISS EB, 1970, J CLIN INVEST, V49, P2256, DOI 10.1172/JCI106445; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544	30	406	430	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					269	U74		10.1038/nature07349	http://dx.doi.org/10.1038/nature07349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849969	Green Accepted			2022-12-24	WOS:000261039300046
J	Chen, YY; Takita, J; Choi, YL; Kato, M; Ohira, M; Sanada, M; Wang, LL; Soda, M; Kikuchi, A; Igarashi, T; Nakagawara, A; Hayashi, Y; Mano, H; Ogawa, S				Chen, Yuyan; Takita, Junko; Choi, Young Lim; Kato, Motohiro; Ohira, Miki; Sanada, Masashi; Wang, Lili; Soda, Manabu; Kikuchi, Akira; Igarashi, Takashi; Nakagawara, Akira; Hayashi, Yasuhide; Mano, Hiroyuki; Ogawa, Seishi			Oncogenic mutations of ALK kinase in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CASPASE-8 GENE; LUNG-CANCER; PROTEIN; FUSION; SYSTEM; ARRAYS; DNA	Neuroblastoma in advanced stages is one of the most intractable paediatric cancers, even with recent therapeutic advances(1). Neuroblastoma harbours a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma(2-5). However, the scarcity of reliable molecular targets has hampered the development of effective therapeutic agents targeting neuroblastoma. Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non- Hodgkin's lymphoma (NPM-ALK)(6-8) and more recently in adenocarcinoma of lung (EML4-ALK)(9,10), is also a frequent target of genetic alteration in advanced neuroblastoma. According to our genome- wide scans of genetic lesions in 215 primary neuroblastoma samples using high- density single- nucleotide polymorphism genotyping microarrays(11-14), the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy number gain and gene amplification. Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumours and 8 out of 24 ( 33%) neuroblastoma- derived cell lines. All but one mutation in the primary samples ( 12 out of 13) were found in stages 3 - 4 of the disease and were harboured in the kinase domain. The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild- type kinase. They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumours in nude mice. Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK. We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK- specific kinase inhibitors might improve its clinical outcome.	[Takita, Junko; Choi, Young Lim; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Tokyo 1138655, Japan; [Chen, Yuyan; Takita, Junko; Kato, Motohiro; Sanada, Masashi; Wang, Lili; Ogawa, Seishi] Univ Tokyo, Canc Genom Project, Grad Sch Med, Tokyo 1138655, Japan; [Choi, Young Lim; Soda, Manabu; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Toguchi 3290498, Japan; [Ohira, Miki; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chiba 2608717, Japan; [Sanada, Masashi; Wang, Lili; Mano, Hiroyuki; Ogawa, Seishi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kikuchi, Akira] Saitama Childrens Med Ctr, Div Hematol Oncol, Saitama 3398551, Japan; [Hayashi, Yasuhide] Gunma Childrens Med Ctr, Shibukawa 3778577, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Jichi Medical University; Chiba Cancer Center; Japan Science & Technology Agency (JST); Saitama Children's Medical Center; Gunma Children's Medical Centre	Ogawa, S (corresponding author), Univ Tokyo, Cell Therapy & Transplantat Med, Tokyo 1138655, Japan.	hayashiy-tky@umin.ac.jp; sogawa-tky@umin.net	wang, lili/HDL-7210-2022; Chen, Yuyan/V-7279-2019; Ogawa, Seishi/AAE-7088-2019	Chen, Yuyan/0000-0002-2894-1430; Kato, Motohiro/0000-0001-5145-1774	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank H. P. Koeffler for critically reading and editing the manuscript. We also thank M. Matsumura, Y. Ogino, S. Ichimura, S. Sohma, E. Matsui, Y. Yin, N. Hoshino and Y. Nakamura for their technical assistance. This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency and by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan for the third-term Comprehensive 10-year Strategy for Cancer Control.	Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Donohoe E, 2005, METH MOLEC MED, V108, P173; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; SMITH EI, 1989, J PEDIATR SURG, V24, P386, DOI 10.1016/S0022-3468(89)80277-5; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; TAKITA J, 1995, ONCOGENE, V11, P1829; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Takita J, 2000, MED PEDIATR ONCOL, V35, P541, DOI 10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	26	654	693	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					971	U56		10.1038/nature07399	http://dx.doi.org/10.1038/nature07399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923524				2022-12-24	WOS:000260038300051
J	Arita, K; Ariyoshi, M; Tochio, H; Nakamura, Y; Shirakawa, M				Arita, Kyohei; Ariyoshi, Mariko; Tochio, Hidehito; Nakamura, Yusuke; Shirakawa, Masahiro			Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism	NATURE			English	Article							BINDING; DOMAIN; DNMT1	DNA methylation of CpG dinucleotides is an important epigenetic modification of mammalian genomes and is essential for the regulation of chromatin structure, of gene expression and of genome stability(1,2). Differences in DNA methylation patterns underlie a wide range of biological processes, such as genomic imprinting, inactivation of the X chromosome, embryogenesis, and carcinogenesis(3-6). Inheritance of the epigenetic methylation pattern is mediated by the enzyme DNA methyltransferase 1 ( Dnmt1), which methylates newly synthesized CpG sequences during DNA replication, depending on the methylation status of the template strands(7,8). The protein UHRF1 ( also known as Np95 and ICBP90) recognizes hemi- methylation sites via a SET and RING- associated ( SRA) domain and directs Dnmt1 to these sites(9-11). Here we report the crystal structures of the SRA domain in free and hemi- methylated DNA- bound states. The SRA domain folds into a globular structure with a basic concave surface formed by highly conserved residues. Binding of DNA to the concave surface causes a loop and an amino- terminal tail of the SRA domain to fold into DNA interfaces at the major and minor grooves of the methylation site. In contrast to fully methylated CpG sites recognized by the methyl- CpG- binding domain(12,13), the methylcytosine base at the hemi- methylated site is flipped out of the DNA helix in the SRA - DNA complex and fits tightly into a protein pocket on the concave surface. The complex structure suggests that the successive flip out of the pre- existing methylated cytosine and the target cytosine to be methylated is associated with the coordinated transfer of the hemi- methylated CpG site from UHRF1 to Dnmt1.	[Arita, Kyohei; Ariyoshi, Mariko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Nakamura, Yusuke] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	ma4@eng.mbox.media.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Tochio, Hidehito/F-6109-2011; Arita, Kyohei/AAJ-6402-2020	Arita, Kyohei/0000-0002-9762-8405; Ariyoshi, Mariko/0000-0002-1361-2642; Tochio, Hidehito/0000-0003-3843-3330	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Global COE Program 'Integrated Materials Science' of MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program 'Integrated Materials Science' of MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Morikawa for discussion, and N. Matsugaki, N. Igarashi, Y. Yamada, M. Suzuki and S. Wakatsuki for data collection at PF-BL5. This work was supported by grants to M.S. from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Japan Science and Technology Agency, and by a Grant- in- Aid for Scientific Research to K. A. from the Japan Society for the Promotion of Science. The authors acknowledge support from the Global COE Program 'Integrated Materials Science' of MEXT of Japan.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGara M, 1996, J MOL BIOL, V263, P597, DOI 10.1006/jmbi.1996.0601; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; SUCK D, 1994, CURR BIOL, V4, P252, DOI 10.1016/S0960-9822(00)00057-9; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tajima S, 1998, J BIOCHEM-TOKYO, V123, P993, DOI 10.1093/oxfordjournals.jbchem.a022066; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	27	340	354	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					818	U12		10.1038/nature07249	http://dx.doi.org/10.1038/nature07249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772891				2022-12-24	WOS:000259854900051
J	Zhu, Z; Chung, WH; Shim, EY; Lee, SE; Ira, G				Zhu, Zhu; Chung, Woo-Hyun; Shim, Eun Yong; Lee, Sang Eun; Ira, Grzegorz			Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends	CELL			English	Article							STALLED REPLICATION FORKS; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-III; ESCHERICHIA-COLI; MITOTIC RECOMBINATION; CHECKPOINT ACTIVATION; ENDONUCLEASE ACTIVITY; GENOME INSTABILITY	Formation of single-strand DNA (ssDNA) tails at a double-strand break (DSB) is a key step in homologous recombination and DNA-damage signaling. The enzyme(s) producing ssDNA at DSBs in eukaryotes remain unknown. We monitored 5'-strand resection at inducible DSB ends in yeast and identified proteins required for two stages of resection: initiation and long-range 50-strand resection. We show that the Mre11-Rad50-Xrs2 complex (MRX) initiates 50 degradation, whereas Sgs1 and Dna2 degrade 50 strands exposing long 30 strands. Deletion of SGS1 or DNA2 reduces resection and DSB repair by single-strand annealing between distant repeats while the remaining long-range resection activity depends on the exonuclease Exo1. In exo1 Delta sgs1 Delta double mutants, the MRX complex together with Sae2 nuclease generate, in a stepwise manner, only few hundred nucleotides of ssDNA at the break, resulting in inefficient gene conversion and G2/M damage checkpoint arrest. These results provide important insights into the early steps of DSB repair in eukaryotes.	[Zhu, Zhu; Chung, Woo-Hyun; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu	Ira, Grzegorz/B-7912-2010		NIH [GM80600-02, GM071011]; Texas Advanced Research Program;  [GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R01GM080600, R01GM120056, R37GM020056, R01GM071011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to James Haber, Virginia Zakian, Steve Brill, Rodney Rothstein, and Judith Campbell for strains and plasmids and to Alma Papusha for technical support. We thank James Haber, Phil Hastings, and Neil Hunter for critical comments on the manuscript. This work was supported by NIH grants GM80600-02 (to G. I.) and GM071011 and Texas Advanced Research Program (to S. E. L.). The preliminary work was supported by GM20056 to J.E. Haber. S. E. L. is a scholar of the Leukemia and Lymphoma Society.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Church G M, 1985, Prog Clin Biol Res, V177, P17; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Formosa T, 1999, GENETICS, V151, P1459; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Magner DB, 2007, MOL CELL, V26, P273, DOI 10.1016/j.molcel.2007.03.012; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Melo JA, 2001, GENE DEV, V15, P2809; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moreau S, 1999, MOL CELL BIOL, V19, P556; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Spies Maria, 2005, P389; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Watt PM, 1996, GENETICS, V144, P935; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	772	778	2	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					981	994		10.1016/j.cell.2008.08.037	http://dx.doi.org/10.1016/j.cell.2008.08.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805091	Bronze, Green Accepted			2022-12-24	WOS:000259318100018
J	Lee, DS; Nioche, P; Hamberg, M; Raman, CS				Lee, Dong-Sun; Nioche, Pierre; Hamberg, Mats; Raman, C. S.			Structural insights into the evolutionary paths of oxylipin biosynthetic enzymes	NATURE			English	Article							ALLENE OXIDE SYNTHASE; LIPOXYGENASE FUSION PROTEIN; HYDROPEROXIDE LYASE; FATTY-ACID; METHYLOBACTERIUM-NODULANS; SIGNAL-TRANSDUCTION; CYTOCHROME-P450; IDENTIFICATION; ARABIDOPSIS; PURIFICATION	The oxylipin pathway generates not only prostaglandin- like jasmonates but also green leaf volatiles ( GLVs), which confer characteristic aromas to fruits and vegetables. Although allene oxide synthase ( AOS) and hydroperoxide lyase are atypical cytochrome P450 family members involved in the synthesis of jasmonates and GLVs, respectively, it is unknown how these enzymes rearrange their hydroperoxide substrates into different products. Here we present the crystal structures of Arabidopsis thaliana AOS, free and in complex with substrate or intermediate analogues. The structures reveal an unusual active site poised to control the reactivity of an epoxyallylic radical and its cation by means of interactions with an aromatic pi- system. Replacing the amino acid involved in these steps by a non- polar residue markedly reduces AOS activity and, unexpectedly, is both necessary and sufficient for converting AOS into a GLV biosynthetic enzyme. Furthermore, by combining our structural data with bioinformatic and biochemical analyses, we have discovered previously unknown hydroperoxide lyase in plant growth- promoting rhizobacteria, AOS in coral, and epoxyalcohol synthase in amphioxus. These results indicate that oxylipin biosynthetic genes were present in the last common ancestor of plants and animals, but were subsequently lost in all metazoan lineages except Placozoa, Cnidaria and Cephalochordata.	[Lee, Dong-Sun; Raman, C. S.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Nioche, Pierre] Univ Paris 05, INSERM, UMR S 747, F-75270 Paris 06, France; [Hamberg, Mats] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	University of Texas System; University of Texas Health Science Center Houston; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Raman, CS (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	ramancs@gmail.com	Lee, Dong Sun/HGV-2436-2022	Hamberg, Mats/0000-0002-8910-7810; Raman, C. S./0000-0002-1036-3193	Pew Charitable Trusts; Pew Scholar Award; The Robert A. Welch Foundation; The National Institutes of Health; American Heart Association; INSERM Avenir Grant; La Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054444] Funding Source: NIH RePORTER	Pew Charitable Trusts; Pew Scholar Award; The Robert A. Welch Foundation(The Welch Foundation); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); INSERM Avenir Grant(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C. S. R. is grateful to the late N. Natarajaratnam and the late T. Traylor for encouragement; R. Cudney for nonanoyl-N- hydroxyethylglucamide (HEGA-9); K. Matsui for tomato HPL complementary DNA; K. Back and D. Park for Arabidopsis and rice cDNA libraries; L. Holland and J. Langeland for the amphioxus cDNA library; M. Medina for A. palmata expressed sequence tags; C. Marx and L. Moulin for M. nodulans cells; R. Muller for S. aurantiaca genomic DNA; L. Roman and B. Masters for the pCWori<SUP>+</SUP> vector; J. Navarro for the single crystal microspectrophotometer; T. Doukov, S. Soltis, A. Cohen and J. Charles for help with acquiring electronic absorption spectra of single crystals; S. Veeraraghavan for generating Fig. 5; R. Bach, T. Bach, A. Beckwith, W. Bernhard, D. Curran, A. Davies, T. Dibble, J. Finnerty, D. Fleischman, J. Froehlich, J. Groves, L. Holland, P. Holland, J. Howieson, H. Kaplan, D. Nelson, M. Newcomb, P. Ortiz de Montellano, N. Porter, T. Poulos, M. Sibi, S. Veeraraghavan and D. Whalen for discussions; Joint Genome Institute for access to sequence data; Stanford Synchrotron Radiation Laboratories (beam lines 9-2 and 11-1, T. Doukov and L. Dunn) and the Advanced Light Source (beam line 8.3.1, J. Holton, G. Meigs and J. Tanamachi; beam lines 8.2.1 and 8.2.2, C. Ralston) for beam time and assistance. This work is supported by Pew Charitable Trusts through a Pew Scholar Award (C.S.R.), The Robert A. Welch Foundation (C.S.R.), The National Institutes of Health (C.S.R.), a Beginning Grant in Aid from the American Heart Association (D.-S.L.), and an INSERM Avenir Grant sponsored by La Fondation pour la Recherche Medicale (P.N.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Beckers GJ, 2007, CURR OPIN PLANT BIOL, V10, P425, DOI 10.1016/j.pbi.2007.06.002; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1988, P NATL ACAD SCI USA, V85, P3382, DOI 10.1073/pnas.85.10.3382; Cartwright P, 2007, INTEGR COMP BIOL, V47, P744, DOI 10.1093/icb/icm071; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Flescher E, 2007, CANCER LETT, V245, P1, DOI 10.1016/j.canlet.2006.03.001; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gershenzon J, 2007, P NATL ACAD SCI USA, V104, P5257, DOI 10.1073/pnas.0700906104; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; GRECHKIN AN, 1995, FEBS LETT, V371, P159, DOI 10.1016/0014-5793(95)00895-G; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V276, P518, DOI 10.1016/0003-9861(90)90753-L; HAMBERG M, 1987, BIOCHIM BIOPHYS ACTA, V920, P76, DOI 10.1016/0005-2760(87)90313-4; Hofmann E, 2006, PLANT CELL, V18, P3201, DOI 10.1105/tpc.106.043984; Hughes RK, 2006, FEBS LETT, V580, P4188, DOI 10.1016/j.febslet.2006.06.075; Itoh A, 2001, J BIOL CHEM, V276, P3620, DOI 10.1074/jbc.M008964200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Jourand P, 2005, MOL PLANT MICROBE IN, V18, P1061, DOI 10.1094/MPMI-18-1061; Keirse MJNC, 2006, CLIN OBSTET GYNECOL, V49, P609, DOI 10.1097/00003081-200609000-00020; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Langeland JA, 1998, DEV GENES EVOL, V208, P569, DOI 10.1007/s004270050216; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIECHTI R, 2006, SCI STKE, pCM3; LIECHTI R, 2006, SCI STKE, pCM2; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson David R., 2006, Phytochemistry Reviews, V5, P193, DOI 10.1007/s11101-006-9015-3; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; Renier A, 2008, SOIL BIOL BIOCHEM, V40, P1404, DOI 10.1016/j.soilbio.2007.12.020; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; RICHARDSON TH, 1993, ARCH BIOCHEM BIOPHYS, V300, P510, DOI 10.1006/abbi.1993.1069; Schlichting I, 2000, ACCOUNTS CHEM RES, V33, P532, DOI 10.1021/ar9900459; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Sheldrick GM, 1997, METHOD ENZYMOL, V276, P628, DOI 10.1016/S0076-6879(97)76083-X; Smith DM, 1998, J AM CHEM SOC, V120, P10223, DOI 10.1021/ja980635m; SONG WC, 1993, J BIOL CHEM, V268, P6293; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; Stumpe Michael, 2006, Phytochemistry Reviews, V5, P347, DOI 10.1007/s11101-006-9038-9; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Van Loon LC, 2006, PLANT-ASSOCIATED BACTERIA, P269; VICK BA, 1976, PLANT PHYSIOL, V57, P780, DOI 10.1104/pp.57.5.780; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wester MR, 2002, METHOD ENZYMOL, V357, P73; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; Williams D, 2000, PERFORM RES, V5, P131; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Zabetakis I, 1997, PLANT CELL TISS ORG, V50, P179, DOI 10.1023/A:1005968913237; ZIMMERMAN DC, 1966, BIOCHEM BIOPH RES CO, V23, P398, DOI 10.1016/0006-291X(66)90740-6	74	208	226	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					363	U27		10.1038/nature07307	http://dx.doi.org/10.1038/nature07307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18716621				2022-12-24	WOS:000259265200038
J	Mao, JH; Kim, IJ; Wu, D; Climent, J; Kang, HC; DelRosario, R; Balmain, A				Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan			FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression	SCIENCE			English	Article							FBW7 UBIQUITIN LIGASE; C-MYC; HCDC4	The enzyme mTOR ( mammalian target of rapamycin) is a major target for therapeutic intervention to treat many human diseases, including cancer, but very little is known about the processes that control levels of mTOR protein. Here, we show that mTOR is targeted for ubiquitination and consequent degradation by binding to the tumor suppressor protein FBXW7. Human breast cancer cell lines and primary tumors showed a reciprocal relation between loss of FBXW7 and deletion or mutation of PTEN ( phosphatase and tensin homolog), which also activates mTOR. Tumor cell lines harboring deletions or mutations in FBXW7 are particularly sensitive to rapamycin treatment, which suggests that loss of FBXW7 may be a biomarker for human cancers susceptible to treatment with inhibitors of the mTOR pathway.	[Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Balmain, Allan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	高, 雨莉/HGU-8187-2022; Mao, Jian-Hua/EIZ-8595-2022; Climent, Joan/O-5877-2017	Mao, Jian-Hua/0000-0001-9320-6021; Climent, Joan/0000-0002-8927-6614	NCI [U01 CA84244]; U. S. Department of Energy [DE-FG02-03ER63630]; University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA116481] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Energy(United States Department of Energy (DOE)); University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Vogelstein for providing us with the HCT116 WT, HCT116 FBXW7<SUP>-/-</SUP>, DLD1 wild-type, and DLD1 FBXW7<SUP>-/-</SUP> cell lines; K. I. Nakayama for providing Fbxw7 knockout mice and vectors (HA-FBXW7 and HA-FBXW7 Delta F); and O. Tetsu for vector encoding HA-ubiquitin. These studies were supported by NCI grant U01 CA84244 and the U. S. Department of Energy (DE-FG02-03ER63630) to A. B., the University of California at San Francisco Research-Evaluation Allocation Committee (REAC) to J.-H.M.A.B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	18	312	325	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1499	1502		10.1126/science.1162981	http://dx.doi.org/10.1126/science.1162981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787170	Green Accepted			2022-12-24	WOS:000259121800044
J	Zimyanin, VL; Belaya, K; Pecreaux, J; Gilchrist, MJ; Clark, A; Davis, I; St Johnston, D				Zimyanin, Vitaly L.; Belaya, Katsiaryna; Pecreaux, Jacques; Gilchrist, Michael J.; Clark, Alejandra; Davis, Ilan; St Johnston, Daniel			In vivo Imaging of oskar mRNA transport reveals the mechanism of posterior localization	CELL			English	Article							DROSOPHILA OOCYTE; MAGO NASHI; KINESIN-I; MAMMALIAN-CELLS; BINDING PROTEIN; AXIS FORMATION; POLE PLASM; GERM PLASM; DYNEIN; STAUFEN	oskar mRNA localization to the posterior of the Drosophila oocyte defines where the abdomen and germ cells form in the embryo. Although this localization requires microtubules and the plus end-directed motor, kinesin, its mechanism is controversial and has been proposed to involve active transport to the posterior, diffusion and trapping, or exclusion from the anterior and lateral cortex. By following oskar mRNA particles in living oocytes, we show that the mRNA is actively transported along microtubules in all directions, with a slight bias toward the posterior. This bias is sufficient to localize the mRNA and is reversed in mago, barentsz, and Tropomyosin II mutants, which mislocalize the mRNA anteriorly. Since almost all transport is mediated by kinesin, oskar mRNA localizes by a biased random walk along a weakly polarized cytoskeleton. We also show that each component of the oskar mRNA complex plays a distinct role in particle formation and transport.	[Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Clark, Alejandra; Davis, Ilan] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	St Johnston, Daniel/C-9568-2009; Davis, Ilan/F-4975-2010; Pecreaux, Jacques/A-4248-2008	Pecreaux, Jacques/0000-0001-9998-4844; St Johnston, Daniel/0000-0001-5582-3301; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust; MRC [G0001292] Funding Source: UKRI; Medical Research Council [G0001292] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Liz Gavis and Bill Saxton for providing fly stocks, Simon Bullock for help with the statistical analysis of particle movement, and I. Palacios and C. P. Heisenberg for support during writing. V. L. Z. and K. B. were supported by the Darwin Trust. This work was supported by the Wellcome Trust.	Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chou TB, 1996, GENETICS, V144, P1673; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Macchi P, 2003, J NEUROSCI, V23, P5778; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Manseau L, 1996, DEVELOPMENT, V122, P2109; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; McGrail M, 1997, DEVELOPMENT, V124, P2409; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mohr SE, 2001, GENE DEV, V15, P2886; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; SERANO TL, 1995, DEVELOPMENT, V121, P3013; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	54	239	242	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					843	853		10.1016/j.cell.2008.06.053	http://dx.doi.org/10.1016/j.cell.2008.06.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775316	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000258947500023
J	Danovaro, R; Dell'Anno, A; Corinaldesi, C; Magagnini, M; Noble, R; Tamburini, C; Weinbauer, M				Danovaro, Roberto; Dell'Anno, Antonio; Corinaldesi, Cinzia; Magagnini, Mirko; Noble, Rachel; Tamburini, Christian; Weinbauer, Markus			Major viral impact on the functioning of benthic deep-sea ecosystems	NATURE			English	Article							MARINE VIRUSES; HYDROSTATIC-PRESSURE; ORGANIC-MATTER; KEY ROLE; MORTALITY; SEDIMENTS; BACTERIOPLANKTON; WATERS; DNA; INFECTION	Viruses are the most abundant biological organisms of the world's oceans. Viral infections are a substantial source of mortality in a range of organisms - including autotrophic and heterotrophic plankton - but their impact on the deep ocean and benthic biosphere is completely unknown. Here we report that viral production in deep- sea benthic ecosystems worldwide is extremely high, and that viral infections are responsible for the abatement of 80% of prokaryotic heterotrophic production. Virus- induced prokaryotic mortality increases with increasing water depth, and beneath a depth of 1,000 m nearly all of the prokaryotic heterotrophic production is transformed into organic detritus. The viral shunt, releasing on a global scale similar to 0.37 - 0.63 gigatonnes of carbon per year, is an essential source of labile organic detritus in the deep- sea ecosystems. This process sustains a high prokaryotic biomass and provides an important contribution to prokaryotic metabolism, allowing the system to cope with the severe organic resource limitation of deep- sea ecosystems. Our results indicate that viruses have an important role in global biogeochemical cycles, in deep- sea metabolism and the overall functioning of the largest ecosystem of our biosphere.	[Danovaro, Roberto; Dell'Anno, Antonio; Corinaldesi, Cinzia; Magagnini, Mirko] Polytech Univ Marche, Dept Marine Sci, Fac Sci, I-60131 Ancona, Italy; [Noble, Rachel] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Tamburini, Christian] Univ Aix Marseille 2, Ctr Oceanol Marseille, CNRS, UMR 6117, F-13288 Marseille 9, France; [Weinbauer, Markus] CNRS, F-06234 Villefranche Sur Mer, France; [Weinbauer, Markus] Lab Oceanog Villefranche, Microbial Ecol & Biogeochem Grp, F-06234 Villefranche Sur Mer, France; [Weinbauer, Markus] Univ Paris 06, Lab Oceanog Villefranche, F-06234 Villefranche Sur Mer, France	Marche Polytechnic University; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Danovaro, R (corresponding author), Polytech Univ Marche, Dept Marine Sci, Fac Sci, Via Brecce Bianche, I-60131 Ancona, Italy.	r.danovaro@univpm.it	Tamburini, Christian/AAO-8577-2020; Weinbauer, Markus/ABC-7017-2020; Weinbauer, Markus/G-8038-2011; Tamburini, Christian/I-7821-2012; Dell'Anno, Antonio AD/G-9468-2012	Tamburini, Christian/0000-0003-3752-7423; Weinbauer, Markus/0000-0002-7697-5571; Tamburini, Christian/0000-0003-3752-7423; Dell'Anno, Antonio AD/0000-0002-4324-7834; Noble, Rachel/0000-0001-9071-8312	project HERMES; ANR POTES	project HERMES(European Commission); ANR POTES(French National Research Agency (ANR))	This work was financially supported by the EU within the framework of the project HERMES. C. T. was supported by the ANR POTES.	Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Corinaldesi C, 2007, LIMNOL OCEANOGR, V52, P508, DOI 10.4319/lo.2007.52.2.0508; Danovaro R, 2003, DEEP-SEA RES PT I, V50, P1411, DOI 10.1016/j.dsr.2003.07.001; Danovaro R, 2001, APPL ENVIRON MICROB, V67, P1384, DOI 10.1128/AEM.67.3.1384-1387.2001; Danovaro R, 2008, FRESHWATER BIOL, V53, P1186, DOI 10.1111/j.1365-2427.2008.01961.x; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Deming J. W., 1993, ORGANIC GEOCHEMISTRY, P119; Druffel ERM, 1999, SCIENCE, V284, P1139, DOI 10.1126/science.284.5417.1139; Fry J. C., 1990, METHODS AQUATIC BACT, P27; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gage J. D., 1991, DEEP SEA BIOL NATURA; Helton RR, 2006, APPL ENVIRON MICROB, V72, P4767, DOI 10.1128/AEM.00297-06; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; Mari X, 2007, APPL ENVIRON MICROB, V73, P5245, DOI 10.1128/AEM.00762-07; Mei ML, 2004, LIMNOL OCEANOGR, V49, P459, DOI 10.4319/lo.2004.49.2.0459; Noble RT, 1999, AQUAT MICROB ECOL, V20, P1, DOI 10.3354/ame020001; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Siem-Jorgensen M, 2008, MAR BIOL RES, V4, P165, DOI 10.1080/17451000801888718; Steward Grieg F., 1992, Marine Microbial Food Webs, V6, P57; SUTTLE CA, 1990, NATURE, V347, P467, DOI 10.1038/347467a0; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tamburini C, 2003, AQUAT MICROB ECOL, V32, P209, DOI 10.3354/ame032209; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weinbauer MG, 1998, AQUAT MICROB ECOL, V15, P103, DOI 10.3354/ame015103; WEINBAUER MG, 1993, APPL ENVIRON MICROB, V59, P4074, DOI 10.1128/AEM.59.12.4074-4082.1993; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021	39	259	292	3	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1084	U27		10.1038/nature07268	http://dx.doi.org/10.1038/nature07268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18756250				2022-12-24	WOS:000258719600030
J	Cheng, J; Turkel, N; Hemati, N; Fuller, MT; Hunt, AJ; Yamashita, YM				Cheng, Jun; Turkel, Nezaket; Hemati, Nahid; Fuller, Margaret T.; Hunt, Alan J.; Yamashita, Yukiko M.			Centrosome misorientation reduces stem cell division during ageing	NATURE			English	Article							SELF-RENEWAL; DROSOPHILA SPERMATOGENESIS; GERMLINE; NICHE; MELANOGASTER; ORIENTATION; CANCER	Asymmetric division of adult stem cells generates one self- renewing stem cell and one differentiating cell, thereby maintaining tissue homeostasis. A decline in stem cell function has been proposed to contribute to tissue ageing, although the underlying mechanism is poorly understood. Here we show that changes in the stem cell orientation with respect to the niche during ageing contribute to the decline in spermatogenesis in the male germ line of Drosophila. Throughout the cell cycle, centrosomes in germline stem cells ( GSCs) are oriented within their niche and this ensures asymmetric division. We found that GSCs containing misoriented centrosomes accumulate with age and that these GSCs are arrested or delayed in the cell cycle. The cell cycle arrest is transient, and GSCs appear to re- enter the cell cycle on correction of centrosome orientation. On the basis of these findings, we propose that cell cycle arrest associated with centrosome misorientation functions as a mechanism to ensure asymmetric stem cell division, and that the inability of stem cells to maintain correct orientation during ageing contributes to the decline in spermatogenesis. We also show that some of the misoriented GSCs probably originate from dedifferentiation of spermatogonia.	[Turkel, Nezaket; Hemati, Nahid; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Cheng, Jun; Hunt, Alan J.] Univ Michigan, Dept Biomed Engn, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Fuller, Margaret T.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu		Fuller, Margaret T/0000-0002-3804-4987; Turkel, Nezaket/0000-0002-4480-7282; Yamashita, Yukiko/0000-0001-5541-0216	University of Michigan; March of Dimes Basil O'Conner Starter Scholar Research Award; Searle Scholar Program; NIH [P01 DK53074, R01GM072006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072006, R01GM086481, R01GM080501] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); March of Dimes Basil O'Conner Starter Scholar Research Award(March of Dimes); Searle Scholar Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Gonzalez, D. McKearin, N. Rusan, M. Peifer and the Bloomington Stock Center for fly stocks; R. Lehmann, C. Field and the Developmental Studies Hybridoma Bank for antibodies; M. Kiel and D. Nakada for help with X-ray irradiation; and S. Morrison and T. Mahowald for comments on the manuscript. This research was supported by a University of Michigan start-up fund, March of Dimes Basil O'Conner Starter Scholar Research Award and the Searle Scholar Program (to Y.M.Y.), and NIH grants P01 DK53074 (to M.T.F.) and R01GM072006 (to A.J.H.).	Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; DING D, 1993, P NATL ACAD SCI USA, V90, P2512, DOI 10.1073/pnas.90.6.2512; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuller Margaret T., 1993, P71; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Serrano M, 2007, NAT REV MOL CELL BIO, V8, P715, DOI 10.1038/nrm2242; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	27	229	238	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					599	U40		10.1038/nature07386	http://dx.doi.org/10.1038/nature07386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18923395	Green Accepted, Green Published			2022-12-24	WOS:000261340000032
J	Caputo, A; Caci, E; Ferrera, L; Pedemonte, N; Barsanti, C; Sondo, E; Pfeffer, U; Ravazzolo, R; Zegarra-Moran, O; Galietta, LJV				Caputo, Antonella; Caci, Emanuela; Ferrera, Loretta; Pedemonte, Nicoletta; Barsanti, Cristina; Sondo, Elvira; Pfeffer, Ulrich; Ravazzolo, Roberto; Zegarra-Moran, Olga; Galietta, Luis J. V.			TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity	SCIENCE			English	Article							CA2+-ACTIVATED CL-CURRENTS; CELL-LINE; TRANSPORT; LUNG	Calcium-dependent chloride channels are required for normal electrolyte and fluid secretion, olfactory perception, and neuronal and smooth muscle excitability. The molecular identity of these membrane proteins is still unclear. Treatment of bronchial epithelial cells with interleukin-4 (IL-4) causes increased calcium-dependent chloride channel activity, presumably by regulating expression of the corresponding genes. We performed a global gene expression analysis to identify membrane proteins that are regulated by IL-4. Transfection of epithelial cells with specific small interfering RNA against each of these proteins shows that TMEM16A, a member of a family of putative plasma membrane proteins with unknown function, is associated with calcium-dependent chloride current, as measured with halide-sensitive fluorescent proteins, short-circuit current, and patch-clamp techniques. Our results indicate that TMEM16A is an intrinsic constituent of the calcium-dependent chloride channel. Identification of a previously unknown family of membrane proteins associated with chloride channel function will improve our understanding of chloride transport physiopathology and allow for the development of pharmacological tools useful for basic research and drug development.	[Caputo, Antonella; Caci, Emanuela; Ferrera, Loretta; Barsanti, Cristina; Sondo, Elvira; Ravazzolo, Roberto; Zegarra-Moran, Olga; Galietta, Luis J. V.] Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy; [Pedemonte, Nicoletta; Galietta, Luis J. V.] Ctr Biotecnol Avanzate, I-16132 Genoa, Italy; [Pfeffer, Ulrich] Natl Inst Canc Res, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST	Galietta, LJV (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy.	galietta@unige.it	Ferrera, Loretta/AGJ-3063-2022; Pfeffer, Ulrich/J-7064-2016; Sondo, Elvira/K-3789-2018; Ferrera, Loretta/AAA-7641-2020; yang, xiao-jun/B-1927-2009; Galietta, Luis JV/HCG-8692-2022; Pedemonte, Nicoletta/B-3607-2010	Pfeffer, Ulrich/0000-0003-0872-4671; Sondo, Elvira/0000-0003-0971-2082; Ferrera, Loretta/0000-0003-0528-1158; Pedemonte, Nicoletta/0000-0002-5161-1720; Galietta, Luis/0000-0001-8686-3461	Telethon Foundation [GGP05103]; Cystic Fibrosis Foundation Therapeutics; Connitato Interministeriale per la Programmazione Economica-Regione Liguria 2007 (Drug Discovery and Delivery); Italian Cystic Fibrosis Foundation	Telethon Foundation(Fondazione Telethon); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Connitato Interministeriale per la Programmazione Economica-Regione Liguria 2007 (Drug Discovery and Delivery); Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation)	This study was supported by grants from the Telethon Foundation (GGP05103), Cystic Fibrosis Foundation Therapeutics, Connitato Interministeriale per la Programmazione Economica-Regione Liguria 2007 (Drug Discovery and Delivery), and the Italian Cystic Fibrosis Foundation.	Carew MA, 2000, J BIOL CHEM, V275, P26906; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; GALIETTA LJV, 1994, PFLUG ARCH EUR J PHY, V426, P534, DOI 10.1007/BF00378531; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Pedemonte N, 2007, J IMMUNOL, V178, P5144, DOI 10.4049/jimmunol.178.8.5144; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Qu ZQ, 2003, AM J PHYSIOL-RENAL, V285, pF326, DOI 10.1152/ajprenal.00034.2003; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999	17	952	1014	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					590	594		10.1126/science.1163518	http://dx.doi.org/10.1126/science.1163518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18772398				2022-12-24	WOS:000260299100044
J	Johnson, AP; Cleaves, HJ; Dworkin, JP; Glavin, DP; Lazcano, A; Bada, JL				Johnson, Adam P.; Cleaves, H. James; Dworkin, Jason P.; Glavin, Daniel P.; Lazcano, Antonio; Bada, Jeffrey L.			The Miller volcanic spark discharge experiment	SCIENCE			English	Article							AMINO-ACIDS		[Bada, Jeffrey L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Johnson, Adam P.] Indiana Univ, Interdisciplinary Biochem Program, Bloomington, IN 47401 USA; [Cleaves, H. James] Carnegie Inst Washington, Washington, DC 20015 USA; [Dworkin, Jason P.; Glavin, Daniel P.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Indiana University System; Indiana University Bloomington; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universidad Nacional Autonoma de Mexico	Bada, JL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jbada@ucsd.edu	Glavin, Daniel P/D-6194-2012; Dworkin, Jason P./C-9417-2012	Glavin, Daniel P/0000-0001-7779-7765; Dworkin, Jason P./0000-0002-3961-8997; Lazcano, Antonio/0000-0001-7365-8557; Cleaves, Henderson/0000-0003-4101-0654				HILL RD, 1991, ORIGINS LIFE EVOL B, V22, P277; Lazcano A, 2003, ORIGINS LIFE EVOL B, V33, P235, DOI 10.1023/A:1024807125069; Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722; McNutt SR, 2000, J VOLCANOL GEOTH RES, V102, P45, DOI 10.1016/S0377-0273(00)00181-5; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MILLER SL, 1955, J AM CHEM SOC, V77, P2351, DOI 10.1021/ja01614a001; RING D, 1984, ORIGINS LIFE EVOL B, V15, P7, DOI 10.1007/BF01809389; RING D, 1972, P NATL ACAD SCI USA, V69, P765, DOI 10.1073/pnas.69.3.765	8	212	221	6	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					404	404		10.1126/science.1161527	http://dx.doi.org/10.1126/science.1161527			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927386				2022-12-24	WOS:000260094500036
J	Lee, J; Natarajan, M; Nashine, VC; Socolich, M; Vo, T; Russ, WP; Benkovic, SJ; Ranganathan, R				Lee, Jeeyeon; Natarajan, Madhusudan; Nashine, Vishal C.; Socolich, Michael; Vo, Tina; Russ, William P.; Benkovic, Stephen J.; Ranganathan, Rama			Surface sites for engineering allosteric control in proteins	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; PHOTOACTIVE YELLOW PROTEIN; BLUE-LIGHT RECEPTOR; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; ENZYME CATALYSIS; STRUCTURAL BASIS; FUNCTIONAL-ROLE; AVENA-SATIVA; PHOTOTROPIN	Statistical analyses of protein families reveal networks of coevolving amino acids that functionally link distantly positioned functional surfaces. Such linkages suggest a concept for engineering allosteric control into proteins: The intramolecular networks of two proteins could be joined across their surface sites such that the activity of one protein might control the activity of the other. We tested this idea by creating PAS-DHFR, a designed chimeric protein that connects a light-sensing signaling domain from a plant member of the Per/Arnt/Sim (PAS) family of proteins with Escherichia coli dihydrofolate reductase (DHFR). With no optimization, PAS-DHFR exhibited light-dependent catalytic activity that depended on the site of connection and on known signaling mechanisms in both proteins. PAS-DHFR serves as a proof of concept for engineering regulatory activities into proteins through interface design at conserved allosteric sites.	[Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Natarajan, Madhusudan; Socolich, Michael; Vo, Tina; Russ, William P.; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lee, Jeeyeon; Nashine, Vishal C.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu		Socolich, Michael/0000-0002-0702-1061; Natarajan, Madhusudan/0000-0003-1607-2917	Robert A. Welch foundation; Defense Advanced Research Projects Agency; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Ranganathan and Benkovic labs for discussions, M. Rosen and K. H. Gardner for discussions and sharing of unpublished data and materials, and J. Wang for solvent accessibility calculations. Supported by the Robert A. Welch foundation (R.R.) and a grant from the Defense Advanced Research Projects Agency (R.R. and S.J.B.).	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; CHEN JT, 1987, BIOCHEMISTRY-US, V26, P4093, DOI 10.1021/bi00387a053; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Cusanovich MA, 2003, BIOCHEMISTRY-US, V42, P4759, DOI 10.1021/bi020690e; EPSTEIN DM, 1995, BIOCHEMISTRY-US, V34, P11037, DOI 10.1021/bi00035a009; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Rajagopalan PTR, 2002, CHEM REC, V2, P24, DOI 10.1002/tcr.10009; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Saraf MC, 2004, P NATL ACAD SCI USA, V101, P4142, DOI 10.1073/pnas.0400065101; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	34	260	262	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					438	442		10.1126/science.1159052	http://dx.doi.org/10.1126/science.1159052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927392	Green Accepted			2022-12-24	WOS:000260094500046
J	Styer, KL; Singh, V; Macosko, E; Steele, SE; Bargmann, CI; Aballay, A				Styer, Katie L.; Singh, Varsha; Macosko, Evan; Steele, Sarah E.; Bargmann, Cornelia I.; Aballay, Alejandro			Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR	SCIENCE			English	Article							C-ELEGANS; SIGNALING PATHWAY; BACILLUS-THURINGIENSIS; SALMONELLA-TYPHIMURIUM; CHEMOSENSORY NEURONS; INFLAMMATORY REFLEX; LARVAL DEVELOPMENT; GENE FAMILIES; MODEL HOST; BODY-FLUID	A large body of evidence indicates that metazoan innate immunity is regulated by the nervous system, but the mechanisms involved in the process and the biological importance of such control remain unclear. We show that a neural circuit involving npr-1, which encodes a G protein-coupled receptor (GPCR) related to mammalian neuropeptide Y receptors, functions to suppress innate immune responses. The immune inhibitory function requires a guanosine 3',5'-monophosphategated ion channel encoded by tax-2 and tax-4 as well as the soluble guanylate cyclase GCY-35. Furthermore, we show that npr-1- and gcy-35-expressing sensory neurons actively suppress immune responses of nonneuronal tissues. A full-genome microarray analysis on animals with altered neural function due to mutation in npr-1 shows an enrichment in genes that are markers of innate immune responses, including those regulated by a conserved PMK-1/p38 mitogen-activated protein kinase signaling pathway. These results present evidence that neurons directly control innate immunity in C. elegans, suggesting that GPCRs may participate in neural circuits that receive inputs from either pathogens or infected sites and integrate them to coordinate appropriate immune responses.	[Styer, Katie L.; Singh, Varsha; Steele, Sarah E.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10021 USA	Duke University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Macosko, Evan/X-4664-2019	Bargmann, Cornelia/0000-0002-8484-0618; Jeney, Sarah Elizabeth Steele/0000-0001-5222-2981	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [GM070977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (University of Minnesota) for strains used in this study. A.A. is funded by the Whitehead Scholars Program, the NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense (grant U54 AI057157), and NIH grant GM070977. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Andersson J, 2005, J INTERN MED, V257, P122, DOI 10.1111/j.1365-2796.2004.01440.x; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Laws TR, 2006, MICROB PATHOGENESIS, V40, P293, DOI 10.1016/j.micpath.2006.03.001; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sattelle David B., 2006, Invertebrate Neuroscience, V6, P1, DOI 10.1007/s10158-005-0014-7; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	47	157	219	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					460	464		10.1126/science.1163673	http://dx.doi.org/10.1126/science.1163673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801967	Green Accepted			2022-12-24	WOS:000260094500052
J	Deng, XZ; Yin, XL; Allan, R; Lu, DD; Maurer, CW; Haimovitz-Friedman, A; Fuks, Z; Shaham, S; Kolesnick, R				Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Maurer, Carine W.; Haimovitz-Friedman, Adriana; Fuks, Zvi; Shaham, Shai; Kolesnick, Richard			Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C-elegans	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DNA-DAMAGE CHECKPOINT; CAENORHABDITIS-ELEGANS; EGL-1; MEMBRANE; CED-4; COMPLEX	Ceramide engagement in apoptotic pathways has been a topic of controversy. To address this controversy, we tested loss- of- function (lf) mutants of conserved genes of sphingolipid metabolism in Caenorhabditis elegans. Although somatic ( developmental) apoptosis was unaffected, ionizing radiation- induced apoptosis of germ cells was obliterated upon inactivation of ceramide synthase and restored upon microinjection of long- chain natural ceramide. Radiation- induced increase in the concentration of ceramide localized to mitochondria and was required for BH3- domain protein EGL-1-mediated displacement of CED-4 ( an APAF-1-like protein) from the CED-9 ( a Bcl-2 family member)/CED- 4 complex, an obligate step in activation of the CED-3 caspase. These studies define CEP-1 ( the worm homolog of the tumor suppressor p53)-mediated accumulation of EGL- 1 and ceramide synthase-mediated generation of ceramide through parallel pathways that integrate at mitochondrial membranes to regulate stress-induced apoptosis.	[Deng, Xinzhu; Yin, Xianglei; Allan, Richard; Lu, Diane D.; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Maurer, Carine W.; Shaham, Shai] Rockefeller Univ, Lab Dev Genet, New York, NY 10021 USA; [Haimovitz-Friedman, Adriana; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org		Maurer, Carine/0000-0002-7892-7127	 [CA85704];  [CA105125-03];  [2R01HD42680-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042680] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA105125, R01CA085704] Funding Source: NIH RePORTER	; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Caenorhabitis Genetics Center and National BioResource Project-Japan for the strains provided; H. R. Horwitz for the anti-CED-4 antibody; Y. Gruenbaum for the anti-Ce-lamin-antibody; M.O. Hengartner for the strain opls219; and S. Davidor, D. Chau, H. Lee, J. Mesicek, and the Molecular Cytology and Genomics Core Laboratory of MSKCC for the technical assistance. This work was supported by grants CA85704 (R.K.), CA105125-03 (A.H.-F.), and 2R01HD42680-06 (S.S.).	Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; del Peso L, 2000, J BIOL CHEM, V275, P27205; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; DUERR JS, 2007, WORM BOOK; Fairlie WD, 2006, CELL DEATH DIFFER, V13, P426, DOI 10.1038/sj.cdd.4401762; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; RIEZMAN H, COMMUNICATION; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030	21	136	161	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					110	115		10.1126/science.1158111	http://dx.doi.org/10.1126/science.1158111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832646	Green Accepted			2022-12-24	WOS:000259680200049
J	Ebersbach, G; Briegel, A; Jensen, GJ; Jacobs-Wagner, C				Ebersbach, Gitte; Briegel, Ariane; Jensen, Grant J.; Jacobs-Wagner, Christine			A self-associating protein critical for chromosome attachment, division, and polar organization in Caulobacter	CELL			English	Article							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIAL-CELL; DNA-REPLICATION; ROD-SHAPE; SEGREGATION; CRESCENTUS; LOCALIZATION; DIVIVA	Cell polarization is an integral part of many unrelated bacterial processes. How intrinsic cell polarization is achieved is poorly understood. Here, we provide evidence that Caulobacter crescentus uses a multimeric pole-organizing factor (PopZ) that serves as a hub to concurrently achieve several polarizing functions. During chromosome segregation, polar PopZ captures the ParB.ori complex and thereby anchors sister chromosomes at opposite poles. This step is essential for stabilizing bipolar gradients of a cell division inhibitor and setting up division near midcell. PopZ also affects polar stalk morphogenesis and mediates the polar localization of the morphogenetic and cell cycle signaling proteins CckA and DivJ. Polar accumulation of PopZ, which is central to its polarizing activity, can be achieved independently of division and does not appear to be dictated by the pole curvature. Instead, evidence suggests that localization of PopZ largely relies on PopZ multimerization in chromosome-free regions, consistent with a self-organizing mechanism.	[Ebersbach, Gitte; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jacobs-Wagner, Christine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; California Institute of Technology; Howard Hughes Medical Institute	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Briegel, Ariane/AAC-1085-2021	Briegel, Ariane/0000-0003-3733-3725; Jacobs-Wagner, Christine/0000-0003-0980-5334	Villum Kann Rasmussen Foundation; Danish Natural Science Research Council; National Institutes of Health [GM065835, AI067548]; Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Villum Kann Rasmussen Foundation(Villum Fonden); Danish Natural Science Research Council(Danish Natural Science Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Mooseker, E. Dufresne, T. Emonet, and J. Wolenski for valuable discussions; K. Gerdes, J. Gober, A. Newton, N. Ohta, L. Shapiro, M. Thanbichler, and P. Viollier for supplying strains or antibody; P. Angelastro, A. Jackson, H. Lam, and W. Schofield for construction of strains; H. J. Ding and D. Rosenman for computational help; M. Mooseker, Z. Jiang, and G. Charbon for assistance with EM; E. Folta-Stogniew and the Keck Foundation Biotechnology Resource Laboratory at Yale for the biophysical analyses, and the Jacobs-Wagner laboratory and T. Emonet for critical reading of the manuscript. G. E. was supported by postdoctoral fellowships from the Villum Kann Rasmussen Foundation and the Danish Natural Science Research Council. This work was funded in part by National Institutes of Health (GM065835 to C.J.-W. and AI067548 to G. J. J.), gifts to Caltech from the Gordon and Betty Moore Foundation and Agouron Institute (to G. J. J.) and the Pew Scholars Program in the Biological Sciences sponsored by the Pew Charitable trust (to C.J.-W.). C.J.-W. is a Howard Hughes Medical Institute investigator.	Bardy SL, 2007, CURR OPIN MICROBIOL, V10, P617, DOI 10.1016/j.mib.2007.10.006; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Dai MH, 2005, METAB ENG, V7, P45, DOI 10.1016/j.ymben.2004.09.002; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Folta-Stogniew Ewa, 2006, V328, P97; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Harry EJ, 2003, MOL MICROBIOL, V47, P37, DOI 10.1046/j.1365-2958.2003.03253.x; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Lawler ML, 2007, CURR OPIN MICROBIOL, V10, P630, DOI 10.1016/j.mib.2007.09.007; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; SOMMER JM, 1991, GENETICS, V129, P623; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	42	213	213	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					956	968		10.1016/j.cell.2008.07.016	http://dx.doi.org/10.1016/j.cell.2008.07.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805089	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000259318100016
J	Drogemuller, C; Karlsson, EK; Hytonen, MK; Perloski, M; Dolf, G; Sainio, K; Lohi, H; Lindblad-Toh, K; Leeb, T				Droegemueller, Cord; Karlsson, Elinor K.; Hytonen, Marjo K.; Perloski, Michele; Dolf, Gaudenz; Sainio, Kirsi; Lohi, Hannes; Lindblad-Toh, Kerstin; Leeb, Tosso			A mutation in hairless dogs implicates FOXI3 in ectodermal development	SCIENCE			English	Article									[Droegemueller, Cord; Dolf, Gaudenz; Leeb, Tosso] Univ Bern, CH-3001 Bern, Switzerland; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02142 USA; [Hytonen, Marjo K.; Sainio, Kirsi] Inst Biomed, Helsinki 00014, Finland; [Hytonen, Marjo K.; Lohi, Hannes] Univ Helsinki, FIN-00014 Helsinki, Finland; [Lindblad-Toh, Kerstin] Uppsala Univ, S-75124 Uppsala, Sweden	University of Bern; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Uppsala University	Leeb, T (corresponding author), Univ Bern, CH-3001 Bern, Switzerland.	Tosso.Leeb@itz.unibe.ch	Lohi, Hannes/F-4596-2011; Leeb, Tosso/G-3187-2014	Lohi, Hannes/0000-0003-1087-5532; Leeb, Tosso/0000-0003-0553-4880; Hytonen, Marjo/0000-0003-1976-5874; Drogemuller, Cord/0000-0001-9773-522X; Karlsson, Elinor/0000-0002-4343-3776	UniBern Research Foundation; Academy of Finland; Sigrid Juselius Foundation.	UniBern Research Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation.(Sigrid Juselius Foundation)	Supported by the UniBern Research Foundation, the Academy of Finland, and the Sigrid Juselius Foundation.	Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kimura T, 1996, EXP ANIM TOKYO, V45, P1, DOI 10.1538/expanim.45.1; O'Brien DP, 2005, J HERED, V96, P727, DOI 10.1093/jhered/esi086; Ohyama T, 2004, DEV DYNAM, V231, P640, DOI 10.1002/dvdy.20160; ROBINSON R, 1985, J HERED, V76, P217, DOI 10.1093/oxfordjournals.jhered.a110074; VONLINNE C, 1958, SYSTEMA NATURAE, P39	6	118	121	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1462	1462		10.1126/science.1162525	http://dx.doi.org/10.1126/science.1162525			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787161				2022-12-24	WOS:000259121800031
J	Green, JL; Inoue, T; Sternberg, PW				Green, Jennifer L.; Inoue, Takao; Sternberg, Paul W.			Opposing wnt pathways orient cell polarity during organogenesis	CELL			English	Article							ELEGANS VULVAL DEVELOPMENT; RECEPTOR TYROSINE KINASE; CAENORHABDITIS-ELEGANS; C-ELEGANS; BETA-CATENIN; RECIPROCAL ASYMMETRY; SIGNALING PATHWAY; DIVISIONS; TRANSCRIPTION; PROTEIN	The orientation of asymmetric cell division contributes to the organization of cells within a tissue or organ. For example, mirror-image symmetry of the C. elegans vulva is achieved by the opposite division orientation of the vulval precursor cells (VPCs) flanking the axis of symmetry. We characterized the molecular mechanisms contributing to this division pattern. Wnts MOM-2 and LIN-44 are expressed at the axis of symmetry and orient the VPCs toward the center. These Wnts act via Fz/LIN-17 and Ryk/LIN-18, which control beta-catenin localization and activate gene transcription. In addition, VPCs on both sides of the axis of symmetry possess a uniform underlying "ground'' polarity, established by the instructive activity of Wnt/EGL-20. EGL-20 establishes ground polarity via a novel type of signaling involving the Ror receptor tyrosine kinase CAM-1 and the planar cell polarity component Van Gogh/VANG-1. Thus, tissue polarity is determined by the integration of multiple Wnt pathways.	[Green, Jennifer L.; Inoue, Takao; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Mail Code 156-29, Pasadena, CA 91125 USA.	pws@caltech.edu		Sternberg, Paul/0000-0002-7699-0173	National Institutes of Health, National Center for Research Resources; Howard Hughes Medical Institute; California Institute of Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023690] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Gladys Medina, Barbara Perry, and Shahla Gharib for technical assistance, members of our lab for helpful discussions, Andrea Choe for artistic input, and Marianne Bronner-Fraser, Scott Fraser, Cheryl Van Buskirk, Mihoko Kato, Elissa Hallem, and Adeline Seah for critically reading the manuscript. Many strains used in this study were provided by the Caenorhabditis Genetics Center, funded by the National Institutes of Health, National Center for Research Resources. Weare grateful to the late Peter Snow for his valuable assistance in making our CAM-1 antibody. P. W. S. is an investigator with the Howard Hughes Medical Institute, who supported this work, and J. L. G. was supported by the Moore Foundation Fellowship for graduate study toward the Doctor of Philosophy degree in Biology at the California Institute of Technology.	Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BRENNER S, 1974, GENETICS, V77, P71; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Huang SY, 2007, DEVELOPMENT, V134, P2685, DOI 10.1242/dev.008268; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Park FD, 2004, CURR BIOL, V14, P2252, DOI 10.1016/j.cub.2004.12.019; Phillips BT, 2007, P NATL ACAD SCI USA, V104, P3231, DOI 10.1073/pnas.0611507104; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sherwood DR, 2005, CELL, V121, P951, DOI 10.1016/j.cell.2005.03.031; Shetty P, 2005, DEV BIOL, V285, P584, DOI 10.1016/j.ydbio.2005.07.008; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Sternberg PW., 2005, C ELEGANS RES COMMUN; Strutt D, 2005, CURR BIOL, V15, pR758, DOI 10.1016/j.cub.2005.08.053; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	46	129	148	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					646	656		10.1016/j.cell.2008.06.026	http://dx.doi.org/10.1016/j.cell.2008.06.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724937	Bronze, Green Accepted			2022-12-24	WOS:000258665800017
J	De Smet, I; Vassileva, V; De Rybel, B; Levesque, MP; Grunewald, W; Van Damme, D; Van Noorden, G; Naudts, M; Van Isterdael, G; De Clercq, R; Wang, JY; Meuli, N; Vanneste, S; Friml, J; Hilson, P; Jurgens, G; Ingram, GC; Inze, D; Benfey, PN; Beeckman, T				De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Levesque, Mitchell P.; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Wang, Jean Y.; Meuli, Nicholas; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Juergens, Gerd; Ingram, Gwyneth C.; Inze, Dirk; Benfey, Philip N.; Beeckman, Tom			Receptor-like kinase ACR4 restricts formative cell divisions in the Arabidopsis root	SCIENCE			English	Article							GENE; DIFFERENTIATION; INITIATION; EPIDERMIS; THALIANA; MERISTEM	During the development of multicellular organisms, organogenesis and pattern formation depend on formative divisions to specify and maintain pools of stem cells. In higher plants, these activities are essential to shape the final root architecture because the functioning of root apical meristems and the de novo formation of lateral roots entirely rely on it. We used transcript profiling on sorted pericycle cells undergoing lateral root initiation to identify the receptor-like kinase ACR4 of Arabidopsis as a key factor both in promoting formative cell divisions in the pericycle and in constraining the number of these divisions once organogenesis has been started. In the root tip meristem, ACR4 shows a similar action by controlling cell proliferation activity in the columella cell lineage. Thus, ACR4 function reveals a common mechanism of formative cell division control in the main root tip meristem and during lateral root initiation.	[De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [De Smet, Ive; Vassileva, Valya; De Rybel, Bert; Grunewald, Wim; Van Damme, Daniel; Van Noorden, Giel; Naudts, Mirande; Van Isterdael, Gert; De Clercq, Rebecca; Vanneste, Steffen; Friml, Jiri; Hilson, Pierre; Inze, Dirk; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Levesque, Mitchell P.; Wang, Jean Y.; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [De Smet, Ive; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol ZMBP, D-72076 Tubingen, Germany; [Meuli, Nicholas; Ingram, Gwyneth C.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Duke University; Duke University; Eberhard Karls University of Tubingen; University of Edinburgh	Beeckman, T (corresponding author), Univ Ghent VIB, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	tom.beeckman@psb.ugent.be	De Smet, Ive/E-6086-2011; van damme, daniel/ABA-1397-2020; Friml, Jiri/D-9511-2012; Beeckman, Tom/ABI-1703-2020; Inzé, Dirk/AAW-6381-2021; Grunewald, Wim/C-6521-2008; Vanneste, Steffen/K-8353-2013; van damme, daniel/F-6139-2014; De Smet, Ive/A-6583-2011; Beeckman, Tom/ABA-1164-2020	De Smet, Ive/0000-0003-4607-8893; van damme, daniel/0000-0002-9385-4851; Friml, Jiri/0000-0002-8302-7596; Beeckman, Tom/0000-0001-8656-2060; Inzé, Dirk/0000-0002-3217-8407; Vanneste, Steffen/0000-0002-9948-9672; van damme, daniel/0000-0002-9385-4851; De Smet, Ive/0000-0003-4607-8893; De Rybel, Bert/0000-0002-9551-042X; Van Isterdael, Gert/0000-0001-6626-1316; Vassileva, Valya/0000-0002-9055-8002; Ingram, Gwyneth/0000-0002-1425-9545	Interuniversity Poles of Attraction Prograin-Belgian Science Policy [P5/13]; U.S. National Science Foundation Arabidopsis 2010 program; non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization [ALTF 108-2006, ALTF 142-2007]; Institute for the Promotion of innovation by Science and Technology in Flanders; Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders	Interuniversity Poles of Attraction Prograin-Belgian Science Policy; U.S. National Science Foundation Arabidopsis 2010 program(National Science Foundation (NSF)); non-European Union researchers from the Belgian Science Policy; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Institute for the Promotion of innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Bijzonder Onderzoeksfonds van de Universitert Gent; Gatsby Charitable Foundation; Research Foundation of Flanders(FWO)	We thank B. Scheres, K. Theres, P. Springer, H. Fukaki, and Nottingharn Arabidopsis Stock Centre for providing seeds. This work was funded by grants from the Interuniversity Poles of Attraction Prograin-Belgian Science Policy (P5/13); grants from the U.S. National Science Foundation Arabidopsis 2010 program to P.N.B.; a fellowship for non-European Union researchers from the Belgian Science Policy (BELSPO) to V.V.; long-term fellowships from the European Molecular Biology Organization ALTF 108-2006 to I.D.S. and ALTF 142-2007 to S.V.; predoctoral fellowships from the Institute for the Promotion of innovation by Science and Technology in Flanders to I.D.S. and S.V., from the Bijzonder Onderzoeksfonds van de Universitert Gent to B.D.R., and from the Gatsby Charitable Foundation to N.M.; a travel grant of the Research Foundation of Flanders to I.D.S.; and a postdoctoral fellowship of the Research Foundation of Flanders to D.V.D. We are. grateful to R. Gross-Hardt, U. Voss, S. Lau, and two anonymous referees for critical comments and suggestions on the manuscript.	Becraft PW, 2001, PLANT PHYSIOL, V127, P486, DOI 10.1104/pp.010299; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dinneny JR, 2008, CELL, V132, P553, DOI 10.1016/j.cell.2008.02.001; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Heidstra Renze, 2007, V45, P1; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; WOLPERT L, 1988, J CELL SCI, P1	21	267	272	6	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					594	597		10.1126/science.1160158	http://dx.doi.org/10.1126/science.1160158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948541				2022-12-24	WOS:000260299100045
J	Schipper, J; Chanson, JS; Chiozza, F; Cox, NA; Hoffmann, M; Katariya, V; Lamoreux, J; Rodrigues, ASL; Stuart, SN; Temple, HJ; Baillie, J; Boitani, L; Lacher, TE; Mittermeier, RA; Smith, AT; Absolon, D; Aguiar, JM; Amori, G; Bakkour, N; Baldi, R; Berridge, RJ; Bielby, J; Black, PA; Blanc, JJ; Brooks, TM; Burton, JA; Butynski, TM; Catullo, G; Chapman, R; Cokeliss, Z; Collen, B; Conroy, J; Cooke, JG; da Fonseca, GAB; Derocher, AE; Dublin, HT; Duckworth, JW; Emmons, L; Emslie, RH; Festa-Bianchet, M; Foster, M; Foster, S; Garshelis, DL; Gates, C; Gimenez-Dixon, M; Gonzalez, S; Gonzalez-Maya, JF; Good, TC; Hammerson, G; Hammond, PS; Happold, D; Happold, M; Hare, J; Harris, RB; Hawkins, CE; Haywood, M; Heaney, LR; Hedges, S; Helgen, KM; Hilton-Taylor, C; Hussain, SA; Ishii, N; Jefferson, TA; Jenkins, RKB; Johnston, CH; Keith, M; Kingdon, J; Knox, DH; Kovacs, KM; Langhammer, P; Leus, K; Lewison, R; Lichtenstein, G; Lowry, LF; Macavoy, Z; Mace, GM; Mallon, DP; Masi, M; McKnight, MW; Medellin, RA; Medici, P; Mills, G; Moehlman, PD; Molur, S; Mora, A; Nowell, K; Oates, JF; Olech, W; Oliver, WRL; Oprea, M; Patterson, BD; Perrin, WF; Polidoro, BA; Pollock, C; Powel, A; Protas, Y; Racey, P; Ragle, J; Ramani, P; Rathbun, G; Reeves, RR; Reilly, SB; Reynolds, JE; Rondinini, C; Rosell-Ambal, RG; Rulli, M; Rylands, AB; Savini, S; Schank, CJ; Sechrest, W; Self-Sullivan, C; Shoemaker, A; Sillero-Zubiri, C; De Silva, N; Smith, DE; Srinivasulu, C; Stephenson, PJ; van Strien, N; Talukdar, BK; Taylor, BL; Timmins, R; Tirira, DG; Tognelli, MF; Tsytsulina, K; Veiga, LM; Vie, JC; Williamson, EA; Wyatt, SA; Xie, Y; Young, BE				Schipper, Jan; Chanson, Janice S.; Chiozza, Federica; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Rodrigues, Ana S. L.; Stuart, Simon N.; Temple, Helen J.; Baillie, Jonathan; Boitani, Luigi; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Smith, Andrew T.; Absolon, Daniel; Aguiar, John M.; Amori, Giovanni; Bakkour, Noura; Baldi, Ricardo; Berridge, Richard J.; Bielby, Jon; Black, Patricia Ann; Blanc, J. Julian; Brooks, Thomas M.; Burton, James A.; Butynski, Thomas M.; Catullo, Gianluca; Chapman, Roselle; Cokeliss, Zoe; Collen, Ben; Conroy, Jim; Cooke, Justin G.; da Fonseca, Gustavo A. B.; Derocher, Andrew E.; Dublin, Holly T.; Duckworth, J. W.; Emmons, Louise; Emslie, Richard H.; Festa-Bianchet, Marco; Foster, Matt; Foster, Sabrina; Garshelis, David L.; Gates, Cormack; Gimenez-Dixon, Mariano; Gonzalez, Susana; Gonzalez-Maya, Jose Fernando; Good, Tatjana C.; Hammerson, Geoffrey; Hammond, Philip S.; Happold, David; Happold, Meredith; Hare, John; Harris, Richard B.; Hawkins, Clare E.; Haywood, Mandy; Heaney, Lawrence R.; Hedges, Simon; Helgen, Kristofer M.; Hilton-Taylor, Craig; Hussain, Syed Ainul; Ishii, Nobuo; Jefferson, Thomas A.; Jenkins, Richard K. B.; Johnston, Charlotte H.; Keith, Mark; Kingdon, Jonathan; Knox, David H.; Kovacs, Kit M.; Langhammer, Penny; Leus, Kristin; Lewison, Rebecca; Lichtenstein, Gabriela; Lowry, Lloyd F.; Macavoy, Zoe; Mace, Georgina M.; Mallon, David P.; Masi, Monica; McKnight, Meghan W.; Medellin, Rodrigo A.; Medici, Patricia; Mills, Gus; Moehlman, Patricia D.; Molur, Sanjay; Mora, Arturo; Nowell, Kristin; Oates, John F.; Olech, Wanda; Oliver, William R. L.; Oprea, Monik; Patterson, Bruce D.; Perrin, William F.; Polidoro, Beth A.; Pollock, Caroline; Powel, Abigail; Protas, Yelizaveta; Racey, Paul; Ragle, Jim; Ramani, Pavithra; Rathbun, Galen; Reeves, Randall R.; Reilly, Stephen B.; Reynolds, John E., III; Rondinini, Carlo; Rosell-Ambal, Ruth Grace; Rulli, Monica; Rylands, Anthony B.; Savini, Simona; Schank, Cody J.; Sechrest, Wes; Self-Sullivan, Caryn; Shoemaker, Alan; Sillero-Zubiri, Claudio; De Silva, Naamal; Smith, David E.; Srinivasulu, Chelmala; Stephenson, Peter J.; van Strien, Nico; Talukdar, Bibhab Kumar; Taylor, Barbara L.; Timmins, Rob; Tirira, Diego G.; Tognelli, Marcelo F.; Tsytsulina, Katerina; Veiga, Liza M.; Vie, Jean-Christophe; Williamson, Elizabeth A.; Wyatt, Sarah A.; Xie, Yan; Young, Bruce E.			The status of the world's land and marine mammals: Diversity, threat, and knowledge	SCIENCE			English	Article							GLOBAL DISTRIBUTION; EXTINCTION RISK; RANGE SIZE; RED LIST; CONSERVATION; PATTERNS	Knowledge of mammalian diversity is still surprisingly disparate, both regionally and taxonomically. Here, we present a comprehensive assessment of the conservation status and distribution of the world's mammals. Data, compiled by 1700+ experts, cover all 5487 species, including marine mammals. Global macroecological patterns are very different for land and marine species but suggest common mechanisms driving diversity and endemism across systems. Compared with land species, threat levels are higher among marine mammals, driven by different processes (accidental mortality and pollution, rather than habitat loss), and are spatially distinct (peaking in northern oceans, rather than in Southeast Asia). Marine mammals are also disproportionately poorly known. These data are made freely available to support further scientific developments and conservation action.	[Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Katariya, Vineet; Lamoreux, John; Stuart, Simon N.; Polidoro, Beth A.; Ragle, Jim] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Schipper, Jan; Chanson, Janice S.; Cox, Neil A.; Hoffmann, Michael; Stuart, Simon N.; Lacher, Thomas E., Jr.; Mittermeier, Russell A.; Aguiar, John M.; Bakkour, Noura; Brooks, Thomas M.; Foster, Matt; Rylands, Anthony B.; De Silva, Naamal; Wyatt, Sarah A.] Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA 22202 USA; [Chiozza, Federica; Boitani, Luigi; Rondinini, Carlo] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Lamoreux, John; Lacher, Thomas E., Jr.; Aguiar, John M.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Rodrigues, Ana S. L.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Temple, Helen J.; Hilton-Taylor, Craig; Pollock, Caroline] IUCN, Species Programme, Cambridge CB3 0DL, England; [Baillie, Jonathan; Bielby, Jon; Cokeliss, Zoe; Collen, Ben] Zool Soc London, Inst Zool, London NW1 4RY, England; [Smith, Andrew T.; Johnston, Charlotte H.; Langhammer, Penny] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00161 Rome, Italy; [Bakkour, Noura] Columbia Univ, Sch Int & Publ Affairs, Dept Environm Sci & Policy, New York, NY 10027 USA; [Baldi, Ricardo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagonico, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Berridge, Richard J.] Mantella Conservat Org, London SE16 7TS, England; [Bielby, Jon; Macavoy, Zoe; Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Black, Patricia Ann] Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Black, Patricia Ann] Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Blanc, J. Julian] MIKE, CITES, Nairobi 00100, Kenya; [Brooks, Thomas M.] Univ Philippines, World Agroforestry Ctr ICRAF, Los Banos 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Hobart, Tas 7001, Australia; [Burton, James A.] Earthwatch Inst Europe, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Butynski, Thomas M.] Eastern Africa Primate Divers & Conservat Program, Nanyuki 10400, Kenya; [Butynski, Thomas M.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Catullo, Gianluca; Masi, Monica; Rulli, Monica; Savini, Simona] Ist Ecol Applicata, I-00162 Rome, Italy; [Conroy, Jim] Celt Environm Ltd, Banchory AB31 4JG, Kincardine, Scotland; [Cooke, Justin G.] Ctr Ecosyst Management Studies, D-79297 Winden, Germany; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dublin, Holly T.] Ctr Biodivers Conservat, S African Natl Biodivers Inst, IUCN Species Survival Commiss, ZA-7735 Cape Town, South Africa; [Duckworth, J. W.] Wildlife Conservat Soc, Asia Programs, Bronx, NY 10460 USA; [Emmons, Louise; Helgen, Kristofer M.; Oprea, Monik] Smithsonian Inst, Dept Vertebrate Zool, Div Mammals, Washington, DC 20013 USA; [Emslie, Richard H.] African Rhino Specialist Grp, IUCN SSC Species Survival Commiss, ZA-3245 Hilton, South Africa; [Festa-Bianchet, Marco] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Foster, Sabrina; Ramani, Pavithra; Schank, Cody J.; Sechrest, Wes; Smith, David E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gates, Cormack] Univ Calgary, Dept Environm Sci, Calgary, AB T2N 1N4, Canada; [Gonzalez, Susana] IIBCE, Fac Ciencias, Montevideo 11600, Uruguay; [Gonzalez-Maya, Jose Fernando] ProCAT Int, Las Alturas, Coto Brus, Costa Rica; [Good, Tatjana C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hammerson, Geoffrey; Young, Bruce E.] NatureServ, Arlington, VA 22209 USA; [Hammond, Philip S.] Univ St Andrews, Sea Mammal Res Unit, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland; [Happold, David; Happold, Meredith] Australian Natl Univ, Canberra, ACT 0200, Australia; [Hare, John] Wild Camel Protect Fdn, Sch Farm, Benenden TN17 4EU, Kent, England; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Hawkins, Clare E.] Dept Primary Ind & Water, Threatened Species Sect, Hobart, Tas 7001, Australia; [Hawkins, Clare E.] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Haywood, Mandy] Univ Otago, Ctr Sci Commun, Dunedin 9054, New Zealand; [Heaney, Lawrence R.; Patterson, Bruce D.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Suginami Ku, Tokyo 1678585, Japan; [Jefferson, Thomas A.; Perrin, William F.; Reilly, Stephen B.; Taylor, Barbara L.] Natl Ocean & Atmospher Adm Fisheries, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Jenkins, Richard K. B.; Racey, Paul] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo, Madagascar; [Keith, Mark] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; [Kingdon, Jonathan] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Knox, David H.] Conservat Int, ZA-7735 Claremont, South Africa; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kovacs, Kit M.] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Leus, Kristin] Copenhagen Zoo & Conservat Breeding Specialist Gr, Reg Off Europe, B-2170 Merksem, Belgium; [Lewison, Rebecca] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1378 Buenos Aires, DF, Argentina; [Lowry, Lloyd F.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Sci, Manchester M1 5GD, Lancs, England; [Medellin, Rodrigo A.] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Medici, Patricia] Inst Pesquisas Ecol, Inst Ecol Res, Lowland Tapir Conservat Initiat, BR-12960000 Sao Paulo, Brazil; [Medici, Patricia] Univ Kent, DICE, Canterbury CT2 7NZ, Kent, England; [Mills, Gus] Tony & Lisette Lewis Fdn, ZA-2196 Sandton, South Africa; [Moehlman, Patricia D.] Wildlife Trust Alliance, Beijing 100011, Peoples R China; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Molur, Sanjay] Wildlife Informat & Liaison Dev Soc, Coimbatore 641004, Tamil Nadu, India; [Mora, Arturo] IUCN S Amer Reg Off, Species Unit, Quito, Pichincha, Ecuador; [Nowell, Kristin] Cat Act Treasury, Cape Neddick 03902, ME USA; [Oates, John F.] CUNY, CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02787 Warsaw, Poland; [Oliver, William R. L.] Fauna & Flora Int, Philippine Biodivers Conservat Programme, Manila 1004, Philippines; [Powel, Abigail] Victoria Univ Wellington, Wellington 6140, New Zealand; [Protas, Yelizaveta] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Rathbun, Galen] Calif Acad Sci, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reeves, Randall R.] Okapi Wildlife Assoc, Quebec City, PQ J0P 1H0, Canada; [Reynolds, John E., III] Mote Marine Lab, Sarasota, FL 34236 USA; [Rosell-Ambal, Ruth Grace] CI Philippines, Quezon City 1101, Philippines; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Shoemaker, Alan] IUCN Tapir Specialist Grp, Columbia, SC 29210 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Tubney OX13 5QL, England; [Srinivasulu, Chelmala] Osmania Univ, Dept Zool, Univ Coll Sci, Hyderabad 500007, Andhra Pradesh, India; [Stephenson, Peter J.] WWF Int, CH-1196 Gland, Switzerland; [van Strien, Nico] White Oak Conservat Ctr, Int Rhino Fdn, Yulee, FL 32097 USA; [Talukdar, Bibhab Kumar] Aaranyak, Guwhati 781028, Assam, India; [Tirira, Diego G.] Fdn Mamiferos & Conservac, Quito, Ecuador; [Tognelli, Marcelo F.] Ctr Sci & Technol Mendoza, CONICET, IADIZA Argentinean Arid Res Inst, RA-5500 Mendoza, Argentina; [Tognelli, Marcelo F.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Tsytsulina, Katerina] Russian Bat Res Grp, St Petersburg 195196, Russia; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, Dept Zool, Belem, Para, Brazil; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Yan] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Conservation International; Sapienza University Rome; Texas A&M University System; Texas A&M University College Station; University of Cambridge; Zoological Society of London; Arizona State University; Arizona State University-Tempe	Schipper, J (corresponding author), IUCN, Species Programme, 28 Rue Mauverney, CH-1196 Gland, Switzerland.	jan.schipper@iucn.org	Keith, Mark/G-7234-2011; Stephenson, PJ/AAC-3081-2021; Keith, Mark/A-2458-2015; Helgen, Kristofer M./AAB-8348-2019; Rodrigues, Ana/GYQ-6273-2022; González, Susana/AAC-7053-2021; Williamson, Elizabeth/B-9090-2011; Tirira, Diego G./E-3617-2018; Bielby, Jon/D-5051-2011; Veiga, Liza/C-6667-2009; Hoffmann, Michael/E-6419-2010; González-Maya, José F./B-6913-2011; Collen, Ben/D-5055-2011; Oprea, Monik/E-6204-2010; Olech, Wanda/AAB-5072-2022; Gonzalez, Susana A/F-1300-2017; Patterson, Bruce D/O-5068-2019; Jenkins, Richard KB/A-4567-2012; Keith, Mark/Q-1527-2018; Mace, Georgina M/I-3072-2016; Schipper, Jan/N-5266-2015; Srinivasulu, Chelmala/AAU-2204-2020; Williamson, Elizabeth/E-4727-2016; Williamson, Elizabeth/N-8958-2019; Derocher, Andrew/J-4469-2012; Collen, Ben/F-2543-2016; Self-Sullivan, Caryn/H-2605-2012; Rondinini, Carlo/E-9027-2011; Rodrigues, Ana S.L./A-5914-2009; Tognelli, Marcelo/L-3958-2019	Keith, Mark/0000-0001-6690-2718; Helgen, Kristofer M./0000-0002-8776-4040; González, Susana/0000-0001-6470-6182; Tirira, Diego G./0000-0002-5344-6175; Hoffmann, Michael/0000-0003-4785-2254; González-Maya, José F./0000-0002-8942-5157; Olech, Wanda/0000-0002-6166-3954; Patterson, Bruce D/0000-0002-2249-7260; Keith, Mark/0000-0001-7179-9989; Mace, Georgina M/0000-0001-8965-5211; Schipper, Jan/0000-0002-8338-7874; Srinivasulu, Chelmala/0000-0003-4331-8580; Williamson, Elizabeth/0000-0001-6848-9154; Williamson, Elizabeth/0000-0001-6848-9154; Derocher, Andrew/0000-0002-1104-7774; Collen, Ben/0000-0003-2564-4243; Self-Sullivan, Caryn/0000-0003-0785-3682; Rodrigues, Ana S.L./0000-0003-4775-0127; Tognelli, Marcelo/0000-0002-9761-4505; Blanc, Julian/0000-0003-4331-5339; Ragle, James/0000-0002-5829-3745; Brooks, Thomas/0000-0001-8159-3116; Festa-Bianchet, Marco/0000-0002-2352-3379; Molur, Sanjay/0000-0001-8230-518X; Bielby, Jon/0000-0003-4586-0429; Hammond, Philip/0000-0002-2381-8302; STEPHENSON, PJ/0000-0002-0087-466X; Rondinini, Carlo/0000-0002-6617-018X; Haywood, Mandy/0000-0002-5012-6926; Hawkins, Clare/0000-0002-1909-2545	Natural Environment Research Council [smru10001, cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; BRYANT PJ, 1995, J MAMMAL, V76, P857, DOI 10.2307/1382754; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; ENTWISTLE AC, 2000, PRIORITIES CONSERVAT, P119; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins BA, 2006, GLOBAL ECOL BIOGEOGR, V15, P461, DOI 10.1111/j.1466-822x.2006.00243.x; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hoffmann M, 2008, NATURE, V454, P159, DOI 10.1038/454159a; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; *IUCN, 1996, 1996 IUCN RED LIST T; MCLEOD B, 2008, ARCTIC, P1; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; REEVES RR, 1978, ATLANTIC WALRUS ODOB; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; SECHREST WW, 2003, THESIS U VIRGINIA CH; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stora J, 2004, MAR MAMMAL SCI, V20, P115, DOI 10.1111/j.1748-7692.2004.tb01143.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105; Turvey ST, 2007, BIOL LETTERS, V3, P193, DOI 10.1098/rsbl.2006.0585; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292	34	999	1052	17	639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					225	230		10.1126/science.1165115	http://dx.doi.org/10.1126/science.1165115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845749	Green Accepted			2022-12-24	WOS:000259902300039
J	Gelbard-Sagiv, H; Mukamel, R; Harel, M; Malach, R; Fried, I				Gelbard-Sagiv, Hagar; Mukamel, Roy; Harel, Michal; Malach, Rafael; Fried, Itzhak			Internally generated reactivation of single neurons in human hippocampus during free recall	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; COGNITIVE NEUROSCIENCE; RECOGNITION MEMORY; RAT HIPPOCAMPUS; HUMAN BRAIN; SEQUENCES; RETRIEVAL; AMYGDALA; SLEEP; EXPERIENCE	The emergence of memory, a trace of things past, into human consciousness is one of the greatest mysteries of the human mind. Whereas the neuronal basis of recognition memory can be probed experimentally in human and nonhuman primates, the study of free recall requires that the mind declare the occurrence of a recalled memory ( an event intrinsic to the organism and invisible to an observer). Here, we report the activity of single neurons in the human hippocampus and surrounding areas when subjects first view cinematic episodes consisting of audiovisual sequences and again later when they freely recall these episodes. A subset of these neurons exhibited selective firing, which often persisted throughout and following specific episodes for as long as 12 seconds. Verbal reports of memories of these specific episodes at the time of free recall were preceded by selective reactivation of the same hippocampal and entorhinal cortex neurons. We suggest that this reactivation is an internally generated neuronal correlate for the subjective experience of spontaneous emergence of human recollection.	[Mukamel, Roy; Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Mukamel, Roy; Fried, Itzhak] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Gelbard-Sagiv, Hagar; Harel, Michal; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fried, Itzhak] Tel Aviv Univ, Funct Neurosurg Unit, Tel Aviv Med Ctr, IL-64239 Tel Aviv, Israel; [Fried, Itzhak] Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Fried, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.	ifried@mednet.ucla.edu	Mukamel, Roy/AAV-2900-2021; Galbard-Sagiv, Hagar/J-8482-2014	Mukamel, Roy/0000-0001-9359-8950; Galbard-Sagiv, Hagar/0000-0003-0379-3854	NINDS; Israel Science Foundation; Binational United States-Israel grant; Human Frontier Science Program Organization; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Israel Science Foundation(Israel Science Foundation); Binational United States-Israel grant; Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients for their cooperation and participation in this study. We also thank E. Ho, B. Scott, E. Behnke, R. Kadivar, T. Fields, A. Postolova, K. Laird, C. Wilson, R. Quian-Quiroga, A. Kraskov, F. Mormann, and M. Cerf for assistance with data acquisition; B. Salaz and I. Wainwright for administrative help; and I. Kahn, Y. Nir, G. Buzsaki, E. Pastalkova, and S. Gilaie-Dotan for discussions and comments on this manuscript. This work was supported by NINDS (to I. Fried), Israel Science Foundation (to R. Malach), Binational United States-Israel grant (to I. Fried and R. Malach), and Human Frontier Science Program Organization (HFSPO) fellowship (to R. Mukamel).	Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Ojemann GA, 2002, NAT NEUROSCI, V5, P64, DOI 10.1038/nn785; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, HIPPOCAMPUS COGNITIV, P380; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015; Schacter DL, 1997, PHILOS T R SOC B, V352, P1689, DOI 10.1098/rstb.1997.0150; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Viskontas IV, 2006, J COGNITIVE NEUROSCI, V18, P1654, DOI 10.1162/jocn.2006.18.10.1654; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	34	310	313	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					96	101		10.1126/science.1164685	http://dx.doi.org/10.1126/science.1164685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18772395	Green Accepted			2022-12-24	WOS:000259680200046
J	Smith, SA; Donoghue, MJ				Smith, Stephen A.; Donoghue, Michael J.			Rates of molecular evolution are linked to life history in flowering plants	SCIENCE			English	Article							ESTIMATING DIVERGENCE TIMES; GENERATION-TIME; BIODIVERSITY HOTSPOTS; METABOLIC-RATE; BODY-SIZE; SEQUENCES; CLOCK; DIVERSIFICATION; ANGIOSPERMS; MALVACEAE	Variable rates of molecular evolution have been documented across the tree of life, but the cause of this observed variation within and among clades remains uncertain. In plants, it has been suggested that life history traits are correlated with the rate of molecular evolution, but previous studies have yielded conflicting results. Exceptionally large phylogenies of five major angiosperm clades demonstrate that rates of molecular evolution are consistently low in trees and shrubs, with relatively long generation times, as compared with related herbaceous plants, which generally have shorter generation times. Herbs show much higher rates of molecular change but also much higher variance in rates. Correlates of life history attributes have long been of interest to biologists, and our results demonstrate how changes in the rate of molecular evolution that are linked to life history traits can affect measurements of the tempo of evolution as well as our ability to identify and conserve biodiversity.	[Smith, Stephen A.; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Smith, SA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St,POB 208105, New Haven, CT 06520 USA.	stephen.smith@yale.edu	Smith, Stephen/AAE-8623-2019; Smith, Stephen/B-3451-2010	Smith, Stephen/0000-0003-2035-9531; 	NSF; Cyberinfrastructure for Phylogenetic Research [EF-0331654]; angiosperm Assembling the Tree of Life [EF-0431258]	NSF(National Science Foundation (NSF)); Cyberinfrastructure for Phylogenetic Research; angiosperm Assembling the Tree of Life	We thank D. Tank, J. Beaulieu, S. Stearns, D. Weinreich, C. Dunn, and E. Edwards for helpful discussions. Funded by the NSF through the Cyberinfrastructure for Phylogenetic Research (EF-0331654) and the angiosperm Assembling the Tree of Life (EF-0431258) projects.	Andreasen K, 2005, CONSERV GENET, V6, P399, DOI 10.1007/s10592-005-4977-z; Andreasen K, 2001, MOL BIOL EVOL, V18, P936, DOI 10.1093/oxfordjournals.molbev.a003894; Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Chase Mark W., 2006, Aliso, V22, P63; Davies TJ, 2006, EVOLUTION, V60, P476; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Hietz P, 2002, J TROP ECOL, V18, P177, DOI 10.1017/S0266467402002122; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KLEKOWSKI EJ, 1989, NATURE, V340, P389, DOI 10.1038/340389a0; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; OHTA T, 1993, P NATL ACAD SCI USA, V90, P10676, DOI 10.1073/pnas.90.22.10676; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sinnott EW, 1916, AM NAT, V50, P466, DOI 10.1086/279557; Soltis D, 2005, PHYLOGENY EVOLUTION; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Verdu M, 2002, EVOLUTION, V56, P1352, DOI 10.1111/j.0014-3820.2002.tb01449.x; Whittle CA, 2003, J MOL EVOL, V56, P223, DOI 10.1007/s00239-002-2395-0; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004	36	545	562	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					86	89		10.1126/science.1163197	http://dx.doi.org/10.1126/science.1163197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832643	Green Published			2022-12-24	WOS:000259680200043
J	Toyama, Y; Peralta, XG; Wells, AR; Kiehart, DP; Edwards, GS				Toyama, Yusuke; Peralta, Xomalin G.; Wells, Adrienne R.; Kiehart, Daniel P.; Edwards, Glenn S.			Apoptotic force and tissue dynamics during Drosophila embryogenesis	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DORSAL CLOSURE; MORPHOGENESIS; GENE; MECHANISMS	Understanding cell morphogenesis during metazoan development requires knowledge of how cells and the extracellular matrix produce and respond to forces. We investigated how apoptosis, which remodels tissue by eliminating supernumerary cells, also contributes forces to a tissue ( the amnioserosa) that promotes cell- sheet fusion ( dorsal closure) in the Drosophila embryo. We showed that expression in the amnioserosa of proteins that suppress or enhance apoptosis slows or speeds dorsal closure, respectively. These changes correlate with the forces produced by the amnioserosa and the rate of seam formation between the cell sheets ( zipping), key processes that contribute to closure. This apoptotic force is used by the embryo to drive cell- sheet movements during development, a role not classically attributed to apoptosis.	[Wells, Adrienne R.; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Free Elect Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Wells, Adrienne/E-3500-2018; Toyama, Yusuke/H-8023-2012; Peralta, Xomalin/F-3710-2014	Wells, Adrienne/0000-0003-3372-5588; Toyama, Yusuke/0000-0003-3230-1062; Peralta, Xomalin/0000-0002-4034-3214	NIH [GM33830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Venakides, U. S. Tulu, and A. Rodiriguez-Diaz for useful discussions and A. Boury and R. Montangue for fly husbandry. This research was supported by NIH grant GM33830.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Peralta XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015004; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Stenn K., 1998, MOL BASIS EPITHELIAL, P111; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116	22	200	200	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1683	1686		10.1126/science.1157052	http://dx.doi.org/10.1126/science.1157052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802000	Green Accepted			2022-12-24	WOS:000259300400038
J	Feinerman, O; Veiga, J; Dorfman, JR; Germain, RN; Altan-Bonnet, G				Feinerman, Ofer; Veiga, Joel; Dorfman, Jeffrey R.; Germain, Ronald N.; Altan-Bonnet, Gregoire			Variability and robustness in T cell activation from regulated heterogeneity in protein levels	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; SINGLE-CELL; LIGAND DISCRIMINATION; NOISE; RESPONSES; SELECTION; DYNAMICS; MEMORY; NUMBER	In T cells, the stochasticity of protein expression could contribute to the useful diversification of biological functions within a clonal population or interfere with accurate antigen discrimination. Combining computer modeling and single- cell measurements, we examined how endogenous variation in the expression levels of signaling proteins might affect antigen responsiveness during T cell activation. We found that the CD8 co- receptor fine- tunes activation thresholds, whereas the soluble hematopoietic phosphatase 1 ( SHP- 1) digitally regulates cell responsiveness. Stochastic variation in the expression of these proteins generates substantial diversity of activation within a clonal population of T cells, but co- regulation of CD8 and SHP- 1 levels ultimately limits this very diversity. These findings reveal how eukaryotic cells can draw on regulated variation in gene expression to achieve phenotypic variability in a controlled manner.	[Feinerman, Ofer; Veiga, Joel; Dorfman, Jeffrey R.; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Computat Biol & Immunol, New York, NY 10065 USA; [Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Immunol Lab, Program Syst Immunol & Infect Dis Modeling,NIH,De, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Altan-Bonnet, G (corresponding author), Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Computat Biol & Immunol, 1275 York Ave,Box 460, New York, NY 10065 USA.	altanbonnet@cbio.mskcc.org	Dorfman, Jeffrey R/M-4218-2017; Germain, Ronald N./Z-1945-2019; Dorfman, Jeffrey R/B-4854-2011; Germain, Ronald/ABE-7090-2020	Dorfman, Jeffrey R/0000-0001-9938-8911; Altan-Bonnet, Gregoire/0000-0002-7283-3162	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000403, ZIAAI000403, Z01AI000757] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000403-24] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, MOL IMMUNOL, V45, P619, DOI 10.1016/j.molimm.2007.03.028; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104	22	238	241	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1081	1084		10.1126/science.1158013	http://dx.doi.org/10.1126/science.1158013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719282	Green Submitted, Green Accepted			2022-12-24	WOS:000258594900038
J	Scholes, RJ; Mace, GM; Turner, W; Geller, GN; Jurgens, N; Larigauderie, A; Muchoney, D; Walther, BA; Mooney, HA				Scholes, R. J.; Mace, G. M.; Turner, W.; Geller, G. N.; Juergens, N.; Larigauderie, A.; Muchoney, D.; Walther, B. A.; Mooney, H. A.			Ecology - Toward a global biodiversity observing system	SCIENCE			English	Editorial Material							INDICATORS		[Scholes, R. J.] CSIR, ZA-0001 Pretoria, South Africa; [Mace, G. M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, NERC, Ascot SL5 7PY, Berks, England; [Turner, W.] NASA Headquarters, Div Earth Sci, Washington, DC 20546 USA; [Geller, G. N.] CALTECH, Jet Prop Lab, NASA Ecol Forecasting Program, Pasadena, CA 91109 USA; [Juergens, N.] Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany; [Juergens, N.] Univ Hamburg, Bot Garden, D-22609 Hamburg, Germany; [Larigauderie, A.; Walther, B. A.] Museum Natl Hist Nat, DIVERSITAS, F-75231 Paris 05, France; [Muchoney, D.] GEO, CH-1211 Geneva 2, Switzerland; [Mooney, H. A.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Council for Scientific & Industrial Research (CSIR) - South Africa; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); National Aeronautics & Space Administration (NASA); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hamburg; University of Hamburg; Museum National d'Histoire Naturelle (MNHN); Stanford University	Scholes, RJ (corresponding author), CSIR, POB 395, ZA-0001 Pretoria, South Africa.	bscholes@csir.co.za	Mace, Georgina M/I-3072-2016; Juergens, Norbert/K-4792-2013	Mace, Georgina M/0000-0001-8965-5211; Scholes, Robert/0000-0001-5537-6935; Geller, Gary/0000-0002-4490-6002; Juergens, Norbert/0000-0003-3211-0549	NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; *CBD, 2008, 9 C PART BONN GERM 1; Faith DP, 2002, CONSERV BIOL, V16, P248, DOI 10.1046/j.1523-1739.2002.00503.x; Hui DF, 2008, BIOL CONSERV, V141, P1091, DOI 10.1016/j.biocon.2008.02.001; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; *ROYAL SOC, 2003, 1103 ROYAL SOC; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; *WORLD MET ORG, 2004, 1219 WORLD MET ORG	10	172	189	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1044	1045		10.1126/science.1162055	http://dx.doi.org/10.1126/science.1162055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719268				2022-12-24	WOS:000258594900022
J	Sacco, A; Doyonnas, R; Kraft, P; Vitorovic, S; Blau, HM				Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.			Self-renewal and expansion of single transplanted muscle stem cells	NATURE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; MYOBLASTS; FATE; RECONSTITUTION; HETEROGENEITY; EXPRESSION	Adult muscle satellite cells have a principal role in postnatal skeletal muscle growth and regeneration(1). Satellite cells reside as quiescent cells underneath the basal lamina that surrounds muscle fibres(2) and respond to damage by giving rise to transient amplifying cells ( progenitors) and myoblasts that fuse with myofibres. Recent experiments showed that, in contrast to cultured myoblasts, satellite cells freshly isolated(3-5) or satellite cells derived from the transplantation of one intact myofibre(6) contribute robustly to muscle repair. However, because satellite cells are known to be heterogeneous(4,6,7), clonal analysis is required to demonstrate stem cell function. Here we show that when a single luciferase- expressing muscle stem cell is transplanted into the muscle of mice it is capable of extensive proliferation, contributes to muscle fibres, and Pax7(+) luciferase(+) mononucleated cells can be readily re- isolated, providing evidence of muscle stem cell self- renewal. In addition, we show using in vivo bioluminescence imaging that the dynamics of muscle stem cell behaviour during muscle repair can be followed in a manner not possible using traditional retrospective histological analyses. By imaging luciferase activity, real- time quantitative and kinetic analyses show that donor- derived muscle stem cells proliferate and engraft rapidly after injection until homeostasis is reached. On injury, donor- derived mononucleated cells generate massive waves of cell proliferation. Together, these results show that the progeny of a single luciferase- expressing muscle stem cell can both self- renew and differentiate after transplantation in mice, providing new evidence at the clonal level that self- renewal is an autonomous property of a single adult muscle stem cell.	[Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA.	hblau@stanford.edu		Doyonnas, Regis/0000-0002-3818-0807	NIH [AG009521, AG024987]; Baxter Foundation; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG024987, R01AG020961, R01AG009521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Alkan for developing the single cell RT-PCR protocol, K. Koleckar, M. Pajcini and T. Doyle for technical support, T. Brazelton, F. Rossi and S. Corbel for comments on the manuscript, J. Ramunas for statistical analysis, and M. Lutolf and P. Gilbert for fabricating the hydrogel microwells. We also thank F. Rossi for providing the integrin-alpha<INF>7</INF>-PE- conjugated antibody, and C. Contag for providing the FLuc mice. This work was supported by NIH grants AG009521, AG024987 and by the Baxter Foundation.	Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; BLAU HM, 1990, ADV EXP MED BIOL, V280, P201; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RANDO TA, 1995, EXP CELL RES, V220, P383, DOI 10.1006/excr.1995.1329; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	26	593	635	7	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					502	506		10.1038/nature07384	http://dx.doi.org/10.1038/nature07384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18806774	Green Accepted			2022-12-24	WOS:000261170500038
J	Keller, PJ; Schmidt, AD; Wittbrodt, J; Stelzer, EHK				Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim; Stelzer, Ernst H. K.			Reconstruction of Zebrafish Early Embryonic Development by Scanned Light Sheet Microscopy	SCIENCE			English	Article							CELL MOVEMENTS; GASTRULATION; EXTENSION; POLARITY; LINEAGE; ONSET	A long- standing goal of biology is to map the behavior of all cells during vertebrate embryogenesis. We developed digital scanned laser light sheet fluorescence microscopy and recorded nuclei localization and movement in entire wild- type and mutant zebrafish embryos over the first 24 hours of development. Multiview in vivo imaging at 1.5 billion voxels per minute provides "digital embryos," that is, comprehensive databases of cell positions, divisions, and migratory tracks. Our analysis of global cell division patterns reveals a maternally defined initial morphodynamic symmetry break, which identifies the embryonic body axis. We further derive a model of germ layer formation and show that the mesendoderm forms from one- third of the embryo's cells in a single event. Our digital embryos, with 55 million nucleus entries, are provided as a resource.	[Keller, Philipp J.; Wittbrodt, Joachim; Stelzer, Ernst H. K.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Keller, Philipp J.; Schmidt, Annette D.; Wittbrodt, Joachim] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Wittbrodt, Joachim] Heidelberg Univ, Inst Zool, Dept Dev Physiol, INF 230, D-69120 Heidelberg, Germany; [Wittbrodt, Joachim] KIT, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Keller, PJ (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	keller@embl.de; wittbrod@embl.de	Stelzer, Ernst H K/A-7648-2011; Keller, Philipp J/F-2343-2010; Wittbrodt, Joachim/D-4735-2014	Stelzer, Ernst H K/0000-0003-1545-0736; Wittbrodt, Joachim/0000-0001-8550-7377; Keller, Philipp/0000-0003-2896-4920	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology;  [EU-FP6-STREP Plurigenes];  [DFG SFB-488]	Studienstiftung des deutschen Volkes; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology; ; 	We thank U. Liebel, M. Alef, and M. Wahlers for excellent KIT/EMBL computer cluster support; the EMBL mechanical workshop for custom hardware; A. Riedinger and G. Ritter for custom electronics; F. Harle and A. Riedinger for custom microscope operating software; W. Dilling for technical drawings; M. Knop, K. Brown, K. Khairy, J. Martinez, D. Gilmour, and C.-P. Heisenberg for critical manuscript comments; L. Centanin for immunostained medaka embryos; C.- P. Heisenberg for MZoep mutants; S. Terjung for Leica SP5 support; G. Giese for Zeiss LSM 510 NLO support. Financial support: EU-FP6-STREP Plurigenes, DFG SFB-488 (J.W.); Studienstiftung des deutschen Volkes (P.J.K.); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, HBIGS (A.D.S.). Contributions: P.J.K. outlined the digital embryo project, designed and built the DSLM, recorded the microscopy data, developed the image processing pipeline, performed the reconstructions and drafted the manuscript. A.D.S. developed the biological methods, performed the biological preparations, contributed to project planning and participated in the writing of the manuscript. E.H.K.S. outlined the DSLM development, cosupervised the project, and participated in manuscript preparation. P.J.K., A.D.S., and J.W. analyzed the digital embryos. J.W. guided the biological research, cosupervised the project, and participated in the writing of the manuscript.	Adams RJ, 2004, GASTRULATION CELLS E, P305; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Concha ML, 1998, DEVELOPMENT, V125, P983; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; England SJ, 2006, DEVELOPMENT, V133, P4613, DOI 10.1242/dev.02678; Gilbert SF, 2006, DEV BIOL; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2002, SEMIN CELL DEV BIOL, V13, P471, DOI 10.1016/S1084952102001003; Hirose Y, 2004, DEVELOPMENT, V131, P2553, DOI 10.1242/dev.01140; HISAOKA KENICHI KENNETH, 1958, J MORPH, V102, P311, DOI 10.1002/jmor.1051020205; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KANE D, 2002, PATTERN FORMATION ZE; KANE DA, 1993, DEVELOPMENT, V119, P447; Kane DA, 1996, DEVELOPMENT, V123, P47; Keller PJ, 2007, NAT METHODS, V4, P843, DOI 10.1038/NMETH1087; Keller PJ, 2006, CURR OPIN CELL BIOL, V18, P117, DOI 10.1016/j.ceb.2005.12.012; Lemaire P, 2006, SCIENCE, V312, P1145, DOI 10.1126/science.1128784; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pezeron G, 2008, CURR BIOL, V18, P276, DOI 10.1016/j.cub.2008.01.028; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rohde LA, 2007, INT REV CYTOL, V261, P159, DOI 10.1016/S0074-7696(07)61004-3; SCHMITZ B, 1994, ROUX ARCH DEV BIOL, V203, P374, DOI 10.1007/BF00188685; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sepich Diane S., 2004, V294, P211; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; SHIH J, 1995, DEVELOPMENT, V121, P2755; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Trinkaus J. P., 1984, CELLS ORGANS FORCES; Tsien R. Y., 2006, HDB BIOL CONFOCAL MI, V3rd, P338, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2_16]; WARGA RM, 1990, DEVELOPMENT, V108, P569; Warga RM, 1998, DEV BIOL, V203, P116, DOI 10.1006/dbio.1998.9022; Wolpert L, 2007, PRINCIPLES DEV	40	1019	1055	20	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 14	2008	322	5904					1065	1069		10.1126/science.1162493	http://dx.doi.org/10.1126/science.1162493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18845710				2022-12-24	WOS:000260867700028
J	Grimson, A; Srivastava, M; Fahey, B; Woodcroft, BJ; Chiang, HR; King, N; Degnan, BM; Rokhsar, DS; Bartel, DP				Grimson, Andrew; Srivastava, Mansi; Fahey, Bryony; Woodcroft, Ben J.; Chiang, H. Rosaria; King, Nicole; Degnan, Bernard M.; Rokhsar, Daniel S.; Bartel, David P.			Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals	NATURE			English	Article							EXPRESSION; GENOME; MECHANISM; EXPANSION; REVEALS; BIOGENESIS; COMPLEX; SIRNAS	In bilaterian animals, such as humans, flies and worms, hundreds of microRNAs ( miRNAs), some conserved throughout bilaterian evolution, collectively regulate a substantial fraction of the transcriptome. In addition to miRNAs, other bilaterian small RNAs, known as Piwi- interacting RNAs (piRNAs), protect the genome from transposons. Here we identify small RNAs from animal phyla that diverged before the emergence of the Bilateria. The cnidarian Nematostella vectensis ( starlet sea anemone), a close relative to the Bilateria, possesses an extensive repertoire of miRNA genes, two classes of piRNAs and a complement of proteins specific to small- RNA biology comparable to that of humans. The poriferan Amphimedon queenslandica ( sponge), one of the simplest animals and a distant relative of the Bilateria, also possesses miRNAs, both classes of piRNAs and a full complement of the small- RNA machinery. Animal miRNA evolution seems to have been relatively dynamic, with precursor sizes and mature miRNA sequences differing greatly between poriferans, cnidarians and bilaterians. Nonetheless, miRNAs and piRNAs have been available as classes of riboregulators to shape gene expression throughout the evolution and radiation of animal phyla.	[Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Fahey, Bryony; Woodcroft, Ben J.; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Queensland; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Degnan, Bernard/0000-0001-7573-8518; Woodcroft, Ben/0000-0003-0670-7480; Rokhsar, Daniel/0000-0002-8704-2224	NIH postdoctoral fellowship; NIH; Center for Integrative Genomics; Gordon and Betty Moore Foundation; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative Genomics; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Abedin and E. Begovic for preparing the Monosiga and Trichoplax samples, respectively, W. Johnston for technical assistance, and J. Grenier, C. Mayr, C. Jan and N. Lau for discussions. This work was supported by an NIH postdoctoral fellowship (A.G.), and by grants from the NIH (D.P.B.), Richard Melmon (M.S., N.K. and D.S.R.), the Center for Integrative Genomics (M.S. and D.S.R.), the Gordon and Betty Moore Foundation (N.K.) and the Australian Research Council (B.F., B.J.W. and B.M.D.). D.P.B. is an investigator of the Howard Hughes Medical Institute.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen K, 2006, COLD SPRING HARB SYM, V71, P149, DOI 10.1101/sqb.2006.71.039; ENGLAND TE, 1977, P NATL ACAD SCI USA, V74, P4839, DOI 10.1073/pnas.74.11.4839; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	35	485	562	4	81	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1193	U15		10.1038/nature07415	http://dx.doi.org/10.1038/nature07415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18830242	Green Accepted			2022-12-24	WOS:000260462100034
J	Hiller, S; Garces, RG; Malia, TJ; Orekhov, VY; Colombini, M; Wagner, G				Hiller, Sebastian; Garces, Robert G.; Malia, Thomas J.; Orekhov, Vladislav Y.; Colombini, Marco; Wagner, Gerhard			Solution structure of the integral human membrane protein VDAC-1 in detergent micelles	SCIENCE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; ANION-SELECTIVE CHANNEL; CYTOCHROME-C; TOPOLOGY; RELEASE; FAMILY; PROBES; SENSOR; SPERM	The voltage- dependent anion channel ( VDAC) mediates trafficking of small molecules and ions across the eukaryotic outer mitochondrial membrane. VDAC also interacts with antiapoptotic proteins from the Bcl- 2 family, and this interaction inhibits release of apoptogenic proteins from the mitochondrion. We present the nuclear magnetic resonance ( NMR) solution structure of recombinant human VDAC- 1 reconstituted in detergent micelles. It forms a 19- stranded beta barrel with the first and last strand parallel. The hydrophobic outside perimeter of the barrel is covered by detergent molecules in a beltlike fashion. In the presence of cholesterol, recombinant VDAC- 1 can form voltage- gated channels in phospholipid bilayers similar to those of the native protein. NMR measurements revealed the binding sites of VDAC- 1 for the Bcl- 2 protein Bcl-x(L), for reduced beta-nicotinamide adenine dinucleotide, and for cholesterol. Bcl-x(L) interacts with the VDAC barrel laterally at strands 17 and 18.	[Hiller, Sebastian; Garces, Robert G.; Malia, Thomas J.; Orekhov, Vladislav Y.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Colombini, Marco] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Orekhov, Vladislav Y.] Univ Gothenburg, Swedish NMR Ctr, S-40530 Gothenburg, Sweden	Harvard University; Harvard Medical School; University System of Maryland; University of Maryland College Park; University of Gothenburg	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu	Orekhov, Vladislav/AAC-8357-2022; Colombini, Marco/A-1540-2014; Hiller, Sebastian/B-3573-2008; Orekhov, Vladislav/AAD-8464-2019	Hiller, Sebastian/0000-0002-6709-4684; Orekhov, Vladislav/0000-0002-7892-6896	NIH roadmap grant [GM075879]; NIH [GM066360, GM47467, EB002026]; Swiss National Science Foundation; Wenner-Gren Foundation, Stockholm; Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467, R01GM075879, P41GM066360] Funding Source: NIH RePORTER	NIH roadmap grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wenner-Gren Foundation, Stockholm; Ludwig Foundation for Cancer Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH roadmap grant GM075879. Purchase, operation, and maintenance of instruments used were supported by NIH grants GM066360, GM47467, and EB002026. S. H. was supported by the Swiss National Science Foundation. V.Y.O. was supported by the Wenner-Gren Foundation, Stockholm. Initial research on this project was supported by the Ludwig Foundation for Cancer Research. We thank V. Gelev from FBReagents.com, Cambridge, Massachusetts, for custom synthesis of the <SUP>2</SUP>H-LDAO; S. Samanta for help with the electrophysiological measurements; and D. Frueh, A. Koglin, Z.-Y.J. Sun, K. Oxenoid, and S. Jenni for technical help and valuable discussions. The atomic coordinates of VDAC-1 in LDAO micelles have been deposited at the Protein Data Bank with code 2k4t.	Brustovetsky N, 2003, J NEUROCHEM, V84, P196, DOI 10.1046/j.1471-4159.2003.01545.x; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Pinto V, 2007, CHEMBIOCHEM, V8, P744, DOI 10.1002/cbic.200700009; DEPINTO V, 1989, EUR J BIOCHEM, V183, P179; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hinsch KD, 2004, J BIOL CHEM, V279, P15281, DOI 10.1074/jbc.M313433200; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Komarov AG, 2004, BIOPHYS J, V86, P152, DOI 10.1016/S0006-3495(04)74093-X; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; MATIA TJ, 2007, BIOCHEMISTRY-US, V46, P514; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; WHITE S, 2008, MEMBRANE PROTEINS KN; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZIZI M, 1994, J BIOL CHEM, V269, P1614	34	536	547	5	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1206	1210		10.1126/science.1161302	http://dx.doi.org/10.1126/science.1161302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755977	Green Accepted			2022-12-24	WOS:000258754400044
J	Yang, YD; Cho, HW; Koo, JY; Tak, MH; Cho, YY; Shim, WS; Park, SP; Lee, J; Lee, B; Kim, BM; Raouf, R; Shin, YK; Oh, U				Yang, Young Duk; Cho, Hawon; Koo, Jae Yeon; Tak, Min Ho; Cho, Yeongyo; Shim, Won-Sik; Park, Seung Pyo; Lee, Jesun; Lee, Byeongjun; Kim, Byung-Moon; Raouf, Ramin; Shin, Young Ki; Oh, Uhtaek			TMEM16A confers receptor-activated calcium-dependent chloride conductance	NATURE			English	Article							CA2+-ACTIVATED CL-CHANNELS; RAT SUBMANDIBULAR-GLAND; PAROTID ACINAR-CELLS; CYSTIC-FIBROSIS; PROTEIN-KINASE; TRANSCRIPTOME ANALYSIS; ENDOTHELIAL-CELLS; AIRWAY EPITHELIA; SMOOTH-MUSCLE; MEMBRANE	Calcium (Ca2+)-activated chloride channels are fundamental mediators in numerous physiological processes including transepithelial secretion, cardiac and neuronal excitation, sensory transduction, smooth muscle contraction and fertilization. Despite their physiological importance, their molecular identity has remained largely unknown. Here we show that transmembrane protein 16A(TMEM16A, which we also call anoctamin 1 (ANO1)) is a bona fide Ca2+-activated chloride channel that is activated by intracellular Ca2+ and Ca2+- mobilizing stimuli. With eight putative transmembrane domains and no apparent similarity to previously characterized channels, ANO1 defines a new family of ionic channels. The biophysical properties as well as the pharmacological profile of ANO1 are in full agreement with native Ca2+- activated chloride currents. ANO1 is expressed in various secretory epithelia, the retina and sensory neurons. Furthermore, knockdown of mouse Ano1 markedly reduced native Ca2+-activated chloride currents as well as saliva production in mice. We conclude that ANO1 is a candidate Ca2+-activated chloride channel that mediates receptor- activated chloride currents in diverse physiological processes.	[Yang, Young Duk; Cho, Hawon; Koo, Jae Yeon; Tak, Min Ho; Cho, Yeongyo; Shim, Won-Sik; Park, Seung Pyo; Lee, Jesun; Lee, Byeongjun; Kim, Byung-Moon; Shin, Young Ki; Oh, Uhtaek] Seoul Natl Univ, Sensory Res Ctr, CRI, Coll Pharm, Seoul 151742, South Korea; [Raouf, Ramin] UCL, Mol Nocicept Grp, London WC1E 6BT, England	Seoul National University (SNU); University of London; University College London	Oh, U (corresponding author), Seoul Natl Univ, Sensory Res Ctr, CRI, Coll Pharm, Seoul 151742, South Korea.	utoh@snu.ac.kr	Shim, Won-Sik/HGU-0398-2022; yang, xiao-jun/B-1927-2009; Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X; Raouf, Ramin/0000-0002-5890-2221	Acceleration Research of MOEST/KOSEF of Korea; Brain Korea 21 Project; Wellcome Trust Foundation, UK	Acceleration Research of MOEST/KOSEF of Korea(Korea Science and Engineering Foundation); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Wellcome Trust Foundation, UK(Wellcome Trust)	We thank R. MacKinnon and J. Wood for a review of the manuscript. We also thank B. Hille for his technical comment on ion permeability. This work was supported by Acceleration Research of MOEST/ KOSEF of Korea. This work was also supported by the Brain Korea 21 Project and by the Wellcome Trust Foundation, UK (R.R.).	ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Arreola J, 2003, J PHYSIOL-LONDON, V547, P197, DOI 10.1113/jphysiol.2002.028373; Arreola J, 2002, J PHYSIOL-LONDON, V545, P207, DOI 10.1113/jphysiol.2002.021980; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; FULLER CM, 1994, J BIOL CHEM, V269, P26642; Greenwood IA, 2002, J BIOL CHEM, V277, P22119, DOI 10.1074/jbc.C200215200; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Guibert C, 1997, CELL CALCIUM, V21, P421, DOI 10.1016/S0143-4160(97)90053-1; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Kenyon JL, 2002, CURR TOP MEMBR, V53, P135; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lee MG, 1997, J BIOL CHEM, V272, P32951, DOI 10.1074/jbc.272.52.32951; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; Nilius B, 2002, CURR TOP MEMBR, V53, P327; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Nilius B, 1997, CELL CALCIUM, V22, P53, DOI 10.1016/S0143-4160(97)90089-0; Piper AS, 2003, J PHYSIOL-LONDON, V547, P181, DOI 10.1113/jphysiol.2002.033688; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Rosenfeld MA, 1996, CHEST, V109, P241, DOI 10.1378/chest.109.1.241; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Zholos A, 2005, J GEN PHYSIOL, V125, P197, DOI 10.1085/jgp.200409161	42	970	1036	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1210	U36		10.1038/nature07313	http://dx.doi.org/10.1038/nature07313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18724360				2022-12-24	WOS:000260462100037
J	Lee, HH; Elia, N; Ghirlando, R; Lippincott-Schwartz, J; Hurley, JH				Lee, Hyung Ho; Elia, Natalie; Ghirlando, Rodolfo; Lippincott-Schwartz, Jennifer; Hurley, James H.			Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55	SCIENCE			English	Article							LATE DOMAINS; CYTOKINESIS; PROTEIN; HIV-1; ALIX; REQUIREMENTS; RECRUITMENT; RELEASE; PATHWAY; TSG101	The ESCRT (endosomal sorting complex required for transport) machinery is required for the scission of membrane necks in processes including the budding of HIV-1 and cytokinesis. An essential step in cytokinesis is recruitment of the ESCRT-I complex and the ESCRT-associated protein ALIX to the midbody (the structure that tethers two daughter cells) by the protein CEP55. Biochemical experiments show that peptides from ALIX and the ESCRT-I subunit TSG101 compete for binding to the ESCRT- and ALIX-binding region (EABR) of CEP55. We solved the crystal structure of EABR bound to an ALIX peptide at a resolution of 2.0 angstroms. The structure shows that EABR forms an aberrant dimeric parallel coiled coil. Bulky and charged residues at the interface of the two central heptad repeats create asymmetry and a single binding site for an ALIX or TSG101 peptide. Both ALIX and ESCRT-i are required for cytokinesis, which suggests that multiple CEP55 dimers are required for function.	[Lee, Hyung Ho; Ghirlando, Rodolfo; Hurley, James H.] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Elia, Natalie; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009		U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NIH intramural suppor; NIDDK; NICHD; IATAP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036125] Funding Source: NIH RePORTER	U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH intramural suppor(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Beach for generating DNA constructs, E. Freed and K. Kutsche for providing DNAs, T. Alber for discussions, and the staff of SER-CAT for user support at the Advanced Photon Source (APS). Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Supported by NIH intramural support, NIDDK (J.H.H.), NICHD (J.L.), and IATAP (J.H.H. and J.L.). Crystallographic coordinates have been deposited in the RCSB Protein Data Bank with accession number 3E1R.	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	189	195	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					576	580		10.1126/science.1162042	http://dx.doi.org/10.1126/science.1162042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948538	Green Accepted			2022-12-24	WOS:000260299100040
J	Takizawa, T; Meaburn, KJ; Misteli, T				Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom			The meaning of gene positioning	CELL			English	Article							NUCLEAR LAMINA; TRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; CHROMOSOME TERRITORIES; SPATIAL-ORGANIZATION; GENOME FUNCTION; LOCUS; REORGANIZATION; EXPRESSION; LOCALIZATION	There is no doubt that genomes are organized nonrandomly in the nucleus of higher eukaryotes. But what is the functional relevance of this nonrandomness? In this Essay, we explore the biological meaning of spatial gene positioning by examining the functional link between the activity of a gene and its radial position in the nucleus.	[Takizawa, Takumi; Meaburn, Karen J.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Meaburn, Karen/J-2482-2019; Takizawa, Takumi/AAH-4996-2020	Meaburn, Karen/0000-0002-1327-5957; Takizawa, Takumi/0000-0003-2169-0787	Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert DM, 2001, J CELL BIOL, V152, pF11, DOI 10.1083/jcb.152.2.F11; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lawrence JB, 2008, J CELL BIOL, V182, P1035, DOI 10.1083/jcb.200808121; Meaburn KJ, 2008, J CELL BIOL, V180, P39, DOI 10.1083/jcb.200708204; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murmann AE, 2005, EXP CELL RES, V311, P14, DOI 10.1016/j.yexcr.2005.07.020; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; [No title captured]	38	170	174	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					9	13		10.1016/j.cell.2008.09.026	http://dx.doi.org/10.1016/j.cell.2008.09.026			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854147	Green Accepted, Bronze			2022-12-24	WOS:000259728100001
J	Kareiva, P; Chang, A; Marvier, M				Kareiva, Peter; Chang, Amy; Marvier, Michelle			Environmental economics - Development and conservation goals in World Bank projects	SCIENCE			English	Editorial Material							NEEDS; HELP		[Kareiva, Peter] Nature Conservancy, Seattle, WA 98105 USA; [Kareiva, Peter; Marvier, Michelle] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Chang, Amy] Nature Conservancy, Santa Clara, CA 95053 USA	Nature Conservancy; Santa Clara University	Kareiva, P (corresponding author), Nature Conservancy, Seattle, WA 98105 USA.	pkareiva@tnc.org		Marvier, Michelle/0000-0001-8360-9265				Agrawal A., 2006, 26 WCS; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Kaimowitz D, 2007, BIOTROPICA, V39, P567, DOI 10.1111/j.1744-7429.2007.00332.x; Koziell I, 2002, PHILOS T ROY SOC A, V360, P1807, DOI 10.1098/rsta.2002.1033; MACKINNON K, 2006, WORLD BANK BIODIVERS; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL, P137; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Robinson J., 2004, GETTING BIODIVERSITY, P10; Sachs JD, 2006, SCIENCE, V312, P1002, DOI 10.1126/science.1124822; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7	12	46	47	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1638	1639		10.1126/science.1162756	http://dx.doi.org/10.1126/science.1162756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801985				2022-12-24	WOS:000259300400019
J	Raschle, M; Knipscheer, P; Enoiu, M; Angelov, T; Sun, JC; Griffith, JD; Ellenberger, TE; Scharer, OD; Walter, JC				Raeschle, Markus; Knipscheer, Puck; Enoiu, Milica; Angelov, Todor; Sun, Jingchuan; Griffith, Jack D.; Ellenberger, Tom E.; Schaerer, Orlando D.; Walter, Johannes C.			Mechanism of replication-coupled DNA interstrand crosslink repair	CELL			English	Article							FANCONI-ANEMIA; RECOMBINATION; RECRUITMENT; ACTIVATION; TOLERANCE; CISPLATIN; PROTEIN; MCM2-7; REV1	DNA interstrand crosslinks (ICLs) are toxic DNA lesions whose repair occurs in the S phase of metazoans via an unknown mechanism. Here, we describe a cell-free system based on Xenopus egg extracts that supports ICL repair. During DNA replication of a plasmid containing a site-specific ICL, two replication forks converge on the crosslink. Subsequent lesion bypass involves advance of a nascent leading strand to within one nucleotide of the ICL, followed by incisions, translesion DNA synthesis, and extension of the nascent strand beyond the lesion. Immunodepletion experiments suggest that extension requires DNA polymerase zeta. Ultimately, a significant portion of the input DNA is fully repaired, but not if DNA replication is blocked. Our experiments establish a mechanism for ICL repair that reveals how this process is coupled to DNA replication.	[Raeschle, Markus; Knipscheer, Puck; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Enoiu, Milica; Angelov, Todor; Schaerer, Orlando D.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sun, Jingchuan; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Ellenberger, Tom E.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Harvard University; Harvard Medical School; University of Zurich; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Schärer, Orlando D./AAF-8613-2021; Scharer, Orlando/B-8908-2008	Scharer, Orlando/0000-0003-2425-2715; Walter, Johannes/0000-0002-4186-7570	NIH [GM62267, GM55390, GM31819]; Leukemia and Lymphoma Scholar Award; Dutch Cancer Society Fellowship; New York State Office of Science and Technology and Academic Research NYSTAR [C040069]; Swiss Cancer League [OCS-01413-080-2003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM055390, R01GM031819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Dutch Cancer Society Fellowship(KWF Kankerbestrijding); New York State Office of Science and Technology and Academic Research NYSTAR; Swiss Cancer League; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Alan D'Andrea for advice and encouragement during early stages of this project. This work was supported by NIH grants GM62267 (J.C.W.), GM55390 (T. E. E.), and GM31819 (J. D. G.), a Leukemia and Lymphoma Scholar Award (J. C. W.), a Dutch Cancer Society Fellowship (P. K.), and grants from the New York State Office of Science and Technology and Academic Research NYSTAR, C040069 (O.D.S.) and the Swiss Cancer League OCS-01413-080-2003 (O.D.S.). We thank Agata Smogorzewska, Ralph Scully, and Alan D'Andrea for critical reading of the manuscript.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Akkari YMN, 2001, MOL GENET METAB, V74, P403, DOI 10.1006/mgme.2001.3259; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hofr C, 2001, J BIOL CHEM, V276, P9655, DOI 10.1074/jbc.M010205200; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li L, 1999, MOL CELL BIOL, V19, P5619; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sobeck A, 2007, MOL CELL BIOL, V27, P4283, DOI 10.1128/MCB.02196-06; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004	33	367	374	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					969	980		10.1016/j.cell.2008.08.030	http://dx.doi.org/10.1016/j.cell.2008.08.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805090	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000259318100017
J	Schroeder, BC; Cheng, T; Jan, YN; Jan, LY				Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh			Expression cloning of TMEM16A as a calcium-activated chloride channel subunit	CELL			English	Article							CYSTIC-FIBROSIS AIRWAY; XENOPUS-LAEVIS OOCYTES; PROTEIN-KINASE-C; TRANSMEMBRANE PROTEIN; GNATHODIAPHYSEAL-DYSPLASIA; TRANSCRIPTOME ANALYSIS; PLASMA-MEMBRANE; SURFACE LIQUID; ION CHANNELS; CELLS	Calcium-activated chloride channels (CaCCs) are major regulators of sensory transduction, epithelial secretion, and smooth muscle contraction. Other crucial roles of CaCCs include action potential generation in Characean algae and prevention of polyspermia in frog egg membrane. None of the known molecular candidates share properties characteristic of most CaCCs in native cells. Using Axolotl oocytes as an expression system, we have identified TMEM16A as the Xenopus oocyte CaCC. The TMEM16 family of "transmembrane proteins with unknown function'' is conserved among eukaryotes, with family members linked to tracheomalacia (mouse TMEM16A), gnatho-diaphyseal dysplasia (human TMEM16E), aberrant X segregation (a Drosophila TMEM16 family member), and increased sodium tolerance (yeast TMEM16). Moreover, mouse TMEM16A and TMEM16B yield CaCCs in Axolotl oocytes and mammalian HEK293 cells and recapitulate the broad CaCC expression. The identification of this new family of ion channels may help the development of CaCC modulators for treating diseases including hypertension and cystic fibrosis.	[Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Human Frontier Science Program; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J.Adelman for SK2 cDNA and N.V. Ravin for the pG591 clone. We are grateful for the help of C. Han with confocal images, T. Muller with image acquisition, X. Qian with patch-clamp experiments, and D. Wang with in situ hybridizations. We also thank P. Lu and P. Soba for discussion. This work was supported by a Human Frontier Science Program fellowship to B.C. S. and a National Institute of Mental Health grant to L.Y.J. L.Y.J. and Y.N.J. are Howard Hughes Medical Institute investigators.	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARREOLA J, 1995, J MEMBRANE BIOL, V147, P95; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BARISH ME, 1984, J PHYSIOL-LONDON, V352, P243, DOI 10.1113/jphysiol.1984.sp015289; BARROSORIA R, 2008, BIOCH BIOPH IN PRESS; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; Blaug S, 2003, AM J PHYSIOL-CELL PH, V284, pC897, DOI 10.1152/ajpcell.00238.2002; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; Callamaras N, 2000, AM J PHYSIOL-CELL PH, V278, pC667, DOI 10.1152/ajpcell.2000.278.4.C667; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jego P., 1986, Advances in Experimental Medicine and Biology, V207, P205; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LUPUMEIRI M, 1989, PFLUG ARCH EUR J PHY, V413, P498, DOI 10.1007/BF00594180; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pusch M, 2004, J GEN PHYSIOL, V123, P323, DOI 10.1085/jgp.200409053; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; SAMEJIMA M, 1982, PLANT CELL PHYSL, V27, P1081; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; TAKAHASHI T, 1987, P NATL ACAD SCI USA, V84, P5063, DOI 10.1073/pnas.84.14.5063; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; YANG YD, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07313	54	882	931	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1019	1029		10.1016/j.cell.2008.09.003	http://dx.doi.org/10.1016/j.cell.2008.09.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805094	Green Accepted, Bronze			2022-12-24	WOS:000259318100021
J	Jaakola, VP; Griffith, MT; Hanson, MA; Cherezov, V; Chien, EYT; Lane, JR; IJzerman, AP; Stevens, RC				Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.			The 2.6 Angstrom Crystal Structure of a Human A(2A) Adenosine Receptor Bound to an Antagonist	SCIENCE			English	Article							MUTAGENESIS; RESIDUES; INSIGHTS; TARGETS; PHARMACOLOGY; MECHANISMS; RHODOPSIN; PROTEINS; ZM241385; REVEALS	The adenosine class of heterotrimeric guanine nucleotide- binding protein ( G protein)- coupled receptors ( GPCRs) mediates the important role of extracellular adenosine in many physiological processes and is antagonized by caffeine. We have determined the crystal structure of the human A(2A) adenosine receptor, in complex with a high- affinity subtype- selective antagonist, ZM241385, to 2.6 angstrom resolution. Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helices relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally determined GPCRs. The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane. The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.	[Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Lane, J. Robert; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Leiden University; Leiden University - Excl LUMC	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	soler, martha maricel m gomez/L-6025-2014; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; IJzerman, Ad/ABG-1353-2020	soler, martha maricel m gomez/0000-0002-4412-8108; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; IJzerman, Ad/0000-0002-1182-2259; Jaakola, Veli-Pekka/0000-0003-2943-6417; Lane, J. Robert/0000-0002-7361-7875	NIH Roadmap Initiative [P50 GM073197]; Protein Structure Initiative [U54 GM074961]; Dutch Top Institute Pharma; GPCR forum program [D1-105]; National Institutes of Health [GM075915]; National Science Foundation [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961, R01GM089857, R01GM075915, P50GM073197] Funding Source: NIH RePORTER	NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Structure Initiative; Dutch Top Institute Pharma; GPCR forum program(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Roadmap Initiative grant P50 GM073197 for technology development, Protein Structure Initiative grant U54 GM074961 for target processing, and Pfizer (R.C.S.). A.P.IJ. and J.R.L. thank the Dutch Top Institute Pharma for financial support through the GPCR forum program (D1-105). The authors thank P. Kuhn for encouragement and support, J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculoviral expression, Q. Li and T. Mulder for biochemical and pharmacological characterization of the receptor constructs, A. Walker for assistance with manuscript preparation, and I. Wilson for scientific feedback and discussions. The authors acknowledge Y. Zheng, The Ohio State University, and M. Caffrey, University of Limerick, for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the National Science Foundation (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3EML. The authors, R.C.S., V.-P.J., M.T.G., M.A.H., and V.C. have filed a patent related to the crystals of human adenosine A<INF>2A</INF> receptor.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Benarroch EE, 2008, NEUROLOGY, V70, P231, DOI 10.1212/01.wnl.0000297939.18236.ec; BIRNBAUMER L, 1994, TEX HEART I J, V21, P16; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Brown RA, 2008, BRIT J PHARMACOL, V153, pS446, DOI 10.1038/bjp.2008.22; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; de Zwart M, 1999, DRUG DEVELOP RES, V48, P95, DOI 10.1002/(SICI)1098-2299(199911)48:3<95::AID-DDR1>3.0.CO;2-B; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Engel CK, 2002, BBA-BIOMEMBRANES, V1564, P38, DOI 10.1016/S0005-2736(02)00398-X; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852; Ferre S, 2008, J NEUROCHEM, V105, P1067, DOI 10.1111/j.1471-4159.2007.05196.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Jaakola VP, 2005, PROTEIN ENG DES SEL, V18, P103, DOI 10.1093/protein/gzi004; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Joost P, 2002, GENOME BIOL, V3; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lahiria S, 2007, RESP PHYSIOL NEUROBI, V157, P123, DOI 10.1016/j.resp.2007.02.015; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mantri M, 2008, J MED CHEM, V51, P4449, DOI 10.1021/jm701594y; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Moro S, 2003, CHEM COMMUN, P2949, DOI 10.1039/b303439a; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ratnaparkhi GS, 2000, BIOCHEMISTRY-US, V39, P12365, DOI 10.1021/bi000775k; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sawynok J, 2003, PROG NEUROBIOL, V69, P313, DOI 10.1016/S0301-0082(03)00050-9; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Scholl DJ, 2000, BIOCHEM PHARMACOL, V60, P1647, DOI 10.1016/S0006-2952(00)00474-3; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shi YR, 2008, J CEREBR BLOOD F MET, V28, P111, DOI 10.1038/sj.jcbfm.9600511; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yuzlenko O, 2009, J COMPUT CHEM, V30, P14, DOI 10.1002/jcc.21001; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	52	1492	1548	1	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1211	1217		10.1126/science.1164772	http://dx.doi.org/10.1126/science.1164772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18832607	Green Accepted			2022-12-24	WOS:000261033400032
J	Ding, L; Getz, G; Wheeler, DA; Mardis, ER; McLellan, MD; Cibulskis, K; Sougnez, C; Greulich, H; Muzny, DM; Morgan, MB; Fulton, L; Fulton, RS; Zhang, QY; Wendl, MC; Lawrence, MS; Larson, DE; Chen, K; Dooling, DJ; Sabo, A; Hawes, AC; Shen, H; Jhangiani, SN; Lewis, LR; Hall, O; Zhu, YM; Mathew, T; Ren, YR; Yao, JQ; Scherer, SE; Clerc, K; Metcalf, GA; Ng, B; Milosavljevic, A; Gonzalez-Garay, ML; Osborne, JR; Meyer, R; Shi, XQ; Tang, YZ; Koboldt, DC; Lin, L; Abbott, R; Miner, TL; Pohl, C; Fewell, G; Haipek, C; Schmidt, H; Dunford-Shore, BH; Kraja, A; Crosby, SD; Sawyer, CS; Vickery, T; Sander, S; Robinson, J; Winckler, W; Baldwin, J; Chirieac, LR; Dutt, A; Fennell, T; Hanna, M; Johnson, BE; Onofrio, RC; Thomas, RK; Tonon, G; Weir, BA; Zhao, XJ; Ziaugra, L; Zody, MC; Giordano, T; Orringer, MB; Roth, JA; Spitz, MR; Wistuba, II; Ozenberger, B; Good, PJ; Chang, AC; Beer, DG; Watson, MA; Ladanyi, M; Broderick, S; Yoshizawa, A; Travis, WD; Pao, W; Province, MA; Weinstock, GM; Varmus, HE; Gabriel, SB; Lander, ES; Gibbs, RA; Meyerson, M; Wilson, RK				Ding, Li; Getz, Gad; Wheeler, David A.; Mardis, Elaine R.; McLellan, Michael D.; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Muzny, Donna M.; Morgan, Margaret B.; Fulton, Lucinda; Fulton, Robert S.; Zhang, Qunyuan; Wendl, Michael C.; Lawrence, Michael S.; Larson, David E.; Chen, Ken; Dooling, David J.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Kraja, Aldi; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Winckler, Wendy; Baldwin, Jennifer; Chirieac, Lucian R.; Dutt, Amit; Fennell, Tim; Hanna, Megan; Johnson, Bruce E.; Onofrio, Robert C.; Thomas, Roman K.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Giordano, Thomas; Orringer, Mark B.; Roth, Jack A.; Spitz, Margaret R.; Wistuba, Ignacio I.; Ozenberger, Bradley; Good, Peter J.; Chang, Andrew C.; Beer, David G.; Watson, Mark A.; Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William; Province, Michael A.; Weinstock, George M.; Varmus, Harold E.; Gabriel, Stacey B.; Lander, Eric S.; Gibbs, Richard A.; Meyerson, Matthew; Wilson, Richard K.			Somatic mutations affect key pathways in lung adenocarcinoma	NATURE			English	Article							HUMAN BREAST; MENDELIAN-INHERITANCE; HOMOZYGOUS DELETIONS; COLORECTAL CANCERS; EGFR MUTATIONS; TOBACCO-SMOKE; KRAS MUTATION; NEVER SMOKERS; RECEPTOR GENE; GEFITINIB	Determining the genetic basis of cancer requires comprehensive analyses of large collections of histopathologically well- classified primary tumours. Here we report the results of a collaborative study to discover somatic mutations in 188 human lung adenocarcinomas. DNA sequencing of 623 genes with known or potential relationships to cancer revealed more than 1,000 somatic mutations across the samples. Our analysis identified 26 genes that are mutated at significantly high frequencies and thus are probably involved in carcinogenesis. The frequently mutated genes include tyrosine kinases, among them the EGFR homologue ERBB4; multiple ephrin receptor genes, notably EPHA3; vascular endothelial growth factor receptor KDR; and NTRK genes. These data provide evidence of somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers - including NF1, APC, RB1 and ATM - and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B. The observed mutational profiles correlate with clinical features, smoking status and DNA repair defects. These results are reinforced by data integration including single nucleotide polymorphism array and gene expression array. Our findings shed further light on several important signalling pathways involved in lung adenocarcinoma, and suggest new molecular targets for treatment.	[Ding, Li; Mardis, Elaine R.; McLellan, Michael D.; Fulton, Lucinda; Fulton, Robert S.; Wendl, Michael C.; Larson, David E.; Chen, Ken; Dooling, David J.; Osborne, John R.; Meyer, Rick; Shi, Xiaoqi; Tang, Yuzhu; Koboldt, Daniel C.; Lin, Ling; Abbott, Rachel; Miner, Tracie L.; Pohl, Craig; Fewell, Ginger; Haipek, Carrie; Schmidt, Heather; Dunford-Shore, Brian H.; Crosby, Seth D.; Sawyer, Christopher S.; Vickery, Tammi; Sander, Sacha; Robinson, Jody; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA; [Getz, Gad; Cibulskis, Kristian; Sougnez, Carrie; Greulich, Heidi; Lawrence, Michael S.; Winckler, Wendy; Baldwin, Jennifer; Dutt, Amit; Fennell, Tim; Hanna, Megan; Onofrio, Robert C.; Weir, Barbara A.; Zhao, Xiaojun; Ziaugra, Liuda; Zody, Michael C.; Gabriel, Stacey B.; Lander, Eric S.; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Genome Biol Program, Cambridge, MA 02142 USA; [Wheeler, David A.; Muzny, Donna M.; Morgan, Margaret B.; Sabo, Aniko; Hawes, Alicia C.; Shen, Hua; Jhangiani, Shalini N.; Lewis, Lora R.; Hall, Otis; Zhu, Yiming; Mathew, Tittu; Ren, Yanru; Yao, Jiqiang; Scherer, Steven E.; Clerc, Kerstin; Metcalf, Ginger A.; Ng, Brian; Milosavljevic, Aleksandar; Gonzalez-Garay, Manuel L.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Greulich, Heidi; Winckler, Wendy; Dutt, Amit; Hanna, Megan; Johnson, Bruce E.; Tonon, Giovanni; Weir, Barbara A.; Zhao, Xiaojun; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhang, Qunyuan; Kraja, Aldi; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63108 USA; [Chirieac, Lucian R.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chirieac, Lucian R.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomas, Roman K.] Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Giordano, Thomas] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Orringer, Mark B.; Chang, Andrew C.; Beer, David G.] Univ Michigan, Thorac Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; [Roth, Jack A.; Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Spitz, Margaret R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Ozenberger, Bradley; Good, Peter J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Watson, Mark A.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ladanyi, Marc; Broderick, Stephen; Yoshizawa, Akihiko; Travis, William D.; Pao, William] Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; [Ladanyi, Marc; Pao, William] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Varmus, Harold E.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA.	matthew_meyerson@dfci.harvard.edu; rwilson@wustl.edu	Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Dutt, Amit/I-1911-2013; Chen, Ken/A-1074-2009; Chen, Ken/AAU-1432-2021; Tonon, Giovanni/J-9804-2018; Wilson, Richard K./AAF-4139-2019; Weinstock, George M/C-6314-2013; Wheeler, David A/M-9740-2018; Meyerson, Matthew L/E-7123-2012; Chirieac, Lucian R./AAD-2030-2019; Ladanyi, Marc/AAG-8585-2019; Wendl, Michael C/A-2741-2008; Yoshizawa, Akihiko/AAM-9519-2020; Mardis, Elaine/W-2202-2019	Dutt, Amit/0000-0002-1119-4774; Chen, Ken/0000-0003-4013-5279; Tonon, Giovanni/0000-0003-2973-5038; Wilson, Richard K./0000-0002-1992-1358; Weinstock, George M/0000-0002-2997-4592; Wheeler, David A/0000-0002-9056-6299; Cibulskis, Kristian/0000-0003-1343-1582; Giordano, Thomas/0000-0003-0641-8873; Gonzalez-Garay, Manuel/0000-0003-3412-0353; MCLELLAN, MICHAEL/0000-0002-2703-8784; Chang, Andrew/0000-0001-9506-0425; Larson, David/0000-0001-7934-5906	National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [P50CA070907, U19CA084953, R01CA154365] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A. Lash, M.F. Zakowski, M.G. Kris and V. Rusch for intellectual contributions, and many members of the Baylor Human Genome Sequencing Center, the Broad Institute of Harvard and MIT, and the Genome Center at Washington University for support. This work was funded by grants from the National Human Genome Research Institute to E.S.L., R.A.G. and R.K.W.	Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chehab NH, 2000, GENE DEV, V14, P278; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOWLEY PM, 1991, COLD SPRING HARB SYM, V56, P149; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Juergens Rosalyn A, 2006, J Natl Compr Canc Netw, V4, P595; Kim JH, 2006, HUM MOL GENET, V15, P1181, DOI 10.1093/hmg/ddl033; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Liu CX, 2000, CANCER RES, V60, P1961; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Packenham JP, 1995, CLIN CANCER RES, V1, P687; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RODENHUIS S, 1988, CANCER RES, V48, P5738; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Sasaki H, 2007, ONCOL REP, V18, P623; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Sellers TA, 1998, GENET EPIDEMIOL, V15, P251, DOI 10.1002/(SICI)1098-2272(1998)15:3<251::AID-GEPI4>3.0.CO;2-7; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sonoda I, 2004, CANCER RES, V64, P3741, DOI 10.1158/0008-5472.CAN-04-0172; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	50	2014	2105	8	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1069	1075		10.1038/nature07423	http://dx.doi.org/10.1038/nature07423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18948947	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000260252600036
J	Choi, PJ; Cai, L; Frieda, K; Xie, S				Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney			A stochastic single-molecule event triggers phenotype switching of a bacterial cell	SCIENCE			English	Article							LAC REPRESSOR; ESCHERICHIA-COLI; GENE-EXPRESSION; OPERATOR COMPLEX; LEVEL; DYNAMICS; PROTEIN; OPERON; TRANSCRIPTION; BINDING	By monitoring fluorescently labeled lactose permease with single-molecule sensitivity, we investigated the molecular mechanism of how an Escherichia coli cell with the lac operon switches from one phenotype to another. At intermediate inducer concentrations, a population of genetically identical cells exhibits two phenotypes: induced cells with highly fluorescent membranes and uninduced cells with a small number of membrane-bound permeases. We found that this basal-level expression results from partial dissociation of the tetrameric lactose repressor from one of its operators on looped DNA. In contrast, infrequent events of complete dissociation of the repressor from DNA result in large bursts of permease expression that trigger induction of the lac operon. Hence, a stochastic single-molecule event determines a cell's phenotype.	[Choi, Paul J.; Cai, Long; Frieda, Kirsten; Xie, Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Xie, S (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010244] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank G. Church, A. Miyawaki, and B. Wanner for bacterial strains and plasmids; J. Hearn for technical assistance; and J. Elf, N. Friedman, and G.W. Li for helpful discussions. This work was supported by the NIH Director's Pioneer Award. P.J.C. acknowledges the John and Fannie Hertz Foundation.	Arkin A, 1998, GENETICS, V149, P1633; Artyomov MN, 2007, P NATL ACAD SCI USA, V104, P18958, DOI 10.1073/pnas.0706110104; BARKLEY MD, 1975, BIOCHEMISTRY-US, V14, P1700, DOI 10.1021/bi00679a024; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; COHEN GN, 1957, BACTERIOL REV, V21, P169, DOI 10.1128/MMBR.21.3.169-194.1957; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Ptashne M, 2004, GENETIC SWITCH PHAGE; REVZIN A, 1977, BIOCHEMISTRY-US, V16, P4769, DOI 10.1021/bi00641a002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	26	333	335	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					442	446		10.1126/science.1161427	http://dx.doi.org/10.1126/science.1161427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18927393	Green Accepted, Green Submitted			2022-12-24	WOS:000260094500047
J	Huertas, P; Cortes-Ledesma, F; Sartori, AA; Aguilera, A; Jackson, SP				Huertas, Pablo; Cortes-Ledesma, Felipe; Sartori, Alessandro A.; Aguilera, Andres; Jackson, Stephen P.			CDK targets Sae2 to control DNA-end resection and homologous recombination	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REPAIR PATHWAYS; DAMAGE RESPONSE; KINASE-ACTIVITY; PROTEIN-KINASE; MRE11 COMPLEX; HUMAN CTIP; GENE	DNA double- strand breaks ( DSBs) are repaired by two principal mechanisms: non- homologous end- joining ( NHEJ) and homologous recombination ( HR)(1). HR is the most accurate DSB repair mechanism but is generally restricted to the S and G2 phases of the cell cycle, when DNA has been replicated and a sister chromatid is available as a repair template(2-5). By contrast, NHEJ operates throughout the cell cycle but assumes most importance in G1 ( refs 4, 6). The choice between repair pathways is governed by cyclindependent protein kinases (CDKs)(2,3,5,7), with a major site of control being at the level of DSB resection, an event that is necessary for HR but not NHEJ, and which takes place most effectively in S and G2 ( refs 2, 5). Here we establish that cell- cycle control of DSB resection in Saccharomyces cerevisiae results from the phosphorylation by CDK of an evolutionarily conserved motif in the Sae2 protein. We show that mutating Ser 267 of Sae2 to a non- phosphorylatable residue causes phenotypes comparable to those of a sae2 Delta null mutant, including hypersensitivity to camptothecin, defective sporulation, reduced hairpin- induced recombination, severely impaired DNA- end processing and faulty assembly and disassembly of HR factors. Furthermore, a Sae2 mutation that mimics constitutive Ser 267 phosphorylation complements these phenotypes and overcomes the necessity of CDK activity for DSB resection. The Sae2 mutations also cause cell- cycle- stage specific hypersensitivity to DNA damage and affect the balance between HR and NHEJ. These findings therefore provide amechanistic basis for cell- cycle control of DSB repair and highlight the importance of regulating DSB resection.	[Huertas, Pablo; Sartori, Alessandro A.; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Huertas, Pablo; Sartori, Alessandro A.; Jackson, Stephen P.] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; [Cortes-Ledesma, Felipe; Aguilera, Andres] Univ Seville, CSIC, Ctr Andaluz Biol Mol & Med Regenerat, CABIMER, Seville 41092, Spain	University of Cambridge; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Ledesma, Felipe Cortés/F-4803-2014; Jackson, Stephen Philip/R-4548-2019; Sartori, Alessandro/AAK-7840-2021; Aguilera, Andres/L-1825-2014; Huertas, Pablo/N-2245-2016; Dry, Kate/I-2328-2014	Ledesma, Felipe Cortés/0000-0002-0440-6783; Jackson, Stephen Philip/0000-0001-9317-7937; Sartori, Alessandro/0000-0003-2770-0333; Aguilera, Andres/0000-0003-4782-1714; Huertas, Pablo/0000-0002-1756-4449; 	Long- Term EMBO Fellowship; Swiss National Foundation Grant; Cancer Research UK; European Community [LSHG-CT-2005-512113)]; Spanish Ministry of Science and Education [BFU2006-05, CDS2007-0015260]; Junta de Andalucia [CVI624]	Long- Term EMBO Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Foundation Grant(Swiss National Science Foundation (SNSF)); Cancer Research UK(Cancer Research UK); European Community(European Commission); Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia)	We thank M. P. Longhese, R. Rothstein, K. Lobachev, M. Lichten and M. Foiani for providing strains, and R. Driscoll, S. Gravel, K. Dry and K. Miller for helpful discussions and comments on the manuscript. P. H. is the recipient of a Long- Term EMBO Fellowship. A. A. S. is supported by a Swiss National Foundation Grant. The S. P. J. laboratory is supported by grants from Cancer Research UK and the European Community ( Integrated Project DNA repair, grant LSHG-CT-2005-512113). The A. A. laboratory is supported by grants from the Spanish Ministry of Science and Education (BFU2006-05260 and CDS2007-0015) and Junta de Andalucia (CVI624).	Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Hinz JM, 2005, DNA REPAIR, V4, P782, DOI 10.1016/j.dnarep.2005.03.005; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Karathanasis E, 2002, GENETICS, V161, P1015; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; McKee AHZ, 1997, GENETICS, V146, P797; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Prinz S, 1997, GENETICS, V146, P781; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913	31	347	355	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					689	U86		10.1038/nature07215	http://dx.doi.org/10.1038/nature07215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18716619	Green Accepted			2022-12-24	WOS:000259639700052
J	Parsons, DW; Jones, S; Zhang, XS; Lin, JCH; Leary, RJ; Angenendt, P; Mankoo, P; Carter, H; Siu, IM; Gallia, GL; Olivi, A; McLendon, R; Rasheed, BA; Keir, S; Nikolskaya, T; Nikolsky, Y; Busam, DA; Tekleab, H; Diaz, LA; Hartigan, J; Smith, DR; Strausberg, RL; Marie, SKN; Shinjo, SMO; Yan, H; Riggins, GJ; Bigner, DD; Karchin, R; Papadopoulos, N; Parmigiani, G; Vogelstein, B; Velculescu, VE; Kinzler, KW				Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Siu, I-Mei; Gallia, Gary L.; Olivi, Alessandro; McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Nikolskaya, Tatiana; Nikolsky, Yuri; Busam, Dana A.; Tekleab, Hanna; Diaz, Luis A., Jr.; Hartigan, James; Smith, Doug R.; Strausberg, Robert L.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Yan, Hai; Riggins, Gregory J.; Bigner, Darell D.; Karchin, Rachel; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.			An integrated genomic analysis of human glioblastoma Multiforme	SCIENCE			English	Article							NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; SECONDARY GLIOBLASTOMA; COLORECTAL CANCERS; MALIGNANT GLIOMAS; GENETIC PATHWAYS; HUMAN BREAST; PIK3CA GENE; MUTATIONS; EXPRESSION; FREQUENCY	Glioblastoma multiforme ( GBM) is the most common and lethal type of brain cancer. To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, determined the presence of amplifications and deletions using high- density oligonucleotide arrays, and performed gene expression analyses using next- generation sequencing technologies in 22 human tumor samples. This comprehensive analysis led to the discovery of a variety of genes that were not known to be altered in GBMs. Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 ( IDH1) in 12% of GBM patients. Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were associated with an increase in overall survival. These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.	[Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Diaz, Luis A., Jr.; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Diaz, Luis A., Jr.; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Mankoo, Parminder; Carter, Hannah; Karchin, Rachel] Johns Hopkins Med Inst, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Siu, I-Mei; Gallia, Gary L.; Olivi, Alessandro; Riggins, Gregory J.] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21231 USA; [McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn, Durham, NC 27710 USA; [McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Nikolskaya, Tatiana] Vavilov Inst Gen Genet, Moscow 117809, Russia; [Nikolsky, Yuri] GeneGo Inc, St Joseph, MI 49085 USA; [Busam, Dana A.; Tekleab, Hanna; Strausberg, Robert L.] J Craig Venter Inst, Rockville, MD 20850 USA; [Hartigan, James; Smith, Doug R.] Agencourt Biosci Corp, Beverly, MA 01915 USA; [Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Duke University; Russian Academy of Sciences; Vavilov Institute of General Genetics; J. Craig Venter Institute; Universidade de Sao Paulo	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	bertvog@gmail.com; velculescu@jhmi.edu; kinzlke@jhmi.edu	Oba-Shinjo, Sueli M./C-4017-2012; Marie, Suely Kazue Nagahashi/D-1870-2012; Papadopoulos, Nickolas/K-7272-2012; Jones, Sian/A-5050-2012; Karchin, Rachel/A-3385-2010; Nikolskaya, Tatiana/M-5008-2013; Olivi, Alessandro/K-6531-2016; Velculescu, Victor/ABF-4846-2020; wang, edwin/G-5372-2010; Carter, Hannah/R-8425-2017	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Olivi, Alessandro/0000-0002-4489-7564; Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501; Diaz, Luis/0000-0002-7079-8914; Carter, Hannah/0000-0002-1729-2463; Edsall, Lee Elizabeth/0000-0002-0326-2829; Karchin, Rachel/0000-0002-5069-1239	Ludwig Fund for Cancer Research; NIH [CA121113, NS052507, CA43460, CA57345, CA62924, CA09547, 5P50-NS-20023, CA108786, CA11898]; Pew Charitable Trusts; Pediatric Brain Tumor Foundation Institute; Hirschhorn Foundation; Alex's Lemonade Stand Foundation; American Brain Tumor Association; American Society of Clinical Oncology; Brain Tumor Research Fund; Beckman Coulter Corporation; NATIONAL CANCER INSTITUTE [R37CA011898, R37CA057345, P50CA108786, R01CA057345, P50CA062924, R01CA011898, R01CA043460, R01CA121113, R37CA043460, T32CA009547, R01CA140316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052507, P50NS020023] Funding Source: NIH RePORTER	Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; Pediatric Brain Tumor Foundation Institute; Hirschhorn Foundation; Alex's Lemonade Stand Foundation; American Brain Tumor Association; American Society of Clinical Oncology; Brain Tumor Research Fund; Beckman Coulter Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Silliman, J. Ptak, L. Dobbyn, and M. Whalen for assistance with PCR amplification; D. Lister, L. J. Ehinger, D. L. Satterfield, J. D. Funkhouser, and P. Killela for assistance with DNA purification; T. Sjoblom for assistance with database management; the Agencourt sequencing team for assistance with automated sequencing; and C.-S. Liu and the SoftGenetics team for their assistance with mutation detection analyses. This project was carried out under the auspices of the Ludwig Brain Tumor Initiative and was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, NIH grants CA121113, NS052507, CA43460, CA57345, CA62924, CA09547, 5P50-NS-20023, CA108786, and CA11898, the Pew Charitable Trusts, the Pediatric Brain Tumor Foundation Institute, the Hirschhorn Foundation, Alex's Lemonade Stand Foundation, the American Brain Tumor Association, the American Society of Clinical Oncology, the Brain Tumor Research Fund and Beckman Coulter Corporation. Under separate licensing agreements between the Johns Hopkins University and Genzyme, Beckman Coulter, and Exact Sciences Corporations, B. V., V. E. V., and K.W. K. are entitled to a share of royalties received by the university on sales of products related to research described in this paper. These authors and the university own Genzyme and Exact Sciences stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by the Johns Hopkins University in accordance with its conflict-of-interest policies.	Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Ekins S, 2007, METH MOL B, V356, P319; Frederick L, 2000, CANCER RES, V60, P1383; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jennings GT, 1997, BIOCHEMISTRY-US, V36, P13743, DOI 10.1021/bi970916r; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KARCHIN R, 2008, STRUCTURAL MODELS MU; Kil IS, 2007, FREE RADICAL BIO MED, V43, P1197, DOI 10.1016/j.freeradbiomed.2007.07.009; Kim SY, 2007, MOL CELL BIOCHEM, V302, P27, DOI 10.1007/s11010-007-9421-x; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; KRAUSRUP.R, 1973, J COMP NEUROL, V148, P211, DOI 10.1002/cne.901480206; LEARY RJ, IN PRESS P NATL ACAD; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nekrutenko A, 1998, MOL BIOL EVOL, V15, P1674, DOI 10.1093/oxfordjournals.molbev.a025894; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHERER JH, 1940, AM J CANCER, V40, P159; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thiel G, 1995, ANTICANCER RES, V15, P2495; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Ueki K, 1996, CANCER RES, V56, P150; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Winter JM, 2006, CANCER BIOL THER, V5, P360, DOI 10.4161/cbt.5.4.2552; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200	47	4194	4440	9	399	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1807	1812		10.1126/science.1164382	http://dx.doi.org/10.1126/science.1164382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18772396	Green Accepted			2022-12-24	WOS:000259501300030
J	Cao, HM; Gerhold, K; Mayers, JR; Wiest, MM; Watkins, SM; Hotamisligil, GS				Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Wiest, Michelle M.; Watkins, Steven M.; Hotamisligil, Goekhan S.			Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism	CELL			English	Article							ACID-BINDING PROTEIN; STEAROYL-COA DESATURASE; FATTY-ACIDS; INSULIN-RESISTANCE; DIABETES-MELLITUS; KNOCKOUT MICE; OBESITY; EXPRESSION; LIVER; DIET	Dysregulation of lipid metabolism in individual tissues leads to systemic disruption of insulin action and glucose metabolism. Utilizing quantitative lipidomic analyses and mice deficient in adipose tissue lipid chaperones aP2 and mal1, we explored how metabolic alterations in adipose tissue are linked to whole-body metabolism through lipid signals. A robust increase in de novo lipogenesis rendered the adipose tissue of these mice resistant to the deleterious effects of dietary lipid exposure. Systemic lipid profiling also led to identification of C16:In7-palmitoleate as an adipose tissue-derived lipid hormone that strongly stimulates muscle insulin action and suppresses hepatosteatosis. Our data reveal a lipid-mediated endocrine network and demonstrate that adipose tissue uses lipokines such as C16: In7-palmitoleate to communicate with distant organs and regulate systemic metabolic homeostasis.	[Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Hotamisligil, Goekhan S.] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Wiest, Michelle M.; Watkins, Steven M.] Lip Technol, W Sacramento, CA 95691 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Cao, Haiming/P-4634-2016	Mayers, Jared/0000-0002-8607-1787	National Institutes of Health (NIH) [DK064360, DK71507-04]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, P30DK040561, R01DK064360, R90DK071507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Deniz Hotamisligil for artistic rendition and design input. We gratefully acknowledge the assistance of Harold Emsheimer and UyenThao Nguyen (Lipomics Technologies) for their help with composing the figures and performing statistic analyses, respectively. We are grateful to the members of the Hotamisligil Lab for their input and contributions, especially Masato Furuhashi for his help with the hyperinsulinemic-euglycemic clamp studies and Rebecca Foote for administrative support. This work was supported by a National Institutes of Health (NIH) grant DK064360 (to G. S. H.), and H. C. is supported by a NIH roadmap fellowship (DK71507-04) and the American Diabetes Association. M. M. W. and S. M. W. are employees of Lipomics Technologies (West Sacramento, CA). G. S. H. serves as a member of the scientific advisory board at Lipomics Technologies.	Avramoglu RK, 2006, CLIN CHIM ACTA, V368, P1, DOI 10.1016/j.cca.2005.12.026; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FIELD CJ, 1984, NUTR RES, V4, P743, DOI 10.1016/S0271-5317(84)80050-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Hiraoka-Yamamoto J, 2004, CLIN EXP PHARMACOL P, V31, P107, DOI 10.1111/j.1440-1681.2004.04121.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Waters KM, 1997, BBA-LIPID LIPID MET, V1349, P33, DOI 10.1016/S0005-2760(97)00069-6; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	31	776	812	3	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					933	944		10.1016/j.cell.2008.07.048	http://dx.doi.org/10.1016/j.cell.2008.07.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805087	Bronze, Green Accepted			2022-12-24	WOS:000259318100014
J	Li, N; DiCarlo, JJ				Li, Nuo; DiCarlo, James J.			Unsupervised natural experience rapidly alters invariant object representation in visual cortex	SCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; EYE-MOVEMENTS; NEURONAL RESPONSES; SINGLE NEURONS; RECOGNITION; SELECTIVITY; ATTENTION; SYSTEM	Object recognition is challenging because each object produces myriad retinal images. Responses of neurons from the inferior temporal cortex ( IT) are selective to different objects, yet tolerant ("invariant") to changes in object position, scale, and pose. How does the brain construct this neuronal tolerance? We report a form of neuronal learning that suggests the underlying solution. Targeted alteration of the natural temporal contiguity of visual experience caused specific changes in IT position tolerance. This unsupervised temporal slowness learning (UTL) was substantial, increased with experience, and was significant in single IT neurons after just 1 hour. Together with previous theoretical work and human object perception experiments, we speculate that UTL may reflect the mechanism by which the visual stream builds and maintains tolerant object representations.	[Li, Nuo; DiCarlo, James J.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Li, Nuo; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DiCarlo, JJ (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dicarlo@mit.edu			NIH [R01-EY014970]; The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Cox, R. Desimone, N. Kanwisher, J. Maunsell, and N. Rust for helpful comments and discussion, and J. Deutsch, B. Kennedy, M. Maloof, and R. Marini for technical support. This work was supported by the NIH (grant R01-EY014970) and The McKnight Endowment Fund for Neuroscience.	Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; Dill M, 2001, PERCEPTION, V30, P707, DOI 10.1068/p2953; Edelman S, 1997, NEURAL COMPUT, V9, P701, DOI 10.1162/neco.1997.9.4.701; Erickson CA, 1999, J NEUROSCI, V19, P10404; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASQUELIER T, 2007, 269 CBCL MIT; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; NAZIR T A, 1990, Spatial Vision, V5, P81, DOI 10.1163/156856890X00011; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	46	172	175	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1502	1507		10.1126/science.1160028	http://dx.doi.org/10.1126/science.1160028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787171	Green Accepted			2022-12-24	WOS:000259121800045
J	Castilla, J; Gonzalez-Romero, D; Saa, P; Morales, R; De Castro, J; Soto, C				Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio			Crossing the species barrier by PrPSc replication in vitro generates unique infectious Prions	CELL			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; MOLECULAR-BASIS; PROTEIN; SCRAPIE; TRANSMISSION; PATHOGENESIS; ADAPTATION; STRAINS	Prions are unconventional infectious agents composed exclusively of misfolded prion protein (PrPSc), which transmits the disease by propagating its abnormal conformation to the cellular prion protein (PrPC). A key characteristic of prions is their species barrier, by which prions from one species can only infect a limited number of other species. Here, we report the generation of infectious prions by interspecies transmission of PrPSc misfolding by in vitro PMCA amplification. Hamster PrPC misfolded by mixing with mouse PrPSc generated unique prions that were infectious to wild-type hamsters, and similar results were obtained in the opposite direction. Successive rounds of PMCA amplification result in adaptation of the in vitro-produced prions, in a process reminiscent of strain stabilization observed upon serial passage in vivo. Our results indicate that PMCA is a valuable tool for the investigation of cross-species transmission and suggest that species barrier and strain generation are determined by the propagation of PrP misfolding.	[Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Saa, Paula] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Morales, Rodrigo] Univ Chile, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Saa, Paula/AAB-6607-2019; Castilla, Joaquin/D-5261-2011; Castilla, Joaquín/J-8414-2019; Morales, Rodrigo/K-7173-2015	Saa, Paula/0000-0001-6077-4532; Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquín/0000-0002-2216-1361; 	National Institutes of Health [R01NS049173, P01AI77774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by National Institutes of Health grants R01NS049173 and P01AI77774 to C. S. C. S. is a founder of Amprion, Inc., a company focused on the development of a diagnosis for prion diseases through the use of the PMCA technology.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Buschmann A, 2005, BERL MUNCH TIERARZTL, V118, P365; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen SG, 2000, ARCH VIROL, P209; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Doherr MG, 2003, ACTA VET SCAND, P33; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Hill Andrew F., 2004, V11, P33; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 1998, MOL BIOTECHNOL, V9, P225, DOI 10.1007/BF02915795; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Moore RA, 2005, ARCH VIROL, P187; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sarafoff NN, 2005, J BIOCHEM BIOPH METH, V63, P213, DOI 10.1016/j.jbbm.2005.05.004; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weber P, 2007, VET MICROBIOL, V123, P346, DOI 10.1016/j.vetmic.2007.04.004; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Xie ZL, 2006, J BIOL CHEM, V281, P4199, DOI 10.1074/jbc.M509052200	44	143	145	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					757	768		10.1016/j.cell.2008.07.030	http://dx.doi.org/10.1016/j.cell.2008.07.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775309	Bronze, Green Accepted			2022-12-24	WOS:000258947500016
J	Ackermann, M; Stecher, B; Freed, NE; Songhet, P; Hardt, WD; Doebeli, M				Ackermann, Martin; Stecher, Baerbel; Freed, Nikki E.; Songhet, Pascal; Hardt, Wolf-Dietrich; Doebeli, Michael			Self-destructive cooperation mediated by phenotypic noise	NATURE			English	Article							GENE-EXPRESSION; IN-VIVO; EVOLUTION; INFECTION	In many biological examples of cooperation, individuals that cooperate cannot benefit from the resulting public good. This is especially clear in cases of self- destructive cooperation, where individuals die when helping others. If self- destructive cooperation is genetically encoded, these genes can only be maintained if they are expressed by just a fraction of their carriers, whereas the other fraction benefits from the public good. One mechanism that can mediate this differentiation into two phenotypically different sub- populations is phenotypic noise(1,2). Here we show that noisy expression of self- destructive cooperation can evolve if individuals that have a higher probability for self- destruction have, on average, access to larger public goods. This situation, which we refer to as assortment, can arise if the environment is spatially structured. These results provide a new perspective on the significance of phenotypic noise in bacterial pathogenesis: it might promote the formation of cooperative sub- populations that die while preparing the ground for a successful infection. We show experimentally that this model captures essential features of Salmonella typhimurium pathogenesis. We conclude that noisily expressed self- destructive cooperative actions can evolve under conditions of assortment, that self- destructive cooperation is a plausible biological function of phenotypic noise, and that self- destructive cooperation mediated by phenotypic noise could be important in bacterial pathogenesis.	[Ackermann, Martin; Freed, Nikki E.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Stecher, Baerbel; Songhet, Pascal; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Doebeli, Michael] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Doebeli, Michael] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of British Columbia; University of British Columbia	Ackermann, M (corresponding author), ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland.	martin.ackermann@env.ethz.ch; hardt@micro.biol.ethz.ch; doebeli@zoology.ubc.ca	Stecher, Bärbel/A-2911-2015; Ackermann, Martin/V-4554-2017; Stecher, Barbel/B-9940-2019; Doebeli, Michael/D-5391-2012	Stecher, Bärbel/0000-0002-7445-5193; Ackermann, Martin/0000-0003-0087-4819; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Roche Research Foundation; Novartis Foundation; NSERC ( Canada); UBS foundation; ETH research foundation [TH-10 06-1]; Swiss National Science Foundation [310000-113623/1]; European Union [SavinMucoPath number 032296]	Roche Research Foundation; Novartis Foundation(Novartis); NSERC ( Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBS foundation; ETH research foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	We are grateful to Markus Schlumberger, K. Aktories, I. Just, S. Hammerschmidt and J. Fletcher for discussions, and M. Barthel and the RCHCI team for professional help with the animal experiments. M. A. and N. E. F. were supported by the Swiss National Science Foundation, and M. A. was also supported by the Roche Research Foundation and the Novartis Foundation. M. D. is supported by NSERC ( Canada). B. S. and W.- D. H. were supported by the UBS foundation. Salmonella work in the Hardt laboratory is supported by grants from the ETH research foundation (TH- 10 06- 1), the Swiss National Science Foundation (310000-113623/1) and the European Union ( SavinMucoPath number 032296).	Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Brown SP, 2008, ECOL LETT, V11, P44, DOI 10.1111/j.1461-0248.2007.01125.x; BULL JJ, 1987, EVOLUTION, V41, P303, DOI 10.1111/j.1558-5646.1987.tb05799.x; CHARLESWORTH B, 1978, J THEOR BIOL, V72, P297, DOI 10.1016/0022-5193(78)90095-4; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; MAY RM, 1995, P ROY SOC B-BIOL SCI, V261, P209, DOI 10.1098/rspb.1995.0138; Metz J. A. J., 1996, STOCHASTIC SPATIAL S, P183; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Wolf DM, 2005, J THEOR BIOL, V234, P255, DOI 10.1016/j.jtbi.2004.11.021	29	282	283	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					987	990		10.1038/nature07067	http://dx.doi.org/10.1038/nature07067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18719588				2022-12-24	WOS:000258591000037
J	Ewald, SE; Lee, BL; Lau, L; Wickliffe, KE; Shi, GP; Chapman, HA; Barton, GM				Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Shi, Guo-Ping; Chapman, Harold A.; Barton, Gregory M.			The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor	NATURE			English	Article							ANTIGEN PRESENTATION; STRANDED-RNA; CPG-DNA; TLR9; ER; TOLL-LIKE-RECEPTOR-9; RECOGNITION; CATHEPSINS; RESPONSES; MEMBRANE	Mammalian Toll-like receptors (TLRs) 3, 7, 8 and 9 initiate immune responses to infection by recognizing microbial nucleic acids(1,2); however, these responses come at the cost of potential autoimmunity owing to inappropriate recognition of self nucleic acids(3). The localization of TLR9 and TLR7 to intracellular compartments seems to have a role in facilitating responses to viral nucleic acids while maintaining tolerance to self nucleic acids, yet the cell biology regulating the transport and localization of these receptors remains poorly understood(4-6). Here we define the route by which TLR9 and TLR7 exit the endoplasmic reticulum and travel to endolysosomes in mouse macrophages and dendritic cells. The ectodomains of TLR9 and TLR7 are cleaved in the endolysosome, such that no full- length protein is detectable in the compartment where ligand is recognized. Notably, although both the full- length and cleaved forms of TLR9 are capable of binding ligand, only the processed form recruits MyD88 on activation, indicating that this truncated receptor, rather than the full- length form, is functional. Furthermore, conditions that prevent receptor proteolysis, including forced TLR9 surface localization, render the receptor non- functional. We propose that ectodomain cleavage represents a strategy to restrict receptor activation to endolysosomal compartments and prevent TLRs from responding to self nucleic acids.	[Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shi, Guo-Ping] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chapman, Harold A.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, 405 Life Sci Addit, Berkeley, CA 94720 USA.	barton@berkeley.edu	Ewald, Sarah/AAM-8918-2020	Ewald, Sarah/0000-0002-5327-7578; Barton, Gregory/0000-0002-3793-0100	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH [HL67204, CA009179, AI072429]; NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429] Funding Source: NIH RePORTER	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Barton and Vance laboratories for discussions, S. Akira for providing TLR knockout mice, and R. Vance and R. Medzhitov for advice. We acknowledge the CHPS Imaging Core and P. Herzmark for assistance with microscopy. This work was supported by a Novel Research Grant from The Lupus Research Institute (G.M.B.), the Hellman Faculty Fund (G.M.B.), and NIH grants HL67204 (H.A.C.), CA009179 (S.E.E.) and AI072429 (G.M.B.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Clair JMS, 2006, BIOL CHEM, V387, P1143, DOI 10.1515/BC.2006.141; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297	23	456	467	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					658	U88		10.1038/nature07405	http://dx.doi.org/10.1038/nature07405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18820679	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000261340000045
J	Hirota, K; Miyoshi, T; Kugou, K; Hoffman, CS; Shibata, T; Ohta, K				Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Hoffman, Charles S.; Shibata, Takehiko; Ohta, Kunihiro			Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs	NATURE			English	Article							BETA-GLOBIN LOCUS; PROTEIN-KINASE-A; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; INTERGENIC TRANSCRIPTION; RECOMBINATION HOTSPOT; GENE; ACTIVATION; RESOLUTION; ADE6-M26	Recent transcriptome analyses using high- density tiling arrays(1-3) and data from large- scale analyses of full- length complementary DNA libraries by the FANTOM3 consortium(4,5) demonstrate that many transcripts are non- coding RNAs ( ncRNAs). These transcriptome analyses indicate that many of the non- coding regions, previously thought to be functionally inert, are actually transcriptionally active regions with various features. Furthermore, most relatively large ( several kilobases) polyadenylated messenger RNA transcripts are transcribed from regions harbouring little coding potential. However, the function of such ncRNAs is mostly unknown and has been a matter of debate(2). Here we show that RNA polymerase II ( RNAPII) transcription of ncRNAs is required for chromatin remodelling at the fission yeast Schizosaccharomyces pombe fbp1(+) locus during transcriptional activation. The chromatin at fbp1(+) is progressively converted to an open configuration, as several species of ncRNAs are transcribed through fbp1(+). This is coupled with the translocation of RNAPII through the region upstream of the eventual fbp1(+) transcriptional start site. Insertion of a transcription terminator into this upstream region abolishes both the cascade of transcription of ncRNAs and the progressive chromatin alteration. Our results demonstrate that transcription through the promoter region is required to make DNA sequences accessible to transcriptional activators and to RNAPII.	[Hirota, Kouji; Kugou, Kazuto; Shibata, Takehiko; Ohta, Kunihiro] RIKEN, Adv Sci Inst, Mol & Cellular Biol Lab, Wako, Saitama 3510198, Japan; [Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Ohta, Kunihiro] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Hoffman, Charles S.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	RIKEN; University of Tokyo; Boston College	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	khirota@rg.med.kyoto-u.ac.jp; kohta@bio.c.u-tokyo.ac.jp		Hoffman, Charles/0000-0001-8700-1863; Kugou, Kazuto/0000-0002-7690-1249; Miyoshi, Tomoichiro/0000-0002-5319-7877	Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046226] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Lin for critically reading this manuscript. This work was supported by grants-in-aid for scientific research in a priority area, the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hayashizaki Y, 2006, PLOS GENET, V2, P492, DOI 10.1371/journal.pgen.0020063; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Hirota K, 2006, EUKARYOT CELL, V5, P1980, DOI 10.1128/EC.00272-06; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Janoo RTK, 2001, GENETICS, V157, P1205; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; WOLFFE AP, 1997, CHROMATIN STRUCTURE	24	197	205	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					130	U15		10.1038/nature07348	http://dx.doi.org/10.1038/nature07348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820678				2022-12-24	WOS:000260674000055
J	Yildiz, A; Tomishige, M; Gennerich, A; Vale, RD				Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.			Intramolecular strain coordinates kinesin stepping behavior along microtubules	CELL			English	Article							HAND-OVER-HAND; PROCESSIVE MOTOR; DIMERIC KINESIN; ATP HYDROLYSIS; NECK LINKER; MYOSIN-V; MECHANISM; MOLECULE; FORCE; HEAD	Kinesin advances 8 nm along a microtubule per ATP hydrolyzed, but the mechanism responsible for coordinating the enzymatic cycles of kinesin's two identical motor domains remains unresolved. Here, we have tested whether such coordination is mediated by intramolecular tension generated by the "neck linkers,'' mechanical elements that span between the motor domains. When tension is reduced by extending the neck linkers with artificial peptides, the coupling between ATP hydrolysis and forward stepping is impaired and motor's velocity decreases as a consequence. However, speed recovers to nearly normal levels when external tension is applied by an optical trap. Remarkably, external load also induces bidirectional stepping of an immotile kinesin that lacks its mechanical element (neck linker) and fuel (ATP). Our results indicate that the kinesin motor domain senses and responds to strain in a manner that facilitates its plus-end-directed stepping and communication between its two motor domains.	[Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Tomishige, Michio] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019; Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund; German Research Foundation [GE 1609/1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499, R37GM038499] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. P. Carter and N. Zhang for their help with protein purification and cloning and J. Kerssemakers and M. Dogterom for supplying their step finding algorithm. This work has been supported by Jane Coffin Childs Memorial Fund (A.Y. and A.G.), Burroughs Wellcome Fund (A.Y.), German Research Foundation (GE 1609/1 [A.G.]), and the Howard Hughes Medical Institute.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Schief WR, 2004, P NATL ACAD SCI USA, V101, P1183, DOI 10.1073/pnas.0304369101; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	46	220	226	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1030	1041		10.1016/j.cell.2008.07.018	http://dx.doi.org/10.1016/j.cell.2008.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805095	Green Accepted, Bronze			2022-12-24	WOS:000259318100022
J	Filippakopoulos, P; Kofler, M; Hantschel, O; Gish, GD; Grebien, F; Salah, E; Neudecker, P; Kay, LE; Turk, BE; Superti-Furga, G; Pawson, T; Knapp, S				Filippakopoulos, Panagis; Kofler, Michael; Hantschel, Oliver; Gish, Gerald D.; Grebien, Florian; Salah, Eidarus; Neudecker, Philipp; Kay, Lewis E.; Turk, Benjamin E.; Superti-Furga, Giulio; Pawson, Tony; Knapp, Stefan			Structural coupling of SH2-kinase domains links fes and Abl substrate recognition and kinase activation	CELL			English	Article							PROTEIN-TYROSINE KINASE; FUJINAMI SARCOMA-VIRUS; TERMINAL SRC KINASE; C-ABL; CELL-ADHESION; V-FPS; PROCESSIVE PHOSPHORYLATION; ACTIVE CONFORMATION; CRYSTAL-STRUCTURE; FAMILY KINASES	The SH2 domain of cytoplasmic tyrosine kinases can enhance catalytic activity and substrate recognition, but the molecular mechanisms by which this is achieved are poorly understood. We have solved the structure of the prototypic SH2-kinase unit of the human Fes tyrosine kinase, which appears specialized for positive signaling. In its active conformation, the SH2 domain tightly interacts with the kinase N-terminal lobe and positions the kinase alpha C helix in an active configuration through essential packing and electrostatic interactions. This interaction is stabilized by ligand binding to the SH2 domain. Our data indicate that Fes kinase activation is closely coupled to substrate recognition through cooperative SH2-kinase-substrate interactions. Similarly, we find that the SH2 domain of the active Abl kinase stimulates catalytic activity and substrate phosphorylation through a distinct SH2-kinase interface. Thus, the SH2 and catalytic domains of active Fes and Abl pro-oncogenic kinases form integrated structures essential for effective tyrosine kinase signaling.	[Hantschel, Oliver; Grebien, Florian; Superti-Furga, Giulio] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; [Filippakopoulos, Panagis; Salah, Eidarus; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Kofler, Michael; Gish, Gerald D.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Neudecker, Philipp; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	Austrian Academy of Sciences; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Yale University; University of Toronto; University of Oxford	Superti-Furga, G (corresponding author), Austrian Acad Sci, Ctr Mol Med, Lazarettgasse 19, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at; pawson@mshri.on.ca; stefan.knapp@sgc.ox.ac.uk	Superti-Furga, Giulio/AAE-5681-2019; Neudecker, Philipp/G-5265-2013; Hantschel, Oliver D/H-4705-2013; Neudecker, Philipp/AAP-9005-2020; Grebien, Florian/H-9234-2019; Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013; Superti-Furga, Giulio/F-4755-2015; Knapp, Stefan/AAG-2347-2019; Hantschel, Oliver/M-7016-2019	Neudecker, Philipp/0000-0002-0557-966X; Hantschel, Oliver D/0000-0001-8569-8169; Neudecker, Philipp/0000-0002-0557-966X; Grebien, Florian/0000-0003-4289-2281; Superti-Furga, Giulio/0000-0002-0570-1768; Knapp, Stefan/0000-0001-5995-6494; Hantschel, Oliver/0000-0001-8569-8169; Filippakopoulos, Panagis/0000-0002-1515-1317	Canadian Institutes for Health Research (CIHR ) [MOP-6849, MOP-13466]; National Cancer Institute of Canada; Canadian Cancer Society; Genome Canada; Ontario Summit Award; Structural Genomics Consortium [1097737]; CIHR; Canadian Foundation for Innovation; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Foundation for Strategic Research; Wellcome Trust; Austrian Science Fund FWF [P18737-B11]	Canadian Institutes for Health Research (CIHR )(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada(Genome Canada); Ontario Summit Award; Structural Genomics Consortium(University of Toronto); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund FWF(Austrian Science Fund (FWF))	We thank Neil Warner for synthesis of the Spots blot membrane and Cristina Virag for excellent technical assistance, Karel Dorey for the initial observation of a positive function of the Abl SH2 domain, and Bhushan Nagar and John Kuriyan for a long-standing collaboration on the role of the SH2 domain in Abl regulation. This research was supported by grants from the Canadian Institutes for Health Research (CIHR grant numbers MOP-6849 and MOP-13466); the National Cancer Institute of Canada with funds from the Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute; and an Ontario Summit Award to T. P. T. P. is a Distinguished Scientist of the CIHR. S. K., E. S., and P. F. are funded by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the CIHR, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Foundation for Strategic Research, and the Wellcome Trust. G. S.-F., O. H., and F. G. are funded by the Austrian Science Fund FWF (grant number P18737-B11).	Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; BROOKSWILSON AR, 1989, MOL CELL BIOL, V9, P2214, DOI 10.1128/MCB.9.5.2214; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eswaran J, 2008, STRUCTURE, V16, P115, DOI 10.1016/j.str.2007.10.026; Evans P., 2007, SCALA SCALE TOGETHER; FOSTER DA, 1985, CELL, V42, P105, DOI 10.1016/S0092-8674(85)80106-9; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; GREER P, 1994, MOL CELL BIOL, V14, P6755, DOI 10.1128/MCB.14.10.6755; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; GROFFEN J, 1983, VIROLOGY, V125, P480, DOI 10.1016/0042-6822(83)90219-2; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; HJERMSTAD SJ, 1993, ONCOGENE, V8, P2283; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Jucker M, 1997, J BIOL CHEM, V272, P2104; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LEE WH, 1980, P NATL ACAD SCI-BIOL, V77, P2018, DOI 10.1073/pnas.77.4.2018; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; LESLIE AGW, 2007, MOSFLM; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parsons SA, 2007, IMMUNOLOGY, V122, P542, DOI 10.1111/j.1365-2567.2007.02670.x; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Read RD, 1997, J BIOL CHEM, V272, P18498, DOI 10.1074/jbc.272.29.18498; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; SHIBUYA M, 1980, P NATL ACAD SCI-BIOL, V77, P6536, DOI 10.1073/pnas.77.11.6536; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; STONE JC, 1984, CELL, V37, P549, DOI 10.1016/0092-8674(84)90385-4; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; WEINMASTER G, 1984, CELL, V37, P559, DOI 10.1016/0092-8674(84)90386-6; WEINMASTER G, 1982, J CELL BIOCHEM, V20, P337, DOI 10.1002/jcb.240200404; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	54	146	150	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					793	803		10.1016/j.cell.2008.07.047	http://dx.doi.org/10.1016/j.cell.2008.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775312	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000258947500019
J	Alekseyenko, AA; Peng, SY; Larschan, E; Gorchakov, AA; Lee, OK; Kharchenko, P; McGrath, SD; Wang, CI; Mardis, ER; Park, PJ; Kuroda, MI				Alekseyenko, Artyom A.; Peng, Shouyong; Larschan, Erica; Gorchakov, Andrey A.; Lee, Ok-Kyung; Kharchenko, Peter; McGrath, Sean D.; Wang, Charlotte I.; Mardis, Elaine R.; Park, Peter J.; Kuroda, Mitzi I.			A sequence motif within chromatin entry sites directs MSL establishment on the Drosophila X chromosome	CELL			English	Article							DOSAGE COMPENSATION COMPLEX; ROX RNA GENES; BINDING-SITES; DNA-BINDING; INACTIVATION CENTER; TARGET GENES; PROTEIN; TRANSCRIPTION; REVEALS; GENOME	The Drosophila MSL complex associates with active genes specifically on the male X chromosome to acetylate histone H4 at lysine 16 and increase expression approximately 2-fold. To date, no DNA sequence has been discovered to explain the specificity of MSL binding. We hypothesized that sequence-specific targeting occurs at "chromatin entry sites,'' but the majority of sites are sequence independent. Here we characterize 150 potential entry sites by ChIP-chip and ChIP-seq and discover a GA-rich MSL recognition element (MRE). The motif is only slightly enriched on the X chromosome (similar to 2fold), but this is doubled when considering its preferential location within or 30 to active genes (> 4-fold enrichment). When inserted on an autosome, a newly identified site can direct local MSL spreading to flanking active genes. These results provide strong evidence for both sequence-dependent and -independent steps in MSL targeting of dosage compensation to the male X chromosome.	[Alekseyenko, Artyom A.; Peng, Shouyong; Larschan, Erica; Gorchakov, Andrey A.; Lee, Ok-Kyung; Park, Peter J.; Kuroda, Mitzi I.] Brigham & Womens Hosp, Dept Med, Div Genet, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Wang, Charlotte I.; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Peng, Shouyong; Kharchenko, Peter; Park, Peter J.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Washington University (WUSTL); Washington University (WUSTL)	Park, PJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, Harvard Partners Ctr Genet & Genom, 75 Francis St, Boston, MA 02115 USA.	peter_park@harvard.edu; mkuroda@genetics.med.harvard.edu	Gorchakov, Andrey A/N-5840-2015; Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020	Gorchakov, Andrey A/0000-0003-2830-4236; McGrath, Sean David/0000-0001-9064-8449; Park, Peter/0000-0001-9378-960X	National Institutes of Health [GM45744, GM67825, HG003079]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, K25GM067825, R01GM045744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Many thanks to M. Gelbart, T. Sural, P. Yang, and M. Tolstorukov for critical comments on the manuscript; H. Oh, J. Bateman, T. Wu, J. Bischof, F. Karch, and K. Basler for key fly stocks; S. Elgin for important discussions; Y. Schwartz and T. Kahn for sharing protocols; and J. Racine and A. Sarovschii for technical assistance. This work was supported by the National Institutes of Health: GM45744 to M. I. K., GM67825 to P. J. P., and HG003079 to E. R. M. (co-PI).	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; Demakova OV, 2003, CHROMOSOMA, V112, P103, DOI 10.1007/s00412-003-0249-1; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fagegaltier D, 2004, PLOS BIOL, V2, P1854, DOI 10.1371/journal.pbio.0020341; Gallach M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-408; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Gilfillan GD, 2007, NUCLEIC ACIDS RES, V35, P3561, DOI 10.1093/nar/gkm282; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Lyman LM, 1997, GENETICS, V147, P1743; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oh H, 2004, CURR BIOL, V14, P481, DOI 10.1016/j.cub.2004.03.004; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; PALMER MJ, 1994, GENE DEV, V8, P698, DOI 10.1101/gad.8.6.698; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Stenberg P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-158; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	51	199	201	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 22	2008	134	4					599	609		10.1016/j.cell.2008.06.033	http://dx.doi.org/10.1016/j.cell.2008.06.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724933	Green Accepted, Bronze			2022-12-24	WOS:000258665800014
J	Kraft, NJB; Valencia, R; Ackerly, DD				Kraft, Nathan J. B.; Valencia, Renato; Ackerly, David D.			Functional traits and niche-based tree community assembly in an amazonian forest	SCIENCE			English	Article							DISTRIBUTIONS; STRATEGIES; HERBIVORES; MECHANISMS; DIVERSITY	It is debated whether species-level differences in ecological strategy, which play a key role in much of coexistence theory, are important in structuring highly diverse communities. We examined the co-occurrence patterns of over 1100 tree species in a 25-hectare Amazonian forest plot in relation to field-measured functional traits. Using a null model approach, we show that co-occurring trees are often less ecologically similar than a niche-free (neutral) model predicts. Furthermore, we find evidence for processes that simultaneously drive convergence and divergence in key aspects of plant strategy, suggesting that at least two distinct niche-based processes are occurring. Our results show that strategy differentiation among species contributes to the maintenance of diversity in one of the most diverse tropical forests in the world.	[Kraft, Nathan J. B.; Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Valencia, Renato] Pontificia Univ Catolica Ecuador, Lab Ecol Plantas, Escuela Ciencias Biol, Quito, Ecuador	University of California System; University of California Berkeley; Pontificia Universidad Catolica del Ecuador	Kraft, NJB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.		Ackerly, David/A-1247-2009; Kraft, Nathan J. B./A-2817-2012	Ackerly, David/0000-0002-1847-7398; Kraft, Nathan J. B./0000-0001-8867-7806; Valencia, Renato/0000-0001-9770-6568	Center for Tropical Forest Science; University of California, Berkeley; Department of Integrative Biology; NSF [DEB-614525, DEB-614055, DEB-614659]	Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of California, Berkeley(University of California System); Department of Integrative Biology; NSF(National Science Foundation (NSF))	N.I.B.K. is grateful to A. Martin, L. Williams, P. Avia, and L. Dunn for field assistance and to A. Thompson, T. Aftandilians, and M. Piven for help with sample analysis. Leaf trait collection was supported by the Center for Tropical Forest Science and the University of California, Berkeley, Department of Integrative Biology. We benefited from interactions with R. Condit, W. Cornwell, P. Fine, S. Kembel, J. Lake, M. Metz, N. Swenson, and four anonymous reviewers. S. J. Wright and N. Gat-wood generously provided unpublished seed data front collection efforts supported by NSF grants DEB-614525, DEB-614055, and DEB-614659. R.V. thanks the government of Ecuador (Donaciones de Impuesto a la Rento 2004-2006), Pontificia Universidad Catolica del Ecuador, the Mellon Foundation, the Tapper Family Foundation, the Smithsonian Tropical Research Institute, and NSF (grants DEB-0090311 and DEB-9806828) for support of the forest census. This research was possible because of the kind permission of the Ministerio del Ambiente of Ecuador.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; CORNWELL WK, ECOL MONOGR IN PRESS, DOI DOI 10.1890/07-1134.A; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	27	772	853	23	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					580	582		10.1126/science.1160662	http://dx.doi.org/10.1126/science.1160662			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948539				2022-12-24	WOS:000260299100041
J	Kunkes, EL; Simonetti, DA; West, RM; Serrano-Ruiz, JC; Gartner, CA; Dumesic, JA				Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.			Catalytic conversion of biomass to monofunctional hydrocarbons and targeted liquid-fuel classes	SCIENCE			English	Article							ALKANES; HYDROGENATION; CONDENSATION; METAL; REDUCTION; ETHANOL; MIBK	It is imperative to develop more efficient processes for conversion of biomass to liquid fuels, such that the cost of these fuels would be competitive with the cost of fuels derived from petroleum. We report a catalytic approach for the conversion of carbohydrates to specific classes of hydrocarbons for use as liquid transportation fuels, based on the integration of several flow reactors operated in a cascade mode, where the effluent from the one reactor is simply fed to the next reactor. This approach can be tuned for production of branched hydrocarbons and aromatic compounds in gasoline, or longer-chain, less highly branched hydrocarbons in diesel and jet fuels. The liquid organic effluent from the first flow reactor contains monofunctional compounds, such as alcohols, ketones, carboxylic acids, and heterocycles, that can also be used to provide reactive intermediates for fine chemicals and polymers markets.	[Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Serrano-Ruiz, Juan Carlos/U-6297-2018; Gaertner, Christian/A-7509-2011	Serrano-Ruiz, Juan Carlos/0000-0002-9078-7390; 	U.S. Department of Energy Office of Basic Energy Sciences; NSF Chemical and Transport Systems Division of the Directorate for Engineering; German Academic Exchange Service (DAAD); Spanish Ministry of Science and Innovation	U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Chemical and Transport Systems Division of the Directorate for Engineering(National Science Foundation (NSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the U.S. Department of Energy Office of Basic Energy Sciences and the NSF Chemical and Transport Systems Division of the Directorate for Engineering. We thank M. Mavrikakis for valuable discussions throughout this project, and E.I. Gurbuz for help with flow reactor experiments. J.C.S.-R. thanks the Spanish Ministry of Science and Innovation for postdoctoral support; C.A.G. thanks the German Academic Exchange Service (DAAD) for a scholarship. J.A.D. owns founders stock in Virent Energy Systems, a company with interest in the area of this research. The Wisconsin Alumni Research Foundation at University of Wisconsin has applied for a patent based partly on the work described here.	Alcala R, 2003, J CATAL, V218, P178, DOI 10.1016/S0021-9517(03)00090-3; Barlow M. T., 1983, Fuel composition. Eur. Pat., Patent No. [EP0082689, 0082689]; BARRATT DJ, 1999, Patent No. 5925152; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; BOND GC, 1965, J CATAL, V4, P211, DOI 10.1016/0021-9517(65)90011-4; BRIDGWATER AV, 1994, APPL CATAL A-GEN, V116, P5, DOI 10.1016/0926-860X(94)80278-5; Carlini C, 2004, J MOL CATAL A-CHEM, V220, P215, DOI 10.1016/j.molcata.2004.05.034; Cho CS, 2005, J MOL CATAL A-CHEM, V240, P55, DOI 10.1016/j.molcata.2005.06.043; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Davda RR, 2005, APPL CATAL B-ENVIRON, V56, P171, DOI 10.1016/j.apcatb.2004.04.027; Di Cosimo JI, 2002, J CATAL, V208, P114, DOI 10.1006/jcat.2002.3551; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Klass DL., 1998, BIOMASS RENEWABLE EN; Lopez J, 2002, J CATAL, V208, P30, DOI 10.1006/jcat.2002.3563; MCMURRY J, 2000, ORGANIC CHEM, P938; Nagashima O, 2005, J MOL CATAL A-CHEM, V227, P231, DOI 10.1016/j.molcata.2004.10.042; Nikolopoulos AA, 2005, APPL CATAL A-GEN, V296, P128, DOI 10.1016/j.apcata.2005.08.022; Pallassana V, 2002, J CATAL, V209, P289, DOI 10.1006/jcat.2002.3585; Perrard A, 2007, APPL CATAL A-GEN, V331, P100, DOI 10.1016/j.apcata.2007.07.033; POWELL SG, 1948, J AM CHEM SOC, V70, P3627, DOI 10.1021/ja01191a027; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; TAKIZAWA TH, 1994, Patent No. 5925152; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Zhang JL, 2005, J AM CHEM SOC, V127, P12480, DOI 10.1021/ja053695i	28	763	832	19	596	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					417	421		10.1126/science.1159210	http://dx.doi.org/10.1126/science.1159210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801970				2022-12-24	WOS:000260094500040
J	Ludwig, DS; Kabat-Zinn, J				Ludwig, David S.; Kabat-Zinn, Jon			Mindfulness in medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS REDUCTION; MEDITATION; PROGRAM		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Kabat-Zinn, Jon] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Grepmair L, 2007, PSYCHOTHER PSYCHOSOM, V76, P332, DOI 10.1159/000107560; Groopman J, 2007, DOCTORS THINK; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Proulx Kathryn, 2008, Eat Disord, V16, P52, DOI 10.1080/10640260701773496; Santorelli S, 1998, HEAL THY SELF; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	15	467	474	7	189	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1350	1352		10.1001/jama.300.11.1350	http://dx.doi.org/10.1001/jama.300.11.1350			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	348ST	18799450				2022-12-24	WOS:000259231100033
J	Nygaard, I; Barber, MD; Burgio, KL; Kenton, K; Meikle, S; Schaffer, J; Spino, C; Whitehead, WE; Wu, J; Brody, DJ				Nygaard, Ingrid; Barber, Matthew D.; Burgio, Kathryn L.; Kenton, Kimberly; Meikle, Susan; Schaffer, Joseph; Spino, Cathie; Whitehead, William E.; Wu, Jennifer; Brody, Debra J.		Pelvic Floor Disorders Network	Prevalence of symptomatic pelvic floor disorders in US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; FEMALE URINARY-INCONTINENCE; FECAL INCONTINENCE; GENITAL PROLAPSE; ORGAN PROLAPSE; ANAL INCONTINENCE; NATIONAL-HEALTH; SEVERITY INDEX; RISK-FACTORS; COMMUNITY	Context Pelvic floor disorders ( urinary incontinence, fecal incontinence, and pelvic organ prolapse) affect many women. No national prevalence estimates derived from the same population- based sample exists for multiple pelvic floor disorders in women in the United States. Objective To provide national prevalence estimates of symptomatic pelvic floor disorders in US women. Design, Setting, and Participants A cross- sectional analysis of 1961 nonpregnant women ( >= 20 years) who participated in the 2005- 2006 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Women were interviewed in their homes and then underwent standardized physical examinations in a mobile examination center. Urinary incontinence ( score of >= 3 on a validated incontinence severity index, constituting moderate to severe leakage), fecal incontinence ( at least monthly leakage of solid, liquid, or mucous stool), and pelvic organ prolapse ( seeing/ feeling a bulge in or outside the vagina) symptoms were assessed. Main Outcome Measures Weighted prevalence estimates of urinary incontinence, fecal incontinence, and pelvic organ prolapse symptoms. Results The weighted prevalence of at least 1 pelvic floor disorder was 23.7% ( 95% confidence interval [ CI], 21.2%- 26.2%), with 15.7% of women ( 95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women ( 95% CI, 7.3%- 10.7%) experiencing fecal incontinence, and 2.9% of women ( 95% CI, 2.1%- 3.7%) experiencing pelvic organ prolapse. The proportion of women reporting at least 1 disorder increased incrementally with age, ranging from 9.7% ( 95% CI, 7.8%- 11.7%) in women between ages 20 and 39 years to 49.7% ( 95% CI, 40.3%- 59.1%) in those aged 80 years or older ( P <. 001), and parity ( 12.8% [ 95% CI, 9.0%- 16.6%], 18.4% [ 95% CI, 12.9%- 23.9%], 24.6% [ 95% CI, 19.5%- 29.8%], and 32.4% [ 95% CI, 27.8%-37.1%] for 0, 1, 2, and 3 or more deliveries, respectively; P <. 001). Overweight and obese women were more likely to report at least 1 pelvic floor disorder than normal weight women ( 26.3% [ 95% CI, 21.7%- 30.9%], 30.4% [ 95% CI, 25.8%- 35.0%], and 15.1% [ 95% CI, 11.6%- 18.7%], respectively; P <. 001). We detected no differences in prevalence by racial/ ethnic group. Conclusion Pelvic floor disorders affect a substantial proportion of women and increase with age.	[Nygaard, Ingrid] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Barber, Matthew D.] Obstet Gynecol & Womens Hlth Inst, Cleveland, OH USA; [Barber, Matthew D.] Cleveland Clin, Cleveland, OH 44106 USA; [Burgio, Kathryn L.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Burgio, Kathryn L.] Dept Vet Affairs, Birmingham, AL USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Obstet & Gynecol, Maywood, IL 60153 USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Urol, Maywood, IL 60153 USA; [Meikle, Susan] NICHHD, Bethesda, MD 20892 USA; [Schaffer, Joseph] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Spino, Cathie] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Whitehead, William E.] Univ N Carolina, Sch Med, Dept Internal Med, Chapel Hill, NC USA; [Wu, Jennifer] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Brody, Debra J.] Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Loyola University Chicago; Loyola University Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Nygaard, I (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, 30 N 1900 E, Salt Lake City, UT 84132 USA.	ingrid.nygaard@hsc.utah.edu	Wu, Jennifer/GRX-1831-2022	Wu, Jennifer/0000-0002-3171-1054; Wu, Jennifer/0000-0002-4477-3932	Eunice Kennedy Shriver NICHD [U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, U10 HD54215]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054214, U10HD041250, U10HD054136, U10HD041267, U10HD041261, UG1HD041267, U10HD054215] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD041248, U01HD041249, U10HD041263, U10HD041269, U10HD041268] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, and U10 HD54215 from the Eunice Kennedy Shriver NICHD and funding from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health Office of Research on Women's Health.	Abramov Y, 2005, OBSTET GYNECOL, V106, P726, DOI 10.1097/01.AOG.0000161367.65261.16; Anger JT, 2006, J UROLOGY, V175, P601, DOI 10.1016/S0022-5347(05)00242-9; [Anonymous], 2000, Eur J Obstet Gynecol Reprod Biol, V93, P135; Barber MD, 2006, AM J OBSTET GYNECOL, V195, P942, DOI 10.1016/j.ajog.2006.02.050; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006; Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030; Bradley CS, 2005, OBSTET GYNECOL, V106, P759, DOI 10.1097/01.AOG.0000180183.03897.72; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Eva UF, 2003, ACTA OBSTET GYN SCAN, V82, P280, DOI 10.1034/j.1600-0412.2003.00103.x; FANTL J, 1996, PUBLICATION US DEP H; Ghetti C, 2005, AM J OBSTET GYNECOL, V193, P53, DOI 10.1016/j.ajog.2004.12.004; Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x; Graham CA, 2001, AM J OBSTET GYNECOL, V185, P116, DOI 10.1067/mob.2001.114914; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hunskaar S, 2005, INCONTINENCE, VOLS 1 AND 2, P255; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Melville JL, 2005, OBSTET GYNECOL, V106, P585, DOI 10.1097/01.AOG.0000173985.39533.37; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Ostbye T, 2004, CAN J AGING, V23, P319, DOI 10.1353/cja.2005.0024; Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; Sandvik H, 2006, INT UROGYNECOL J, V17, P520, DOI 10.1007/s00192-005-0060-z; Shah AD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.042; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Swithinbank LV, 1999, WORLD J UROL, V17, P225, DOI 10.1007/s003450050137; Teunissen TAM, 2004, INT UROGYNECOL J, V15, P10, DOI 10.1007/s00192-003-1106-8; Thom DH, 2006, J UROLOGY, V175, P259, DOI 10.1016/S0022-5347(05)00039-X; United States Census Bureau, US INT PROJ AG SEX R; Varma MG, 2006, DIS COLON RECTUM, V49, P841, DOI 10.1007/s10350-006-0535-0; Waetjen LE, 2007, AM J EPIDEMIOL, V165, P309, DOI 10.1093/aje/kwk018	42	1084	1121	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1311	1316		10.1001/jama.300.11.1311	http://dx.doi.org/10.1001/jama.300.11.1311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799443	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000259231100026
J	Contopoulos-Ioannidis, DG; Alexiou, GA; Gouvias, TC; Ioannidis, JPA				Contopoulos-Ioannidis, Despina G.; Alexiou, George A.; Gouvias, Theodore C.; Ioannidis, John P. A.			Medicine - Life cycle of translational research for medical interventions	SCIENCE			English	Editorial Material									[Alexiou, George A.; Gouvias, Theodore C.; Ioannidis, John P. A.] Univ Ioannina, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, Sch Med, GR-45110 Ioannina, Greece; [Contopoulos-Ioannidis, Despina G.] Univ Ioannina, Sch Med, Dept Pediat, GR-45110 Ioannina, Greece; [Contopoulos-Ioannidis, Despina G.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20037 USA; [Ioannidis, John P. A.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Inst Biomed Res, Ioannina, Greece	University of Ioannina; University of Ioannina; George Washington University; Tufts Medical Center; Tufts University; Foundation for Research & Technology - Hellas (FORTH)	Ioannidis, JPA (corresponding author), Univ Ioannina, Clin Trials & Evidence Based Med Unit, Dept Hyg & Epidemiol, Sch Med, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481				Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Cuatrecasas P, 2006, J CLIN INVEST, V116, P2837, DOI 10.1172/JCI29999; Duyk G, 2003, SCIENCE, V302, P603, DOI 10.1126/science.1090521; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Marincola Francesco M, 2003, J Transl Med, V1, P1, DOI 10.1186/1479-5876-1-1; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	12	133	140	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1298	1299		10.1126/science.1160622	http://dx.doi.org/10.1126/science.1160622			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772421				2022-12-24	WOS:000258914300031
J	Yoder, A; Yu, DY; Dong, L; Iyer, SR; Xu, XH; Kelly, J; Liu, J; Wang, WF; Vorster, PJ; Agulto, L; Stephany, DA; Cooper, JN; Marsh, JW; Wu, YT				Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Xu, Xuehua; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Stephany, David A.; Cooper, James N.; Marsh, Jon W.; Wu, Yuntao			HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells	CELL			English	Article							IMMUNOLOGICAL SYNAPSE; CHEMOKINE; PROTEIN; ENTRY; NEF; LYMPHOCYTES; INFECTION; COMPLEX; CXCR4; PHOSPHORYLATION	Binding of the HIV envelope to the chemokine coreceptors triggers membrane fusion and signal transduction. The fusion process has been well characterized, yet the role of coreceptor signaling remains elusive. Here, we describe a critical function of the chemokine coreceptor signaling in facilitating HIV infection of resting CD4 T cells. We find that static cortical actin in resting T cells represents a restriction and that HIV utilizes the G alpha i-dependent signaling from the chemokine coreceptor CXCR4 to activate a cellular actin-depolymerizing factor, cofilin, to overcome this restriction. HIV envelope-mediated cofilin activation and actin dynamics are important for a postentry process that leads to viral nuclear localization. Inhibition of HIV-mediated actin rearrangement markedly diminishes viral latent infection of resting T cells. Conversely, induction of active cofilin greatly facilitates it. These findings shed light on viral exploitation of cellular machinery in resting T cells, where chemokine receptor signaling becomes obligatory.	[Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Cooper, James N.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Xu, Xuehua] NIAID, Immunogenet Lab, NIH, Rockville, MD 20851 USA; [Stephany, David A.] NIAID, Flow Cytometry Sect, NIH, Bethesda, MD 20892 USA; [Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA.	marshj@mail.nih.gov; ywu8@gmu.edu	wang, weifeng/N-4140-2013; xu, xuehua/R-1163-2019	xu, xuehua/0000-0002-3863-9593; Love, Zelda/0000-0002-2478-7720	National Defense Science and Engineering Fellowship; GMU; NIMH/NIH; NIAID [AI069981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002629] Funding Source: NIH RePORTER	National Defense Science and Engineering Fellowship(United States Department of Defense); GMU; NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the George Mason University (GMU) Student Health Center; the Department of Transfusion Medicine, the National Institutes of Health (NIH); V. Chandhoke and C. Bailey for blood donation; the NIH AIDS Research and Reference Reagent Program for reagents; H. A. Nash of the National Institute of Mental Health (NIMH)/NIH; K. Jeang of the National Institute of Allergy and Infectious Diseases (NIAID)/NIH; D. Rekosh of the University of Virginia; L. Liotta, E. Petricoin and D. Cox for comments; T. Meckel and T. Jin of NIAID/NIH for confocal microscopy and imaging analyses; K. L. Holmes of NIAID/NIH for fusion assay; A. Biancotto and L. Margolis of the National Institute of Child Health and Human Development/NIH for tonsillar T cells; Y. Samstag for protocols; and A. Wu for digital graphic design. A. Y. was supported by the National Defense Science and Engineering Fellowship. This work was supported by GMU, the Intramural Program of the NIMH/NIH, and in part by the Public Health Service grant AI069981 from NIAID to Y. W.	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DE BP, 1993, J BIOL CHEM, V268, P5703; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; FENYO EM, 1988, J VIROL, V62, P4414; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRAY LS, 1989, J IMMUNOL, V142, P1631; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; KUBBIES M, 1989, EUR J IMMUNOL, V19, P1393, DOI 10.1002/eji.1830190807; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu Y, 2007, CURR HIV RES, V5, P394; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	48	215	220	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					782	792		10.1016/j.cell.2008.06.036	http://dx.doi.org/10.1016/j.cell.2008.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775311	Green Accepted, Bronze			2022-12-24	WOS:000258947500018
J	Badcock, C; Crespi, B				Badcock, Christopher; Crespi, Bernard			Battle of the sexes may set the brain	NATURE			English	Editorial Material									[Badcock, Christopher] London Sch Econ, London WC2A 2AE, England; [Crespi, Bernard] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	University of London; London School Economics & Political Science; Simon Fraser University	Badcock, C (corresponding author), London Sch Econ, Houghton St, London WC2A 2AE, England.	crespi@sfu.ca						Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; HAMILTON WD, 2005, NARROW ROADS GENE LA, V3, P206	3	42	42	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2008	454	7208					1054	1055		10.1038/4541054a	http://dx.doi.org/10.1038/4541054a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18756240	Bronze			2022-12-24	WOS:000258719600021
J	Seale, P; Bjork, B; Yang, WL; Kajimura, S; Chin, S; Kuang, SH; Scime, A; Devarakonda, S; Conroe, HM; Erdjument-Bromage, H; Tempst, P; Rudnicki, MA; Beier, DR; Spiegelman, BM				Seale, Patrick; Bjork, Bryan; Yang, Wenli; Kajimura, Shingo; Chin, Sherry; Kuang, Shihuan; Scime, Anthony; Devarakonda, Srikripa; Conroe, Heather M.; Erdjument-Bromage, Hediye; Tempst, Paul; Rudnicki, Michael A.; Beier, David R.; Spiegelman, Bruce M.			PRDM16 controls a brown fat/skeletal muscle switch	NATURE			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; WHITE FAT; UNCOUPLING PROTEIN; SKELETAL-MUSCLE; GENE-EXPRESSION; SATELLITE CELLS; ADULT HUMANS; STEM-CELLS	Brown fat can increase energy expenditure and protect against obesity through a specialized program of uncoupled respiration. Here we show by in vivo fate mapping that brown, but not white, fat cells arise from precursors that express Myf5, a gene previously thought to be expressed only in the myogenic lineage. We also demonstrate that the transcriptional regulator PRDM16 ( PRD1- BF1- RIZ1 homologous domain containing 16) controls a bidirectional cell fate switch between skeletal myoblasts and brown fat cells. Loss of PRDM16 from brown fat precursors causes a loss of brown fat characteristics and promotes muscle differentiation. Conversely, ectopic expression of PRDM16 in myoblasts induces their differentiation into brown fat cells. PRDM16 stimulates brown adipogenesis by binding to PPAR-gamma (peroxisome-proliferator-activated receptor-gamma) and activating its transcriptional function. Finally, Prdm16-deficient brown fat displays an abnormal morphology, reduced thermogenic gene expression and elevated expression of muscle-specific genes. Taken together, these data indicate that PRDM16 specifies the brown fat lineage from a progenitor that expresses myoblast markers and is not involved in white adipogenesis.	[Seale, Patrick; Yang, Wenli; Kajimura, Shingo; Chin, Sherry; Devarakonda, Srikripa; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Seale, Patrick; Yang, Wenli; Kajimura, Shingo; Chin, Sherry; Devarakonda, Srikripa; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bjork, Bryan; Beier, David R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Kuang, Shihuan; Scime, Anthony; Rudnicki, Michael A.] Ottawa Hlth Res Inst, Program Mol Med, Sprott Ctr Stem Cell Res, Ottawa, ON K1H 8L6, Canada; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Ottawa; Ottawa Hospital Research Institute; Memorial Sloan Kettering Cancer Center	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Kuang, Shihuan/0000-0001-9180-3180; Rudnicki, Michael/0000-0002-3866-5249; Tempst, Paul/0000-0002-6680-3987	American Heart Association; Japan Society for the Promotion of Science; Susan Komen Breast Cancer Foundation; Picower Foundation; National Institutes of Health; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Picower Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank V. Seale and F. LeGrand for help with the lineage tracing studies and R. Gupta for discussions. We are grateful to P. Soriano for the Myf5-Cre mice and F. Constantini for the R26R3-YFP reporter mice. P. S. is supported by a fellowship from the American Heart Association. S. Kajimura is supported by a fellowship from the Japan Society for the Promotion of Science. S. D. is supported by the Susan Komen Breast Cancer Foundation. This work is funded by the Picower Foundation and a National Institutes of Health grant to B. M. S. and an National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant to M. A. R.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; COUSIN B, 1992, J CELL SCI, V103, P931; Dong FY, 2006, DEVELOPMENT, V133, P4891, DOI 10.1242/dev.02693; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GARRUTI G, 1992, INT J OBESITY, V16, P383; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200	44	1616	1747	6	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					961	U27		10.1038/nature07182	http://dx.doi.org/10.1038/nature07182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18719582	Green Accepted			2022-12-24	WOS:000258591000031
J	Grimes, DA				Grimes, David A.			The nomogram epidemic: Resurgence of a medical relic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROSTATE-CANCER; RECURRENCE; MEN	The obsolete calculators known as nomograms have become epidemic in recent medical literature. The frequency of articles in PubMed retrieved with this search term nearly doubled between 1990 to 1999 and 2000 to 2007. Popular in medicine from about 1925 to 1975, a nomogram is a crude graphical means for solving an equation by placing a straightedge across several scales. Today, most reported nomograms are inconsistent with both established definitions and half a century of clinical use. The need for nomograms disappeared with the advent of personal computing. Instead of constructing nomograms, authors should develop software, such as prediction models, that can either be downloaded to personal digital assistants or be used on the Internet. Modern computing features both accuracy and speed; nomograms offer only the latter.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org			U.S. Agency	U.S. Agency	By Family Health International, with funds from the U. S. Agency for International Development.	ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; ANDERSON DM, 2003, DORLANDS ILLUSTRATED; DEAN AG, 1991, AM J PREV MED, V7, P178, DOI 10.1016/S0749-3797(18)30936-X; Ellett Marsha L Cirgin, 2005, Clin Nurs Res, V14, P11, DOI 10.1177/1054773804270919; ELLETT ML, 2005, CLIN NURS RES, V14, P28; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; GANDON F, HIST COMPUTER SCI; Gold JS, 2007, ANN SURG ONCOL, V14, P3159, DOI 10.1245/s10434-007-9542-1; Grobman WA, 2007, OBSTET GYNECOL, V109, P806, DOI 10.1097/01.AOG.0000259312.36053.02; Hankins TL, 1999, ISIS, V90, P50, DOI 10.1086/384241; Kattan MW, 2003, STAT MED, V22, P3515, DOI 10.1002/sim.1574; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Lang T., 1997, REPORT STAT MED ANNO, DOI 10.1097/00006205-199705000-00022; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Mondaini N, 2002, INT J IMPOT RES, V14, P283, DOI 10.1038/sj.ijir.3900887; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Ota H, 2000, FERTIL STERIL, V74, P313, DOI 10.1016/S0015-0282(00)00638-5; Pugh MB, 2000, STEDMANS MED DICT; Rujiwetpongstorn Jittima, 2007, Archives of Gynecology and Obstetrics, V276, P351, DOI 10.1007/s00404-007-0352-2; Stephenson AJ, 2006, BJU INT, V98, P39, DOI 10.1111/j.1464-410X.2006.06173.x; TUFTE E, NOMOGRAMS; Veerkamp MJ, 2004, CIRCULATION, V109, P2980, DOI 10.1161/01.CIR.0000130646.93255.86; Wikipedia, NOM; DEFINITION NOMOGRAM	24	67	69	2	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2008	149	4					273	275		10.7326/0003-4819-149-4-200808190-00010	http://dx.doi.org/10.7326/0003-4819-149-4-200808190-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338RQ	18711159				2022-12-24	WOS:000258526700008
J	Weyand, S; Shimamura, T; Yajima, S; Suzuki, S; Mirza, O; Krusong, K; Carpenter, EP; Rutherford, NG; Hadden, JM; O'Reilly, J; Ma, P; Saidijam, M; Patching, SG; Hope, RJ; Norbertczak, HT; Roach, PCJ; Iwata, S; Henderson, PJF; Cameron, AD				Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Suzuki, Shun'ichi; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Iwata, So; Henderson, Peter J. F.; Cameron, Alexander D.			Structure and Molecular Mechanism of a Nucleobase-Cation-Symport-1 Family Transporter	SCIENCE			English	Article							PURINE-CYTOSINE PERMEASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL-ANALYSIS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; BINDING-SITE; PROTEINS; REVEALS	The nucleobase- cation- symport- 1 ( NCS1) transporters are essential components of salvage pathways for nucleobases and related metabolites. Here, we report the 2.85- angstrom resolution structure of the NCS1 benzyl- hydantoin transporter, Mhp1, from Microbacterium liquefaciens. Mhp1 contains 12 transmembrane helices, 10 of which are arranged in two inverted repeats of five helices. The structures of the outward- facing open and substrate- bound occluded conformations were solved, showing how the outward- facing cavity closes upon binding of substrate. Comparisons with the leucine transporter LeuT(Aa) and the galactose transporter vSGLT reveal that the outwardand inward- facing cavities are symmetrically arranged on opposite sides of the membrane. The reciprocal opening and closing of these cavities is synchronized by the inverted repeat helices 3 and 8, providing the structural basis of the alternating access model for membrane transport.	[Weyand, Simone; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Diamond Light Source Ltd, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Weyand, Simone; Shimamura, Tatsuro; Yajima, Shunsuke; Mirza, Osman; Krusong, Kuakarun; Carpenter, Elisabeth P.; Iwata, So; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Shimamura, Tatsuro; Iwata, So] Japan Sci & Technol Agcy, Human Receptor Crystallog Project, ERATO, Sakyo Ku, Kyoto 6068501, Japan; [Suzuki, Shun'ichi; Rutherford, Nicholas G.; Hadden, Jonathan M.; O'Reilly, John; Ma, Pikyee; Saidijam, Massoud; Patching, Simon G.; Hope, Ryan J.; Norbertczak, Halina T.; Roach, Peter C. J.; Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Saidijam, Massoud] Hamedan Univ Med Sci, Sch Med, Hamadan, Iran; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; Japan Science & Technology Agency (JST); University of Leeds; RIKEN	Iwata, S (corresponding author), Diamond Light Source Ltd, Membrane Prot Lab, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England.	s.iwata@imperial.ac.uk; p.j.f.henderson@leeds.ac.uk	Patching, Simon G./Z-3906-2019; Ma, Pikyee/B-8282-2012; Cameron, Alexander/L-7288-2013; Saidijam, Massoud/G-2646-2017; Henderson, Peter JF/Q-1907-2018	Patching, Simon G./0000-0001-6132-5317; Ma, Pikyee/0000-0003-4080-2908; Saidijam, Massoud/0000-0001-8910-556X; Henderson, Peter/0000-0002-9187-0938; Cameron, Alexander/0000-0001-8776-3518; Carpenter, Liz/0000-0001-9138-2937; Mirza, Osman Asghar/0000-0001-9435-0690	Biotechnology and Biological Sciences Research Council [B17935, BB/C51725]; Ajinomoto Incorporated; European Membrane Protein consortium [LSHG-CT-2004-504601]; Membrane Protein Structure Initiative [BBS/B/14418]; Wellcome Trust [062164/Z/00/Z]; Leverhulme Trust; European Molecular Biology Organization long-term fellowship; Biotechnology and Biological Sciences Research Council [BB/C51725X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ajinomoto Incorporated; European Membrane Protein consortium; Membrane Protein Structure Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded primarily by the Biotechnology and Biological Sciences Research Council (grant nos. B17935 and BB/C51725), with important contributions from Ajinomoto Incorporated, the European Membrane Protein consortium (grant no. LSHG-CT-2004-504601), the Membrane Protein Structure Initiative (grant no. BBS/B/14418), and the Wellcome Trust (grant no. 062164/Z/00/Z). We wish to thank the Membrane Protein Laboratory (MPL) at the Diamond Light Source Limited for use of the MPL facilities. J. Abramson kindly provided us with the coordinates of vSGLT before their release from the Protein Data Bank (PDB). We are also grateful to S. Phillips, S. Baldwin, P. Gilmartin, S. Radford, D. Drew, M. Jormakka, K. Watanabe, and M. Iwata for support or advice. The Japan Society for the Promotion of Science provided personal funding to S.Y. and the Leverhulme Trust to P.J.F.H. S.W. was a recipient of a European Molecular Biology Organization long-term fellowship. The coordinates and the structure factors for Mhp1 without substrate and the hydantoin complex have been deposited in the PDB (entries 2JLN and 2JLO, respectively).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BLOCH JC, 1992, MOL MICROBIOL, V6, P2989, DOI 10.1111/j.1365-2958.1992.tb01757.x; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; BRETHES D, 1992, EUR J BIOCHEM, V204, P699, DOI 10.1111/j.1432-1033.1992.tb16684.x; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Ferreira T, 1997, J BIOL CHEM, V272, P9697; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HENDERSON PJF, 1994, ANTON LEEUW INT J G, V65, P349, DOI 10.1007/BF00872218; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	36	289	291	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 31	2008	322	5902					709	713		10.1126/science.1164440	http://dx.doi.org/10.1126/science.1164440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18927357	Green Accepted			2022-12-24	WOS:000260605200039
J	Adilakshmi, T; Bellur, DL; Woodson, SA				Adilakshmi, Tadepalli; Bellur, Deepti L.; Woodson, Sarah A.			Concurrent nucleation of 16S folding and induced fit in 30S ribosome assembly	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOMES; PARALLEL PATHWAYS; RNA; SUBUNIT; PROTEIN; VITRO; DOMAINS; S4	Rapidly growing cells produce thousands of new ribosomes each minute, in a tightly regulated process that is essential to cell growth(1,2). How the Escherichia coli 16S ribosomal RNA and the 20 proteins that make up the 30S ribosomal subunit can assemble correctly in a few minutes remains a challenging problem, partly because of the lack of real- time data on the earliest stages of assembly. By providing snapshots of individual RNA and protein interactions as they emerge in real time, here we show that 30S assembly nucleates concurrently from different points along the rRNA. Time- resolved hydroxyl radical footprinting(3) was used to map changes in the structure of the rRNA within 20 milliseconds after the addition of total 30S proteins. Helical junctions in each domain fold within 100 ms. In contrast, interactions surrounding the decoding site and between the 5', the central and the 3' domains require 2 - 200 seconds to form. Unexpectedly, nucleotides contacted by the same protein are protected at different rates, indicating that initial RNA - protein encounter complexes refold during assembly. Although early steps in assembly are linked to intrinsically stable rRNA structure, later steps correspond to regions of induced fit between the proteins and the rRNA.	[Adilakshmi, Tadepalli; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Bellur, Deepti L.] Johns Hopkins Univ, Program Cell Mol & Dev Biol & Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	swoodson@jhu.edu		Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health [GM60819, P41-EB0001979.]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001979, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Moss, A. Cukras, L. Cochella and R. Green for help with ribosome preparation and peptidyl transferase assays, P. Fleming for help with Calc-Surf software, and S. Gupta, M. Sullivan and M. Brenowitz for help with X-ray footprinting. This work was supported by the National Institutes of Health (NIH; GM60819). The NSLS X28C and the Center for Synchrotron Biosciences are supported by NIH P41-EB0001979.	Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; DODD J, 1991, BIOCHIMIE, V73, P757, DOI 10.1016/0300-9084(91)90055-6; Dutca LM, 2008, J MOL BIOL, V376, P92, DOI 10.1016/j.jmb.2007.10.083; HELD WA, 1973, J BIOL CHEM, V248, P5720; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; Laederach A, 2006, J MOL BIOL, V358, P1179, DOI 10.1016/j.jmb.2006.02.075; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; Noller H. F, 1987, ESCHERICHIA COLI SAL, P104; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; POWERS T, 1995, J BIOL CHEM, V270, P1238, DOI 10.1074/jbc.270.3.1238; POWERS T, 1995, RNA, V1, P194; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	28	138	138	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1268	1272		10.1038/nature07298	http://dx.doi.org/10.1038/nature07298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784650	Green Accepted			2022-12-24	WOS:000260462100051
J	Durniak, KJ; Bailey, S; Steitz, TA				Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.			The structure of a transcribing T7 RNA polymerase in transition from initiation to elongation	SCIENCE			English	Article							MAJOR CONFORMATIONAL-CHANGES; TRANSCRIPTION INITIATION; ANGSTROM RESOLUTION; PROMOTER CLEARANCE; COMPLEX; RELEASE; T7-RNA-POLYMERASE; BACTERIOPHAGE-T7; HOLOENZYME; MECHANISM	Structural studies of the T7 bacteriophage DNA-dependent RNA polymerase (T7 RNAP) have shown that the conformation of the amino-terminal domain changes substantially between the initiation and elongation phases of transcription, but how this transition is achieved remains unclear. We report crystal structures of T7 RNAP bound to promoter DNA containing either a 7- or an 8-nucleotide (nt) RNA transcript that illuminate intermediate states along the transition pathway. The amino-terminal domain comprises the C-helix subdomain and the promoter binding domain (PBD), which consists of two segments separated by subdomain H. The structures of the intermediate complex reveal that the PBD and the bound promoter rotate by -45 degrees upon synthesis of an 8-nt RNA transcript. This allows the promoter contacts to be maintained while the active site is expanded to accommodate a growing heteroduplex. The C-helix subdomain moves modestly toward its elongation conformation, whereas subdomain H remains in its initiation- rather than its elongation-phase location, more than 70 angstroms away.	[Durniak, Kimberly J.; Bailey, Scott; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Bailey, Scott; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Steitz, Thomas A./C-6559-2009	Durniak, Kimberly/0000-0002-4114-7135	NIH [GM57510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamline 24-ID and at the. National. Synchrotron Light Source beamline X25. We also thank T. Jorgensen for help with the supplemental movie and the staff of the Center for Structural Biology core facility at Yale University. This work was Supported by NIH grant GM57510 (to T.A.S.). The coordinates have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3E2E and 3E3J for the 7- and 8-nt RNA intermediate complex structures, respectively.	Bandwar RP, 2007, J BIOL CHEM, V282, P22879, DOI 10.1074/jbc.M702589200; Bandwar RP, 2006, J MOL BIOL, V360, P466, DOI 10.1016/j.jmb.2006.05.029; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; CHEETHAM GMT, 1988, SCIENCE, V27, P3966; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He B, 1997, J MOL BIOL, V265, P275, DOI 10.1006/jmbi.1996.0741; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; IKEDA RA, 1987, J BIOL CHEM, V262, P3790; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Ma KY, 2005, P NATL ACAD SCI USA, V102, P17612, DOI 10.1073/pnas.0508865102; Ma KY, 2002, J BIOL CHEM, V277, P43206, DOI 10.1074/jbc.M206658200; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; Theis K, 2004, BIOCHEMISTRY-US, V43, P12709, DOI 10.1021/bi0486987; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P6165, DOI 10.1021/bi700058b; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	32	75	85	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					553	557		10.1126/science.1163433	http://dx.doi.org/10.1126/science.1163433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948533	Green Accepted			2022-12-24	WOS:000260299100033
J	Yang, GD; Wu, LY; Jiang, B; Yang, W; Qi, JS; Cao, K; Meng, QH; Mustafa, AK; Mu, WT; Zhang, SM; Snyder, SH; Wang, R				Yang, Guangdong; Wu, Lingyun; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Meng, Qinghe; Mustafa, Asif K.; Mu, Weitong; Zhang, Shengming; Snyder, Solomon H.; Wang, Rui			H2S as a physiologic vasorelaxant: Hypertension in mice with deletion of cystathionine gamma-lyase	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-SULFIDE GENERATION; KNOCKOUT MICE; RAT; INHIBITION; RELAXATION; CALMODULIN; MODULATION; LACKING; GENE	Studies of nitric oxide over the past two decades have highlighted the fundamental importance of gaseous signaling molecules in biology and medicine. The physiological role of other gases such as carbon monoxide and hydrogen sulfide (H2S) is now receiving increasing attention. Here we show that H2S is physiologically generated by cystathionine gamma-lyase (CSE) and that genetic deletion of this enzyme in mice markedly reduces H2S levels in the serum, heart, aorta, and other tissues, Mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation. CSE is physiologically activated by calcium-calmodulin, which is a mechanism for H2S formation in response to vascular activation. These findings provide direct evidence that H2S is a physiologic vasodilator and regulator of blood pressure.	[Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada; [Yang, Guangdong; Jiang, Bo; Yang, Wei; Qi, Jiansong; Cao, Kun; Wang, Rui] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Meng, Qinghe] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 5E5, Canada; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Mustafa, Asif K.; Mu, Weitong; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Yang, Guangdong; Zhang, Shengming; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Mu, Weitong] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Lakehead University; Johns Hopkins University	Wu, LY (corresponding author), Univ Saskatchewan, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada.	lily.wu@usask.ca; ssnyder@jhmi.edu; rwang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011	Wang, Rui/0000-0003-3825-3620; 	U.S. Public Health Service [MH18501]; Research Scientist Award [DA00074]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Watkins for experimental and conceptual assistance. Supported by U.S. Public Health Service grant MH18501 and Research Scientist Award DA00074 to S.H.S., and operating grants of Canadian Institutes of Health Research to L.W. and R.W.	Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Cooke CLM, 2003, CARDIOVASC RES, V60, P635, DOI 10.1016/j.cardiores.2003.08.011; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; HEINONEN K, 1973, BIOCHEM J, V136, P1011, DOI 10.1042/bj1361011; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Iwata C, 2007, LIFE SCI, V80, P873, DOI 10.1016/j.lfs.2006.11.012; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Lake-Bruse KD, 1999, AM J PHYSIOL-HEART C, V277, pH770, DOI 10.1152/ajpheart.1999.277.2.H770; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Ndisang JF, 2004, J HYPERTENS, V22, P1057, DOI 10.1097/00004872-200406000-00002; Searcy DG, 1998, J EXP ZOOL, V282, P310, DOI 10.1002/(SICI)1097-010X(19981015)282:3<310::AID-JEZ4>3.0.CO;2-P; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65	28	1819	1929	10	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					587	590		10.1126/science.1162667	http://dx.doi.org/10.1126/science.1162667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948540	Green Accepted			2022-12-24	WOS:000260299100043
J	Zhou, Q; Brown, J; Kanarek, A; Rajagopal, J; Melton, DA				Zhou, Qiao; Brown, Juliana; Kanarek, Andrew; Rajagopal, Jayaraj; Melton, Douglas A.			In vivo reprogramming of adult pancreatic exocrine cells to beta-cells	NATURE			English	Article							TO-MESENCHYMAL TRANSITION; INSULIN-SECRETING CELLS; STEM-CELLS; B-CELLS; DIFFERENTIATION; FIBROBLASTS; TRANSDIFFERENTIATION; GENES; LIVER; GENERATION	One goal of regenerative medicine is to instructively convert adult cells into other cell types for tissue repair and regeneration. Although isolated examples of adult cell reprogramming are known, there is no general understanding of how to turn one cell type into another in a controlled manner. Here, using a strategy of re- expressing key developmental regulators in vivo, we identify a specific combination of three transcription factors (Ngn3 ( also known as Neurog3) Pdx1 and Mafa) that reprograms differentiated pancreatic exocrine cells in adult mice into cells that closely resemble beta-cells. The induced beta-cells are indistinguishable from endogenous islet beta-cells in size, shape and ultrastructure. They express genes essential for beta-cell function and can ameliorate hyperglycaemia by remodelling local vasculature and secreting insulin. This study provides an example of cellular reprogramming using defined factors in an adult organ and suggests a general paradigm for directing cell reprogramming without reversion to a pluripotent stem cell state.	[Zhou, Qiao; Kanarek, Andrew; Rajagopal, Jayaraj; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Brown, Juliana] Harvard Univ, Sch Med, Childrens Hosp, Dept Pathol,Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Wilson, Matthew H/K-3193-2013; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zhou, Qiao/0000-0002-0099-3909	Damon-Runyon Cancer Research Foundation Postdoctoral Fellowship; Pathway to Independence (PI) Award; National Institute of Health; Harvard Stem Cell Institute; NIH	Damon-Runyon Cancer Research Foundation Postdoctoral Fellowship; Pathway to Independence (PI) Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Ericsson for expert assistance on electron microscopy, R. Hellmiss-Peralta for advice on graphics, and B. Tilton and P. Rogers for FACS. We thank R. Martinez and G. Kenty for technical assistance; H. Edlund for the gift of Ptf1a antiserum; A. Kweudjeu for microarray analysis; members of the Melton laboratory for advice and feedback; and J. Sneddon, J. Annes and W. Anderson for critical reading of the manuscript. Q.Z. was supported by a Damon-Runyon Cancer Research Foundation Postdoctoral Fellowship and a Pathway to Independence (PI) Award from the National Institute of Health. D.A.M. is an HHMI investigator and this work was supported in part by the Harvard Stem Cell Institute and the NIH.	Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; DEROBERTIS EM, 1977, P NATL ACAD SCI USA, V74, P2470; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, FRONT BIOSCI-LANDMRK, V13, P5824; Miyatsuka T, 2003, BIOCHEM BIOPH RES CO, V310, P1017, DOI 10.1016/j.bbrc.2003.09.108; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Okuno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE158, DOI 10.1152/ajpendo.00180.2006; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wang AY, 2004, HUM GENE THER, V15, P405, DOI 10.1089/104303404322959551; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	41	1497	1655	2	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					627	U30		10.1038/nature07314	http://dx.doi.org/10.1038/nature07314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18754011	Green Accepted			2022-12-24	WOS:000259639700038
J	Jones, S; Zhang, XS; Parsons, DW; Lin, JCH; Leary, RJ; Angenendt, P; Mankoo, P; Carter, H; Kamiyama, H; Jimeno, A; Hong, SM; Fu, BJ; Lin, MT; Calhoun, ES; Kamiyama, M; Walter, K; Nikolskaya, T; Nikolsky, Y; Hartigan, J; Smith, DR; Hidalgo, M; Leach, SD; Klein, AP; Jaffee, EM; Goggins, M; Maitra, A; Iacobuzio-Donahue, C; Eshleman, JR; Kern, SE; Hruban, RH; Karchin, R; Papadopoulos, N; Parmigiani, G; Vogelstein, B; Velculescu, VE; Kinzler, KW				Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Kamiyama, Hirohiko; Jimeno, Antonio; Hong, Seung-Mo; Fu, Baojin; Lin, Ming-Tseh; Calhoun, Eric S.; Kamiyama, Mihoko; Walter, Kimberly; Nikolskaya, Tatiana; Nikolsky, Yuri; Hartigan, James; Smith, Douglas R.; Hidalgo, Manuel; Leach, Steven D.; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.; Karchin, Rachel; Papadopoulos, Nickolas; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.			Core signaling pathways in human pancreatic cancers revealed by global genomic analyses	SCIENCE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; GENE; PROGRESSION; MUTATIONS	There are currently few therapeutic options for patients with pancreatic cancer, and new insights into the pathogenesis of this lethal disease are urgently needed. Toward this end, we performed a comprehensive genetic analysis of 24 pancreatic cancers. We first determined the sequences of 23,219 transcripts, representing 20,661 protein-coding genes, in these samples. Then, we searched for homozygous deletions and amplifications in the tumor DNA by using microarrays containing probes for similar to 10(6) single- nucleotide polymorphisms. We found that pancreatic cancers contain an average of 63 genetic alterations, the majority of which are point mutations. These alterations defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors. Analysis of these tumors' transcriptomes with next- generation sequencing- by- synthesis technologies provided independent evidence for the importance of these pathways and processes. Our data indicate that genetically altered core pathways and regulatory processes only become evident once the coding regions of the genome are analyzed in depth. Dysregulation of these core pathways and processes through mutation can explain the major features of pancreatic tumorigenesis.	[Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Jimeno, Antonio; Calhoun, Eric S.; Hidalgo, Manuel; Leach, Steven D.; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.; Papadopoulos, Nickolas; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Ludwig Ctr, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Jimeno, Antonio; Calhoun, Eric S.; Hidalgo, Manuel; Leach, Steven D.; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.; Papadopoulos, Nickolas; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Mankoo, Parminder; Carter, Hannah; Karchin, Rachel] Johns Hopkins Med Inst, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Kamiyama, Hirohiko; Hong, Seung-Mo; Fu, Baojin; Lin, Ming-Tseh; Kamiyama, Mihoko; Walter, Kimberly; Klein, Alison P.; Jaffee, Elizabeth M.; Goggins, Michael; Maitra, Anirban; Iacobuzio-Donahue, Christine; Eshleman, James R.; Kern, Scott E.; Hruban, Ralph H.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Nikolskaya, Tatiana] NI Vavilov Gen Genet Res Inst, Moscow 117809, Russia; [Nikolsky, Yuri] GeneGo Inc, St Joseph, MI 49085 USA; [Hartigan, James; Smith, Douglas R.] Agencourt Biosci Corp, Beverly, MA 01915 USA; [Leach, Steven D.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21231 USA; [Parmigiani, Giovanni] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Russian Academy of Sciences; Vavilov Institute of General Genetics; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Sol Goldman Pancreat Canc Res Ctr, Ludwig Ctr, Baltimore, MD 21231 USA.	bertvog@gmail.com; velculescu@jhmi.edu; kinzlke@jhmi.edu	Nikolskaya, Tatiana/M-5008-2013; Jones, Sian/A-5050-2012; HIDALGO, MANUEL/I-4995-2015; Papadopoulos, Nickolas/K-7272-2012; wang, edwin/G-5372-2010; Iacobuzio-Donahue, Christine/ABF-1295-2020; Karchin, Rachel/A-3385-2010; Velculescu, Victor/ABF-4846-2020; Carter, Hannah/R-8425-2017	HIDALGO, MANUEL/0000-0002-3765-3318; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501; Jaffee, Elizabeth/0000-0003-3841-6549; Carter, Hannah/0000-0002-1729-2463; Karchin, Rachel/0000-0002-5069-1239; Hong, Seung-Mo/0000-0002-8888-6007	Sol Goldman Charitable Trust; Lillian Goldman Charitable Trust; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Susan G. Komen Foundation; Michael Rolfe Pancreatic Cancer Foundation; Joseph C. Monastra Foundation for Pancreatic Cancer; Viragh Family Foundation; Broad Foundation; Emerald Foundation; NIH [CA62924, CA43460, CA57345, CA121113]; Beckman Coulter Corporation; NATIONAL CANCER INSTITUTE [R01CA121113, R01CA043460, R37CA057345, P50CA062924, R37CA043460, R01CA057345] Funding Source: NIH RePORTER	Sol Goldman Charitable Trust; Lillian Goldman Charitable Trust; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Michael Rolfe Pancreatic Cancer Foundation; Joseph C. Monastra Foundation for Pancreatic Cancer; Viragh Family Foundation; Broad Foundation; Emerald Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Coulter Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Ptak, N. Silliman, L. Dobbyn, M. Whalen, M. Borges, G. Cusatis, M. Griffith, C. Henderson, C. Karikari, G. Mo, M. Mullendore, E. Palmisano, M. Raben, S. Solt, and D. Trusty for expert technical assistance; T. Sjoblom for help with database management for mutational analyses; Y. Ding for help with bioinformatic analyses; and J. Cameron, G. Feldmann, S. Salaria, L. Hua, and C. Yeo for helpful discussions. This project was performed under the auspices of the Goldman Pancreatic Cancer Genome Initiative and was funded by the Sol Goldman Charitable Trust; the Lillian Goldman Charitable Trust; the Lustgarten Foundation for Pancreatic Cancer Research; the Virginia and D. K. Ludwig Fund for Cancer Research; the Susan G. Komen Foundation; the Michael Rolfe Pancreatic Cancer Foundation; the Joseph C. Monastra Foundation for Pancreatic Cancer; the family and friends of George Rubis; the Viragh Family Foundation; the Broad Foundation; the Emerald Foundation; NIH grants CA62924, CA43460, CA57345, and CA121113; and Beckman Coulter Corporation. Under separate licensing agreements between the Johns Hopkins University and Genzyme, Beckman Coulter, and Exact Sciences Corporations, K. W. K., B. V., and V. E. V. are entitled to a share of royalties received by the university on sales of products related to research described in this paper. These authors and the university own Genzyme and Exact Sciences stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by the Johns Hopkins University in accordance with its conflict-of- interest policies.	Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; Edelman EJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040028; Efthimiou E, 2001, PANCREATOLOGY, V1, P571, DOI 10.1159/000055865; Ekins S, 2007, METH MOL B, V356, P319; Furukawa T, 1996, AM J PATHOL, V148, P1763; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mimeault M, 2005, PANCREAS, V31, P301, DOI 10.1097/01.mpa.0000175893.04660.1b; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Owens AH, 1982, TUMOR CELL HETEROGEN; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	24	2843	2986	10	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1801	1806		10.1126/science.1164368	http://dx.doi.org/10.1126/science.1164368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18772397	Green Accepted			2022-12-24	WOS:000259501300029
J	Johnston, MI; Fauci, AS				Johnston, Margaret I.; Fauci, Anthony S.			An HIV vaccine - Challenges and prospects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Johnston, Margaret I.; Fauci, Anthony S.] NIAID, Vaccine Res Program, Div AIDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Johnston, MI (corresponding author), NIAID, Vaccine Res Program, Div AIDS, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Franzeck, Fabian C/B-5055-2011					Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267	5	88	94	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2008	359	9					888	890		10.1056/NEJMp0806162	http://dx.doi.org/10.1056/NEJMp0806162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341IU	18753644				2022-12-24	WOS:000258708300002
J	Liang, HL; Nien, CY; Liu, HY; Metzstein, MM; Kirov, N; Rushlow, C				Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Metzstein, Mark M.; Kirov, Nikolai; Rushlow, Christine			The zinc-finger protein Zelda is a key activator of the early zygotic genome in Drosophila	NATURE			English	Article							POLARIZED MEMBRANE GROWTH; REPRESSION; BINDING; CELLULARIZATION; INSERTIONS; TRANSITION; REGULATOR; CLEAVAGE; ENCODES; TARGETS	In all animals, the initial events of embryogenesis are controlled by maternal gene products that are deposited into the developing oocyte. At some point after fertilization, control of embryogenesis is transferred to the zygotic genome in a process called the maternal- to-zygotic transition. During this time, many maternal RNAs are degraded and transcription of zygotic RNAs ensues(1). There is a long-standing question as to which factors regulate these events. The recent findings that microRNAs(2,3) and Smaug(4) mediate maternal transcript degradation have shed new light on this aspect of the problem. However, the transcription factor(s) that activate the zygotic genomeremain elusive. The discovery that many of the early transcribed genes in Drosophila share a cis- regulatory heptamer motif, CAGGTAG and related sequences(5,6), collectively referred to as TAGteam sites(5) raised the possibility that a dedicated transcription factor could interact with these sites to activate transcription. Here we report that the zinc- finger protein Zelda ( Zld; Zinc- finger early Drosophila activator) binds specifically to these sites and is capable of activating transcription in transient transfection assays. Mutant embryos lacking zld are defective in cellular blastoderm formation, and fail to activate many genes essential for cellularization, sex determination and pattern formation. Global expression profiling confirmed that Zld has an important role in the activation of the early zygotic genome and suggests that Zld may also regulate maternal RNA degradation during the maternal- to- zygotic transition.	[Liang, Hsiao-Lan; Nien, Chung-Yi; Liu, Hsiao-Yun; Kirov, Nikolai; Rushlow, Christine] NYU, Dept Biol, New York, NY 10003 USA; [Metzstein, Mark M.] Univ Utah, Inst Human Genet, Salt Lake City, UT 84112 USA	New York University; Utah System of Higher Education; University of Utah	Rushlow, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	chris.rushlow@nyu.edu			National Institutes of Health [GM63024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for gifts of RNA probes, plasmids, antibodies and fly stocks: J. Erickson, R. Lehmann, R. Cinalli, R. Martinho, C. Navarro, J. Treisman and L. Pick. We thank J. Rhee and A. Chung for help with isolating and characterizing zld null mutants, and S. Fu for help locating TAGteam sites in Zelda target genes. We are grateful to M. Siegel and K. Birnbaum for help with the microarray analysis, and C. Desplan, P. Struffi, S. Small and R. Lehmann for critical reading of the manuscript. This work was supported by a grant from the National Institutes of Health (GM63024).	Biemar F, 2005, P NATL ACAD SCI USA, V102, P15907, DOI 10.1073/pnas.0507817102; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SCHWEISGUTH F, 1990, GENE DEV, V4, P922, DOI 10.1101/gad.4.6.922; SIMPSON L, 1990, DEVELOPMENT, V110, P851; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Staudt N, 2006, MOL BIOL CELL, V17, P2356, DOI 10.1091/mbc.E05-11-1056; Stein JA, 2002, DEVELOPMENT, V129, P3925; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0	28	312	318	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					400	U67		10.1038/nature07388	http://dx.doi.org/10.1038/nature07388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18931655	Green Accepted			2022-12-24	WOS:000261039600046
J	Downs, JP; Daeschler, EB; Jenkins, FA; Shubin, NH				Downs, Jason P.; Daeschler, Edward B.; Jenkins, Farish A., Jr.; Shubin, Neil H.			The cranial endoskeleton of Tiktaalik roseae	NATURE			English	Article							EARLIEST-KNOWN TETRAPOD; EARLY EVOLUTION; DEVONIAN FISH; BRAINCASE; STAPES; AUSTRALIA; ORIGIN; EAR	Among themorphological changes that occurred during the 'fish- to- tetrapod' transition was a marked reorganization of the cranial endoskeleton. Details of this transition, including the sequence of character acquisition, have not been evident from the fossil record. Here we describe the braincase, palatoquadrate and branchial skeleton of Tiktaalik roseae, the Late Devonian sarcopterygian fish most closely related to tetrapods. Although retaining a primitive configuration in many respects, the cranial endoskeleton of T. roseae shares derived features with tetrapods such as a large basal articulation and a flat, horizontally oriented entopterygoid. Other features in T. roseae, like the short, straight hyomandibula, show morphology intermediate between the condition observed in more primitive fish and that observed in tetrapods. The combination of characters in T. roseae helps to resolve the relative timing of modifications in the cranial endoskeleton. The sequence of modifications suggests changes in head mobility and intracranial kinesis that have ramifications for the origin of vertebrate terrestriality.	[Downs, Jason P.; Daeschler, Edward B.] Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Jenkins, Farish A., Jr.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Shubin, Neil H.] Field Museum Nat Hist, Chicago, IL 60605 USA	Drexel University; Harvard University; Harvard University; University of Chicago; Field Museum of Natural History (Chicago)	Downs, JP (corresponding author), Acad Nat Sci Philadelphia, 1900 Benjamin Franklin Pkwy, Philadelphia, PA 19103 USA.	downs@ansp.org; nshubin@uchicago.edu			Polar Continental Shelf Project; Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago; National Science Foundation; National Geographic Society Committee for Research and Exploration	Polar Continental Shelf Project(Natural Resources Canada); Canadian Museum of Nature; Academy of Natural Sciences of Philadelphia; Putnam Expeditionary Fund (Harvard University); University of Chicago(University of Chicago); National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society)	The illustrations are the work of K. Monoyios. Specimen preparation was performed by C.F. Mullison. This research was made possible by permits from the Nunavut Ministry of Culture, Languages, Elders and Youth, the Grise Fiord Hamlet and HTA, with logistical support from the Polar Continental Shelf Project and collections support from the Canadian Museum of Nature. M. Brazeau improved interpretation of P. rhombolepis and offered input. Assistance in the field (1999-2006) was provided by W. Amaral, B. Atagootak, J. Conrad, M. Davis, S. Gatesy, A. Gillis, B. Kilbourne, S. Madsen, K. Middleton, J. Miller, K. Monoyios, C. Schaff, M. Shapiro, R. Shearman and C. Sullivan. This research was supported by an anonymous donor, the Academy of Natural Sciences of Philadelphia, the Putnam Expeditionary Fund (Harvard University), the University of Chicago, the National Science Foundation, and the National Geographic Society Committee for Research and Exploration.	Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Carroll R. L., 1980, TERRESTRIAL ENV ORIG, P293; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; CLACK JA, 1996, EVOLUTIONARY BIOL HE, P405; Clack Jennifer A., 2000, Amphibian Biology, V4, P979; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Fox Richard C., 1995, Memoirs of the Queensland Museum, V38, P97; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; Johanson Z, 1997, T ROY SOC EDIN-EARTH, V88, P39, DOI 10.1017/S0263593300002303; Lebedev Oleg A., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P287; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; ROMER ALFRED S., 1937, BULL MUS COMP ZOOL, V82, P1; Romer AS, 1941, J MORPHOL, V69, P141, DOI 10.1002/jmor.1050690106; Schultze Hans-Peter, 1996, P316; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P292; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SMITHSON TR, 1982, ZOOL J LINN SOC-LOND, V74, P93, DOI 10.1111/j.1096-3642.1982.tb01142.x; Thomson K. S., 1965, Proceedings of the Linnean Society of London, V176, P181; THOMSON KEITH STEWART, 1967, J LINN SOC LONDON ZOOL, V46, P223; Vorobyeva E., 1991, P68; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x	31	43	46	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					925	929		10.1038/nature07189	http://dx.doi.org/10.1038/nature07189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923515				2022-12-24	WOS:000260038300041
J	George, RE; Sanda, T; Hanna, M; Frohling, S; Luther, W; Zhang, JM; Ahn, Y; Zhou, WJ; London, WB; McGrady, P; Xue, LQ; Zozulya, S; Gregor, VE; Webb, TR; Gray, NS; Gilliland, DG; Diller, L; Greulich, H; Morris, SW; Meyerson, M; Look, AT				George, Rani E.; Sanda, Takaomi; Hanna, Megan; Frohling, Stefan; Luther, William, II; Zhang, Jianming; Ahn, Yebin; Zhou, Wenjun; London, Wendy B.; McGrady, Patrick; Xue, Liquan; Zozulya, Sergey; Gregor, Vlad E.; Webb, Thomas R.; Gray, Nathanael S.; Gilliland, D. Gary; Diller, Lisa; Greulich, Heidi; Morris, Stephan W.; Meyerson, Matthew; Look, A. Thomas			Activating mutations in ALK provide a therapeutic target in neuroblastoma	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; HIGH-RISK NEUROBLASTOMA; EML4-ALK FUSION GENE; CELL LUNG-CANCER; GEFITINIB; IDENTIFICATION; INHIBITOR; TRANSPLANTATION; TRANSFORMATION; PLEIOTROPHIN	Neuroblastoma, an embryonal tumour of the peripheral sympathetic nervous system, accounts for approximately 15% of all deaths due to childhood cancer(1). High- risk neuroblastomas are rapidly progressive; even with intensive myeloablative chemotherapy, relapse is common and almost uniformly fatal(2,3). Here we report the detection of previously unknown mutations in the ALK gene, which encodes a receptor tyrosine kinase, in 8% of primary neuroblastomas. Five non- synonymous sequence variations were identified in the kinase domain of ALK, of which three were somatic and two were germ line. The most frequent mutation, F1174L, was also identified in three different neuroblastoma cell lines. ALK complementary DNAs encoding the F1174L and R1275Q variants, but not the wild- type ALK cDNA, transformed interleukin-3-dependent murine haematopoietic Ba/F3 cells to cytokine-independent growth. Ba/F3 cells expressing these mutations were sensitive to the small- molecule inhibitor of ALK, TAE684 (ref. 4). Furthermore, two human neuroblastoma cell lines harbouring the F1174L mutation were also sensitive to the inhibitor. Cytotoxicity was associated with increased amounts of apoptosis as measured by TdT-mediated dUTP nick end labelling ( TUNEL). Short hairpin RNA (shRNA)- mediated knockdown of ALK expression in neuroblastoma cell lines with the F1174L mutation also resulted in apoptosis and impaired cell proliferation. Thus, activating alleles of the ALK receptor tyrosine kinase are present in primary neuroblastoma tumours and in established neuroblastoma cell lines, and confer sensitivity to ALK inhibition with small molecules, providing a molecular rationale for targeted therapy of this disease.	[George, Rani E.; Sanda, Takaomi; Luther, William, II; Ahn, Yebin; Diller, Lisa; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Zhang, Jianming; Zhou, Wenjun; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hanna, Megan; Greulich, Heidi; Meyerson, Matthew] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA; [Frohling, Stefan; Gilliland, D. Gary] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [London, Wendy B.; McGrady, Patrick] Univ Florida, Childrens Oncol Grp Stat & Data Ctr, Gainesville, FL 32601 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Webb, Thomas R.] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Zozulya, Sergey; Gregor, Vlad E.] ChemBridge Res Labs Inc, San Diego, CA 92127 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Children's Oncology Group (COG); State University System of Florida; University of Florida; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu; thomas_look@dfci.harvard.edu	George, Rani/AAG-7635-2019; London, Wendy/ABD-4624-2021; Meyerson, Matthew L/E-7123-2012; London, Wendy Beth/ABA-8948-2021; Webb, Thomas/J-4511-2013; Zozulya, Sergey A/F-2986-2015	London, Wendy Beth/0000-0003-3571-6538; Zozulya, Sergey A/0000-0002-1179-2993; Zhang, Jianming/0000-0001-6326-3906	National Institutes of Health; Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI [CA69129]; Cancer Center Core [CA21765]; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA069129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends for Life Neuroblastoma Fund; Children's Oncology Group; Alex's Lemonade Stand Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Elechko and L. Moreau for technical assistance, A. Azarova for help with cell culture and cell growth assays, Q. Jiang and X. Cui for assistance during ALK small-molecule inhibitor development, and A. Kung for Ba/F3 cells and retroviral vectors. Weacknowledge the Children's Oncology Group for provision of neuroblastoma tumour and matched normal DNAs, and tumour touch prep slides. We thank J. Maris for neuroblastoma cell lines. We thank Abbott Molecular International for the Vysis LSI ALK Dual Color, Break Apart Rearrangement Probe. This work was supported by grants from the National Institutes of Health (R.E.G.), the Friends for Life Neuroblastoma Fund (R.E.G.), the Children's Oncology Group (R.E.G.), Alex's Lemonade Stand Foundation (M.H. and M.M.), NCI CA69129 (L.X. and S.W.M.), Cancer Center Core grant CA21765 (T.R.W., L.X. and S.W.M.), the American Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital (T.R.W., L.X. and S.W.M.).	Calvet L, 2006, ONCOGENE, V25, P3150, DOI 10.1038/sj.onc.1209348; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; George RE, 2006, J CLIN ONCOL, V24, P2891, DOI 10.1200/JCO.2006.05.6986; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Li RS, 2008, MED RES REV, V28, P372, DOI 10.1002/med.20109; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; *NCI, 2005, SURV EP END RES DAT; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946	27	631	672	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					975	978		10.1038/nature07397	http://dx.doi.org/10.1038/nature07397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18923525	Green Accepted			2022-12-24	WOS:000260038300052
J	Gaspard, N; Bouschet, T; Hourez, R; Dimidschstein, J; Naeije, G; van den Ameele, J; Espuny-Camacho, I; Herpoel, A; Passante, L; Schiffmann, SN; Gaillard, A; Vanderhaeghen, P				Gaspard, Nicolas; Bouschet, Tristan; Hourez, Raphael; Dimidschstein, Jordane; Naeije, Gilles; van den Ameele, Jelle; Espuny-Camacho, Ira; Herpoel, Adele; Passante, Lara; Schiffmann, Serge N.; Gaillard, Afsaneh; Vanderhaeghen, Pierre			An intrinsic mechanism of corticogenesis from embryonic stem cells	NATURE			English	Article							DEVELOPING CEREBRAL-CORTEX; DIRECTED DIFFERENTIATION; CORTICAL DEVELOPMENT; PROJECTION NEURON; RADIAL GLIA; SPECIFICATION; FATE; NEOCORTEX; TRANSPLANTATION; PRECURSORS	The cerebral cortex develops through the coordinated generation of dozens of neuronal subtypes, but the mechanisms involved remain unclear. Here we show that mouse embryonic stem cells, cultured without any morphogen but in the presence of a sonic hedgehog inhibitor, recapitulate in vitro the major milestones of cortical development, leading to the sequential generation of a diverse repertoire of neurons that display most salient features of genuine cortical pyramidal neurons. When grafted into the cerebral cortex, these neurons develop patterns of axonal projections corresponding to a wide range of cortical layers, but also to highly specific cortical areas, in particular visual and limbic areas, thereby demonstrating that the identity of a cortical area can be specified without any influence from the brain. The discovery of intrinsic corticogenesis sheds new light on the mechanisms of neuronal specification, and opens new avenues for the modelling and treatment of brain diseases.	[Gaspard, Nicolas; Bouschet, Tristan; Dimidschstein, Jordane; Naeije, Gilles; van den Ameele, Jelle; Espuny-Camacho, Ira; Herpoel, Adele; Passante, Lara; Vanderhaeghen, Pierre] Univ Libre Bruxelles, IRIBHN, Inst Interdisciplinary Res, B-1070 Brussels, Belgium; [Hourez, Raphael; Schiffmann, Serge N.] Univ Libre Bruxelles, Neurophysiol Lab, B-1070 Brussels, Belgium; [Gaillard, Afsaneh] Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Vanderhaeghen, P (corresponding author), Univ Libre Bruxelles, IRIBHN, Inst Interdisciplinary Res, 808 Route Lennik, B-1070 Brussels, Belgium.	pierre.vanderhaeghen@ulb.ac.be	Espuny, Ira/AAM-1991-2021; Bouschet, Tristan/C-8265-2019; Naeije, Gilles/AFT-2241-2022	Espuny, Ira/0000-0002-2356-2159; Bouschet, Tristan/0000-0002-7858-6115; Naeije, Gilles/0000-0003-1580-1970; van den Ameele, Jelle/0000-0002-2744-0810; Schiffmann, Serge/0000-0002-0118-9816; Dimidschstein, Jordane/0000-0001-6289-6891; Vanderhaeghen, Pierre/0000-0001-7899-5720	Belgian FNRS, the Action de Recherches Concertees (ARC) Programs; Interuniversity Attraction Poles Program (IUAP); Belgian State; Federal Office; Walloon Region Excellence Program CIBLES; Belgian Queen Elizabeth Medical Foundation; UCB Neuroscience Award; Tournesol FNRS/CNRS Program; Televie; Marie Curie Grant; Research Fellows of the FNRS	Belgian FNRS, the Action de Recherches Concertees (ARC) Programs(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); Belgian State; Federal Office; Walloon Region Excellence Program CIBLES; Belgian Queen Elizabeth Medical Foundation; UCB Neuroscience Award; Tournesol FNRS/CNRS Program; Televie; Marie Curie Grant(European Commission); Research Fellows of the FNRS	We thank G. Vassart, M. Pandolfo and members of the laboratory and IRIBHM for support and discussions. We are indebted to A. Bilheu for technical assistance, J.-M. Vanderwinden for help with confocal microscopy, and V.De Maertelaer for statistical analyses. We thank F. Polleux, B. Hassan and C. Blanpain for comments on the manuscript. We are grateful to S. Arber, A. Goffinet, R. Hevner, R. di Lauro, Y. Sasai, S. Stifani, M. Studer and V. Tarabykin for providing us with antibodies, and to Y.-A. Barde for providing Tau-GFP ESC lines. This work was funded by the Belgian FNRS, the Action de Recherches Concertees (ARC) Programs (to P.V. and S.N.S.), the Interuniversity Attraction Poles Program (IUAP), Belgian State, Federal Office, the Walloon Region Excellence Program CIBLES, the Belgian Queen Elizabeth Medical Foundation and a UCB Neuroscience Award (to P.V.), the Tournesol FNRS/CNRS Program (to P.V. and A.G.), Televie (to S.N.S.), and a Marie Curie Grant (to T.B.). P.V. is a Senior Research Associate of the FNRS, and N.G., R.H., T.B., J.D. and L.P. were funded as Research Fellows of the FNRS.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; BARBE MF, 1995, J NEUROSCI, V15, P1819, DOI 10.1523/JNEUROSCI.15-03-01819.1995; Bayer S.A., 1991, NEOCORTICAL DEV; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; EBRAHIMIGAILLARD A, 1994, DEV BRAIN RES, V77, P271, DOI 10.1016/0165-3806(94)90203-8; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Frost SB, 2000, J COMP NEUROL, V421, P29, DOI 10.1002/(SICI)1096-9861(20000522)421:1<29::AID-CNE3>3.0.CO;2-9; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Glaser T, 2005, TRENDS NEUROSCI, V28, P397, DOI 10.1016/j.tins.2005.05.008; Gotz M, 2005, DEVELOPMENT, V132, P3327, DOI 10.1242/dev.01931; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Pinaudeau C, 2000, EUR J NEUROSCI, V12, P2486, DOI 10.1046/j.1460-9568.2000.00148.x; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Puelles L, 2001, PHILOS T R SOC B, V356, P1583, DOI 10.1098/rstb.2001.0973; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Sansom SN, 2005, DEVELOPMENT, V132, P3947, DOI 10.1242/dev.01968; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Vanderhaeghen P, 2004, TRENDS NEUROSCI, V27, P384, DOI 10.1016/j.tins.2004.05.009; Von Economo C.B., 1925, CYTOARCHITECTONICS A; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	45	445	456	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					351	U10		10.1038/nature07287	http://dx.doi.org/10.1038/nature07287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18716623	Green Submitted			2022-12-24	WOS:000259265200036
J	Santiago, ML; Montano, M; Benitez, R; Messer, RJ; Yonemoto, W; Chesebro, B; Hasenkrug, KJ; Greene, WC				Santiago, Mario L.; Montano, Mauricio; Benitez, Robert; Messer, Ronald J.; Yonemoto, Wes; Chesebro, Bruce; Hasenkrug, Kim J.; Greene, Warner C.			Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection	SCIENCE			English	Article							FRIEND-VIRUS LEUKEMIA; RESISTANCE GENE; ENZYME APOBEC3G; RECOVERY; IDENTIFICATION; AFFINITY; VIREMIA; BLOCKS	Recovery from Friend virus 3 ( Rfv3) is a single autosomal gene encoding a resistance trait that influences retroviral neutralizing antibody responses and viremia. Despite extensive research for 30 years, the molecular identity of Rfv3 has remained elusive. Here, we demonstrate that Rfv3 is encoded by Apobec3. Apobec3 maps to the same chromosome region as Rfv3 and has broad inhibitory activity against retroviruses, including HIV. Not only did genetic inactivation of Apobec3 convert Rfv3- resistant mice to a susceptible phenotype, but Apobec3 was also found to be naturally disabled by aberrant messenger RNA splicing in Rfv3- susceptible strains. The link between Apobec3 and neutralizing antibody responses highlights an Apobec3- dependent mechanism of host protection that might extend to HIV and other human retroviral infections.	[Messer, Ronald J.; Chesebro, Bruce; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA; [Santiago, Mario L.; Montano, Mauricio; Benitez, Robert; Yonemoto, Wes; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hasenkrug, KJ (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA.	khasenkrug@nih.gov; wgreene@gladstone.ucsf.edu		Santiago, Mario L./0000-0001-7792-2706	NIAID Division of Intramural Research at NIH; NIH [R01 AI065329]	NIAID Division of Intramural Research at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Transgenic Core Laboratory, the Animal Facility, and S. Espineda at the J. David Gladstone Institutes for technical assistance; L. Evans, J. Portis, R. Gallo, R. Locksley, and members of the Greene and Hasenkrug Laboratory for helpful discussions; and R. Givens, S. Cammack, and G. Howard for manuscript preparation. This work was supported by the NIAID Division of Intramural Research at NIH to K. J. H. and B. C., an NIH R01 AI065329 to W. C. G., and an NIH facility grant to the J. David Gladstone Institutes. Sequences are deposited in GenBank, with accession numbers EU707568 to EU707571.	Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; BRITT WJ, 1983, J EXP MED, V157, P1736, DOI 10.1084/jem.157.6.1736; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CHESEBRO B, 1979, P NATL ACAD SCI USA, V76, P425, DOI 10.1073/pnas.76.1.425; CHESEBRO B, 1976, J EXP MED, V143, P73, DOI 10.1084/jem.143.1.73; CHESEBRO B, 1978, ADV COMP LEUKEMIA RE, P69; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10; Gonzalez-Fernandez A, 1998, IMMUNOLOGY, V93, P149; Hasenkrug KJ, 1999, J VIROL, V73, P6468, DOI 10.1128/JVI.73.8.6468-6473.1999; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; HASENKRUG KJ, 1995, J VIROL, V69, P2617, DOI 10.1128/JVI.69.4.2617-2620.1995; Kanari Y, 2005, AIDS, V19, P1015, DOI 10.1097/01.aids.0000174447.48003.dd; KIM YT, 1974, CLIN EXP IMMUNOL, V17, P329; Li W, 2006, J VIROL, V80, P5777, DOI 10.1128/JVI.02711-05; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; MONROE JG, 1984, IMMUNOL REV, V80, P103, DOI 10.1111/j.1600-065X.1984.tb00497.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; PORTIS JL, 1992, J ACQ IMMUN DEF SYND, V5, P1272, DOI 10.1097/00126334-199212000-00011; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Super HJ, 1999, J VIROL, V73, P7848, DOI 10.1128/JVI.73.9.7848-7852.1999; VANDERGAAG HC, 1990, VIROLOGY, V177, P837, DOI 10.1016/0042-6822(90)90561-5; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	26	114	117	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1343	1346		10.1126/science.1161121	http://dx.doi.org/10.1126/science.1161121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772436	Green Accepted			2022-12-24	WOS:000258914300047
J	Marles-Wright, J; Grant, T; Delumeau, O; van Duinen, G; Firbank, SJ; Lewis, PJ; Murray, JW; Newman, JA; Quin, MB; Race, PR; Rohou, A; Tichelaar, W; van Heel, M; Lewis, RJ				Marles-Wright, Jon; Grant, Tim; Delumeau, Olivier; van Duinen, Gijs; Firbank, Susan J.; Lewis, Peter J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin; Lewis, Richard J.			Molecular architecture of the "stressosome," a signal integration and transduction hub	SCIENCE			English	Article							TRANSCRIPTION FACTOR SIGMA(B); BACILLUS-SUBTILIS; SERINE KINASE; PATHWAY; PROTEIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; REGULATORS; RSBR	A commonly used strategy by microorganisms to survive multiple stresses involves a signal transduction cascade that increases the expression of stress- responsive genes. Stress signals can be integrated by a multiprotein signaling hub that responds to various signals to effect a single outcome. We obtained a medium- resolution cryo- electron microscopy reconstruction of the 1.8- megadalton "stressosome" from Bacillus subtilis. Fitting known crystal structures of components into this reconstruction gave a pseudoatomic structure, which had a virus capsid- like core with sensory extensions. We suggest that the different sensory extensions respond to different signals, whereas the conserved domains in the core integrate the varied signals. The architecture of the stressosome provides the potential for cooperativity, suggesting that the response could be tuned dependent on the magnitude of chemophysical insult.	[Grant, Tim; van Duinen, Gijs; Rohou, Alexis; Tichelaar, Willem; van Heel, Marin] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England; [Marles-Wright, Jon; Delumeau, Olivier; Firbank, Susan J.; Murray, James W.; Newman, Joseph A.; Quin, Maureen B.; Race, Paul R.; Lewis, Richard J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lewis, Peter J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Imperial College London; Newcastle University - UK; University of Newcastle	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, London SW7 2AZ, England.	m.vanheel@imperial.ac.uk; r.lewis@ncl.ac.uk		Grant, Tim/0000-0002-4855-8703; Marles-Wright, Jon/0000-0002-9156-3284; newman, Joseph/0000-0003-4488-0516; lewis, richard/0000-0003-2641-8643; Rohou, Alexis/0000-0002-3343-9621; Quin, Maureen/0000-0001-7193-639X; Murray, James/0000-0002-8897-0161	Biotechnology and Biological Sciences Research Council; Newcastle University; Australian Research Council; University of Newcastle (Australia); European Union NOE [LSHG-CT-2004-502828]; Dutch Ministry of Economic Affairs [BSIK 03036]; BBSRC; Glaxo Wellcome; SmithKline Beecham; BBSRC [BB/F001533/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000521/1, BB/F001533/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University; Australian Research Council(Australian Research Council); University of Newcastle (Australia); European Union NOE(European Commission); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Glaxo Wellcome; SmithKline Beecham(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council ( BBSRC), Newcastle University (UK), Australian Research Council, University of Newcastle (Australia) by grants from the European Union NOE, Contract LSHG-CT-2004-502828), and the Dutch Ministry of Economic Affairs ("Cyttron", BSIK 03036). The electron microscopes used for this work were purchased with financial support from the BBSRC, Glaxo Wellcome, and SmithKline Beecham. We are grateful to M. Schatz (Image Science, Berlin, Germany) for IMAGIC software support and to W. Haldenwang for strain BSK5. We thank R. Harris, H. Gilbert, M. Embley, and N. Robinson for advice and useful comments on the manuscript and E. Lowe for help with curve fitting. We are grateful for access to the Diamond synchrotron light source and its beamline scientists for help during data collection. Coordinates and structure factors for MtRsbS are deposited in the Protein Databank with the accession number 2VY9. Electron microscopy-derived molecular envelopes are deposited in the Electron Microscopy Database at the Macromolecular Structure Database Group with the following accession numbers:RsbR<INF>(146-274)</INF>: RsbS, 1558; RsbR: RsbS, 1555; and RsbR: RsbS: RsbT 1556.	Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; BENSON AK, 1993, J BACTERIOL, V175, P1929, DOI 10.1128/JB.175.7.1929-1935.1993; Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dufour A, 1996, J BACTERIOL, V178, P3701, DOI 10.1128/jb.178.13.3701-9sigma.1996; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Hardwick SW, 2007, J BIOL CHEM, V282, P11562, DOI 10.1074/jbc.M609733200; Kang CM, 1996, J BACTERIOL, V178, P3846, DOI 10.1128/jb.178.13.3846-3853.1996; Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Kuo S, 2004, MICROBIOL-SGM, V150, P4125, DOI 10.1099/mic.0.27421-0; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Woodbury RL, 2004, J BACTERIOL, V186, P2789, DOI 10.1128/JB.186.9.2789-2797.2004; Zhang SY, 2003, J BACTERIOL, V185, P5714, DOI 10.1128/JB.185.19.5714-5721.2003	30	122	124	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					92	96		10.1126/science.1159572	http://dx.doi.org/10.1126/science.1159572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832644				2022-12-24	WOS:000259680200045
J	Wu, KM; Lu, YH; Feng, HQ; Jiang, YY; Zhao, JZ				Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Jiang, Yu-Ying; Zhao, Jian-Zhou			Suppression of cotton bollworm in multiple crops in china in areas with Bt toxin-containing cotton	SCIENCE			English	Article							PEST-MANAGEMENT; SEASONAL ABUNDANCE; TRANSGENIC COTTON; PINK-BOLLWORM; RESISTANCE; HEMIPTERA; MIRIDAE; FIELD	Transgenic cotton that has been engineered to produce insecticidal toxins from Bacillus thuringiensis (Bt) and so to resist the pest cotton bollworm (Helicoverpa armigera) has been widely planted in Asia. Analysis of the population dynamics of H. armigera from 1992 to 2007 in China indicated that a marked decrease in regional outbreaks of this pest in multiple crops was associated with the planting of Bt cotton. The study area included six provinces in northern China with an annual total of 3 million hectares of cotton and 22 million hectares of other crops (corn, peanuts, soybeans, and vegetables) grown by more than 10 million resource- poor farmers. Our data suggest that Bt cotton not only controls H. armigera on transgenic cotton designed to resist this pest but also may reduce its presence on other host crops and may decrease the need for insecticide sprays in general.	[Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Zhao, Jian-Zhou] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Jiang, Yu-Ying] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn		Lu, Yanhui/0000-0002-6552-0248; Zhao, Jianzhou/0000-0001-9136-2442; Feng, Hongqiang/0000-0002-1171-248X	973 Projects Grant [2007CB109204]; Ministry of Science and Technology of China; National Natural Science Foundation of China [30625028]	973 Projects Grant(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by 973 Projects Grant (2007CB109204) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30625028). We thank A. M. Shelton (Cornell University) and two anonymous referees for comments and suggestions.	Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; *EPA, PEST NEWS STOR EPA A; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; JAMES C, 2007, ISAAA BRIEFS, V37; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012	18	536	720	20	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1676	1678		10.1126/science.1160550	http://dx.doi.org/10.1126/science.1160550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801998				2022-12-24	WOS:000259300400035
J	Roguev, A; Bandyopadhyay, S; Zofall, M; Zhang, K; Fischer, T; Collins, SR; Qu, HJ; Shales, M; Park, HO; Hayles, J; Hoe, KL; Kim, DU; Ideker, T; Grewal, SI; Weissman, JS; Krogan, NJ				Roguev, Assen; Bandyopadhyay, Sourav; Zofall, Martin; Zhang, Ke; Fischer, Tamas; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Park, Han-Oh; Hayles, Jacqueline; Hoe, Kwang-Lae; Kim, Dong-Uk; Ideker, Trey; Grewal, Shiv I.; Weissman, Jonathan S.; Krogan, Nevan J.			Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast	SCIENCE			English	Article							POLYMERASE-II HOLOENZYME; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HISTONE-3 LYSINE-4; PROTEIN COMPLEXES; GENE-EXPRESSION; DNA-DAMAGE; CHECKPOINT; TRANSCRIPTION; ORGANIZATION	An epistasis map (E-MAP) was constructed in the fission yeast, Schizosaccharomyces pombe, by systematically measuring the phenotypes associated with pairs of mutations. This high-density, quantitative genetic interaction map focused on various aspects of chromosome function, including transcription regulation and DNA repair/replication. The E-MAP uncovered a previously unidentified component of the RNA interference (RNAi) machinery (rsh1) and linked the RNAi pathway to several other biological processes. Comparison of the S. pombe E-MAP to an analogous genetic map from the budding yeast revealed that, whereas negative interactions were conserved between genes involved in similar biological processes, positive interactions and overall genetic profiles between pairs of genes coding for physically associated proteins were even more conserved. Hence, conservation occurs at the level of the functional module (protein complex), but the genetic cross talk between modules can differ substantially.	[Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Program Bioinformat, La Jolla, CA 92093 USA; [Zofall, Martin; Zhang, Ke; Fischer, Tamas; Grewal, Shiv I.] NCI, Biochem & Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Collins, Sean R.; Weissman, Jonathan S.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Park, Han-Oh] Bioneer Corp, Taejon, South Korea; [Hayles, Jacqueline] London Res Inst, Canc Res UK, Cell Cycle Lab, London WC2A 3PX, England; [Hoe, Kwang-Lae; Kim, Dong-Uk] Korea Res Inst Biosci & Biotechnol, Genom Res Ctr, Taejon, South Korea; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Cancer Research UK; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu; grewals@mail.nih.gov; weissman@cmp.ucsf.edu; krogan@cmpmail.ucsf.edu	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X; Ideker, Trey/0000-0002-1708-8454; Hoe, Kwang Lae/0000-0002-3943-4549	NIH [GM084279]; Sandler Family Foundation; Howard Hughes Medical Institute; National Cancer Institute; Center for Cancer Research; California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE [ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Beltrao and G. Cagney for critical reading of the manuscript; M. Wiren and S. Forsburg for discussion; P. Kemmeren for setting up the web database; S. Wang, C. Wen, and D. Avdic for technical help; and F. Stewart for sharing unpublished data. This work was supported by NIH [National Institute of General Medical Sciences grant GM084279 (T.I. and N.J.K.)], the Sandler Family Foundation (N. J. K), the Howard Hughes Medical Institute (J.S.W.), National Cancer Institute (S.I.G.), Center for Cancer Research (S.I.G.), and the California Institute of Quantitative Biology (N.J.K.).	Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sakurai H, 1998, GENE, V221, P11, DOI 10.1016/S0378-1119(98)00449-1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sipiczki M, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	39	262	264	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					405	410		10.1126/science.1162609	http://dx.doi.org/10.1126/science.1162609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18818364	Green Accepted			2022-12-24	WOS:000260094500037
J	Dong, XP; Cheng, XP; Mills, E; Delling, M; Wang, FD; Kurz, T; Xu, HX				Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Delling, Markus; Wang, Fudi; Kurz, Tino; Xu, Haoxing			The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel	NATURE			English	Article							RECEPTOR POTENTIAL CHANNEL; MEMBRANE-PROTEIN; MUTATIONS; METABOLISM; PATHWAY; DISEASE; MICE; SKIN	TRPML1 ( mucolipin 1, also known as MCOLN1) is predicted to be an intracellular late endosomal and lysosomal ion channel protein that belongs to the mucolipin subfamily of transient receptor potential ( TRP) proteins(1-3). Mutations in the human TRPML1 gene cause mucolipidosis type IV disease ( ML4)4,5.ML4 patients have motor impairment, mental retardation, retinal degeneration and iron- deficiency anaemia. Because aberrant iron metabolism may cause neural and retinal degeneration(6,7), it may be a primary cause of ML4 phenotypes. In most mammalian cells, release of iron from endosomes and lysosomes after iron uptake by endocytosis of Fe(3+)- bound transferrin receptors(6), or after lysosomal degradation of ferritin - iron complexes and autophagic ingestion of iron-containing macromolecules(6,8), is the chief source of cellular iron. The divalent metal transporter protein DMT1 ( also known as SLC11A2) is the only endosomal Fe(2+) transporter known at present and it is highly expressed in erythroid precursors(6,9). Genetic studies, however, suggest the existence of a DMT1-independent endosomal and lysosomal Fe(2+) transport protein(9). By measuring radiolabelled iron uptake, by monitoring the levels of cytosolic and intralysosomal iron and by directly patch- clamping the late endosomal and lysosomal membrane, here we show that TRPML1 functions as a Fe(2+) permeable channel in late endosomes and lysosomes. ML4 mutations are shown to impair the ability of TRPML1 to permeate Fe(2+) at varying degrees, which correlate well with the disease severity. A comparison of TRPML1(-/-) ML4 and control human skin fibroblasts showed a reduction in cytosolic Fe(2+) levels, an increase in intralysosomal Fe(2+) levels and an accumulation of lipofuscin- like molecules in TRPML1(-/-) cells. We propose that TRPML1 mediates a mechanism by which Fe(2+) is released from late endosomes and lysosomes. Our results indicate that impaired iron transportmay contribute to both haematological and degenerative symptoms of ML4 patients.	[Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Delling, Markus] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Wang, Fudi] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kurz, Tino] Linkoping Univ, Dept Pharmacol, Fac Hlth Sci, S-58185 Linkoping, Sweden	University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Linkoping University	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Nat Sci Bldg Kraus,830 N Univ, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	Wang, Fudi/L-7888-2018; xu, hao/GWQ-7394-2022	Wang, Fudi/0000-0001-8730-0003; Dong, Xianping/0000-0002-4496-7104	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by start-up funds to H. X. from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan. We thank U. Brunk, M. Saito, R. Hume, C. Duan, M. Akaaboune, J. Kuwada, S. Low, S. Punthambaker and S. Dellal for assistance, and D. Clapham, N. Andrews, L. DeFelice, L. Yue, D. Ren, C. Jiang and S. Xu for comments on an earlier version of the manuscript. We also thank K. Kiselyov for sharing his unpublished results on lysosomal iron staining of ML4 cells. We appreciate the encouragement and helpful comments from other members of the Xu laboratory.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bargal R, 2002, NEUROPEDIATRICS, V33, P199, DOI 10.1055/s-2002-34496; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kress GJ, 2002, J NEUROSCI, V22, P5848; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lee DW, 2006, MOL INTERV, V6, P89, DOI 10.1124/mi.6.2.6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrat F, 2000, ARCH BIOCHEM BIOPHYS, V376, P74, DOI 10.1006/abbi.2000.1711; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004	25	374	382	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					992	U78		10.1038/nature07311	http://dx.doi.org/10.1038/nature07311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18794901	Green Accepted, Green Published			2022-12-24	WOS:000260038300056
J	Mefford, HC; Sharp, AJ; Baker, C; Itsara, A; Jiang, ZS; Buysse, K; Huang, SW; Maloney, VK; Crolla, JA; Baralle, D; Collins, A; Mercer, C; Norga, K; de Ravel, T; Devriendt, K; Bongers, EMHF; de Leeuw, N; Reardon, W; Gimelli, S; Bena, F; Hennekam, RC; Male, A; Gaunt, L; Clayton-Smith, J; Simonic, I; Park, SM; Mehta, SG; Nik-Zainal, S; Woods, CG; Firth, HV; Parkin, G; Fichera, M; Reitano, S; Lo Giudice, M; Li, KE; Casuga, I; Broomer, A; Conrad, B; Schwerzmann, M; Raber, L; Gallati, S; Striano, P; Coppola, A; Tolmie, JL; Tobias, ES; Lilley, C; Armengol, L; Spysschaert, Y; Verloo, P; De Coene, A; Goossens, L; Mortier, G; Speleman, F; van Binsbergen, E; Nelen, MR; Hochstenbach, R; Poot, M; Gallagher, L; Gill, M; McClellan, J; King, MC; Regan, R; Skinner, C; Stevenson, RE; Antonarakis, SE; Chen, CF; Estivill, X; Menten, B; Gimelli, G; Gribble, S; Schwartz, S; Sutcliffe, JS; Walsh, T; Knight, SJL; Sebat, J; Romano, C; Schwartz, CE; Veltman, JA; de Vries, BBA; Vermeesch, JR; Barber, JCK; Willatt, L; Tassabehji, M; Eichler, EE				Mefford, Heather C.; Sharp, Andrew J.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; Buysse, Karen; Huang, Shuwen; Maloney, Viv K.; Crolla, John A.; Baralle, Diana; Collins, Amanda; Mercer, Catherine; Norga, Koen; de Ravel, Thomy; Devriendt, Koen; Bongers, Ernie M. H. F.; de Leeuw, Nicole; Reardon, William; Gimelli, Stefania; Bena, Frederique; Hennekam, Raoul C.; Male, Alison; Gaunt, Lorraine; Clayton-Smith, Jill; Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Li, Kelly E.; Casuga, Iris; Broomer, Adam; Conrad, Bernard; Schwerzmann, Markus; Raber, Lorenz; Gallati, Sabina; Striano, Pasquale; Coppola, Antonietta; Tolmie, John L.; Tobias, Edward S.; Lilley, Chris; Armengol, Lluis; Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde; Mortier, Geert; Speleman, Frank; van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin; Gallagher, Louise; Gill, Michael; McClellan, Jon; King, Mary-Claire; Regan, Regina; Skinner, Cindy; Stevenson, Roger E.; Antonarakis, Stylianos E.; Chen, Caifu; Estivill, Xavier; Menten, Bjorn; Gimelli, Giorgio; Gribble, Susan; Schwartz, Stuart; Sutcliffe, James S.; Walsh, Tom; Knight, Samantha J. L.; Sebat, Jonathan; Romano, Corrado; Schwartz, Charles E.; Veltman, Joris A.; de Vries, Bert B. A.; Vermeesch, Joris R.; Barber, John C. K.; Willatt, Lionel; Tassabehji, May; Eichler, Evan E.			Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY-NUMBER VARIATION; ARRAY-CGH; SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; MICRODELETION; DELETION; POLYMORPHISM; MUTATION; WIDE; HYBRIDIZATION	Background: Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of submicroscopic imbalances in large numbers of patients. Methods: We tested for the presence of microdeletions and microduplications at a specific region of chromosome 1q21.1 in two groups of patients with unexplained mental retardation, autism, or congenital anomalies and in unaffected persons. Results: We identified 25 persons with a recurrent 1.35-Mb deletion within 1q21.1 from screening 5218 patients. The microdeletions had arisen de novo in eight patients, were inherited from a mildly affected parent in three patients, were inherited from an apparently unaffected parent in six patients, and were of unknown inheritance in eight patients. The deletion was absent in a series of 4737 control persons (P=1.1 x 10(-7))). We found considerable variability in the level of phenotypic expression of the microdeletion; phenotypes included mild-to-moderate mental retardation, microcephaly, cardiac abnormalities, and cataracts. The reciprocal duplication was enriched in nine children with mental retardation or autism spectrum disorder and other variable features (P=0.02). We identified three deletions and three duplications of the 1q21.1 region in an independent sample of 788 patients with mental retardation and congenital anomalies. Conclusions: We have identified recurrent molecular lesions that elude syndromic classification and whose disease manifestations must be considered in a broader context of development as opposed to being assigned to a specific disease. Clinical diagnosis in patients with these lesions may be most readily achieved on the basis of genotype rather than phenotype.	[Mefford, Heather C.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; McClellan, Jon; King, Mary-Claire; Walsh, Tom; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Sharp, Andrew J.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gimelli, Stefania] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Buysse, Karen; Mortier, Geert; Speleman, Frank; Menten, Bjorn] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde] Ghent Univ Hosp, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Huang, Shuwen; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Natl Genet Reference Lab, Salisbury, Wilts, England; [Maloney, Viv K.; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Baralle, Diana; Collins, Amanda; Mercer, Catherine] Southampton Univ Hosp Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [Hennekam, Raoul C.] UCL, London, England; [Male, Alison] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Gaunt, Lorraine; Clayton-Smith, Jill] Univ Manchester, St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Tassabehji, May] Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; [Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Willatt, Lionel] Addenbrookes Hosp NHS Trust, Cambridge, England; [Gribble, Susan] Wellcome Trust Sanger Inst, Cambridge, England; [Regan, Regina; Knight, Samantha J. L.] Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England; [Norga, Koen] Katholieke Univ Leuven, Childrens Hosp, Louvain, Belgium; [Norga, Koen] Katholieke Univ Leuven, Vlaams Interuniv Inst Biotechnol, Louvain, Belgium; [de Ravel, Thomy; Devriendt, Koen; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Bongers, Ernie M. H. F.; de Leeuw, Nicole; Veltman, Joris A.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin] Univ Med Ctr, Utrecht, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Reardon, William] Our Ladys Hosp Sick Children, Dublin, Ireland; [Gallagher, Louise; Gill, Michael] St James Hosp, Dublin 8, Ireland; [Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, Troina, Italy; [Striano, Pasquale; Coppola, Antonietta] Univ Naples Federico II, Naples, Italy; [Striano, Pasquale] Osped Gaslini, Unita Neuromuscolare, Genoa, Italy; [Gimelli, Giorgio] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Li, Kelly E.; Casuga, Iris; Broomer, Adam; Chen, Caifu] Appl Biosyst Inc, Foster City, CA 94404 USA; [Conrad, Bernard; Gallati, Sabina] Bern Univ Childrens Hosp, Bern, Switzerland; [Schwerzmann, Markus; Raber, Lorenz] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Tolmie, John L.; Tobias, Edward S.; Lilley, Chris] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Armengol, Lluis; Estivill, Xavier] CIBERESP, Biomed Res Ctr Epidemiol & Publ Hlth, Barcelona, Spain; [Armengol, Lluis; Estivill, Xavier] Pompeu Fabra Univ, Barcelona, Spain; [Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Schwartz, Stuart] Univ Chicago, Chicago, IL 60637 USA; [Sutcliffe, James S.] Vanderbilt Univ, Nashville, TN USA; [Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Geneva; University of Geneva; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; KU Leuven; KU Leuven; KU Leuven; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Our Ladys Children Hospital Crumlin; Trinity College Dublin; IRCCS Oasi Maria SS; University of Naples Federico II; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Thermo Fisher Scientific; Applied Biosystems; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Glasgow; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Greenwood Genetic Center; University of Chicago; Vanderbilt University; Cold Spring Harbor Laboratory	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, Foege Bldg S413A,Box 355065,1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Striano, Pasquale/F-9117-2014; Menten, Björn/B-3072-2013; Fichera, Marco/K-9220-2016; Romano, Corrado/B-9695-2008; Estivill, Xavier/A-3125-2013; speleman, frank/AAR-5184-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Veltman, Joris A/F-5128-2010; woods, christopher g/A-1361-2010; de Leeuw, N./L-4480-2015; Bongers, M.H.F./L-4214-2015; Schwerzmann, Markus/AAD-9368-2022; /AAB-8553-2019; Mortier, Geert/D-2542-2012; Sander-Effron, Samuel/AAX-2231-2020; Nelen, Marcel R./L-4542-2015; Sutcliffe, James S/C-1348-2012; Nik-Zainal, Serena/ABD-4437-2020; Tobias, Edward/D-4246-2009; Poot, Martin/F-9427-2010; Antonarakis, Stylianos E/N-8866-2014; Giudice, Mariangela Lo/D-4261-2017; Estivill, Xavier/E-2957-2012; Norga, Koenraad/D-1137-2017	Striano, Pasquale/0000-0002-6065-1476; Fichera, Marco/0000-0002-8225-6880; Romano, Corrado/0000-0003-1049-0683; Estivill, Xavier/0000-0002-0723-2256; speleman, frank/0000-0002-6628-8559; Veltman, Joris A/0000-0002-3218-8250; Schwerzmann, Markus/0000-0002-4006-8929; Mortier, Geert/0000-0001-9871-4578; Sutcliffe, James S/0000-0001-5200-6007; Tobias, Edward/0000-0003-2649-7695; Antonarakis, Stylianos E/0000-0001-8907-5823; Giudice, Mariangela Lo/0000-0001-5961-0362; de Ravel, Thomy/0000-0002-3361-3781; Nik-Zainal, Serena/0000-0001-5054-1727; Verloo, Patrick/0000-0003-2077-0275; Walsh, Tom/0000-0002-8875-0310; Gill, Michael/0000-0003-0206-5337; Gallagher, Louise/0000-0001-9462-2836; Menten, Bjorn/0000-0001-8182-659X; Reardon, Willie/0000-0001-7329-9179; King, Mary-Claire/0000-0001-9426-1743; Sebat, Jonathan/0000-0002-9087-526X; Norga, Koenraad/0000-0002-9231-0350; Vermeesch, Joris/0000-0002-3071-1191; Baralle, Diana/0000-0003-3217-4833; Knight, Samantha/0000-0002-6047-3462	National Institutes of Health [HD043569]; South Carolina Department of Disabilities and Special Needs; Wellcome Trust [061183]; Andre & Cyprien Foundation; University Hospitals of Geneva; European Union [219250]; AnEUploidy [037627]; Wellcome Trust; Health Research Board; Dutch Foundation for Brain Research [2008(1)34]; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs; Wellcome Trust(Wellcome TrustEuropean Commission); Andre & Cyprien Foundation; University Hospitals of Geneva; European Union(European Commission); AnEUploidy; Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; Dutch Foundation for Brain Research; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants from the National Institutes of Health (HD043569, to Dr. Eichler), the South Carolina Department of Disabilities and Special Needs ( to Drs. Skinner, Stevenson, and Schwartz), the Wellcome Trust (061183, to Dr. Tassabehji), the Andre & Cyprien Foundation and the University Hospitals of Geneva ( to Drs. Antonarakis, Bena, and Gallati), and the European Union (project 219250, to Dr. Sharp; AnEUploidy project 037627, to Drs. Leeuw, Armengol, Antonarakis, Estivill, Veltman, and de Vries). The Irish Autism Study was funded by the Wellcome Trust and the Health Research Board (a grant to Drs. Gallagher and Gill). Dr. Poot was supported by a grant from the Dutch Foundation for Brain Research (Hersenstichting grant 2008(1)34); Drs. Regan and Knight, by the Oxford Partnership Comprehensive Biomedical Research Centre; Dr. Willatt, by the Cambridge Biomedical Research Centre, with funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Drs. Huang and Maloney, as part of the National Genetics Reference Laboratory (Wessex) by the United Kingdom Department of Health; Ms. Buysse, as a research assistant of the Research Foundation - Flanders (FWO-Vlaanderen); and Dr. Eichler, as an investigator of the Howard Hughes Medical Institute. The views expressed in this publication are those of the authors and not necessarily those of the United Kingdom Department of Health.; Drs. Mefford and Sharp report giving invited Webinars and seminars for NimbleGen, a manufacturer of microarrays; Drs. Li, Casuga, Broomer, and Chen report being employees of Applied Biosystems, manufacturer of the TaqMan assay and reagents; and Dr. Eichler reports being an invited speaker at an Applied Biosystems workshop on human copy- number variation. No other potential conflict of interest relevant to this article was reported. We thank Francesca Antonacci for performing fluorescence in situ hybridization analysis. This study used data from the SNP Database at the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository ( http:// ccr. coriell. org/ ninds), as well as clinical data. The Illumina genotyping was performed in the laboratories of Drs. Singleton and Hardy ( National Institute of Aging [ NIA], Laboratory of Neurogenetics [ LNG]), Bethesda, MD.	Barber JCK, 2008, EUR J HUM GENET, V16, P18, DOI 10.1038/sj.ejhg.5201932; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Cheroki C, 2008, J MED GENET, V45, P228, DOI 10.1136/jmg.2007.051839; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; de Stahl TD, 2008, HUM MUTAT, V29, P398, DOI 10.1002/humu.20659; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gu H, 2003, CIRC RES, V93, P201, DOI 10.1161/01.RES.0000084852.65396.70; HANNES FD, 2008, J MED GENET     0611; Hauer RNW, 2006, ADV CARDIOL, V42, P284, DOI 10.1159/000092579; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Juang JM, 2007, INT J CARDIOL, V116, P107, DOI 10.1016/j.ijcard.2006.03.037; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2008, HUM MOL GENET, V17, P466, DOI 10.1093/hmg/ddm321; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; STEFANSSON H, 2008, NATURE          0730; STONE JL, 2008, NATURE          0730; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vanita V, 2008, MOL VIS, V14, P323; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	53	555	571	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1685	U130		10.1056/NEJMoa0805384	http://dx.doi.org/10.1056/NEJMoa0805384			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18784092	Green Accepted, Green Published			2022-12-24	WOS:000260041400007
J	Colwell, RK; Brehm, G; Cardelus, CL; Gilman, AC; Longino, JT				Colwell, Robert K.; Brehm, Gunnar; Cardelus, Catherine L.; Gilman, Alex C.; Longino, John T.			Global warming, elevational range shifts, and lowland biotic attrition in the wet tropics	SCIENCE			English	Article							CLIMATE-CHANGE; SPECIES RICHNESS; FOREST; RESPONSES; BIODIVERSITY; PATTERNS; IMPACTS; GROWTH	Many studies suggest that global warming is driving species ranges poleward and toward higher elevations at temperate latitudes, but evidence for range shifts is scarce for the tropics, where the shallow latitudinal temperature gradient makes upslope shifts more likely than poleward shifts. Based on new data for plants and insects on an elevational transect in Costa Rica, we assess the potential for lowland biotic attrition, range-shift gaps, and mountaintop extinctions under projected warming. We conclude that tropical lowland biotas may face a level of net lowland biotic attrition without parallel at higher latitudes (where range shifts may be compensated for by species from lower latitudes) and that a high proportion of tropical species soon faces gaps between current and projected elevational ranges.	[Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Brehm, Gunnar] Univ Jena, Inst Spezielle Zool, D-07743 Jena, Germany; [Brehm, Gunnar] Univ Jena, Evolutionsbiol Phyletischem Museum, D-07743 Jena, Germany; [Cardelus, Catherine L.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Gilman, Alex C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90950 USA; [Longino, John T.] Evergreen State Coll, Olympia, WA 98505 USA	University of Connecticut; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Colgate University; University of California System; University of California Los Angeles	Colwell, RK (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	colwell@uconn.edu	Colwell, Robert K/C-7276-2015; Cardelus, Catherine/ABA-8409-2020; Brehm, Gunnar/D-5831-2013	Cardelus, Catherine/0000-0003-0526-7612; Brehm, Gunnar/0000-0002-7599-2847	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF [DEB-0072702, DEB-0640015, DEB-0639979]; Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft [BR 2280/1-1]	Organization for Tropical Studies; Conservation International; University of Connecticut; U.S. NSF(National Science Foundation (NSF)); Research Fellowship and Dissertation Improvement Grant; Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Organization for Tropical Studies; the Tropical Ecology Assessment and Monitoring (TEAM) project of Conservation International; University of Connecticut (R.K.C. and C.L.C.); UCLA (A.C.G.); U.S. NSF (DEB-0072702: R.K.C., G.B., and J.T.L.; DEB-0640015: J.T.L.; DEB-0639979: R.K.C.; Research Fellowship and Dissertation Improvement Grant: C.L.C.); Sigma Phi, Explorer's Club, and Steven Vavra Plant Systematics Fund (A.C.G.); and the Deutsche Forschungsgemeinschaft (BR 2280/1-1: G.B.). We thank M. B. Bush, R.L. Chazdon, D.A. Clark, R.R. Dunn, K.M. Kuhn, C. Rahbek, T.F.L.V.B. Rangel, M. R. Silman, and our peer reviewers for comments.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; [Anonymous], 1878, TROPICAL NATURE OTHE; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Bush MB, 2008, PHILOS T R SOC B, V363, P1795, DOI 10.1098/rstb.2007.0014; Bush Mark B., 2005, P125; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Cowling SA, 2004, PHILOS T R SOC B, V359, P539, DOI 10.1098/rstb.2003.1427; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobzhansky T., 1950, American Scientist, V38, P209; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; FIENLEY JR, 1998, CLIMATIC CHANGE, V39, P177; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; HANNAH L, 2007, TROPICAL RAINFOREST, P351; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Phillips O.L., 2007, TROPICAL RAINFOREST, P317; Pounds J. Alan, 2005, P70; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	32	803	861	12	475	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					258	261		10.1126/science.1162547	http://dx.doi.org/10.1126/science.1162547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845754				2022-12-24	WOS:000259902300048
J	Napoli, I; Mercaldo, V; Boyl, PP; Eleuteri, B; Zalfa, F; De Rubeis, S; Di Marino, D; Mohr, E; Massimi, M; Falconi, M; Witke, W; Costa-Mattioli, M; Sonenberg, N; Achsel, T; Bagni, C				Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; Eleuteri, Boris; Zalfa, Francesca; De Rubeis, Silvia; Di Marino, Daniele; Mohr, Evita; Massimi, Marzia; Falconi, Mattia; Witke, Walter; Costa-Mattioli, Mauro; Sonenberg, Nahum; Achsel, Tilmann; Bagni, Claudia			The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP	CELL			English	Article							MENTAL-RETARDATION PROTEIN; INITIATION-FACTOR 4E; MESSENGER-RNA; DROSOPHILA CUP; BC1 RNA; BINDING; FMRP; LOCALIZATION; STABILITY; PATHWAY	Strong evidence indicates that regulated mRNA translation in neuronal dendrites underlies synaptic plasticity and brain development. The fragile X mental retardation protein (FMRP) is involved in this process; here, we show that it acts by inhibiting translation initiation. A binding partner of FMRP, CYFIP1/Sra1, directly binds the translation initiation factor eIF4E through a domain that is structurally related to those present in 4E-BP translational inhibitors. Brain cytoplasmic RNA 1 (BC1), another FMRP binding partner, increases the affinity of FMRP for the CYFIP1-eIF4E complex in the brain. Levels of proteins encoded by known FMRP target mRNAs are increased upon reduction of CYFIP1 in neurons. Translational repression is regulated in an activity-dependent manner because BDNF or DHPG stimulation of neurons causes CYFIP1 to dissociate from eIF4E at synapses, thereby resulting in protein synthesis. Thus, the translational repression activity of FMRP in the brain is mediated, at least in part, by CYFIP1.	[Napoli, Ilaria; Mercaldo, Valentina; Eleuteri, Boris; Zalfa, Francesca; Achsel, Tilmann; Bagni, Claudia] IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy; [Napoli, Ilaria; De Rubeis, Silvia; Di Marino, Daniele; Falconi, Mattia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; De Rubeis, Silvia; Achsel, Tilmann; Bagni, Claudia] Catholic Univ Louvain VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zalfa, Francesca; Bagni, Claudia] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Mohr, Evita] Univ Hosp Hamburg Eppendorf, Dept Anat Cellular Neurobiol 1, D-20246 Hamburg, Germany; [Massimi, Marzia; Witke, Walter] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Costa-Mattioli, Mauro; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada	IRCCS Santa Lucia; University of Rome Tor Vergata; Flanders Institute for Biotechnology (VIB); University of Rome Tor Vergata; University of Hamburg; University Medical Center Hamburg-Eppendorf; European Molecular Biology Laboratory (EMBL); McGill University	Bagni, C (corresponding author), IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy.	claudia.bagni@med.kuleuven.be	Di Marino, Daniele/AAB-9653-2019; Di Marino, Daniele/ABB-2333-2020; De Rubeis, Silvia/E-9852-2013; Cabrera, Mariel/GMX-2706-2022; Mercaldo, Valentina/AAA-6000-2019; Zalfa, Francesca/J-7759-2018	Di Marino, Daniele/0000-0001-6961-3129; De Rubeis, Silvia/0000-0001-9383-6883; Zalfa, Francesca/0000-0002-1922-9468; Pilo Boyl, Pietro/0000-0002-7535-4802; Bagni, Claudia/0000-0002-4419-210X; Napoli, Ilaria/0000-0002-0649-1950; FALCONI, MATTIA/0000-0002-3990-4758	FP6 Marie Curie fellowship [MEST-CT-2004-504640]; Conquer Fragile X Foundation; Telethon [GGP05269]; Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	FP6 Marie Curie fellowship(European Commission); Conquer Fragile X Foundation; Telethon(Fondazione Telethon); Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	We thank Rasmus Herlo, Adriana Gambardella, and Emanuela Pasciuto for sharing preliminary data and Antonio Totaro and Caroline Lacoux for some help with protein purifications. We are grateful to Ben Oostra for the FMR1 KO mice and to Jurgen Brosius for the BC1 KO mice. We thank Kris Dickson for critical reading of the manuscript and discussion, Jesus Avila, Itzhak Fisher, and Gary Bassell for MAP1B antibodies, Stefano Biffo for eIF6/p27 antibody, Sebastian Munk for helping us with the confocal images, Nicola Gray and Fatima Gebauer for the MS2 reporter constructs, Oswald Steward for the full-length Arc cDNA, and Massimo Regoli for assistance with the statistical analysis. We thank Giorgio Bernardi for his support. M. M. was supported by a FP6 Marie Curie MEST-CT-2004-504640 fellowship. P. P. B. was partially supported by Conquer Fragile X Foundation. C. B. is supported by grants from the following agencies: Telethon (GGP05269), Ministero della Sanita e dell' Universita (FIRB), and Flanders Interuniversity Institute for Biotechnology (VIB).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Centonze D, 2008, BIOL PSYCHIAT, V63, P963, DOI 10.1016/j.biopsych.2007.09.008; Centonze D, 2007, J NEUROSCI, V27, P8885, DOI 10.1523/JNEUROSCI.0548-07.2007; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RICHTER JD, 2007, TRANSLATIONAL CONTRO, P489; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	58	419	427	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1042	1054		10.1016/j.cell.2008.07.031	http://dx.doi.org/10.1016/j.cell.2008.07.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805096	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000259318100023
J	Ferrari, R; Pellegrini, M; Horwitz, GA; Xie, W; Berk, AJ; Kurdistani, SK				Ferrari, Roberto; Pellegrini, Matteo; Horwitz, Gregory A.; Xie, Wei; Berk, Arnold J.; Kurdistani, Siavash K.			Epigenetic reprogramming by adenovirus e1a	SCIENCE			English	Article							VIRAL MECHANISM; REVEALS; CELLS	Adenovirus e1a induces quiescent human cells to replicate. We found that e1a causes global relocalization of the RB ( retinoblastoma) proteins ( RB, p130, and p107) and p300/ CBP histone acetyltransferases on promoters, the effect of which is to restrict the acetylation of histone 3 lysine- 18 ( H3K18ac) to a limited set of genes, thereby stimulating cell cycling and inhibiting antiviral responses and cellular differentiation. Soon after expression, e1a binds transiently to promoters of cell cycle and growth genes, causing enrichment of p300/ CBP, PCAF ( p300/ CBP- associated factor), and H3K18ac; depletion of RB proteins; and transcriptional activation. e1a also associates transiently with promoters of antiviral genes, causing enrichment for RB, p130, and H4K16ac; increased nucleosome density; and transcriptional repression. At later times, e1a and p107 bind mainly to promoters of development and differentiation genes, repressing transcription. The temporal order of e1a binding requires its interactions with p300/ CBP and RB proteins. Our data uncover a defined epigenetic reprogramming leading to cellular transformation.	[Ferrari, Roberto; Xie, Wei; Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Horwitz, Gregory A.; Berk, Arnold J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Berk, Arnold J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu	Ferrari, Roberto/O-8143-2015; BERK, ARNOLD/AAF-7052-2020; Xie, Wei/J-1380-2017	Ferrari, Roberto/0000-0002-0453-0899; Xie, Wei/0000-0003-2126-3849; Kurdistani, Siavash/0000-0003-3295-3511; Pellegrini, Matteo/0000-0001-9355-9564	U. S. Public Health Service [CA25235]; HHMI Early Career Award; UCLA Specialized Program of Research Excellence in Prostate Cancer; American Society Cancer grant; NATIONAL CANCER INSTITUTE [R01CA025235, R37CA025235] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); HHMI Early Career Award(Howard Hughes Medical Institute); UCLA Specialized Program of Research Excellence in Prostate Cancer; American Society Cancer grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Carey for critical comments, M. Grunstein for providing the histone acetylation antibodies, and C. Millar and A. Sperling and for help with microarrays. Supported by U. S. Public Health Service grant CA25235 (A. J. B.), an HHMI Early Career Award, a UCLA Specialized Program of Research Excellence in Prostate Cancer grant, and an Society American Cancer grant ( S. K. K.). Microarray data have been deposited in the Gene Expression Omnibus under accession numbers GSE12045, GSE12046, and GSE12047.	Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Miller DL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r58; MONTELL C, 1984, CELL, V36, P951, DOI 10.1016/0092-8674(84)90045-X; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; NEVINS JR, 1994, CURR OPIN GENET DEV, V4, P130, DOI 10.1016/0959-437X(94)90101-5; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	12	173	176	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1086	1088		10.1126/science.1155546	http://dx.doi.org/10.1126/science.1155546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719284	Green Accepted			2022-12-24	WOS:000258594900040
J	Moritz, C; Patton, JL; Conroy, CJ; Parra, JL; White, GC; Beissinger, SR				Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; White, Gary C.; Beissinger, Steven R.			Impact of a century of climate change on small-mammal communities in Yosemite National Park, USA	SCIENCE			English	Article							SPECIES RANGE; GREAT-BASIN; 20TH-CENTURY; RESPONSES; EXTINCTION; CALIFORNIA; SHIFT	We provide a century-scale view of small-mammal responses to global warming, without confounding effects of land-use change, by repeating Grinnell's early-20th century survey across a 3000-meter-elevation gradient that spans Yosemite National Park, California, USA. Using occupancy modeling to control for variation in detectability, we show substantial (similar to 500 meters on average) upward changes in elevational limits for half of 28 species monitored, consistent with the observed similar to 3 degrees C increase in minimum temperatures. Formerly low-elevation species expanded their ranges and high-elevation species contracted theirs, leading to changed community composition at mid- and high elevations. Elevational replacement among congeners changed because species' responses were idiosyncratic. Though some high-elevation species are threatened, protection of elevation gradients allows other species to respond via migration.	[Moritz, Craig; Patton, James L.; Conroy, Chris J.; Parra, Juan L.; Beissinger, Steven R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Moritz, Craig; Patton, James L.; Parra, Juan L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [White, Gary C.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Beissinger, Steven R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Colorado State University; University of California System; University of California Berkeley	Moritz, C (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	craigm@berkeley.edu	White, Gary/CAG-1290-2022; Beissinger, Steven R/F-3809-2012		Yosemite Foundation; National Parks Service; NSF [DEB 0640859]	Yosemite Foundation; National Parks Service; NSF(National Science Foundation (NSF))	Supported by funding from the Yosemite Foundation, the National Parks Service, and NSF (DEB 0640859). Assistance was received from A. Chang, H. Shofi, K. Tsao, D. Yang, W. Monahan, R. Hijmans, and M. Koo. L. Chow (U.S. Geological Survey Yosemite) and S. Thompson (Yosemite National Park) stimulated and participated in the project. Comments from R. Colwell, M. Power, F. Hamer, and L. Shoo improved this manuscript.	Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Chao A., 2005, ENCY STAT SCI; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Grayson DK, 2006, QUATERNARY SCI REV, V25, P2964, DOI 10.1016/j.quascirev.2006.03.004; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Grinnell Joseph, 1910, Popular Science Monthly, V77; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MacKenzie D.I., 2006, INFERRING PATTERNS D; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rowe RJ, 2007, AM NAT, V170, P242, DOI 10.1086/518948; Rowe RJ, 2005, J BIOGEOGR, V32, P1883, DOI 10.1111/j.1365-2699.2005.01346.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	28	720	757	9	438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					261	264		10.1126/science.1163428	http://dx.doi.org/10.1126/science.1163428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845755				2022-12-24	WOS:000259902300049
J	Hashimoto, H; Horton, JR; Zhang, X; Bostick, M; Jacobsen, SE; Cheng, XD				Hashimoto, Hideharu; Horton, John R.; Zhang, Xing; Bostick, Magnolia; Jacobsen, Steven E.; Cheng, Xiaodong			The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix	NATURE			English	Article							ADENINE METHYLTRANSFERASE; SUBSTRATE-RECOGNITION; BINDING DOMAIN; METHYLATED DNA; TARGET BASE; PROTEIN; CELLS; NP95; ESTABLISHMENT; MAINTENANCE	Maintenance methylation of hemimethylated CpG dinucleotides at DNA replication forks is the key to faithful mitotic inheritance of genomic methylation patterns. UHRF1 ( ubiquitin- like, containing PHD and RING finger domains 1) is required for maintenance methylation by interacting with DNA nucleotide methyltransferase 1 ( DNMT1), the maintenance methyltransferase, and with hemi-methylated CpG, the substrate for DNMT1 ( refs 1 and 2). Here we present the crystal structure of the SET and RING- associated ( SRA) domain of mouse UHRF1 in complex with DNA containing a hemimethylated CpGsite. The DNA is contacted in both the major and minor grooves by two loops that penetrate into the middle of the DNA helix. The 5- methylcytosine has flipped completely out of the DNA helix and is positioned in a binding pocket with planar stacking contacts, Watson - Crick polar hydrogen bonds and van der Waals interactions specific for 5- methylcytosine. Hence, UHRF1 contains a previously unknown DNA- binding module and is the first example of a non- enzymatic, sequence- specific DNA- binding protein domain to use the base flipping mechanism to interact with DNA.	[Hashimoto, Hideharu; Horton, John R.; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Bostick, Magnolia; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Emory University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	xcheng@emory.edu	Hu, Ruogu/B-2203-2008; Horton, John R/ABB-4770-2020; hashimoto, hal/C-2079-2012; Horton, John/F-2375-2010	hashimoto, hal/0000-0002-5674-5779; Horton, John/0000-0001-9749-8068	National Institutes of Health [GM049245, GM060398]; NIH-NSRA Fellowship [CA1263022]; Howard Hughes Medical Institute; Georgia Research Alliance Eminent Scholar; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NSRA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Georgia Research Alliance Eminent Scholar; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. M. Blumenthal for critical comments. The Emory University School of Medicine supported the use of SER- CAT beamlines. This work was supported by grant GM049245 to X. C. from the National Institutes of Health ( NIH). Work in the Jacobsen laboratory is funded by the NIH grant GM060398. M. B. is funded by NIH-NSRA Fellowship number CA1263022. S. E. J. is an Investigator of the Howard Hughes Medical Institute and X. C. is a Georgia Research Alliance Eminent Scholar.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Jeltsch A, 2006, CURR TOP MICROBIOL, V301, P203; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Unoki M, 2008, RADIAT RES, V169, P240, DOI 10.1667/RR1209.1; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973	36	303	313	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					826	U14		10.1038/nature07280	http://dx.doi.org/10.1038/nature07280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772888	Green Accepted			2022-12-24	WOS:000259854900053
J	Soucek, L; Whitfield, J; Martins, CP; Finch, AJ; Murphy, DJ; Sodir, NM; Karnezis, AN; Swigart, LB; Nasi, S; Evan, GI				Soucek, Laura; Whitfield, Jonathan; Martins, Carla P.; Finch, Andrew J.; Murphy, Daniel J.; Sodir, Nicole M.; Karnezis, Anthony N.; Swigart, Lamorna Brown; Nasi, Sergio; Evan, Gerard I.			Modelling Myc inhibition as a cancer therapy	NATURE			English	Article							C-MYC; NEOPLASTIC PHENOTYPE; EXPRESSION; PROLIFERATION; PROGRESSION; ONCOGENE; PROMOTER; GENE; SKIN; DIMERIZATION	Myc is a pleiotropic basic helix - loop - helix leucine zipper transcription factor that coordinates expression of the diverse intracellular and extracellular programs that together are necessary for growth and expansion of somatic cells(1). In principle, this makes inhibition of Myc an attractive pharmacological approach for treating diverse types of cancer. However, enthusiasm has been muted by lack of direct evidence that Myc inhibition would be therapeutically efficacious, concerns that it would induce serious side effects by inhibiting proliferation of normal tissues, and practical difficulties in designing Myc inhibitory drugs. We have modelled genetically both the therapeutic impact and the side effects of systemic Myc inhibition in a preclinical mouse model of Ras- induced lung adenocarcinoma by reversible, systemic expression of a dominant- interfering Myc mutant. We show that Myc inhibition triggers rapid regression of incipient and established lung tumours, defining an unexpected role for endogenous Myc function in the maintenance of Ras- dependent tumours in vivo. Systemic Myc inhibition also exerts profound effects on normal regenerating tissues. However, these effects are well tolerated over extended periods and rapidly and completely reversible. Our data demonstrate the feasibility of targeting Myc, a common downstream conduit for many oncogenic signals, as an effective, efficient and tumour- specific cancer therapy.	[Soucek, Laura; Whitfield, Jonathan; Martins, Carla P.; Finch, Andrew J.; Murphy, Daniel J.; Sodir, Nicole M.; Karnezis, Anthony N.; Nasi, Sergio; Evan, Gerard I.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Soucek, Laura; Whitfield, Jonathan; Martins, Carla P.; Finch, Andrew J.; Murphy, Daniel J.; Sodir, Nicole M.; Karnezis, Anthony N.; Swigart, Lamorna Brown; Evan, Gerard I.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Nasi, Sergio] Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Evan, GI (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu	Whitfield, Jonathan/N-6690-2014; Soucek, Laura/AAG-7393-2019; Soucek, Laura/AAG-8377-2019; Murphy, Daniel/V-1079-2019	Whitfield, Jonathan/0000-0002-4925-7283; Soucek, Laura/0000-0002-4750-7971; Murphy, Daniel/0000-0002-5538-5468; Finch, Andrew/0000-0002-8065-4623	National Cancer Institute [2R01 CA98018]; AIRC; ASI; CNR; MIUR FIRB; FIRS; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [T32CA108462, R01CA098018] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIRC(Fondazione AIRC per la ricerca sul cancro); ASI(Agenzia Spaziale Italiana (ASI)); CNR(Consiglio Nazionale delle Ricerche (CNR)); MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); FIRS; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Jacks and S. Artandi for their gifts of LSL-Kras<SUP>G12D</SUP> and beta-actin-rtTA+ mice, respectively. We thank F. Rostker for technical assistance and Y. Yaron and L. Johnson for advice on the LSL-Kras<SUP>G12D</SUP> model and adenovirus inhalation. We thank our laboratory colleagues for their comments and feedback. This study was supported by grant 2R01 CA98018 from the National Cancer Institute (to G.I.E.). S.N. acknowledges support from AIRC, ASI, CNR, MIUR FIRB and FIRS. C.P.M. is a Leukemia and Lymphoma Society Fellow. J.W. acknowledges support from Human Frontier Science Program. This paper is dedicated to the memory of Judah Folkman.	AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Arvanitis C, 2005, CANCER LETT, V226, P95, DOI 10.1016/j.canlet.2004.10.043; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; CHEN J, 1995, NAT MED, V1, P638, DOI 10.1038/nm0795-638; Evan GI, 2006, CANCER CELL, V10, P345, DOI 10.1016/j.ccr.2006.10.013; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; FURTH PA, 1991, NUCLEIC ACIDS RES, V19, P6205, DOI 10.1093/nar/19.22.6205; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; KOTHARY R, 1991, MECH DEVELOP, V35, P25, DOI 10.1016/0925-4773(91)90038-8; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nair SK, 2006, CURR TOP MICROBIOL, V302, P123; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sawamura D, 1999, J INVEST DERMATOL, V112, P828, DOI 10.1046/j.1523-1747.1999.00583.x; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Zhan Y, 2000, DNA CELL BIOL, V19, P639, DOI 10.1089/10445490050199045	30	585	624	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					679	683		10.1038/nature07260	http://dx.doi.org/10.1038/nature07260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18716624	Green Accepted			2022-12-24	WOS:000259639700050
J	Li, Y; Van Hooser, SD; Mazurek, M; White, LE; Fitzpatrick, D				Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David			Experience with moving visual stimuli drives the early development of cortical direction selectivity	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; OCULAR DOMINANCE COLUMNS; RECEPTIVE-FIELDS; ORIENTATION MAPS; IN-VIVO; CORTEX; CAT; ORGANIZATION; KITTENS; SENSITIVITY	The onset of vision occurs when neural circuits in the visual cortex are immature, lacking both the full complement of connections(1,2) and the response selectivity that defines functional maturity(3,4). Direction- selective responses are particularly vulnerable to the effects of early visual deprivation, but it remains unclear how stimulus- driven neural activity guides the emergence of cortical direction selectivity. Here we report observations from a motion training protocol that allowed us to monitor the impact of experience on the development of direction- selective responses in visually naive ferrets. Using intrinsic signal imaging techniques, we found that training with a single axis of motion induced the rapid emergence of direction columns that were confined to cortical regions preferentially activated by the training stimulus. Using two- photon calcium imaging techniques, we found that single neurons in visually naive animals exhibited weak directional biases and lacked the strong local coherence in the spatial organization of direction preference that was evident in mature animals. Training with a moving stimulus, but not with a flashed stimulus, strengthened the direction- selective responses of individual neurons and preferentially reversed the direction biases of neurons that deviated from their neighbours. Both effects contributed to an increase in local coherence. We conclude that early experience with moving visual stimuli drives the rapid emergence of direction-selective responses in the visual cortex.	[Li, Ye; Van Hooser, Stephen D.; Mazurek, Mark; White, Leonard E.; Fitzpatrick, David] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [White, Leonard E.] Duke Univ, Sch Med, Dept Community & Family Med, Doctor Phys Therapy Div, Durham, NC 27710 USA; [Fitzpatrick, David] Duke Univ, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA.	fitzpat@neuro.duke.edu		Van Hooser, Stephen/0000-0002-1112-5832	Whitehall Foundation; US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY011488, P30EY005722, F32EY018064] Funding Source: NIH RePORTER	Whitehall Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank P. Kara, T. Mrsic-Flogel and A. Kerlin for help with two- photon imaging techniques, T. Tucker and J. Heiner for technical assistance and M. Christensson and the members of the Fitzpatrick lab for comments on the manuscript. This work was supported by grants from the Whitehall Foundation to L.E.W. and the US National Institutes of Health to D.F. and S.D.V.H.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DAW NW, 1978, SCIENCE, V199, P565, DOI 10.1126/science.622560; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Shmuel A, 1996, J NEUROSCI, V16, P6945; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tanaka S, 2006, NEUROIMAGE, V30, P462, DOI 10.1016/j.neuroimage.2005.09.056; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; ZHOU YF, 1995, J NEUROSCI, V15, P689	30	129	131	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 18	2008	456	7224					952	956		10.1038/nature07417	http://dx.doi.org/10.1038/nature07417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384TY	18946471	Green Accepted			2022-12-24	WOS:000261768300046
J	Novembre, J; Johnson, T; Bryc, K; Kutalik, Z; Boyko, AR; Auton, A; Indap, A; King, KS; Bergmann, S; Nelson, MR; Stephens, M; Bustamante, CD				Novembre, John; Johnson, Toby; Bryc, Katarzyna; Kutalik, Zoltan; Boyko, Adam R.; Auton, Adam; Indap, Amit; King, Karen S.; Bergmann, Sven; Nelson, Matthew R.; Stephens, Matthew; Bustamante, Carlos D.			Genes mirror geography within Europe	NATURE			English	Article							GENOME-WIDE ASSOCIATION; STRATIFICATION; ANCESTRY; GENOTYPE; LOCI	Understanding the genetic structure of human populations is of fundamental interest to medical, forensic and anthropological sciences. Advances in high- throughput genotyping technology have markedly improved our understanding of global patterns of human genetic variation and suggest the potential to use large samples to uncover variation among closely spaced populations(1-5). Here we characterize genetic variation in a sample of 3,000 European individuals genotyped at over half a million variable DNA sites in the human genome. Despite low average levels of genetic differentiation among Europeans, we find a close correspondence between genetic and geographic distances; indeed, a geographical map of Europe arises naturally as an efficient two-dimensional summary of genetic variation in Europeans. The results emphasize that when mapping the genetic basis of a disease phenotype, spurious associations can arise if genetic structure is not properly accounted for. In addition, the results are relevant to the prospects of genetic ancestry testing(6); an individual's DNA can be used to infer their geographic origin with surprising accuracy often to within a few hundred kilometres.	[Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Interdept Program Bioinformat, Los Angeles, CA 90095 USA; [Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Johnson, Toby; Kutalik, Zoltan; Bergmann, Sven] Univ Lausanne, CHUV, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Johnson, Toby] Univ Lausanne, CHUV, Univ Inst Social & Preventat Med, CH-1005 Lausanne, Switzerland; [Johnson, Toby; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, Cent Adm, CH-1015 Lausanne, Switzerland; [Bryc, Katarzyna; Boyko, Adam R.; Auton, Adam; Indap, Amit; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [King, Karen S.; Nelson, Matthew R.] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA	University of California System; University of California Los Angeles; University of Chicago; University of Chicago; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Cornell University; GlaxoSmithKline	Novembre, J (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Interdept Program Bioinformat, Los Angeles, CA 90095 USA.	jnovembre@ucla.edu	Kutalik, Zoltan/HHZ-5697-2022; Colaus, PsyColaus/K-6607-2013; Novembre, John/G-1339-2011; Auton, Adam J/B-1159-2009	Kutalik, Zoltan/0000-0001-8285-7523; Johnson, Toby/0000-0002-5998-3270; Bergmann, Sven/0000-0002-6785-9034; Bustamante, Carlos D./0000-0002-4187-7920; Indap, Amit/0000-0002-3322-4735	Giorgi-Cavaglieri Foundation; Swiss National Science Foundation; US National Science Foundation Postdoctoral Fellowship in Bioinformatics; US National Institutes of Health; GlaxoSmithKline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER	Giorgi-Cavaglieri Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation Postdoctoral Fellowship in Bioinformatics(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kooner and J. Chambers of the LOLIPOP study and G. Waeber, P. Vollenweider, D. Waterworth, J.S. Beckmann, M. Bochud and V. Mooser of the CoLaus study for providing access to their collections. Financial support was provided by the Giorgi-Cavaglieri Foundation (S.B.), the Swiss National Science Foundation (S.B.), US National Science Foundation Postdoctoral Fellowship in Bioinformatics (J.N.), US National Institutes of Health (M.S., C.D.B.) and GlaxoSmithKline (M.R.)	Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, V292; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Falush D, 2003, GENETICS, V164, P1567; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NELSON MR, IN PRESS AM J HUM GE; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	28	872	892	11	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					98	U5		10.1038/nature07331	http://dx.doi.org/10.1038/nature07331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18758442	Green Accepted, Green Submitted			2022-12-24	WOS:000260674000048
J	Lupardus, PJ; Shen, A; Bogyo, M; Garcia, KC				Lupardus, Patrick J.; Shen, Aimee; Bogyo, Matthew; Garcia, K. Christopher			Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; BACTERIAL; CLEAVAGE; DEPENDS; MICE	Vibrio cholerae RTX (repeats in toxin) is an actin-disrupting toxin that is autoprocessed by an internal cysteine protease domain (CPD). The RTX CPD is efficiently activated by the eukaryote-specific small molecule inositol hexakisphosphate (InsP(6)), and we present the 2.1 angstrom structure of the RTX CPD in complex with InsP(6). InsP(6) binds to a conserved basic cleft that is distant from the protease active site. Biochemical and kinetic analyses of CPD mutants indicate that InsP(6) binding induces an allosteric switch that leads to the autoprocessing and intracellular release of toxin-effector domains.	[Shen, Aimee; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lupardus, Patrick J.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Bogyo, M (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mbogyo@stanford.edu; kcgarcia@stanford.edu		Shen, Aimee/0000-0002-9786-5742; Bogyo, Matthew/0000-0003-3753-4412	Damon Runyon Cancer Research Foundation; NIH Keck Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Foundation; Searle Scholars Program; NIH National Technology Center for Networks and Pathways [U54RR020843]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH Keck Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Searle Scholars Program; NIH National Technology Center for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Juo for assistance with data collection and structure determination, E.D. Sandoval for assistance with kinetic analyses and helpful discussion, M. Blokech and G. Schoolnik for help with V. cholerae strain construction, and A. Guzzetta for intact mass analysis of SeMet-labeled CPD. P.J.L. is a Damon Runyon Fellow, supported by the Damon Runyon Cancer Research Foundation. K.C.G. is supported by the NIH Keck Foundation and the Howard Hughes Medical Institute. M.B. is supported by the Burroughs Wellcome Foundation, the Searle Scholars Program, and the NIH National Technology Center for Networks and Pathways (grant U54RR020843). P.J.L, A.S., M.B., and K.C.G. are listed as inventors on a patent application related to use of the V. cholerae RTX CPD for biotechnical applications. Coordinates and structure factors have been deposited in the Protein Data Bank (www.rcsb.org) under accession number 3EEB.	Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700	13	95	96	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					265	268		10.1126/science.1162403	http://dx.doi.org/10.1126/science.1162403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845756	Green Accepted			2022-12-24	WOS:000259902300050
J	Tang, JW; Settles, GS				Tang, J. W.; Settles, G. S.			Coughing and aerosols	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Settles, Gary S/D-5260-2009						0	52	52	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					E19	E19		10.1056/NEJMicm072576	http://dx.doi.org/10.1056/NEJMicm072576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18843121				2022-12-24	WOS:000259903100010
J	Liu, OW; Chun, CD; Chow, ED; Chen, CB; Madhani, HD; Noble, SM				Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.; Noble, Suzanne M.			Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans	CELL			English	Article							SIGNATURE-TAGGED MUTAGENESIS; HUMAN-IMMUNODEFICIENCY-VIRUS; UDP-GLUCOSE DEHYDROGENASE; CENTRAL-NERVOUS-SYSTEM; INSERTIONAL MUTAGENESIS; YEAST; CELL; GENOME; ENZYME; STRESS	The fungus Cryptococcus neoformans is a leading cause of mortality and morbidity among HIV-infected individuals. We utilized the completed genome sequence and optimized methods for homologous DNA replacement using high-velocity particle bombardment to engineer 1201 gene knockout mutants. We screened this resource in vivo for proliferation in murine lung tissue and in vitro for three well-recognized virulence attributes-polysaccharide capsule formation, melanization, and growth at body temperature. We identified dozens of previously uncharacterized genes that affect these known attributes as well as 40 infectivity mutants without obvious defects in these traits. The latter mutants affect predicted regulatory factors, secreted proteins, and immune-related factors, and represent powerful tools for elucidating novel virulence mechanisms. In particular, we describe a GATA family transcription factor that inhibits phagocytosis by murine macrophages independently of the capsule, indicating a previously unknown mechanism of innate immune modulation.	[Liu, Oliver W.; Chun, Cheryl D.; Chow, Eric D.; Chen, Changbin; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Noble, Suzanne M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Noble, Suzanne/0000-0001-9855-8448; Madhani, Hiten/0000-0001-7400-6657	Herb and Marion Sandler Foundation; NIAID [R01AI065519]; Howard Hughes Medical Institute (HHMI); Host Defense Training Program [T32AI060537]; National Science Foundation; Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians; Burroughs-Wellcome Fund Career Development Award; NIH [K08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, R01AI065519] Funding Source: NIH RePORTER	Herb and Marion Sandler Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Host Defense Training Program; National Science Foundation(National Science Foundation (NSF)); Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship; Stewart Family Trust; HHMI Postdoctoral Fellowship for Physicians(Howard Hughes Medical Institute); Burroughs-Wellcome Fund Career Development Award(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to J. Lodge, C. Hull, J. Heitman, T. Kozel, and G. Cox for strains, reagents, training, and assistance with protocols, to S. O'Brien for assistance with bioinformatics, and to J. Cox and J. Brown for helpful discussion and comments on the manuscript. This work was supported by an Opportunity Grant from the Herb and Marion Sandler Foundation to H.D.M. and a grant from the NIAID (R01AI065519) to H.D.M. O.W.L. was supported by a Howard Hughes Medical Institute (HHMI) Predoctoral Fellowship and by the NIAID-sponsored UCSF Microbial Pathogenesis and Host Defense Training Program (T32AI060537). C.D.C. was supported by a National Science Foundation Predoctoral Fellowship. C.C. was supported by a Department of Biochemistry and Biophysics Boyer Postdoctoral Fellowship and a grant from the Stewart Family Trust. S.M.N. was supported by a HHMI Postdoctoral Fellowship for Physicians, a Burroughs-Wellcome Fund Career Development Award, and an NIH K08 award. O.W.L. and E.D.C. generated and profiled the deletion library. O.W.L. and C.C. reconstructed and retested deletion strains. C.C. constructed the overexpression strain and performed microarray experiments. C.D.C. and O.W.L. constructed double mutant strains and performed macrophage phagocytosis experiments. S.M.N. developed protocols for the STM assay, and provided reagents, training, and guidance. Strain requests should be addressed to H.D.M.	Akhter S, 2003, INFECT IMMUN, V71, P5794, DOI 10.1128/IAI.71.10.5794-5802.2003; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bader GD, 2003, TRENDS CELL BIOL, V13, P344, DOI 10.1016/S0962-8924(03)00127-2; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chow ED, 2007, CURR GENET, V52, P137, DOI 10.1007/s00294-007-0147-9; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Fujimoto D, 2002, PHYSIOL MOL PLANT P, V61, P77, DOI 10.1006/pmpp.2002.0418; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hull CM, 2004, INFECT IMMUN, V72, P3643, DOI 10.1128/IAI.72.6.3643-3645.2004; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Monari C, 2006, FEMS YEAST RES, V6, P537, DOI 10.1111/j.1567-1364.2006.00072.x; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; Nelson RT, 2001, GENETICS, V157, P935; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Shea JM, 2006, INFECT IMMUN, V74, P5977, DOI 10.1128/IAI.00768-06; Siafakas AR, 2007, J BIOL CHEM, V282, P37508, DOI 10.1074/jbc.M707913200; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; Warnock DW, 2006, MED MYCOL, V44, P697, DOI 10.1080/13693780601009493	46	308	316	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					174	188		10.1016/j.cell.2008.07.046	http://dx.doi.org/10.1016/j.cell.2008.07.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854164	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000259728100018
J	Prabhakar, S; Visel, A; Akiyama, JA; Shoukry, M; Lewis, KD; Holt, A; Plajzer-Frick, I; Morrison, H; FitzPatrick, DR; Afzal, V; Pennacchio, LA; Rubin, EM; Noonan, JP				Prabhakar, Shyam; Visel, Axel; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Morrison, Harris; FitzPatrick, David R.; Afzal, Veena; Pennacchio, Len A.; Rubin, Edward M.; Noonan, James P.			Human-specific gain of function in a developmental enhancer	SCIENCE			English	Article							NONCODING SEQUENCES; GENE-EXPRESSION; HUMAN GENOME; EVOLUTION; ADAPTATION; VERTEBRATE; ELEMENTS; MICE	Changes in gene regulation are thought to have contributed to the evolution of human development. However, in vivo evidence for uniquely human developmental regulatory function has remained elusive. In transgenic mice, a conserved noncoding sequence (HACNS1) that evolved extremely rapidly in humans acted as an enhancer of gene expression that has gained a strong limb expression domain relative to the orthologous elements from chimpanzee and rhesus macaque. This gain of function was consistent across two developmental stages in the mouse and included the presumptive anterior wrist and proximal thumb. In vivo analyses with synthetic enhancers, in which human- specific substitutions were introduced into the chimpanzee enhancer sequence or reverted in the human enhancer to the ancestral state, indicated that 13 substitutions clustered in an 81- base pair module otherwise highly constrained among terrestrial vertebrates were sufficient to confer the human- specific limb expression domain.	[Prabhakar, Shyam; Visel, Axel; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Afzal, Veena; Pennacchio, Len A.; Rubin, Edward M.; Noonan, James P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Morrison, Harris; FitzPatrick, David R.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Pennacchio, Len A.; Rubin, Edward M.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Edinburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Rubin, EM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA.	emrubin@lbl.gov; james.noonan@yale.edu	FitzPatrick, David R/C-7301-2013; Noonan, James/ABF-1320-2021; Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; FitzPatrick, David R./0000-0003-4861-969X; Pennacchio, Len/0000-0002-8748-3732	National Heart, Lung and Blood Institute [HL066681]; National Human Genome Research Institute [HG003988]; Agency for Science, Technology, and Research of Singapore; American Heart Association postdoctoral fellowship; NIH National Research Service Award fellowship [1-F32-GM074367]; Department of Genetics, Yale University School of Medicine; MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074367] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); American Heart Association postdoctoral fellowship(American Heart Association); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Genetics, Yale University School of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Pennacchio and Rubin laboratories for critical comments on the manuscript. Research was done under Department of Energy Contract DE-AC02-05CH11231, University of California, E. O. Lawrence Berkeley National Laboratory, and supported by National Heart, Lung and Blood Institute grant HL066681 and National Human Genome Research Institute grant HG003988 (L.A.P.); the Agency for Science, Technology, and Research of Singapore (S.P.); an American Heart Association postdoctoral fellowship (A.V.); and NIH National Research Service Award fellowship 1-F32-GM074367 and the Department of Genetics, Yale University School of Medicine (J.P.N.).	Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOTHARY R, 1989, DEVELOPMENT, V105, P707; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TRINKAUS E, 1993, CAMBRIDGE ENCY HUMAN, P346; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	25	221	226	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1346	1350		10.1126/science.1159974	http://dx.doi.org/10.1126/science.1159974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772437	Green Accepted			2022-12-24	WOS:000258914300048
J	Stadtfeld, M; Nagaya, M; Utikal, J; Weir, G; Hochedlinger, K				Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad			Induced Pluripotent Stem Cells Generated Without Viral Integration	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; INDUCTION; LIVER	Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome- integrating viruses. We generated mouse induced pluripotent stem ( iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c- Myc. These adenoviral iPS ( adeno- iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient- specific stem cells and for comparing embryonic stem cells and iPS cells.	[Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Nagaya, Masaki; Weir, Gordon] Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02115 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Stadtfeld, Matthias/0000-0002-5852-9906; Utikal, Jochen/0000-0001-5316-0241	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship; Juvenile Diabetes Research Foundation; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship(Deutsche Krebshilfe); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Hock for critical comments on the manuscript and L. Prickett and K. Folz-Donahue for expert help with flow cytometry. We are especially grateful to J. Lee of the Harvard Gene Therapy Initiative for help with the generation of adenoviral vectors. M. S. was supported by a Schering postdoctoral fellowship, J.U. was supported by a Mildred Scheel postdoctoral fellowship and M.N. and G.W. received support from the Juvenile Diabetes Research Foundation. Support to K.H. was from the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation. The authors are filing a patent based on the results reported in this paper.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; EMINLI S, 2008, STEM CELLS IN P 0617; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; STADTFELD M, 2008, CURR BIOL; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamada S, 2006, ENDOCR J, V53, P789, DOI 10.1507/endocrj.K06-116; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	1189	1431	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					945	949		10.1126/science.1162494	http://dx.doi.org/10.1126/science.1162494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18818365	Green Accepted			2022-12-24	WOS:000260674100048
J	Chin, L; Meyerson, M; Aldape, K; Bigner, D; Mikkelsen, T; VandenBerg, S; Kahn, A; Penny, R; Ferguson, ML; Gerhard, DS; Getz, G; Brennan, C; Taylor, BS; Winckler, W; Park, P; Ladanyi, M; Hoadley, KA; Verhaak, RGW; Hayes, DN; Spellman, PT; Absher, D; Weir, BA; Ding, L; Wheeler, D; Lawrence, MS; Cibulskis, K; Mardis, E; Zhang, JH; Wilson, RK; Donehower, L; Wheeler, DA; Purdom, E; Wallis, J; Laird, PW; Herman, JG; Schuebel, KE; Weisenberger, DJ; Baylin, SB; Schultz, N; Yao, J; Wiedemeyer, R; Weinstein, J; Sander, C; Gibbs, RA; Gray, J; Kucherlapati, R; Lander, ES; Myers, RM; Perou, CM; McLendon, R; Friedman, A; Van Meir, EG; Brat, DJ; Mastrogianakis, GM; Olson, JJ; Lehman, N; Yung, WKA; Bogler, O; Berger, M; Prados, M; Muzny, D; Morgan, M; Scherer, S; Sabo, A; Nazareth, L; Lewis, L; Hall, O; Zhu, YM; Ren, YR; Alvi, O; Yao, JQ; Hawes, A; Jhangiani, S; Fowler, G; San Lucas, A; Kovar, C; Cree, A; Dinh, H; Santibanez, J; Joshi, V; Gonzalez-Garay, ML; Miller, CA; Milosavljevic, A; Sougnez, C; Fennell, T; Mahan, S; Wilkinson, J; Ziaugra, L; Onofrio, R; Bloom, T; Nicol, R; Ardlie, K; Baldwin, J; Gabriel, S; Fulton, RS; McLellan, MD; Larson, DE; Shi, XQ; Abbott, R; Fulton, L; Chen, K; Koboldt, DC; Wendl, MC; Meyer, R; Tang, YZ; Lin, L; Osborne, JR; Dunford-Shore, BH; Miner, TL; Delehaunty, K; Markovic, C; Swift, G; Courtney, W; Pohl, C; Abbott, S; Hawkins, A; Leong, S; Haipek, C; Schmidt, H; Wiechert, M; Vickery, T; Scott, S; Dooling, DJ; Chinwalla, A; Weinstock, GM; O'Kelly, M; Robinson, J; Alexe, G; Beroukhim, R; Carter, S; Chiang, D; Gould, J; Gupta, S; Korn, J; Mermel, C; Mesirov, J; Monti, S; Nguyen, H; Parkin, M; Reich, M; Stransky, N; Garraway, L; Golub, T; Protopopov, A; Perna, I; Aronson, S; Sathiamoorthy, N; Ren, G; Kim, H; Kong, SK; Xiao, YH; Kohane, IS; Seidman, J; Cope, L; Pan, F; Van Den Berg, D; Van Neste, L; Yi, JM; Li, JZ; Southwick, A; Brady, S; Aggarwal, A; Chung, T; Sherlock, G; Brooks, JD; Jakkula, LR; Lapuk, AV; Marr, H; Dorton, S; Choi, YG; Han, J; Ray, A; Wang, V; Durinck, S; Robinson, M; Wang, NJ; Vranizan, K; Peng, V; Van Name, E; Fontenay, GV; Ngai, J; Conboy, JG; Parvin, B; Feiler, HS; Speed, TP; Socci, ND; Olshen, A; Lash, A; Reva, B; Antipin, Y; Stukalov, A; Gross, B; Cerami, E; Wang, WQ; Qin, LX; Seshan, VE; Villafania, L; Cavatore, M; Borsu, L; Viale, A; Gerald, W; Topal, MD; Qi, Y; Balu, S; Shi, Y; Wu, G; Bittner, M; Shelton, T; Lenkiewicz, E; Morris, S; Beasley, D; Sanders, S; Sfeir, R; Chen, J; Nassau, D; Feng, L; Hickey, E; Schaefer, C; Madhavan, S; Buetow, K; Barker, A; Vockley, J; Compton, C; Vaught, J; Fielding, P; Collins, F; Good, P; Guyer, M; Ozenberger, B; Peterson, J; Thomson, E				Chin, L.; Meyerson, M.; Aldape, K.; Bigner, D.; Mikkelsen, T.; VandenBerg, S.; Kahn, A.; Penny, R.; Ferguson, M. L.; Gerhard, D. S.; Getz, G.; Brennan, C.; Taylor, B. S.; Winckler, W.; Park, P.; Ladanyi, M.; Hoadley, K. A.; Verhaak, R. G. W.; Hayes, D. N.; Spellman, Paul T.; Absher, D.; Weir, B. A.; Ding, L.; Wheeler, D.; Lawrence, M. S.; Cibulskis, K.; Mardis, E.; Zhang, Jinghui; Wilson, R. K.; Donehower, L.; Wheeler, D. A.; Purdom, E.; Wallis, J.; Laird, P. W.; Herman, J. G.; Schuebel, K. E.; Weisenberger, D. J.; Baylin, S. B.; Schultz, N.; Yao, Jun; Wiedemeyer, R.; Weinstein, J.; Sander, C.; Gibbs, R. A.; Gray, J.; Kucherlapati, R.; Lander, E. S.; Myers, R. M.; Perou, C. M.; McLendon, Roger; Friedman, Allan; Van Meir, Erwin G; Brat, Daniel J; Mastrogianakis, Gena Marie; Olson, Jeffrey J; Lehman, Norman; Yung, W. K. Alfred; Bogler, Oliver; Berger, Mitchel; Prados, Michael; Muzny, Donna; Morgan, Margaret; Scherer, Steve; Sabo, Aniko; Nazareth, Lynn; Lewis, Lora; Hall, Otis; Zhu, Yiming; Ren, Yanru; Alvi, Omar; Yao, Jiqiang; Hawes, Alicia; Jhangiani, Shalini; Fowler, Gerald; San Lucas, Anthony; Kovar, Christie; Cree, Andrew; Dinh, Huyen; Santibanez, Jireh; Joshi, Vandita; Gonzalez-Garay, Manuel L.; Miller, Christopher A.; Milosavljevic, Aleksandar; Sougnez, Carrie; Fennell, Tim; Mahan, Scott; Wilkinson, Jane; Ziaugra, Liuda; Onofrio, Robert; Bloom, Toby; Nicol, Rob; Ardlie, Kristin; Baldwin, Jennifer; Gabriel, Stacey; Fulton, Robert S.; McLellan, Michael D.; Larson, David E.; Shi, Xiaoqi; Abbott, Rachel; Fulton, Lucinda; Chen, Ken; Koboldt, Daniel C.; Wendl, Michael C.; Meyer, Rick; Tang, Yuzhu; Lin, Ling; Osborne, John R.; Dunford-Shore, Brian H.; Miner, Tracie L.; Delehaunty, Kim; Markovic, Chris; Swift, Gary; Courtney, William; Pohl, Craig; Abbott, Scott; Hawkins, Amy; Leong, Shin; Haipek, Carrie; Schmidt, Heather; Wiechert, Maddy; Vickery, Tammi; Scott, Sacha; Dooling, David J.; Chinwalla, Asif; Weinstock, George M.; O'Kelly, Michael; Robinson, Jim; Alexe, Gabriele; Beroukhim, Rameen; Carter, Scott; Chiang, Derek; Gould, Josh; Gupta, Supriya; Korn, Josh; Mermel, Craig; Mesirov, Jill; Monti, Stefano; Nguyen, Huy; Parkin, Melissa; Reich, Michael; Stransky, Nicolas; Garraway, Levi; Golub, Todd; Protopopov, Alexei; Perna, Ilana; Aronson, Sandy; Sathiamoorthy, Narayan; Ren, Georgia; Kim, Hyunsoo; Kong, Sek Won; Xiao, Yonghong; Kohane, Isaac S.; Seidman, Jon; Cope, Leslie; Pan, Fei; Van Den Berg, David; Van Neste, Leander; Yi, Joo Mi; Li, Jun Z.; Southwick, Audrey; Brady, Shannon; Aggarwal, Amita; Chung, Tisha; Sherlock, Gavin; Brooks, James D.; Jakkula, Lakshmi R.; Lapuk, Anna V.; Marr, Henry; Dorton, Shannon; Choi, Yoon Gi; Han, Ju; Ray, Amrita; Wang, Victoria; Durinck, Steffen; Robinson, Mark; Wang, Nicholas J.; Vranizan, Karen; Peng, Vivian; Van Name, Eric; Fontenay, Gerald V.; Ngai, John; Conboy, John G.; Parvin, Bahram; Feiler, Heidi S.; Speed, Terence P.; Socci, Nicholas D.; Olshen, Adam; Lash, Alex; Reva, Boris; Antipin, Yevgeniy; Stukalov, Alexey; Gross, Benjamin; Cerami, Ethan; Wang, Wei Qing; Qin, Li-Xuan; Seshan, Venkatraman E.; Villafania, Liliana; Cavatore, Magali; Borsu, Laetitia; Viale, Agnes; Gerald, William; Topal, Michael D.; Qi, Yuan; Balu, Sai; Shi, Yan; Wu, George; Bittner, Michael; Shelton, Troy; Lenkiewicz, Elizabeth; Morris, Scott; Beasley, Debbie; Sanders, Sheri; Sfeir, Robert; Chen, Jessica; Nassau, David; Feng, Larry; Hickey, Erin; Schaefer, Carl; Madhavan, Subha; Buetow, Ken; Barker, Anna; Vockley, Joseph; Compton, Carolyn; Vaught, Jim; Fielding, Peter; Collins, Francis; Good, Peter; Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Thomson, Elizabeth		Canc Genome Atlas Res Network; Tissue Source Sites; Genome Sequencing Ctr; Canc Genome Characterization Ctr; Project Teams	Comprehensive genomic characterization defines human glioblastoma genes and core pathways	NATURE			English	Article							MISMATCH REPAIR; NF1 GENE; SOMATIC MUTATIONS; MALIGNANT GLIOMAS; HIGH-FREQUENCY; PIK3CA GENE; MGMT; INACTIVATION; TEMOZOLOMIDE; CANCER	Human cancer cells typically harbour multiple chromosomal aberrations, nucleotide substitutions and epigenetic modifications that drive malignant transformation. The Cancer Genome Atlas ( TCGA) pilot project aims to assess the value of large- scale multi- dimensional analysis of these molecular characteristics in human cancer and to provide the data rapidly to the research community. Here we report the interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas - the most common type of primary adult brain cancer - and nucleotide sequence aberrations in 91 of the 206 glioblastomas. This analysis provides new insights into the roles of ERBB2, NF1 and TP53, uncovers frequent mutations of the phosphatidylinositol- 3- OH kinase regulatory subunit gene PIK3R1, and provides a network view of the pathways altered in the development of glioblastoma. Furthermore, integration of mutation, DNA methylation and clinical treatment data reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated glioblastomas, an observation with potential clinical implications. Together, these findings establish the feasibility and power of TCGA, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.	[Chin, L.; Meyerson, M.; Winckler, W.; Verhaak, R. G. W.; Weir, B. A.; Wiedemeyer, R.; Beroukhim, Rameen; Chiang, Derek; Mermel, Craig; Garraway, Levi] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chin, L.; Yao, Jun; Protopopov, Alexei; Perna, Ilana; Ren, Georgia; Xiao, Yonghong] Dana Farber Canc Inst, Ctr Appl Canc Sci, Belfer Inst innovat Canc Sci, Boston, MA 02115 USA; [Chin, L.; Robinson, Jim; Alexe, Gabriele; Carter, Scott] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Meyerson, M.; Getz, G.; Winckler, W.; Verhaak, R. G. W.; Weir, B. A.; Lawrence, M. S.; Lander, E. S.; O'Kelly, Michael; Beroukhim, Rameen; Chiang, Derek; Gould, Josh; Gupta, Supriya; Korn, Josh; Mermel, Craig; Mesirov, Jill; Monti, Stefano; Nguyen, Huy; Parkin, Melissa; Reich, Michael; Stransky, Nicolas; Garraway, Levi; Golub, Todd] Harvard Univ, Cambridge, MA 02142 USA; [Bigner, D.; McLendon, Roger] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Friedman, Allan] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Mikkelsen, T.] Henry Ford Hosp, Dept Neurol Surg, Detroit, MI 48202 USA; [VandenBerg, S.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Aldape, K.] Univ Texas Houston MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Yung, W. K. Alfred] Univ Texas Houston MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Bogler, Oliver] Univ Texas Houston MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Kahn, A.; Sfeir, Robert; Chen, Jessica; Nassau, David; Feng, Larry; Hickey, Erin] SRA Int, Fairfax, VA 22033 USA; NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20852 USA; [Collins, Francis; Good, Peter; Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Thomson, Elizabeth] NIH, Natl Human Genome Res Inst, Bethesda, MD 20892 USA; [Gerhard, D. S.; Barker, Anna; Vockley, Joseph; Compton, Carolyn; Vaught, Jim; Fielding, Peter] NCI, NIH, Bethesda, MD 20892 USA; [Penny, R.; Shelton, Troy; Lenkiewicz, Elizabeth; Morris, Scott; Beasley, Debbie; Sanders, Sheri] Int Genom Consortium, Phoenix, AZ 85004 USA; [Ferguson, M. L.] MLF Consulting, Arlington, MA 02474 USA; [Ding, L.; Mardis, E.; Wilson, R. K.; Wallis, J.; Fennell, Tim; Baldwin, Jennifer; Fulton, Robert S.; McLellan, Michael D.; Larson, David E.; Shi, Xiaoqi; Abbott, Rachel; Fulton, Lucinda; Chen, Ken; Koboldt, Daniel C.; Wendl, Michael C.; Meyer, Rick; Tang, Yuzhu; Lin, Ling; Osborne, John R.; Dunford-Shore, Brian H.; Miner, Tracie L.; Delehaunty, Kim; Markovic, Chris; Swift, Gary; Courtney, William; Pohl, Craig; Abbott, Scott; Hawkins, Amy; Leong, Shin; Haipek, Carrie; Schmidt, Heather; Wiechert, Maddy; Vickery, Tammi; Scott, Sacha; Dooling, David J.; Chinwalla, Asif; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA; Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA; [Park, P.; Aronson, Sandy; Sathiamoorthy, Narayan; Kim, Hyunsoo; Kohane, Isaac S.] Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Boston, MA 02115 USA; [Park, P.; Kucherlapati, R.; Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Park, P.; Kong, Sek Won; Kohane, Isaac S.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Brennan, C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Taylor, B. S.; Schultz, N.; Sander, C.; Socci, Nicholas D.; Lash, Alex; Reva, Boris; Antipin, Yevgeniy; Stukalov, Alexey; Gross, Benjamin; Cerami, Ethan; Wang, Wei Qing; Gerald, William] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Taylor, B. S.] Weill Cornell Grad Sch Med Sci, Dept Physiol & Biophys, New York, NY 10065 USA; [Ladanyi, M.; Borsu, Laetitia] Mem Sloan Kettering Canc Ctr, Dept Pathol, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Spellman, Paul T.; Gray, J.; Jakkula, Lakshmi R.; Lapuk, Anna V.; Marr, Henry; Dorton, Shannon; Han, Ju; Ray, Amrita; Durinck, Steffen; Wang, Nicholas J.; Fontenay, Gerald V.; Conboy, John G.; Parvin, Bahram; Feiler, Heidi S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Purdom, E.; Wang, Victoria; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 95720 USA; [Choi, Yoon Gi; Vranizan, Karen; Peng, Vivian; Van Name, Eric; Ngai, John] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 95720 USA; [Robinson, Mark; Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Southwick, Audrey; Brady, Shannon; Aggarwal, Amita; Chung, Tisha; Sherlock, Gavin] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Brooks, James D.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Wheeler, D.; Donehower, L.; Wheeler, D. A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Perou, C. M.; Miller, Christopher A.; Milosavljevic, Aleksandar] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Perou, C. M.; Milosavljevic, Aleksandar] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ N Carolina, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hoadley, K. A.; Topal, Michael D.] Univ N Carolina, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Qi, Yuan] Univ N Carolina, Dept Internal Med, Lineberger Comprehens Canc Ctr, Div Med Oncol, Chapel Hill, NC 27599 USA; [Hayes, D. N.; Herman, J. G.; Schuebel, K. E.; Baylin, S. B.; Yi, Joo Mi] Johns Hopkins Univ, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Cope, Leslie] Johns Hopkins Univ, Biometry & Clin Trials Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Van Neste, Leander] Univ Ghent, Fac Biosci & Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Van Meir, Erwin G; Mastrogianakis, Gena Marie; Olson, Jeffrey J] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G; Olson, Jeffrey J] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G; Brat, Daniel J; Olson, Jeffrey J] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Brat, Daniel J] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Laird, P. W.; Weisenberger, D. J.; Pan, Fei; Van Den Berg, David] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90089 USA; [Lehman, Norman] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Berger, Mitchel; Prados, Michael] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Cibulskis, K.; Sougnez, Carrie] MIT, Eli & Edythe L Broad Inst, Canc Genome Project, Cambridge, MA 02142 USA; [Sougnez, Carrie] MIT, Eli & Edythe L Broad Inst, Med Resequencing Project, Cambridge, MA 02142 USA; [Lander, E. S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, E. S.] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Golub, Todd] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Seidman, Jon] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Absher, D.; Myers, R. M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Olshen, Adam; Qin, Li-Xuan; Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Villafania, Liliana; Cavatore, Magali; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Bittner, Michael] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ 85004 USA; [Zhang, Jinghui; Schaefer, Carl; Madhavan, Subha; Buetow, Ken] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20852 USA; [Weinstein, J.] Univ Texas Houston MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kong, Sek Won] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Duke University; Duke University; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Genomics Consortium; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Walter & Eliza Hall Institute; Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Ghent University; Emory University; Emory University; Emory University; Emory University; University of Southern California; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; HudsonAlpha Institute for Biotechnology; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Chin, L (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu; matthew_meyerson@dfci.harvard.edu	Brennan, Cameron/R-7082-2019; Meyerson, Matthew L/E-7123-2012; Weisenberger, Daniel/AAA-8314-2020; Chen, Ken/A-1074-2009; Kucherlapati, Raju/ABC-8807-2021; Zhang, Jing/HII-4294-2022; Weinstock, George M/C-6314-2013; Mardis, Elaine/W-2202-2019; Perou, Charles M/H-9934-2014; Wilson, Richard K./AAF-4139-2019; Ladanyi, Marc/AAG-8585-2019; Reva, Boris/AAB-8932-2022; Van Den Berg, David J/G-8598-2017; Califano, Andrea/F-7239-2012; Robinson, Mark D/A-6432-2015; Lawrence, Michael/AAC-8202-2020; Sherlock, Gavin J/E-9110-2012; Laird, Peter W/G-8683-2012; Mermel, Craig/AAZ-7322-2020; Prados, Michael/N-5220-2019; Reva, Boris A./B-6436-2014; Zhang, Jing/GWZ-7332-2022; Cibulskis, Kristian/AAC-7380-2019; Sander, Chris/H-1452-2011; Robinson, Mark D./O-2254-2019; Schultz, Nikolaus/ABE-6347-2020; Chiang, Derek/L-6452-2019; Mesirov, Jill/AGF-7626-2022; Wheeler, David A/M-9740-2018; Chen, Ken/AAU-1432-2021; Kohane, Isaac Kohane/K-3716-2012; Miller, Christopher A./A-1060-2009; Lehman, Norman L/A-7351-2015; Speed, Terence P/B-8085-2009; Stukalov, Alexey/AAS-3208-2021; Verhaak, Roel/ABE-7058-2020; Wendl, Michael C/A-2741-2008	Brennan, Cameron/0000-0003-4064-8891; Weisenberger, Daniel/0000-0001-8303-2603; Weinstock, George M/0000-0002-2997-4592; Perou, Charles M/0000-0001-9827-2247; Wilson, Richard K./0000-0002-1992-1358; Van Den Berg, David J/0000-0002-5404-5218; Robinson, Mark D/0000-0002-3048-5518; Laird, Peter W/0000-0001-9117-3641; Mermel, Craig/0000-0002-0816-3395; Reva, Boris A./0000-0002-8805-389X; Sander, Chris/0000-0001-6059-6270; Robinson, Mark D./0000-0002-3048-5518; Wheeler, David A/0000-0002-9056-6299; Chen, Ken/0000-0003-4013-5279; Kohane, Isaac Kohane/0000-0003-2192-5160; Miller, Christopher A./0000-0003-4266-6700; Speed, Terence P/0000-0002-5403-7998; Stukalov, Alexey/0000-0002-4981-8124; Larson, David/0000-0001-7934-5906; MCLELLAN, MICHAEL/0000-0002-2703-8784; Lash, Alex/0000-0003-3787-1590; Weinstein, John/0000-0001-9401-6908; Van Meir, Erwin G./0000-0003-2444-7707; Lehman, Norman/0000-0001-8394-2607; Li, Jun/0000-0001-6727-0812; Hoadley, Katherine/0000-0002-1216-477X; Chinwalla, Asif/0000-0001-7831-3996; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Hayes, D. Neil/0000-0001-6203-7771; Nicol, Robert/0000-0003-1932-1392; Sherlock, Gavin/0000-0002-1692-4983; Bogler, Oliver/0000-0002-3700-0480; Cibulskis, Kristian/0000-0003-1343-1582; Reich, Michael/0000-0003-4735-5514; Park, Peter/0000-0001-9378-960X	United States National Institutes of Health [U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA126544, U24CA126546, U24CA126551, U24CA126554, U24CA126561, U24CA126563]; NATIONAL CANCER INSTITUTE [U24CA126546, U24CA126561, U24CA126554, U24CA126544, ZIHBC010470, U24CA126563, U24CA143848, R01CA099041, U24CA126543, U24CA126551] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003079, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of TCGA's External Scientific Committee, the Glioblastoma Disease Working Group (http:// cancergenome.nih.gov/components) and D. N. Louis for discussions; A. Mirick, J. Melone and C. Collins for administrative coordination of TCGA activities; and L. Gaffney for graphic art. This work was supported by the following grants from the United States National Institutes of Health: U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA126544, U24CA126546, U24CA126551, U24CA126554, U24CA126561 and U24CA126563.	Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Casorelli I, 2008, ANTI-CANCER AGENT ME, V8, P368, DOI 10.2174/187152008784220276; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hirose Y, 2003, J NEUROSURG, V98, P591, DOI 10.3171/jns.2003.98.3.0591; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Mischel PS, 2003, BRAIN PATHOL, V13, P52; Mischel PS, 2003, CANCER BIOL THER, V2, P242, DOI 10.4161/cbt.2.3.369; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nutt CL, 2003, CANCER RES, V63, P1602; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Philp AJ, 2001, CANCER RES, V61, P7426; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TAYLOR BS, PLOS 1 IN PRESS; Thiel G, 1995, ANTICANCER RES, V15, P2495; Upadhyaya M, 1997, HUM GENET, V99, P88; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Yang JL, 2008, INT J CANCER, V123, P258, DOI 10.1002/ijc.23535; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	50	5371	5504	23	621	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1061	1068		10.1038/nature07385	http://dx.doi.org/10.1038/nature07385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18772890	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000260252600035
J	Wen, L; Ley, RE; Volchkov, PY; Stranges, PB; Avanesyan, L; Stonebraker, AC; Hu, CY; Wong, FS; Szot, GL; Bluestone, JA; Gordon, JI; Chervonsky, AV				Wen, Li; Ley, Ruth E.; Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Hu, Changyun; Wong, F. Susan; Szot, Gregory L.; Bluestone, Jeffrey A.; Gordon, Jeffrey I.; Chervonsky, Alexander V.			Innate immunity and intestinal microbiota in the development of Type 1 diabetes	NATURE			English	Article							PANCREATIC LYMPH-NODES; T-CELL REACTIVITY; GUT MICROBIOME; MICE; OBESITY; MOUSE; IDENTIFICATION; DIVERSITY; TOLL; RECOGNITION	Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T- cell- mediated destruction of insulin- producing beta-cells. Its incidence has increased during the past several decades in developed countries(1,2), suggesting that changes in the environment ( including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in nonobese diabetic ( NOD) mice can be affected by the microbial environment in the animal housing facility(3) or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products(4,5). Here we show that specific pathogen-free NOD mice lacking MyD88 protein ( an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ- free MyD88- negative NOD mice develop robust diabetes, whereas colonization of these germ- free MyD88- negative NOD mice with a defined microbial consortium ( representing bacterial phyla normally present in human gut) attenuates T1D. Wealso find thatMyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen- free MyD88negativeNODdonors attenuates T1D in germ- free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.	[Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Chervonsky, Alexander V.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wong, F. Susan] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Szot, Gregory L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wen, Li; Hu, Changyun] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Ley, Ruth E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA	University of Chicago; Jackson Laboratory; University of Bristol; University of California System; University of California San Francisco; Yale University; Washington University (WUSTL)	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu	Ley, Ruth E/M-8542-2014; hu, changyun/B-1189-2011; Volchkov, Pavel Y/H-4743-2013	Ley, Ruth E/0000-0002-9087-1672; Wen, Li/0000-0002-8805-2934; Stranges, Peter Benjamin/0000-0003-1377-7321; Szot, Gregory/0000-0002-3921-049X; Wong, F. Susan/0000-0002-2812-8845; Chervonsky, Alexander/0000-0001-7547-871X	ADA [1-05-RA-142]; JDRF [19-2006-1075, 4-2005-1168, 2005-204, 2007-353]; NIH [DK45735, R37 AI46643, P30 DK63720, DK30292, DK70977, DK063452]; W.M. Keck Foundation; NIH/NIDDK Digestive Disease Research Core Center [DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, P30DK042086, R37DK030292, R21DK063452, P30DK045735, R01DK070977, P30DK056341, P30DK063720] Funding Source: NIH RePORTER	ADA(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NIH/NIDDK Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are thankful to A. Putnam, T. Park, D. Schumann, M. Prokhorovich, W. Du, D. O'Donnell, M. Karlsson and S. Wagoner for help with experiments, and S. Dryden Perkins and M. Garcia for assistance with sequence analysis. This work was supported by the ADA grant 1-05-RA-142 to L.W.; JDRF grant 19-2006-1075 to L.W. and F.S.W.; Animal Genetic Core of Diabetes Endocrinology Research Center (NIH grant DK45735) to L.W.; NIH grants R37 AI46643 and P30 DK63720 as well as the JDRF 4-2005-1168 grant to J.A.B.; NIH grants DK30292 and DK70977, and a W.M. Keck Foundation award to J.I.G.; NIH grant DK063452 to A.V.C.; JDRF grants 2005-204 and 2007-353 to A.V.C.; and the NIH/NIDDK Digestive Disease Research Core Center grant DK42086.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amrani A, 1999, J CLIN INVEST, V103, P1201, DOI 10.1172/JCI6266; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; FUNDA DP, 2007, P 13 INT C IMM BRAZ; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; SUZUKI T, 1985, IMMUNE DEFICIENT ANI, P112; Takaki T, 2004, J IMMUNOL, V173, P2530, DOI 10.4049/jimmunol.173.4.2530; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	40	1392	1468	19	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1109	U10		10.1038/nature07336	http://dx.doi.org/10.1038/nature07336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806780	Green Accepted			2022-12-24	WOS:000260252600045
J	Barber, LJ; Youds, JL; Ward, JD; McIlwraith, MJ; O'Neil, NJ; Petalcorin, MIR; Martin, JS; Collis, SJ; Cantor, SB; Auclair, M; Tissenbaum, H; West, SC; Rose, AM; Boulton, SJ				Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; McIlwraith, Michael J.; O'Neil, Nigel J.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Cantor, Sharon B.; Auclair, Melissa; Tissenbaum, Heidi; West, Stephen C.; Rose, Ann M.; Boulton, Simon J.			RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination	CELL			English	Article							SACCHAROMYCES-CEREVISIAE SRS2; STRAND BREAK REPAIR; BOX DNA HELICASE; BLOOMS-SYNDROME HELICASE; CROSS-LINK REPAIR; CAENORHABDITIS-ELEGANS; C-ELEGANS; HYPER-RECOMBINATION; IONIZING-RADIATION; DAMAGE CHECKPOINT	Homologous recombination (HR) is an important conserved process for DNA repair and ensures maintenance of genome integrity. Inappropriate HR causes gross chromosomal rearrangements and tumorigenesis in mammals. In yeast, the Srs2 helicase eliminates inappropriate recombination events, but the functional equivalent of Srs2 in higher eukaryotes has been elusive. Here, we identify C. elegans RTEL-1 as a functional analog of Srs2 and describe its vertebrate counterpart, RTEL1, which is required for genome stability and tumor avoidance. We find that rtel-1 mutant worms and RTEL1-depleted human cells share characteristic phenotypes with yeast srs2 mutants: lethality upon deletion of the sgs1/BLM homolog, hyperrecombination, and DNA damage sensitivity. In vitro, purified human RTEL1 antagonizes HR by promoting the disassembly of D loop recombination intermediates in a reaction dependent upon ATP hydrolysis. We propose that loss of HR control after deregulation of RTEL1 may be a critical event that drives genome instability and cancer.	[Barber, Louise J.; Youds, Jillian L.; Ward, Jordan D.; Petalcorin, Mark I. R.; Martin, Julie S.; Collis, Spencer J.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Youds, Jillian L.; O'Neil, Nigel J.; Rose, Ann M.] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Cantor, Sharon B.] Univ Massachusetts, Sch Med, Program Canc Biol, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Auclair, Melissa; Tissenbaum, Heidi] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Cancer Research UK; University of British Columbia; Cancer Research UK; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	O'Neil, Nigel/J-4012-2014; Barber, Louise J./L-8579-2019; Ward, Jordan/H-3444-2019; Ward, Jordan/C-1505-2008	O'Neil, Nigel/0000-0002-1992-6976; Barber, Louise J./0000-0001-9265-3516; Ward, Jordan/0000-0001-9870-8936; Ward, Jordan/0000-0001-9870-8936; Mcilwraith, Michael/0000-0003-1559-4369; Collis, Spencer/0000-0002-7874-1891; Petalcorin, Mark/0000-0001-8211-9440; West, Stephen/0000-0001-8848-9418	William Randolph Hearst Foundation; National Institutes of Health [AG25891]; Natural Sciences and Engineering Research Council; National Cancer Institute of Canada; Michael Smith Foundation; Louis-Jeantet Foundation; Cancer Research UK; NATIONAL INSTITUTE ON AGING [R01AG025891, R01AG031237] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Louis-Jeantet Foundation; Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank Shohei Mitani (National Bioresource Project, Japan) and the C. elegans Knockout Consortium for providing nematode strains; Cancer Research UK Cell Services, Helen Bryant and Thomas Helleday for cells; Ian Hickson for BLM protein; and Helen Bryant, Thomas Helleday, and Janet Cronshaw for plasmids. H. A. T. is funded by the William Randolph Hearst Foundation; H. A. T. and M. A. are also funded by a grant from the National Institutes of Health (AG25891); A. M. R. is funded by the Natural Sciences and Engineering Research Council; J.L.Y. was funded by National Cancer Institute of Canada and Michael Smith Foundation for Health Research; S. C. W. is supported by the Louis-Jeantet Foundation and is part of the EU DNA Repair Consortium; and the labs of S. C. W and S. J. B. receive funding from Cancer Research UK.	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; AGUILERA A, 1988, GENETICS, V119, P779; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BRENNER S, 1974, GENETICS, V77, P71; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Chiolo I, 2007, MOL CELL BIOL, V27, P7439, DOI 10.1128/MCB.00963-07; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jeong YS, 2003, DNA REPAIR, V2, P1309, DOI 10.1016/j.dnarep.2003.07.003; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Klein H, 2001, GENETICS, V157, P557; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; Lee SJ, 2004, DEVELOPMENT, V131, P2565, DOI 10.1242/dev.01136; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; PALLADINO F, 1992, GENETICS, V132, P23; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; RONG L, 1991, GENETICS, V127, P75; ROSE AM, 1979, GENETICS, V92, P409; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang SW, 2001, NUCLEIC ACIDS RES, V29, P2963, DOI 10.1093/nar/29.14.2963; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103; Wicky C, 2004, MOL CELL BIOL, V24, P5016, DOI 10.1128/MCB.24.11.5016-5027.2004; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2006, GENETICS, V173, P697, DOI 10.1534/genetics.106.056879; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	66	268	279	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					261	271		10.1016/j.cell.2008.08.016	http://dx.doi.org/10.1016/j.cell.2008.08.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957201	Green Accepted, Bronze			2022-12-24	WOS:000260130400016
J	Avvakumov, GV; Walker, JR; Xue, S; Li, YJ; Duan, SL; Bronner, C; Arrowsmith, CH; Dhe-Paganon, S				Avvakumov, George V.; Walker, John R.; Xue, Sheng; Li, Yanjun; Duan, Shili; Bronner, Christian; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano			Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1	NATURE			English	Article							BINDING; ICBP90; TARGET; CELLS; DNMT1; NP95; CPG	Epigenetic inheritance in mammals is characterized by high- fidelity replication of CpG methylation patterns during development(1,2). UHRF1 ( also known as ICBP90 in humans and Np95 in mouse)(3) is an E3 ligase important for the maintenance of global and local DNA methylation in vivo(4,5). The preferential affinity of UHRF1 for hemi- methylated DNA over symmetrically methylated DNA by means of its SET and RING- associated ( SRA) domain(6) and its association with the maintenance DNA methyltransferase 1 ( DNMT1) suggests a role in replication of the epigenetic code(4,5,7). Here we report the 1.7 angstrom crystal structure of the apo SRA domain of human UHRF1 and a 2.2 angstrom structure of its complex with hemi- methylated DNA, revealing a previously unknown reading mechanism for methylated CpG sites ( mCpG). The SRA - DNA complex has several notable structural features including a binding pocket that accommodates the 5-methylcytosine that is flipped out of the duplex DNA. Two specialized loops reach through the resulting gap in the DNA from both the major and the minor grooves to read the other three bases of the CpG duplex. The major groove loop confers both specificity for the CpG dinucleotide and discrimination against methylation of deoxycytidine of the complementary strand. The structure, along with mutagenesis data, suggests how UHRF1 acts as a key factor for DNMT1 maintenance methylation through recognition of a fundamental unit of epigenetic inheritance, mCpG.	[Avvakumov, George V.; Walker, John R.; Xue, Sheng; Li, Yanjun; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L5, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L5, Canada; [Bronner, Christian] Univ Louis Pasteur Strasbourg 1, Dept Pharmacol & Pharmacochim Interact Cellulaire, Fac Pharm, CNRS,IGL,UMR 7175, F-67401 Illkirch Graffenstaden, France; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L5, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, 100 Coll St, Toronto, ON M5G 1L5, Canada.	sirano.dhepaganon@utoronto.ca	Bronner, Christian/R-8488-2016	Bronner, Christian/0000-0002-3101-9279; Arrowsmith, Cheryl/0000-0002-4971-3250; /0000-0002-5255-895X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut; Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Canadian Cancer Society	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Genomics Institute; GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Cancer Society(Canadian Cancer Society (CCS))	We thank F. Chedin, A. Edwards and R. Klose for discussions, and A. Dong for collecting data at the synchrotron. Diffraction data were measured at the Advanced Photon Source (Argonne, Illinois), which was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. This research was also supported by the Canadian Cancer Society (S.D. and C.H.A.).	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2008, RADIAT RES, V169, P240, DOI 10.1667/RR1209.1; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	22	340	354	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					822	U13		10.1038/nature07273	http://dx.doi.org/10.1038/nature07273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772889				2022-12-24	WOS:000259854900052
J	Tan, I; Yong, J; Dong, JM; Lim, L; Leung, T				Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas			A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow	CELL			English	Article							CDC42-BINDING KINASE-ALPHA; FOCAL ADHESION DYNAMICS; RHO-DEPENDENT KINASE; MIGRATING CELLS; MYOSIN-II; ACTIN CYTOSKELETON; MAMMALIAN-CELLS; PROTRUSION; MOTILITY; CDC42	Actomyosin retrograde flow underlies the contraction essential for cell motility. Retrograde flow in both lamellipodia and lamella is required for membrane protrusion and for force generation by coupling to cell adhesion. We report that the Rac/Cdc42-binding kinase MRCK and myosin II-related MYO18A linked by the adaptor protein LRAP35a form a functional tripartite complex, which is responsible for the assembly of lamellar actomyosin bundles and of a subnuclear actomyosin network. LRAP35a binds independently to MYO18A and MRCK. This binding leads to MRCK activation and its phosphorylation of MYO18A, independently of ROK and MLCK. The MRCK complex moves in concert with the retrograde flow of actomyosin bundles, with MRCK being able to influence other flow components such as MYO2A. The promotion of persistent protrusive activity and inhibition of cell motility by the respective expression of wild-type and dominant-negative mutant components of the MRCK complex show it to be crucial to cell protrusion and migration.	[Tan, Ivan; Yong, Jeffery; Dong, Jing Ming; Lim, Louis; Leung, Thomas] Inst Mol & Cell Biol, GSK IMCB Grp, Singapore 138673, Singapore; [Yong, Jeffery; Leung, Thomas] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 119260, Singapore; [Lim, Louis] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; National University of Singapore; University of London; University College London	Leung, T (corresponding author), Inst Mol & Cell Biol, GSK IMCB Grp, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbthoml@imcb.a-star.edu.sg			GSK (Singapore) Research Fund	GSK (Singapore) Research Fund(GlaxoSmithKline)	We thank Robin Philps for peptide sequencing and Ed Manser for valuable comments on the manuscript. This work was supported by the GSK (Singapore) Research Fund.	Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Ng Y, 2004, J BIOL CHEM, V279, P34156, DOI 10.1074/jbc.M405252200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	37	94	108	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					123	136		10.1016/j.cell.2008.09.018	http://dx.doi.org/10.1016/j.cell.2008.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854160	Bronze			2022-12-24	WOS:000259728100014
J	Gandin, V; Miluzio, A; Barbieri, AM; Beugnet, A; Kiyokawa, H; Marchisio, PC; Biffo, S				Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Kiyokawa, Hiroaki; Marchisio, Pier Carlo; Biffo, Stefano			Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation	NATURE			English	Article							INITIATION FACTOR-6; PROTEIN; P27(BBP); TRANSDUCTION; ACTIVATION; MECHANISMS; EXPRESSION; STRESS; CELLS; BOP1	Cell growth and proliferation require coordinated ribosomal biogenesis and translation. Eukaryotic initiation factors ( eIFs) control translation at the rate- limiting step of initiation(1,2). So far, only two eIFs connect extracellular stimuli to global translation rates(3): eIF4E acts in the eIF4F complex and regulates binding of capped messenger RNA to 40S subunits, downstream of growth factors(4,5), and eIF2 controls loading of the ternary complex on the 40S subunit and is inhibited on stress stimuli(6,7). No eIFs have been found to link extracellular stimuli to the activity of the large 60S ribosomal subunit. eIF6 binds 60S ribosomes precluding ribosome joining in vitro(8-10). However, studies in yeasts showed that eIF6 is required for ribosome biogenesis rather than translation(11-14). Here we show that mammalian eIF6 is required for efficient initiation of translation, in vivo. eIF6 null embryos are lethal at preimplantation. Heterozygous mice have 50% reduction of eIF6 levels in all tissues, and show reduced mass of hepatic and adipose tissues due to a lower number of cells and to impaired G1/S cell cycle progression. eIF6(+/-) cells retain sufficient nucleolar eIF6 and normal ribosome biogenesis. The liver of eIF6(+/-) mice displays an increase of 80S in polysomal profiles, indicating a defect in initiation of translation. Consistently, isolated hepatocytes have impaired insulin- stimulated translation. Heterozygous mouse embryonic fibroblasts recapitulate the organism phenotype and have normal ribosome biogenesis, reduced insulin- stimulated translation, and delayed G1/S phase progression. Furthermore, eIF6(+/-) cells are resistant to oncogene- induced transformation. Thus, eIF6 is the first eIF associated with the large 60S subunit that regulates translation in response to extracellular signals.	[Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Marchisio, Pier Carlo; Biffo, Stefano] Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, I-20132 Milan, Italy; [Kiyokawa, Hiroaki] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Marchisio, Pier Carlo] Univ Vita Salute, Sch Med, I-20132 Milan, Italy; [Biffo, Stefano] Univ Piemonte Orientale, DISAV, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwestern University; Feinberg School of Medicine; Vita-Salute San Raffaele University; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, Via Olgettina 58, I-20132 Milan, Italy.	stefano.biffo@hsr.it	Barbieri, Anna Maria/AAA-6328-2020	Kiyokawa, Hiroaki/0000-0002-7942-6455; Miluzio, Annarita/0000-0002-2838-2659; biffo, stefano/0000-0002-3780-1050; Gandin, Valentina/0000-0003-2627-1303	AIRC [05-360]; TELETHON [GGB05043, CARIPLO, NIH-RO10578]; NATIONAL CANCER INSTITUTE [R01CA112282] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); TELETHON(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants AIRC (S.B., P.C.M.), TELETHON GGB05043, CARIPLO 0578 (S.B.) and NIH-RO1 (H.K.). A. B. is supported by grant AICR 05-360. The manuscript has been improved thanks to suggestions from N. Offenhaeuser and A. Boletta. We are indebted to P. G. Pelicci for anti-NPM antibodies, H. Hirai for preliminary soft agar assays, S. Modina for blastocyst preparation, M. Vidali for hepatocytes preparation, M. Malosio for insulin receptor antibodies, S. Gregori for FACS analysis, D. Bartel for reporter constructs, G. Manfioletti for HMGA2 antibodies and F. Loreni for rpS19 antibodies. We acknowledge L. Magri for preliminary experiments, and V. Volta and S. Grosso for suggestions.	Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; CLARK RL, 1980, BIOCHEM J, V190, P615, DOI 10.1042/bj1900615; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Sanvito F, 2000, CANCER RES, V60, P510; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Si K, 1999, MOL CELL BIOL, V19, P1416; Sonenberg N, 2006, SCIENCE, V314, P428, DOI 10.1126/science.1134031; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653; Yang YL, 2007, CELL PROLIFERAT, V40, P397, DOI 10.1111/j.1365-2184.2007.00443.x; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	33	161	164	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					684	U81		10.1038/nature07267	http://dx.doi.org/10.1038/nature07267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18784653	Green Accepted			2022-12-24	WOS:000259639700051
J	Busche, MA; Eichhoff, G; Adelsberger, H; Abramowski, D; Wiederhold, KH; Haass, C; Staufenbiel, M; Konnerth, A; Garaschuk, O				Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Abramowski, Dorothee; Wiederhold, Karl-Heinz; Haass, Christian; Staufenbiel, Matthias; Konnerth, Arthur; Garaschuk, Olga			Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease	SCIENCE			English	Article							IN-VIVO; A-BETA; LINKED MUTATIONS; VISUAL-CORTEX; SYNAPSE LOSS; OLIGOMERS; MICE; NETWORKS; MEMORY; DISRUPTION	The neurodegeneration observed in Alzheimer's disease has been associated with synaptic dismantling and progressive decrease in neuronal activity. We tested this hypothesis in vivo by using two- photon Ca(2+) imaging in a mouse model of Alzheimer's disease. Although a decrease in neuronal activity was seen in 29% of layer 2/3 cortical neurons, 21% of neurons displayed an unexpected increase in the frequency of spontaneous Ca(2+) transients. These "hyperactive" neurons were found exclusively near the plaques of amyloid beta-depositing mice. The hyperactivity appeared to be due to a relative decrease in synaptic inhibition. Thus, we suggest that a redistribution of synaptic drive between silent and hyperactive neurons, rather than an overall decrease in synaptic activity, provides a mechanism for the disturbed cortical function in Alzheimer's disease.	[Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Konnerth, Arthur; Garaschuk, Olga] Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany; [Abramowski, Dorothee; Wiederhold, Karl-Heinz; Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Haass, Christian] Univ Munich, Dept Biochem, Lab Neurodegenerat Dis Res, Adolf Butenandt Inst, D-80336 Munich, Germany; [Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Haass, Christian; Konnerth, Arthur; Garaschuk, Olga] Ctr Integrated Prot Sci, D-81377 Munich, Germany	Technical University of Munich; Novartis; University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Eichhoff, Gerhard/L-4075-2019; Garaschuk, Olga/G-5633-2015	Busche, Marc Aurel/0000-0002-4416-7553	Deutsche Forschungsgemeinschaft [SFB 596, GA 654/1-1, HO 2156/2-1]; Helmholtz Gemeinschaft.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft.(Helmholtz Association)	A. K. is a Carl-von-Linde Fellow of the Institute for Advanced Study of the TUM. We thank L. B. Cohen for comments on the manuscript. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, GA 654/1-1, and HO 2156/2-1) and the Helmholtz Gemeinschaft.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arns M, 1999, BEHAV BRAIN RES, V106, P151, DOI 10.1016/S0166-4328(99)00103-5; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Christie RH, 2001, J NEUROSCI, V21, P858, DOI 10.1523/JNEUROSCI.21-03-00858.2001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Phinney AL, 1999, J NEUROSCI, V19, P8552; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004	40	679	694	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1686	1689		10.1126/science.1162844	http://dx.doi.org/10.1126/science.1162844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802001				2022-12-24	WOS:000259300400039
J	Duda, DM; Borg, LA; Scott, DC; Hunt, HW; Hammel, M; Schulman, BA				Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Hammel, Michal; Schulman, Brenda A.			Structural insights into NEDD8 activation of Cullin-RING ligases: Conformational control of conjugation	CELL			English	Article							UBIQUITIN-LIKE PROTEINS; E3 LIGASE; SACCHAROMYCES-CEREVISIAE; CUL5-RBX2 MODULES; GENOME-WIDE; IN-VIVO; COMPLEX; SCF; BINDING; DOMAIN	Cullin-RING ligases (CRLs) comprise the largest ubiquitin E3 subclass, in which a central cullin subunit links a substrate-binding adaptor with an E2-binding RING. Covalent attachment of the ubiquitin-like protein NEDD8 to a conserved C-terminal domain (ctd) lysine stimulates CRL ubiquitination activity and prevents binding of the inhibitor CAND1. Here we report striking conformational rearrangements in the crystal structure of NEDD8 similar to CuI5(ctd)-Rbx1 and SAXS analysis of NEDD8 similar to CuI1(ctd)-Rbx1 relative to their unmodified counterparts. In NEDD8ylated CRL structures, the cullin WHB and Rbx1 RING subdomains are dramatically reoriented, eliminating a CAND1-binding site and imparting multiple potential catalytic geometries to an associated E2. Biochemical analyses indicate that the structural malleability is important for both CRL NEDD8ylation and subsequent ubiquitination activities. Thus, our results point to a conformational control of CRL activity, with ligation of NEDD8 shifting equilibria to disfavor inactive CAND1-bound closed architectures, and favor dynamic, open forms that promote polyubiquitination.	[Duda, David M.; Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Hammel, Michal/0000-0002-5610-9289	U.S. DOE [DE-AC02-05CH11231]; NSLS [DE-AC02-98CH10886]; American Lebanese Syrian Associated Charities of St. Jude,; NIH [P30CA021765, R01GM069530]; Howard Hughes Medical Institute; Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD [DAMD17-03-0420]; American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER	U.S. DOE(United States Department of Energy (DOE)); NSLS; American Lebanese Syrian Associated Charities of St. Jude,(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. King and S. Zhou for mass spectrometry/Edman sequencing, J. Endicott for cdk2 plasmid, C. Ross and Staff at ALS 8.2.1, ALS 12.3.1, and NSLS X25 beamlines, V. Pagala, P. Murray, R. Deshaies, Z.Q. Pan, J. W. Harper, M. Lee, B. Dye, D. Miller, S. Bozeman, and members of the Schulman lab for assistance, advice, and/or discussions. ALS is supported by U.S. DOE Contract No. DE-AC02-05CH11231, and NSLS by DE-AC02-98CH10886. This work was supported in part by American Lebanese Syrian Associated Charities of St. Jude, by NIH P30CA021765 to St. Jude, the Howard Hughes Medical Institute, a Beckman Young Investigator Award, a Pew Scholar Award, the Phillip and Elizabeth Gross Foundation, the NIH (R01GM069530), and DOD (DAMD17-03-0420) to B. A. S. and by an American Cancer Society fellowship to D.M.D. B.A.S. is an Investigator of the Howard Hughes Medical Institute.	Amir RE, 2002, J BIOL CHEM, V277, P23253, DOI 10.1074/jbc.M200967200; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; KRATKY O, 1949, RONTGENUNTERSUCHUNG, P1106; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	62	554	568	4	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					995	1006		10.1016/j.cell.2008.07.022	http://dx.doi.org/10.1016/j.cell.2008.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805092	Bronze, Green Accepted			2022-12-24	WOS:000259318100019
J	Takeuchi, A; Reyes, N; Artigas, P; Gadsby, DC				Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.			The ion pathway through the opened Na+,K+-ATPase pump	NATURE			English	Article							NA,K-ATPASE ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT M1; CALCIUM-PUMP; CRYSTAL-STRUCTURE; K+-ATPASE; BINDING; CYSTEINE; OCCLUSION; MECHANISM; TRANSPORT	P-type ATPases pump ions across membranes, generating steep electrochemical gradients that are essential for the function of all cells. Access to the ion-binding sites within the pumps alternates between the two sides of the membrane(1) to avoid the dissipation of the gradients that would occur during simultaneous access. In Na+,K+-ATPase pumps treated with the marine agent palytoxin, this strict alternation is disrupted and binding sites are sometimes simultaneously accessible from both sides of the membrane, transforming the pumps into ion channels (see, for example, refs 2, 3). Current recordings in these channels can monitor accessibility of introduced cysteine residues to water-soluble sulphydryl-specific reagents(4). We found previously(5) that Na+,K+ pump-channels open to the extracellular surface through a deep and wide vestibule that emanates from a narrower pathway between transmembrane helices 4 and 6 (TM4 and TM6). Here we report that cysteine scans from TM1 to TM6 reveal a single unbroken cation pathway that traverses palytoxin-bound Na+,K+ pump-channels from one side of the membrane to the other. This pathway comprises residues from TM1, TM2, TM4 and TM6, passes through ion-binding site II,and is probably conserved in structurally and evolutionarily related P-type pumps, such as sarcoplasmic- and endoplasmic-reticulum Ca2+-ATPases and H+,K+-ATPases.	[Takeuchi, Ayako; Reyes, Nicolas; Artigas, Pablo; Gadsby, David C.] Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA	Rockefeller University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10065 USA.	gadsby@rockefeller.edu		Reyes, Nicolas/0000-0001-6618-8307	NIH; Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vicente Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Fataliev for help with molecular biology, the late R. F. Rakowski for cDNAs encoding Xenopus alpha<INF>1</INF> and beta<INF>3</INF> Na<SUP>+</SUP>,K<SUP>+</SUP>-ATPase subunits, and P. Nissen, B. Vilsen and J. V. Moller for providing atomic coordinates before their publication. The work was supported by a grant from the NIH (to D. C. G.) and a fellowship from the Vicente Trust (to P. A.); N. R. is presently a Jane Coffin Fund Fellow. We dedicate this paper to the memory of our colleague R. F. Rakowski.	Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; CANESSA CM, 1992, EMBO J, V11, P1681, DOI 10.1002/j.1460-2075.1992.tb05218.x; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Guennoun S, 2002, FEBS LETT, V513, P277, DOI 10.1016/S0014-5793(02)02323-2; Harmel N, 2006, J GEN PHYSIOL, V128, P103, DOI 10.1085/jgp.200609505; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; INESI G, 1987, J BIOL CHEM, V262, P16338; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lauger P., 1991, ELECTROGENIC ION PUM; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Rakowski RF, 2007, J GEN PHYSIOL, V130, P41, DOI 10.1085/jgp.200709770; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Sakmann B., 1995, SINGLE CHANNEL RECOR; SCHEINERBOBIS G, 1994, MOL PHARMACOL, V45, P1132; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	30	63	66	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					413	416		10.1038/nature07350	http://dx.doi.org/10.1038/nature07350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18849964	Green Accepted			2022-12-24	WOS:000261039600049
J	Saitoh, T; Fujita, N; Jang, MH; Uematsu, S; Yang, BG; Satoh, T; Omori, H; Noda, T; Yamamoto, N; Komatsu, M; Tanaka, K; Kawai, T; Tsujimura, T; Takeuchi, O; Yoshimori, T; Akira, S				Saitoh, Tatsuya; Fujita, Naonobu; Jang, Myoung Ho; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Omori, Hiroko; Noda, Takeshi; Yamamoto, Naoki; Komatsu, Masaaki; Tanaka, Keiji; Kawai, Taro; Tsujimura, Tohru; Takeuchi, Osamu; Yoshimori, Tamotsu; Akira, Shizuo			Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1 beta production	NATURE			English	Article							GENOME-WIDE ASSOCIATION; IMMUNE ACTIVATION; CROHN-DISEASE; INNATE; MACROPHAGES; CELLS; INFLAMMASOME; RECOGNITION; RECEPTORS; MEMBRANE	Systems for protein degradation are essential for tight control of the inflammatory immune response(1,2). Autophagy, a bulk degradation system that delivers cytoplasmic constituents into autolysosomes, controls degradation of long- lived proteins, insoluble protein aggregates and invading microbes, and is suggested to be involved in the regulation of inflammation(3-5). However, the mechanism underlying the regulation of inflammatory response by autophagy is poorly understood. Here we show that Atg16L1 ( autophagy-related 16-like 1), which is implicated in Crohn's disease(6,7), regulates endotoxin- induced inflammasome activation in mice. Atg16L1- deficiency disrupts the recruitment of the Atg12-Atg5 conjugate to the isolation membrane, resulting in a loss of microtubule- associated protein 1 light chain 3 ( LC3) conjugation to phosphatidylethanolamine. Consequently, both autophagosome formation and degradation of long- lived proteins are severely impaired in Atg16L1- deficient cells. Following stimulation with lipopolysaccharide, a ligand for Toll- like receptor 4 ( refs 8, 9), Atg16L1- deficient macrophages produce high amounts of the inflammatory cytokines IL-1 beta and IL-18. In lipopolysaccharide-stimulated macrophages, Atg16L1- deficiency causes Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta ( TRIF)dependent activation of caspase- 1, leading to increased production of IL-1 beta. Mice lacking Atg16L1 in haematopoietic cells are highly susceptible to dextran sulphate sodium- induced acute colitis, which is alleviated by injection of anti-IL-1 beta and IL-18 antibodies, indicating the importance of Atg16L1 in the suppression of intestinal inflammation. These results demonstrate that Atg16L1 is an essential component of the autophagic machinery responsible for control of the endotoxin- induced inflammatory immune response.	[Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Saitoh, Tatsuya; Uematsu, Satoshi; Yang, Bo-Gie; Satoh, Takashi; Kawai, Taro; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; [Fujita, Naonobu; Omori, Hiroko; Noda, Takeshi; Yoshimori, Tamotsu] Osaka Univ, Res Inst Microbial Dis, Dept Cellular Regulat, Suita, Osaka 5650871, Japan; [Yamamoto, Naoki] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Yoshimori, Tamotsu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Osaka University; Osaka University; Osaka University; Osaka University; National Institute of Infectious Diseases (NIID); Tokyo Metropolitan Institute of Medical Science; Juntendo University; Japan Science & Technology Agency (JST); Hyogo College of Medicine; Japan Science & Technology Agency (JST)	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011; Fujita, Naonobu/A-1218-2010; Jang, Myoung Ho/D-1714-2009; Komatsu, Masaaki/B-8321-2011; surname, name s/A-2183-2010; Noda, Takeshi/B-7240-2008; Takeuchi, Osamu/AAG-9359-2019	Jang, Myoung Ho/0000-0001-8909-4725; Komatsu, Masaaki/0000-0001-7672-7722; Noda, Takeshi/0000-0003-3581-7961; Takeuchi, Osamu/0000-0002-1260-6232; Kawai, Taro/0000-0001-7510-4662; Fujita, Naonobu/0000-0003-1914-8438; Yang, Bo-Gie/0000-0002-1538-8488	NIH [AI070167]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to T. Kitamura, S. Yamaoka and N. Mizushima for providing materials. We thank K. J. Ishii, M. Yamamoto and members of the Laboratory of Host Defense for discussions; Y. Fujiwara, M. Shiokawa, R. Nakayama and N. Kitagaki for technical assistance; and M. Hashimoto and E. Kamada for secretarial assistance. This work was in part supported by grants from NIH (AI070167) and the Ministry of Health, Labour and Welfare of Japan, and by Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Ishikura T, 2003, J GASTROEN HEPATOL, V18, P960, DOI 10.1046/j.1440-1746.2003.03097.x; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	31	1535	1610	3	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					264	U68		10.1038/nature07383	http://dx.doi.org/10.1038/nature07383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18849965				2022-12-24	WOS:000261039300045
J	Penna, A; Demuro, A; Yeromin, AV; Zhang, SYL; Safrina, O; Parker, I; Cahalan, MD				Penna, Aubin; Demuro, Angelo; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.			The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers	NATURE			English	Article							CA2+ SENSOR; STORE; SUBUNIT; ARCHITECTURE; PROTEIN; PORE	Ca2+-release- activated Ca2+ (CRAC) channels underlie sustained Ca2+ signalling in lymphocytes and numerous other cells after Ca2+ liberation from the endoplasmic reticulum (ER). RNA interference screening approaches identified two proteins, Stim(1,2) and Orai(3-5), that together form the molecular basis for CRAC channel activity(6,7). Stim senses depletion of the ER Ca2+ store and physically relays this information by translocating from the ER to junctions adjacent to the plasma membrane(1,8,9), and Orai embodies the pore of the plasma membrane calcium channel(10-12). A close interaction between Stim and Orai, identified by co-immunoprecipitation(12) and by Forster resonance energy transfer(13), is involved in the opening of the Ca2+ channel formed by Orai subunits. Most ion channels are multimers of pore- forming subunits surrounding a central channel, which are preassembled in the ER and transported in their final stoichiometry to the plasma membrane. Here we show, by biochemical analysis after cross- linking in cell lysates and intact cells and by using non- denaturing gel electrophoresis without cross- linking, that Orai is predominantly a dimer in the plasma membrane under resting conditions. Moreover, single- molecule imaging of green fluorescent protein (GFP)- tagged Orai expressed in Xenopus oocytes showed predominantly two- step photobleaching, again consistent with a dimeric basal state. In contrast, co- expression of GFP- tagged Orai with the carboxy terminus of Stim as a cytosolic protein to activate the Orai channel without inducing Ca2+ store depletion or clustering of Orai into punctae yielded mostly four- step photobleaching, consistent with a tetrameric stoichiometry of the active Orai channel. Interaction with the C terminus of Stim thus induces Orai dimers to dimerize, forming tetramers that constitute the Ca2+-selective pore. This represents a new mechanism in which assembly and activation of the functional ion channel are mediated by the same triggering molecule.	[Penna, Aubin; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Cahalan, Michael D.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu	penna, aubin/AAD-2550-2019; PENNA, aubin/E-2208-2018	penna, aubin/0000-0002-1070-5990; PENNA, aubin/0000-0002-1070-5990	National Institutes of Health; George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Forrest for assistance in cell culture; T. Holmes and S. Leverrier for discussion during the course of the study; A. Amcheslavsky, A. Froger, K. Kalman and K. Cahalan for help with oocytes; W. Jiang for assistance in some of the co-immunoprecipitation experiments; M. Ramjeesingh for help with the PFO-PAGE technique; F.-A. Rassendren for the P2X2 construct; and E. Isacoff and M. Ulbrich for discussion and help during a pilot photobleaching study. This work was supported by grants from the National Institutes of Health (M.D.C. and I.P.) and by a fellowship from the George E. Hewitt Foundation (A.P.).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Dargan Sheila L., 2006, V322, P103; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nielsen PA, 2002, J BIOL CHEM, V277, P38272, DOI 10.1074/jbc.M205348200; PARKER I, 1985, PROC R SOC SER B-BIO, V223, P279, DOI 10.1098/rspb.1985.0002; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	31	294	305	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					116	U12		10.1038/nature07338	http://dx.doi.org/10.1038/nature07338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820677	Green Accepted, Green Submitted			2022-12-24	WOS:000260674000052
J	Chivian, D; Brodie, EL; Alm, EJ; Culley, DE; Dehal, PS; DeSantis, TZ; Gihring, TM; Lapidus, A; Lin, LH; Lowry, SR; Moser, DP; Richardson, PM; Southam, G; Wanger, G; Pratt, LM; Andersen, GL; Hazen, TC; Brockman, FJ; Arkin, AP; Onstott, TC				Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Culley, David E.; Dehal, Paramvir S.; DeSantis, Todd Z.; Gihring, Thomas M.; Lapidus, Alla; Lin, Li-Hung; Lowry, Stephen R.; Moser, Duane P.; Richardson, Paul M.; Southam, Gordon; Wanger, Greg; Pratt, Lisa M.; Andersen, Gary L.; Hazen, Terry C.; Brockman, Fred J.; Arkin, Adam P.; Onstott, Tullis C.			Environmental genomics reveals a single-species ecosystem deep within earth	SCIENCE			English	Article							COMMUNITY STRUCTURE; SOUTH-AFRICA; SUBSURFACE; DIVERSITY; PROKARYOTES; METABOLISM; BACTERIUM; WATER; SEA	DNA from low-biodiversity fracture water collected at 2.8-kilometer depth in a South African gold mine was sequenced and assembled into a single, complete genome. This bacterium, Candidatus Desulforudis audaxviator, composes > 99.9% of the microorganisms inhabiting the fluid phase of this particular fracture. Its genome indicates a motile, sporulating, sulfate-reducing, chemoautotrophic thermophile that can fix its own nitrogen and carbon by using machinery shared with archaea. Candidatus Desulforudis audaxviator is capable of an independent life-style well suited to long-term isolation from the photosphere deep within Earth's crust and offers an example of a natural ecosystem that appears to have its biological component entirely encoded within a single genome.	[Chivian, Dylan; Dehal, Paramvir S.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chivian, Dylan; Brodie, Eoin L.; Alm, Eric J.; Dehal, Paramvir S.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.; Arkin, Adam P.] Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Brodie, Eoin L.; DeSantis, Todd Z.; Andersen, Gary L.; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Culley, David E.] Pacific NW Natl Lab, Energy & Efficiency Technol Div, Richland, WA 99352 USA; [Gihring, Thomas M.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Lapidus, Alla; Lowry, Stephen R.; Richardson, Paul M.] US DOE, Joint Genom Inst, Genom Technol Program, Berkeley, CA 94598 USA; [Lin, Li-Hung] Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan; [Moser, Duane P.] Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV 89119 USA; [Southam, Gordon; Wanger, Greg] Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; [Pratt, Lisa M.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Pratt, Lisa M.; Hazen, Terry C.; Onstott, Tullis C.] NASA Astrobiol Inst, IPTAI, Bloomington, IN 47405 USA; [Brockman, Fred J.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Onstott, Tullis C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; Florida State University; United States Department of Energy (DOE); National Taiwan University; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Western University (University of Western Ontario); Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California Berkeley; Princeton University	Chivian, D (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	DCChivian@lbl.gov	Arkin, Adam P/A-6751-2008; Lapidus, Alla L/I-4348-2013; Lin, Li-Hung/K-8091-2012; Andersen, Gary/G-2792-2015; Arkin, Adam/M-9941-2019; Hazen, Terry C/C-1076-2012; Brodie, Eoin L/A-7853-2008; Southam, Gordon/D-1983-2013	Arkin, Adam P/0000-0002-4999-2931; Lapidus, Alla L/0000-0003-0427-8731; Andersen, Gary/0000-0002-1618-9827; Arkin, Adam/0000-0002-4999-2931; Hazen, Terry C/0000-0002-2536-9993; Brodie, Eoin L/0000-0002-8453-8435; Southam, Gordon/0000-0002-8941-1249; Onstott, Tullis/0000-0002-2898-3374; Chivian, Dylan/0000-0001-8189-8729; Lin, Li-Hung/0000-0002-0985-1464	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL [DE-AC02-05CH11231]; NASA Astrobiology Institute [NNA01CC03A]; Howard Hughes Medical Institute	DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL(United States Department of Energy (DOE)); NASA Astrobiology Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Banfield and G. Tyson for helpful discussion; J. Bruckner and B. Baker for assistance with microscopy; F. Warnecke for advice on 16S fluorescent in situ hybridization; T. Kieft, G. Zane, and the MicrobesOnline team (M. Price, K. Keller, and K. Huang) for advice; and D. Kershaw and colleagues at the Mponeng mine and AngloGold Ashanti Limited, RSA. This work was part of the Virtual Institute for Microbial Stress and Survival (http://vimss.lbl.gov), supported by DOE, Office of Science, Office of Biological and Environmental Research, Genomics Program: GTL through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and DOE. This work was also supported by the NASA Astrobiology Institute through award NNA01CC03A to the IPTAI Team co-directed by L.M.P. and T.C.O. A.P.A. received support from the Howard Hughes Medical Institute. The genome sequence and 16S library sequences reported in this study have been deposited in GenBank under the accession numbers CP000860 and EU730965 to EU731008, respectively.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Deutschbauer AM, 2006, CURR OPIN BIOTECH, V17, P229, DOI 10.1016/j.copbio.2006.04.003; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Lefticariu L, 2006, GEOCHIM COSMOCHIM AC, V70, P4889, DOI 10.1016/j.gca.2006.07.026; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; Mussmann M, 2005, J BACTERIOL, V187, P7126, DOI 10.1128/JB.187.20.7126-7137.2005; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Zverlov V, 2005, J BACTERIOL, V187, P2203, DOI 10.1128/JB.187.6.2203-2208.2005	26	306	320	6	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					275	278		10.1126/science.1155495	http://dx.doi.org/10.1126/science.1155495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18845759	Green Submitted			2022-12-24	WOS:000259902300053
J	Zhang, XQ; Zhang, G; Zhang, H; Karin, M; Bai, H; Cai, DS				Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Karin, Michael; Bai, Hua; Cai, Dongsheng			Hypothalamic IKK beta/NF-kappa B and ER stress link overnutrition to energy imbalance and obesity	CELL			English	Article							INDUCED INSULIN-RESISTANCE; ENHANCED LEPTIN SENSITIVITY; DIET-INDUCED OBESITY; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; BODY-WEIGHT; RECEPTOR; BRAIN; MICE; REPRODUCTION	Overnutrition is associated with chronic inflammation in metabolic tissues. Whether metabolic inflammation compromises the neural regulatory systems and therefore promotes overnutrition-associated diseases remains unexplored. Here we show that a mediator of metabolic inflammation, IKK beta/NF-kappa B, normally remains inactive although enriched in hypothalamic neurons. Overnutrition atypically activates hypothalamic IKK beta/NF-kappa B at least in part through elevated endoplasmic reticulum stress in the hypothalamus. While forced activation of hypothalamic IKK beta/NF-kappa B interrupts central insulin/leptin signaling and actions, site- or cell-specific suppression of IKK beta either broadly across the brain or locally within the mediobasal hypothalamus, or specifically in hypothalamic AGRP neurons significantly protects against obesity and glucose intolerance. The molecular mechanisms involved include regulation by IKK beta/NF-kappa B of SOCS3, a core inhibitor of insulin and leptin signaling. Our results show that the hypothalamic IKK beta/NF-kappa B program is a general neural mechanism for energy imbalance underlying obesity and suggest that suppressing hypothalamic IKK beta/NF-kappa B may represent a strategy to combat obesity and related diseases.	[Zhang, Xiaoqing; Zhang, Guo; Zhang, Hai; Bai, Hua; Cai, Dongsheng] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Zhang, Hai] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53706 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Cai, DS (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	dcai@physiology.wisc.edu	Zhang, Guo/Q-8513-2016; Zhang, Xiaoqing/O-3424-2017	Zhang, Xiaoqing/0000-0002-7405-1893; Zhang, Guo/0000-0003-0841-4710; Bai, Hua/0000-0002-0448-4052; Zhang, Guo/0000-0002-3880-6996	NIH [R56, R01 DK078750]; American Diabetes Association Junior Faculty Award [1-07-JF-09]; UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078750, R01DK078750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Junior Faculty Award(American Diabetes Association); UW-Madison Start-up funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Barsh and A. Xu for AGRP-Cre mice; T. Blackwell for NGL mice; P. Mellon for GT1-7 cells; L. Rui for HEK 293-lepR cells; J. Seufert for SOCS3 cDNA; R. Bruick for SOCS3-pGL3; S. Albelda for Cre adenovirus; G. Francisco for synpasin promoter-controlled lentiviral vector; and S. Miyamoto for p65 antibody. We thank S. Shoelson, M. Hendrickson, A. Attie, D. Sun, C. Berridge, R. Weindruch, and Cai lab members for suggestions and technical assistance. This study was supported by NIH grants (R56 and R01 DK078750), American Diabetes Association Junior Faculty Award (1-07-JF-09), and UW-Madison Start-up funds (all to D. C.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	34	1001	1028	0	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					61	73		10.1016/j.cell.2008.07.043	http://dx.doi.org/10.1016/j.cell.2008.07.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854155	Bronze, Green Accepted			2022-12-24	WOS:000259728100009
J	Fatkenheuer, G; Nelson, M; Lazzarin, A; Konourina, I; Hoepelman, AIM; Lampiris, H; Hirschel, B; Tebas, P; Raffi, F; Trottier, B; Bellos, N; Saag, M; Cooper, DA; Westby, M; Tawadrous, M; Sullivan, JF; Ridgway, C; Dunne, MW; Felstead, S; Mayer, H; van der Ryst, E				Faetkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; Hoepelman, Andy I. M.; Lampiris, Harry; Hirschel, Bernard; Tebas, Pablo; Raffi, Francois; Trottier, Benoit; Bellos, Nicholaos; Saag, Michael; Cooper, David A.; Westby, Mike; Tawadrous, Margaret; Sullivan, John F.; Ridgway, Caroline; Dunne, Michael W.; Felstead, Steve; Mayer, Howard; van der Ryst, Elna		MOTIVATE 1 Study Team; MOTIVATE 2 Study Team	Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; DRUG-RESISTANT HIV-1; TMC125 ETRAVIRINE; PROGNOSTIC VALUE; CCR5 ANTAGONIST; DOUBLE-BLIND; EFFICACY; VIRUS; HEPATITIS	Background We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment- Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better characterize the efficacy and safety of maraviroc in key subgroups of patients. Methods We analyzed pooled data from week 48 from the two studies according to sex, race or ethnic group, clade, CC chemokine receptor 5 (CCR5) delta32 genotype, viral load at the time of screening, the use or nonuse of enfuvirtide in optimized background therapy (OBT), the baseline CD4 cell count, the number of active antiretroviral drugs coadministered, the first use of selected background agents, and tropism at baseline. Changes in viral tropism and the CD4 count at treatment failure were evaluated. Data on aminotransferase levels in patients coinfected with hepatitis B virus (HBV) or hepatitis C virus (HCV) were also analyzed. Results A treatment benefit of maraviroc plus OBT over placebo plus OBT was shown in all subgroups, including patients with a low CD4 cell count at baseline, those with a high viral load at screening, and those who had not received active agents in OBT. Analyses of the virologic response according to the first use of selected background drugs showed the additional benefit of adding a potent new drug to maraviroc at the initiation of maraviroc therapy. More patients in whom maraviroc failed had a virus binding to the CXC chemokine receptor 4 (CXCR4) at failure, but there was no evidence of a decrease in the CD4 cell count at failure in such patients as compared with those in whom placebo failed. Subanalyses involving patients coinfected with HBV or HCV revealed no evidence of excess hepatotoxic effects as compared with baseline. Conclusions Subanalyses of pooled data from week 48 indicate that maraviroc provides a valuable treatment option for a wide spectrum of patients with R5 HIV-1 infection who have been treated previously. (ClinicalTrials. gov numbers, NCT00098306 and NCT00098722.).	[Faetkenheuer, Gerd] Universitatsklin Koln, D-50924 Cologne, Germany; [Nelson, Mark] Chelsea & Westminster Hosp, London, England; [Konourina, Irina; Westby, Mike; Sullivan, John F.; Ridgway, Caroline; Felstead, Steve; van der Ryst, Elna] Pfizer Global Res & Dev, Sandwich, Kent, England; [Lazzarin, Adriano] Ist Ric & Cura Carattere Sci San Raffaele, Milan, Italy; [Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Lampiris, Harry] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lampiris, Harry] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Hirschel, Bernard] Univ Hosp Geneva, Geneva, Switzerland; [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Raffi, Francois] Med Univ Nantes, Hotel Dieu, Univ Hosp, Nantes, France; [Trottier, Benoit] Clin Med Lactuel, Montreal, PQ, Canada; [Bellos, Nicholaos] SW Infect Dis Assoc, Dallas, TX USA; [Saag, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Tawadrous, Margaret; Dunne, Michael W.; Mayer, Howard] Pfizer Global Res & Dev, New London, CT USA; [Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Cologne; Imperial College London; Pfizer; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Geneva; University of Pennsylvania; Nantes Universite; CHU de Nantes; University of Alabama System; University of Alabama Birmingham; Pfizer; University of New South Wales Sydney; Kirby Institute	Fatkenheuer, G (corresponding author), Universitatsklin Koln, D-50924 Cologne, Germany.	g.faetkenheuer@uni-koeln.de	Dunne, Michael W/AAD-7418-2020; Tawadrous, Margaret/AAY-3551-2020; Montaner, Julio/K-7621-2012; LAZZARIN, Adriano/K-3607-2018; Pulido, Federico/B-8417-2009; Gisslen, Magnus/D-7454-2015	Dunne, Michael W/0000-0001-6186-5196; LAZZARIN, Adriano/0000-0003-2551-7754; Smiatacz, Tomasz/0000-0003-2793-3671; Pulido, Federico/0000-0002-7414-8812; Koirala, Janak/0000-0002-3608-474X; Tebas, Pablo/0000-0001-5345-7942; Easterbrook, Philippa/0000-0002-2603-5418; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Gisslen, Magnus/0000-0002-2357-1020; Moutschen, Michel/0000-0002-6405-1785; Leen, Clifford/0000-0001-8439-7719; Stapleton, Jack/0000-0002-2302-9055	Gilead Sciences; GlaxoSmithKline; Monogram Biosciences; Pfizer; Roche; Schering-Plough; Tibotec; Bristol-Myers Squibb; Abbott; Boehringer Ingelheim; Merck Sharp Dohme; JanssenCilag; Novartis; VGX Pharmaceuticals; Wyeth; Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI051966] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Monogram Biosciences; Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Tibotec; Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); JanssenCilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); VGX Pharmaceuticals; Wyeth(Wyeth); Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Fatkenheuer reports receiving consulting fees from Gilead Sciences, GlaxoSmithKline, Monogram Biosciences, Pfizer, Roche, Schering-Plough, Tibotec, and Bristol-Myers Squibb, lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Schering-Plough, and Tibotec, and grant support from Pfizer; Dr. Nelson, receiving consulting fees from Merck Sharp & Dohme, Pfizer, Abbott, Roche, Gilead Sciences, Bristol- Myers Squibb, GlaxoSmithKline, and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Pfizer, Abbott, Gilead Sciences, Bristol-Myers Squibb, and Roche, and grant support from Gilead Sciences, Pfizer, Tibotec, and Merck Sharp & Dohme; Dr. Lazzarin, receiving consulting fees from Abbott, GlaxoSmithKline, Bristol- Myers Squibb, and JanssenCilag and lecture fees from Roche, Boehringer Ingelheim, and Gilead Sciences; Dr. Hoepelman, receiving consulting fees from Pfizer, Bristol-Myers Squibb, Novartis, and Tibotec and lecture fees from Gilead Sciences and Roche; Dr. Lampiris, receiving consulting fees from Abbott and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Monogram Biosciences, and Boehringer Ingelheim, and grant support from Gilead Sciences, Roche, Pfizer; and Tibotec; Dr. Hirschel, receiving consulting fees from Merck Sharp & Dohme, Tibotec, Pfizer, and Bristol-Myers Squibb and lecture fees from GlaxoSmithKline; Dr. Tebas, receiving consulting fees from VGX Pharmaceuticals, Merck Sharp & Dohme, Bristol-Myers Squibb, Tibotec, and Boehringer Ingelheim and grant support from Wyeth, Pfizer, Roche, and GlaxoSmithKline; Dr. Trottier, receiving consulting and lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer, Roche, and Tibotec; Dr. Bellos, receiving consulting and lecture fees from GlaxoSmithKline, Pfizer, and Tibotec and grant support from Gilead Sciences, Abbott, and GlaxoSmithKline; Dr. Saag, receiving consulting fees from Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Monogram Biosciences, Panacos, Pfizer, Progenics, Roche, Tibotec, and Virco and grant support from Achillion Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Panacos, Pfizer, Progenics, Roche, Serono, and Tibotec; Dr. Cooper, holding stock and stock options in Pfizer and receiving consulting fees and grant support from Pfizer; Dr. Westby, being an employee of Pfizer and holding stock options in Pfizer; Drs. Tawadrous, Konourina, Dunne, Felstead, Mayer, and van der Ryst and Mr. Sullivan, being employees of Pfizer and holding stock and stock options in Pfizer; and Ms. Ridgway, being an employee of Pfizer. No other potential conflict of interest relevant to this article was reported.; We thank the study participants as well as the study investigators and site staff at the 239 participating study sites (for a complete list of the investigators, site staff, and study sites, see the Supplementary Appendix).	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Clotet B, 2008, LANCET, V371, P116; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; *DEP HHS, 2007, GUID US ANT AG HIV 1; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; FATKENHEUER G, 2008, 15 C RETR OPP INF BO; Goodrich JM, 2007, 45 ANN M INF DIS SOC; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; GULICK R, 2007, 4 IAS C HIV PATH TRE; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; MCFADYEN L, 2007, 11 EUR AIDS C MADR O; Mocroft A, 2005, ANTIVIR THER, V10, P779; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; *REG COMPL CTR, DIV AIDS TABL GRAD S; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tierney C, 2003, J INFECT DIS, V187, P144, DOI 10.1086/345870; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weatherley B., 2008, 9 INT WORKSH CLIN PH; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, CURR OPIN HIV AIDS, V2, P137, DOI 10.1097/COH.0b013e3280142007; Wheeler J, 2007, ANTIVIR THER, V12, P233; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P1399; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660	38	282	290	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1442	U46		10.1056/NEJMoa0803154	http://dx.doi.org/10.1056/NEJMoa0803154			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832245				2022-12-24	WOS:000259631700005
J	Beasley, R; Clayton, T; Crane, J; von Mutius, E; Lai, CKW; Montefort, S; Stewart, A				Beasley, Richard; Clayton, Tadd; Crane, Julian; von Mutius, Erika; Lai, Christopher K. W.; Montefort, Stephen; Stewart, Alistair		ISAAC Phase Three Study Grp	Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme	LANCET			English	Article							WORLDWIDE VARIATIONS; ALLERGIC DISEASES; ACETAMINOPHEN USE; EARLY-LIFE; DRUG-USE; PREVALENCE; SYMPTOMS; ASPIRIN; IBUPROFEN; MANAGEMENT	Background Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma. Methods As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, rhinoconjunctivitis, and eczema, and several risk factors, including the use of paracetamol for fever in the child's first year of life and the frequency of paracetamol use in the past 12 months. The primary outcome variable was the odds ratio (OR) of asthma symptoms in these children associated with the use of paracetamol for fever in the first year of life, as calculated by logistic regression. Findings 205 487 children aged 6-7 years from 73 centres in 31. countries were included in the analysis. In the multivariate analyses, use of paracetamol for fever in the first year of life was associated with an increased risk of asthma symptoms when aged 6-7 years (OR 1.46 [95% Cl 1.36-1.56]). Current use of paracetamol was associated with a dose-dependent increased risk of asthma symptoms (1.61 [1.46-1.77] and 3.23 [2.9]-3.60] for medium and high use vs no use, respectively). Use of paracetamol was similarly associated with the risk of severe asthma symptoms, with population-attributable risks between 22% and 38%. Paracetamol use, both in the first year of life and in children aged 6-7 years, was also associated with an increased risk of symptoms of rhinoconjunctivitis and eczema. Interpretation Use of paracetamol in the first year of life and in later childhood, is associated with risk of asthma, rhinoconjunctivitis, and eczema at age 6 to 7 years. We suggest that exposure to paracetamol might be a risk factor for the development of asthma in childhood. Funding The BUPA Foundation, the Health Research Council of New Zealand, the Asthma and Respiratory Foundation of New Zealand, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, Glaxo Wellcome New Zealand, the New Zealand Lottery Board, Astra Zeneca New Zealand, and Glaxo Wellcome international Medical Affairs.	[Beasley, Richard] Med Res Inst New Zealand, Wellington 6143, New Zealand; [Clayton, Tadd] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Crane, Julian] Univ Otago, Dept Med, Wellington, New Zealand; [von Mutius, Erika] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Lai, Christopher K. W.] Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Montefort, Stephen] Univ Malta, Dept Med, Msida, Malta; [Stewart, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Medical Research Institute Of New Zealand; University of Auckland; University of Otago; University of Munich; University of Hong Kong; University of Malta; University of Auckland	Beasley, R (corresponding author), Med Res Inst New Zealand, POB 10055, Wellington 6143, New Zealand.	Richard.Beasley@mrinz.ac.nz	Ellwood, Philippa/G-7555-2015; Martínez-Gimeno, Antonio/A-9416-2010; Masjedi, Mohammad Reza/J-9776-2017; Garcia-Almaraz, Roberto/G-8506-2018; Anderson, Hugh R/A-7417-2016; González-Díaz, Sandra Nora/H-3271-2018; Steriu, Andreea/AAQ-5127-2021; Clayton, Tadd O/B-7914-2009; Wong, Gary WK/AAY-9207-2020; Beasley, Richard/AAH-3908-2019	Ellwood, Philippa/0000-0002-1994-4023; Martínez-Gimeno, Antonio/0000-0003-4051-1860; Masjedi, Mohammad Reza/0000-0002-6871-382X; Garcia-Almaraz, Roberto/0000-0001-5828-1771; González-Díaz, Sandra Nora/0000-0002-3612-0042; Steriu, Andreea/0000-0002-2998-8644; Wong, Gary WK/0000-0001-5939-812X; Beasley, Richard/0000-0003-0337-406X; Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753; von Mutius, Erika/0000-0002-8893-4515; brunekreef, bert/0000-0001-9908-0060; Mallol, Javier/0000-0003-2528-8672; Garcia-Marcos, Luis/0000-0002-0925-3851; Pearce, Neil/0000-0002-9938-7852; Pattemore, Philip/0000-0002-4968-1287; Masjedi, Mohammadreza/0000-0003-4964-3851; williams, hywel/0000-0002-5646-3093	ISAAC International Data Centre (IIDC) is The BUPA Foundation	ISAAC International Data Centre (IIDC) is The BUPA Foundation	We thank the children and parents who participated in ISAAC Phase Three, and the school staff for their coordination and assistance. The authors also acknowledge and thank die many funding bodies throughout the world that supported the individual ISAAC centres, collaborators, and their meetings. Currently, the main source of funding for the ISAAC International Data Centre (IIDC) is The BUPA Foundation. Many funding bodies in New Zealand have contributed to support the IIDC during the periods of fieldwork arid data compilation: the Health Research Council of New Zealand, the Asthma arid Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, GlaxoWellcome New Zealand, the New Zealand Lottery Board, and Astra Zeneca New Zealand. GlaxoWellcome International Medical Affairs supported the regional coordination for Phase Three and the IIDC.	AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Ajayi I O, 2006, Afr J Med Med Sci, V35, P85; Allmers H, 2005, J ALLERGY CLIN IMMUN, V116, P859, DOI 10.1016/j.jaci.2005.07.019; Anderson HR, 2008, INT J EPIDEMIOL, V37, P573, DOI 10.1093/ije/dyn039; ARROWSMITH JB, 1987, PEDIATRICS, V79, P858; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2000, J ALLERGY CLIN IMMUN, V105, pS466, DOI 10.1016/S0091-6749(00)90044-7; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Benoni Giuseppina, 2005, Pediatr Med Chir, V27, P67; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Cohet C, 2004, J EPIDEMIOL COMMUN H, V58, P852, DOI 10.1136/jech.2003.019182; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Del-Rio-Navarro BE, 2007, J INVEST ALLERG CLIN, V17, P77; Dodge R, 1996, J ALLERGY CLIN IMMUN, V98, P48, DOI 10.1016/S0091-6749(96)70225-7; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Fawole O I, 2001, West Afr J Med, V20, P152; GARCIAMARCOS L, 2008, INT ARCH ALLERGY IMM; Koniman R, 2007, PEDIAT ALLERG IMM-UK, V18, P128, DOI 10.1111/j.1399-3038.2006.00484.x; Kuschnir FC, 2007, PEDIAT ALLERG IMM-UK, V18, P142, DOI 10.1111/j.1399-3038.2006.00477.x; Lagerlov Per, 2004, Tidsskr Nor Laegeforen, V124, P1620; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; Maison P, 1998, EUR J CLIN PHARMACOL, V54, P659, DOI 10.1007/s002280050530; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matricardi PM, 2002, ASTHMA: CRITICAL DEBATES, P3; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; OLOUGHLIN EV, 1995, J PAEDIATR CHILD H, V31, P189, DOI 10.1111/j.1440-1754.1995.tb00783.x; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; REBORDOSA C, 2007, AM J RESP CRIT CARE, V175, pA80; SETTIPANE GA, 1983, AM J MED, V74, P102, DOI 10.1016/0002-9343(83)90537-5; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Taddio A, 2007, PEDIATRICS, V120, pE637, DOI 10.1542/peds.2006-3351; Taylor BJ, 1996, J PAEDIATR CHILD H, V32, P316, DOI 10.1111/j.1440-1754.1996.tb02561.x; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; VEDANTHAN PK, 1977, J ALLERGY CLIN IMMUN, V60, P8, DOI 10.1016/0091-6749(77)90077-X; Vennemann MMT, 2005, ARCH DIS CHILD, V90, P520, DOI 10.1136/adc.2004.065581; Vlaski E, 2007, IRAN J ALLERGY ASTHM, V6, P143; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS LA, 1991, ASHP MIDY CLIN M, V26; Wong GWK, 2007, CLIN EXP ALLERGY, V37, P174, DOI 10.1111/j.1365-2222.2007.02649.x; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x	54	259	266	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1039	1048		10.1016/S0140-6736(08)61445-2	http://dx.doi.org/10.1016/S0140-6736(08)61445-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805332				2022-12-24	WOS:000259648500030
J	Haydon, DJ; Stokes, NR; Ure, R; Galbraith, G; Bennett, JM; Brown, DR; Baker, PJ; Barynin, VV; Rice, DW; Sedelnikova, SE; Heal, JR; Sheridan, JM; Aiwale, ST; Chauhan, PK; Srivastava, A; Taneja, A; Collins, I; Errington, J; Czaplewski, LG				Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.; Heal, Jonathan R.; Sheridan, Joseph M.; Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.			An inhibitor of FtsZ with potent and selective anti-staphylococcal activity	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; SMALL-MOLECULE; ANTIBIOTICS; TUBULIN; CYTOKINESIS; DISCOVERY; INSIGHTS; TARGET	FtsZ is an essential bacterial guanosine triphosphatase and homolog of mammalian beta-tubulin that polymerizes and assembles into a ring to initiate cell division. We have created a class of small synthetic antibacterials, exemplified by PC190723, which inhibits FtsZ and prevents cell division. PC190723 has potent and selective in vitro bactericidal activity against staphylococci, including methicillin- and multi- drug- resistant Staphylococcus aureus. The putative inhibitor- binding site of PC190723 was mapped to a region of FtsZ that is analogous to the Taxol- binding site of tubulin. PC190723 was efficacious in an in vivo model of infection, curing mice infected with a lethal dose of S. aureus. The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti- staphylococcal therapy.	[Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.] Prolysis, Oxford OX5 1PF, England; [Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Heal, Jonathan R.; Sheridan, Joseph M.] Prosarix, Cambridge CB22 7ZE, England; [Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit] Jubilant Chemsys, Noida 201301, India; [Errington, Jeff] Univ Newcastle, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; Newcastle University - UK	Stokes, NR (corresponding author), Prolysis, Begbroke Sci Pk, Oxford OX5 1PF, England.	neil.stokes@prolysis.com	Errington, Jeff/G-1832-2011; Stokes, Neil/ABA-4660-2020	Errington, Jeff/0000-0002-6977-9388; Bennett, James/0000-0003-1396-8400; Baker, Patrick/0000-0003-1995-5643	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative; UK Biotechnology and Biological Sciences Research Council; UK Department of Trade and Industry;  [AppGen55]	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department of Trade and Industry; 	We thank various colleagues for assistance and advice and S. Ruston for support. This work was funded by investments from L. Clay and East Hill Management (Boston, MA, USA), The Wellcome Trust under the Seeding Drug Discovery Initiative, and a grant (AppGen55) in applied genomics from the UK Biotechnology and Biological Sciences Research Council and the UK Department of Trade and Industry. D. J. H., N.R.S., R.U., G.G., J.M.B., D.R.B., I.C., and L.G.C. are or have been paid employees of Prolysis. In addition, each has been offered share options in the company. J. E. founded Prolysis and retains an equity stake (in terms of shares issued) in the organization. He is the chief scientific officer and a director of Prolysis, and for this part-time role he is paid as a consultant. All other coauthors (that is, those not affiliated with Prolysis) do not declare any conflicts of interest. The evaluation of compound activity in vivo was performed by MDS Pharma Services. Compounds are the subject of patent application PCT/GB2007/001012. The atomic coordinates and structure factors of B. subtilis FtsZ have been deposited with the Protein Data Bank under the accession numbers 2vxy and r2vxysf. The sequences of the ftsZ wild-type and mutant strains have been deposited in GenBank with the accession numbers EU914258 to EU914264.	ARNOS LA, 1999, CHEM BIOL, V6, pR65; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; O'Neill AJ, 2004, EXPERT OPIN INV DRUG, V13, P1045, DOI 10.1517/13543784.13.8.1045; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Paradis-Bleau C, 2007, BIOORGAN MED CHEM, V15, P1330, DOI 10.1016/j.bmc.2006.11.015; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200	17	339	358	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1673	1675		10.1126/science.1159961	http://dx.doi.org/10.1126/science.1159961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	349RG	18801997				2022-12-24	WOS:000259300400034
J	Mahrus, S; Trinidad, JC; Barkan, DT; Sali, A; Burlingame, AL; Wells, JA				Mahrus, Sami; Trinidad, Jonathan C.; Barkan, David T.; Sali, Andrej; Burlingame, Alma L.; Wells, James A.			Global Sequencing of proteolytic cleavage sites in apoptosis by specific Labeling of protein N termini	CELL			English	Article							MASS-SPECTROMETRY; DATABASE; PROTEOMICS; INHIBITORS; RECEPTOR; MODELS; PHOSPHORYLATION; CHEMOTHERAPY; SUBTILIGASE; RECOGNITION	The nearly 600 proteases in the human genome regulate a diversity of biological processes, including programmed cell death. Comprehensive characterization of protease signaling in complex biological samples is limited by available proteomic methods. We have developed a general approach for global identification of proteolytic cleavage sites using an engineered enzyme to selectively biotinylate free protein N termini for positive enrichment of corresponding N-terminal peptides. Using this method to study apoptosis, we have sequenced 333 caspase-like cleavage sites distributed among 292 protein substrates. These sites are generally not predicted by in vitro caspase substrate specificity but can be used to predict other physiological caspase cleavage sites. Structural bioinformatic studies show that caspase cleavage sites often appear in surface-accessible loops and even occasionally in helical regions. Strikingly, we also find that a disproportionate number of caspase substrates physically interact, suggesting that these dimeric proteases target protein complexes and networks to elicit apoptosis.	[Mahrus, Sami; Trinidad, Jonathan C.; Sali, Andrej; Burlingame, Alma L.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Mahrus, Sami; Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Barkan, David T.] Univ Calif San Francisco, Grad Grp Bioinformat, San Francisco, CA 94158 USA; [Barkan, David T.; Sali, Andrej] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Trinidad, Jonathan/GWR-2077-2022; Wells, Jim A/O-9854-2016		National Institutes of Health (NIH) [F32 GM074458, R01 GM081051, R01, P01 GM71790, U54 GM074945]; Hartwell Foundation; NIH NCRR [01614]; Adelson Medical Research Foundation; Sandler Family Supporting Foundation; Hewlett-Packard; NetApps; IBM; Intel; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054762, P01GM071790, U54GM074945, R01GM081051, F32GM074458] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Adelson Medical Research Foundation; Sandler Family Supporting Foundation; Hewlett-Packard; NetApps; IBM(International Business Machines (IBM)); Intel(Intel Corporation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Wells, Burlingame, and Sali labs for useful discussions. This work was supported by National Institutes of Health (NIH) F32 GM074458 (S. M.), NIH R01 GM081051 (J. A. W.), the Hartwell Foundation (J. A. W.), NIH NCRR 01614 (A. L. B.), the Adelson Medical Research Foundation (A. L. B.), NIH R01 GM54762 (A. S.), NIH P01 GM71790 (A. S.), NIH U54 GM074945 (A. S.), the Sandler Family Supporting Foundation (A. S.), Hewlett-Packard (A. S.), NetApps (A. S.), IBM (A. S.), and Intel (A. S.).	ABRAHMSEN L, 1991, BIOCHEMISTRY-US, V30, P4151, DOI 10.1021/bi00231a007; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Braisted AC, 1997, METHOD ENZYMOL, V289, P298; BROWN JL, 1976, J BIOL CHEM, V251, P1009; CHANG TK, 1994, P NATL ACAD SCI USA, V91, P12544, DOI 10.1073/pnas.91.26.12544; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Collins MO, 2007, PROTEOMICS, V7, P2751, DOI 10.1002/pmic.200700145; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Fulda S, 2001, ONCOGENE, V20, P1063, DOI 10.1038/sj.onc.1204141; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Olofsson MH, 2007, CLIN CANCER RES, V13, P3198, DOI 10.1158/1078-0432.CCR-07-0009; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, BIOCHEM J, V407, P41, DOI 10.1042/BJ20070775; Tozser J, 2003, BIOCHEM J, V372, P137, DOI 10.1042/BJ20021901; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wiegand UK, 2001, CELL DEATH DIFFER, V8, P734, DOI 10.1038/sj.cdd.4400867	46	337	346	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					866	876		10.1016/j.cell.2008.08.012	http://dx.doi.org/10.1016/j.cell.2008.08.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18722006	Green Accepted, Bronze			2022-12-24	WOS:000258947500025
J	Bredemeyer, AL; Helmink, BA; Innes, CL; Calderon, B; McGinnis, LM; Mahowald, GK; Gapud, EJ; Walker, LM; Collins, JB; Weaver, BK; Mandik-Nayak, L; Schreiber, RD; Allen, PM; May, MJ; Paules, RS; Bassing, CH; Sleckman, BP				Bredemeyer, Andrea L.; Helmink, Beth A.; Innes, Cynthia L.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Collins, Jennifer B.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; May, Michael J.; Paules, Richard S.; Bassing, Craig H.; Sleckman, Barry P.			DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes	NATURE			English	Article							NF-KAPPA-B; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; LYMPHOID ORGANS; IONIZING-RADIATION; BONE-MARROW; ATM; EXPRESSION; DAMAGE; DIFFERENTIATION	DNA double- strand breaks are generated by genotoxic agents and by cellular endonucleases as intermediates of several important physiological processes. The cellular response to genotoxic DNA breaks includes the activation of transcriptional programs known primarily to regulate cell- cycle checkpoints and cell survival(1-5). DNA double- strand breaks are generated in all developing lymphocytes during the assembly of antigen receptor genes, a process that is essential for normal lymphocyte development. Here we show that in murine lymphocytes these physiological DNA breaks activate a broad transcriptional program. This program transcends the canonical DNA double- strand break response and includes many genes that regulate diverse cellular processes important for lymphocyte development. Moreover, the expression of several of these genes is regulated similarly in response to genotoxic DNA damage. Thus, physiological DNA double- strand breaks provide cues that can regulate cell- type- specific processes not directly involved in maintaining the integrity of the genome, and genotoxic DNA breaks could disrupt normal cellular functions by corrupting these processes.	[Bredemeyer, Andrea L.; Helmink, Beth A.; Calderon, Boris; McGinnis, Lisa M.; Mahowald, Grace K.; Gapud, Eric J.; Walker, Laura M.; Weaver, Brian K.; Mandik-Nayak, Laura; Schreiber, Robert D.; Allen, Paul M.; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Environm Stress & Canc Grp, Res Triangle Pk, NC 27709 USA; [Innes, Cynthia L.; Collins, Jennifer B.; Paules, Richard S.] NIEHS, Microarray Grp, Res Triangle Pk, NC 27709 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Ctr Childhood Canc Res,Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bassing, Craig H.] Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Sleckman@immunology.wustl.edu	Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Helmink, Beth/0000-0002-8206-0351; Bredemeyer, Andrea/0000-0003-2970-5998; May, Michael/0000-0002-2485-3716; Schreiber, Robert/0000-0003-1590-2341; Paules, Richard S/0000-0001-9106-7486; Calderon, Boris/0000-0003-1575-0739; Mahowald, Grace/0000-0003-4541-4920	National Institutes of Health [AI47829]; Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences; Research Scholar Award from the American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Department of Pathology and Immunology; Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia; Abramson Family Cancer Research Institute; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Research Scholar Award from the American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Bednarski, B. Van Honten andM. Diaz for critical review of the manuscript, F. W. Alt for providing us with the Artemis 2/2 mice and D. Ballard for providing us with the I kappa B alpha-Delta N construct. This research is supported by the National Institutes of Health (NIH, grant AI47829) and the Washington University Department of Pathology and Immunology ( to B.P.S.); the Department of Pathology and Center for Childhood Cancer Research of the Children's Hospital of Philadelphia, and the Abramson Family Cancer Research Institute (to C.H.B.); and the intramural research program of the NIH, National Institute of Environmental Health Sciences (to R.S.P.). B.P.S. is a recipient of a Research Scholar Award from the American Cancer Society. C.H.B. is a Pew Scholar in the Biomedical Sciences. A.L.B. is supported by a post-doctoral training grant from the NIH.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Innes CL, 2006, MOL CANCER RES, V4, P197, DOI 10.1158/1541-7786.MCR-05-0154; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Kashatus D, 2006, GENE DEV, V20, P225, DOI 10.1101/gad.1352206; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Mandik-Nayak L, 2006, J EXP MED, V203, P1985, DOI 10.1084/jem.20060701; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	109	114	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2008	456	7223					819	U113		10.1038/nature07392	http://dx.doi.org/10.1038/nature07392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TX	18849970	Green Accepted			2022-12-24	WOS:000261559900055
J	Zilberman, D; Coleman-Derr, D; Ballinger, T; Henikoff, S				Zilberman, Daniel; Coleman-Derr, Devin; Ballinger, Tracy; Henikoff, Steven			Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks	NATURE			English	Article							GENOME-WIDE; VARIANT; ARABIDOPSIS; NUCLEOSOME; PROMOTERS; GENES; EUCHROMATIN; DYNAMICS; YEAST	Eukaryotic chromatin is separated into functional domains differentiated by post- translational histone modifications, histone variants and DNA methylation(1-6). Methylation is associated with repression of transcriptional initiation in plants and animals, and is frequently found in transposable elements. Proper methylation patterns are crucial for eukaryotic development(4,5), and aberrant methylation- induced silencing of tumour suppressor genes is a common feature of human cancer(7). In contrast to methylation, the histone variant H2A. Z is preferentially deposited by the Swr1 ATPase complex near 59 ends of genes where it promotes transcriptional competence(8-20). How DNA methylation and H2A.Z influence transcription remains largely unknown. Here we show that in the plant Arabidopsis thaliana regions of DNA methylation are quantitatively deficient in H2A.Z. Exclusion of H2A.Z is seen at sites of DNA methylation in the bodies of actively transcribed genes and in methylated transposons. Mutation of the MET1 DNA methyltransferase, which causes both losses and gains of DNA methylation(4,5), engenders opposite changes ( gains and losses) in H2A.Z deposition, whereas mutation of the PIE1 subunit of the Swr1 complex that deposits H2A.Z(17) leads to genome- wide hypermethylation. Our findings indicate that DNA methylation can influence chromatin structure and effect gene silencing by excluding H2A.Z, and that H2A.Z protects genes from DNA methylation.	[Zilberman, Daniel; Coleman-Derr, Devin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ballinger, Tracy; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ballinger, Tracy; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Zilberman, D (corresponding author), Univ Calif Berkeley, 211 Koshland Hall, Berkeley, CA 94720 USA.	daniel.zilberman@nature.berkely.edu; steveh@fhcrc.org	Hu, Ruogu/B-2203-2008	Zilberman, Daniel/0000-0002-0123-8649; Henikoff, Steven/0000-0002-7621-8685	NSF	NSF(National Science Foundation (NSF))	We thank J. Henikoff and B. Nguyen for help with computational analyses, P. Talbert for assistance with cytology, T. Bryson and A. Morgan for technical support, M. Gehring and B. Staskawicz for the root culture protocol, R. Deal and R. Meagher for H2A.Z antibodies, the FHCRC DNA array facility for carrying out microarray hybridizations, and M. Orozco for transgenic lines. D.C.-D. is supported by an NSF predoctoral fellowship. D. Z. is a Leukemia and Lymphoma Society fellow.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	30	394	408	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					125	U14		10.1038/nature07324	http://dx.doi.org/10.1038/nature07324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18815594	Green Accepted			2022-12-24	WOS:000260674000054
J	Kim, N; Stiegler, AL; Cameron, TO; Hallock, PT; Gomez, AM; Huang, JH; Hubbard, SR; Dustin, ML; Burden, SJ				Kim, Natalie; Stiegler, Amy L.; Cameron, Thomas O.; Hallock, Peter T.; Gomez, Andrea M.; Huang, Julie H.; Hubbard, Stevan R.; Dustin, Michael L.; Burden, Steven J.			Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK	CELL			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; MUSCLE-SPECIFIC KINASE; ALPHA-DYSTROGLYCAN; SYNAPSE; PHOSPHORYLATION; AGGREGATION; PROTEIN-4; MEMBRANE; CALCIUM; PATHWAY	Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic nerve terminal. MuSK, a receptor tyrosine kinase that is expressed in skeletal muscle, and Agrin, a motor neuron-derived ligand that stimulates MuSK phosphorylation, play critical roles in synaptic differentiation, as synapses do not form in their absence, and mutations in MuSK or downstream effectors are a major cause of a group of neuromuscular disorders, termed congenital myasthenic syndromes (CMS). How Agrin activates MuSK and stimulates synaptic differentiation is not known and remains a fundamental gap in our understanding of signaling at neuromuscular synapses. Here, we report that Lrp4, a member of the LDLR family, is a receptor for Agrin, forms a complex with MuSK, and mediates MuSK activation by Agrin.	[Kim, Natalie; Stiegler, Amy L.; Hallock, Peter T.; Gomez, Andrea M.; Burden, Steven J.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY 10016 USA; [Stiegler, Amy L.; Hubbard, Stevan R.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Struct Biol Program, New York, NY 10016 USA; [Cameron, Thomas O.; Huang, Julie H.; Dustin, Michael L.] NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University; New York University	Burden, SJ (corresponding author), NYU, Sch Med, Helen & Martin Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Gomez, Andrea/0000-0002-2923-6362; Hubbard, Stevan/0000-0002-2707-9383; Burden, Steven/0000-0002-3550-6891	National Cancer Institute Cancer Center Support [P30 CA016087]; National Institutes of Health [NS36193, R21 GM075180]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053414, R37NS036193, R01NS036193] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Katherine Anderson, Lee Niswander, and Scott Weatherbee for providing us with lrp4 mutant mice and David Russell for the human LDLR plasmid. We are grateful to Jihua Fan for excellent technical assistance and Peter Lopez for help with the flow cytometry analysis. The flow cytometry core is supported by a National Cancer Institute Cancer Center Support Grant (P30 CA016087). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B., R21 GM075180 to M.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Beeson D, 2008, ANN NY ACAD SCI, V1132, P99, DOI 10.1196/annals.1405.049; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drogemuller C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-5; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Dustin ML, 1997, J BIOL CHEM, V272, P15782, DOI 10.1074/jbc.272.25.15782; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 2008, ANN NY ACAD SCI, V1132, P104, DOI 10.1196/annals.1405.039; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hopf C, 1998, EUR J BIOCHEM, V253, P382, DOI 10.1046/j.1432-1327.1998.2530382.x; Jacobson C, 1998, J NEUROSCI, V18, P6340; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kleiman RJ, 1996, CELL, V85, P461, DOI 10.1016/S0092-8674(00)81245-3; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Megeath LJ, 1998, J NEUROSCI, V18, P672; Meier T, 1996, EMBO J, V15, P2625, DOI 10.1002/j.1460-2075.1996.tb00622.x; Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SEALOCK R, 1994, CELL, V77, P617, DOI 10.1016/0092-8674(94)90045-0; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vincent A, 2005, CURR OPIN NEUROL, V18, P519, DOI 10.1097/01.wco.0000180660.57801.3f; Vincent Angela, 2002, Adv Neurol, V88, P159; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	47	460	479	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					334	342		10.1016/j.cell.2008.10.002	http://dx.doi.org/10.1016/j.cell.2008.10.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18848351	Bronze, Green Accepted			2022-12-24	WOS:000260130400022
J	Rodeheffer, MS; Birsoy, K; Friedman, JM				Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.			Identification of White Adipocyte Progenitor Cells In Vivo	CELL			English	Article							MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; ADIPOSE-TISSUE; HEMATOPOIETIC STEM; FAT PADS; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; MAMMARY-GLAND; CELLULARITY; OBESITY	The increased white adipose tissue (WAT) mass associated with obesity is the result of both hyperplasia and hypertrophy of adipocytes. However, the mechanisms controlling adipocyte number are unknown in part because the identity of the physiological adipocyte progenitor cells has not been defined in vivo. In this report, we employ a variety of approaches, including a noninvasive assay for following fat mass reconstitution in vivo, to identify a subpopulation of early adipocyte progenitor cells (Lin(-): CD29(+): CD34(+): Sca-1(+): CD24(+)) resident in adult WAT. When injected into the residual fat pads of A-Zip lipodystrophic mice, these cells reconstitute a normal WAT depot and rescue the diabetic phenotype that develops in these animals. This report provides the identification of an undifferentiated adipocyte precursor subpopulation resident within the adipose tissue stroma that is capable of proliferating and differentiating into an adipose depot in vivo.	[Rodeheffer, Matthew S.; Birsoy, Kivanc; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Rodeheffer, Matthew S.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2000, METH MOL B, V155, P21; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; DEOME KB, 1959, CANCER RES, V19, P515; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gonzalez FJ, 2005, CELL METAB, V1, P85, DOI 10.1016/j.cmet.2005.01.004; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hong L, 2006, CELLS TISSUES ORGANS, V183, P133, DOI 10.1159/000095987; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; JOHNSON PR, 1971, J LIPID RES, V12, P706; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lane MD, 2005, BIRTH DEFECTS RES A, V73, P476, DOI 10.1002/bdra.20150; Lee JH, 2005, EXP CELL RES, V307, P174, DOI 10.1016/j.yexcr.2005.03.008; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LEMONNIER D, 1970, EXPERIENTIA, V26, P974, DOI 10.1007/BF02114140; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SIMON G, 1965, HDB PHYSL 5; SMITH GH, 1988, J CELL SCI, V90, P173; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TANG W, 2008, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1156232; Thayer KA, 2001, HUM REPROD, V16, P988, DOI 10.1093/humrep/16.5.988; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WASSERMANN F, 1926, Z ZELLFORSCH MIKROSK, V3, P325; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; WISE A, 1975, NUTR METAB, V19, P291; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	54	660	680	5	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 17	2008	135	2					240	249		10.1016/j.cell.2008.09.036	http://dx.doi.org/10.1016/j.cell.2008.09.036			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18835024	Bronze			2022-12-24	WOS:000260130400014
J	Murray, H; Errington, J				Murray, Heath; Errington, Jeff			Dynamic control of the DNA replication initiation protein DnaA by Soj/ParA	CELL			English	Article							BACTERIAL CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SPO0J PARB; SOJ PARA; PSEUDOMONAS-AERUGINOSA; PARTITIONING PROTEIN; CELL-DIVISION; SPORULATION; PLASMID	Regulation of DNA replication and segregation is essential for all cells. Orthologs of the plasmid partitioning genes parA, parB, and parS are present in bacterial genomes throughout the prokaryotic evolutionary tree and are required for accurate chromosome segregation. However, the mechanism(s) by which parABS genes ensure proper DNA segregation have remained unclear. Here we report that the ParA ortholog in B. subtilis (Soj) controls the activity of the DNA replication initiator protein DnaA. Subcellular localization of several Soj mutants indicates that Soj acts as a spatially regulated molecular switch, capable of either inhibiting or activating DnaA. We show that the classical effect of Soj inhibiting sporulation is an indirect consequence of its action on DnaA through activation of the Sda DNA replication checkpoint. These results suggest that the pleiotropy manifested by chromosomal parABS mutations could be the indirect effects of a primary activity regulating DNA replication initiation.	[Murray, Heath; Errington, Jeff] Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Murray, H (corresponding author), Univ Newcastle Upon Tyne, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	heath.murray@ncl.ac.uk	Errington, Jeff/G-1832-2011	Errington, Jeff/0000-0002-6977-9388; Murray, Heath/0000-0002-6467-3656	BBSRC [43/G18654]; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP)	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	We thank Kenn Gerdes, Stephan Gruber, Leendert Hamoen, Christine Jacobs-Wagner, and Ling Juan Wu for critical reading of the manuscript. We thank Richard Daniel, Yoshikazu Kawai, and Ian Selmes for scientific and technical assistance. We are grateful to the Grossman Lab (MIT) for strains and Soj antibodies, to the Burkholder Lab (Stanford) for strains and communicating results prior to publication, and to the Spiegelman Lab for communicating results prior to publication. This work was supported by grant number 43/G18654 from the BBSRC to J.E. H.M. was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and the Human Frontier Science Program (HFSP).	AUSTIN S, 1983, J MOL BIOL, V169, P373, DOI 10.1016/S0022-2836(83)80056-4; Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; Cervin MA, 1998, MOL MICROBIOL, V29, P85, DOI 10.1046/j.1365-2958.1998.00905.x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2005, PHILOS T R SOC B, V360, P497, DOI 10.1098/rstb.2004.1605; ERRINGTON J, 1983, J GEN MICROBIOL, V129, P2091; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Hassan AKM, 1997, J BACTERIOL, V179, P2494, DOI 10.1128/jb.179.8.2494-2502.1997; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; HRANUELI D, 1974, J BACTERIOL, V119, P684, DOI 10.1128/JB.119.3.684-690.1974; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Ishikawa S, 2007, DNA RES, V14, P155, DOI 10.1093/dnares/dsm017; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Jakimowicz D, 2007, MOL MICROBIOL, V65, P625, DOI 10.1111/j.1365-2958.2007.05815.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Kornberg A., 1992, DNA REPLICATION; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonard TA, 2004, MOL MICROBIOL, V53, P419, DOI 10.1111/j.1365-2958.2004.04133.x; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; LOVE PE, 1984, J BACTERIOL, V160, P910, DOI 10.1128/JB.160.3.910-920.1984; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; McLeod BN, 2005, J BACTERIOL, V187, P2532, DOI 10.1128/JB.187.7.2532-2536.2005; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Moriya S, 1997, DNA Res, V4, P115, DOI 10.1093/dnares/4.2.115; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ogura Y, 2003, J BACTERIOL, V185, P6316, DOI 10.1128/JB.185.21.6316-6324.2003; Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	57	155	155	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 3	2008	135	1					74	84		10.1016/j.cell.2008.07.044	http://dx.doi.org/10.1016/j.cell.2008.07.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854156	Bronze			2022-12-24	WOS:000259728100010
J	Ishikawa, H; Barber, GN				Ishikawa, Hiroki; Barber, Glen N.			STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling	NATURE			English	Article							RIG-I; ANTIVIRAL RESPONSES; PROTEIN-SYNTHESIS; RNA VIRUSES; KAPPA-B; RECOGNITION; ACTIVATION; MECHANISM; HELICASES; PATHWAY	The cellular innate immune system is essential for recognizing pathogen infection and for establishing effective host defence. But critical molecular determinants responsible for facilitating an appropriate immune response - following infection with DNA and RNA viruses, for example - remain to be identified. Here we report the identification, following expression cloning, of a molecule ( STING; stimulator of interferon genes) that appears essential for effective innate immune signalling processes. It comprises five putative transmembrane regions, predominantly resides in the endoplasmic reticulum and is able to activate both NF-kappa B and IRF3 transcription pathways to induce expression of type I interferon (IFN-alpha and IFN-beta) and exert a potent anti- viral state following expression. In contrast, loss of STING rendered murine embryonic fibroblasts extremely susceptible to negative-stranded virus infection, including vesicular stomatitis virus. Further, STING ablation abrogated the ability of intracellular B-form DNA, as well as members of the herpesvirus family, to induce IFN-beta, but did not significantly affect the Toll- like receptor ( TLR) pathway. Yeast two- hybrid and co- immunoprecipitation studies indicated that STING interacts with RIG- I and with SSR2 ( also known as TRAP beta), which is a member of the translocon-associated protein ( TRAP) complex required for protein translocation across the endoplasmic reticulum membrane following translation(1,2.) Ablation by RNA interference of both TRAPb and translocon adaptor SEC61 beta was subsequently found to inhibit STING's ability to stimulate expression of IFN-beta. Thus, as well as identifying a regulator of innate immune signalling, our results imply a potential role for the translocon in innate signalling pathways activated by select viruses as well as intracellular DNA.	[Ishikawa, Hiroki; Barber, Glen N.] Univ Miami, Sch Med, Dept Med, Miami, FL 33136 USA; [Ishikawa, Hiroki; Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Med, Miami, FL 33136 USA.	gbarber@med.miami.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079336] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI079336-01, R01 AI079336] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Guo W, 2004, TRENDS CELL BIOL, V14, P61, DOI 10.1016/j.tcb.2003.12.008; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Mavinakere MS, 2006, J VIROL, V80, P6771, DOI 10.1128/JVI.00492-06; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	25	1852	1978	23	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					674	U74		10.1038/nature07317	http://dx.doi.org/10.1038/nature07317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18724357	Green Accepted			2022-12-24	WOS:000259639700049
J	Firestein, R; Bass, AJ; Kim, SY; Dunn, IF; Silver, SJ; Guney, I; Freed, E; Ligon, AH; Vena, N; Ogino, S; Chheda, MG; Tamayo, P; Finn, S; Shrestha, Y; Boehm, JS; Jain, S; Bojarski, E; Mermel, C; Barretina, J; Chan, JA; Baselga, J; Tabernero, J; Root, DE; Fuchs, CS; Loda, M; Shivdasani, RA; Meyerson, M; Hahn, WC				Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Tamayo, Pablo; Finn, Stephen; Shrestha, Yashaswi; Boehm, Jesse S.; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Baselga, Jose; Tabernero, Josep; Root, David E.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.			CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity	NATURE			English	Article							GENE-EXPRESSION; C-MYC; ACTIVATION; APC; IDENTIFICATION; MUTATIONS; PATHWAY; COMPLEX; CELLS; MELANOMA	Aberrant activation of the canonical WNT/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival(1,2). Although dysregulated beta-catenin activity drives colon tumorigenesis, further genetic perturbations are required to elaborate full malignant transformation(3). To identify genes that both modulate beta-catenin activity and are essential for colon cancer cell proliferation, we conducted two loss-of-function screens in human colon cancer cells and compared genes identified in these screens with an analysis of copy number alterations in colon cancer specimens. One of these genes, CDK8, which encodes a member of the mediator complex(4), is located at 13q12.13, a region of recurrent copy number gain in a substantial fraction of colon cancers. Here we show that the suppression of CDK8 expression inhibits proliferation in colon cancer cells characterized by high levels of CDK8 and beta-catenin hyperactivity. CDK8 kinase activity was necessary for beta-catenin-driven transformation and for expression of several beta-catenin transcriptional targets. Together these observations suggest that therapeutic interventions targeting CDK8 may confer a clinical benefit in beta-catenin-driven malignancies.	[Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Firestein, Ron; Ligon, Azra H.; Ogino, Shuji; Finn, Stephen; Chan, Jennifer A.; Loda, Massimo; Meyerson, Matthew] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bass, Adam J.; Kim, So Young; Shivdasani, Ramesh A.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Finn, Stephen; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chheda, Milan G.] Massachusetts Gen Hosp, Dept Neurooncol, Boston, MA 02114 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Shrestha, Yashaswi; Mermel, Craig; Barretina, Jordi; Root, David E.; Fuchs, Charles S.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Chheda, Milan G.; Tamayo, Pablo; Shrestha, Yashaswi; Boehm, Jesse S.; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Root, David E.; Meyerson, Matthew; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Baselga, Jose; Tabernero, Josep] Hosp Gen Valle Hebron, Dept Med Oncol, Barcelona 08035, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hospital Universitari Vall d'Hebron	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Finn, Stephen/V-3236-2019; Meyerson, Matthew L/E-7123-2012; Tabernero, Josep/AAG-5026-2019; Mermel, Craig/AAZ-7322-2020; Barretina, Jordi/A-7192-2013	Finn, Stephen/0000-0002-8628-5814; Tabernero, Josep/0000-0002-2495-8139; Mermel, Craig/0000-0002-0816-3395; Barretina, Jordi/0000-0002-3478-4080; Ogino, Shuji/0000-0002-3909-2323	US NCI/NIH [R33CA128625]; NIH [T32]; GI SPORE Career Development [P50CA127003]; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships; Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE [K08CA134931, R33CA128625, T32CA009172, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI SPORE Career Development; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships(United States Department of Defense); Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Shin for technical assistance with immunohistochemistry, M. Miri for assistance with sample collection and G. Getz for assistance with SNP array analysis. This work was supported in part by a grant from the US NCI/NIH R33CA128625 (W.C.H.), T32 NIH grant (R.F.) and a GI SPORE Career Development Grant (P50CA127003; R.F.), a Harvard-MIT Clinical Investigator Training Program Fellowship (A.J.B), Department of Defense Prostate Cancer Postdoctoral Fellowships (I.G. and S.Y.K.), Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships (I.F.D.) and K12 award (M.G.C.). J.B. is a Beatriu de Pinos Fellow of the Departament d'Educacio i Universitats de la Generalita de Catalunya.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gold MO, 1998, NUCLEIC ACIDS RES, V26, P3784, DOI 10.1093/nar/26.16.3784; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sparks AB, 1998, CANCER RES, V58, P1130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	30	499	528	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					547	U60		10.1038/nature07179	http://dx.doi.org/10.1038/nature07179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794900	Green Accepted			2022-12-24	WOS:000259449600049
J	Chen, CH; Budas, GR; Churchill, EN; Disatnik, MH; Hurley, TD; Mochly-Rosen, D				Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Hurley, Thomas D.; Mochly-Rosen, Daria			Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart	SCIENCE			English	Article							PROTEIN-KINASE-C; RAT-HEART; EPSILON; CARDIOPROTECTION; INHIBITION; PROTECTION; ETHANOL; CLONING; PKC	There is substantial interest in the development of drugs that limit the extent of ischemia- induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 ( ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high- throughput screen yielded a small- molecule activator of ALDH2 ( Alda- 1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda- 1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild- type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.	[Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mochly@stanford.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; HURLEY, THOMAS/0000-0002-5942-1163	NIH [AA11147]; Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147, R01AA011147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank K. Inagaki and C. L. Murriel for initial studies; D. Solow-Cordero for the high-throughput screen; and F. Conti, D. Cheng, and A. Masoud Sadaghiani for the biochemical characterization of Alda-1. Supported by NIH grant AA11147 (to D.M.-R.) and by Stanford's SPARK Program (C.-H.C.). D.M.-R. is the founder and a shareholder of KAI Pharmaceuticals; however, none of the work described here was done in collaboration with, or with support from, this company. C.-H.C., T.D.H., and D.M.-R. are listed as inventors in three pending patents filed by Stanford University that are related to this work.	Blasi P, 2002, MOL GENET METAB, V76, P348, DOI 10.1016/S1096-7192(02)00105-1; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Chen CH, 2001, J MOL CELL CARDIOL, V33, P581, DOI 10.1006/jmcc.2000.1330; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; DEITRICH RA, 1976, BIOCHEM PHARMACOL, V25, P2733, DOI 10.1016/0006-2952(76)90265-3; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; DUESTER G, 1984, P NATL ACAD SCI-BIOL, V81, P4055, DOI 10.1073/pnas.81.13.4055; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hill M, 2001, CIRCULATION, V104, P694, DOI 10.1161/hc3201.092218; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Nakano A, 2000, PHARMACOL THERAPEUT, V86, P263, DOI 10.1016/S0163-7258(00)00058-9	19	568	620	6	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1493	1495		10.1126/science.1158554	http://dx.doi.org/10.1126/science.1158554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787169	Green Accepted			2022-12-24	WOS:000259121800042
J	Hsu, PP; Sabatini, DM				Hsu, Peggy P.; Sabatini, David M.			Cancer cell metabolism: Warburg and beyond	CELL			English	Article							AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; TUMOR-GROWTH; RAG GTPASES; C-MYC; EXPRESSION; HYPOXIA; OVEREXPRESSION; ACTIVATION; PROTEIN	Described decades ago, the Warburg effect of aerobic glycolysis is a key metabolic hallmark of cancer, yet its significance remains unclear. In this Essay, we re-examine the Warburg effect and establish a framework for understanding its contribution to the altered metabolism of cancer cells.	[Hsu, Peggy P.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@w.mit.edu		/0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129105-02, R01 CA129105] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fukumura D, 2001, CANCER RES, V61, P6020; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; KAELIN WG, 2008, J MOL CELL, V30, P393; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koehler SE, 2004, MOL PHARMACOL, V66, P620; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; WARBURG O, 1956, SCIENCE, V124, P269; Wiesener MS, 2001, CANCER RES, V61, P5215; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095; Zhong H, 1999, CANCER RES, V59, P5830	41	1635	1720	10	345	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					703	707		10.1016/j.cell.2008.08.021	http://dx.doi.org/10.1016/j.cell.2008.08.021			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775299	Bronze			2022-12-24	WOS:000258947500006
J	Pastalkova, E; Itskov, V; Amarasingham, A; Buzsaki, G				Pastalkova, Eva; Itskov, Vladimir; Amarasingham, Asohan; Buzsaki, Gyoergy			Internally generated cell assembly sequences in the rat hippocampus	SCIENCE			English	Article							PHASE PRECESSION; PATH-INTEGRATION; PYRAMIDAL CELLS; ENTORHINAL CORTEX; ENSEMBLE ACTIVITY; UNIT-ACTIVITY; MEMORY; NEURONS; SPACE; DYNAMICS	A long- standing conjecture in neuroscience is that aspects of cognition depend on the brain's ability to self- generate sequential neuronal activity. We found that reliably and continually changing cell assemblies in the rat hippocampus appeared not only during spatial navigation but also in the absence of changing environmental or body- derived inputs. During the delay period of a memory task, each moment in time was characterized by the activity of a particular assembly of neurons. Identical initial conditions triggered a similar assembly sequence, whereas different conditions gave rise to different sequences, thereby predicting behavioral choices, including errors. Such sequences were not formed in control ( nonmemory) tasks. We hypothesize that neuronal representations, evolved for encoding distance in spatial navigation, also support episodic recall and the planning of action sequences.	[Pastalkova, Eva; Itskov, Vladimir; Amarasingham, Asohan; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Itskov, Vladimir/0000-0002-7619-7255; Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS34994, MH54671]; NSF [SBE 0542013]; James S. McDonnell Foundation; Swartz Foundation; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Swartz Foundation; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Hirase for sharing his data and C. Curto, C. Geisler, S. Ozen, S. Fujisawa, K. Mizuseki, A. Sirota, D. W. Sullivan, and R. L. Wright for comments. Supported by NIH (NS34994 and MH54671), NSF (SBE 0542013), the James S. McDonnell Foundation, NSF (A.A.), the Swartz Foundation (V.I.), and the Robert Leet and Clara Guthrie Patterson Trust (E.P.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Abeles M., 1991, CORTICOTRONICS NEURA; Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; [Anonymous], 1983, CANADIAN PSYCHOL; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Levy WB, 2005, NEURAL NETWORKS, V18, P1242, DOI 10.1016/j.neunet.2005.08.005; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	40	708	710	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1322	1327		10.1126/science.1159775	http://dx.doi.org/10.1126/science.1159775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772431	Green Accepted			2022-12-24	WOS:000258914300041
J	Sumbre, G; Muto, A; Baier, H; Poo, MM				Sumbre, German; Muto, Akira; Baier, Herwig; Poo, Mu-ming			Entrained rhythmic activities of neuronal ensembles as perceptual memory of time interval	NATURE			English	Article							EVENT-RELATED POTENTIALS; IN-VIVO; PREFRONTAL CORTEX; LARVAL ZEBRAFISH; OPTIC TECTUM; PSYCHOPHYSICS; NETWORKS; PROTEIN; MACAQUE; RETINA	The ability to process temporal information is fundamental to sensory perception, cognitive processing and motor behaviour of all living organisms, from amoebae to humans(1-4). Neural circuit mechanisms based on neuronal and synaptic properties have been shown to process temporal information over the range of tens of microseconds to hundreds of milliseconds(5-7). How neural circuits process temporal information in the range of seconds to minutes is much less understood. Studies of working memory in monkeys and rats have shown that neurons in the prefrontal cortex(8-10), the parietal cortex(9,11) and the thalamus(12) exhibit ramping activities that linearly correlate with the lapse of time until the end of a specific time interval of several seconds that the animal is trained to memorize. Many organisms can also memorize the time interval of rhythmic sensory stimuli in the timescale of seconds and can coordinate motor behaviour accordingly, for example, by keeping the rhythm after exposure to the beat of music. Here we report a form of rhythmic activity among specific neuronal ensembles in the zebrafish optic tectum, which retains the memory of the time interval ( in the order of seconds) of repetitive sensory stimuli for a duration of up to similar to 20 s. After repetitive visual conditioning stimulation ( CS) of zebrafish larvae, we observed rhythmic post-CS activities among specific tectal neuronal ensembles, with a regular interval that closely matched the CS. Visuomotor behaviour of the zebrafish larvae also showed regular post- CS repetitions at the entrained time interval that correlated with rhythmic neuronal ensemble activities in the tectum. Thus, rhythmic activities among specific neuronal ensembles may act as an adjustable 'metronome' for time intervals in the order of seconds, and serve as a mechanism for the short- term perceptual memory of rhythmic sensory experience.	[Sumbre, German; Poo, Mu-ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; [Muto, Akira; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@berkeley.edu	Sumbre, German/K-7538-2017; Muto, Akira/E-2580-2015	Sumbre, German/0000-0003-4436-6840; Muto, Akira/0000-0003-4276-1775	US National Institutes of Health; NATIONAL EYE INSTITUTE [R01EY012406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kampff, F. Engert, Y. Fu and S. Smith for their help with two- photon microscopy, C. Niell for advice on the zebrafish preparation, N. Farchi, Y. Loewenstein, B. Hochner, G. de Polavieja and A. Noe for comments on the manuscript, and A. Arrenberg, B. Barak, V. Yoon, R. Chen and J. Sumbre for their technical help. This work was supported by the US National Institutes of Health.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BULLOCK TH, 1994, ELECTROEN CLIN NEURO, V91, P42, DOI 10.1016/0013-4694(94)90017-5; BULLOCK TH, 1993, J COMP PHYSIOL A, V172, P501, DOI 10.1007/BF00213532; BULLOCK TH, 1990, J NEUROPHYSIOL, V64, P903, DOI 10.1152/jn.1990.64.3.903; BULLOCK TH, 1990, J EXP ZOOL, V256, P142; Buonomano DV, 2007, NAT CHEM BIOL, V3, P594, DOI 10.1038/nchembio1007-594; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Easter SS, 1996, DEV BIOL, V180, P646; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lister JA, 1999, DEVELOPMENT, V126, P3757; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MEEK J, 1983, BRAIN RES, V287, P247; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; O'Malley DM, 2004, METHOD CELL BIOL, V76, P261; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Schwartz G, 2007, NAT NEUROSCI, V10, P552, DOI 10.1038/nn1887; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	38	108	109	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					102	U6		10.1038/nature07351	http://dx.doi.org/10.1038/nature07351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18923391	Green Accepted			2022-12-24	WOS:000260674000049
J	Kipping, RR; Jago, R; Lawlor, DA				Kipping, Ruth R.; Jago, Russell; Lawlor, Debbie A.			Obesity in children. Part 2: Prevention and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHILDHOOD OBESITY; INTERVENTIONS; ADOLESCENTS; METAANALYSIS; OVERWEIGHT; PROGRAMS; OUTCOMES; RISK		[Kipping, Ruth R.; Lawlor, Debbie A.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Jago, Russell] Univ Bristol, Dept Exercise Nutr & Hlth Sci, Bristol BS8 1TP, Avon, England; [Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England	University of Bristol; University of Bristol; University of Bristol	Kipping, RR (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	ruth.kipping@bristol.ac.uk	Jago, Russell/ABD-6271-2021	Jago, Russell/0000-0002-3394-0176; Lawlor, Debbie A/0000-0002-6793-2262; Kipping, Ruth/0000-0002-5446-8077				Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Curioni C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006162.pub2; DeMattia L, 2007, OBES REV, V8, P69, DOI 10.1111/j.1467-789X.2006.00259.x; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Foresight (Program) & Great Britain, 2007, TACKL OB FUT CHOIC P; Freemark M, 2007, DIABETES CARE, V30, P395, DOI 10.2337/dc06-1569; Gately PJ, 2005, PEDIATRICS, V116, P73, DOI 10.1542/peds.2004-0397; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Lawson ML, 2006, J PEDIATR SURG, V41, P137, DOI 10.1016/j.jpedsurg.2005.10.017; National Health and Medical Research Council, 2003, CLIN PRACT GUID MAN; *NIH CLIN EXC, QUICK REF GUID 2 NHS; Padwal RS, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004094.pub2, DOI 10.1002/14651858.CD004094.PUB2]; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; Rudolf M, 2006, ARCH DIS CHILD, V91, P736, DOI 10.1136/adc.2005.089896; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; SACHER PM, 2007, OBES REV S3, V8, P7; Schilling PL, 2008, J AM COLL SURGEONS, V206, P1, DOI 10.1016/j.jamcollsurg.2007.07.028; Shield JPH, 2008, ARCH DIS CHILD, V93, P369, DOI 10.1136/adc.2006.113316; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Westley H, 2007, BRIT MED J, V335, P1236, DOI 10.1136/bmj.39409.451678.AD; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Young KM, 2007, CLIN PSYCHOL REV, V27, P240, DOI 10.1016/j.cpr.2006.08.003	28	28	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2008	337	7676							a1848	10.1136/bmj.a1848	http://dx.doi.org/10.1136/bmj.a1848			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18945733				2022-12-24	WOS:000260298800037
J	Rogers, CS; Stoltz, DA; Meyerholz, DK; Ostedgaard, LS; Rokhlina, T; Taft, PJ; Rogan, MP; Pezzulo, AA; Karp, PH; Itani, OA; Kabel, AC; Wohlford-Lenane, CL; Davis, GJ; Hanfland, RA; Smith, TL; Samuel, M; Wax, D; Murphy, CN; Rieke, A; Whitworth, K; Uc, A; Starner, TD; Brogden, KA; Shilyansky, J; McCray, PB; Zabner, J; Prather, RS; Welsh, MJ				Rogers, Christopher S.; Stoltz, David A.; Meyerholz, David K.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Wohlford-Lenane, Christine L.; Davis, Greg J.; Hanfland, Robert A.; Smith, Tony L.; Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Uc, Aliye; Starner, Timothy D.; Brogden, Kim A.; Shilyansky, Joel; McCray, Paul B., Jr.; Zabner, Joseph; Prather, Randall S.; Welsh, Michael J.			Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs	SCIENCE			English	Article							INFLAMMATION; INFANTS; LOCALIZATION; PANCREAS; DISEASE	Almost two decades after CFTR was identified as the gene responsible for cystic fibrosis ( CF), we still lack answers to many questions about the pathogenesis of the disease, and it remains incurable. Mice with a disrupted CFTR gene have greatly facilitated CF studies, but the mutant mice do not develop the characteristic manifestations of human CF, including abnormalities of the pancreas, lung, intestine, liver, and other organs. Because pigs share many anatomical and physiological features with humans, we generated pigs with a targeted disruption of both CFTR alleles. Newborn pigs lacking CFTR exhibited defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and focal biliary cirrhosis, replicating abnormalities seen in newborn humans with CF. The pig model may provide opportunities to address persistent questions about CF pathogenesis and accelerate discovery of strategies for prevention and treatment.	[Rogers, Christopher S.; Stoltz, David A.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Davis, Greg J.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Karp, Philip H.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wohlford-Lenane, Christine L.; Uc, Aliye; Starner, Timothy D.; McCray, Paul B., Jr.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Hanfland, Robert A.; Smith, Tony L.; Shilyansky, Joel] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Surg, Iowa City, IA 52242 USA; [Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Missouri System; University of Missouri Columbia; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Prather, Randall S/B-4528-2012; Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Zabner, Joseph/0000-0002-9606-1339; Pezzulo, Alejandro/0000-0001-7544-5109; Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442; Prather, Randall/0000-0002-6012-4035; Uc, Aliye/0000-0003-2004-5743; Shilyansky, Joel/0000-0003-0766-4785; Starner, Timothy/0000-0002-1933-7477; McCray, Paul/0000-0002-4067-577X; Stoltz, David/0000-0003-0893-9015	National Heart Lung and Blood Institute [HL51670]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Food for the 21st Century, the Cystic Fibrosis Foundation; NIH [HL07638]; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Food for the 21st Century, the Cystic Fibrosis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Arias, E. Bagnall, J. Bartlett, B. Bauer, T. Bohnert, E. Burnight, K. Dobbs, C. Dohrn, L. Dowell, L. Gakhar, D. Guilliams, Y. Hao, S. C. Isom, S. Jones, S. Korte, B. Kussman, J. Launspach, M. Linville, E. Mahan, T. Mayhew, C. McHughes, K. Munson, M. Parker, C. Randak, S. Ramachandran, J. Ross, A. Small, L. Spate, D. Vermeer, E. Walters, and J. Whyte for excellent assistance. We thank our patients with CF for inspiration, and we also thank Cystic Fibrosis Foundation Therapeutics and R. Bridges for the gift of GlyH-101. This work was supported by the National Heart Lung and Blood Institute (grant HL51670), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), Food for the 21st Century, the Cystic Fibrosis Foundation, and HHMI. C. S. R. was supported by NIH training grant HL07638. D. A. S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M. J. W. is an Investigator of the HHMI. C.S.R., R.S.P., M.J.W., and the University of Iowa Foundation have applied for a patent related to the work reported in this paper, and C. S. R. and M. J. W. are founders of Exemplar Genetics, a company that is licensing materials and technology related to this work. C. S. R. is currently Director of Research and Development at Exemplar Genetics.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Clarke LL, 1996, LAB ANIM SCI, V46, P612; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; IMRIE JR, 1979, AM J PATHOL, V95, P697; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; OPPENHEIMER EH, 1975, J PEDIATR-US, V86, P683, DOI 10.1016/S0022-3476(75)80351-9; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilschanski M, 1998, J ROY SOC MED, V91, P40, DOI 10.1177/014107689809134S07	26	573	612	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1837	1841		10.1126/science.1163600	http://dx.doi.org/10.1126/science.1163600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818360	Green Accepted			2022-12-24	WOS:000259501300039
J	Scheerer, P; Park, JH; Hildebrand, PW; Kim, YJ; Krauss, N; Choe, HW; Hofmann, KP; Ernst, OP				Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Krauss, Norbert; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.			Crystal structure of opsin in its G-protein-interacting conformation	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; CATALYZED TRANSDUCIN ACTIVATION; CARBOXYLIC-ACID GROUP; ALPHA-SUBUNIT; NUCLEOTIDE EXCHANGE; COUPLED RECEPTOR; SQUID RHODOPSIN; DARK-ADAPTATION; PROTON UPTAKE; BINDING-SITE	Opsin, the ligand- free form of the G- protein- coupled receptor rhodopsin, at low pH adopts a conformationally distinct, active G- protein- binding state known as Ops*. A synthetic peptide derived from the main binding site of the heterotrimeric G protein - the carboxy terminus of the alpha-subunit (G alpha CT) - stabilizes Ops*. Here we present the 3.2 angstrom crystal structure of the bovine Ops* - G alpha CT peptide complex. G alpha CT binds to a site in opsin that is opened by an outward tilt of transmembrane helix ( TM) 6, a pairing of TM5 and TM6, and a restructured TM7 - helix 8 kink. Contacts along the inner surface of TM5 and TM6 induce an alpha- helical conformation in G alpha CT with a C- terminal reverse turn. Main- chain carbonyl groups in the reverse turn constitute the centre of a hydrogen- bonded network, which links the two receptor regions containing the conserved E( D) RY and NPxxY(x)(5,6)F motifs. On the basis of the Ops* - G alpha CT structure and known conformational changes in G alpha, we discuss signal transfer from the receptor to the G protein nucleotide- binding site.	[Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.] Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Krauss, Norbert] Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England; [Choe, Hui-Woog] Chonbuk Natl Univ, Dept Chem, Coll Nat Sci, Chonju 561756, South Korea; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London; Jeonbuk National University; Humboldt University of Berlin	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	hwchoe@chonbuk.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@charite.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Krauss, Norbert/0000-0002-7128-4632; Scheerer, Patrick/0000-0001-5028-2075	Protein Structure Factory; Freie Universitat Berlin [BL 14.1, BL 14.2]; Deutsche Forschungsgemeinschaft [Sfb449, Sfb740]; DFG-KOSEF international cooperation [ER 294/1-1, F01-2004-000-10054-0]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	Protein Structure Factory; Freie Universitat Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-KOSEF international cooperation(Korea Science and Engineering Foundation); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann and C. Koch for technical assistance; P. Henklein for peptide synthesis; C. Enenkel and M. Sommer for critically reading the manuscript; U. Muller and the scientific staff of the Protein Structure Factory and the Freie Universitat Berlin at beamlines BL 14.1 and BL 14.2 at BESSY for continuous support of the project. This work was supported by the Deutsche Forschungsgemeinschaft Sfb449 ( to O.P.E.), Sfb740 ( to O.P.E. and K.P.H.), DFG-KOSEF international cooperation ER 294/1-1 ( to O.P.E.) and F01-2004-000-10054-0 ( to H.-W.C.), and CBNU funds for overseas research 2006-2007 ( to H.-W.C.) and a fellowship of the Leibniz Graduate School of Molecular Biophysics, Berlin ( to Y.J.K.).	Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	58	895	916	3	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					497	U30		10.1038/nature07330	http://dx.doi.org/10.1038/nature07330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818650				2022-12-24	WOS:000259449600038
J	Brandl, K; Plitas, G; Mihu, CN; Ubeda, C; Jia, T; Fleisher, M; Schnabl, B; DeMatteo, RP; Pamer, EG				Brandl, Katharina; Plitas, George; Mihu, Coralia N.; Ubeda, Carles; Jia, Ting; Fleisher, Martin; Schnabl, Bernd; DeMatteo, Ronald P.; Pamer, Eric G.			Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits	NATURE			English	Article							TOLL-LIKE RECEPTOR-4; INTESTINAL COLONIZATION; BACTERICIDAL LECTIN; MICE; GUT; LIPOPOLYSACCHARIDE; TRANSLOCATION; RECOGNITION; INFECTIONS; THERAPY	Infection with antibiotic- resistant bacteria, such as vancomycin-resistant Enterococcus ( VRE), is a dangerous and costly complication of broad- spectrum antibiotic therapy(1,2). How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic- resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIII gamma ( also known as Reg3g), a secreted C- type lectin that kills Gram- positive bacteria, including VRE. Downregulation of RegIII gamma markedly decreases in vivo killing of VRE in the intestine of antibiotic- treated mice. Stimulation of intestinal Toll- like receptor 4 by oral administration of lipopolysaccharide re-induces RegIII gamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad- spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll- like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic- resistant microbes.	[Brandl, Katharina; Mihu, Coralia N.; Ubeda, Carles; Jia, Ting; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, Program Immunol,Sloan Kettering Inst, New York, NY 10021 USA; [Plitas, George; DeMatteo, Ronald P.] Mem Sloan Kettering Canc Ctr, Hepatobiliary Serv, New York, NY 10021 USA; [Fleisher, Martin; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; [Schnabl, Bernd] Columbia Univ, Dept Med, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Infect Dis Serv, Dept Med, Program Immunol,Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	pamere@mskcc.org	Ubeda, Carles/L-6815-2014	Ubeda, Carles/0000-0003-0560-4658; Brandl, Katharina/0000-0001-5485-9206	Alexander von Humboldt Foundation; NIH [AI39031, AI42135]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039031, R01AI042135, R37AI039031, R01AI080619] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank L. V. Hooper for providing polyclonal RegIII gamma antiserum, I. Leiner for technical assistance, and W. Falk, B. Salzberger and all members of the Pamer laboratory for discussions. This research was supported by the Alexander von Humboldt Foundation through a Feodor Lynen postdoctoral fellowship to KB and NIH grant AI39031 and AI42135 to EGP.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Donskey CJ, 2004, CLIN INFECT DIS, V39, P219, DOI 10.1086/422002; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Hammett-Stabler CA, 1998, CLIN CHEM, V44, P1129; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lotz M, 2007, INT J MED MICROBIOL, V297, P379, DOI 10.1016/j.ijmm.2007.03.010; Miyazaki S, 2001, J MED MICROBIOL, V50, P695, DOI 10.1099/0022-1317-50-8-695; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Pultz NJ, 2005, J INFECT DIS, V191, P949, DOI 10.1086/428090; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rice LB, 2001, EMERG INFECT DIS, V7, P183, DOI 10.3201/eid0702.010205; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stiefel U, 2004, INFECT CONT HOSP EP, V25, P373, DOI 10.1086/502408; WELLS CL, 1990, J INFECT DIS, V162, P82, DOI 10.1093/infdis/162.1.82; WELLS CL, 1988, ANTIMICROB AGENTS CH, V32, P1769, DOI 10.1128/AAC.32.12.1769; Wenzel RP, 2000, NEW ENGL J MED, V343, P1961, DOI 10.1056/NEJM200012283432610	28	456	477	1	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					804	U8		10.1038/nature07250	http://dx.doi.org/10.1038/nature07250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18724361	Green Accepted			2022-12-24	WOS:000259854900048
J	Cars, O; Hogberg, LD; Murray, M; Nordberg, O; Sivaraman, S; Lundborg, CS; So, AD; Tomson, G				Cars, Otto; Hogberg, Liselotte Diaz; Murray, Mary; Nordberg, Olle; Sivaraman, Satya; Lundborg, Cecilia Stalsby; So, Anthony D.; Tomson, Goran			Meeting the challenge of antibiotic resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIONS; TIME		[Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hogberg, Liselotte Diaz] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Murray, Mary] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Nordberg, Olle] Dag Hammarskjold Fdn, Uppsala, Sweden; [Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth IHCAR, Stockholm, Sweden; [Lundborg, Cecilia Stalsby] Nordic Sch Publ Hlth, Gothenburg, Sweden; [So, Anthony D.] Duke Univ, Program Global Hlth & Technol Access, Terry Sanford Inst Publ Policy, Durham, NC USA; [Tomson, Goran] Karolinska Inst, MMC, Stockholm, Sweden	Uppsala University; Uppsala University; University of South Australia	Cars, O (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	otto.cars@medsci.uu.se		Tomson, Goran/0000-0001-9222-3604; Stalsby Lundborg, Cecilia/0000-0001-6525-1861				[Anonymous], 2007, EXTENDING CURE POLIC; [Anonymous], 2001, WHO GLOB STRAT CONT; Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P135, DOI 10.1007/s00228-005-0089-4; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carbon C, 2002, CLIN MICROBIOL INFEC, V8, P92, DOI 10.1046/j.1469-0691.8.s.2.8.x; Cars O, 2007, ESCMID NEWS, V2, P22; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Del Mar C, 2007, BMJ-BRIT MED J, V335, P407, DOI 10.1136/bmj.39307.642963.80; Dollman WB, 2005, MED J AUSTRALIA, V182, P617, DOI 10.5694/j.1326-5377.2005.tb06847.x; *EUR CDPC, 2007, ANN EP REP COMM DIS; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; HARBARTH S, 2005, EMERG INFECT DIS, V11; Hawkey PM, 1998, LANCET, V351, P1298, DOI 10.1016/S0140-6736(98)22018-6; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; *NAT STAT, MRSA DEATHS DECR 200; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Outterson K, 2007, LANCET INFECT DIS, V7, P559, DOI 10.1016/S1473-3099(07)70188-3; Payne D, 2004, CURR OPIN MICROBIOL, V7, P435, DOI 10.1016/j.mib.2004.08.017; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; *REACT ACT ANT RES, 2007, BURD RES MULT GRAM N; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; TREPKA M, 2001, PEDIATRICS, V107, P6; *WHO, 2000, REP INF DIS 2000 OV; World Health Organization, 2007, WORLD HLTH REP 2007; *WORLD HLTH ASS, 1998, EM OTH COMM DIS ANT; *WORLD HLTH ASS, 2005, IMPR CONT ANT RES; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; 2007, 21 CENTURY	38	103	106	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1438	10.1136/bmj.a1438	http://dx.doi.org/10.1136/bmj.a1438			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18801866				2022-12-24	WOS:000259797600036
J	Lin, GN; Xu, N; Xi, RW				Lin, Guonan; Xu, Na; Xi, Rongwen			Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells	NATURE			English	Article							EXPRESSION; ARMADILLO; NICHE; PROTEIN; MIDGUT; SHAGGY; ROLES; FATES	In the Drosophila midgut, multipotent intestinal stem cells (ISCs) that are scattered along the epithelial basement membrane maintain tissue homeostasis by their ability to steadily produce daughters that differentiate into either enterocytes or enteroendocrine cells, depending on the levels of Notch activity(1-3). However, the mechanisms controlling ISC self- renewal remain elusive. Here we show that a canonical Wnt signalling pathway controls ISC self-renewal. The ligand Wingless (Wg) is specifically expressed in the circular muscles next to ISCs, separated by a thin layer of basement membrane. Reduced function of wg causes ISC quiescence and differentiation, whereas wg overexpression produces excessive ISC- like cells that express high levels of the Notch ligand, Delta. Clonal analysis shows that the main downstream components of the Wg pathway, including Frizzled, Dishevelled and Armadillo, are autonomously required for ISC self- renewal. Furthermore, epistatic analysis suggests that Notch acts downstream of the Wg pathway and a hierarchy of Wg/Notch signalling pathways controls the balance between self- renewal and differentiation of ISCs. These data suggest that the underlying circular muscle constitutes the ISC niche, which produce Wg signals that act directly on ISCs to promote ISC self-renewal. This study demonstrates markedly conserved mechanisms regulating ISCs from Drosophila to mammals. The identification of the Drosophila ISC niche and the principal self- renewal signal will facilitate further understanding of intestinal homeostasis control and tumorigenesis.	[Lin, Guonan; Xu, Na; Xi, Rongwen] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Lin, Guonan] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Lin, Guonan] Chinese Acad Med Sci, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xi, RW (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	xirongwen@nibs.ac.cn			Chinese Ministry of Science and Technology [2007AA02Z1A2]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank G. Struhl, L. Cooley, S. Hayashi, T. Xie, the Bloomington Stock Center for fly stocks, and members of the Xi laboratory for comments and discussions. This work was supported by an '863' grant 2007AA02Z1A2 to R.X. from the Chinese Ministry of Science and Technology.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CM, 1999, DEVELOPMENT, V126, P5441; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Heslip TR, 1997, DEVELOPMENT, V124, P1069; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	24	249	254	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1119	U11		10.1038/nature07329	http://dx.doi.org/10.1038/nature07329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806781				2022-12-24	WOS:000260252600047
J	Gillis, AJ; Schuller, AP; Skordalakes, E				Gillis, Andrew J.; Schuller, Anthony P.; Skordalakes, Emmanuel			Structure of the Tribolium castaneum telomerase catalytic subunit TERT	NATURE			English	Article							TEMPLATE BOUNDARY DEFINITION; HIV-1 REVERSE-TRANSCRIPTASE; RNA-BINDING DOMAIN; FUNCTIONAL MULTIMERIZATION; CELLULAR SENESCENCE; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURE; IN-VIVO; YEAST; POLYMERASE	A common hallmark of human cancers is the overexpression of telomerase, a ribonucleoprotein complex that is responsible for maintaining the length and integrity of chromosome ends. Telomere length deregulation and telomerase activation is an early, and perhaps necessary, step in cancer cell evolution. Here we present the high- resolution structure of the Tribolium castaneum catalytic subunit of telomerase, TERT. The protein consists of three highly conserved domains, organized into a ring- like structure that shares common features with retroviral reverse transcriptases, viral RNA polymerases and B- family DNA polymerases. Domain organization places motifs implicated in substrate binding and catalysis in the interior of the ring, which can accommodate seven to eight bases of double- stranded nucleic acid. Modelling of an RNA - DNA heteroduplex in the interior of this ring demonstrates a perfect fit between the protein and the nucleic acid substrate, and positions the 39- end of the DNA primer at the active site of the enzyme, providing evidence for the formation of an active telomerase elongation complex.	[Gillis, Andrew J.; Schuller, Anthony P.; Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	The Wistar Institute	Skordalakes, E (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	skorda@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833; Schuller, Anthony/0000-0003-3098-3055	Pennsylvania Department of Health; The Ellison Medical Foundation	Pennsylvania Department of Health; The Ellison Medical Foundation(Lawrence Ellison Foundation)	We thank R. Marmorstein for critical reading of this manuscript. This project was funded by the Pennsylvania Department of Health and The Ellison Medical Foundation.	Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bosoy D, 2001, J BIOL CHEM, V276, P46305, DOI 10.1074/jbc.M108168200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan TM, 2003, MOL BIOL CELL, V14, P4794, DOI 10.1091/mbc.E03-07-0474; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Finger SN, 2008, NUCLEIC ACIDS RES, V36, P1260, DOI 10.1093/nar/gkm866; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Hammond PW, 1998, BIOCHEMISTRY-US, V37, P5162, DOI 10.1021/bi972988o; Hossain S, 2002, J BIOL CHEM, V277, P36174, DOI 10.1074/JBC.m201976200; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; LEE MS, 1993, MOL CELL BIOL, V13, P6586, DOI 10.1128/MCB.13.10.6586; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lue NF, 2005, J BIOL CHEM, V280, P26586, DOI 10.1074/jbc.M503028200; Lue NF, 2003, MOL CELL BIOL, V23, P8440, DOI 10.1128/MCB.23.23.8440-8449.2003; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Osanai M, 2006, GENE, V376, P281, DOI 10.1016/j.gene.2006.04.022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Seto AG, 2003, RNA, V9, P1323, DOI 10.1261/rna.5570803; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Smith RA, 2006, J VIROL, V80, P7169, DOI 10.1128/JVI.00322-06; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; WRIGHT WE, 1975, EXP CELL RES, V96, P113, DOI 10.1016/S0014-4827(75)80043-7	56	218	226	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					633	U36		10.1038/nature07283	http://dx.doi.org/10.1038/nature07283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18758444				2022-12-24	WOS:000259639700039
J	Courbet, S; Gay, S; Arnoult, N; Wronka, G; Anglana, M; Brison, O; Debatisse, M				Courbet, Sylvain; Gay, Sophie; Arnoult, Nausica; Wronka, Gerd; Anglana, Mauro; Brison, Olivier; Debatisse, Michelle			Replication fork movement sets chromatin loop size and origin choice in mammalian cells	NATURE			English	Article							SITE-SPECIFIC INITIATION; COMMON FRAGILE SITES; DNA-REPLICATION; NUCLEAR-MATRIX; CHROMOSOMAL DNA; REPLICON; TRANSCRIPTION; ORIGNAI3; DYNAMICS; DOMAINS	Genome stability requires one, and only one, DNA duplication at each S phase. The mechanisms preventing origin firing on newly replicated DNA are well documented(1), but much less is known about the mechanisms controlling the spacing of initiation events 2,3, namely the completion of DNA replication. Here we show that origin use in Chinese hamster cells depends on both the movement of the replication forks and the organization of chromatin loops. We found that slowing the replication speed triggers the recruitment of latent origins within minutes, allowing the completion of S phase in a timely fashion. When slowly replicating cells are shifted to conditions of fast fork progression, although the decrease in the overall number of active origins occurs within 2 h, the cells still have to go through a complete cell cycle before the efficiency specific to each origin is restored. We observed a strict correlation between replication speed during a given S phase and the size of chromatin loops in the next G1 phase. Furthermore, we found that origins located at or near sites of anchorage of chromatin loops in G1 are activated preferentially in the following S phase. These data suggest a mechanism of origin programming in which replication speed determines the spacing of anchorage regions of chromatin loops, that, in turn, controls the choice of initiation sites.	[Courbet, Sylvain; Gay, Sophie; Arnoult, Nausica; Wronka, Gerd; Anglana, Mauro; Brison, Olivier; Debatisse, Michelle] Inst Curie, F-75248 Paris, France; [Courbet, Sylvain; Gay, Sophie; Arnoult, Nausica; Wronka, Gerd; Anglana, Mauro; Brison, Olivier; Debatisse, Michelle] Univ Paris 06, UPMC, F-75005 Paris, France; [Courbet, Sylvain; Gay, Sophie; Arnoult, Nausica; Wronka, Gerd; Anglana, Mauro; Brison, Olivier; Debatisse, Michelle] CNRS, UMR 7147, F-75700 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Debatisse, M (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr		Arnoult, Nausica/0000-0003-2633-0270	ARC; Ministere de la Recherche; La Ligue Nationale contre le Cancer; Agence Nationale de la Recherche	ARC(Australian Research Council); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank E. Blackburn, R. Rothstein and F. Toledo for discussions and critical reading of the manuscript, and Genomic Vision for making available the DNA combing technology. S.C. is supported by a grant from the ARC ( Association pour la Recherche sur le Cancer), and S.G. and N.A. are supported by a grant from the Ministere de la Recherche. The M.D. team is supported by La Ligue Nationale contre le Cancer and the Agence Nationale de la Recherche (ANR).	Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0; DEBATISSE M, 1982, MOL CELL BIOL, V2, P1346, DOI 10.1128/MCB.2.11.1346; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Dietzel S, 2001, NAT CELL BIOL, V3, P767, DOI 10.1038/35087089; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Fernandez MA, 1997, J CELL BIOCHEM, V67, P541, DOI 10.1002/(SICI)1097-4644(19971215)67:4<541::AID-JCB11>3.0.CO;2-C; Gilbert DM, 2007, CHROMOSOMA, V116, P341, DOI 10.1007/s00412-007-0105-9; GILBERT DM, 1995, MOL CELL BIOL, V15, P2942; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Lawlis SJ, 1996, J CELL BIOL, V135, P1207, DOI 10.1083/jcb.135.5.1207; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; PARDOLL DM, 1980, CELL, V19, P527, DOI 10.1016/0092-8674(80)90527-9; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; Svetlova EY, 2001, J CELL BIOCHEM, P170; Toledo F, 1999, NUCLEIC ACIDS RES, V27, P1600, DOI 10.1093/nar/27.7.1600; Toledo F, 1998, NUCLEIC ACIDS RES, V26, P2313, DOI 10.1093/nar/26.10.2313; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270	27	169	171	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					557	560		10.1038/nature07233	http://dx.doi.org/10.1038/nature07233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18716622				2022-12-24	WOS:000259449600051
J	Horwitz, GA; Zhang, KL; McBrian, MA; Grunstein, M; Kurdistani, SK; Berk, AJ				Horwitz, Gregory A.; Zhang, Kangling; McBrian, Matthew A.; Grunstein, Michael; Kurdistani, Siavash K.; Berk, Arnold J.			Adenovirus small e1a alters global patterns of histone modification	SCIENCE			English	Article							CELL-CYCLE CONTROL; TRANSFORMATION; PROTEIN; E1A-PROTEINS; EXPRESSION; TARGETS; COMPLEX	Adenovirus small early region 1a ( e1a) protein drives cells into S phase by binding RB family proteins and the closely related histone acetyl transferases p300 and CBP. The interaction with RB proteins displaces them from DNA- bound E2F transcription factors, reversing their repression of cell cycle genes. However, it has been unclear how the e1a interaction with p300 and CBP promotes passage through the cell cycle. We show that this interaction causes a threefold reduction in total cellular histone H3 lysine 18 acetylation ( H3K18ac). CBP and p300 are required for acetylation at this site because their knockdown causes specific hypoacetylation at H3K18. SV40 T antigen also induces H3K18 hypoacetylation. Because global hypoacetylation at this site is observed in prostate carcinomas with poor prognosis, this suggests that processes resulting in global H3K18 hypoacetylation may be linked to oncogenic transformation.	[Horwitz, Gregory A.; Berk, Arnold J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Zhang, Kangling] Loma Linda Univ, Mass Spectrometry Facil, Dept Biochem, Sch Med, Loma Linda, CA 92350 USA; [McBrian, Matthew A.; Grunstein, Michael; Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Berk, Arnold J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Loma Linda University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Berk, AJ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	berk@mbi.ucla.edu	BERK, ARNOLD/AAF-7052-2020	Kurdistani, Siavash/0000-0003-3295-3511	NIH [CA25235]; NATIONAL CANCER INSTITUTE [R01CA025235, R37CA025235] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH grant CA25235 to A. J. B. and a Beckman Young Investigator Award to S. K. K. We thank C. Eng for technical assistance.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; MONTELL C, 1984, CELL, V36, P951, DOI 10.1016/0092-8674(84)90045-X; NEVINS JR, 1994, CURR OPIN GENET DEV, V4, P130, DOI 10.1016/0959-437X(94)90101-5; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Rasti M, 2005, J VIROL, V79, P5594, DOI 10.1128/JVI.79.9.5594-5605.2005; ROCHETTEEGLY C, 1990, GENE DEV, V4, P137, DOI 10.1101/gad.4.1.137; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Wang G, 2002, J VIROL, V76, P9186, DOI 10.1128/JVI.76.18.9186-9193.2002; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	17	164	166	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1084	1085		10.1126/science.1155544	http://dx.doi.org/10.1126/science.1155544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719283	Green Accepted			2022-12-24	WOS:000258594900039
J	Newton, K; Matsumoto, ML; Wertz, IE; Kirkpatrick, DS; Lill, JR; Tan, J; Dugger, D; Gordon, N; Sidhu, SS; Fellouse, FA; Komuves, L; French, DM; Ferrando, RE; Lam, C; Compaan, D; Yu, C; Bosanac, I; Hymowitz, SG; Kelley, RF; Dixit, VM				Newton, Kim; Matsumoto, Marissa L.; Wertz, Ingrid E.; Kirkpatrick, Donald S.; Lill, Jennie R.; Tan, Jenille; Dugger, Debra; Gordon, Nathaniel; Sidhu, Sachdev S.; Fellouse, Frederic A.; Komuves, Laszlo; French, Dorothy M.; Ferrando, Ronald E.; Lam, Cynthia; Compaan, Deanne; Yu, Christine; Bosanac, Ivan; Hymowitz, Sarah G.; Kelley, Robert F.; Dixit, Vishva M.			Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies	CELL			English	Article							RECEPTOR-ASSOCIATED KINASE; KAPPA-B ACTIVATION; LYS63-LINKED POLYUBIQUITINATION; BINDING; MULTIUBIQUITINATION; LIBRARIES; RESPONSES; REQUIRES; COMPLEX; SYSTEM	Posttranslational modification of proteins with polyubiquitin occurs in diverse signaling pathways and is tightly regulated to ensure cellular homeostasis. Studies employing ubiquitin mutants suggest that the fate of polyubiquitinated proteins is determined by which lysine within ubiquitin is linked to the C terminus of an adjacent ubiquitin. We have developed linkage-specific antibodies that recognize polyubiquitin chains joined through lysine 63 (K63) or 48 (K48). A cocrystal structure of an anti-K63 linkage Fab bound to K63-linked diubiquitin provides insight into the molecular basis for specificity. We use these antibodies to demonstrate that RIP1, which is essential for tumor necrosis factor-induced NF-kappa B activation, and IRAK1, which participates in signaling by interleukin-1b and Toll-like receptors, both undergo polyubiquitin editing in stimulated cells. Both kinase adaptors initially acquire K63-linked polyubiquitin, while at later times K48-linked polyubiquitin targets them for proteasomal degradation. Polyubiquitin editing may therefore be a general mechanism for attenuating innate immune signaling.	[Newton, Kim; Tan, Jenille; Dugger, Debra; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Matsumoto, Marissa L.; Gordon, Nathaniel; Sidhu, Sachdev S.; Fellouse, Frederic A.; Kelley, Robert F.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Wertz, Ingrid E.; Lam, Cynthia; Compaan, Deanne; Yu, Christine; Bosanac, Ivan; Hymowitz, Sarah G.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Kirkpatrick, Donald S.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Komuves, Laszlo; French, Dorothy M.; Ferrando, Ronald E.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Matsumoto, Marissa/0000-0002-5353-1097; Kirkpatrick, Donald/0000-0003-3091-2804				Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Thomas JA, 1999, J IMMUNOL, V163, P978; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	29	441	457	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 22	2008	134	4					668	678		10.1016/j.cell.2008.07.039	http://dx.doi.org/10.1016/j.cell.2008.07.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724939	Bronze			2022-12-24	WOS:000258665800019
J	Belogurov, GA; Vassylyeva, MN; Sevostyanova, A; Appleman, JR; Xiang, AX; Lira, R; Webber, SE; Klyuyev, S; Nudler, E; Artsimovitch, I; Vassylyev, DG				Belogurov, Georgiy A.; Vassylyeva, Marina N.; Sevostyanova, Anastasiya; Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.; Klyuyev, Sergiy; Nudler, Evgeny; Artsimovitch, Irina; Vassylyev, Dmitry G.			Transcription inactivation through local refolding of the RNA polymerase structure	NATURE			English	Article							OPEN COMPLEX-FORMATION; ELECTRON-DENSITY MAPS; II ELONGATION COMPLEX; ANGSTROM RESOLUTION; START SITE; DNA; INHIBITION; HOLOENZYME; MOLSCRIPT	Structural studies of antibiotics not only provide a shortcut to medicine allowing for rational structure- based drug design, but may also capture snapshots of dynamic intermediates that become 'frozen' after inhibitor binding(1,2). Myxopyronin inhibits bacterial RNA polymerase ( RNAP) by an unknown mechanism(3). Here we report the structure of dMyx - a desmethyl derivative of myxopyronin B-4 - complexed with a Thermus thermophilus RNAP holoenzyme. The antibiotic binds to a pocket deep inside the RNAP clamp head domain, which interacts with the DNA template in the transcription bubble(5,6). Notably, binding of dMyx stabilizes refolding of the beta'-subunit switch- 2 segment, resulting in a configuration that might indirectly compromise binding to, or directly clash with, the melted template DNA strand. Consistently, footprinting data show that the antibiotic binding does not prevent nucleation of the promoter DNA melting but instead blocks its propagation towards the active site. Myxopyronins are thus, to our knowledge, a first structurally characterized class of antibiotics that target formation of the pre- catalytic transcription initiation complex the decisive step in gene expression control. Notably, mutations designed in switch- 2 mimic the dMyx effects on promoter complexes in the absence of antibiotic. Overall, our results indicate a plausible mechanism of the dMyx action and a stepwise pathway of open complex formation in which core enzyme mediates the final stage of DNA melting near the transcription start site, and that switch- 2 might act as a molecular checkpoint for DNA loading in response to regulatory signals or antibiotics. The universally conserved switch- 2 may have the same role in all multisubunit RNAPs.	[Belogurov, Georgiy A.; Sevostyanova, Anastasiya; Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Vassylyeva, Marina N.; Klyuyev, Sergiy; Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Appleman, James R.; Xiang, Alan X.; Lira, Ricardo; Webber, Stephen E.] Anadys Pharmaceut Inc, San Diego, CA 92121 USA; [Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; New York University	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	artsimovitch.1@osu.edu; dmitry@uab.edu	Artsimovitch, Irina/L-3467-2019; Vassylyev, Dmitry/A-9005-2008	Nudler, Evgeny/0000-0002-8811-3071; Belogurov, Georgiy/0000-0002-3070-6843	US Department of Energy, Office of Energy Research [W-31-109-Eng-38]; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840, R01GM058750, R01GM074252] Funding Source: NIH RePORTER	US Department of Energy, Office of Energy Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T. Townes for critical reading of the manuscript and R. Saecker for many stimulating discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Energy Research under contract No. W-31-109-Eng-38. This work was supported by National Institutes of Health grants to I.A. and D.G.V.	Artsimovitch I, 2005, CELL, V122, P351, DOI 10.1016/j.cell.2005.07.014; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 1996, P NATL ACAD SCI USA, V93, P9408, DOI 10.1073/pnas.93.18.9408; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; IRSCHIK H, 1983, J ANTIBIOT, V36, P1651, DOI 10.7164/antibiotics.36.1651; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Lira R, 2007, BIOORG MED CHEM LETT, V17, P6797, DOI 10.1016/j.bmcl.2007.10.017; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Severinov K, 1997, P NATL ACAD SCI USA, V94, P13481, DOI 10.1073/pnas.94.25.13481; SUH WC, 1993, SCIENCE, V259, P358, DOI 10.1126/science.8420002; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770	31	106	113	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2009	457	7227					332	U8		10.1038/nature07510	http://dx.doi.org/10.1038/nature07510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	394IR	18946472	Green Accepted			2022-12-24	WOS:000262440900043
J	Janes, KA; Reinhardt, HC; Yaffe, MB				Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.			Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength	CELL			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; GENE-EXPRESSION; ERK ACTIVATION; MESSENGER-RNA; MAP KINASE; CANCER; IDENTIFICATION; MIGRATION; TNF	Signaling networks respond to diverse stimuli, but how the state of the signaling network is relayed to downstream cellular responses is unclear. We modeled how incremental activation of signaling molecules is transmitted to control apoptosis as a function of signal strength and dynamic range. A linear relationship between signal input and response output, with the dynamic range of signaling molecules uniformly distributed across activation states, most accurately predicted cellular responses. When nonlinearized signals with compressed dynamic range relay network activation to apoptosis, we observe catastrophic, stimulus-specific prediction failures. We develop a general computational technique, "model-breakpoint analysis,'' to analyze the mechanism of these failures, identifying new time- and stimulus-specific roles for Akt, ERK, and MK2 kinase activity in apoptosis, which were experimentally verified. Dynamic range is rarely measured in signal-transduction studies, but our experiments using model-break-point analysis suggest it may be a greater determinant of cell fate than measured signal strength.	[Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; [Janes, Kevin A.; Reinhardt, H. Christian; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Janes, Kevin A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu			National Institute of Health [GM68762, CA112967, ES015339]; Deutsche Forschungsgemeinschaft [RE2246/1-1]; David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society [PF-05-224-01-MGO]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); David H. Koch Fund; Edgerly Science Innovation Fund; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Neil Kumar for providing the phosphoproteomic model and Suzanne Gaudet, Greg Hoffman, and Stephanie Walker for critically reading this manuscript. This work was supported by the National Institute of Health (GM68762, CA112967, ES015339 to M.B.Y.), the Deutsche Forschungsgemeinschaft (RE2246/1-1 to H. C. R.), the David H. Koch Fund, the Edgerly Science Innovation Fund, and the American Cancer Society ( New England Division-SpinOdyssey 2005, PF-05-224-01-MGO to K.A.J.).	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Efron B., 1994, INTRO BOOTSTRAP; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Martens H., 2001, MULTIVARIATE ANAL QU; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Miller-Jensen K, 2006, J CELL SCI, V119, P3788, DOI 10.1242/jcs.03102; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pradervand S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r11; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Spencer KSR, 2000, J CELL BIOL, V148, P385, DOI 10.1083/jcb.148.2.385; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Tufte E., 2006, BEAUTIFUL EVIDENCE; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WOLD S, 1994, CHEMOMETR INTELL LAB, V23, P149, DOI 10.1016/0169-7439(93)E0075-F; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094	38	75	77	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 17	2008	135	2					343	354		10.1016/j.cell.2008.08.034	http://dx.doi.org/10.1016/j.cell.2008.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	361LY	18957207	Bronze, Green Accepted			2022-12-24	WOS:000260130400023
J	Nicewicz, DA; MacMillan, DWC				Nicewicz, David A.; MacMillan, David W. C.			Merging photoredox catalysis with organocatalysis: The direct asymmetric alkylation of aldehydes	SCIENCE			English	Article							ELECTRON-TRANSFER; RADICALS; PHOTOCHEMISTRY; PHOTOPHYSICS; POTENTIALS; ACTIVATION; REDUCTION; ENAMINES	Photoredox catalysis and organocatalysis represent two powerful fields of molecule activation that have found widespread application in the areas of inorganic and organic chemistry, respectively. We merged these two catalysis fields to solve problems in asymmetric chemical synthesis. Specifically, the enantioselective intermolecular alpha-alkylation of aldehydes has been accomplished using an interwoven activation pathway that combines both the photoredox catalyst Ru(bpy)(3)Cl-2 (where bpy is 2,2 '-bipyridine) and an imidazolidinone organocatalyst. This broadly applicable, yet previously elusive, alkylation reaction is now highly enantioselective and operationally trivial.	[Nicewicz, David A.; MacMillan, David W. C.] Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu	昊翀, 谭/AAC-5077-2021		NIH General Medical Sciences [R01 GM078201-01-01]; Merck; Amgen; Bristol-Myers Squibb; NIH National Service Research Award [F32GM076816]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076816, R01GM078201] Funding Source: NIH RePORTER	NIH General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Merck(Merck & Company); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); NIH National Service Research Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bernhard for his assistance in performing quenching experiments, as well as many insightful discussions. Additionally, we thank T.J. Rainey for performing DFT calculations. Financial support was provided by the NIH General Medical Sciences (grant R01 GM078201-01-01) and gifts from Merck, Amgen, and Bristol-Myers Squibb. D.A.N. is grateful for a NIH National Service Research Award fellowship (F32GM076816).	Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; BOCK CR, 1979, J AM CHEM SOC, V101, P4815, DOI 10.1021/ja00511a007; Dai X, 2008, J AM CHEM SOC, V130, P3302, DOI 10.1021/ja8009428; Dalko P. I., 2007, ENANTIOSELECTIVE ORG; FUKUZUMI S, 1990, J PHYS CHEM-US, V94, P722, DOI 10.1021/j100365a039; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Jang HY, 2007, J AM CHEM SOC, V129, P7004, DOI 10.1021/ja0719428; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; Kim H, 2008, J AM CHEM SOC, V130, P398, DOI 10.1021/ja077212h; RENAUD P, 1990, SYNLETT, P624; Renaud P., 2001, RADICALS ORGANIC SYN; RUSSELL GA, 1991, J ORG CHEM, V56, P3475, DOI 10.1021/jo00011a007; Sibi MP, 2007, J AM CHEM SOC, V129, P4124, DOI 10.1021/ja069245n; TANNER DD, 1986, J ORG CHEM, V51, P5182, DOI 10.1021/jo00376a024; Vignola N, 2004, J AM CHEM SOC, V126, P450, DOI 10.1021/ja0392566; WAYNER DDM, 1986, CHEM PHYS LETT, V131, P189, DOI 10.1016/0009-2614(86)80542-5	18	1646	1656	45	1060	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					77	80		10.1126/science.1161976	http://dx.doi.org/10.1126/science.1161976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18772399	Green Accepted			2022-12-24	WOS:000259680200040
J	Wang, WJ; Black, SS; Edwards, MD; Miller, S; Morrison, EL; Bartlett, W; Dong, CJ; Naismith, JH; Booth, IR				Wang, Wenjian; Black, Susan S.; Edwards, Michelle D.; Miller, Samantha; Morrison, Emma L.; Bartlett, Wendy; Dong, Changjiang; Naismith, James H.; Booth, Ian R.			The structure of an open form of an E. coli mechanosensitive channel at 3.45 angstrom resolution	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; ION-CHANNEL; K+ CHANNEL; MSCS; MECHANISM; COOPERATIVITY; DOMAIN; WATER; CYCLE	How ion channels are gated to regulate ion flux in and out of cells is the subject of intense interest. The Escherichia coli mechanosensitive channel, MscS, opens to allow rapid ion efflux, relieving the turgor pressure that would otherwise destroy the cell. We present a 3.45 angstrom-resolution structure for the MscS channel in an open conformation. This structure has a pore diameter of similar to 13 angstroms created by substantial rotational rearrangement of the three transmembrane helices. The structure suggests a molecular mechanism that underlies MscS gating and its decay of conductivity during prolonged activation. Support for this mechanism is provided by single-channel analysis of mutants with altered gating characteristics.	[Wang, Wenjian; Dong, Changjiang; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Black, Susan S.; Edwards, Michelle D.; Miller, Samantha; Morrison, Emma L.; Bartlett, Wendy; Booth, Ian R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of St Andrews; University of Aberdeen	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, N Haugh, St Andrews KY16 9ST, Fife, Scotland.	naismith@st-and.ac.uk; i.r.booth@abdn.ac.uk	Miller, Samantha/A-4799-2010; Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Miller, Samantha/0000-0002-8223-9693	Wellcome Trust [GR077564MA, 040174]; Medical Research Council [G0400277]; Unilever (UK); Biotechnology Biological Sciences Research Council (BBSRC) [BB/F003455/1]; Scottish Funding Council; Biotechnology and Biological Sciences Research Council [BB/F003455/1] Funding Source: researchfish; BBSRC [BB/F003455/1] Funding Source: UKRI; MRC [G0400277] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Unilever (UK)(Unilever); Biotechnology Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Funding Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Our research was supported by the Wellcome Trust ( grants GR077564MA and 040174), Medical Research Council ( G0400277), Unilever ( UK), and Biotechnology Biological Sciences Research Council (BBSRC) (BB/F003455/1). Structural biology used the facilities of the Scottish Structural Proteomics Facility funded by the Scottish Funding Council and BBSRC. We thank K. Johnson, T. Rasmussen, and F. Flett for their contributions to this work; D. Rees and R. Bass for advice on crystallization and for pre- release of x-ray intensities; and A. Leslie for a critical reading of the manuscript. Coordinates and data have been deposited in the Protein Data Bank (www. rcsb. org) with accession number 2vv5.	Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Booth IR, 2003, BIOCHEMISTRY-US, V42, P10045, DOI 10.1021/bi034953w; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Edwards MD, 2008, BIOPHYS J, V94, P3003, DOI 10.1529/biophysj.107.123448; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koprowski P, 1998, J MEMBRANE BIOL, V164, P253, DOI 10.1007/s002329900410; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525	36	162	165	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2008	321	5893					1179	1183		10.1126/science.1159262	http://dx.doi.org/10.1126/science.1159262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341ZM	18755969	Green Accepted			2022-12-24	WOS:000258754400035
J	Dix, MM; Simon, GM; Cravatt, BF				Dix, Melissa M.; Simon, Gabriel M.; Cravatt, Benjamin F.			Global mapping of the topography and magnitude of proteolytic events in apoptosis	CELL			English	Article							CASPASE-MEDIATED ACTIVATION; 2-DIMENSIONAL GEL-ELECTROPHORESIS; QUANTITATIVE PROTEOME ANALYSIS; AMINO-ACIDS; SUBSTRATE; IDENTIFICATION; PROTEASES; PROTEINS; CLEAVAGE; DISCOVERY	Proteolysis is a key regulatory process that promotes the (in) activation, translocation, and/or degradation of proteins. As such, there is considerable interest in methods to comprehensively characterize proteolytic pathways in biological systems. Here, we describe a robust and versatile proteomic platform that enables direct visualization of the topography and magnitude of proteolytic events on a global scale. We use this method to generate a proteome-wide map of proteolytic events induced by the intrinsic apoptotic pathway. This profile contained 91 characterized caspase substrates as well as 170 additional proteins not previously known to be cleaved during apoptosis. Surprisingly, the vast majority of proteolyzed proteins, regardless of the extent of cleavage, yielded persistent fragments that correspond to discrete protein domains, suggesting that the generation of active effector proteins may be a principal function of apoptotic proteolytic cascades.	[Dix, Melissa M.; Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dix, Melissa M.; Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu			National Institutes of Health [CA087660]; ARCS Foundation; Koshland Graduate Fellowship; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; Koshland Graduate Fellowship; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Andrew Su for programming assistance. This work was supported by National Institutes of Health (CA087660), the ARCS Foundation (G. M. S.), a Koshland Graduate Fellowship in Enzyme Biochemistry (G. M. S.), and the Skaggs Institute for Chemical Biology.	Abdel-Rahman HM, 2004, BIOL CHEM, V385, P1035, DOI 10.1515/BC.2004.134; Abud HE, 2004, CELL DEATH DIFFER, V11, P797, DOI 10.1038/sj.cdd.4401455; Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Correia JD, 2007, J BIOL CHEM, V282, P12557, DOI 10.1074/jbc.M609587200; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Craig R, 2005, RAPID COMMUN MASS SP, V19, P1844, DOI 10.1002/rcm.1992; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Feng GP, 2002, AM J PHYSIOL-GASTR L, V282, pG825, DOI 10.1152/ajpgi.00467.2001; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Keller UAD, 2007, BIOL CHEM, V388, P1159, DOI 10.1515/BC.2007.146; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lohaus C, 2007, J PROTEOME RES, V6, P105, DOI 10.1021/pr060247g; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Matrisian L.M., 1990, Current Topics in Developmental Biology, V24, P219, DOI 10.1016/S0070-2153(08)60089-7; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; McDonald L, 2005, NAT METHODS, V2, P955, DOI 10.1038/NMETH811; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Schmidt F, 2007, ELECTROPHORESIS, V28, P4359, DOI 10.1002/elps.200700119; Shi R, 2007, J PROTEOME RES, V6, P2963, DOI 10.1021/pr0605668; Thiede B, 2006, PROTEOMICS, V6, P614, DOI 10.1002/pmic.200500120; Thiede B, 2005, PROTEOMICS, V5, P2123, DOI 10.1002/pmic.200401110; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Timmer JC, 2007, BIOCHEM J, V407, P41, DOI 10.1042/BJ20070775; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	52	281	289	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					679	691		10.1016/j.cell.2008.06.038	http://dx.doi.org/10.1016/j.cell.2008.06.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724940	Green Accepted, Bronze			2022-12-24	WOS:000258665800020
J	Schuldiner, M; Metz, J; Schmid, V; Denic, V; Rakwalska, M; Schmitt, HD; Schwappach, B; Weissman, JS				Schuldiner, Maya; Metz, Jutta; Schmid, Volker; Denic, Vladimir; Rakwalska, Magdalena; Schmitt, Hans Dieter; Schwappach, Blanche; Weissman, Jonathan S.			The GET complex mediates insertion of tail-anchored proteins into the ER membrane	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; NUCLEAR-ENVELOPE; GLOBAL ANALYSIS; YEAST; GOLGI; TRANSLOCATION; SED5; IDENTIFICATION	Tail-anchored (TA) proteins, defined by the presence of a single C-terminal transmembrane domain (TMD), play critical roles throughout the secretory pathway and in mitochondria, yet the machinery responsible for their proper membrane insertion remains poorly characterized. Here we show that Get3, the yeast homolog of the TA-interacting factor Asna1/Trc40, specifically recognizes TMDs of TA proteins destined for the secretory pathway. Get3 recognition represents a key decision step, whose loss can lead to misinsertion of TA proteins into mitochondria. Get3-TA protein complexes are recruited for endoplasmic reticulum (ER) membrane insertion by the Get1/Get2 receptor. In vivo, the absence of Get1/Get2 leads to cytosolic aggregation of Get3-TA complexes and broad defects in TA protein biogenesis. In vitro reconstitution demonstrates that the Get proteins directly mediate insertion of newly synthesized TA proteins into ER membranes. Thus, the GET complex represents a critical mechanism for ensuring efficient and accurate targeting of TA proteins.	[Schuldiner, Maya; Denic, Vladimir; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Schuldiner, Maya; Denic, Vladimir; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Metz, Jutta; Schmid, Volker; Rakwalska, Magdalena; Schwappach, Blanche] Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Schmitt, Hans Dieter] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Max Planck Society	Schwappach, B (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	blanche.schwappach@manchester.ac.uk; weissman@cmp.ucsf.edu	Schuldiner, Maya/C-9488-2009	Schwappach, Blanche/0000-0003-0225-6432; Schuldiner, Maya/0000-0001-9947-115X; Weissman, Jonathan/0000-0003-2445-670X	International Human Frontier Science Program Organization; NIH [K99/R00]; DFG [SFB523, SCHW823/1-1, SFB638]; EMBO Young Investigator Programme; ZMBH; ZMBH, and a Wellcome Trust Senior Research Fellowship; HHMI	International Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); ZMBH; ZMBH, and a Wellcome Trust Senior Research Fellowship; HHMI(Howard Hughes Medical Institute)	We thank the following individuals: B. Toyama for graphical design; B. Farese and B. Dobberstein for sharing unpublished data and discussions; F. Hass, P. March (FLS Bioimaging Facility), and K. Thorn (UCSF Nikon Imaging Center) for help with microscopy; R. Hegde, J. Brodsky, P. Walter, J. Nunnari, D. Gallwitz, D. Gorlich, S. Schroder-Kohne, H. Riezman, A. Spang, R. Tsien, J. Audhya, D. Breslow, D. Cameron, and M. Seedorf for reagents and advice; O. Schuldiner, K. Filaski, D. Cameron, S. Collins, K. Tipton, M. Bassik, J. Weibe-zahn, M. Jonikas, N. Ignolia, and E. Rodriguez for discussions and comments on the manuscript. M. S. was supported by the International Human Frontier Science Program Organization, and is currently supported by an NIH K99/R00 award. H. D. S. was supported by DFG grant SFB523. B. S. was supported by an individual grant from the DFG (SCHW823/1-1), the SFB638, the EMBO Young Investigator Programme, the ZMBH, and a Wellcome Trust Senior Research Fellowship. J. S. W. is supported by HHMI. The authors declare that they have no competing financial interests.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Brodsky JL, 2005, METHODS, V35, P354, DOI 10.1016/j.ymeth.2004.10.007; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Enyenihi AH, 2003, GENETICS, V163, P47; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; James P, 1996, GENETICS, V144, P1425; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Labbe S, 1999, TRENDS MICROBIOL, V7, P500, DOI 10.1016/S0966-842X(99)01638-8; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; Pfanner N, 1997, CURR BIOL, V7, pR100, DOI 10.1016/S0960-9822(06)00048-0; Rabu C, 2007, CURR BIOL, V17, pR472, DOI 10.1016/j.cub.2007.04.031; RACHUBINSKI RA, 1980, J CELL BIOL, V84, P705, DOI 10.1083/jcb.84.3.705; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shen J, 2003, BIOMETALS, V16, P369, DOI 10.1023/A:1022504311669; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Weinberger A, 2005, MOL BIOL CELL, V16, P4918, DOI 10.1091/mbc.E05-02-0101; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	55	351	357	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					634	645		10.1016/j.cell.2008.06.025	http://dx.doi.org/10.1016/j.cell.2008.06.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724936	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000258665800016
J	Lin, YX; Bloodgood, BL; Hauser, JL; Lapan, AD; Koon, AC; Kim, TK; Hu, LS; Malik, AN; Greenberg, ME				Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Lapan, Ariya D.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.			Activity-dependent regulation of inhibitory synapse development by Npas4	NATURE			English	Article							NEUROTROPHIC FACTOR; CRITICAL PERIOD; MICE DEFICIENT; 65-KDA ISOFORM; VISUAL-CORTEX; PLASTICITY; TRANSCRIPTION; EXPRESSION; GENES; MOUSE	Neuronal activity regulates the development and maturation of excitatory and inhibitory synapses in the mammalian brain. Several recent studies have identified signalling networks within neurons that control excitatory synapse development. However, less is known about the molecular mechanisms that regulate the activity- dependent development of GABA (gamma-aminobutyric acid)- releasing inhibitory synapses. Here we report the identification of a transcription factor, Npas4, that plays a role in the development of inhibitory synapses by regulating the expression of activity- dependent genes, which in turn control the number of GABA- releasing synapses that form on excitatory neurons. These findings demonstrate that the activity- dependent gene program regulates inhibitory synapse development, and suggest a new role for this program in controlling the homeostatic balance between synaptic excitation and inhibition.	[Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lapan, Ariya D.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Malik, Athar N.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; Bloodgood, Brenda/0000-0002-4797-9119; /0000-0002-7002-1275; Koon, Alex/0000-0002-4274-7052; Hauser Chatterjee, Jessica/0000-0002-9992-1736	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award; Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship; Jane Coffin Childs Memorial Fund; Mental Retardation Research Center [HD18655]; National Institutes of Health [NS27572, NS48276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS048276] Funding Source: NIH RePORTER	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Mental Retardation Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Greenberg laboratory for suggestions; S. Paradis, J. M. Gray, S. S. Margolis, J. Zieg and C. M. Fletcher for reading the manuscript; S. Vasquez for preparing primary neuronal cell cultures; M. Thompson, Y. Zhou and H. Ye for assistance in generating Npas4<SUP>-/-</SUP> mice; T. Diefenbach and the Neurobiology Program Imaging Center for assistance with confocal microscopy; M. Fagiolini for help with dissection of the visual cortex; and X. J. Liu and C. Chen for help with electrophysiology. M. E. G. acknowledges the generous support of the F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital and support from the Nancy Lurie Marks Family Foundation. This work was supported by a Lefler Foundation postdoctoral fellowship (Y.L.), a Ruth L. Kirschstein National Research Service Award and a Helen Hay Whitney postdoctoral fellowship (B.L.B.), a National Science Foundation Graduate Research Fellowship (A.D.L.), the Jane Coffin Childs Memorial Fund (T.- K.K.) and Mental Retardation Research Center grant HD18655 and National Institutes of Health grants NS27572 and NS48276 (M.E.G.).	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Benson DL, 1996, J NEUROSCI, V16, P6424; Brown P, 1996, BRAIN, V119, P309, DOI 10.1093/brain/119.1.309; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Buschges A, 1998, CURR OPIN NEUROBIOL, V8, P733, DOI 10.1016/S0959-4388(98)80115-3; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hester I, 2007, BRAIN RES, V1135, P1, DOI 10.1016/j.brainres.2006.11.083; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marty S, 2000, J NEUROSCI, V20, P8087; Micheva KD, 1997, CAN J PHYSIOL PHARM, V75, P470, DOI 10.1139/cjpp-75-5-470; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 1996, EXP NEUROL, V138, P327, DOI 10.1006/exnr.1996.0071; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WORLEY PF, 1990, PROG BRAIN RES, V86, P277; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	50	383	392	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1198	U23		10.1038/nature07319	http://dx.doi.org/10.1038/nature07319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815592	Green Accepted			2022-12-24	WOS:000260462100035
J	Falkowski, PG; Isozaki, Y				Falkowski, Paul G.; Isozaki, Yukio			Geology - The story of O(2)	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; CARBON-CYCLE; EVOLUTION; WATER; NITROGEN; ORIGIN; EARTH; MODEL; TIME; RISE		[Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Isozaki, Yukio] Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Tokyo	Falkowski, PG (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu; isozaki@ea.c.u-tokyo.ac.jp	Isozaki, Yukio/A-1806-2009	Isozaki, Yukio/0000-0002-3596-581X	Grants-in-Aid for Scientific Research [20224012] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barber J, 2008, PHILOS T R SOC B, V363, P1125, DOI 10.1098/rstb.2007.2227; Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2006, GEOLOGY, V34, P413, DOI 10.1130/G22470.1; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Catling DC, 2005, EARTH PLANET SC LETT, V237, P1, DOI 10.1016/j.epsl.2005.06.013; Falkowski P, 2007, EVOLUTION PRIMARY PR; Falkowski PG, 2008, PHILOS T R SOC B, V363, P2705, DOI 10.1098/rstb.2008.0054; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KEELING RF, 1993, GLOBAL BIOGEOCHEM CY, V7, P37, DOI 10.1029/92GB02733; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Maruyama S, 2005, INT GEOL REV, V47, P775, DOI 10.2747/0020-6814.47.8.775; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Tappert R, 2005, GEOLOGY, V33, P565, DOI 10.1130/G21637.1	22	45	49	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					540	542		10.1126/science.1162641	http://dx.doi.org/10.1126/science.1162641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948530				2022-12-24	WOS:000260299100028
J	Atarashi, K; Nishimura, J; Shima, T; Umesaki, Y; Yamamoto, M; Onoue, M; Yagita, H; Ishii, N; Evans, R; Honda, K; Takeda, K				Atarashi, Koji; Nishimura, Junichi; Shima, Tatsuichiro; Umesaki, Yoshinori; Yamamoto, Masahiro; Onoue, Masaharu; Yagita, Hideo; Ishii, Naoto; Evans, Richard; Honda, Kenya; Takeda, Kiyoshi			ATP drives lamina propria T(H)17 cell differentiation	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; T-CELLS; TGF-BETA; P2X RECEPTORS; GENERATION; IMMUNITY; PATHWAY; IL-21; MICE	Interleukin ( IL)- 17- producing CD4 1 T lymphocytes ( T(H)17 cells) constitute a subset of T- helper cells involved in host defence and several immune disorders(1,2). An intriguing feature of T(H)17 cells is their selective and constitutive presence in the intestinal lamina propria(3). Here we show that adenosine 5 '- triphosphate ( ATP) that can be derived from commensal bacteria activates a unique subset of lamina propria cells, CD70(high) CD11c(low) cells, leading to the differentiation of T(H)17 cells. Germ- free mice exhibit much lower concentrations of luminal ATP, accompanied by fewer lamina propria T(H)17 cells, compared to specific- pathogen- free mice. Systemic or rectal administration of ATP into these germ- free mice results in a marked increase in the number of lamina propria T(H)17 cells. A CD70(high) CD11c(low) subset of the lamina propria cells expresses T(H)17- prone molecules, such as IL- 6, IL- 23p19 and trans-forming-growth- factor-beta-activating integrin-alpha V and -beta 8, in response to ATP stimulation, and preferentially induces T(H)17 differentiation of co- cultured naive CD4(+) T cells. The critical role of ATP is further underscored by the observation that administration of ATP exacerbates a T- cell- mediated colitis model with enhanced T(H)17 differentiation. These observations highlight the importance of commensal bacteria and ATP for T(H)17 differentiation in health and disease, and offer an explanation of why T(H)17 cells specifically present in the intestinal lamina propria.	[Atarashi, Koji; Nishimura, Junichi; Yamamoto, Masahiro; Honda, Kenya; Takeda, Kiyoshi] Osaka Univ, Lab Immune Regulat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Shima, Tatsuichiro; Umesaki, Yoshinori; Onoue, Masaharu] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Yamamoto, Masahiro; Honda, Kenya; Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Evans, Richard] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Osaka University; Yakult Honsha Company, Limited; Osaka University; Juntendo University; Tohoku University; University of Leicester	Honda, K (corresponding author), Osaka Univ, Lab Immune Regulat, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	honda@ongene.med.osaka-u.ac.jp; ktakeda@ongene.med.osaka-u.ac.jp	Atarashi, Koji/I-5363-2014; Takeda, Kiyoshi/C-9331-2009; Honda, Kenya/N-5297-2015; Nishimura, Junichi/K-8390-2015	Atarashi, Koji/0000-0001-5422-0736; Nishimura, Junichi/0000-0001-8220-3423; Takeda, Kiyoshi/0000-0002-1778-6332; Ishii, Naoto/0000-0002-0549-8245	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare; Osaka Foundation for the Promotion of Clinical Immunology; Ichiro Kanehara Foundation; Sumitomo Foundation; Senri Life Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Osaka Foundation for the Promotion of Clinical Immunology; Ichiro Kanehara Foundation; Sumitomo Foundation; Senri Life Science Foundation; Naito Foundation(Naito Memorial Foundation)	We thank A. Iwasaki and N. Tsuji for discussion, M. H. Jang, H. Ohno, H. Yamane, M. Yoshida and H. Shiomi for technical advice and reagents, and J. Borst for CD27-deficient mice. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, the Osaka Foundation for the Promotion of Clinical Immunology, the Ichiro Kanehara Foundation, Sumitomo Foundation, Senri Life Science Foundation and the Naito Foundation.	Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betti M, 2006, ANN ONCOL, V17, P235; Chang SY, 2008, J IMMUNOL, V180, P1609, DOI 10.4049/jimmunol.180.3.1609; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2006, NAT IMMUNOL, V7, P557, DOI 10.1038/ni0606-557; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanova EP, 2006, INT MICROBIOL, V9, P37; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Leach MW, 1996, AM J PATHOL, V148, P1503; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mizoguchi E, 2003, GASTROENTEROLOGY, V125, P148, DOI 10.1016/S0016-5085(03)00665-6; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Takeda K, 1998, J IMMUNOL, V161, P4652; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	32	784	814	5	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					808	U10		10.1038/nature07240	http://dx.doi.org/10.1038/nature07240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18716618				2022-12-24	WOS:000259854900049
J	Cai, L; Dalal, CK; Elowitz, MB				Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.			Frequency-modulated nuclear localization bursts coordinate gene regulation	NATURE			English	Article							TRANSCRIPTION FACTOR; PROTEIN EXPRESSION; GLOBAL ANALYSIS; CALCINEURIN; YEAST; OSCILLATIONS; VARIABILITY; NOISE; CELLS; DEPENDENCE	In yeast, the transcription factor Crz1 is dephosphorylated and translocates into the nucleus in response to extracellular calcium. Here we show, using time- lapse microscopy, that Crz1 exhibits short bursts of nuclear localization ( typically lasting 2 min) that occur stochastically in individual cells and propagate to the expression of downstream genes. Strikingly, calcium concentration controls the frequency, but not the duration, of localization bursts. Using an analytic model, we also show that this frequency modulation of bursts ensures proportional expression of multiple target genes across a wide dynamic range of expression levels, independent of promoter characteristics. We experimentally confirm this theory with natural and synthetic Crz1 target promoters. Another stress- response transcription factor, Msn2, exhibits similar, but largely uncorrelated, localization bursts under calcium stress suggesting that frequency- modulation regulation of localization bursts may be a general control strategy used by the cell to coordinate multi- gene responses to external signals.	[Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, M-C 114-96, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Dalal, Chiraj/0000-0002-3624-8409	Beckman Fellows Program at Caltech; National Institutes of Health [R01GM079771]; National Centers of Systems Biology, and the Packard Foundation [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, P50GM068763] Funding Source: NIH RePORTER	Beckman Fellows Program at Caltech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers of Systems Biology, and the Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cyert for the CDRE and Crz1 mutant plasmids, K. Cunningham for the Crz1 overexpression plasmid pLE66, J. Stadler for the pGW845FRET plasmid, S. Ramanathan for image analysis code, and K. Thorn, C.- L. Guo and L. LeBon for technical assistance. We thank U. Alon, M. Carlson, M. Cyert, H. Garcia, R. Kishony, G. Lahav, J.-G. Ojalvo, I. Riedel-Kruse, B. Shraiman, G. Suel, members of the laboratory, and especially N. Friedman for discussions. L. C. is supported by the Beckman Fellows Program at Caltech. This work was supported by National Institutes of Health grants R01GM079771 and P50 GM068763 for National Centers of Systems Biology, and the Packard Foundation.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Armstrong EH, 1936, P IRE, V24, P689, DOI 10.1109/JRPROC.1936.227383; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Song GB, 1999, J GUID CONTROL DYNAM, V22, P433, DOI 10.2514/2.4415; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	48	352	359	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					485	U16		10.1038/nature07292	http://dx.doi.org/10.1038/nature07292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818649	Green Accepted			2022-12-24	WOS:000259449600036
J	Stetson, DB; Ko, JS; Heidmann, T; Medzhitov, R				Stetson, Daniel B.; Ko, Joan S.; Heidmann, Thierry; Medzhitov, Ruslan			Trex1 prevents cell-intrinsic initiation of autoimmunity	CELL			English	Article							AICARDI-GOUTIERES-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; FAMILIAL CHILBLAIN LUPUS; INNATE IMMUNE-RESPONSES; DNA EXONUCLEASE TREX1; I INTERFERONS; ENDOGENOUS RETROVIRUSES; DENDRITIC CELLS; GENE INDUCTION	Detection of nucleic acids and induction of type I interferons (IFNs) are principal elements of antiviral defense but can cause autoimmunity if misregulated. Cytosolic DNA detection activates a potent, cell-intrinsic antiviral response through a poorly defined pathway. In a screen for proteins relevant to this IFN-stimulatory DNA (ISD) response, we identify 30 repair exonuclease 1 (Trex1). Mutations in the human trex1 gene cause Aicardi-Goutieres syndrome (AGS) and chilblain lupus, but the molecular basis of these diseases is unknown. We define Trex1 as an essential negative regulator of the ISD response and delineate the genetic pathway linking Trex1 deficiency to lethal autoimmunity. We show that single-stranded DNA derived fromendogenous retroelements accumulates in Trex1-deficient cells, and that Trex1 can metabolize reverse-transcribed DNA. These findings reveal a cell-intrinsic mechanism for initiation of autoimmunity, implicate the ISD pathway as the cause of AGS, and suggest an unanticipated contribution of endogenous retroelements to autoimmunity.	[Stetson, Daniel B.; Ko, Joan S.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Stetson, Daniel B.; Ko, Joan S.; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Heidmann, Thierry] Inst Gustave Roussy, CNRS, Unite Retrovirus Endogenes & Elements Retroides E, UMR8122, F-94805 Villejuif, France	Howard Hughes Medical Institute; Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Stetson, DB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	stetson@u.washington.edu; ruslan.medzhitov@yale.edu		Ko, Joan/0000-0002-5442-6416	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084914, K99AI072945] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K99 AI072945, R01 AI084914, K99 AI072945-01A1, 1K99AI072945-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Colmegna I, 2006, INFECT DIS CLIN N AM, V20, P913, DOI 10.1016/j.idc.2006.09.008; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Lower R, 1999, TRENDS MICROBIOL, V7, P350, DOI 10.1016/S0966-842X(99)01565-6; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Martin DA, 2006, ARTHRITIS RHEUM-US, V54, P951, DOI 10.1002/art.21677; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stoye JP, 1999, TRENDS MICROBIOL, V7, P430, DOI 10.1016/S0966-842X(99)01616-9; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	57	872	900	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 22	2008	134	4					587	598		10.1016/j.cell.2008.06.032	http://dx.doi.org/10.1016/j.cell.2008.06.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	340SR	18724932	Bronze, Green Accepted			2022-12-24	WOS:000258665800013
J	Srivastava, M; Begovic, E; Chapman, J; Putnam, NH; Hellsten, U; Kawashima, T; Kuo, A; Mitros, T; Salamov, A; Carpenter, ML; Signorovitch, AY; Moreno, MA; Kamm, K; Grimwood, J; Schmutz, J; Shapiro, H; Grigoriev, IV; Buss, LW; Schierwater, B; Dellaporta, SL; Rokhsar, DS				Srivastava, Mansi; Begovic, Emina; Chapman, Jarrod; Putnam, Nicholas H.; Hellsten, Uffe; Kawashima, Takeshi; Kuo, Alan; Mitros, Therese; Salamov, Asaf; Carpenter, Meredith L.; Signorovitch, Ana Y.; Moreno, Maria A.; Kamm, Kai; Grimwood, Jane; Schmutz, Jeremy; Shapiro, Harris; Grigoriev, Igor V.; Buss, Leo W.; Schierwater, Bernd; Dellaporta, Stephen L.; Rokhsar, Daniel S.			The Trichoplax genome and the nature of placozoans	NATURE			English	Article							ADHAERENS SCHULZE,F.E. PLACOZOA; MAXIMUM-LIKELIHOOD; PROTEIN FAMILIES; ORIGIN; GENES; EVOLUTION; PHYLUM; DIVERSITY; CNIDARIAN; POSITION	As arguably the simplest free- living animals, placozoans may represent a primitive metazoan form, yet their biology is poorly understood. Here we report the sequencing and analysis of the similar to 98 million base pair nuclear genome of the placozoan Trichoplax adhaerens. Whole- genome phylogenetic analysis suggests that placozoans belong to a 'eumetazoan' clade that includes cnidarians and bilaterians, with sponges as the earliest diverging animals. The compact genome shows conserved gene content, gene structure and synteny in relation to the human and other complex eumetazoan genomes. Despite the apparent cellular and organismal simplicity of Trichoplax, its genome encodes a rich array of transcription factor and signalling pathway genes that are typically associated with diverse cell types and developmental processes in eumetazoans, motivating further searches for cryptic cellular complexity and/ or as yet unobserved life history stages.	[Srivastava, Mansi; Begovic, Emina; Kawashima, Takeshi; Mitros, Therese; Carpenter, Meredith L.; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Srivastava, Mansi; Begovic, Emina; Kawashima, Takeshi; Mitros, Therese; Carpenter, Meredith L.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Begovic, Emina; Chapman, Jarrod; Putnam, Nicholas H.; Hellsten, Uffe; Kuo, Alan; Salamov, Asaf; Shapiro, Harris; Grigoriev, Igor V.; Rokhsar, Daniel S.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kawashima, Takeshi] Okinawa Inst Sci & Technol, Okinawa 9042234, Japan; [Signorovitch, Ana Y.; Moreno, Maria A.; Schierwater, Bernd; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Signorovitch, Ana Y.; Buss, Leo W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Buss, Leo W.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Kamm, Kai; Schierwater, Bernd] Stiftung Tieraerztliche Hochsch Hannover, Div Ecol & Evolut, Inst Tierokol & Zellbiol, D-30559 Hannover, Germany; [Grimwood, Jane; Schmutz, Jeremy] Stanford Univ, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Okinawa Institute of Science & Technology Graduate University; Yale University; Yale University; Yale University; Stanford University	Srivastava, M (corresponding author), Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA.	msrivast@berkeley.edu; dsrokhsar@yahoo.com	Grimwood, Jane/ABD-5737-2021; Kawashima, Takeshi/M-4510-2015; Putnam, Nicholas/B-9968-2008; Carpenter, Meredith/B-4290-2011; Schmutz, Jeremy/N-3173-2013	Putnam, Nicholas/0000-0002-1315-782X; Schmutz, Jeremy/0000-0001-8062-9172; Kamm, Kai/0000-0001-8038-2843; Rokhsar, Daniel/0000-0002-8704-2224; Carpenter, Meredith/0000-0002-9798-9374; Grigoriev, Igor/0000-0002-3136-8903	USA Department of Energy's Office of Science, Biological and Environmental Research Program; Gordon and Betty Moore Foundation; National Science Foundation; German Science Foundation	USA Department of Energy's Office of Science, Biological and Environmental Research Program; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); German Science Foundation(German Research Foundation (DFG))	This work was performed under the auspices of the USA Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory and Los Alamos National Laboratory. The Center for Integrative Genomics is supported by a grant from the Gordon and Betty Moore Foundation. D. S. R. acknowledges support from R. A. Melmon. L. W. B., S. L. D. and M. A. M. were supported by the National Science Foundation. B. S. acknowledges support from the German Science Foundation.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Butschli O, 1884, MORPHOLOGISCHES JB, P415; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; da Silva FB, 2007, GENET MOL BIOL, V30, P127, DOI 10.1590/S1415-47572007000100022; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Erwin DH, 2002, DEVELOPMENT, V129, P3021; GRELL K G, 1971, Naturwissenschaftliche Rundschau, V24, P160; GRELL KG, 1981, ZOOMORPHOLOGY, V98, P47, DOI 10.1007/BF00310320; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1991, PLACOZOA PORIFERA CN, P13; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; Haen KM, 2007, MOL BIOL EVOL, V24, P1518, DOI 10.1093/molbev/msm070; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Martinelli C, 2004, GENE EXPR PATTERNS, V4, P443, DOI 10.1016/j.modgep.2004.01.002; Martinelli C, 2003, DEV GENES EVOL, V213, P492, DOI 10.1007/s00427-003-0353-5; Maruyama YK, 2004, BIOL BULL-US, V206, P55, DOI 10.2307/1543198; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; Muller W.E.G., 1996, Progress in Molecular and Subcellular Biology, V17, P183; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; PEARSE V B, 1989, Pacific Science, V43, P117; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; RISINGER C, 1993, J BIOL CHEM, V268, P24408; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; SCHIERWATER B, IN PRESS PLOS 1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHUCHERT P, 1993, ACTA ZOOL-STOCKHOLM, V74, P115, DOI 10.1111/j.1463-6395.1993.tb01227.x; Schulze FE, 1883, ZOOL ANZ, V6, P92; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Signorovitch AY, 2005, P NATL ACAD SCI USA, V102, P15518, DOI 10.1073/pnas.0504031102; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; SYED T, 2002, SENCKENBERG LETH, V82, P259; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; WENDEROTH H, 1986, Z NATURFORSCH C, V41, P343	56	604	643	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2008	454	7207					955	U19		10.1038/nature07191	http://dx.doi.org/10.1038/nature07191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339QB	18719581	hybrid, Green Submitted			2022-12-24	WOS:000258591000030
J	Dimitrov, A; Quesnoit, M; Moutel, S; Cantaloube, I; Pous, C; Perez, F				Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Cantaloube, Isabelle; Pous, Christian; Perez, Franck			Detection of GTP-Tubulin Conformation in Vivo Reveals a Role for GTP Remnants in Microtubule Rescues	SCIENCE			English	Article							STABILIZE MICROTUBULES; DYNAMIC INSTABILITY; P-I; CAP; POLYMERIZATION; HYDROLYSIS; TAXOL	Microtubules display dynamic instability, with alternating phases of growth and shrinkage separated by catastrophe and rescue events. The guanosine triphosphate (GTP) cap at the growing end of microtubules, whose presence is essential to prevent microtubule catastrophes in vitro, has been difficult to observe in vivo. We selected a recombinant antibody that specifically recognizes GTP- bound tubulin in microtubules and found that GTP- tubulin was indeed present at the plus end of growing microtubules. Unexpectedly, GTP- tubulin remnants were also present in older parts of microtubules, which suggests that GTP hydrolysis is sometimes incomplete during polymerization. Observations in living cells suggested that these GTP remnants may be responsible for the rescue events in which microtubules recover from catastrophe.	[Dimitrov, Ariane; Quesnoit, Melanie; Perez, Franck] Inst Curie, CNRS, UMR144, F-75248 Paris 05, France; [Dimitrov, Ariane; Quesnoit, Melanie; Moutel, Sandrine; Perez, Franck] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Quesnoit, Melanie; Cantaloube, Isabelle; Pous, Christian] Univ Paris 11, Fac Pharm, IFR141, F-92296 Chatenay Malabry, France; [Moutel, Sandrine] Inst Curie, Translat Res Dept, F-75248 Paris 05, France; [Pous, Christian] Hop Antoine Beclere, AP HP, F-92141 Clamart, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Perez, F (corresponding author), Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75248 Paris 05, France.	franck.perez@curie.fr	Perez, Franck/A-1558-2014; POÜS, Christian/R-5089-2018	Perez, Franck/0000-0002-9129-9401; Moutel, Sandrine/0000-0002-9585-4855; POUS, Christian/0000-0002-2502-7854	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer; French Ministry of Research; Association Francaise contre les Myopathies; CNRS; Agence Nationale de la Recherche; Human Frontier Science Program Organization; ARC; French Ministry of Research [ACI-BCMS 338]	Institut de Recherches International Servier; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Human Frontier Science Program Organization(Human Frontier Science Program); ARC(Australian Research Council); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We thank P. Benaroch for the selection of the TSB antibody, A. Khodjakov for the Ptk2 GFP-tubulin cell line, F. Severin and T. Hyman for help and advice, J. Sillibourne and D. Job for reading and commenting on the manuscript, and B. Goud for his constant support. Supported by the Institut de Recherches International Servier and the Association pour la Recherche sur le Cancer ( ARC) (M.Q.), by the French Ministry of Research and the Association Francaise contre les Myopathies ( A. D.), and by CNRS, the Agence Nationale de la Recherche (ANR non thematique), the Human Frontier Science Program Organization, ARC, and French Ministry of Research grant ACI-BCMS 338.	ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Caplow M, 1998, BIOCHEMISTRY-US, V37, P12994, DOI 10.1021/bi972602+; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1991, J BIOL CHEM, V266, P12361; CARLIER MF, 1989, BIOCHEMISTRY-US, V28, P1783, DOI 10.1021/bi00430a054; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dougherty CA, 1998, BIOCHEMISTRY-US, V37, P10861, DOI 10.1021/bi980677n; Draberova E, 2000, EUR J CELL BIOL, V79, P982, DOI 10.1078/0171-9335-00129; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; MELKI R, 1990, BIOCHEMISTRY-US, V29, P8921, DOI 10.1021/bi00490a007; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Vandecandelaere A, 1999, BIOCHEMISTRY-US, V38, P8179, DOI 10.1021/bi9830765; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606	18	182	182	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2008	322	5906					1353	1356		10.1126/science.1165401	http://dx.doi.org/10.1126/science.1165401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FX	18927356				2022-12-24	WOS:000261170600031
J	Nagai, S; Dubrana, K; Tsai-Pflugfelder, M; Davidson, MB; Roberts, TM; Brown, GW; Varela, E; Hediger, F; Gasser, SM; Krogan, NJ				Nagai, Shigeki; Dubrana, Karine; Tsai-Pflugfelder, Monika; Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.; Varela, Elisa; Hediger, Florence; Gasser, Susan M.; Krogan, Nevan J.			Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN COMPLEXES; YEAST; DYNAMICS; REPAIR; RECOMBINATION; ORGANIZATION; REPLICATION; SUMOYLATION; INSTABILITY	Recent findings suggest important roles for nuclear organization in gene expression. In contrast, little is known about how nuclear organization contributes to genome stability. Epistasis analysis (E-MAP) using DNA repair factors in yeast indicated a functional relationship between a nuclear pore subcomplex and Slx5/Slx8, a small ubiquitin-like modifier (SUMO)-dependent ubiquitin ligase, which we show physically interact. Real-time imaging and chromatin immunoprecipitation confirmed stable recruitment of damaged DNA to nuclear pores. Relocation required the Nup84 complex and Mec1/Tel1 kinases. Spontaneous gene conversion can be enhanced in a Slx8- and Nup84-dependent manner by tethering donor sites at the nuclear periphery. This suggests that strand breaks are shunted to nuclear pores for a repair pathway controlled by a conserved SUMO-dependent E3 ligase.	[Nagai, Shigeki; Tsai-Pflugfelder, Monika; Varela, Elisa; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Nagai, Shigeki; Dubrana, Karine; Hediger, Florence; Gasser, Susan M.] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Davidson, Marta B.; Roberts, Tania M.; Brown, Grant W.] Univ Toronto, Dept Biochem, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Friedrich Miescher Institute for Biomedical Research; University of Geneva; University of Geneva; University of Toronto; University of California System; University of California San Francisco	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	dubrana, karine/AAK-1447-2020	dubrana, karine/0000-0002-1269-2564; Roberts, Tania/0000-0001-9518-3011; Gasser, Susan/0000-0003-3610-9123; Brown, Grant/0000-0002-9002-5003	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation; Sandler Family Foundation; NIH; National Cancer Institute of Canada; Canadian Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Novartis Research Foundation; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sandler Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. E. Haber, M. Lisby, S. Jinks-Robertson, R. Kolodner, and R. Rothstein for generously providing strains; M. Shales for artwork; K. Saeturn and V. Kalck for technical help; and C. J. Ingles, J. E. Haber, and our laboratories for discussions. We acknowledge the Novartis Research Foundation, Swiss Cancer League, Swiss National Science Foundation, Sandler Family Foundation, NIH, National Cancer Institute of Canada, and Canadian Cancer Society for support.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Freedman JA, 2002, GENETICS, V162, P15; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Mullen JR, 2001, GENETICS, V157, P103; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	29	327	332	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					597	602		10.1126/science.1162790	http://dx.doi.org/10.1126/science.1162790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18948542	Green Accepted			2022-12-24	WOS:000260299100046
J	Konig, R; Zhou, YY; Elleder, D; Diamond, TL; Bonamy, GMC; Irelan, JT; Chiang, CY; Tu, BP; De Jesus, PD; Lilley, CE; Seidel, S; Opaluch, AM; Caldwell, JS; Weitzman, MD; Kuhen, KL; Bandyopadhyay, S; Ideker, T; Orth, AP; Miraglia, LJ; Bushman, FD; Young, JA; Chanda, SK				Konig, Renate; Zhou, Yingyao; Elleder, Daniel; Diamond, Tracy L.; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; De Jesus, Paul D.; Lilley, Caroline E.; Seidel, Shannon; Opaluch, Amanda M.; Caldwell, Jeremy S.; Weitzman, Matthew D.; Kuhen, Kelli L.; Bandyopadhyay, Sourav; Ideker, Trey; Orth, Anthony P.; Miraglia, Loren J.; Bushman, Frederic D.; Young, John A.; Chanda, Sumit K.			Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication	CELL			English	Article							DNA INTEGRATION; NUCLEAR IMPORT; VIRUS; TRANSCRIPTION; COMPLEX; CHROMATIN	Human Immunodeficiency Viruses (HIV-1 and HIV-2) rely upon host-encoded proteins to facilitate their replication. Here, we combined genome-wide siRNA analyses with interrogation of human interactome databases to assemble a host-pathogen biochemical network containing 213 confirmed host cellular factors and 11 HIV-1-encoded proteins. Protein complexes that regulate ubiquitin conjugation, proteolysis, DNA-damage response, and RNA splicing were identified as important modulators of early-stage HIV-1 infection. Additionally, over 40 new factors were shown to specifically influence the initiation and/or kinetics of HIV-1 DNA synthesis, including cytoskeletal regulatory proteins, modulators of post-translational modification, and nucleic acid-binding proteins. Finally, 15 proteins with diverse functional roles, including nuclear transport, prostaglandin synthesis, ubiquitination, and transcription, were found to influence nuclear import or viral DNA integration. Taken together, the multiscale approach described here has uncovered multiprotein virus-host interactions that likely act in concert to facilitate the early steps of HIV-1 infection.	[Elleder, Daniel; Seidel, Shannon; Young, John A.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Konig, Renate; De Jesus, Paul D.; Opaluch, Amanda M.; Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Lilley, Caroline E.; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Diamond, Tracy L.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Zhou, Yingyao; Bonamy, Ghislain M. C.; Irelan, Jeffrey T.; Chiang, Chih-Yuan; Tu, Buu P.; Caldwell, Jeremy S.; Kuhen, Kelli L.; Orth, Anthony P.; Miraglia, Loren J.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Bonamy, Ghislain M. C.] Hudson Alpha Inst Biotechnol, Huntsville, AL 35801 USA	Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; University of California System; University of California San Diego; University of Pennsylvania; Novartis	Young, JA (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu; schanda@burnham.org	Elleder, Daniel/G-3551-2014; König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179; Ideker, Trey/0000-0002-1708-8454; Bushman, Frederic/0000-0003-4740-4056; Bonamy, Ghislain/0000-0002-2826-5225	United States National Institutes of Health [1 RO1 AI072645-01, RO1 AI052845]; University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072645, R01AI052845] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Tracy L. Diamond is a Leukemia and Lymphoma Society Fellow (Grant #5217-06). We thank U. O'Doherty and J.J. Yu for technical advice with the Alu-PCR assay and Zhang J. for excellent technical assistance; Walter Tian and Eric Lader (Qiagen GMBGH) for facilitating the acquisition of reagents used for this study; and John Hogenesch for critical feedback on the manuscript. This work was supported by a grant from the United States National Institutes of Health (1 RO1 AI072645-01 to J.A.Y. and RO1 AI052845 to F.D.B.) and the University of Pennsylvania Center for AIDS Research.	Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Ciuffi A, 2006, TRENDS GENET, V22, P388, DOI 10.1016/j.tig.2006.05.006; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kuraoka I, 2008, J BIOL CHEM, V283, P940, DOI 10.1074/jbc.M706647200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Mannioui A, 2004, VIROLOGY, V329, P77, DOI 10.1016/j.virol.2004.08.022; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006; Zar JH, 1999, BIOSTATISTICAL ANAL	33	760	788	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 3	2008	135	1					49	60		10.1016/j.cell.2008.07.032	http://dx.doi.org/10.1016/j.cell.2008.07.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	355SH	18854154	Bronze, Green Accepted			2022-12-24	WOS:000259728100008
J	Ishii, K; Ogiyama, Y; Chikashige, Y; Soejima, S; Masuda, F; Kakuma, T; Hiraoka, Y; Takahashi, K				Ishii, Kojiro; Ogiyama, Yuki; Chikashige, Yuji; Soejima, Saeko; Masuda, Fumie; Kakuma, Tatsuyuki; Hiraoka, Yasushi; Takahashi, Kohta			Heterochromatin integrity affects chromosome reorganization after centromere dysfunction	SCIENCE			English	Article							FISSION YEAST; CHROMATIN; DISTINCT; REQUIRES; MEIOSIS; PROTEIN; GENOME; RNAI	The centromere is essential for the inheritance of genetic information on eukaryotic chromosomes. Epigenetic regulation of centromere identity has been implicated in genome stability, karyotype evolution, and speciation. However, little is known regarding the manner in which centromere dysfunction affects the chromosomal architectures. Here we show that in the fission yeast Schizosaccharomyces pombe, the conditional deletion of the centromere produces survivors that carry either a neocentromere- acquired chromosome at the subtelomeric region or an acentric chromosome rescued by intertelomere fusion with either of the remaining chromosomes. The ratio of neocentromere formation to telomere fusion is considerably decreased by the inactivation of genes involved in RNA interference- dependent heterochromatin formation. By affecting the modes of chromosomal reorganization, the genomic distribution of heterochromatin may influence the fate of karyotype evolution.	[Ishii, Kojiro; Ogiyama, Yuki; Soejima, Saeko; Masuda, Fumie; Takahashi, Kohta] Kurume Univ, Div Cell Biol, Inst Life Sci, Kurume, Fukuoka 830, Japan; [Chikashige, Yuji; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Kobe Adv Informat & Commun Technol Res Ctr, Kobe, Hyogo, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	Kurume University; National Institute of Information & Communications Technology (NICT) - Japan; Kurume University; Osaka University	Takahashi, K (corresponding author), Kurume Univ, Div Cell Biol, Inst Life Sci, Kurume, Fukuoka 830, Japan.	takahash@lsi.kurume-u.ac.jp	Hiraoka, Yasushi/B-5111-2009; Ishii, Kojiro/L-5102-2017	Hiraoka, Yasushi/0000-0001-9407-8228; 	Ministry of Education, Culture, Sports, Science, and Technology, Japan;; Time's Arrow and Biosignaling; Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology, Japan;(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Time's Arrow and Biosignaling; Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank K. Nagao, S. Saitoh, and H. Kimura for their technical expertise and discussion and M. Yanagida, A. Carr, J. Nakayama, and K. Gull for providing experimental materials. This work was supported by Grants- in- Aid for Exploratory Research and Scientific Research on Priority Areas (Nuclear Dynamics, Chromosome Cycle, Decode Systems) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and a grant from Time's Arrow and Biosignaling, Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency.	Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Craig JM, 2003, HUM MOL GENET, V12, P3109, DOI 10.1093/hmg/ddg330; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Maggert KA, 2001, GENETICS, V158, P1615; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Murnane JP, 2004, BIOESSAYS, V26, P1164, DOI 10.1002/bies.20125; Partridge JF, 2000, GENE DEV, V14, P783; Saitoh S, 2005, MOL BIOL CELL, V16, P3666, DOI 10.1091/mbc.E05-01-0014; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Villasante A, 2007, CELL CYCLE, V6, P2872, DOI 10.4161/cc.6.23.5047; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758	19	157	158	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2008	321	5892					1088	1091		10.1126/science.1158699	http://dx.doi.org/10.1126/science.1158699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	339RL	18719285				2022-12-24	WOS:000258594900041
J	Mimitou, EP; Symington, LS				Mimitou, Eleni P.; Symington, Lorraine S.			Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; MRE11 COMPLEX; REPAIR; CHECKPOINT; PROTEINS; DAMAGE; YEAST; INTERACTS	DNA ends exposed after introduction of double- strand breaks ( DSBs) undergo 5 '-3 ' nucleolytic degradation to generate single- stranded DNA, the substrate for binding by the Rad51 protein to initiate homologous recombination. This process is poorly understood in eukaryotes, but several factors have been implicated, including the Mre11 complex ( Mre11 - Rad50 - Xrs2/ NBS1), Sae2/ CtIP/ Ctp1 and Exo1. Here we demonstrate that yeast Exo1 nuclease and Sgs1 helicase function in alternative pathways for DSB processing. Novel, partially resected intermediates accumulate in a double mutant lacking Exo1 and Sgs1, which are poor substrates for homologous recombination. The early processing step that generates partly resected intermediates is dependent on Sae2. When Sae2 is absent, in addition to Exo1 and Sgs1, unprocessed DSBs accumulate and homology- dependent repair fails. These results suggest a two- step mechanism for DSB processing during homologous recombination. First, the Mre11 complex and Sae2 remove a small oligonucleotide( s) from the DNA ends to form an early intermediate. Second, Exo1 and/ or Sgs1 rapidly process this intermediate to generate extensive tracts of single- stranded DNA that serve as substrate for Rad51.	[Mimitou, Eleni P.; Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	Columbia University	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	lss5@columbia.edu			National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank M. Lichten, J. McCusker, A. Rattray and R. Rothstein for gifts of strains and plasmids, and W. K. Holloman and R. Rothstein for comments on the manuscript. This study was supported by a grant from the National Institutes of Health.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Borde V, 1999, MOL CELL BIOL, V19, P4832; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ivanov EL, 1996, GENETICS, V142, P693; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Karmakar P, 2006, BIOCHEM BIOPH RES CO, V348, P62, DOI 10.1016/j.bbrc.2006.07.037; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mozlin AM, 2008, GENETICS, V178, P113, DOI 10.1534/genetics.107.082677; Mullen JR, 2000, GENETICS, V154, P1101; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sherman F., 1986, METHODS YEAST GENETI; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	37	742	753	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					770	U3		10.1038/nature07312	http://dx.doi.org/10.1038/nature07312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18806779	Green Accepted			2022-12-24	WOS:000259854900040
J	Cai, L; Makhov, AM; Schafer, DA; Bear, JE				Cai, Liang; Makhov, Alexander M.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia	CELL			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; ARP2/3 COMPLEX; CELL MOTILITY; F-ACTIN; PROTEIN; NUCLEATION; NETWORKS; MYCOBACTERIA; DISSOCIATION; FILAMENTS	The dendritic actin network generated by the Arp2/3 complex in lamellipodia underlies formation of protrusions, directional sensing, and migration. While the generation of this network is well studied, the mechanisms regulating network disassembly are poorly understood. We report that Coronin 1B disassembles Arp2/3-containing actin filament branches by inducing Arp2/3 dissociation. This activity is antagonized by Cortactin, a filament branch stabilizer. Consistent with this biochemical competition, depletion of both proteins partially rescues defects in lamellipodial dynamics observed upon depletion of either protein alone. Coronin 1B targets actin branches in a manner that is mutually exclusive with the Arp2/3 complex and alters the branch angle. We conclude that Coronin 1B replaces the Arp2/3 complex at actin filament branches as the dendritic network matures and drives the turnover of branched actin networks.	[Cai, Liang; Bear, James E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Makhov, Alexander M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NIH [CA16086, GM31819, GM067222, GM083035]; Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI) [1U54CA119343]; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA119343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM083035, R01GM067222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge F. Gertler, S. Rogers, R. Cheney, and members of the Bear lab for critical comments on this manuscript; M. Welch for the p41Arc antibody; and the substantial assistance of Jack Griffith in the LCCC Electron Microscopy core (supported by NIH CA16086 and GM31819). This work was supported by NIH grants to D. A. S. (GM067222) and J. E. B. (GM083035). J. E. B. is also supported by the Sontag Foundation and the Carolina Center for Cancer Nanotechnology Excellence (NCI, 1U54CA119343).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	27	155	159	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					828	842		10.1016/j.cell.2008.06.054	http://dx.doi.org/10.1016/j.cell.2008.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775315	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000258947500022
J	Maier, T; Leibundgut, M; Ban, N				Maier, Timm; Leibundgut, Marc; Ban, Nenad			The crystal structure of a mammalian fatty acid synthase	SCIENCE			English	Article							ACYL CARRIER PROTEIN; ACTIVE-SITE; DOMAIN; REDUCTASE; MECHANISM; CANCER; BIOSYNTHESIS; TRANSACYLASE; ORGANIZATION; ARCHITECTURE	Mammalian fatty acid synthase is a large multienzyme that catalyzes all steps of fatty acid synthesis. We have determined its crystal structure at 3.2 angstrom resolution covering five catalytic domains, whereas the flexibly tethered terminal acyl carrier protein and thioesterase domains remain unresolved. The structure reveals a complex architecture of alternating linkers and enzymatic domains. Substrate shuttling is facilitated by flexible tethering of the acyl carrier protein domain and by the limited contact between the condensing and modifying portions of the multienzyme, which are mainly connected by linkers rather than direct interaction. The structure identifies two additional nonenzymatic domains: ( i) a pseudo- ketoreductase and ( ii) a peripheral pseudo- methyltransferase that is probably a remnant of an ancestral methyltransferase domain maintained in some related polyketide synthases. The structural comparison of mammalian fatty acid synthase with modular polyketide synthases shows how their segmental construction allows the variation of domain composition to achieve diverse product synthesis.	[Maier, Timm; Leibundgut, Marc; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363	Swiss National Science Foundation (SNSF); National Center of Excellence in Research Structural Biology program of the SNSF	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research Structural Biology program of the SNSF(Swiss National Science Foundation (SNSF))	All data were collected at the Swiss Light Source (SLS, Paul Scherrer Institute, Villigen). We thank C. Schulze-Briese, S. Gutmann, R. Bingel-Erlenmeyer, S. Russo, A. Pauluhn, and T. Tomizaki for their outstanding support at the SLS; S. Jenni and M. Sutter for critically reading the manuscript and all members of the Ban laboratory for suggestions and discussions; R. Grosse-Kunstleve, P. Afonine, and P. Adams for support with the PHENIX software; and A. Jones for support with the program O. This work was supported by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research Structural Biology program of the SNSF. Structure factors and atomic coordinates of the porcine FAS in the apo- and NADP<SUP>+</SUP>-bound form have been deposited in the Protein Data Bank with accession codes 2vz8 and 2vz9.	Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Baldock C, 1998, J MOL BIOL, V284, P1529, DOI 10.1006/jmbi.1998.2271; Bunkoczi G, 2007, CHEM BIOL, V14, P1243, DOI 10.1016/j.chembiol.2007.10.013; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Joshi AK, 2003, CHEM BIOL, V10, P169, DOI 10.1016/S1074-5521(03)00023-1; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Molnar I, 2000, CHEM BIOL, V7, P97, DOI 10.1016/S1074-5521(00)00075-2; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Pasta S, 2007, CHEM BIOL, V14, P1377, DOI 10.1016/j.chembiol.2007.11.007; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Rangan VS, 2001, BIOCHEMISTRY-US, V40, P10792, DOI 10.1021/bi015535z; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; Richter CD, 2008, NAT CHEM BIOL, V4, P75, DOI 10.1038/nchembio.2007.61; Richter CD, 2007, FEBS J, V274, P2196, DOI 10.1111/j.1742-4658.2007.05757.x; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Saito J, 2008, PROTEIN SCI, V17, P691, DOI 10.1110/ps.073288808; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Shimomura Y, 2003, J BACTERIOL, V185, P4211, DOI 10.1128/JB.185.14.4211-4218.2003; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; THOM JM, 1995, J MOL BIOL, V249, P785; Weissman KJ, 2006, CHEMBIOCHEM, V7, P485, DOI 10.1002/cbic.200500435; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 1997, BIOCHEMISTRY-US, V36, P16338, DOI 10.1021/bi972242q; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	61	332	345	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1315	1322		10.1126/science.1161269	http://dx.doi.org/10.1126/science.1161269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772430				2022-12-24	WOS:000258914300040
J	Kaganovich, D; Kopito, R; Frydman, J				Kaganovich, Daniel; Kopito, Ron; Frydman, Judith			Misfolded proteins partition between two distinct quality control compartments	NATURE			English	Article							TUMOR-SUPPRESSOR COMPLEX; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; FLUORESCENT PROTEIN; IN-VIVO; POLYGLUTAMINE EXPANSION; MOLECULAR CHAPERONES; ALPHA-SYNUCLEIN; YEAST; DEGRADATION	The accumulation of misfolded proteins in intracellular amyloid inclusions, typical of many neurodegenerative disorders including Huntington's and prion disease, is thought to occur after failure of the cellular protein quality control mechanisms. Here we examine the formation of misfolded protein inclusions in the eukaryotic cytosol of yeast and mammalian cell culture models. We identify two intracellular compartments for the sequestration of misfolded cytosolic proteins. Partition of quality control substrates to either compartment seems to depend on their ubiquitination status and aggregation state. Soluble ubiquitinated misfolded proteins accumulate in a juxtanuclear compartment where proteasomes are concentrated. In contrast, terminally aggregated proteins are sequestered in a perivacuolar inclusion. Notably, disease- associated Huntingtin and prion proteins are preferentially directed to the perivacuolar compartment. Enhancing ubiquitination of a prion protein suffices to promote its delivery to the juxtanuclear inclusion. Our findings provide a framework for understanding the preferential accumulation of amyloidogenic proteins in inclusions linked to human disease.	[Kaganovich, Daniel; Kopito, Ron; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kaganovich, Daniel; Kopito, Ron; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Kaganovich, Daniel/K-2376-2012	Kaganovich, Daniel/0000-0003-2398-1596; , judith/0000-0003-2302-6943	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Tsien, S. Michaelis, J. Glover, C. Enenkel and V. Albanese for reagents; J. Mulholland for electron microscopy and deconvolution microscopy help; S. Yamada and W. J. Nelson for help with the live cell microscopy. We thank R. Andino, W. Burkholder, J. England, R. Geller, M. Kaganovich, E. Bennett, J. Nelson and members of the Frydman laboratory for discussions and comments on the manuscript. This work was supported by grants from NIH to R. K. and J. F.	Adams A, 1997, METHODS YEAST GENETI; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kruse KB, 2006, AUTOPHAGY, V2, P135, DOI 10.4161/auto.2.2.2388; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Tongaonkar P, 1999, ANAL BIOCHEM, V272, P263, DOI 10.1006/abio.1999.4190; Vang S, 2005, FEBS J, V272, P2037, DOI 10.1111/j.1742-4658.2005.04630.x; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WRIGHT R, 1989, METHOD CELL BIOL, V31, P473; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	56	665	673	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2008	454	7208					1088	U36		10.1038/nature07195	http://dx.doi.org/10.1038/nature07195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341MW	18756251	Green Accepted			2022-12-24	WOS:000258719600031
J	Karim, Z; Gerard, B; Bakouh, N; Alili, R; Leroy, C; Beck, L; Silve, C; Planelles, G; Urena-Torres, P; Grandchamp, B; Friedlander, G; Prie, D				Karim, Zoubida; Gerard, Benedicte; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Silve, Caroline; Planelles, Gabrielle; Urena-Torres, Pablo; Grandchamp, Bernard; Friedlander, Gerard; Prie, Dominique			NHERF1 mutations and responsiveness of renal parathyroid hormone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY FACTOR-I; PHOSPHATE-TRANSPORT; RECEPTOR; COTRANSPORTER; PTH; IIA; CALCIUM; INTERNALIZATION; NEPHROLITHIASIS; EXPRESSION	Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans.	[Karim, Zoubida; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Planelles, Gabrielle; Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Univ Paris 05, INSERM, Unite 845, Fac Med, Paris, France; [Gerard, Benedicte; Silve, Caroline; Grandchamp, Bernard] Assistance Publ Hop Paris, Hop Bichat Claude Bernard, Paris, France; [Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Assistance Publ Hop Paris, Hop Necker Enfants Malad, Paris, France; [Friedlander, Gerard] Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Paris, France; [Silve, Caroline] Univ Paris Diderot, INSERM Unite 773, Unite Format & Rech Med, Paris, France; [Grandchamp, Bernard] Univ Paris Diderot, Inst Federat Rech 02, Paris, France; [Urena-Torres, Pablo] Clin Landy, St Ouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Hop Necker Enfants Malad, Serv Explorat Fonctionelles, 149 Rue Sevres, F-75015 Paris, France.	prie@necker.fr	BECK, Laurent/P-2952-2014; Planelles, Gabrielle/F-9603-2013	BECK, Laurent/0000-0002-6730-2762; Planelles, Gabrielle/0000-0002-7314-8837; KARIM, Zoubida/0000-0002-3724-5592; Bastepe, Murat/0000-0002-2643-3504; Friedlander, Gerard/0000-0002-6854-4261	INSERM; Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by a grant from INSERM, Universit, Paris Descartes, Association Laboratoire de Recherches Physiologiques, and l'Agence Nationale pour la Recherche (ANR-07-PHYSIO-017-01).	ARMBRECHT HJ, 1984, AM J PHYSIOL, V246, pE102; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DEVERNEJOUL MC, 1982, CALCIFIED TISSUE INT, V34, P219, DOI 10.1007/BF02411240; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lee KC, 1996, AM J PHYSIOL-RENAL, V270, pF186, DOI 10.1152/ajprenal.1996.270.1.F186; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Prie D, 2004, CURR OPIN NEPHROL HY, V13, P675, DOI 10.1097/00041552-200411000-00015; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; VANDOP C, 1989, SEMIN NEPHROL, V9, P168; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V291, pF254; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V290, pF838, DOI 10.1152/ajprenal.00374.2005; Weinman EJ, 2002, PATHOBIOLOGY, V70, P314, DOI 10.1159/000071271	26	127	130	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1128	1135		10.1056/NEJMoa0802836	http://dx.doi.org/10.1056/NEJMoa0802836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	19073985				2022-12-24	WOS:000259078200008
